,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1386382,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,117581,TWIST2,https://ctdbase.org/detail.go?type=gene&acc=117581,,,117581.0,TWIST2,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of TWIST2 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
1,1386497,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),MAPK1 inhibits the reaction [doxorubicin results in decreased expression of TXNIP mrna],,,PMID:24885895,https://www.ncbi.nlm.nih.gov/pubmed/24885895,24885895,,
2,1386498,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,10090.0,Mus musculus (house mouse),Doxorubicin affects the expression of TXNIP mRNA,,,PMID:16243910,https://www.ncbi.nlm.nih.gov/pubmed/16243910,16243910,,
3,1386499,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,54957,TXNL4B,https://ctdbase.org/detail.go?type=gene&acc=54957,,,54957.0,TXNL4B,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of TXNL4B mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
4,1386500,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1890,TYMP,https://ctdbase.org/detail.go?type=gene&acc=1890,,,1890.0,TYMP,9606.0,Homo sapiens (human),[doxorubicin co-treated with cyclophosphamide] results in increased expression of TYMP protein,,,PMID:15150550,https://www.ncbi.nlm.nih.gov/pubmed/15150550,15150550,,
5,1386611,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,6675,UAP1,https://ctdbase.org/detail.go?type=gene&acc=6675,,,6675.0,UAP1,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of UAP1 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
6,1386612,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7317,UBA1,https://ctdbase.org/detail.go?type=gene&acc=7317,,,7317.0,UBA1,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of UBA1 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
7,1386613,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7317,UBA1,https://ctdbase.org/detail.go?type=gene&acc=7317,,,7317.0,UBA1,10090.0,Mus musculus (house mouse),Doxorubicin results in increased expression of UBA1 mRNA,,,PMID:25896364,https://www.ncbi.nlm.nih.gov/pubmed/25896364,25896364,,
8,1386614,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,79876,UBA5,https://ctdbase.org/detail.go?type=gene&acc=79876,,,79876.0,UBA5,10090.0,Mus musculus (house mouse),Doxorubicin results in decreased expression of UBA5 mRNA,,,PMID:17888722,https://www.ncbi.nlm.nih.gov/pubmed/17888722,17888722,,
9,1386615,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,550112,UBA6-DT,https://ctdbase.org/detail.go?type=gene&acc=550112,,,550112.0,UBA6-DT,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of UBA6-DT mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
10,1386616,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7318,UBA7,https://ctdbase.org/detail.go?type=gene&acc=7318,,,7318.0,UBA7,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of UBA7 mRNA,,,PMID:29803840|PMID:30031762,https://www.ncbi.nlm.nih.gov/pubmed/29803840|https://www.ncbi.nlm.nih.gov/pubmed/30031762,29803840|30031762,,
11,1388894,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),Doxorubicin results in increased expression of VEGFA protein|nfkb1 protein affects the reaction [doxorubicin results in increased expression of VEGFA protein],,,PMID:17912235,https://www.ncbi.nlm.nih.gov/pubmed/17912235,17912235,,
12,1389370,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,64601,VPS16,https://ctdbase.org/detail.go?type=gene&acc=64601,,,64601.0,VPS16,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of VPS16 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
13,1389371,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,57617,VPS18,https://ctdbase.org/detail.go?type=gene&acc=57617,,,57617.0,VPS18,9606.0,Homo sapiens (human),Doxorubicin affects the expression of VPS18 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
14,1389372,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,51160,VPS28,https://ctdbase.org/detail.go?type=gene&acc=51160,,,51160.0,VPS28,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of VPS28 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
15,1390105,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,197335,WDR90,https://ctdbase.org/detail.go?type=gene&acc=197335,,,197335.0,WDR90,9606.0,Homo sapiens (human),Doxorubicin results in increased expression of WDR90 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
16,1390106,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7465,WEE1,https://ctdbase.org/detail.go?type=gene&acc=7465,,,7465.0,WEE1,9606.0,Homo sapiens (human),"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine inhibits the reaction [doxorubicin results in increased phosphorylation of WEE1 protein]|doxorubicin results in increased phosphorylation of WEE1 protein",,,PMID:20826841,https://www.ncbi.nlm.nih.gov/pubmed/20826841,20826841,,
17,1390107,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7465,WEE1,https://ctdbase.org/detail.go?type=gene&acc=7465,,,7465.0,WEE1,10090.0,Mus musculus (house mouse),Doxorubicin results in increased expression of WEE1 mrna|lovastatin inhibits the reaction [doxorubicin results in increased expression of WEE1 mrna],,,PMID:22712078,https://www.ncbi.nlm.nih.gov/pubmed/22712078,22712078,,
18,1390108,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,123720,WHAMM,https://ctdbase.org/detail.go?type=gene&acc=123720,,,123720.0,WHAMM,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of WHAMM mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
19,1390987,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,10138,YAF2,https://ctdbase.org/detail.go?type=gene&acc=10138,,,10138.0,YAF2,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of YAF2 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
20,1390988,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,10413,YAP1,https://ctdbase.org/detail.go?type=gene&acc=10413,,,10413.0,YAP1,9606.0,Homo sapiens (human),"[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in decreased phosphorylation of and affects the localization of YAP1 protein|doxorubicin results in increased expression of YAP1 protein modified form|wortmannin promotes the reaction [doxorubicin results in increased expression of YAP1 protein modified form]|yap1 protein promotes the reaction [[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]|[yap1 protein promotes the reaction [[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein|[yap1 protein promotes the reaction [[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein|[yap1 protein promotes the reaction [[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein|[yap1 protein promotes the reaction [[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein|[yap1 protein promotes the reaction [[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein",,,PMID:21214929,https://www.ncbi.nlm.nih.gov/pubmed/21214929,21214929,,
21,1390989,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,10413,YAP1,https://ctdbase.org/detail.go?type=gene&acc=10413,,,10413.0,YAP1,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of YAP1 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
22,1390990,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,10413,YAP1,https://ctdbase.org/detail.go?type=gene&acc=10413,,,10413.0,YAP1,10116.0,Rattus norvegicus (Norway rat),Doxorubicin results in decreased expression of YAP1 mrna|doxorubicin results in decreased expression of YAP1 protein|yap1 protein results in decreased susceptibility to doxorubicin|doxorubicin inhibits the reaction [YAP1 protein binds to PRKN promoter],,,PMID:32434049,https://www.ncbi.nlm.nih.gov/pubmed/32434049,32434049,,
23,1390991,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,10413,YAP1,https://ctdbase.org/detail.go?type=gene&acc=10413,,,10413.0,YAP1,10116.0,Rattus norvegicus (Norway rat),YAP1 protein affects the reaction [melatonin inhibits the reaction [doxorubicin results in increased expression of ACSL4 protein]]|yap1 protein affects the reaction [melatonin inhibits the reaction [doxorubicin results in increased expression of BAX protein]]|yap1 protein affects the reaction [melatonin inhibits the reaction [doxorubicin results in decreased expression of BCL2 protein]]|yap1 protein affects the reaction [melatonin inhibits the reaction [doxorubicin results in increased expression of FUNDC1 protein]]|melatonin inhibits the reaction [doxorubicin results in increased phosphorylation of YAP1 protein]|doxorubicin results in increased phosphorylation of YAP1 protein|yap1 protein affects the reaction [melatonin inhibits the reaction [doxorubicin results in decreased expression of OPA1 protein]]|yap1 protein affects the reaction [melatonin inhibits the reaction [doxorubicin results in increased expression of NPPB protein]]|yap1 protein affects the reaction [melatonin inhibits the reaction [doxorubicin results in decreased expression of and results in increased cleavage of CASP9 protein]]|verteporfin inhibits the reaction [melatonin inhibits the reaction [doxorubicin results in increased phosphorylation of YAP1 protein]],,,PMID:35093381,https://www.ncbi.nlm.nih.gov/pubmed/35093381,35093381,,
24,1390992,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,51067,YARS2,https://ctdbase.org/detail.go?type=gene&acc=51067,,,51067.0,YARS2,10090.0,Mus musculus (house mouse),Doxorubicin results in decreased expression of YARS2 mrna|[doxorubicin co-treated with dexrazoxane] results in increased expression of YARS2 mRNA,,,PMID:26873546,https://www.ncbi.nlm.nih.gov/pubmed/26873546,26873546,,
25,1393402,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7596,ZNF45,https://ctdbase.org/detail.go?type=gene&acc=7596,,,7596.0,ZNF45,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of ZNF45 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
26,1393403,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,58499,ZNF462,https://ctdbase.org/detail.go?type=gene&acc=58499,,,58499.0,ZNF462,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of ZNF462 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
27,1393404,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,84627,ZNF469,https://ctdbase.org/detail.go?type=gene&acc=84627,,,84627.0,ZNF469,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of ZNF469 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
28,1393532,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,84450,ZNF512,https://ctdbase.org/detail.go?type=gene&acc=84450,,,84450.0,ZNF512,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of ZNF512 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
29,1393533,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,130557,ZNF513,https://ctdbase.org/detail.go?type=gene&acc=130557,,,130557.0,ZNF513,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of ZNF513 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
30,1394578,33032,Comparative Toxicogenomics Database (CTD),Glutamic Acid,D018698,Glutamic Acid,https://ctdbase.org/detail.go?type=chem&acc=D018698,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A inhibits the reaction [[estradiol co-treated with glutamic acid] results in increased phosphorylation of MAPK1 protein]|flutamide inhibits the reaction [[bisphenol A co-treated with glutamic acid] results in increased phosphorylation of MAPK1 protein]|[bisphenol A co-treated with glutamic acid] results in increased phosphorylation of MAPK1 protein|bisphenol A inhibits the reaction [[dihydrotestosterone co-treated with glutamic acid] results in increased phosphorylation of MAPK1 protein]|[estradiol co-treated with glutamic acid] results in increased phosphorylation of MAPK1 protein|afimoxifene inhibits the reaction [[bisphenol A co-treated with glutamic acid] results in increased phosphorylation of MAPK1 protein]|[dihydrotestosterone co-treated with glutamic acid] results in increased phosphorylation of MAPK1 protein,,,PMID:30707916,https://www.ncbi.nlm.nih.gov/pubmed/30707916,30707916,,
31,1394579,33032,Comparative Toxicogenomics Database (CTD),Glutamic Acid,D018698,Glutamic Acid,https://ctdbase.org/detail.go?type=chem&acc=D018698,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),"AM 251 inhibits the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein]|grm5 protein affects the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein]|[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein|[jzl 184 co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein|6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein]|grm5 protein affects the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein]|6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein]|cnr1 protein affects the reaction [glutamic acid results in increased phosphorylation of MAPK3 protein]|am 251 inhibits the reaction [[JZL 184 co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein]|[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein|6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[JZL 184 co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein]|grm5 protein affects the reaction [glutamic acid results in increased phosphorylation of MAPK3 protein]|grm5 protein affects the reaction [[JZL 184 co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein]|am 251 inhibits the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein]|glutamic acid results in increased phosphorylation of MAPK3 protein",,,PMID:27543109,https://www.ncbi.nlm.nih.gov/pubmed/27543109,27543109,,
32,1394580,33032,Comparative Toxicogenomics Database (CTD),Glutamic Acid,D018698,Glutamic Acid,https://ctdbase.org/detail.go?type=chem&acc=D018698,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),[TNF protein co-treated with glutamic acid] results in increased activity of MAP3K7 protein,,,PMID:36912451,https://www.ncbi.nlm.nih.gov/pubmed/36912451,36912451,,
33,1394581,33474,Therapeutic Target Database (TTD),Ripazepam,D03EQH,RIPAZEPAM,https://idrblab.net/ttd/data/drug/details/D03EQH,T51487,GABA(A) receptor alpha-1 (GABRA1),https://idrblab.net/ttd/data/target/details/T51487,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
34,1394582,33613,Drug Gene Interaction database (DGIdb),Amoxicillin,,AMOXICILLIN ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1297882,,HLA-C,https://www.dgidb.org/genes/hgnc:4933,,,3107.0,HLA-C,9606.0,Homo sapiens (human),,,,,,,,
35,1394701,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0001114,Vascular cell adhesion protein 1,http://www.t3db.ca/biodb/bio_entities/BE0001114,P19320,Vascular cell adhesion protein 1,7412.0,VCAM1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
36,1394702,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0005532,Nuclear receptor ROR-gamma,http://www.t3db.ca/biodb/bio_entities/BE0005532,P51449,Nuclear receptor ROR-gamma,6097.0,RORC,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
37,1394703,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0002793,Cytochrome P450 2C9,http://www.t3db.ca/biodb/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
38,1394704,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0002638,Cytochrome P450 3A4,http://www.t3db.ca/biodb/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
39,1394815,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0003549,Cytochrome P450 2B6,http://www.t3db.ca/biodb/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
40,1394816,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0001032,Multidrug resistance protein 1,http://www.t3db.ca/biodb/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
41,1394817,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0003536,Cytochrome P450 2C19,http://www.t3db.ca/biodb/bio_entities/BE0003536,P33261,Cytochrome P450 2C19,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
42,1394818,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0000886,Bile salt sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000886,Q06520,Sulfotransferase 2A1,6822.0,SULT2A1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
43,1394819,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0002189,Glutathione S-transferase A2,http://www.t3db.ca/biodb/bio_entities/BE0002189,P09210,Glutathione S-transferase A2,2939.0,GSTA2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
44,1394820,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0005490,Nuclear factor erythroid 2-related factor 2,http://www.t3db.ca/biodb/bio_entities/BE0005490,Q16236,Nuclear factor erythroid 2-related factor 2,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
45,1394821,34192,Toxin and Toxin Target Database (T3DB),Thiobencarb,T3D1011,Thiobencarb,http://www.t3db.ca/toxins/T3D1011,BE0003541,UDP-glucuronosyltransferase 1-1,http://www.t3db.ca/biodb/bio_entities/BE0003541,P22309,UDP-glucuronosyltransferase 1A1 ,54658.0,UGT1A1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
46,1394822,34230,Comparative Toxicogenomics Database (CTD),Nigericin,D009550,Nigericin,https://ctdbase.org/detail.go?type=chem&acc=D009550,366,AQP9,https://ctdbase.org/detail.go?type=gene&acc=366,,,366.0,AQP9,9606.0,Homo sapiens (human),Nigericin inhibits the reaction [AQP9 protein results in increased uptake of selenious acid]|nigericin inhibits the reaction [AQP9 protein results in increased uptake of lactic acid],,,PMID:28798983,https://www.ncbi.nlm.nih.gov/pubmed/28798983,28798983,,
47,1394823,34230,Comparative Toxicogenomics Database (CTD),Nigericin,D009550,Nigericin,https://ctdbase.org/detail.go?type=chem&acc=D009550,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,9606.0,Homo sapiens (human),CASP1 protein affects the reaction [nigericin results in increased secretion of IL1B protein],,,PMID:18403674,https://www.ncbi.nlm.nih.gov/pubmed/18403674,18403674,,
48,1387754,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,57610,RANBP10,https://ctdbase.org/detail.go?type=gene&acc=57610,,,57610.0,RANBP10,10116.0,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RANBP10 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
49,1387755,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,57826,RAP2C,https://ctdbase.org/detail.go?type=gene&acc=57826,,,57826.0,RAP2C,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RAP2C mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
50,1388730,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,257887,OR4A67,https://ctdbase.org/detail.go?type=gene&acc=257887,,,257887.0,Or4a67,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR4A67 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
51,1388731,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,258523,OR4C100,https://ctdbase.org/detail.go?type=gene&acc=258523,,,258523.0,Or4c100,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR4C100 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
52,1388732,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,404825,OR4C112B,https://ctdbase.org/detail.go?type=gene&acc=404825,,,404825.0,Or4c112b,10116.0,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of OR4C112B mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
53,1388733,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,256144,OR4C3,https://ctdbase.org/detail.go?type=gene&acc=256144,,,256144.0,OR4C3,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR4C3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
54,1388734,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,124538,OR4D2,https://ctdbase.org/detail.go?type=gene&acc=124538,,,124538.0,OR4D2,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR4D2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
55,1388735,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,404822,OR4P18B,https://ctdbase.org/detail.go?type=gene&acc=404822,,,404822.0,Or4p18b,10116.0,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of OR4P18B mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
56,1388736,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,258339,OR4X6,https://ctdbase.org/detail.go?type=gene&acc=258339,,,258339.0,Or4x6,10116.0,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of OR4X6 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
57,1388737,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,401663,OR51H1,https://ctdbase.org/detail.go?type=gene&acc=401663,,,401663.0,OR51H1,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR51H1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
58,1389217,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,219858,OR8B12,https://ctdbase.org/detail.go?type=gene&acc=219858,,,219858.0,OR8B12,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR8B12 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
59,1389218,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,258777,OR8B55,https://ctdbase.org/detail.go?type=gene&acc=258777,,,258777.0,Or8b55,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR8B55 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
60,1389219,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,258871,OR8C20,https://ctdbase.org/detail.go?type=gene&acc=258871,,,258871.0,Or8c20,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OR8C20 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
61,1391759,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
62,1391760,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,90523,MLIP,https://ctdbase.org/detail.go?type=gene&acc=90523,,,90523.0,MLIP,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MLIP mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
63,1391761,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,22877,MLXIP,https://ctdbase.org/detail.go?type=gene&acc=22877,,,22877.0,MLXIP,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MLXIP mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
64,1391762,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,326625,MMAB,https://ctdbase.org/detail.go?type=gene&acc=326625,,,326625.0,MMAB,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MMAB mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
65,1391763,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116.0,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MMP2 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
66,1391764,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,64066,MMP27,https://ctdbase.org/detail.go?type=gene&acc=64066,,,64066.0,MMP27,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MMP27 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
67,1391765,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,79148,MMP28,https://ctdbase.org/detail.go?type=gene&acc=79148,,,79148.0,MMP28,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MMP28 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
68,1392014,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,374977,MROH7,https://ctdbase.org/detail.go?type=gene&acc=374977,,,374977.0,MROH7,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MROH7 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
69,1392015,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,64981,MRPL34,https://ctdbase.org/detail.go?type=gene&acc=64981,,,64981.0,MRPL34,10116.0,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of MRPL34 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
70,1392016,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,341116,MS4A10,https://ctdbase.org/detail.go?type=gene&acc=341116,,,341116.0,MS4A10,10116.0,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MS4A10 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
71,1392017,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,503497,MS4A13,https://ctdbase.org/detail.go?type=gene&acc=503497,,,503497.0,MS4A13,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MS4A13 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
72,1392018,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,4438,MSH4,https://ctdbase.org/detail.go?type=gene&acc=4438,,,4438.0,MSH4,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MSH4 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
73,1392129,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,2956,MSH6,https://ctdbase.org/detail.go?type=gene&acc=2956,,,2956.0,MSH6,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MSH6 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
74,1392130,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,4481,MSR1,https://ctdbase.org/detail.go?type=gene&acc=4481,,,4481.0,MSR1,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MSR1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
75,1392131,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,118490,MSS51,https://ctdbase.org/detail.go?type=gene&acc=118490,,,118490.0,MSS51,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MSS51 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
76,1392132,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,50994,MTAG2,https://ctdbase.org/detail.go?type=gene&acc=50994,,,50994.0,Mtag2,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTAG2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
77,1392133,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,4524,MTHFR,https://ctdbase.org/detail.go?type=gene&acc=4524,,,4524.0,MTHFR,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MTHFR mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
78,1392134,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,57489,ODF2L,https://ctdbase.org/detail.go?type=gene&acc=57489,,,57489.0,ODF2L,10116.0,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ODF2L mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
79,1392135,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,4534,MTM1,https://ctdbase.org/detail.go?type=gene&acc=4534,,,4534.0,MTM1,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
80,1392614,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,266812,NAP1L5,https://ctdbase.org/detail.go?type=gene&acc=266812,,,266812.0,NAP1L5,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NAP1L5 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
81,1392615,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,8775,NAPA,https://ctdbase.org/detail.go?type=gene&acc=8775,,,8775.0,NAPA,10116.0,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NAPA protein",,,PMID:21673325,https://www.ncbi.nlm.nih.gov/pubmed/21673325,21673325,,
82,1392616,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,4678,NASP,https://ctdbase.org/detail.go?type=gene&acc=4678,,,4678.0,NASP,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NASP mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
83,1392617,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,9027,NAT8,https://ctdbase.org/detail.go?type=gene&acc=9027,,,9027.0,NAT8,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NAT8 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
84,1392618,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,93673,NAT8F2,https://ctdbase.org/detail.go?type=gene&acc=93673,,,93673.0,Nat8f2,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NAT8F2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
85,1392619,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,69049,NAT8F5,https://ctdbase.org/detail.go?type=gene&acc=69049,,,69049.0,Nat8f5,10116.0,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NAT8F5 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
86,1392620,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,89797,NAV2,https://ctdbase.org/detail.go?type=gene&acc=89797,,,89797.0,NAV2,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NAV2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
87,1395100,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,10220,GDF11,https://ctdbase.org/detail.go?type=gene&acc=10220,,,10220.0,GDF11,10116.0,Rattus norvegicus (Norway rat),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of GDF11 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
88,1395101,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,9518,GDF15,https://ctdbase.org/detail.go?type=gene&acc=9518,,,9518.0,GDF15,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of GDF15 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
89,1395102,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,392255,GDF6,https://ctdbase.org/detail.go?type=gene&acc=392255,,,392255.0,GDF6,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GDF6 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
90,1395103,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,81544,GDPD5,https://ctdbase.org/detail.go?type=gene&acc=81544,,,81544.0,GDPD5,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GDPD5 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
91,1395487,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,29926,GMPPA,https://ctdbase.org/detail.go?type=gene&acc=29926,,,29926.0,GMPPA,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GMPPA mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
92,1395488,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,8833,GMPS,https://ctdbase.org/detail.go?type=gene&acc=8833,,,8833.0,GMPS,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GMPS mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
93,1395489,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,2774,GNAL,https://ctdbase.org/detail.go?type=gene&acc=2774,,,2774.0,GNAL,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GNAL mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
94,1395490,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,2784,GNB3,https://ctdbase.org/detail.go?type=gene&acc=2784,,,2784.0,GNB3,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GNB3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
95,1395491,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,2791,GNG11,https://ctdbase.org/detail.go?type=gene&acc=2791,,,2791.0,GNG11,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of GNG11 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
96,1395492,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,51764,GNG13,https://ctdbase.org/detail.go?type=gene&acc=51764,,,51764.0,GNG13,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GNG13 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
97,1395616,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,2239,GPC4,https://ctdbase.org/detail.go?type=gene&acc=2239,,,2239.0,GPC4,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of GPC4 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
98,1395617,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,2262,GPC5,https://ctdbase.org/detail.go?type=gene&acc=2262,,,2262.0,GPC5,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPC5 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
99,1395618,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,283554,GPR137C,https://ctdbase.org/detail.go?type=gene&acc=283554,,,283554.0,GPR137C,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPR137C mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
100,1395619,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,76206,GPR165,https://ctdbase.org/detail.go?type=gene&acc=76206,,,76206.0,Gpr165,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPR165 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
101,1398432,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3861,KRT14,https://ctdbase.org/detail.go?type=gene&acc=3861,,,3861.0,KRT14,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of KRT14 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
102,1398433,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3866,KRT15,https://ctdbase.org/detail.go?type=gene&acc=3866,,,3866.0,KRT15,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of KRT15 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
103,1398434,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3885,KRT34,https://ctdbase.org/detail.go?type=gene&acc=3885,,,3885.0,KRT34,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of KRT34 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
104,1398435,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,112802,KRT71,https://ctdbase.org/detail.go?type=gene&acc=112802,,,112802.0,KRT71,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT71 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
105,1398436,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,196374,KRT78,https://ctdbase.org/detail.go?type=gene&acc=196374,,,196374.0,KRT78,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT78 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
106,1398437,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3891,KRT85,https://ctdbase.org/detail.go?type=gene&acc=3891,,,3891.0,KRT85,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT85 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
107,1398563,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3911,LAMA5,https://ctdbase.org/detail.go?type=gene&acc=3911,,,3911.0,LAMA5,10116.0,Rattus norvegicus (Norway rat),"2,5,2',5'-tetrachlorobiphenyl results in decreased expression of LAMA5 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
108,1398564,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,347404,LANCL3,https://ctdbase.org/detail.go?type=gene&acc=347404,,,347404.0,LANCL3,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LANCL3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
109,1398565,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,51574,LARP7,https://ctdbase.org/detail.go?type=gene&acc=51574,,,51574.0,LARP7,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LARP7 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
110,1398566,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3930,LBR,https://ctdbase.org/detail.go?type=gene&acc=3930,,,3930.0,LBR,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LBR mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
111,1398567,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,167691,LCA5,https://ctdbase.org/detail.go?type=gene&acc=167691,,,167691.0,LCA5,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LCA5 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
112,1398568,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,73730,LCE1L,https://ctdbase.org/detail.go?type=gene&acc=73730,,,73730.0,Lce1l,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LCE1L mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
113,1398679,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,286256,LCN12,https://ctdbase.org/detail.go?type=gene&acc=286256,,,286256.0,LCN12,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LCN12 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
114,1398680,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,11155,LDB3,https://ctdbase.org/detail.go?type=gene&acc=11155,,,11155.0,LDB3,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of LDB3 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
115,1398681,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,11155,LDB3,https://ctdbase.org/detail.go?type=gene&acc=11155,,,11155.0,LDB3,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LDB3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
116,1398682,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3939,LDHA,https://ctdbase.org/detail.go?type=gene&acc=3939,,,3939.0,LDHA,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of LDHA mRNA",,,PMID:21703328,https://www.ncbi.nlm.nih.gov/pubmed/21703328,21703328,,
117,1398683,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,197257,LDHD,https://ctdbase.org/detail.go?type=gene&acc=197257,,,197257.0,LDHD,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of LDHD mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
118,1398684,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176.0,LEF1,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LEF1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
119,1398685,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3953,LEPR,https://ctdbase.org/detail.go?type=gene&acc=3953,,,3953.0,LEPR,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
120,1398686,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,10116.0,Rattus norvegicus (Norway rat),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of LGALS1 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
121,1398687,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3959,LGALS3BP,https://ctdbase.org/detail.go?type=gene&acc=3959,,,3959.0,LGALS3BP,10116.0,Rattus norvegicus (Norway rat),"2,5,2',5'-tetrachlorobiphenyl results in decreased expression of LGALS3BP mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
122,1399716,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,8997,KALRN,https://ctdbase.org/detail.go?type=gene&acc=8997,,,8997.0,KALRN,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KALRN mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
123,1399717,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,256949,KANK3,https://ctdbase.org/detail.go?type=gene&acc=256949,,,256949.0,KANK3,10116.0,Rattus norvegicus (Norway rat),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of KANK3 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
124,1400296,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,23263,MCF2L,https://ctdbase.org/detail.go?type=gene&acc=23263,,,23263.0,MCF2L,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MCF2L mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
125,1400297,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,55388,MCM10,https://ctdbase.org/detail.go?type=gene&acc=55388,,,55388.0,MCM10,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM10 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
126,1400298,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,4171,MCM2,https://ctdbase.org/detail.go?type=gene&acc=4171,,,4171.0,MCM2,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
127,1400299,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,4172,MCM3,https://ctdbase.org/detail.go?type=gene&acc=4172,,,4172.0,MCM3,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
128,1400300,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,4173,MCM4,https://ctdbase.org/detail.go?type=gene&acc=4173,,,4173.0,MCM4,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM4 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
129,1400301,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,4174,MCM5,https://ctdbase.org/detail.go?type=gene&acc=4174,,,4174.0,MCM5,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM5 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
130,1400302,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,4175,MCM6,https://ctdbase.org/detail.go?type=gene&acc=4175,,,4175.0,MCM6,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM6 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
131,1400303,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,55283,MCOLN3,https://ctdbase.org/detail.go?type=gene&acc=55283,,,55283.0,MCOLN3,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of MCOLN3 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
132,1400641,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,92342,METTL18,https://ctdbase.org/detail.go?type=gene&acc=92342,,,92342.0,METTL18,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of METTL18 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
133,1400642,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,728464,METTL24,https://ctdbase.org/detail.go?type=gene&acc=728464,,,728464.0,METTL24,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of METTL24 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
134,1400643,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,92312,MEX3A,https://ctdbase.org/detail.go?type=gene&acc=92312,,,92312.0,MEX3A,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MEX3A mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
135,1400644,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,84206,MEX3B,https://ctdbase.org/detail.go?type=gene&acc=84206,,,84206.0,MEX3B,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of MEX3B mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
136,1400645,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,84206,MEX3B,https://ctdbase.org/detail.go?type=gene&acc=84206,,,84206.0,MEX3B,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MEX3B mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
137,1400646,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,9848,MFAP3L,https://ctdbase.org/detail.go?type=gene&acc=9848,,,9848.0,MFAP3L,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MFAP3L mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
138,1400647,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,4239,MFAP4,https://ctdbase.org/detail.go?type=gene&acc=4239,,,4239.0,MFAP4,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MFAP4 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
139,1400648,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,9258,MFHAS1,https://ctdbase.org/detail.go?type=gene&acc=9258,,,9258.0,MFHAS1,10116.0,Rattus norvegicus (Norway rat),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of MFHAS1 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
140,1400649,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,148808,MFSD4A,https://ctdbase.org/detail.go?type=gene&acc=148808,,,148808.0,MFSD4A,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MFSD4A mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
141,1400767,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,71001,MGAT4E,https://ctdbase.org/detail.go?type=gene&acc=71001,,,71001.0,Mgat4e,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGAT4E mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
142,1400768,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,4249,MGAT5,https://ctdbase.org/detail.go?type=gene&acc=4249,,,4249.0,MGAT5,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGAT5 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
143,1400769,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,11343,MGLL,https://ctdbase.org/detail.go?type=gene&acc=11343,,,11343.0,MGLL,10116.0,Rattus norvegicus (Norway rat),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of MGLL mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
144,1400770,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,4259,MGST3,https://ctdbase.org/detail.go?type=gene&acc=4259,,,4259.0,MGST3,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGST3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
145,1400771,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,104564225,MHRT,https://ctdbase.org/detail.go?type=gene&acc=104564225,,,104564225.0,MHRT,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MHRT mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
146,1400772,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,440823,MIAT,https://ctdbase.org/detail.go?type=gene&acc=440823,,,440823.0,MIAT,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of MIAT mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
147,1400773,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,64780,MICAL1,https://ctdbase.org/detail.go?type=gene&acc=64780,,,64780.0,MICAL1,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of MICAL1 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
148,1400774,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,9645,MICAL2,https://ctdbase.org/detail.go?type=gene&acc=9645,,,9645.0,MICAL2,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MICAL2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
149,1396151,37261,Toxin and Toxin Target Database (T3DB),"(5-benzylfuran-2-yl)methyl (1S,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",T3D1025,Cismethrin,http://www.t3db.ca/toxins/T3D1025,BE0000218,Calcium-transporting ATPase type 2C member 1,http://www.t3db.ca/biodb/bio_entities/BE0000218,P98194,Calcium-transporting ATPase type 2C member 1,27032.0,ATP2C1,9606.0,Homo sapiens (human),"This pyrethroid inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
150,1396152,37261,Toxin and Toxin Target Database (T3DB),"(5-benzylfuran-2-yl)methyl (1S,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",T3D1025,Cismethrin,http://www.t3db.ca/toxins/T3D1025,BE0005014,Calcium-transporting ATPase type 2C member 2,http://www.t3db.ca/biodb/bio_entities/BE0005014,O75185,Calcium-transporting ATPase type 2C member 2,9914.0,ATP2C2,9606.0,Homo sapiens (human),"This pyrethroid inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
151,1396153,37261,Toxin and Toxin Target Database (T3DB),"(5-benzylfuran-2-yl)methyl (1S,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",T3D1025,Cismethrin,http://www.t3db.ca/toxins/T3D1025,BE0003888,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,http://www.t3db.ca/biodb/bio_entities/BE0003888,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 ,487.0,ATP2A1,9606.0,Homo sapiens (human),"This pyrethroid inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
152,1396154,37261,Toxin and Toxin Target Database (T3DB),"(5-benzylfuran-2-yl)methyl (1S,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",T3D1025,Cismethrin,http://www.t3db.ca/toxins/T3D1025,BE0003477,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,http://www.t3db.ca/biodb/bio_entities/BE0003477,P16615,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,488.0,ATP2A2,9606.0,Homo sapiens (human),"This pyrethroid inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
153,1403617,37542,Drug Gene Interaction database (DGIdb),Ribavirin,,RIBAVIRIN,https://www.dgidb.org/drugs/rxcui:9344,,HLA-B,https://www.dgidb.org/genes/hgnc:4932,,,3106.0,HLA-B,9606.0,Homo sapiens (human),,,,,,,,
154,1403618,37542,BindingDB,Ribavirin,50154375,"Adenosine receptor agonist, 16",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50154375,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,,,PMID:32852058|DOI:10.1002/med.21724,https://www.ncbi.nlm.nih.gov/pubmed/32852058|https://doi.org/10.1002/med.21724,32852058,10.1002/med.21724,
155,1403619,37723,Comparative Toxicogenomics Database (CTD),Glc(b1-3)[Glc(b1-6)]Glc(b1-3)Glc(b1-3)Glc(b1-3)[Glc(b1-6)]b-Glc,D007912,Lentinan,https://ctdbase.org/detail.go?type=chem&acc=D007912,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),Lentinan results in decreased expression of CYP1A1,,,PMID:15630237,https://www.ncbi.nlm.nih.gov/pubmed/15630237,15630237,,
156,1403620,37723,Comparative Toxicogenomics Database (CTD),Glc(b1-3)[Glc(b1-6)]Glc(b1-3)Glc(b1-3)Glc(b1-3)[Glc(b1-6)]b-Glc,D007912,Lentinan,https://ctdbase.org/detail.go?type=chem&acc=D007912,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,10090.0,Mus musculus (house mouse),Lentinan results in decreased expression of CYP1A2,,,PMID:15630237,https://www.ncbi.nlm.nih.gov/pubmed/15630237,15630237,,
157,1398427,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3313,HSPA9,https://ctdbase.org/detail.go?type=gene&acc=3313,,,3313.0,HSPA9,10116.0,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of HSPA9 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
158,1398428,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,9606.0,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of HSPB1 mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
159,1398429,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,26353,HSPB8,https://ctdbase.org/detail.go?type=gene&acc=26353,,,26353.0,HSPB8,10090.0,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in decreased expression of HSPB8 protein,,,PMID:26558463,https://www.ncbi.nlm.nih.gov/pubmed/26558463,26558463,,
160,1398430,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3329,HSPD1,https://ctdbase.org/detail.go?type=gene&acc=3329,,,3329.0,HSPD1,9606.0,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of HSPD1 protein,,,PMID:24675778,https://www.ncbi.nlm.nih.gov/pubmed/24675778,24675778,,
161,1398431,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3336,HSPE1,https://ctdbase.org/detail.go?type=gene&acc=3336,,,3336.0,HSPE1,9606.0,Homo sapiens (human),U 0126 affects the reaction [1-methyl-4-phenylpyridinium affects the expression of HSPE1 mrna],,,PMID:12710931,https://www.ncbi.nlm.nih.gov/pubmed/12710931,12710931,,
162,1398678,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,10410,IFITM3,https://ctdbase.org/detail.go?type=gene&acc=10410,,,10410.0,IFITM3,10116.0,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in decreased expression of IFITM3 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
163,1399593,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Donepezil inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of IL1B protein]|donepezil inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of IL1B mrna],,,PMID:26114860,https://www.ncbi.nlm.nih.gov/pubmed/26114860,26114860,,
164,1399594,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of IL1B protein]|sesamin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of IL1B mrna]|sesamin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of IL1B protein]|quercetin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of IL1B mrna],,,PMID:22919443,https://www.ncbi.nlm.nih.gov/pubmed/22919443,22919443,,
165,1399595,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of IL1B protein,,,PMID:31351185|PMID:31376345|PMID:31430510,https://www.ncbi.nlm.nih.gov/pubmed/31351185|https://www.ncbi.nlm.nih.gov/pubmed/31376345|https://www.ncbi.nlm.nih.gov/pubmed/31430510,31351185|31376345|31430510,,
166,1399596,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),KANK2 protein inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of IL1B protein],,,PMID:31376345,https://www.ncbi.nlm.nih.gov/pubmed/31376345,31376345,,
167,1399597,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Oridonin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of IL1B protein],,,PMID:31430510,https://www.ncbi.nlm.nih.gov/pubmed/31430510,31430510,,
168,1399598,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,10116.0,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of IL1R1 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
169,1399599,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,51561,IL23A,https://ctdbase.org/detail.go?type=gene&acc=51561,,,51561.0,IL23A,10116.0,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of IL23A mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
170,1400304,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3638,INSIG1,https://ctdbase.org/detail.go?type=gene&acc=3638,,,3638.0,INSIG1,10116.0,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in decreased expression of INSIG1 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
171,1401616,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,51056,LAP3,https://ctdbase.org/detail.go?type=gene&acc=51056,,,51056.0,LAP3,10090.0,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in increased expression of LAP3 protein,,,PMID:26558463,https://www.ncbi.nlm.nih.gov/pubmed/26558463,26558463,,
172,1401617,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,9215,LARGE1,https://ctdbase.org/detail.go?type=gene&acc=9215,,,9215.0,LARGE1,9606.0,Homo sapiens (human),1-methyl-4-phenylpyridinium results in decreased expression of LARGE1 mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
173,1401618,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,55323,LARP6,https://ctdbase.org/detail.go?type=gene&acc=55323,,,55323.0,LARP6,9606.0,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of LARP6 mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
174,1401619,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,51520,LARS1,https://ctdbase.org/detail.go?type=gene&acc=51520,,,51520.0,LARS1,10116.0,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of LARS1 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
175,1401620,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,81606,LBH,https://ctdbase.org/detail.go?type=gene&acc=81606,,,81606.0,LBH,9606.0,Homo sapiens (human),1-methyl-4-phenylpyridinium results in decreased expression of LBH mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
176,1401621,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,3929,LBP,https://ctdbase.org/detail.go?type=gene&acc=3929,,,3929.0,LBP,10116.0,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in decreased expression of LBP mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
177,1403033,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,4217,MAP3K5,https://ctdbase.org/detail.go?type=gene&acc=4217,,,4217.0,MAP3K5,9606.0,Homo sapiens (human),1-methyl-4-phenylpyridinium results in decreased expression of MAP3K5 mRNA,,,PMID:25234470,https://www.ncbi.nlm.nih.gov/pubmed/25234470,25234470,,
178,1403034,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,4217,MAP3K5,https://ctdbase.org/detail.go?type=gene&acc=4217,,,4217.0,MAP3K5,9606.0,Homo sapiens (human),Schisanhenol inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein]|geranylgeranylacetone inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein]|1-methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein|1-methylpropyl-2-imidazolyl disulfide inhibits the reaction [schisanhenol inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein]],,,PMID:34732784,https://www.ncbi.nlm.nih.gov/pubmed/34732784,34732784,,
179,1403035,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,4217,MAP3K5,https://ctdbase.org/detail.go?type=gene&acc=4217,,,4217.0,MAP3K5,9606.0,Homo sapiens (human),"8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione inhibits the reaction [1-methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein]|1-methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein",,,PMID:20946892,https://www.ncbi.nlm.nih.gov/pubmed/20946892,20946892,,
180,1403036,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7546,ZIC2,https://ctdbase.org/detail.go?type=gene&acc=7546,,,7546.0,ZIC2,10116.0,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in decreased expression of ZIC2 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
181,1403037,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,4217,MAP3K5,https://ctdbase.org/detail.go?type=gene&acc=4217,,,4217.0,MAP3K5,10090.0,Mus musculus (house mouse),1-methyl-4-phenylpyridinium promotes the reaction [MAP3K5 protein binds to TRAF2 protein]|cib1 protein inhibits the reaction [1-methyl-4-phenylpyridinium promotes the reaction [MAP3K5 protein binds to TRAF2 protein]]|1-methyl-4-phenylpyridinium promotes the reaction [MAP3K5 protein binds to MAP2K7 protein]|1-methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein|cib1 protein inhibits the reaction [1-methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein]|cib1 protein inhibits the reaction [1-methyl-4-phenylpyridinium promotes the reaction [MAP3K5 protein binds to MAP2K7 protein]]|1-methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein,,,PMID:28939911,https://www.ncbi.nlm.nih.gov/pubmed/28939911,28939911,,
182,1403038,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,9064,MAP3K6,https://ctdbase.org/detail.go?type=gene&acc=9064,,,9064.0,MAP3K6,9606.0,Homo sapiens (human),1-methyl-4-phenylpyridinium results in decreased expression of MAP3K6 mRNA,,,PMID:25234470,https://www.ncbi.nlm.nih.gov/pubmed/25234470,25234470,,
183,1403039,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,5871,MAP4K2,https://ctdbase.org/detail.go?type=gene&acc=5871,,,5871.0,MAP4K2,9606.0,Homo sapiens (human),1-methyl-4-phenylpyridinium results in decreased expression of MAP4K2 mRNA,,,PMID:25234470,https://www.ncbi.nlm.nih.gov/pubmed/25234470,25234470,,
184,1404423,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,406958,MIR182,https://ctdbase.org/detail.go?type=gene&acc=406958,,,406958.0,MIR182,10090.0,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in increased expression of MIR182 mRNA,,,PMID:32016794,https://www.ncbi.nlm.nih.gov/pubmed/32016794,32016794,,
185,1404424,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,399726,MIR1915HG,https://ctdbase.org/detail.go?type=gene&acc=399726,,,399726.0,MIR1915HG,9606.0,Homo sapiens (human),1-methyl-4-phenylpyridinium results in decreased expression of MIR1915HG mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
186,1404425,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,8544,PIR,https://ctdbase.org/detail.go?type=gene&acc=8544,,,8544.0,PIR,9606.0,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of PIR mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
187,1404426,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,406983,MIR200A,https://ctdbase.org/detail.go?type=gene&acc=406983,,,406983.0,MIR200A,9606.0,Homo sapiens (human),MIR200A mRNA inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form]|1-methyl-4-phenylpyridinium results in decreased expression of and results in decreased secretion of MIR200A mRNA,,,PMID:32016794,https://www.ncbi.nlm.nih.gov/pubmed/32016794,32016794,,
188,1367749,51605,Comparative Toxicogenomics Database (CTD),Fenoxycarb,C052034,fenoxycarb,https://ctdbase.org/detail.go?type=chem&acc=C052034,4728,NDUFS8,https://ctdbase.org/detail.go?type=gene&acc=4728,,,4728.0,NDUFS8,150844.0,Moina macrocopa,Fenoxycarb results in decreased expression of NDUFS8 mRNA,,,PMID:31927065,https://www.ncbi.nlm.nih.gov/pubmed/31927065,31927065,,
189,1386904,60663,IUPHAR/BPS Guide to PHARMACOLOGY,Mibefradil,2522,mibefradil,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2522,535,Cav3.1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=535,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,8913.0,CACNA1G,9606.0,Homo sapiens (human),Antagonist,pIC50,6 - 6.6,PMID:10991994,https://www.ncbi.nlm.nih.gov/pubmed/10991994,10991994,,
190,1386905,60699,Drug Gene Interaction database (DGIdb),Topotecan Hydrochloride,,TOPOTECAN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:266573,,TOP1MT,https://www.dgidb.org/genes/hgnc:29787,,,116447.0,TOP1MT,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
191,1386906,60699,Drug Gene Interaction database (DGIdb),Topotecan Hydrochloride,,TOPOTECAN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:266573,,RB1,https://www.dgidb.org/genes/hgnc:9884,,,5925.0,RB1,9606.0,Homo sapiens (human),,,,,,,,
192,1386907,60703,Comparative Toxicogenomics Database (CTD),Eliprodil,C058083,eliprodil,https://ctdbase.org/detail.go?type=chem&acc=C058083,3757,KCNH2,https://ctdbase.org/detail.go?type=gene&acc=3757,,,3757.0,KCNH2,9606.0,Homo sapiens (human),Eliprodil inhibits the reaction [KCNH2 protein results in increased transport of thallium],,,PMID:19583963,https://www.ncbi.nlm.nih.gov/pubmed/19583963,19583963,,
193,1389694,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,10116.0,Rattus norvegicus (Norway rat),Irinotecan results in decreased expression of CDK1 mRNA,,,PMID:20097248,https://www.ncbi.nlm.nih.gov/pubmed/20097248,20097248,,
194,1389695,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,8621,CDK13,https://ctdbase.org/detail.go?type=gene&acc=8621,,,8621.0,CDK13,9606.0,Homo sapiens (human),Irinotecan results in decreased expression of CDK13 mrna|irinotecan metabolite results in decreased expression of CDK13 mRNA,,,PMID:15956246,https://www.ncbi.nlm.nih.gov/pubmed/15956246,15956246,,
195,1389696,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,8941,CDK5R2,https://ctdbase.org/detail.go?type=gene&acc=8941,,,8941.0,CDK5R2,9606.0,Homo sapiens (human),Irinotecan results in increased expression of CDK5R2 mrna|irinotecan metabolite results in increased expression of CDK5R2 mRNA,,,PMID:15956246,https://www.ncbi.nlm.nih.gov/pubmed/15956246,15956246,,
196,1390694,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Irinotecan metabolite results in decreased activity of CYP3A4 protein|irinotecan results in decreased activity of CYP3A4 protein,,,PMID:11901092,https://www.ncbi.nlm.nih.gov/pubmed/11901092,11901092,,
197,1390695,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),CYP3A4 protein results in increased metabolism of irinotecan,,,PMID:16271446,https://www.ncbi.nlm.nih.gov/pubmed/16271446,16271446,,
198,1390696,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606.0,Homo sapiens (human),[selenomethylselenocysteine co-treated with irinotecan] results in increased expression of CYP3A5,,,PMID:15897249,https://www.ncbi.nlm.nih.gov/pubmed/15897249,15897249,,
199,1390697,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606.0,Homo sapiens (human),CYP3A5 protein results in increased metabolism of irinotecan,,,PMID:16271446,https://www.ncbi.nlm.nih.gov/pubmed/16271446,16271446,,
200,1390698,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,1580,CYP4B1,https://ctdbase.org/detail.go?type=gene&acc=1580,,,1580.0,CYP4B1,10116.0,Rattus norvegicus (Norway rat),Irinotecan affects the expression of CYP4B1 mRNA,,,PMID:20097248,https://www.ncbi.nlm.nih.gov/pubmed/20097248,20097248,,
201,1391909,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,2669,GEM,https://ctdbase.org/detail.go?type=gene&acc=2669,,,2669.0,GEM,10116.0,Rattus norvegicus (Norway rat),Irinotecan results in increased expression of GEM mRNA,,,PMID:20097248,https://www.ncbi.nlm.nih.gov/pubmed/20097248,20097248,,
202,1391910,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,2678,GGT1,https://ctdbase.org/detail.go?type=gene&acc=2678,,,2678.0,GGT1,9606.0,Homo sapiens (human),Irinotecan analog results in decreased expression of GGT1 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
203,1391911,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,9606.0,Homo sapiens (human),Irinotecan analog affects the expression of GJA1 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
204,1391912,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,10116.0,Rattus norvegicus (Norway rat),Irinotecan results in increased expression of GJA1 mRNA,,,PMID:20097248,https://www.ncbi.nlm.nih.gov/pubmed/20097248,20097248,,
205,1392279,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3099,HK2,https://ctdbase.org/detail.go?type=gene&acc=3099,,,3099.0,HK2,10116.0,Rattus norvegicus (Norway rat),Irinotecan affects the expression of HK2 mRNA,,,PMID:20097248,https://www.ncbi.nlm.nih.gov/pubmed/20097248,20097248,,
206,1392280,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3106,HLA-B,https://ctdbase.org/detail.go?type=gene&acc=3106,,,3106.0,HLA-B,9606.0,Homo sapiens (human),Irinotecan analog results in decreased expression of HLA-B mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
207,1392405,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,83982,IFI27L2,https://ctdbase.org/detail.go?type=gene&acc=83982,,,83982.0,IFI27L2,9606.0,Homo sapiens (human),[fluorouracil co-treated with irinotecan] results in increased expression of IFI27L2 mRNA,,,PMID:16391804,https://www.ncbi.nlm.nih.gov/pubmed/16391804,16391804,,
208,1392406,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,2537,IFI6,https://ctdbase.org/detail.go?type=gene&acc=2537,,,2537.0,IFI6,9606.0,Homo sapiens (human),Irinotecan analog results in increased expression of IFI6 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
209,1392407,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,8519,IFITM1,https://ctdbase.org/detail.go?type=gene&acc=8519,,,8519.0,IFITM1,9606.0,Homo sapiens (human),Irinotecan analog results in increased expression of IFITM1 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
210,1392863,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,10116.0,Rattus norvegicus (Norway rat),Thalidomide promotes the reaction [irinotecan results in decreased expression of IL2 protein]|thalidomide inhibits the reaction [irinotecan results in decreased expression of IL2 protein]|irinotecan results in decreased expression of IL2 protein,,,PMID:16815871,https://www.ncbi.nlm.nih.gov/pubmed/16815871,16815871,,
211,1392864,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,90865,IL33,https://ctdbase.org/detail.go?type=gene&acc=90865,,,90865.0,IL33,9606.0,Homo sapiens (human),Irinotecan results in increased expression of IL33 mrna|irinotecan results in increased secretion of IL33 protein|luteolin inhibits the reaction [irinotecan results in increased secretion of IL33 protein]|rosiglitazone inhibits the reaction [irinotecan results in increased secretion of IL33 protein]|luteolin inhibits the reaction [irinotecan results in increased expression of IL33 mrna]|rosiglitazone inhibits the reaction [irinotecan results in increased expression of IL33 mrna],,,PMID:34699766,https://www.ncbi.nlm.nih.gov/pubmed/34699766,34699766,,
212,1392865,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),IL6 protein results in decreased susceptibility to irinotecan,,,PMID:17537833,https://www.ncbi.nlm.nih.gov/pubmed/17537833,17537833,,
213,1392866,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Irinotecan results in increased expression of IL6 mRNA,,,PMID:26431797|PMID:35728726,https://www.ncbi.nlm.nih.gov/pubmed/26431797|https://www.ncbi.nlm.nih.gov/pubmed/35728726,26431797|35728726,,
214,1392867,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Irinotecan results in increased expression of IL6 protein,,,PMID:26431797|PMID:28454924,https://www.ncbi.nlm.nih.gov/pubmed/26431797|https://www.ncbi.nlm.nih.gov/pubmed/28454924,26431797|28454924,,
215,1392868,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),TLR2 protein affects the reaction [irinotecan results in increased expression of IL6 mrna]|myd88 protein affects the reaction [irinotecan results in increased expression of IL6 mrna]|tlr4 protein affects the reaction [irinotecan results in increased expression of IL6 mrna],,,PMID:35728726,https://www.ncbi.nlm.nih.gov/pubmed/35728726,35728726,,
216,1392869,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Silymarin inhibits the reaction [irinotecan results in increased expression of IL6 protein],,,PMID:28454924,https://www.ncbi.nlm.nih.gov/pubmed/28454924,28454924,,
217,1392870,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Irinotecan inhibits the reaction [mitogens results in increased expression of IL6 protein]|ciprofloxacin inhibits the reaction [irinotecan inhibits the reaction [mitogens results in increased expression of IL6 protein]]|irinotecan promotes the reaction [mitogens results in increased expression of IL6 protein]|ciprofloxacin inhibits the reaction [irinotecan promotes the reaction [mitogens results in increased expression of IL6 protein]],,,PMID:19401694,https://www.ncbi.nlm.nih.gov/pubmed/19401694,19401694,,
218,1393116,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,51155,JPT1,https://ctdbase.org/detail.go?type=gene&acc=51155,,,51155.0,JPT1,9606.0,Homo sapiens (human),Irinotecan analog results in decreased expression of JPT1 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
219,1393117,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Irinotecan results in increased expression of JUN mrna|irinotecan metabolite results in increased expression of JUN mRNA,,,PMID:15956246,https://www.ncbi.nlm.nih.gov/pubmed/15956246,15956246,,
220,1393118,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10116.0,Rattus norvegicus (Norway rat),Irinotecan results in increased expression of JUN mRNA,,,PMID:20097248,https://www.ncbi.nlm.nih.gov/pubmed/20097248,20097248,,
221,1393119,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,284058,KANSL1,https://ctdbase.org/detail.go?type=gene&acc=284058,,,284058.0,KANSL1,9606.0,Homo sapiens (human),KANSL1 protein affects the susceptibility to [fluorouracil co-treated with irinotecan analog],,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
222,1393120,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,8850,KAT2B,https://ctdbase.org/detail.go?type=gene&acc=8850,,,8850.0,KAT2B,9606.0,Homo sapiens (human),Irinotecan analog results in increased expression of KAT2B mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
223,1393121,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,3764,KCNJ8,https://ctdbase.org/detail.go?type=gene&acc=3764,,,3764.0,KCNJ8,10116.0,Rattus norvegicus (Norway rat),Irinotecan results in increased expression of KCNJ8 mRNA,,,PMID:20097248,https://www.ncbi.nlm.nih.gov/pubmed/20097248,20097248,,
224,1393122,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,10657,KHDRBS1,https://ctdbase.org/detail.go?type=gene&acc=10657,,,10657.0,KHDRBS1,9606.0,Homo sapiens (human),Irinotecan analog results in decreased expression of KHDRBS1 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
225,1393123,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,9674,KIAA0040,https://ctdbase.org/detail.go?type=gene&acc=9674,,,9674.0,KIAA0040,9606.0,Homo sapiens (human),Irinotecan analog results in increased expression of KIAA0040 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
226,1393124,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,9928,KIF14,https://ctdbase.org/detail.go?type=gene&acc=9928,,,9928.0,KIF14,9606.0,Homo sapiens (human),Irinotecan analog results in decreased expression of KIF14 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
227,1393125,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314.0,KLF4,9606.0,Homo sapiens (human),Irinotecan analog results in increased expression of KLF4 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
228,1393126,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,687,KLF9,https://ctdbase.org/detail.go?type=gene&acc=687,,,687.0,KLF9,9606.0,Homo sapiens (human),Irinotecan metabolite results in increased expression of KLF9 mrna|irinotecan results in increased expression of KLF9 mRNA,,,PMID:15956246,https://www.ncbi.nlm.nih.gov/pubmed/15956246,15956246,,
229,1394427,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,10090.0,Mus musculus (house mouse),Irinotecan affects the expression of NR1I2 mrna|tlr4 protein affects the reaction [irinotecan affects the expression of NR1I2 mrna]|tlr2 protein affects the reaction [irinotecan affects the expression of NR1I2 mrna]|myd88 protein affects the reaction [irinotecan affects the expression of NR1I2 mrna],,,PMID:35728726,https://www.ncbi.nlm.nih.gov/pubmed/35728726,35728726,,
230,1394428,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,10090.0,Mus musculus (house mouse),Irinotecan affects the expression of NR1I3 mrna|tlr4 protein affects the reaction [irinotecan affects the expression of NR1I3 mrna]|tlr2 protein affects the reaction [irinotecan affects the expression of NR1I3 mrna]|myd88 protein affects the reaction [irinotecan affects the expression of NR1I3 mrna],,,PMID:35728726,https://www.ncbi.nlm.nih.gov/pubmed/35728726,35728726,,
231,1394429,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,9606.0,Homo sapiens (human),NR3C1 protein results in decreased susceptibility to irinotecan,,,PMID:16734730,https://www.ncbi.nlm.nih.gov/pubmed/16734730,16734730,,
232,1394430,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,4306,NR3C2,https://ctdbase.org/detail.go?type=gene&acc=4306,,,4306.0,NR3C2,10116.0,Rattus norvegicus (Norway rat),Irinotecan affects the expression of NR3C2 mRNA,,,PMID:20097248,https://www.ncbi.nlm.nih.gov/pubmed/20097248,20097248,,
233,1394431,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,8204,NRIP1,https://ctdbase.org/detail.go?type=gene&acc=8204,,,8204.0,NRIP1,9606.0,Homo sapiens (human),[fluorouracil co-treated with irinotecan] results in increased expression of NRIP1 mRNA,,,PMID:16391804,https://www.ncbi.nlm.nih.gov/pubmed/16391804,16391804,,
234,1394432,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,4905,NSF,https://ctdbase.org/detail.go?type=gene&acc=4905,,,4905.0,NSF,9606.0,Homo sapiens (human),Irinotecan analog results in decreased expression of NSF mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
235,1394433,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,8439,NSMAF,https://ctdbase.org/detail.go?type=gene&acc=8439,,,8439.0,NSMAF,9606.0,Homo sapiens (human),Irinotecan results in decreased expression of NSMAF mRNA,,,PMID:20185912,https://www.ncbi.nlm.nih.gov/pubmed/20185912,20185912,,
236,1394434,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,9972,NUP153,https://ctdbase.org/detail.go?type=gene&acc=9972,,,9972.0,NUP153,9606.0,Homo sapiens (human),Irinotecan analog results in decreased expression of NUP153 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
237,1395234,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,5562,PRKAA1,https://ctdbase.org/detail.go?type=gene&acc=5562,,,5562.0,PRKAA1,9606.0,Homo sapiens (human),Irinotecan analog results in decreased expression of PRKAA1 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
238,1395235,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,9606.0,Homo sapiens (human),Irinotecan metabolite results in increased phosphorylation of PRKCA protein|irinotecan results in increased phosphorylation of PRKCA protein,,,PMID:15723263,https://www.ncbi.nlm.nih.gov/pubmed/15723263,15723263,,
239,1395236,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,9606.0,Homo sapiens (human),Irinotecan results in increased phosphorylation of PRKCB protein|irinotecan metabolite results in increased phosphorylation of PRKCB protein,,,PMID:15723263,https://www.ncbi.nlm.nih.gov/pubmed/15723263,15723263,,
240,1395237,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Irinotecan metabolite results in increased phosphorylation of PRKCD protein|irinotecan results in increased phosphorylation of PRKCD protein,,,PMID:15723263,https://www.ncbi.nlm.nih.gov/pubmed/15723263,15723263,,
241,1395238,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,5584,PRKCI,https://ctdbase.org/detail.go?type=gene&acc=5584,,,5584.0,PRKCI,9606.0,Homo sapiens (human),Irinotecan results in increased phosphorylation of PRKCI protein|irinotecan metabolite results in increased phosphorylation of PRKCI protein,,,PMID:15723263,https://www.ncbi.nlm.nih.gov/pubmed/15723263,15723263,,
242,1395239,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,5591,PRKDC,https://ctdbase.org/detail.go?type=gene&acc=5591,,,5591.0,PRKDC,9606.0,Homo sapiens (human),IC486241 inhibits the reaction [irinotecan results in increased phosphorylation of PRKDC protein],,,PMID:21221710,https://www.ncbi.nlm.nih.gov/pubmed/21221710,21221710,,
243,1395240,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,5591,PRKDC,https://ctdbase.org/detail.go?type=gene&acc=5591,,,5591.0,PRKDC,9606.0,Homo sapiens (human),Irinotecan results in increased phosphorylation of PRKDC protein,,,PMID:17441964|PMID:21221710,https://www.ncbi.nlm.nih.gov/pubmed/17441964|https://www.ncbi.nlm.nih.gov/pubmed/21221710,17441964|21221710,,
244,1395241,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,5618,PRLR,https://ctdbase.org/detail.go?type=gene&acc=5618,,,5618.0,PRLR,10116.0,Rattus norvegicus (Norway rat),Irinotecan affects the expression of PRLR mRNA,,,PMID:20097248,https://www.ncbi.nlm.nih.gov/pubmed/20097248,20097248,,
245,1395242,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,8842,PROM1,https://ctdbase.org/detail.go?type=gene&acc=8842,,,8842.0,PROM1,9606.0,Homo sapiens (human),Irinotecan metabolite results in decreased expression of PROM1 mrna|irinotecan results in decreased expression of PROM1 mRNA,,,PMID:15956246,https://www.ncbi.nlm.nih.gov/pubmed/15956246,15956246,,
246,1395243,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,54458,PRR13,https://ctdbase.org/detail.go?type=gene&acc=54458,,,54458.0,PRR13,9606.0,Homo sapiens (human),[fluorouracil co-treated with irinotecan] results in increased expression of PRR13 mRNA,,,PMID:16391804,https://www.ncbi.nlm.nih.gov/pubmed/16391804,16391804,,
247,1395369,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,7803,PTP4A1,https://ctdbase.org/detail.go?type=gene&acc=7803,,,7803.0,PTP4A1,9606.0,Homo sapiens (human),Irinotecan analog results in decreased expression of PTP4A1 mRNA,,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
248,1395370,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,5783,PTPN13,https://ctdbase.org/detail.go?type=gene&acc=5783,,,5783.0,PTPN13,9606.0,Homo sapiens (human),Irinotecan metabolite results in decreased expression of PTPN13 mrna|irinotecan results in decreased expression of PTPN13 mRNA,,,PMID:15956246,https://www.ncbi.nlm.nih.gov/pubmed/15956246,15956246,,
249,1398927,60937,DrugBank,Tiludronic Acid,DB01133,Tiludronic acid,https://www.drugbank.ca/drugs/DB01133,BE0009961,V-type proton ATPase subunit C 1,https://www.drugbank.ca/bio_entities/BE0009961,P21283,V-type proton ATPase subunit C 1,528.0,ATP6V1C1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:8889850|PMID:22652318|PMID:30555553,https://www.ncbi.nlm.nih.gov/pubmed/8889850|https://www.ncbi.nlm.nih.gov/pubmed/22652318|https://www.ncbi.nlm.nih.gov/pubmed/30555553,8889850|22652318|30555553,,
250,1398928,60937,DrugBank,Tiludronic Acid,DB01133,Tiludronic acid,https://www.drugbank.ca/drugs/DB01133,BE0009961,V-type proton ATPase subunit C 2,https://www.drugbank.ca/bio_entities/BE0009961,Q8NEY4,V-type proton ATPase subunit C 2,245973.0,ATP6V1C2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:8889850|PMID:22652318|PMID:30555553,https://www.ncbi.nlm.nih.gov/pubmed/8889850|https://www.ncbi.nlm.nih.gov/pubmed/22652318|https://www.ncbi.nlm.nih.gov/pubmed/30555553,8889850|22652318|30555553,,
251,1398929,60937,DrugBank,Tiludronic Acid,DB01133,Tiludronic acid,https://www.drugbank.ca/drugs/DB01133,BE0009961,V-type proton ATPase subunit D,https://www.drugbank.ca/bio_entities/BE0009961,Q9Y5K8,V-type proton ATPase subunit D,51382.0,ATP6V1D,9606.0,Homo sapiens (human),Inhibitor,,,PMID:8889850|PMID:22652318|PMID:30555553,https://www.ncbi.nlm.nih.gov/pubmed/8889850|https://www.ncbi.nlm.nih.gov/pubmed/22652318|https://www.ncbi.nlm.nih.gov/pubmed/30555553,8889850|22652318|30555553,,
252,1398930,60937,DrugBank,Tiludronic Acid,DB01133,Tiludronic acid,https://www.drugbank.ca/drugs/DB01133,BE0009961,V-type proton ATPase subunit d 1,https://www.drugbank.ca/bio_entities/BE0009961,P61421,V-type proton ATPase subunit d 1,9114.0,ATP6V0D1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:8889850|PMID:22652318|PMID:30555553,https://www.ncbi.nlm.nih.gov/pubmed/8889850|https://www.ncbi.nlm.nih.gov/pubmed/22652318|https://www.ncbi.nlm.nih.gov/pubmed/30555553,8889850|22652318|30555553,,
253,1399160,60937,DrugBank,Tiludronic Acid,DB01133,Tiludronic acid,https://www.drugbank.ca/drugs/DB01133,BE0009961,V-type proton ATPase subunit H,https://www.drugbank.ca/bio_entities/BE0009961,Q9UI12,V-type proton ATPase subunit H,51606.0,ATP6V1H,9606.0,Homo sapiens (human),Inhibitor,,,PMID:8889850|PMID:22652318|PMID:30555553,https://www.ncbi.nlm.nih.gov/pubmed/8889850|https://www.ncbi.nlm.nih.gov/pubmed/22652318|https://www.ncbi.nlm.nih.gov/pubmed/30555553,8889850|22652318|30555553,,
254,1399161,60937,DrugBank,Tiludronic Acid,DB01133,Tiludronic acid,https://www.drugbank.ca/drugs/DB01133,BE0009961,V-type proton ATPase subunit S1,https://www.drugbank.ca/bio_entities/BE0009961,Q15904,V-type proton ATPase subunit S1,537.0,ATP6AP1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:8889850|PMID:22652318|PMID:30555553,https://www.ncbi.nlm.nih.gov/pubmed/8889850|https://www.ncbi.nlm.nih.gov/pubmed/22652318|https://www.ncbi.nlm.nih.gov/pubmed/30555553,8889850|22652318|30555553,,
255,1399162,60937,DrugBank,Tiludronic Acid,DB01133,Tiludronic acid,https://www.drugbank.ca/drugs/DB01133,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Binder,,,,,,,
256,1399163,60949,Drug Gene Interaction database (DGIdb),Apaxifylline,,APAXIFYLLINE,https://www.dgidb.org/drugs/ncit:C81046,,ADORA1,https://www.dgidb.org/genes/hgnc:262,,,134.0,ADORA1,9606.0,Homo sapiens (human),,,,,,,,
257,1399164,60953,Drug Gene Interaction database (DGIdb),Capecitabine,,CAPECITABINE,https://www.dgidb.org/drugs/rxcui:194000,,ATM,https://www.dgidb.org/genes/hgnc:795,,,472.0,ATM,9606.0,Homo sapiens (human),,,,,,,,
258,1399165,60953,Drug Gene Interaction database (DGIdb),Capecitabine,,CAPECITABINE,https://www.dgidb.org/drugs/rxcui:194000,,DPYD,https://www.dgidb.org/genes/hgnc:3012,,,1806.0,DPYD,9606.0,Homo sapiens (human),,,,,,,,
259,1399166,60953,Drug Gene Interaction database (DGIdb),Capecitabine,,CAPECITABINE,https://www.dgidb.org/drugs/rxcui:194000,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
260,1399167,60953,Drug Gene Interaction database (DGIdb),Capecitabine,,CAPECITABINE,https://www.dgidb.org/drugs/rxcui:194000,,TYMS,https://www.dgidb.org/genes/hgnc:12441,,,7298.0,TYMS,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
261,1399168,61100,Drug Gene Interaction database (DGIdb),Phenelzine Sulfate,,PHENELZINE SULFATE,https://www.dgidb.org/drugs/rxcui:8124,,MAOB,https://www.dgidb.org/genes/hgnc:6834,,,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
262,1399838,61565,Comparative Toxicogenomics Database (CTD),Erionite,C083174,erionite,https://ctdbase.org/detail.go?type=chem&acc=C083174,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Erionite results in increased secretion of IL1B protein|erionite results in increased expression of IL1B mRNA,,,PMID:23937860,https://www.ncbi.nlm.nih.gov/pubmed/23937860,23937860,,
263,1399839,61565,Comparative Toxicogenomics Database (CTD),Erionite,C083174,erionite,https://ctdbase.org/detail.go?type=chem&acc=C083174,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),Erionite results in increased expression of IL4 protein,,,PMID:29279043,https://www.ncbi.nlm.nih.gov/pubmed/29279043,29279043,,
264,1399840,61565,Comparative Toxicogenomics Database (CTD),Erionite,C083174,erionite,https://ctdbase.org/detail.go?type=chem&acc=C083174,3567,IL5,https://ctdbase.org/detail.go?type=gene&acc=3567,,,3567.0,IL5,10090.0,Mus musculus (house mouse),Erionite results in increased expression of IL5 protein,,,PMID:29279043,https://www.ncbi.nlm.nih.gov/pubmed/29279043,29279043,,
265,1399841,61565,Comparative Toxicogenomics Database (CTD),Erionite,C083174,erionite,https://ctdbase.org/detail.go?type=chem&acc=C083174,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10116.0,Rattus norvegicus (Norway rat),Erionite results in increased expression of JUN mRNA,,,PMID:9705890,https://www.ncbi.nlm.nih.gov/pubmed/9705890,9705890,,
266,1399842,61565,Comparative Toxicogenomics Database (CTD),Erionite,C083174,erionite,https://ctdbase.org/detail.go?type=chem&acc=C083174,11275,KLHL2,https://ctdbase.org/detail.go?type=gene&acc=11275,,,11275.0,KLHL2,10090.0,Mus musculus (house mouse),Erionite results in decreased expression of KLHL2 mRNA,,,PMID:29279043,https://www.ncbi.nlm.nih.gov/pubmed/29279043,29279043,,
267,1400910,62347,Toxin and Toxin Target Database (T3DB),Glycoluril,T3D4830,Glycoluril,http://www.t3db.ca/toxins/T3D4830,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
268,1400911,62667,Drug Gene Interaction database (DGIdb),Aluminum potassium sulfate dodecahydrate,,"ALUM, POTASSIUM",https://www.dgidb.org/drugs/rxcui:221456,,EPCAM,https://www.dgidb.org/genes/hgnc:11529,,,4072.0,EPCAM,9606.0,Homo sapiens (human),,,,,,,,
269,1400912,62779,Toxin and Toxin Target Database (T3DB),trans-Oxazolam,T3D4651,Oxazolam,http://www.t3db.ca/toxins/T3D4651,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000795,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
270,1400913,62779,Toxin and Toxin Target Database (T3DB),trans-Oxazolam,T3D4651,Oxazolam,http://www.t3db.ca/toxins/T3D4651,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,http://www.t3db.ca/biodb/bio_entities/BE0000381,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606.0,Homo sapiens (human),,,,PMID:6738302|PMID:2867566,https://www.ncbi.nlm.nih.gov/pubmed/6738302|https://www.ncbi.nlm.nih.gov/pubmed/2867566,6738302|2867566,,
271,1400914,62779,Toxin and Toxin Target Database (T3DB),trans-Oxazolam,T3D4651,Oxazolam,http://www.t3db.ca/toxins/T3D4651,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,http://www.t3db.ca/biodb/bio_entities/BE0000523,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606.0,Homo sapiens (human),,,,PMID:6738302|PMID:2867566,https://www.ncbi.nlm.nih.gov/pubmed/6738302|https://www.ncbi.nlm.nih.gov/pubmed/2867566,6738302|2867566,,
272,1387058,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3490,IGFBP7,https://ctdbase.org/detail.go?type=gene&acc=3490,,,3490.0,IGFBP7,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IGFBP7 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
273,1387059,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3492,IGH,https://ctdbase.org/detail.go?type=gene&acc=3492,,,3492.0,IGH,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [lipopolysaccharides results in increased expression of IGH mrna]|2,5,2',5'-tetrachlorobiphenyl inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [lipopolysaccharides results in increased expression of IGH mrna]]",,,PMID:12628580,https://www.ncbi.nlm.nih.gov/pubmed/12628580,12628580,,
274,1387060,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,434036,IGKV13-85,https://ctdbase.org/detail.go?type=gene&acc=434036,,,434036.0,Igkv13-85,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IGKV13-85 mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
275,1387061,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,402665,IGLON5,https://ctdbase.org/detail.go?type=gene&acc=402665,,,402665.0,IGLON5,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IGLON5 mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
276,1387062,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,93185,IGSF8,https://ctdbase.org/detail.go?type=gene&acc=93185,,,93185.0,IGSF8,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IGSF8 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
277,1387180,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3596,IL13,https://ctdbase.org/detail.go?type=gene&acc=3596,,,3596.0,IL13,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl results in increased secretion of IL13 protein",,,PMID:29216392,https://www.ncbi.nlm.nih.gov/pubmed/29216392,29216392,,
278,1387181,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3600,IL15,https://ctdbase.org/detail.go?type=gene&acc=3600,,,3600.0,IL15,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL15 mRNA",,,PMID:28351761,https://www.ncbi.nlm.nih.gov/pubmed/28351761,28351761,,
279,1387182,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,55540,IL17RB,https://ctdbase.org/detail.go?type=gene&acc=55540,,,55540.0,IL17RB,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL17RB mRNA",,,PMID:19692669,https://www.ncbi.nlm.nih.gov/pubmed/19692669,19692669,,
280,1387183,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,132014,IL17RE,https://ctdbase.org/detail.go?type=gene&acc=132014,,,132014.0,IL17RE,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IL17RE mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
281,1387184,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl affects the expression of IL18 mRNA",,,PMID:21703328,https://www.ncbi.nlm.nih.gov/pubmed/21703328,21703328,,
282,1387185,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1A mRNA",,,PMID:26519613|PMID:28351761|PMID:35618242,https://www.ncbi.nlm.nih.gov/pubmed/26519613|https://www.ncbi.nlm.nih.gov/pubmed/28351761|https://www.ncbi.nlm.nih.gov/pubmed/35618242,26519613|28351761|35618242,,
283,1387302,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B mRNA",,,PMID:22262711|PMID:26519613|PMID:28351761|PMID:30768972|PMID:35618242,https://www.ncbi.nlm.nih.gov/pubmed/22262711|https://www.ncbi.nlm.nih.gov/pubmed/26519613|https://www.ncbi.nlm.nih.gov/pubmed/28351761|https://www.ncbi.nlm.nih.gov/pubmed/30768972|https://www.ncbi.nlm.nih.gov/pubmed/35618242,22262711|26519613|28351761|30768972|35618242,,
284,1387303,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),"Alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B mrna]",,,PMID:22262711,https://www.ncbi.nlm.nih.gov/pubmed/22262711,22262711,,
285,1387304,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B mRNA",,,PMID:29216392|PMID:37080397|PMID:37598416,https://www.ncbi.nlm.nih.gov/pubmed/29216392|https://www.ncbi.nlm.nih.gov/pubmed/37080397|https://www.ncbi.nlm.nih.gov/pubmed/37598416,29216392|37080397|37598416,,
286,1387305,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B protein|acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B protein]|melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B mrna]|acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B mrna]|melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B protein]",,,PMID:37598416,https://www.ncbi.nlm.nih.gov/pubmed/37598416,37598416,,
287,1387306,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl results in increased secretion of IL1B protein",,,PMID:29216392,https://www.ncbi.nlm.nih.gov/pubmed/29216392,29216392,,
288,1387887,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3643,INSR,https://ctdbase.org/detail.go?type=gene&acc=3643,,,3643.0,INSR,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl affects the expression of INSR mRNA",,,PMID:37080397,https://www.ncbi.nlm.nih.gov/pubmed/37080397,37080397,,
289,1387888,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,57117,INTS12,https://ctdbase.org/detail.go?type=gene&acc=57117,,,57117.0,INTS12,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of INTS12 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
290,1387889,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,100148736,IQSEC1B,https://ctdbase.org/detail.go?type=gene&acc=100148736,,,100148736.0,iqsec1b,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IQSEC1B mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
291,1387890,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,23096,IQSEC2,https://ctdbase.org/detail.go?type=gene&acc=23096,,,23096.0,IQSEC2,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IQSEC2 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
292,1389220,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3861,KRT14,https://ctdbase.org/detail.go?type=gene&acc=3861,,,3861.0,KRT14,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KRT14 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
293,1389221,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3866,KRT15,https://ctdbase.org/detail.go?type=gene&acc=3866,,,3866.0,KRT15,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KRT15 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
294,1389222,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3866,KRT15,https://ctdbase.org/detail.go?type=gene&acc=3866,,,3866.0,KRT15,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KRT15 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
295,1389223,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3875,KRT18,https://ctdbase.org/detail.go?type=gene&acc=3875,,,3875.0,KRT18,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KRT18 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
296,1389224,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3875,KRT18,https://ctdbase.org/detail.go?type=gene&acc=3875,,,3875.0,KRT18,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KRT18 mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
297,1389225,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3880,KRT19,https://ctdbase.org/detail.go?type=gene&acc=3880,,,3880.0,KRT19,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KRT19 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
298,1389226,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3851,KRT4,https://ctdbase.org/detail.go?type=gene&acc=3851,,,3851.0,KRT4,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KRT4 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
299,1389850,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,10990,LILRB5,https://ctdbase.org/detail.go?type=gene&acc=10990,,,10990.0,LILRB5,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LILRB5 mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
300,1389851,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3984,LIMK1,https://ctdbase.org/detail.go?type=gene&acc=3984,,,3984.0,LIMK1,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LIMK1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
301,1389852,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,735292,LIMK1A,https://ctdbase.org/detail.go?type=gene&acc=735292,,,735292.0,limk1a,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LIMK1A mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
302,1389853,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3985,LIMK2,https://ctdbase.org/detail.go?type=gene&acc=3985,,,3985.0,LIMK2,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LIMK2 mRNA",,,PMID:19692669,https://www.ncbi.nlm.nih.gov/pubmed/19692669,19692669,,
303,1389968,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,29995,LMCD1,https://ctdbase.org/detail.go?type=gene&acc=29995,,,29995.0,LMCD1,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LMCD1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
304,1389969,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,4001,LMNB1,https://ctdbase.org/detail.go?type=gene&acc=4001,,,4001.0,LMNB1,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LMNB1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
305,1389970,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,8543,LMO4,https://ctdbase.org/detail.go?type=gene&acc=8543,,,8543.0,LMO4,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LMO4 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
306,1389971,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,4008,LMO7,https://ctdbase.org/detail.go?type=gene&acc=4008,,,4008.0,LMO7,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LMO7 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
307,1389972,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,4012,LNPEP,https://ctdbase.org/detail.go?type=gene&acc=4012,,,4012.0,LNPEP,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LNPEP mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
308,1389973,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,4015,LOX,https://ctdbase.org/detail.go?type=gene&acc=4015,,,4015.0,LOX,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LOX mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
309,1389974,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,404621,LOXA,https://ctdbase.org/detail.go?type=gene&acc=404621,,,404621.0,loxa,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LOXA mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
310,1390830,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,69293.0,Gasterosteus aculeatus (three-spined stickleback),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1B1 mRNA",,,PMID:21354474,https://www.ncbi.nlm.nih.gov/pubmed/21354474,21354474,,
311,1390831,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),"Estradiol promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1B1 mrna]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1B1 mrna]|fulvestrant promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1B1 mrna]",,,PMID:21513769,https://www.ncbi.nlm.nih.gov/pubmed/21513769,21513769,,
312,1390832,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl affects the expression of CYP1B1 mRNA",,,PMID:21703328,https://www.ncbi.nlm.nih.gov/pubmed/21703328,21703328,,
313,1392271,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,8525,DGKZ,https://ctdbase.org/detail.go?type=gene&acc=8525,,,8525.0,DGKZ,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of DGKZ mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
314,1392272,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,1717,DHCR7,https://ctdbase.org/detail.go?type=gene&acc=1717,,,1717.0,DHCR7,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DHCR7 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
315,1392273,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,50846,DHH,https://ctdbase.org/detail.go?type=gene&acc=50846,,,50846.0,DHH,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of DHH mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
316,1392274,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,553684,DHRS7CB,https://ctdbase.org/detail.go?type=gene&acc=553684,,,553684.0,dhrs7cb,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of DHRS7CB mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
317,1392275,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,10170,DHRS9,https://ctdbase.org/detail.go?type=gene&acc=10170,,,10170.0,DHRS9,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl affects the expression of DHRS9 mRNA",,,PMID:21703328,https://www.ncbi.nlm.nih.gov/pubmed/21703328,21703328,,
318,1392276,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,23405,DICER1,https://ctdbase.org/detail.go?type=gene&acc=23405,,,23405.0,DICER1,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DICER1 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
319,1392277,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,1733,DIO1,https://ctdbase.org/detail.go?type=gene&acc=1733,,,1733.0,DIO1,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of DIO1 mRNA",,,PMID:20959002,https://www.ncbi.nlm.nih.gov/pubmed/20959002,20959002,,
320,1392278,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,568954,DIP2BB,https://ctdbase.org/detail.go?type=gene&acc=568954,,,568954.0,dip2bb,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DIP2BB mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
321,1392508,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,562742,DLGAP4A,https://ctdbase.org/detail.go?type=gene&acc=562742,,,562742.0,dlgap4a,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DLGAP4A mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
322,1392509,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,8788,DLK1,https://ctdbase.org/detail.go?type=gene&acc=8788,,,8788.0,DLK1,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of DLK1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
323,1392739,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,1803,DPP4,https://ctdbase.org/detail.go?type=gene&acc=1803,,,1803.0,DPP4,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DPP4 mRNA",,,PMID:37080397,https://www.ncbi.nlm.nih.gov/pubmed/37080397,37080397,,
324,1392740,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,1809,DPYSL3,https://ctdbase.org/detail.go?type=gene&acc=1809,,,1809.0,DPYSL3,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DPYSL3 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
325,1392741,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,568643,DSCAMA,https://ctdbase.org/detail.go?type=gene&acc=568643,,,568643.0,dscama,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DSCAMA mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
326,1392742,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,386937,DSCAMB,https://ctdbase.org/detail.go?type=gene&acc=386937,,,386937.0,dscamb,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DSCAMB mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
327,1392743,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,57453,DSCAML1,https://ctdbase.org/detail.go?type=gene&acc=57453,,,57453.0,DSCAML1,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DSCAML1 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
328,1392744,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,1838,DTNB,https://ctdbase.org/detail.go?type=gene&acc=1838,,,1838.0,DTNB,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of DTNB mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
329,1392860,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,124454,EARS2,https://ctdbase.org/detail.go?type=gene&acc=124454,,,124454.0,EARS2,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of EARS2 mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
330,1392861,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,565310,EBF1A,https://ctdbase.org/detail.go?type=gene&acc=565310,,,565310.0,ebf1a,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of EBF1A mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
331,1392862,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,567751,EBF3A,https://ctdbase.org/detail.go?type=gene&acc=567751,,,567751.0,ebf3a,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of EBF3A mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
332,1393232,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,23301,EHBP1,https://ctdbase.org/detail.go?type=gene&acc=23301,,,23301.0,EHBP1,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of EHBP1 mRNA",,,PMID:20959002,https://www.ncbi.nlm.nih.gov/pubmed/20959002,20959002,,
333,1393233,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,557083,EHBP1L1A,https://ctdbase.org/detail.go?type=gene&acc=557083,,,557083.0,ehbp1l1a,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of EHBP1L1A mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
334,1393234,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,30845,EHD3,https://ctdbase.org/detail.go?type=gene&acc=30845,,,30845.0,EHD3,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl affects the expression of EHD3 mRNA",,,PMID:20702594,https://www.ncbi.nlm.nih.gov/pubmed/20702594,20702594,,
335,1393235,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,1964,EIF1AX,https://ctdbase.org/detail.go?type=gene&acc=1964,,,1964.0,EIF1AX,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl affects the expression of EIF1AX mRNA",,,PMID:21703328,https://www.ncbi.nlm.nih.gov/pubmed/21703328,21703328,,
336,1393236,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,561049,EIF3EB,https://ctdbase.org/detail.go?type=gene&acc=561049,,,561049.0,eif3eb,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of EIF3EB mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
337,1393237,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,8665,EIF3F,https://ctdbase.org/detail.go?type=gene&acc=8665,,,8665.0,EIF3F,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of EIF3F mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
338,1395233,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in decreased phosphorylation of FOXO3 protein|3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [benzo(a)pyrene results in increased phosphorylation of FOXO3 protein]|mdm2 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased phosphorylation of FOXO3 protein]",,,PMID:20840854,https://www.ncbi.nlm.nih.gov/pubmed/20840854,20840854,,
339,1395493,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,325423,FSTL1A,https://ctdbase.org/detail.go?type=gene&acc=325423,,,325423.0,fstl1a,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FSTL1A mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
340,1395494,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2512,FTL,https://ctdbase.org/detail.go?type=gene&acc=2512,,,2512.0,FTL,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FTL protein",,,PMID:25686467,https://www.ncbi.nlm.nih.gov/pubmed/25686467,25686467,,
341,1395495,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2517,FUCA1,https://ctdbase.org/detail.go?type=gene&acc=2517,,,2517.0,FUCA1,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FUCA1 mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
342,1395496,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2521,FUS,https://ctdbase.org/detail.go?type=gene&acc=2521,,,2521.0,FUS,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FUS mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
343,1396155,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2645,GCK,https://ctdbase.org/detail.go?type=gene&acc=2645,,,2645.0,GCK,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl affects the expression of GCK mRNA",,,PMID:37080397,https://www.ncbi.nlm.nih.gov/pubmed/37080397,37080397,,
344,1396156,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2645,GCK,https://ctdbase.org/detail.go?type=gene&acc=2645,,,2645.0,GCK,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GCK mRNA",,,PMID:20959002,https://www.ncbi.nlm.nih.gov/pubmed/20959002,20959002,,
345,1396157,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2646,GCKR,https://ctdbase.org/detail.go?type=gene&acc=2646,,,2646.0,GCKR,10116.0,Rattus norvegicus (Norway rat),"AHR gene mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GCKR mrna]|3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GCKR mRNA",,,PMID:34256052,https://www.ncbi.nlm.nih.gov/pubmed/34256052,34256052,,
346,1396158,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GCLC mRNA",,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
347,1396159,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GCLC mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
348,1396160,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2650,GCNT1,https://ctdbase.org/detail.go?type=gene&acc=2650,,,2650.0,GCNT1,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GCNT1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
349,1396161,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2651,GCNT2,https://ctdbase.org/detail.go?type=gene&acc=2651,,,2651.0,GCNT2,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GCNT2 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
350,1397212,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2937,GSS,https://ctdbase.org/detail.go?type=gene&acc=2937,,,2937.0,GSS,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GSS mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
351,1397213,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,10090.0,Mus musculus (house mouse),"[3,4,5,3',4'-pentachlorobiphenyl co-treated with sunphenon] affects the expression of GSTA1 mRNA",,,PMID:24378064,https://www.ncbi.nlm.nih.gov/pubmed/24378064,24378064,,
352,1397214,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GSTA1 mRNA",,,PMID:37080397,https://www.ncbi.nlm.nih.gov/pubmed/37080397,37080397,,
353,1399589,63094,Toxin and Toxin Target Database (T3DB),"2,3,4',5,6-Pentachlorobiphenyl",T3D0506,"2,3,4',5,6-Pentachlorobiphenyl",http://www.t3db.ca/toxins/T3D0506,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
354,1399590,63095,Toxin and Toxin Target Database (T3DB),"2,2',3,5,6'-Pentachlorobiphenyl",T3D0483,"2,2',3,5,6'-Pentachlorobiphenyl",http://www.t3db.ca/toxins/T3D0483,BE0000792,Estrogen receptor beta,http://www.t3db.ca/biodb/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606.0,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
355,1399591,63095,Toxin and Toxin Target Database (T3DB),"2,2',3,5,6'-Pentachlorobiphenyl",T3D0483,"2,2',3,5,6'-Pentachlorobiphenyl",http://www.t3db.ca/toxins/T3D0483,BE0000951,Estrogen sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000951,P49888,Sulfotransferase 1E1,6783.0,SULT1E1,9606.0,Homo sapiens (human),"Pcbs can cause endocrine disurption by binding to estrogen sulfotransferase, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. (A3, A66)",,,PMID:11386736|PMID:10803601,https://www.ncbi.nlm.nih.gov/pubmed/11386736|https://www.ncbi.nlm.nih.gov/pubmed/10803601,11386736|10803601,,
356,1399592,63095,Toxin and Toxin Target Database (T3DB),"2,2',3,5,6'-Pentachlorobiphenyl",T3D0483,"2,2',3,5,6'-Pentachlorobiphenyl",http://www.t3db.ca/toxins/T3D0483,BE0002151,Aromatic-L-amino-acid decarboxylase,http://www.t3db.ca/biodb/bio_entities/BE0002151,P20711,Aromatic-L-amino-acid decarboxylase,1644.0,DDC,9606.0,Homo sapiens (human),PCB inhibition of aromatic-L-amino-acid decarboxylase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
357,1401516,64139,Comparative Toxicogenomics Database (CTD),Efavirenz,C098320,efavirenz,https://ctdbase.org/detail.go?type=chem&acc=C098320,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9606.0,Homo sapiens (human),Efavirenz results in decreased expression of ADIPOQ mrna|efavirenz results in decreased secretion of ADIPOQ protein,,,PMID:21619898,https://www.ncbi.nlm.nih.gov/pubmed/21619898,21619898,,
358,1401517,64139,Comparative Toxicogenomics Database (CTD),Efavirenz,C098320,efavirenz,https://ctdbase.org/detail.go?type=chem&acc=C098320,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606.0,Homo sapiens (human),Efavirenz binds to ALB protein,,,PMID:15814459|PMID:16336266,https://www.ncbi.nlm.nih.gov/pubmed/15814459|https://www.ncbi.nlm.nih.gov/pubmed/16336266,15814459|16336266,,
359,1401518,64139,Comparative Toxicogenomics Database (CTD),Efavirenz,C098320,efavirenz,https://ctdbase.org/detail.go?type=chem&acc=C098320,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018.0,BCL2L11,9606.0,Homo sapiens (human),Efavirenz metabolite results in increased expression of BCL2L11 protein|efavirenz results in increased expression of BCL2L11 protein|efavirenz results in increased expression of BCL2L11 mrna|efavirenz metabolite results in increased expression of BCL2L11 mrna|bcl2l11 protein results in increased susceptibility to efavirenz metabolite,,,PMID:21958719,https://www.ncbi.nlm.nih.gov/pubmed/21958719,21958719,,
360,1401519,64139,Comparative Toxicogenomics Database (CTD),Efavirenz,C098320,efavirenz,https://ctdbase.org/detail.go?type=chem&acc=C098320,821,CANX,https://ctdbase.org/detail.go?type=gene&acc=821,,,821.0,CANX,9606.0,Homo sapiens (human),Efavirenz affects the localization of CANX protein,,,PMID:28940366,https://www.ncbi.nlm.nih.gov/pubmed/28940366,28940366,,
361,1401520,64139,Comparative Toxicogenomics Database (CTD),Efavirenz,C098320,efavirenz,https://ctdbase.org/detail.go?type=chem&acc=C098320,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Efavirenz results in increased cleavage of and results in increased activity of CASP3 protein|efavirenz metabolite results in increased cleavage of and results in increased activity of CASP3 protein,,,PMID:21958719,https://www.ncbi.nlm.nih.gov/pubmed/21958719,21958719,,
362,1401521,64139,Comparative Toxicogenomics Database (CTD),Efavirenz,C098320,efavirenz,https://ctdbase.org/detail.go?type=chem&acc=C098320,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Zinc inhibits the reaction [[efavirenz co-treated with lamivudine co-treated with tenofovir] results in increased activity of CASP3 protein]|[efavirenz co-treated with lamivudine co-treated with tenofovir] results in increased activity of CASP3 protein,,,PMID:36309141,https://www.ncbi.nlm.nih.gov/pubmed/36309141,36309141,,
363,1401522,64139,Comparative Toxicogenomics Database (CTD),Efavirenz,C098320,efavirenz,https://ctdbase.org/detail.go?type=chem&acc=C098320,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),[efavirenz co-treated with lamivudine co-treated with tenofovir] results in decreased activity of CAT protein,,,PMID:34118364,https://www.ncbi.nlm.nih.gov/pubmed/34118364,34118364,,
364,1400294,64718,Comparative Toxicogenomics Database (CTD),Simvastatin acid,C063287,simvastatin acid,https://ctdbase.org/detail.go?type=chem&acc=C063287,28232,SLCO3A1,https://ctdbase.org/detail.go?type=gene&acc=28232,,,28232.0,SLCO3A1,9606.0,Homo sapiens (human),Simvastatin acid results in decreased expression of SLCO3A1 protein|indican promotes the reaction [SLCO3A1 protein results in increased uptake of simvastatin acid]|estrone sulfate promotes the reaction [SLCO3A1 protein results in increased uptake of simvastatin acid]|cyclosporine promotes the reaction [SLCO3A1 protein results in increased uptake of simvastatin acid]|slco3a1 protein results in increased uptake of simvastatin acid|simvastatin acid affects the reaction [SLCO3A1 protein results in increased uptake of fluorescein]|penicillin G promotes the reaction [SLCO3A1 protein results in increased uptake of simvastatin acid],,,PMID:28887287,https://www.ncbi.nlm.nih.gov/pubmed/28887287,28887287,,
365,1400295,64735,Comparative Toxicogenomics Database (CTD),Lanthanum chloride,C028521,lanthanum chloride,https://ctdbase.org/detail.go?type=chem&acc=C028521,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,9606.0,Homo sapiens (human),[cerous chloride co-treated with lanthanum chloride] results in decreased expression of PRDX1 mRNA,,,PMID:28954213,https://www.ncbi.nlm.nih.gov/pubmed/28954213,28954213,,
366,1400640,64760,Comparative Toxicogenomics Database (CTD),Zomepirac glucuronide,C027368,zomepirac glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C027368,3577,CXCR1,https://ctdbase.org/detail.go?type=gene&acc=3577,,,3577.0,CXCR1,9606.0,Homo sapiens (human),Zomepirac glucuronide results in increased expression of CXCR1 mRNA,,,PMID:26528891,https://www.ncbi.nlm.nih.gov/pubmed/26528891,26528891,,
367,1400764,64760,Comparative Toxicogenomics Database (CTD),Zomepirac glucuronide,C027368,zomepirac glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C027368,4494,MT1F,https://ctdbase.org/detail.go?type=gene&acc=4494,,,4494.0,MT1F,9606.0,Homo sapiens (human),Zomepirac glucuronide results in increased expression of MT1F mRNA,,,PMID:26528891,https://www.ncbi.nlm.nih.gov/pubmed/26528891,26528891,,
368,1400765,64760,Comparative Toxicogenomics Database (CTD),Zomepirac glucuronide,C027368,zomepirac glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C027368,4495,MT1G,https://ctdbase.org/detail.go?type=gene&acc=4495,,,4495.0,MT1G,9606.0,Homo sapiens (human),Zomepirac glucuronide results in increased expression of MT1G mRNA,,,PMID:26528891,https://www.ncbi.nlm.nih.gov/pubmed/26528891,26528891,,
369,1400766,64760,Comparative Toxicogenomics Database (CTD),Zomepirac glucuronide,C027368,zomepirac glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C027368,4496,MT1H,https://ctdbase.org/detail.go?type=gene&acc=4496,,,4496.0,MT1H,9606.0,Homo sapiens (human),Zomepirac glucuronide results in increased expression of MT1H mRNA,,,PMID:26528891,https://www.ncbi.nlm.nih.gov/pubmed/26528891,26528891,,
370,1402233,64928,BindingDB,Clofop,28803,2-[4-(4-chlorophenoxy)phenoxy]propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28803,3441,Peroxisome proliferator-activated receptor alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3441,,,,,,,,,,PMID:18799592|DOI:10.1124/jpet.108.143271,https://www.ncbi.nlm.nih.gov/pubmed/18799592|https://doi.org/10.1124/jpet.108.143271,18799592,10.1124/jpet.108.143271,
371,1402234,64928,BindingDB,Clofop,28803,2-[4-(4-chlorophenoxy)phenoxy]propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28803,50001090,Peroxisome proliferator-activated receptor alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001090,P23204,Peroxisome proliferator-activated receptor alpha,19013.0,Ppara,10090.0,Mus musculus (house mouse),,,,PMID:18799592|DOI:10.1124/jpet.108.143271,https://www.ncbi.nlm.nih.gov/pubmed/18799592|https://doi.org/10.1124/jpet.108.143271,18799592,10.1124/jpet.108.143271,
372,1402235,64928,BindingDB,Clofop,28803,2-[4-(4-chlorophenoxy)phenoxy]propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28803,50001091,Peroxisome proliferator-activated receptor alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001091,P37230,Peroxisome proliferator-activated receptor alpha,25747.0,Ppara,10116.0,Rattus norvegicus (Norway rat),,,,PMID:18799592|DOI:10.1124/jpet.108.143271,https://www.ncbi.nlm.nih.gov/pubmed/18799592|https://doi.org/10.1124/jpet.108.143271,18799592,10.1124/jpet.108.143271,
373,1402236,64928,Comparative Toxicogenomics Database (CTD),Clofop,C006012,fenofibric acid,https://ctdbase.org/detail.go?type=chem&acc=C006012,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),[fenofibric acid binds to PPARA protein] which results in increased expression of ACADM mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of ASCC1 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of GNG12 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of AADAC mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of ABHD3 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of ISCA1 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of VNN1 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of SERPINE1 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of CAT mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of FABP1 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of ACSL1 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of HADHA mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of AQP3 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of PCK1 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of HADHB mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of ACADVL mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of CPT1A mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of SLC16A1 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of CEBPA mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of SLC25A20 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of ID2 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of PDZK1 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of TXNIP mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of ANGPTL4 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of HMOX1 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of PLIN2 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of TMEM53 mrna|[fenofibric acid binds to PPARA protein] which results in increased expression of HMGCS2 mRNA,,,PMID:16197558,https://www.ncbi.nlm.nih.gov/pubmed/16197558,16197558,,
374,1402237,64928,Comparative Toxicogenomics Database (CTD),Clofop,C006012,fenofibric acid,https://ctdbase.org/detail.go?type=chem&acc=C006012,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),Fenofibric acid results in increased activity of PPARA protein,,,PMID:15273253,https://www.ncbi.nlm.nih.gov/pubmed/15273253,15273253,,
375,1402465,64928,Comparative Toxicogenomics Database (CTD),Clofop,C006012,fenofibric acid,https://ctdbase.org/detail.go?type=chem&acc=C006012,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),Fenofibric acid results in decreased secretion of SERPINE1 protein|fenofibric acid results in decreased expression of SERPINE1 mRNA,,,PMID:10364093,https://www.ncbi.nlm.nih.gov/pubmed/10364093,10364093,,
376,1402466,64928,Comparative Toxicogenomics Database (CTD),Clofop,C006012,fenofibric acid,https://ctdbase.org/detail.go?type=chem&acc=C006012,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,9606.0,Homo sapiens (human),[fenofibric acid binds to PPARA protein] which results in increased expression of SLC16A1 mRNA,,,PMID:16197558,https://www.ncbi.nlm.nih.gov/pubmed/16197558,16197558,,
377,1402467,64928,Comparative Toxicogenomics Database (CTD),Clofop,C006012,fenofibric acid,https://ctdbase.org/detail.go?type=chem&acc=C006012,788,SLC25A20,https://ctdbase.org/detail.go?type=gene&acc=788,,,788.0,SLC25A20,9606.0,Homo sapiens (human),[fenofibric acid binds to PPARA protein] which results in increased expression of SLC25A20 mRNA,,,PMID:16197558,https://www.ncbi.nlm.nih.gov/pubmed/16197558,16197558,,
378,1402468,64928,Comparative Toxicogenomics Database (CTD),Clofop,C006012,fenofibric acid,https://ctdbase.org/detail.go?type=chem&acc=C006012,10599,SLCO1B1,https://ctdbase.org/detail.go?type=gene&acc=10599,,,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Fenofibric acid inhibits the reaction [SLCO1B1 protein results in increased uptake of estradiol-17 beta-glucuronide],,,PMID:16316932,https://www.ncbi.nlm.nih.gov/pubmed/16316932,16316932,,
379,1447516,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Epigallocatechin gallate inhibits the reaction [lipopolysaccharides results in increased secretion of TNF protein]|[epigallocatechin gallate co-treated with gallocatechol co-treated with epicatechin gallate co-treated with catechin analog] inhibits the reaction [lipopolysaccharides results in increased secretion of TNF protein],,,PMID:26187476,https://www.ncbi.nlm.nih.gov/pubmed/26187476,26187476,,
380,1447517,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Epigallocatechin gallate inhibits the reaction [glucose results in increased expression of TNF mrna]|epigallocatechin gallate inhibits the reaction [glucose results in increased expression of TNF protein],,,PMID:19557821,https://www.ncbi.nlm.nih.gov/pubmed/19557821,19557821,,
381,1447518,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Epigallocatechin gallate inhibits the reaction [paraquat results in increased expression of TNF mrna]|epigallocatechin gallate inhibits the reaction [paraquat results in increased expression of TNF protein]|epigallocatechin gallate inhibits the reaction [paraquat results in increased expression of and results in increased secretion of TNF protein],,,PMID:27890776,https://www.ncbi.nlm.nih.gov/pubmed/27890776,27890776,,
382,1448181,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,9881,TRANK1,https://ctdbase.org/detail.go?type=gene&acc=9881,,,9881.0,TRANK1,9606.0,Homo sapiens (human),Epigallocatechin gallate results in increased expression of TRANK1 mrna|[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TRANK1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
383,1448182,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,9881,TRANK1,https://ctdbase.org/detail.go?type=gene&acc=9881,,,9881.0,TRANK1,9606.0,Homo sapiens (human),Epigallocatechin gallate results in increased expression of TRANK1 protein,,,PMID:31195006,https://www.ncbi.nlm.nih.gov/pubmed/31195006,31195006,,
384,1448183,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,60684,TRAPPC11,https://ctdbase.org/detail.go?type=gene&acc=60684,,,60684.0,TRAPPC11,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TRAPPC11 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
385,1401335,65359,ChEMBL,Oxiglutatione,CHEMBL1372,OXIGLUTATIONE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1372/,CHEMBL2755,Glutathione reductase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2755/,P00390,"Glutathione reductase, mitochondrial",2936.0,GSR,9606.0,Homo sapiens (human),Glutathione reductase,,,,,,,
386,1401336,65387,Comparative Toxicogenomics Database (CTD),Dapsone hydroxylamine,C018209,4-amino-4'-hydroxylaminodiphenylsulfone,https://ctdbase.org/detail.go?type=chem&acc=C018209,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),4-amino-4'-hydroxylaminodiphenylsulfone results in increased activity of CASP3 protein,,,PMID:31428780,https://www.ncbi.nlm.nih.gov/pubmed/31428780,31428780,,
387,1401337,65387,Comparative Toxicogenomics Database (CTD),Dapsone hydroxylamine,C018209,4-amino-4'-hydroxylaminodiphenylsulfone,https://ctdbase.org/detail.go?type=chem&acc=C018209,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),4-amino-4'-hydroxylaminodiphenylsulfone results in decreased activity of CAT protein,,,PMID:18602405,https://www.ncbi.nlm.nih.gov/pubmed/18602405,18602405,,
388,1403765,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,28955,DEXI,https://ctdbase.org/detail.go?type=gene&acc=28955,,,28955.0,DEXI,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of DEXI mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
389,1403766,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,8694,DGAT1,https://ctdbase.org/detail.go?type=gene&acc=8694,,,8694.0,DGAT1,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of DGAT1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
390,1403767,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,84649,DGAT2,https://ctdbase.org/detail.go?type=gene&acc=84649,,,84649.0,DGAT2,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of DGAT2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
391,1403768,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,347516,DGAT2L6,https://ctdbase.org/detail.go?type=gene&acc=347516,,,347516.0,DGAT2L6,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of DGAT2L6 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
392,1401338,65463,Comparative Toxicogenomics Database (CTD),Buclizine Hydrochloride,C046894,buclizine,https://ctdbase.org/detail.go?type=chem&acc=C046894,3757,KCNH2,https://ctdbase.org/detail.go?type=gene&acc=3757,,,3757.0,KCNH2,9606.0,Homo sapiens (human),Buclizine results in decreased activity of KCNH2 protein,,,PMID:28551711,https://www.ncbi.nlm.nih.gov/pubmed/28551711,28551711,,
393,1401339,65482,Comparative Toxicogenomics Database (CTD),Sinefungin,C006235,sinefungin,https://ctdbase.org/detail.go?type=chem&acc=C006235,1312,COMT,https://ctdbase.org/detail.go?type=gene&acc=1312,,,1312.0,COMT,9823.0,Sus scrofa (pig),Sinefungin results in decreased activity of COMT protein,,,PMID:26577531,https://www.ncbi.nlm.nih.gov/pubmed/26577531,26577531,,
394,1401340,65482,Comparative Toxicogenomics Database (CTD),Sinefungin,C006235,sinefungin,https://ctdbase.org/detail.go?type=chem&acc=C006235,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,9606.0,Homo sapiens (human),Sinefungin results in decreased activity of DNMT1 protein,,,PMID:23671287,https://www.ncbi.nlm.nih.gov/pubmed/23671287,23671287,,
395,1401341,65482,Comparative Toxicogenomics Database (CTD),Sinefungin,C006235,sinefungin,https://ctdbase.org/detail.go?type=chem&acc=C006235,1788,DNMT3A,https://ctdbase.org/detail.go?type=gene&acc=1788,,,1788.0,DNMT3A,10090.0,Mus musculus (house mouse),Sinefungin results in decreased activity of DNMT3A protein,,,PMID:23671287,https://www.ncbi.nlm.nih.gov/pubmed/23671287,23671287,,
396,1401342,65576,Comparative Toxicogenomics Database (CTD),Tomatidine,C003677,tomatidine,https://ctdbase.org/detail.go?type=chem&acc=C003677,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,9606.0,Homo sapiens (human),Tomatidine results in decreased activity of BCHE protein,,,PMID:31152736,https://www.ncbi.nlm.nih.gov/pubmed/31152736,31152736,,
397,1401939,66199,Toxin and Toxin Target Database (T3DB),Silver bromide,T3D1753,Silver bromide,http://www.t3db.ca/toxins/T3D1753,BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,http://www.t3db.ca/biodb/bio_entities/BE0002345,P28472,Gamma-aminobutyric acid receptor subunit beta-3,2562.0,GABRB3,9606.0,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
398,1401940,66199,Toxin and Toxin Target Database (T3DB),Silver bromide,T3D1753,Silver bromide,http://www.t3db.ca/toxins/T3D1753,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,http://www.t3db.ca/biodb/bio_entities/BE0003592,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
399,1401941,66199,Toxin and Toxin Target Database (T3DB),Silver bromide,T3D1753,Silver bromide,http://www.t3db.ca/toxins/T3D1753,BE0000816,Glutathione peroxidase 1,http://www.t3db.ca/biodb/bio_entities/BE0000816,P07203,Glutathione peroxidase 1,2876.0,GPX1,9606.0,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
400,1401942,66199,Toxin and Toxin Target Database (T3DB),Silver bromide,T3D1753,Silver bromide,http://www.t3db.ca/toxins/T3D1753,BE0000817,Glutathione peroxidase 2,http://www.t3db.ca/biodb/bio_entities/BE0000817,P18283,Glutathione peroxidase 2,2877.0,GPX2,9606.0,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
401,1402898,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),Nonylphenol results in increased expression of AR mRNA,,,PMID:15159206,https://www.ncbi.nlm.nih.gov/pubmed/15159206,15159206,,
402,1402899,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,10090.0,Mus musculus (house mouse),Nonylphenol analog results in decreased expression of AR mRNA,,,PMID:25242005,https://www.ncbi.nlm.nih.gov/pubmed/25242005,25242005,,
403,1403467,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,7955.0,Danio rerio (zebrafish),[bisphenol A co-treated with nonylphenol] results in decreased activity of CAT protein|nonylphenol results in decreased activity of CAT protein,,,PMID:21805498,https://www.ncbi.nlm.nih.gov/pubmed/21805498,21805498,,
404,1403468,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,7955.0,Danio rerio (zebrafish),Nonylphenol affects the expression of CAT mrna|nonylphenol affects the activity of CAT protein,,,PMID:34843692,https://www.ncbi.nlm.nih.gov/pubmed/34843692,34843692,,
405,1403469,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Nonylphenol results in decreased activity of CAT protein,,,PMID:21472897,https://www.ncbi.nlm.nih.gov/pubmed/21472897,21472897,,
406,1404270,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,140634,CYP1A,https://ctdbase.org/detail.go?type=gene&acc=140634,,,140634.0,cyp1a,8049.0,Gadus morhua (Atlantic cod),Nonylphenol results in decreased expression of CYP1A mRNA,,,PMID:19167021,https://www.ncbi.nlm.nih.gov/pubmed/19167021,19167021,,
407,1404271,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,85417.0,Gobius niger (black goby),Nonylphenol results in decreased expression of CYP1A1 mRNA,,,PMID:15597882,https://www.ncbi.nlm.nih.gov/pubmed/15597882,15597882,,
408,1404272,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Nonylphenol results in increased expression of CYP1A1 protein|nonylphenol results in increased expression of CYP1A1 mRNA,,,PMID:34974051,https://www.ncbi.nlm.nih.gov/pubmed/34974051,34974051,,
409,1404273,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),Nonylphenol inhibits the reaction [tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]|nonylphenol inhibits the reaction [AHR protein binds to CYP1A1 promoter]|nonylphenol inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 mrna],,,PMID:11248424,https://www.ncbi.nlm.nih.gov/pubmed/11248424,11248424,,
410,1404274,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,8022.0,Oncorhynchus mykiss (rainbow trout),"Nonylphenol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mrna]",,,PMID:16291559,https://www.ncbi.nlm.nih.gov/pubmed/16291559,16291559,,
411,1404275,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),Nonylphenol results in increased expression of CYP1A2 protein|nonylphenol results in increased expression of CYP1A2 mRNA,,,PMID:34974051,https://www.ncbi.nlm.nih.gov/pubmed/34974051,34974051,,
412,1449274,67505,Comparative Toxicogenomics Database (CTD),"1,2,3-Benzothiadiazole",C015700,"benzo-1,2,3-thiadiazole",https://ctdbase.org/detail.go?type=chem&acc=C015700,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,10116.0,Rattus norvegicus (Norway rat),"Benzo-1,2,3-thiadiazole results in increased expression of EPHX1 mRNA",,,PMID:8951341,https://www.ncbi.nlm.nih.gov/pubmed/8951341,8951341,,
413,1449275,67505,Comparative Toxicogenomics Database (CTD),"1,2,3-Benzothiadiazole",C015700,"benzo-1,2,3-thiadiazole",https://ctdbase.org/detail.go?type=chem&acc=C015700,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10116.0,Rattus norvegicus (Norway rat),"Benzo-1,2,3-thiadiazole results in increased expression of GSTA2 mRNA",,,PMID:8951341,https://www.ncbi.nlm.nih.gov/pubmed/8951341,8951341,,
414,1449276,67505,Comparative Toxicogenomics Database (CTD),"1,2,3-Benzothiadiazole",C015700,"benzo-1,2,3-thiadiazole",https://ctdbase.org/detail.go?type=chem&acc=C015700,4548,MTR,https://ctdbase.org/detail.go?type=gene&acc=4548,,,4548.0,MTR,10116.0,Rattus norvegicus (Norway rat),"Benzo-1,2,3-thiadiazole analog results in decreased activity of MTR protein",,,PMID:17222188,https://www.ncbi.nlm.nih.gov/pubmed/17222188,17222188,,
415,1449277,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,84440,RAB11FIP4,https://ctdbase.org/detail.go?type=gene&acc=84440,,,84440.0,RAB11FIP4,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of RAB11FIP4 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
416,1449278,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,25837,RAB26,https://ctdbase.org/detail.go?type=gene&acc=25837,,,25837.0,RAB26,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of RAB26 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
417,1449279,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,572060,RAB33BA,https://ctdbase.org/detail.go?type=gene&acc=572060,,,572060.0,rab33ba,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of RAB33BA mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
418,1449469,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,57148,RALGAPB,https://ctdbase.org/detail.go?type=gene&acc=57148,,,57148.0,RALGAPB,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of RALGAPB mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
419,1449470,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,10268,RAMP3,https://ctdbase.org/detail.go?type=gene&acc=10268,,,10268.0,RAMP3,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of RAMP3 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
420,1449471,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,202151,RANBP3L,https://ctdbase.org/detail.go?type=gene&acc=202151,,,202151.0,RANBP3L,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of RANBP3L mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
421,1449472,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,11069,RAPGEF4,https://ctdbase.org/detail.go?type=gene&acc=11069,,,11069.0,RAPGEF4,10090.0,Mus musculus (house mouse),Perfluoro-n-nonanoic acid results in increased expression of RAPGEF4 mRNA,,,PMID:28558994,https://www.ncbi.nlm.nih.gov/pubmed/28558994,28558994,,
422,1450483,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6309,SC5D,https://ctdbase.org/detail.go?type=gene&acc=6309,,,6309.0,SC5D,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SC5D mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
423,1450484,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,567501,SCAF4A,https://ctdbase.org/detail.go?type=gene&acc=567501,,,567501.0,scaf4a,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of SCAF4A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
424,1450485,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,51435,SCARA3,https://ctdbase.org/detail.go?type=gene&acc=51435,,,51435.0,SCARA3,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SCARA3 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
425,1450486,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,9467,SH3BP5,https://ctdbase.org/detail.go?type=gene&acc=9467,,,9467.0,SH3BP5,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of SH3BP5 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
426,1450487,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,286133,SCARA5,https://ctdbase.org/detail.go?type=gene&acc=286133,,,286133.0,SCARA5,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SCARA5 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
427,1453561,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,54498,SMOX,https://ctdbase.org/detail.go?type=gene&acc=54498,,,54498.0,SMOX,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of SMOX mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
428,1453562,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6610,SMPD2,https://ctdbase.org/detail.go?type=gene&acc=6610,,,6610.0,SMPD2,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SMPD2 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
429,1453563,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,399690,SMTNL,https://ctdbase.org/detail.go?type=gene&acc=399690,,,399690.0,smtnl,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SMTNL mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
430,1453564,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,569027,SMYD1B,https://ctdbase.org/detail.go?type=gene&acc=569027,,,569027.0,smyd1b,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SMYD1B mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
431,1453565,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,30273,SNAI1A,https://ctdbase.org/detail.go?type=gene&acc=30273,,,30273.0,snai1a,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SNAI1A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
432,1453566,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6591,SNAI2,https://ctdbase.org/detail.go?type=gene&acc=6591,,,6591.0,SNAI2,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of SNAI2 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
433,1455447,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,374403,TBC1D10C,https://ctdbase.org/detail.go?type=gene&acc=374403,,,374403.0,TBC1D10C,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TBC1D10C mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
434,1455448,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,4943,TBC1D25,https://ctdbase.org/detail.go?type=gene&acc=4943,,,4943.0,TBC1D25,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of TBC1D25 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
435,1455449,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6907,TBL1X,https://ctdbase.org/detail.go?type=gene&acc=6907,,,6907.0,TBL1X,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TBL1X mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
436,1455450,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6908,TBP,https://ctdbase.org/detail.go?type=gene&acc=6908,,,6908.0,TBP,8022.0,Oncorhynchus mykiss (rainbow trout),Perfluoro-n-nonanoic acid results in increased expression of TBP mRNA,,,PMID:21984479,https://www.ncbi.nlm.nih.gov/pubmed/21984479,21984479,,
437,1455451,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,84897,TBRG1,https://ctdbase.org/detail.go?type=gene&acc=84897,,,84897.0,TBRG1,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TBRG1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
438,1458055,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,23331,TTC28,https://ctdbase.org/detail.go?type=gene&acc=23331,,,23331.0,TTC28,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of TTC28 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
439,1458056,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,143941,TTC36,https://ctdbase.org/detail.go?type=gene&acc=143941,,,143941.0,TTC36,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of TTC36 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
440,1458057,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,22996,TTC39A,https://ctdbase.org/detail.go?type=gene&acc=22996,,,22996.0,TTC39A,10090.0,Mus musculus (house mouse),Perfluoro-n-nonanoic acid results in increased expression of TTC39A mRNA,,,PMID:28558994,https://www.ncbi.nlm.nih.gov/pubmed/28558994,28558994,,
441,1458058,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,158219,TTC39B,https://ctdbase.org/detail.go?type=gene&acc=158219,,,158219.0,TTC39B,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TTC39B mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
442,1458059,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7272,TTK,https://ctdbase.org/detail.go?type=gene&acc=7272,,,7272.0,TTK,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TTK mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
443,1458060,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,150465,TTL,https://ctdbase.org/detail.go?type=gene&acc=150465,,,150465.0,TTL,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TTL mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
444,1458061,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,158135,TTLL11,https://ctdbase.org/detail.go?type=gene&acc=158135,,,158135.0,TTLL11,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TTLL11 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
445,1458062,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7274,TTPA,https://ctdbase.org/detail.go?type=gene&acc=7274,,,7274.0,TTPA,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TTPA mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
446,1459107,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,10493,VAT1,https://ctdbase.org/detail.go?type=gene&acc=10493,,,10493.0,VAT1,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of VAT1 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
447,1459108,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7409,VAV1,https://ctdbase.org/detail.go?type=gene&acc=7409,,,7409.0,VAV1,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of VAV1 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
448,1459109,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of VEGFA protein,,,PMID:32916415,https://www.ncbi.nlm.nih.gov/pubmed/32916415,32916415,,
449,1459743,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,124857,WFIKKN2,https://ctdbase.org/detail.go?type=gene&acc=124857,,,124857.0,WFIKKN2,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of WFIKKN2 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
450,1459744,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,11197,WIF1,https://ctdbase.org/detail.go?type=gene&acc=11197,,,11197.0,WIF1,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of WIF1 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
451,1460211,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,79693,YRDC,https://ctdbase.org/detail.go?type=gene&acc=79693,,,79693.0,YRDC,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of YRDC mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
452,1460644,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7705,ZNF146,https://ctdbase.org/detail.go?type=gene&acc=7705,,,7705.0,ZNF146,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of ZNF146 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
453,1460645,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7570,ZNF22,https://ctdbase.org/detail.go?type=gene&acc=7570,,,7570.0,ZNF22,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of ZNF22 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
454,1460646,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,57335,ZNF286A,https://ctdbase.org/detail.go?type=gene&acc=57335,,,57335.0,ZNF286A,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of ZNF286A mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
455,1460647,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,126068,ZNF441,https://ctdbase.org/detail.go?type=gene&acc=126068,,,126068.0,ZNF441,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of ZNF441 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
456,1460648,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,84858,ZNF503,https://ctdbase.org/detail.go?type=gene&acc=84858,,,84858.0,ZNF503,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of ZNF503 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
457,1460649,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,84215,ZNF541,https://ctdbase.org/detail.go?type=gene&acc=84215,,,84215.0,ZNF541,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of ZNF541 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
458,1460650,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,51042,ZNF593,https://ctdbase.org/detail.go?type=gene&acc=51042,,,51042.0,ZNF593,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of ZNF593 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
459,1460651,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,23060,ZNF609,https://ctdbase.org/detail.go?type=gene&acc=23060,,,23060.0,ZNF609,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of ZNF609 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
460,1460652,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,80110,ZNF614,https://ctdbase.org/detail.go?type=gene&acc=80110,,,80110.0,ZNF614,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of ZNF614 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
461,1367605,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,181307,COL-178,https://ctdbase.org/detail.go?type=gene&acc=181307,,,181307.0,col-178,6239.0,Caenorhabditis elegans,Mianserin results in increased expression of COL-178 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
462,1367606,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,180397,COL-19,https://ctdbase.org/detail.go?type=gene&acc=180397,,,180397.0,col-19,6239.0,Caenorhabditis elegans,Mianserin results in increased expression of COL-19 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
463,1367607,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,174370,COL-38,https://ctdbase.org/detail.go?type=gene&acc=174370,,,174370.0,col-38,6239.0,Caenorhabditis elegans,Mianserin results in increased expression of COL-38 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
464,1367608,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,181610,COL-41,https://ctdbase.org/detail.go?type=gene&acc=181610,,,181610.0,col-41,6239.0,Caenorhabditis elegans,Mianserin results in decreased expression of COL-41 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
465,1367609,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,189274,COL-78,https://ctdbase.org/detail.go?type=gene&acc=189274,,,189274.0,col-78,6239.0,Caenorhabditis elegans,Mianserin results in decreased expression of COL-78 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
466,1461303,68848,IUPHAR/BPS Guide to PHARMACOLOGY,Mesulergine,206,mesulergine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=206,12,5-HT7 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=12,P32305,5-hydroxytryptamine receptor 7 ,65032.0,Htr7,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,7.7 - 8.2,PMID:8394362,https://www.ncbi.nlm.nih.gov/pubmed/8394362,8394362,,
467,1463208,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,50808,AK3,https://ctdbase.org/detail.go?type=gene&acc=50808,,,50808.0,AK3,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of AK3 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
468,1463209,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,567365,AKAP12B,https://ctdbase.org/detail.go?type=gene&acc=567365,,,567365.0,akap12b,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of AKAP12B mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
469,1463210,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,8227,AKAP17A,https://ctdbase.org/detail.go?type=gene&acc=8227,,,8227.0,AKAP17A,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of AKAP17A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
470,1463211,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,556208,AKAP1B,https://ctdbase.org/detail.go?type=gene&acc=556208,,,556208.0,akap1b,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of AKAP1B mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
471,1463212,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,26993,AKAP8L,https://ctdbase.org/detail.go?type=gene&acc=26993,,,26993.0,AKAP8L,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of AKAP8L mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
472,1463213,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,415138,AKR1B1.1,https://ctdbase.org/detail.go?type=gene&acc=415138,,,415138.0,akr1b1.1,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of AKR1B1.1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
473,1463214,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,84335,AKT1S1,https://ctdbase.org/detail.go?type=gene&acc=84335,,,84335.0,AKT1S1,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of AKT1S1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
474,1463215,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of ALAS1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
475,1463674,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,100006399,ALX4A,https://ctdbase.org/detail.go?type=gene&acc=100006399,,,100006399.0,alx4a,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of ALX4A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
476,1463675,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,262,AMD1,https://ctdbase.org/detail.go?type=gene&acc=262,,,262.0,AMD1,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of AMD1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
477,1464077,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,447893,ANXA3A,https://ctdbase.org/detail.go?type=gene&acc=447893,,,447893.0,anxa3a,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of ANXA3A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
478,1464078,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,64265,AOX5,https://ctdbase.org/detail.go?type=gene&acc=64265,,,64265.0,aox5,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of AOX5 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
479,1464079,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,55435,AP1AR,https://ctdbase.org/detail.go?type=gene&acc=55435,,,55435.0,AP1AR,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of AP1AR mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
480,1464080,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,160,AP2A1,https://ctdbase.org/detail.go?type=gene&acc=160,,,160.0,AP2A1,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of AP2A1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
481,1464081,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,321051,AP2M1A,https://ctdbase.org/detail.go?type=gene&acc=321051,,,321051.0,ap2m1a,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of AP2M1A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
482,1464082,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,394001,AP2M1B,https://ctdbase.org/detail.go?type=gene&acc=394001,,,394001.0,ap2m1b,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of AP2M1B mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
483,1464083,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,8120,AP3B2,https://ctdbase.org/detail.go?type=gene&acc=8120,,,8120.0,AP3B2,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of AP3B2 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
484,1464084,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,327160,APBA2B,https://ctdbase.org/detail.go?type=gene&acc=327160,,,327160.0,apba2b,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of APBA2B mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
485,1464085,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,54518,APBB1IP,https://ctdbase.org/detail.go?type=gene&acc=54518,,,54518.0,APBB1IP,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of APBB1IP mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
486,1464086,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,100506013,APELA,https://ctdbase.org/detail.go?type=gene&acc=100506013,,,100506013.0,APELA,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of APELA mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
487,1464531,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,503736,APOBEC2A,https://ctdbase.org/detail.go?type=gene&acc=503736,,,503736.0,apobec2a,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of APOBEC2A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
488,1464532,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,341,APOC1,https://ctdbase.org/detail.go?type=gene&acc=341,,,341.0,APOC1,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of APOC1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
489,1464741,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,572251,ARK2CA,https://ctdbase.org/detail.go?type=gene&acc=572251,,,572251.0,ark2ca,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of ARK2CA mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
490,1464742,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,390790,ARL5C,https://ctdbase.org/detail.go?type=gene&acc=390790,,,390790.0,ARL5C,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of ARL5C mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
491,1464743,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,450076,ARL6IP5A,https://ctdbase.org/detail.go?type=gene&acc=450076,,,450076.0,arl6ip5a,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of ARL6IP5A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
492,1464744,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,127829,ARL8A,https://ctdbase.org/detail.go?type=gene&acc=127829,,,127829.0,ARL8A,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of ARL8A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
493,1464745,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,80210,ARMC9,https://ctdbase.org/detail.go?type=gene&acc=80210,,,80210.0,ARMC9,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of ARMC9 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
494,1465600,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,326977,ATP5L,https://ctdbase.org/detail.go?type=gene&acc=326977,,,326977.0,atp5l,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of ATP5L mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
495,1465601,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,516,ATP5MC1,https://ctdbase.org/detail.go?type=gene&acc=516,,,516.0,ATP5MC1,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of ATP5MC1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
496,1466226,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,794333,BAHCC1B,https://ctdbase.org/detail.go?type=gene&acc=794333,,,794333.0,bahcc1b,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of BAHCC1B mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
497,1466227,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,22893,BAHD1,https://ctdbase.org/detail.go?type=gene&acc=22893,,,22893.0,BAHD1,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of BAHD1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
498,1466228,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,9031,BAZ1B,https://ctdbase.org/detail.go?type=gene&acc=9031,,,9031.0,BAZ1B,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of BAZ1B mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
499,1466229,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,11176,BAZ2A,https://ctdbase.org/detail.go?type=gene&acc=11176,,,11176.0,BAZ2A,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of BAZ2A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
500,1466230,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,56898,BDH2,https://ctdbase.org/detail.go?type=gene&acc=56898,,,56898.0,BDH2,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of BDH2 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
501,1466231,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,56898,BDH2,https://ctdbase.org/detail.go?type=gene&acc=56898,,,56898.0,BDH2,9606.0,Homo sapiens (human),Perfluorooctanesulfonamide analog results in increased expression of BDH2 mRNA,,,PMID:35337807,https://www.ncbi.nlm.nih.gov/pubmed/35337807,35337807,,
502,1468244,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,10983,CCNI,https://ctdbase.org/detail.go?type=gene&acc=10983,,,10983.0,CCNI,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CCNI mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
503,1468245,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,553269,CCNL1A,https://ctdbase.org/detail.go?type=gene&acc=553269,,,553269.0,ccnl1a,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CCNL1A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
504,1469261,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,84181,CHD6,https://ctdbase.org/detail.go?type=gene&acc=84181,,,84181.0,CHD6,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of CHD6 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
505,1469262,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,55636,CHD7,https://ctdbase.org/detail.go?type=gene&acc=55636,,,55636.0,CHD7,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CHD7 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
506,1471015,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,11052,CPSF6,https://ctdbase.org/detail.go?type=gene&acc=11052,,,11052.0,CPSF6,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CPSF6 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
507,1471016,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,503502,CRABP2B,https://ctdbase.org/detail.go?type=gene&acc=503502,,,503502.0,crabp2b,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CRABP2B mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
508,1471017,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,1397,CRIP2,https://ctdbase.org/detail.go?type=gene&acc=1397,,,1397.0,CRIP2,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of CRIP2 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
509,1471018,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,1398,CRK,https://ctdbase.org/detail.go?type=gene&acc=1398,,,1398.0,CRK,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CRK mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
510,1471629,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,797445,CUX1A,https://ctdbase.org/detail.go?type=gene&acc=797445,,,797445.0,cux1a,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of CUX1A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
511,1471630,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,57703,CWC22,https://ctdbase.org/detail.go?type=gene&acc=57703,,,57703.0,CWC22,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CWC22 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
512,1471631,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,54883,CWC25,https://ctdbase.org/detail.go?type=gene&acc=54883,,,54883.0,CWC25,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CWC25 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
513,1471632,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,143884,CWF19L2,https://ctdbase.org/detail.go?type=gene&acc=143884,,,143884.0,CWF19L2,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CWF19L2 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
514,1471633,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,352944,CXCL12A,https://ctdbase.org/detail.go?type=gene&acc=352944,,,352944.0,cxcl12a,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CXCL12A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
515,1471634,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,9547,CXCL14,https://ctdbase.org/detail.go?type=gene&acc=9547,,,9547.0,CXCL14,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CXCL14 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
516,1471635,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,140747,CXCR4A,https://ctdbase.org/detail.go?type=gene&acc=140747,,,140747.0,cxcr4a,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of CXCR4A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
517,1471636,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,1537,CYC1,https://ctdbase.org/detail.go?type=gene&acc=1537,,,1537.0,CYC1,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of CYC1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
518,1471637,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,415158,CYCSB,https://ctdbase.org/detail.go?type=gene&acc=415158,,,415158.0,cycsb,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of CYCSB mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
519,1472320,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,100003026,DCTN1B,https://ctdbase.org/detail.go?type=gene&acc=100003026,,,100003026.0,dctn1b,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of DCTN1B mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
520,1472321,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,192303,DCUN1D2A,https://ctdbase.org/detail.go?type=gene&acc=192303,,,192303.0,dcun1d2a,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of DCUN1D2A mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
521,1472322,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,1642,DDB1,https://ctdbase.org/detail.go?type=gene&acc=1642,,,1642.0,DDB1,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of DDB1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
522,1472323,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,54541,DDIT4,https://ctdbase.org/detail.go?type=gene&acc=54541,,,54541.0,DDIT4,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of DDIT4 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
523,1472324,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,1662,DDX10,https://ctdbase.org/detail.go?type=gene&acc=1662,,,1662.0,DDX10,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of DDX10 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
524,1472325,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,10521,DDX17,https://ctdbase.org/detail.go?type=gene&acc=10521,,,10521.0,DDX17,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of DDX17 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
525,1472326,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,8886,DDX18,https://ctdbase.org/detail.go?type=gene&acc=8886,,,8886.0,DDX18,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of DDX18 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
526,1472327,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,11269,DDX19B,https://ctdbase.org/detail.go?type=gene&acc=11269,,,11269.0,DDX19B,7955.0,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in increased expression of DDX19B mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
527,1475069,72291,Comparative Toxicogenomics Database (CTD),Ilimaquinone,C467077,ilimaquinone,https://ctdbase.org/detail.go?type=chem&acc=C467077,5338,PLD2,https://ctdbase.org/detail.go?type=gene&acc=5338,,,5338.0,PLD2,9606.0,Homo sapiens (human),1-butanol inhibits the reaction [ilimaquinone results in increased activity of PLD2 protein]|ilimaquinone results in increased activity of PLD2 protein,,,PMID:17897952,https://www.ncbi.nlm.nih.gov/pubmed/17897952,17897952,,
528,1475070,72291,Comparative Toxicogenomics Database (CTD),Ilimaquinone,C467077,ilimaquinone,https://ctdbase.org/detail.go?type=chem&acc=C467077,8797,TNFRSF10A,https://ctdbase.org/detail.go?type=gene&acc=8797,,,8797.0,TNFRSF10A,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10A mrna]|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10A protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10A mrna]|ilimaquinone results in increased expression of TNFRSF10A mrna|ilimaquinone results in increased expression of TNFRSF10A protein|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10A mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10A protein],,,PMID:24930757,https://www.ncbi.nlm.nih.gov/pubmed/24930757,24930757,,
529,1475071,72291,Comparative Toxicogenomics Database (CTD),Ilimaquinone,C467077,ilimaquinone,https://ctdbase.org/detail.go?type=chem&acc=C467077,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606.0,Homo sapiens (human),Ilimaquinone results in increased expression of TNFRSF10B mrna|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10B mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10B protein]|ilimaquinone results in increased expression of TNFRSF10B protein|acetylcysteine inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10B mrna]|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10B protein]|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10B mrna],,,PMID:24930757,https://www.ncbi.nlm.nih.gov/pubmed/24930757,24930757,,
530,1475072,72291,Comparative Toxicogenomics Database (CTD),Ilimaquinone,C467077,ilimaquinone,https://ctdbase.org/detail.go?type=chem&acc=C467077,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606.0,Homo sapiens (human),Ilimaquinone promotes the reaction [TNFSF10 protein results in increased cleavage of CASP3 protein]|[ilimaquinone results in increased susceptibility to TNFSF10 protein] which results in increased cleavage of PARP1 protein|[ilimaquinone results in increased susceptibility to TNFSF10 protein] which results in increased cleavage of CASP3 protein|ilimaquinone results in increased susceptibility to TNFSF10 protein|ilimaquinone promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:24930757,https://www.ncbi.nlm.nih.gov/pubmed/24930757,24930757,,
531,1475073,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,1814,DRD3,https://ctdbase.org/detail.go?type=gene&acc=1814,,,1814.0,DRD3,10116.0,Rattus norvegicus (Norway rat),Tetrahydropalmatine binds to DRD3 protein,,,PMID:17361394,https://www.ncbi.nlm.nih.gov/pubmed/17361394,17361394,,
532,1403180,73064,BindingDB,3-Aminopentanedioic acid,92996,3-Aminoglutarate,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92996,5351,Bifunctional aspartokinase/homoserine dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5351,P00561,Bifunctional aspartokinase/homoserine dehydrogenase 1,945803.0,thrA,83333.0,Escherichia coli K-12,,Ki (nM),45000000,PMID:1731937|DOI:10.1021/bi00118a023,https://www.ncbi.nlm.nih.gov/pubmed/1731937|https://doi.org/10.1021/bi00118a023,1731937,10.1021/bi00118a023,
533,1403181,73157,Drug Gene Interaction database (DGIdb),Lobaric acid,,LOBARIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL551842,,VDR,https://www.dgidb.org/genes/hgnc:12679,,,7421.0,VDR,9606.0,Homo sapiens (human),,,,,,,,
534,1403182,73172,BindingDB,Pyrazinecarbonitrile,92861,"PncA Inhibitor, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92861,5302,Pyrazinamidase/nicotinamidase PncA,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5302,,,,,,,,Ki (nM),6.1e+4,PMID:20879713|DOI:10.1021/bi1011157,https://www.ncbi.nlm.nih.gov/pubmed/20879713|https://doi.org/10.1021/bi1011157,20879713,10.1021/bi1011157,
535,1403183,73191,Drug Gene Interaction database (DGIdb),Nodakenin,,NODAKENIN,https://www.dgidb.org/drugs/chembl:CHEMBL459825,,GAA,https://www.dgidb.org/genes/hgnc:4065,,,2548.0,GAA,9606.0,Homo sapiens (human),,,,,,,,
536,1403184,73212,IUPHAR/BPS Guide to PHARMACOLOGY,Lead (II) ion,2525,Pb2+,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2525,490,TRPC5,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=490,Q9UL62,Short transient receptor potential channel 5,7224.0,TRPC5,9606.0,Homo sapiens (human),,,6.2,,,,,
537,1403185,73252,Drug Gene Interaction database (DGIdb),Tetrachloro-O-benzoquinone,,CHEMBL:CHEMBL364729,https://www.dgidb.org/drugs/chembl:CHEMBL364729,,WRN,https://www.dgidb.org/genes/hgnc:12791,,,7486.0,WRN,9606.0,Homo sapiens (human),,,,,,,,
538,1403186,73252,Drug Gene Interaction database (DGIdb),Tetrachloro-O-benzoquinone,,CHEMBL:CHEMBL364729,https://www.dgidb.org/drugs/chembl:CHEMBL364729,,NSD2,https://www.dgidb.org/genes/hgnc:12766,,,7468.0,NSD2,9606.0,Homo sapiens (human),,,,,,,,
539,1453340,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,55502,HES6,https://ctdbase.org/detail.go?type=gene&acc=55502,,,55502.0,HES6,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of HES6 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
540,1453341,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,56941,HMCES,https://ctdbase.org/detail.go?type=gene&acc=56941,,,56941.0,HMCES,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of HMCES mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
541,1453342,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,559054,HMGCRA,https://ctdbase.org/detail.go?type=gene&acc=559054,,,559054.0,hmgcra,7955.0,Danio rerio (zebrafish),Prochloraz results in decreased expression of HMGCRA mRNA,,,PMID:32553615,https://www.ncbi.nlm.nih.gov/pubmed/32553615,32553615,,
542,1453343,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,541479,HMGCRB,https://ctdbase.org/detail.go?type=gene&acc=541479,,,541479.0,hmgcrb,7955.0,Danio rerio (zebrafish),Prochloraz results in increased expression of HMGCRB mRNA,,,PMID:21158436,https://www.ncbi.nlm.nih.gov/pubmed/21158436,21158436,,
543,1453344,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,3292,HSD17B1,https://ctdbase.org/detail.go?type=gene&acc=3292,,,3292.0,HSD17B1,7955.0,Danio rerio (zebrafish),Prochloraz results in increased expression of HSD17B1 mRNA,,,PMID:21158436,https://www.ncbi.nlm.nih.gov/pubmed/21158436,21158436,,
544,1455288,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Prochloraz results in increased activity of RARA protein,,,PMID:20143881,https://www.ncbi.nlm.nih.gov/pubmed/20143881,20143881,,
545,1455289,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,5649,RELN,https://ctdbase.org/detail.go?type=gene&acc=5649,,,5649.0,RELN,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of RELN mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
546,1455290,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,5979,RET,https://ctdbase.org/detail.go?type=gene&acc=5979,,,5979.0,RET,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of RET mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
547,1455291,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,56963,RGMA,https://ctdbase.org/detail.go?type=gene&acc=56963,,,56963.0,RGMA,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of RGMA mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
548,1455292,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,55005,RMND1,https://ctdbase.org/detail.go?type=gene&acc=55005,,,55005.0,RMND1,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of RMND1 mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
549,1455293,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,100003397,RNASEL2,https://ctdbase.org/detail.go?type=gene&acc=100003397,,,100003397.0,rnasel2,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of RNASEL2 mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
550,1455294,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,6091,ROBO1,https://ctdbase.org/detail.go?type=gene&acc=6091,,,6091.0,ROBO1,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of ROBO1 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
551,1455295,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,393724,RPE65A,https://ctdbase.org/detail.go?type=gene&acc=393724,,,393724.0,rpe65a,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of RPE65A mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
552,1455296,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,6235,RPS29,https://ctdbase.org/detail.go?type=gene&acc=6235,,,6235.0,RPS29,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of RPS29 mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
553,1456695,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,219699,UNC5B,https://ctdbase.org/detail.go?type=gene&acc=219699,,,219699.0,UNC5B,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of UNC5B mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
554,1456696,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,565736,USP12A,https://ctdbase.org/detail.go?type=gene&acc=565736,,,565736.0,usp12a,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of USP12A mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
555,1456697,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,27183,VPS4A,https://ctdbase.org/detail.go?type=gene&acc=27183,,,27183.0,VPS4A,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of VPS4A mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
556,1456698,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,151525,WDSUB1,https://ctdbase.org/detail.go?type=gene&acc=151525,,,151525.0,WDSUB1,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of WDSUB1 mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
557,1456699,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,26118,WSB1,https://ctdbase.org/detail.go?type=gene&acc=26118,,,26118.0,WSB1,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of WSB1 mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
558,1459288,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5707,PSMD1,https://ctdbase.org/detail.go?type=gene&acc=5707,,,5707.0,PSMD1,7955.0,Danio rerio (zebrafish),Flusilazole results in increased expression of PSMD1 mrna|flusilazole results in decreased expression of PSMD1 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
559,1459289,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5709,PSMD3,https://ctdbase.org/detail.go?type=gene&acc=5709,,,5709.0,PSMD3,7955.0,Danio rerio (zebrafish),Flusilazole results in decreased expression of PSMD3 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
560,1459290,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5800,PTPRO,https://ctdbase.org/detail.go?type=gene&acc=5800,,,5800.0,PTPRO,7955.0,Danio rerio (zebrafish),Flusilazole results in decreased expression of PTPRO mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
561,1459291,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,335623,PVALB5,https://ctdbase.org/detail.go?type=gene&acc=335623,,,335623.0,pvalb5,7955.0,Danio rerio (zebrafish),Flusilazole affects the expression of PVALB5 mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
562,1459292,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,360208,PVALB8,https://ctdbase.org/detail.go?type=gene&acc=360208,,,360208.0,pvalb8,7955.0,Danio rerio (zebrafish),Flusilazole affects the expression of PVALB8 mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
563,1459293,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5834,PYGB,https://ctdbase.org/detail.go?type=gene&acc=5834,,,5834.0,PYGB,7955.0,Danio rerio (zebrafish),Flusilazole results in decreased expression of PYGB mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
564,1459451,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,51552,RAB14,https://ctdbase.org/detail.go?type=gene&acc=51552,,,51552.0,RAB14,10090.0,Mus musculus (house mouse),Flusilazole affects the expression of RAB14 mRNA,,,PMID:21195148,https://www.ncbi.nlm.nih.gov/pubmed/21195148,21195148,,
565,1459452,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,10116.0,Rattus norvegicus (Norway rat),Flusilazole results in increased expression of RARB mRNA,,,PMID:28263823,https://www.ncbi.nlm.nih.gov/pubmed/28263823,28263823,,
566,1459453,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5928,RBBP4,https://ctdbase.org/detail.go?type=gene&acc=5928,,,5928.0,RBBP4,7955.0,Danio rerio (zebrafish),Flusilazole affects the expression of RBBP4 mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
567,1459454,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,568032,RBP2A,https://ctdbase.org/detail.go?type=gene&acc=568032,,,568032.0,rbp2a,7955.0,Danio rerio (zebrafish),Flusilazole affects the expression of RBP2A mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
568,1459455,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,568032,RBP2A,https://ctdbase.org/detail.go?type=gene&acc=568032,,,568032.0,rbp2a,7955.0,Danio rerio (zebrafish),Flusilazole results in decreased expression of RBP2A mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
569,1431264,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2902,GRIN1,https://ctdbase.org/detail.go?type=gene&acc=2902,,,2902.0,GRIN1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of GRIN1 mRNA",,,PMID:34748853,https://www.ncbi.nlm.nih.gov/pubmed/34748853,34748853,,
570,1431265,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,80273,GRPEL1,https://ctdbase.org/detail.go?type=gene&acc=80273,,,80273.0,GRPEL1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GRPEL1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
571,1431266,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1687,GSDME,https://ctdbase.org/detail.go?type=gene&acc=1687,,,1687.0,GSDME,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GSDME protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
572,1453213,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of IL10 mRNA",,,PMID:37216864,https://www.ncbi.nlm.nih.gov/pubmed/37216864,37216864,,
573,1453214,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3593,IL12B,https://ctdbase.org/detail.go?type=gene&acc=3593,,,3593.0,IL12B,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in increased expression of IL12B mRNA",,,PMID:34850234,https://www.ncbi.nlm.nih.gov/pubmed/34850234,34850234,,
574,1453215,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55540,IL17RB,https://ctdbase.org/detail.go?type=gene&acc=55540,,,55540.0,IL17RB,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of IL17RB mRNA",,,PMID:34850234,https://www.ncbi.nlm.nih.gov/pubmed/34850234,34850234,,
575,1453216,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,54756,IL17RD,https://ctdbase.org/detail.go?type=gene&acc=54756,,,54756.0,IL17RD,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of IL17RD mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
576,1453217,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of IL18 mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
577,1454167,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,51315,KRCC1,https://ctdbase.org/detail.go?type=gene&acc=51315,,,51315.0,KRCC1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of KRCC1 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
578,1454168,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3875,KRT18,https://ctdbase.org/detail.go?type=gene&acc=3875,,,3875.0,KRT18,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KRT18 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
579,1454169,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3880,KRT19,https://ctdbase.org/detail.go?type=gene&acc=3880,,,3880.0,KRT19,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KRT19 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
580,1454170,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3885,KRT34,https://ctdbase.org/detail.go?type=gene&acc=3885,,,3885.0,KRT34,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KRT34 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
581,1454171,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3855,KRT7,https://ctdbase.org/detail.go?type=gene&acc=3855,,,3855.0,KRT7,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KRT7 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
582,1454172,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3856,KRT8,https://ctdbase.org/detail.go?type=gene&acc=3856,,,3856.0,KRT8,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KRT8 mRNA",,,PMID:35598417,https://www.ncbi.nlm.nih.gov/pubmed/35598417,35598417,,
583,1454173,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3856,KRT8,https://ctdbase.org/detail.go?type=gene&acc=3856,,,3856.0,KRT8,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KRT8 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
584,1454174,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3857,KRT9,https://ctdbase.org/detail.go?type=gene&acc=3857,,,3857.0,KRT9,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KRT9 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
585,1454175,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3895,KTN1,https://ctdbase.org/detail.go?type=gene&acc=3895,,,3895.0,KTN1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KTN1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
586,1454579,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3945,LDHB,https://ctdbase.org/detail.go?type=gene&acc=3945,,,3945.0,LDHB,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of LDHB protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
587,1454580,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of LDLR mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
588,1454581,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,116842,LEAP2,https://ctdbase.org/detail.go?type=gene&acc=116842,,,116842.0,LEAP2,9031.0,Gallus gallus (chicken),"4,4'-hexafluorisopropylidene diphenol results in increased expression of LEAP2 mRNA",,,PMID:33465250,https://www.ncbi.nlm.nih.gov/pubmed/33465250,33465250,,
589,1454582,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,221496,LEMD2,https://ctdbase.org/detail.go?type=gene&acc=221496,,,221496.0,LEMD2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of LEMD2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
590,1454583,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol inhibits the reaction [[INS protein co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with rosiglitazone] results in increased expression of LEP mrna]",,,PMID:31596606,https://www.ncbi.nlm.nih.gov/pubmed/31596606,31596606,,
591,1454584,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3954,LETM1,https://ctdbase.org/detail.go?type=gene&acc=3954,,,3954.0,LETM1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of LETM1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
592,1454585,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of LGALS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
593,1454586,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3958,LGALS3,https://ctdbase.org/detail.go?type=gene&acc=3958,,,3958.0,LGALS3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of LGALS3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
594,1454587,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3959,LGALS3BP,https://ctdbase.org/detail.go?type=gene&acc=3959,,,3959.0,LGALS3BP,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of LGALS3BP protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
595,1455163,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23175,LPIN1,https://ctdbase.org/detail.go?type=gene&acc=23175,,,23175.0,LPIN1,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of LPIN1 mRNA",,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
596,1455164,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23175,LPIN1,https://ctdbase.org/detail.go?type=gene&acc=23175,,,23175.0,LPIN1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of LPIN1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
597,1455165,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of LPL protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
598,1456700,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,90550,MCU,https://ctdbase.org/detail.go?type=gene&acc=90550,,,90550.0,MCU,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of MCU mrna|[bisphenol A co-treated with bisphenol B co-treated with bisphenol F co-treated with 4,4'-hexafluorisopropylidene diphenol] results in decreased expression of MCU mRNA",,,PMID:37418940,https://www.ncbi.nlm.nih.gov/pubmed/37418940,37418940,,
599,1456701,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,90550,MCU,https://ctdbase.org/detail.go?type=gene&acc=90550,,,90550.0,MCU,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MCU protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
600,1456702,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4190,MDH1,https://ctdbase.org/detail.go?type=gene&acc=4190,,,4190.0,MDH1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MDH1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
601,1456703,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4191,MDH2,https://ctdbase.org/detail.go?type=gene&acc=4191,,,4191.0,MDH2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MDH2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
602,1456704,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,9606.0,Homo sapiens (human),"[4,4'-hexafluorisopropylidene diphenol co-treated with cylindrospermopsin] results in increased expression of MDM2 mRNA",,,PMID:32244372,https://www.ncbi.nlm.nih.gov/pubmed/32244372,32244372,,
603,1456868,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5469,MED1,https://ctdbase.org/detail.go?type=gene&acc=5469,,,5469.0,MED1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol inhibits the reaction [ESR1 protein binds to MED1 protein]",,,PMID:29389661,https://www.ncbi.nlm.nih.gov/pubmed/29389661,29389661,,
604,1456869,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4208,MEF2C,https://ctdbase.org/detail.go?type=gene&acc=4208,,,4208.0,MEF2C,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MEF2C mRNA",,,PMID:31981723,https://www.ncbi.nlm.nih.gov/pubmed/31981723,31981723,,
605,1457350,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of PRPS1 mRNA",,,PMID:31121516,https://www.ncbi.nlm.nih.gov/pubmed/31121516,31121516,,
606,1457351,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PRPS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
607,1458629,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5868,RAB5A,https://ctdbase.org/detail.go?type=gene&acc=5868,,,5868.0,RAB5A,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB5A protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
608,1458630,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5878,RAB5C,https://ctdbase.org/detail.go?type=gene&acc=5878,,,5878.0,RAB5C,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB5C protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
609,1458631,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5870,RAB6A,https://ctdbase.org/detail.go?type=gene&acc=5870,,,5870.0,RAB6A,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB6A protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
610,1458632,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7879,RAB7A,https://ctdbase.org/detail.go?type=gene&acc=7879,,,7879.0,RAB7A,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB7A protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
611,1458633,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5876,RABGGTB,https://ctdbase.org/detail.go?type=gene&acc=5876,,,5876.0,RABGGTB,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RABGGTB mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
612,1459294,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1104,RCC1,https://ctdbase.org/detail.go?type=gene&acc=1104,,,1104.0,RCC1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RCC1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
613,1459295,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55920,RCC2,https://ctdbase.org/detail.go?type=gene&acc=55920,,,55920.0,RCC2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RCC2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
614,1459296,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5954,RCN1,https://ctdbase.org/detail.go?type=gene&acc=5954,,,5954.0,RCN1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RCN1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
615,1459297,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5955,RCN2,https://ctdbase.org/detail.go?type=gene&acc=5955,,,5955.0,RCN2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RCN2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
616,1460837,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10903,MTMR11,https://ctdbase.org/detail.go?type=gene&acc=10903,,,10903.0,MTMR11,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MTMR11 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
617,1460838,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of MTOR mRNA",,,PMID:34748853,https://www.ncbi.nlm.nih.gov/pubmed/34748853,34748853,,
618,1460839,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,136319,MTPN,https://ctdbase.org/detail.go?type=gene&acc=136319,,,136319.0,MTPN,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MTPN protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
619,1460840,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,92154,MTSS2,https://ctdbase.org/detail.go?type=gene&acc=92154,,,92154.0,MTSS2,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of MTSS2 mRNA",,,PMID:37611474,https://www.ncbi.nlm.nih.gov/pubmed/37611474,37611474,,
620,1461010,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9961,MVP,https://ctdbase.org/detail.go?type=gene&acc=9961,,,9961.0,MVP,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MVP protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
621,1461011,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10608,MXD4,https://ctdbase.org/detail.go?type=gene&acc=10608,,,10608.0,MXD4,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of MXD4 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
622,1461012,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,439921,MXRA7,https://ctdbase.org/detail.go?type=gene&acc=439921,,,439921.0,MXRA7,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MXRA7 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
623,1461013,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,54587,MXRA8,https://ctdbase.org/detail.go?type=gene&acc=54587,,,54587.0,MXRA8,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MXRA8 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
624,1461014,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,91663,MYADM,https://ctdbase.org/detail.go?type=gene&acc=91663,,,91663.0,MYADM,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MYADM protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
625,1461015,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4602,MYB,https://ctdbase.org/detail.go?type=gene&acc=4602,,,4602.0,MYB,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MYB mRNA",,,PMID:28591870,https://www.ncbi.nlm.nih.gov/pubmed/28591870,28591870,,
626,1462288,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55967,NDUFA12,https://ctdbase.org/detail.go?type=gene&acc=55967,,,55967.0,NDUFA12,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NDUFA12 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
627,1462289,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,51079,NDUFA13,https://ctdbase.org/detail.go?type=gene&acc=51079,,,51079.0,NDUFA13,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NDUFA13 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
628,1462290,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4697,NDUFA4,https://ctdbase.org/detail.go?type=gene&acc=4697,,,4697.0,NDUFA4,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NDUFA4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
629,1462598,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4714,NDUFB8,https://ctdbase.org/detail.go?type=gene&acc=4714,,,4714.0,NDUFB8,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NDUFB8 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
630,1462599,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4715,NDUFB9,https://ctdbase.org/detail.go?type=gene&acc=4715,,,4715.0,NDUFB9,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NDUFB9 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
631,1462600,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4718,NDUFC2,https://ctdbase.org/detail.go?type=gene&acc=4718,,,4718.0,NDUFC2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NDUFC2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
632,1462601,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4719,NDUFS1,https://ctdbase.org/detail.go?type=gene&acc=4719,,,4719.0,NDUFS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NDUFS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
633,1462602,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4720,NDUFS2,https://ctdbase.org/detail.go?type=gene&acc=4720,,,4720.0,NDUFS2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NDUFS2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
634,1462603,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4722,NDUFS3,https://ctdbase.org/detail.go?type=gene&acc=4722,,,4722.0,NDUFS3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NDUFS3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
635,1462746,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4729,NDUFV2,https://ctdbase.org/detail.go?type=gene&acc=4729,,,4729.0,NDUFV2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NDUFV2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
636,1462747,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55707,NECAP2,https://ctdbase.org/detail.go?type=gene&acc=55707,,,55707.0,NECAP2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NECAP2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
637,1462748,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,140609,NEK7,https://ctdbase.org/detail.go?type=gene&acc=140609,,,140609.0,NEK7,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NEK7 mRNA",,,PMID:37611474,https://www.ncbi.nlm.nih.gov/pubmed/37611474,37611474,,
638,1462893,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,564518,NF1B,https://ctdbase.org/detail.go?type=gene&acc=564518,,,564518.0,nf1b,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of NF1B mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
639,1462894,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,561772,NFATC3A,https://ctdbase.org/detail.go?type=gene&acc=561772,,,561772.0,nfatc3a,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NFATC3A mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
640,1462895,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4793,NFKBIB,https://ctdbase.org/detail.go?type=gene&acc=4793,,,4793.0,NFKBIB,9606.0,Homo sapiens (human),"[4,4'-hexafluorisopropylidene diphenol binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to NFKBIB protein modified form]",,,PMID:28751236,https://www.ncbi.nlm.nih.gov/pubmed/28751236,28751236,,
641,1462896,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4793,NFKBIB,https://ctdbase.org/detail.go?type=gene&acc=4793,,,4793.0,NFKBIB,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol inhibits the reaction [ESR1 protein binds to NFKBIB protein]",,,PMID:29389661,https://www.ncbi.nlm.nih.gov/pubmed/29389661,29389661,,
642,1462897,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9054,NFS1,https://ctdbase.org/detail.go?type=gene&acc=9054,,,9054.0,NFS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NFS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
643,1462898,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,27247,NFU1,https://ctdbase.org/detail.go?type=gene&acc=27247,,,27247.0,NFU1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NFU1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
644,1462899,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,387921,NHLRC3,https://ctdbase.org/detail.go?type=gene&acc=387921,,,387921.0,NHLRC3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NHLRC3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
645,1462900,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55651,NHP2,https://ctdbase.org/detail.go?type=gene&acc=55651,,,55651.0,NHP2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NHP2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
646,1462901,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,116496,NIBAN1,https://ctdbase.org/detail.go?type=gene&acc=116496,,,116496.0,NIBAN1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of NIBAN1 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
647,1464023,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,51119,SBDS,https://ctdbase.org/detail.go?type=gene&acc=51119,,,51119.0,SBDS,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SBDS protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
648,1464024,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10067,SCAMP3,https://ctdbase.org/detail.go?type=gene&acc=10067,,,10067.0,SCAMP3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SCAMP3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
649,1464025,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,113178,SCAMP4,https://ctdbase.org/detail.go?type=gene&acc=113178,,,113178.0,SCAMP4,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SCAMP4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
650,1464026,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of SCARB1 mrna|4,4'-hexafluorisopropylidene diphenol results in decreased expression of SCARB1 protein",,,PMID:29575470,https://www.ncbi.nlm.nih.gov/pubmed/29575470,29575470,,
651,1464027,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of SCARB1 mrna|4,4'-hexafluorisopropylidene diphenol results in decreased expression of SCARB1 protein",,,PMID:22504055|PMID:35605789,https://www.ncbi.nlm.nih.gov/pubmed/22504055|https://www.ncbi.nlm.nih.gov/pubmed/35605789,22504055|35605789,,
652,1464028,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,950,SCARB2,https://ctdbase.org/detail.go?type=gene&acc=950,,,950.0,SCARB2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SCARB2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
653,1464153,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6342,SCP2,https://ctdbase.org/detail.go?type=gene&acc=6342,,,6342.0,SCP2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SCP2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
654,1465114,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5824,PEX19,https://ctdbase.org/detail.go?type=gene&acc=5824,,,5824.0,PEX19,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PEX19 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
655,1465115,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5198,PFAS,https://ctdbase.org/detail.go?type=gene&acc=5198,,,5198.0,PFAS,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PFAS protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
656,1465116,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5203,PFDN4,https://ctdbase.org/detail.go?type=gene&acc=5203,,,5203.0,PFDN4,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PFDN4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
657,1465117,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5209,PFKFB3,https://ctdbase.org/detail.go?type=gene&acc=5209,,,5209.0,PFKFB3,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of PFKFB3 mRNA",,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
658,1465167,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,54576,UGT1A8,https://ctdbase.org/detail.go?type=gene&acc=54576,,,54576.0,UGT1A8,9606.0,Homo sapiens (human),"UGT1A8 protein results in increased glucuronidation of and results in decreased activity of 4,4'-hexafluorisopropylidene diphenol",,,PMID:24349450,https://www.ncbi.nlm.nih.gov/pubmed/24349450,24349450,,
659,1465168,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,54600,UGT1A9,https://ctdbase.org/detail.go?type=gene&acc=54600,,,54600.0,UGT1A9,9606.0,Homo sapiens (human),"UGT1A9 protein results in increased glucuronidation of 4,4'-hexafluorisopropylidene diphenol",,,PMID:30408883,https://www.ncbi.nlm.nih.gov/pubmed/30408883,30408883,,
660,1465474,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5230,PGK1,https://ctdbase.org/detail.go?type=gene&acc=5230,,,5230.0,PGK1,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PGK1 mRNA",,,PMID:35598417,https://www.ncbi.nlm.nih.gov/pubmed/35598417,35598417,,
661,1465475,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5230,PGK1,https://ctdbase.org/detail.go?type=gene&acc=5230,,,5230.0,PGK1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PGK1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
662,1465476,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5232,PGK2,https://ctdbase.org/detail.go?type=gene&acc=5232,,,5232.0,PGK2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PGK2 mRNA",,,PMID:31121516,https://www.ncbi.nlm.nih.gov/pubmed/31121516,31121516,,
663,1465477,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,25796,PGLS,https://ctdbase.org/detail.go?type=gene&acc=25796,,,25796.0,PGLS,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PGLS protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
664,1465478,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5236,PGM1,https://ctdbase.org/detail.go?type=gene&acc=5236,,,5236.0,PGM1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PGM1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
665,1465479,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55276,PGM2,https://ctdbase.org/detail.go?type=gene&acc=55276,,,55276.0,PGM2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PGM2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
666,1465480,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5238,PGM3,https://ctdbase.org/detail.go?type=gene&acc=5238,,,5238.0,PGM3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PGM3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
667,1465481,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol inhibits the reaction [progesterone binds to PGR protein]",,,PMID:31195007,https://www.ncbi.nlm.nih.gov/pubmed/31195007,31195007,,
668,1465482,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606.0,Homo sapiens (human),"Fulvestrant inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of PGR mrna]|4,4'-hexafluorisopropylidene diphenol promotes the reaction [ESR1 protein binds to PGR protein]",,,PMID:29389661,https://www.ncbi.nlm.nih.gov/pubmed/29389661,29389661,,
669,1465483,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PGR mRNA",,,PMID:28591870|PMID:29389661|PMID:31388671|PMID:36190352,https://www.ncbi.nlm.nih.gov/pubmed/28591870|https://www.ncbi.nlm.nih.gov/pubmed/29389661|https://www.ncbi.nlm.nih.gov/pubmed/31388671|https://www.ncbi.nlm.nih.gov/pubmed/36190352,28591870|29389661|31388671|36190352,,
670,1466345,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5358,PLS3,https://ctdbase.org/detail.go?type=gene&acc=5358,,,5358.0,PLS3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PLS3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
671,1466346,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,564882,PLSCR3A,https://ctdbase.org/detail.go?type=gene&acc=564882,,,564882.0,plscr3a,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PLSCR3A mRNA",,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
672,1466560,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7520,XRCC5,https://ctdbase.org/detail.go?type=gene&acc=7520,,,7520.0,XRCC5,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of XRCC5 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
673,1466735,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,8531,YBX3,https://ctdbase.org/detail.go?type=gene&acc=8531,,,8531.0,YBX3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of YBX3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
674,1466736,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7525,YES1,https://ctdbase.org/detail.go?type=gene&acc=7525,,,7525.0,YES1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of YES1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
675,1466737,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,253943,YTHDF3,https://ctdbase.org/detail.go?type=gene&acc=253943,,,253943.0,YTHDF3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of YTHDF3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
676,1467573,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,25824,PRDX5,https://ctdbase.org/detail.go?type=gene&acc=25824,,,25824.0,PRDX5,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PRDX5 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
677,1467574,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9588,PRDX6,https://ctdbase.org/detail.go?type=gene&acc=9588,,,9588.0,PRDX6,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PRDX6 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
678,1467575,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5550,PREP,https://ctdbase.org/detail.go?type=gene&acc=5550,,,5550.0,PREP,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PREP protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
679,1468527,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,677845,SNORA79,https://ctdbase.org/detail.go?type=gene&acc=677845,,,677845.0,SNORA79,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of SNORA79 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
680,1468528,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,26815,SNORD36A,https://ctdbase.org/detail.go?type=gene&acc=26815,,,26815.0,SNORD36A,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SNORD36A mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
681,1468529,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,619571,SNORD96A,https://ctdbase.org/detail.go?type=gene&acc=619571,,,619571.0,SNORD96A,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SNORD96A mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
682,1468530,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23020,SNRNP200,https://ctdbase.org/detail.go?type=gene&acc=23020,,,23020.0,SNRNP200,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SNRNP200 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
683,1468531,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,154007,SNRNP48,https://ctdbase.org/detail.go?type=gene&acc=154007,,,154007.0,SNRNP48,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SNRNP48 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
684,1468532,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6625,SNRNP70,https://ctdbase.org/detail.go?type=gene&acc=6625,,,6625.0,SNRNP70,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SNRNP70 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
685,1468533,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6626,SNRPA,https://ctdbase.org/detail.go?type=gene&acc=6626,,,6626.0,SNRPA,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SNRPA protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
686,1468534,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6627,SNRPA1,https://ctdbase.org/detail.go?type=gene&acc=6627,,,6627.0,SNRPA1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SNRPA1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
687,1468711,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,283219,KCTD21,https://ctdbase.org/detail.go?type=gene&acc=283219,,,283219.0,KCTD21,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KCTD21 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
688,1468712,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2531,KDSR,https://ctdbase.org/detail.go?type=gene&acc=2531,,,2531.0,KDSR,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KDSR protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
689,1468713,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10657,KHDRBS1,https://ctdbase.org/detail.go?type=gene&acc=10657,,,10657.0,KHDRBS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of KHDRBS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
690,1468714,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3832,KIF11,https://ctdbase.org/detail.go?type=gene&acc=3832,,,3832.0,KIF11,9606.0,Homo sapiens (human),"[4,4'-hexafluorisopropylidene diphenol binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to KIF11 protein modified form]",,,PMID:28751236,https://www.ncbi.nlm.nih.gov/pubmed/28751236,28751236,,
691,1468827,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,30732.0,Oryzias melastigma (Indian medaka),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of SOD1 mRNA",,,PMID:36116629,https://www.ncbi.nlm.nih.gov/pubmed/36116629,36116629,,
692,1468828,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of SOD1 mrna|4,4'-hexafluorisopropylidene diphenol results in decreased expression of SOD1 protein",,,PMID:35605789,https://www.ncbi.nlm.nih.gov/pubmed/35605789,35605789,,
693,1468829,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SOD2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
694,1468830,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SOD2 protein",,,PMID:34134381,https://www.ncbi.nlm.nih.gov/pubmed/34134381,34134381,,
695,1468831,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of SOD2 protein|4,4'-hexafluorisopropylidene diphenol results in decreased expression of SOD2 mRNA",,,PMID:35605789,https://www.ncbi.nlm.nih.gov/pubmed/35605789,35605789,,
696,1468832,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10580,SORBS1,https://ctdbase.org/detail.go?type=gene&acc=10580,,,10580.0,SORBS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SORBS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
697,1468988,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SPARC protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
698,1468989,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23111,SPART,https://ctdbase.org/detail.go?type=gene&acc=23111,,,23111.0,SPART,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SPART protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
699,1469525,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10250,SRRM1,https://ctdbase.org/detail.go?type=gene&acc=10250,,,10250.0,SRRM1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SRRM1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
700,1469526,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23524,SRRM2,https://ctdbase.org/detail.go?type=gene&acc=23524,,,23524.0,SRRM2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SRRM2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
701,1469527,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10772,SRSF10,https://ctdbase.org/detail.go?type=gene&acc=10772,,,10772.0,SRSF10,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SRSF10 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
702,1469528,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6429,SRSF4,https://ctdbase.org/detail.go?type=gene&acc=6429,,,6429.0,SRSF4,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SRSF4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
703,1469529,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6430,SRSF5,https://ctdbase.org/detail.go?type=gene&acc=6430,,,6430.0,SRSF5,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SRSF5 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
704,1469530,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6431,SRSF6,https://ctdbase.org/detail.go?type=gene&acc=6431,,,6431.0,SRSF6,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SRSF6 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
705,1469531,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6741,SSB,https://ctdbase.org/detail.go?type=gene&acc=6741,,,6741.0,SSB,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SSB protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
706,1469532,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6742,SSBP1,https://ctdbase.org/detail.go?type=gene&acc=6742,,,6742.0,SSBP1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SSBP1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
707,1469533,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,8082,SSPN,https://ctdbase.org/detail.go?type=gene&acc=8082,,,8082.0,SSPN,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SSPN mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
708,1469534,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,6745,SSR1,https://ctdbase.org/detail.go?type=gene&acc=6745,,,6745.0,SSR1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SSR1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
709,1473212,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,81628,TSC22D4,https://ctdbase.org/detail.go?type=gene&acc=81628,,,81628.0,TSC22D4,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of TSC22D4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
710,1473213,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10102,TSFM,https://ctdbase.org/detail.go?type=gene&acc=10102,,,10102.0,TSFM,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of TSFM protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
711,1473214,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7251,TSG101,https://ctdbase.org/detail.go?type=gene&acc=7251,,,7251.0,TSG101,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of TSG101 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
712,1473974,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7317,UBA1,https://ctdbase.org/detail.go?type=gene&acc=7317,,,7317.0,UBA1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of UBA1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
713,1473975,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55236,UBA6,https://ctdbase.org/detail.go?type=gene&acc=55236,,,55236.0,UBA6,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of UBA6 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
714,1473976,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,794012,UBALD1A,https://ctdbase.org/detail.go?type=gene&acc=794012,,,794012.0,ubald1a,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of UBALD1A mRNA",,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
715,1473977,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9898,UBAP2L,https://ctdbase.org/detail.go?type=gene&acc=9898,,,9898.0,UBAP2L,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of UBAP2L protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
716,1473978,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3093,UBE2K,https://ctdbase.org/detail.go?type=gene&acc=3093,,,3093.0,UBE2K,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of UBE2K protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
717,1386228,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6303,SAT1,https://ctdbase.org/detail.go?type=gene&acc=6303,,,6303.0,SAT1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SAT1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of SAT1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
718,1386229,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9953,HS3ST3B1,https://ctdbase.org/detail.go?type=gene&acc=9953,,,9953.0,HS3ST3B1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of HS3ST3B1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of HS3ST3B1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of HS3ST3B1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
719,1386230,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,64711,HS3ST6,https://ctdbase.org/detail.go?type=gene&acc=64711,,,64711.0,HS3ST6,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of HS3ST6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
720,1386231,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9394,HS6ST1,https://ctdbase.org/detail.go?type=gene&acc=9394,,,9394.0,HS6ST1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of HS6ST1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of HS6ST1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of HS6ST1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
721,1386232,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,440498,HSBP1L1,https://ctdbase.org/detail.go?type=gene&acc=440498,,,440498.0,HSBP1L1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of HSBP1L1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
722,1386233,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,150274,HSCB,https://ctdbase.org/detail.go?type=gene&acc=150274,,,150274.0,HSCB,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of HSCB mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of HSCB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
723,1386234,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3290,HSD11B1,https://ctdbase.org/detail.go?type=gene&acc=3290,,,3290.0,HSD11B1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid inhibits the reaction [hydrocortisone results in increased expression of hsd11b1]|perfluorooctane sulfonic acid results in decreased expression of HSD11B1,,,PMID:27288094,https://www.ncbi.nlm.nih.gov/pubmed/27288094,27288094,,
724,1387052,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55681,SCYL2,https://ctdbase.org/detail.go?type=gene&acc=55681,,,55681.0,SCYL2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of SCYL2 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
725,1387053,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57147,SCYL3,https://ctdbase.org/detail.go?type=gene&acc=57147,,,57147.0,SCYL3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of SCYL3 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of SCYL3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
726,1387054,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55153,SDAD1,https://ctdbase.org/detail.go?type=gene&acc=55153,,,55153.0,SDAD1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of SDAD1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
727,1387055,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6383,SDC2,https://ctdbase.org/detail.go?type=gene&acc=6383,,,6383.0,SDC2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of SDC2 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of SDC2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
728,1387056,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6385,SDC4,https://ctdbase.org/detail.go?type=gene&acc=6385,,,6385.0,SDC4,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of SDC4 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
729,1387057,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6385,SDC4,https://ctdbase.org/detail.go?type=gene&acc=6385,,,6385.0,SDC4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of SDC4 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of SDC4 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of SDC4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
730,1387186,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of HSPB1 protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
731,1387187,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,126393,HSPB6,https://ctdbase.org/detail.go?type=gene&acc=126393,,,126393.0,HSPB6,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of HSPB6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
732,1387188,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,27129,HSPB7,https://ctdbase.org/detail.go?type=gene&acc=27129,,,27129.0,HSPB7,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of HSPB7 mrna|perfluorooctane sulfonic acid results in increased expression of HSPB7 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
733,1387189,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,27129,HSPB7,https://ctdbase.org/detail.go?type=gene&acc=27129,,,27129.0,HSPB7,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of HSPB7 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
734,1387190,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,26353,HSPB8,https://ctdbase.org/detail.go?type=gene&acc=26353,,,26353.0,HSPB8,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of HSPB8 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
735,1387307,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3329,HSPD1,https://ctdbase.org/detail.go?type=gene&acc=3329,,,3329.0,HSPD1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of HSPD1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
736,1387308,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3329,HSPD1,https://ctdbase.org/detail.go?type=gene&acc=3329,,,3329.0,HSPD1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of HSPD1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of HSPD1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of HSPD1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
737,1387309,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,432551,HSPD1-PS3,https://ctdbase.org/detail.go?type=gene&acc=432551,,,432551.0,Hspd1-ps3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of HSPD1-PS3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
738,1387310,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3336,HSPE1,https://ctdbase.org/detail.go?type=gene&acc=3336,,,3336.0,HSPE1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of HSPE1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of HSPE1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of HSPE1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
739,1387311,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3339,HSPG2,https://ctdbase.org/detail.go?type=gene&acc=3339,,,3339.0,HSPG2,9913.0,Bos taurus (cattle),Perfluorooctane sulfonic acid results in decreased expression of HSPG2 mrna|perfluorooctane sulfonic acid results in decreased methylation of HSPG2 intron,,,PMID:34762985,https://www.ncbi.nlm.nih.gov/pubmed/34762985,34762985,,
740,1387312,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3339,HSPG2,https://ctdbase.org/detail.go?type=gene&acc=3339,,,3339.0,HSPG2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of HSPG2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
741,1387429,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,728655,HULC,https://ctdbase.org/detail.go?type=gene&acc=728655,,,728655.0,HULC,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of HULC mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
742,1387891,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55829,SELENOS,https://ctdbase.org/detail.go?type=gene&acc=55829,,,55829.0,SELENOS,9739.0,Tursiops truncatus (common bottlenose dolphin),Perfluorooctane sulfonic acid results in decreased expression of SELENOS mRNA,,,PMID:19010555,https://www.ncbi.nlm.nih.gov/pubmed/19010555,19010555,,
743,1387892,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,352917,SELENOT2,https://ctdbase.org/detail.go?type=gene&acc=352917,,,352917.0,selenot2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of SELENOT2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
744,1387893,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6415,SELENOW,https://ctdbase.org/detail.go?type=gene&acc=6415,,,6415.0,SELENOW,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of SELENOW mRNA,,,PMID:16221955|PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/16221955|https://www.ncbi.nlm.nih.gov/pubmed/19162173,16221955|19162173,,
745,1387894,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6403,SELP,https://ctdbase.org/detail.go?type=gene&acc=6403,,,6403.0,SELP,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of SELP mRNA,,,PMID:22269386,https://www.ncbi.nlm.nih.gov/pubmed/22269386,22269386,,
746,1387895,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,30266,SEMA3AA,https://ctdbase.org/detail.go?type=gene&acc=30266,,,30266.0,sema3aa,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of SEMA3AA mrna|[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SEMA3AA mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
747,1387896,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,30267,SEMA3AB,https://ctdbase.org/detail.go?type=gene&acc=30267,,,30267.0,sema3ab,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SEMA3AB mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
748,1387897,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10512,SEMA3C,https://ctdbase.org/detail.go?type=gene&acc=10512,,,10512.0,SEMA3C,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of SEMA3C mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
749,1389362,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,103142,RDH9,https://ctdbase.org/detail.go?type=gene&acc=103142,,,103142.0,Rdh9,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of RDH9 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RDH9 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
750,1389363,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5962,RDX,https://ctdbase.org/detail.go?type=gene&acc=5962,,,5962.0,RDX,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RDX mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
751,1389364,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5962,RDX,https://ctdbase.org/detail.go?type=gene&acc=5962,,,5962.0,RDX,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of RDX protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
752,1389365,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,283677,REC114,https://ctdbase.org/detail.go?type=gene&acc=283677,,,283677.0,REC114,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of REC114 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
753,1389366,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9985,REC8,https://ctdbase.org/detail.go?type=gene&acc=9985,,,9985.0,REC8,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of REC8 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of REC8 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
754,1389367,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8434,RECK,https://ctdbase.org/detail.go?type=gene&acc=8434,,,8434.0,RECK,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of RECK mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
755,1389368,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8434,RECK,https://ctdbase.org/detail.go?type=gene&acc=8434,,,8434.0,RECK,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RECK mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
756,1389369,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5965,RECQL,https://ctdbase.org/detail.go?type=gene&acc=5965,,,5965.0,RECQL,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of RECQL mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
757,1389854,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56729,RETN,https://ctdbase.org/detail.go?type=gene&acc=56729,,,56729.0,RETN,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RETN mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
758,1389855,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57262,RETNLA,https://ctdbase.org/detail.go?type=gene&acc=57262,,,57262.0,Retnla,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of RETNLA mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
759,1389856,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,245195,RETNLG,https://ctdbase.org/detail.go?type=gene&acc=245195,,,245195.0,Retnlg,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of RETNLG mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
760,1389857,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54463,RETREG1,https://ctdbase.org/detail.go?type=gene&acc=54463,,,54463.0,RETREG1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RETREG1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of RETREG1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
761,1389858,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,79137,RETREG2,https://ctdbase.org/detail.go?type=gene&acc=79137,,,79137.0,RETREG2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RETREG2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
762,1389859,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,162427,RETREG3,https://ctdbase.org/detail.go?type=gene&acc=162427,,,162427.0,RETREG3,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of RETREG3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
763,1389860,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,162427,RETREG3,https://ctdbase.org/detail.go?type=gene&acc=162427,,,162427.0,RETREG3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RETREG3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
764,1389975,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51455,REV1,https://ctdbase.org/detail.go?type=gene&acc=51455,,,51455.0,REV1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of REV1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
765,1389976,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5980,REV3L,https://ctdbase.org/detail.go?type=gene&acc=5980,,,5980.0,REV3L,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of REV3L mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
766,1389977,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55049,REX1BD,https://ctdbase.org/detail.go?type=gene&acc=55049,,,55049.0,REX1BD,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of REX1BD mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
767,1389978,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,25996,REXO2,https://ctdbase.org/detail.go?type=gene&acc=25996,,,25996.0,REXO2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of REXO2 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
768,1390098,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,100038773,RFX1A,https://ctdbase.org/detail.go?type=gene&acc=100038773,,,100038773.0,rfx1a,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of RFX1A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
769,1390099,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5992,RFX4,https://ctdbase.org/detail.go?type=gene&acc=5992,,,5992.0,RFX4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RFX4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
770,1390100,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5994,RFXAP,https://ctdbase.org/detail.go?type=gene&acc=5994,,,5994.0,RFXAP,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of RFXAP mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of RFXAP mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
771,1390101,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,28984,RGCC,https://ctdbase.org/detail.go?type=gene&acc=28984,,,28984.0,RGCC,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of RGCC mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
772,1390102,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,28984,RGCC,https://ctdbase.org/detail.go?type=gene&acc=28984,,,28984.0,RGCC,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of RGCC mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
773,1390103,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,28984,RGCC,https://ctdbase.org/detail.go?type=gene&acc=28984,,,28984.0,RGCC,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of RGCC mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
774,1390104,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,28984,RGCC,https://ctdbase.org/detail.go?type=gene&acc=28984,,,28984.0,RGCC,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in increased expression of RGCC mRNA,,,PMID:18692542,https://www.ncbi.nlm.nih.gov/pubmed/18692542,18692542,,
775,1390983,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6016,RIT1,https://ctdbase.org/detail.go?type=gene&acc=6016,,,6016.0,RIT1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of RIT1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RIT1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of RIT1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
776,1390984,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,402990,RLBP1B,https://ctdbase.org/detail.go?type=gene&acc=402990,,,402990.0,rlbp1b,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of RLBP1B mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
777,1390985,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6018,RLF,https://ctdbase.org/detail.go?type=gene&acc=6018,,,6018.0,RLF,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of RLF mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
778,1390986,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51115,RMDN1,https://ctdbase.org/detail.go?type=gene&acc=51115,,,51115.0,RMDN1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RMDN1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
779,1393011,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6175,RPLP0,https://ctdbase.org/detail.go?type=gene&acc=6175,,,6175.0,RPLP0,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RPLP0 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of RPLP0 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
780,1393012,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6176,RPLP1,https://ctdbase.org/detail.go?type=gene&acc=6176,,,6176.0,RPLP1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of RPLP1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RPLP1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of RPLP1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
781,1393013,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,114134,SLC2A13,https://ctdbase.org/detail.go?type=gene&acc=114134,,,114134.0,SLC2A13,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of SLC2A13 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
782,1393014,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of SLC2A2 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
783,1393681,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23412,COMMD3,https://ctdbase.org/detail.go?type=gene&acc=23412,,,23412.0,COMMD3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of COMMD3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
784,1450636,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in increased expression of PPARG mRNA,,,PMID:23500012,https://www.ncbi.nlm.nih.gov/pubmed/23500012,23500012,,
785,1450637,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,8030.0,Salmo salar (Atlantic salmon),Perfluorooctane sulfonic acid results in increased expression of PPARG mRNA,,,PMID:18424238|PMID:19747560,https://www.ncbi.nlm.nih.gov/pubmed/18424238|https://www.ncbi.nlm.nih.gov/pubmed/19747560,18424238|19747560,,
786,1450942,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5481,PPID,https://ctdbase.org/detail.go?type=gene&acc=5481,,,5481.0,PPID,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid promotes the reaction [BAX protein binds to PPID protein],,,PMID:34006824,https://www.ncbi.nlm.nih.gov/pubmed/34006824,34006824,,
787,1450943,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5481,PPID,https://ctdbase.org/detail.go?type=gene&acc=5481,,,5481.0,PPID,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PPID mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
788,1450944,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10105,PPIF,https://ctdbase.org/detail.go?type=gene&acc=10105,,,10105.0,PPIF,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PPIF mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PPIF mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
789,1450945,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9360,PPIG,https://ctdbase.org/detail.go?type=gene&acc=9360,,,9360.0,PPIG,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PPIG mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
790,1450946,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51645,PPIL1,https://ctdbase.org/detail.go?type=gene&acc=51645,,,51645.0,PPIL1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PPIL1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
791,1450947,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,53938,PPIL3,https://ctdbase.org/detail.go?type=gene&acc=53938,,,53938.0,PPIL3,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PPIL3 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
792,1450948,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,85313,PPIL4,https://ctdbase.org/detail.go?type=gene&acc=85313,,,85313.0,PPIL4,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PPIL4 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
793,1450949,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,559938,PPIP5K1B,https://ctdbase.org/detail.go?type=gene&acc=559938,,,559938.0,ppip5k1b,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PPIP5K1B mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
794,1450950,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23262,PPIP5K2,https://ctdbase.org/detail.go?type=gene&acc=23262,,,23262.0,PPIP5K2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PPIP5K2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
795,1450951,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23262,PPIP5K2,https://ctdbase.org/detail.go?type=gene&acc=23262,,,23262.0,PPIP5K2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PPIP5K2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
796,1451133,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5493,PPL,https://ctdbase.org/detail.go?type=gene&acc=5493,,,5493.0,PPL,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PPL mrna|[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of PPL mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
797,1451134,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,30704,PPM1AA,https://ctdbase.org/detail.go?type=gene&acc=30704,,,30704.0,ppm1aa,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PPM1AA mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
798,1451135,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8493,PPM1D,https://ctdbase.org/detail.go?type=gene&acc=8493,,,8493.0,PPM1D,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of PPM1D mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
799,1451136,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5496,PPM1G,https://ctdbase.org/detail.go?type=gene&acc=5496,,,5496.0,PPM1G,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PPM1G mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
800,1451928,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,101883969,PQLC1,https://ctdbase.org/detail.go?type=gene&acc=101883969,,,101883969.0,pqlc1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PQLC1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PQLC1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
801,1451929,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,419472,PQLC2,https://ctdbase.org/detail.go?type=gene&acc=419472,,,419472.0,PQLC2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PQLC2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
802,1451930,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,11230,PRAF2,https://ctdbase.org/detail.go?type=gene&acc=11230,,,11230.0,PRAF2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PRAF2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
803,1452512,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5566,PRKACA,https://ctdbase.org/detail.go?type=gene&acc=5566,,,5566.0,PRKACA,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PRKACA mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
804,1452683,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1452,CSNK1A1,https://ctdbase.org/detail.go?type=gene&acc=1452,,,1452.0,CSNK1A1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CSNK1A1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of CSNK1A1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
805,1453345,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56259,CTNNBL1,https://ctdbase.org/detail.go?type=gene&acc=56259,,,56259.0,CTNNBL1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of CTNNBL1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of CTNNBL1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
806,1453346,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1500,CTNND1,https://ctdbase.org/detail.go?type=gene&acc=1500,,,1500.0,CTNND1,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of CTNND1 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
807,1453347,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1501,CTNND2,https://ctdbase.org/detail.go?type=gene&acc=1501,,,1501.0,CTNND2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of CTNND2 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
808,1453348,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1503,CTPS1,https://ctdbase.org/detail.go?type=gene&acc=1503,,,1503.0,CTPS1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CTPS1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CTPS1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CTPS1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
809,1453349,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,445245,CTPS1B,https://ctdbase.org/detail.go?type=gene&acc=445245,,,445245.0,ctps1b,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CTPS1B mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
810,1453869,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,27339,PRPF19,https://ctdbase.org/detail.go?type=gene&acc=27339,,,27339.0,PRPF19,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PRPF19 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PRPF19 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
811,1453870,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9129,PRPF3,https://ctdbase.org/detail.go?type=gene&acc=9129,,,9129.0,PRPF3,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PRPF3 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
812,1453871,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55119,PRPF38B,https://ctdbase.org/detail.go?type=gene&acc=55119,,,55119.0,PRPF38B,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PRPF38B mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
813,1454305,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5396,PRRX1,https://ctdbase.org/detail.go?type=gene&acc=5396,,,5396.0,PRRX1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of PRRX1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
814,1454306,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8492,PRSS12,https://ctdbase.org/detail.go?type=gene&acc=8492,,,8492.0,PRSS12,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PRSS12 mrna|[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of PRSS12 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
815,1454307,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,11098,PRSS23,https://ctdbase.org/detail.go?type=gene&acc=11098,,,11098.0,PRSS23,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PRSS23 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
816,1454458,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51706,CYB5R1,https://ctdbase.org/detail.go?type=gene&acc=51706,,,51706.0,CYB5R1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CYB5R1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
817,1454459,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51700,CYB5R2,https://ctdbase.org/detail.go?type=gene&acc=51700,,,51700.0,CYB5R2,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of CYB5R2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
818,1454460,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1727,CYB5R3,https://ctdbase.org/detail.go?type=gene&acc=1727,,,1727.0,CYB5R3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CYB5R3 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CYB5R3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
819,1454461,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1535,CYBA,https://ctdbase.org/detail.go?type=gene&acc=1535,,,1535.0,CYBA,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CYBA mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
820,1454462,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CYBB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
821,1454710,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23362,PSD3,https://ctdbase.org/detail.go?type=gene&acc=23362,,,23362.0,PSD3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PSD3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
822,1454711,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23550,PSD4,https://ctdbase.org/detail.go?type=gene&acc=23550,,,23550.0,PSD4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PSD4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
823,1455597,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5693,PSMB5,https://ctdbase.org/detail.go?type=gene&acc=5693,,,5693.0,PSMB5,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PSMB5 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PSMB5 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PSMB5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
824,1455598,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5693,PSMB5,https://ctdbase.org/detail.go?type=gene&acc=5693,,,5693.0,PSMB5,10090.0,Mus musculus (house mouse),PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of PSMB5 mrna]|perfluorooctane sulfonic acid results in increased expression of PSMB5 mRNA,,,PMID:20936131,https://www.ncbi.nlm.nih.gov/pubmed/20936131,20936131,,
825,1455599,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5694,PSMB6,https://ctdbase.org/detail.go?type=gene&acc=5694,,,5694.0,PSMB6,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of PSMB6 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
826,1455600,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5694,PSMB6,https://ctdbase.org/detail.go?type=gene&acc=5694,,,5694.0,PSMB6,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PSMB6 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
827,1455601,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5694,PSMB6,https://ctdbase.org/detail.go?type=gene&acc=5694,,,5694.0,PSMB6,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PSMB6 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PSMB6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
828,1456084,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5702,PSMC3,https://ctdbase.org/detail.go?type=gene&acc=5702,,,5702.0,PSMC3,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of PSMC3 protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
829,1456085,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5704,PSMC4,https://ctdbase.org/detail.go?type=gene&acc=5704,,,5704.0,PSMC4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PSMC4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
830,1456860,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56448,CYP2D22,https://ctdbase.org/detail.go?type=gene&acc=56448,,,56448.0,Cyp2d22,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of CYP2D22 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
831,1456861,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56448,CYP2D22,https://ctdbase.org/detail.go?type=gene&acc=56448,,,56448.0,Cyp2d22,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CYP2D22 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CYP2D22 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CYP2D22 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
832,1456862,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,76279,CYP2D26,https://ctdbase.org/detail.go?type=gene&acc=76279,,,76279.0,Cyp2d26,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of CYP2D26 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
833,1456863,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,76279,CYP2D26,https://ctdbase.org/detail.go?type=gene&acc=76279,,,76279.0,Cyp2d26,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CYP2D26 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
834,1456864,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,627860,CYP2D37-PS,https://ctdbase.org/detail.go?type=gene&acc=627860,,,627860.0,Cyp2d37-ps,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CYP2D37-PS mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
835,1456865,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,71754,CYP2D40,https://ctdbase.org/detail.go?type=gene&acc=71754,,,71754.0,Cyp2d40,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of CYP2D40 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CYP2D40 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
836,1456866,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,271300,CYP2D41-PS,https://ctdbase.org/detail.go?type=gene&acc=271300,,,271300.0,Cyp2d41-ps,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CYP2D41-PS mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CYP2D41-PS mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
837,1456867,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid inhibits the reaction [CYP2D6 protein results in increased oxidation of bufuralol],,,PMID:21964418,https://www.ncbi.nlm.nih.gov/pubmed/21964418,21964418,,
838,1457916,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PTGS1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
839,1457917,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of PTGS2 mRNA,,,PMID:22269386,https://www.ncbi.nlm.nih.gov/pubmed/22269386,22269386,,
840,1458778,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51651,PTRH2,https://ctdbase.org/detail.go?type=gene&acc=51651,,,51651.0,PTRH2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PTRH2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
841,1458779,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51651,PTRH2,https://ctdbase.org/detail.go?type=gene&acc=51651,,,51651.0,PTRH2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PTRH2 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PTRH2 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PTRH2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
842,1459579,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5831,PYCR1,https://ctdbase.org/detail.go?type=gene&acc=5831,,,5831.0,PYCR1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PYCR1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
843,1459580,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,100149838,PYCR1B,https://ctdbase.org/detail.go?type=gene&acc=100149838,,,100149838.0,pycr1b,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PYCR1B mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
844,1459581,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,65263,PYCR3,https://ctdbase.org/detail.go?type=gene&acc=65263,,,65263.0,PYCR3,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PYCR3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
845,1459582,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,65263,PYCR3,https://ctdbase.org/detail.go?type=gene&acc=65263,,,65263.0,PYCR3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PYCR3 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PYCR3 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PYCR3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
846,1459583,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5834,PYGB,https://ctdbase.org/detail.go?type=gene&acc=5834,,,5834.0,PYGB,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of PYGB mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PYGB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
847,1459584,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5834,PYGB,https://ctdbase.org/detail.go?type=gene&acc=5834,,,5834.0,PYGB,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of PYGB protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
848,1459585,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836.0,PYGL,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PYGL mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
849,1459586,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836.0,PYGL,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of PYGL mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
850,1459587,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5837,PYGM,https://ctdbase.org/detail.go?type=gene&acc=5837,,,5837.0,PYGM,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PYGM mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
851,1461565,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,7955.0,Danio rerio (zebrafish),[NFE2L2A gene mutant form affects the susceptibility to perfluorooctane sulfonic acid] which results in increased expression of PPARG mRNA,,,PMID:29524743,https://www.ncbi.nlm.nih.gov/pubmed/29524743,29524743,,
852,1461566,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid affects the expression of PPARG mRNA,,,PMID:30738844,https://www.ncbi.nlm.nih.gov/pubmed/30738844,30738844,,
853,1461567,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid binds to and results in increased activity of PPARG protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
854,1461568,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid binds to PPARG protein,,,PMID:35752307,https://www.ncbi.nlm.nih.gov/pubmed/35752307,35752307,,
855,1461569,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,25788,RAD54B,https://ctdbase.org/detail.go?type=gene&acc=25788,,,25788.0,RAD54B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of RAD54B mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RAD54B mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of RAD54B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
856,1461570,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23132,RAD54L2,https://ctdbase.org/detail.go?type=gene&acc=23132,,,23132.0,RAD54L2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RAD54L2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
857,1461571,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5883,RAD9A,https://ctdbase.org/detail.go?type=gene&acc=5883,,,5883.0,RAD9A,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of RAD9A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
858,1461572,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,144715,RAD9B,https://ctdbase.org/detail.go?type=gene&acc=144715,,,144715.0,RAD9B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RAD9B mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of RAD9B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
859,1461573,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55698,RADIL,https://ctdbase.org/detail.go?type=gene&acc=55698,,,55698.0,RADIL,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of RADIL mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
860,1461747,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51635,DHRS7,https://ctdbase.org/detail.go?type=gene&acc=51635,,,51635.0,DHRS7,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of DHRS7 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of DHRS7 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
861,1461748,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,25979,DHRS7B,https://ctdbase.org/detail.go?type=gene&acc=25979,,,25979.0,DHRS7B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of DHRS7B mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of DHRS7B mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of DHRS7B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
862,1461749,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10170,DHRS9,https://ctdbase.org/detail.go?type=gene&acc=10170,,,10170.0,DHRS9,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of DHRS9 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
863,1461750,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55526,DHTKD1,https://ctdbase.org/detail.go?type=gene&acc=55526,,,55526.0,DHTKD1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of DHTKD1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
864,1463039,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,25780,RASGRP3,https://ctdbase.org/detail.go?type=gene&acc=25780,,,25780.0,RASGRP3,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of RASGRP3 mrna|[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of RASGRP3 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
865,1463040,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,25780,RASGRP3,https://ctdbase.org/detail.go?type=gene&acc=25780,,,25780.0,RASGRP3,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of RASGRP3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
866,1463041,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,91608,RASL10B,https://ctdbase.org/detail.go?type=gene&acc=91608,,,91608.0,RASL10B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RASL10B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
867,1463042,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,387496,RASL11A,https://ctdbase.org/detail.go?type=gene&acc=387496,,,387496.0,RASL11A,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of RASL11A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
868,1463043,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,387496,RASL11A,https://ctdbase.org/detail.go?type=gene&acc=387496,,,387496.0,RASL11A,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of RASL11A mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
869,1463044,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,283349,RASSF3,https://ctdbase.org/detail.go?type=gene&acc=283349,,,283349.0,RASSF3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RASSF3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
870,1463045,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,494494,RASSF4A,https://ctdbase.org/detail.go?type=gene&acc=494494,,,494494.0,rassf4a,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of RASSF4A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
871,1469806,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2200,FBN1,https://ctdbase.org/detail.go?type=gene&acc=2200,,,2200.0,FBN1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of FBN1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
872,1469807,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2201,FBN2,https://ctdbase.org/detail.go?type=gene&acc=2201,,,2201.0,FBN2,9031.0,Gallus gallus (chicken),Perfluorooctane sulfonic acid results in decreased expression of FBN2 mRNA,,,PMID:17560707,https://www.ncbi.nlm.nih.gov/pubmed/17560707,17560707,,
873,1469808,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2203,FBP1,https://ctdbase.org/detail.go?type=gene&acc=2203,,,2203.0,FBP1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of FBP1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of FBP1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of FBP1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
874,1469809,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8789,FBP2,https://ctdbase.org/detail.go?type=gene&acc=8789,,,8789.0,FBP2,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of FBP2 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
875,1469810,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8789,FBP2,https://ctdbase.org/detail.go?type=gene&acc=8789,,,8789.0,FBP2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of FBP2 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of FBP2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
876,1469811,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,64319,FBRS,https://ctdbase.org/detail.go?type=gene&acc=64319,,,64319.0,FBRS,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of FBRS mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
877,1469812,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,64319,FBRS,https://ctdbase.org/detail.go?type=gene&acc=64319,,,64319.0,FBRS,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of FBRS mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
878,1469813,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,146330,FBXL16,https://ctdbase.org/detail.go?type=gene&acc=146330,,,146330.0,FBXL16,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of FBXL16 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
879,1470563,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,197258,FCSK,https://ctdbase.org/detail.go?type=gene&acc=197258,,,197258.0,FCSK,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of FCSK mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
880,1470564,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2222,FDFT1,https://ctdbase.org/detail.go?type=gene&acc=2222,,,2222.0,FDFT1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of FDFT1 mRNA,,,PMID:36864359,https://www.ncbi.nlm.nih.gov/pubmed/36864359,36864359,,
881,1470565,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2222,FDFT1,https://ctdbase.org/detail.go?type=gene&acc=2222,,,2222.0,FDFT1,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of FDFT1 mRNA,,,PMID:19429403|PMID:20936131,https://www.ncbi.nlm.nih.gov/pubmed/19429403|https://www.ncbi.nlm.nih.gov/pubmed/20936131,19429403|20936131,,
882,1470566,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2222,FDFT1,https://ctdbase.org/detail.go?type=gene&acc=2222,,,2222.0,FDFT1,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of FDFT1 mRNA,,,PMID:22071372,https://www.ncbi.nlm.nih.gov/pubmed/22071372,22071372,,
883,1470567,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2224,FDPS,https://ctdbase.org/detail.go?type=gene&acc=2224,,,2224.0,FDPS,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of FDPS mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
884,1470568,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2224,FDPS,https://ctdbase.org/detail.go?type=gene&acc=2224,,,2224.0,FDPS,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of FDPS mRNA,,,PMID:32588087|PMID:36864359,https://www.ncbi.nlm.nih.gov/pubmed/32588087|https://www.ncbi.nlm.nih.gov/pubmed/36864359,32588087|36864359,,
885,1471019,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2244,FGB,https://ctdbase.org/detail.go?type=gene&acc=2244,,,2244.0,FGB,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of FGB mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
886,1471020,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2244,FGB,https://ctdbase.org/detail.go?type=gene&acc=2244,,,2244.0,FGB,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of FGB mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of FGB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
887,1471021,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2245,FGD1,https://ctdbase.org/detail.go?type=gene&acc=2245,,,2245.0,FGD1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of FGD1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
888,1471022,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,121512,FGD4,https://ctdbase.org/detail.go?type=gene&acc=121512,,,121512.0,FGD4,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of FGD4 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
889,1471023,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55785,FGD6,https://ctdbase.org/detail.go?type=gene&acc=55785,,,55785.0,FGD6,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of FGD6 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of FGD6 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of FGD6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
890,1471024,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2246,FGF1,https://ctdbase.org/detail.go?type=gene&acc=2246,,,2246.0,FGF1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of FGF1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of FGF1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
891,1471025,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,359830,FGF10A,https://ctdbase.org/detail.go?type=gene&acc=359830,,,359830.0,fgf10a,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of FGF10A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
892,1472050,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,79147,FKRP,https://ctdbase.org/detail.go?type=gene&acc=79147,,,79147.0,FKRP,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of FKRP mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
893,1472051,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2218,FKTN,https://ctdbase.org/detail.go?type=gene&acc=2218,,,2218.0,FKTN,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of FKTN mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of FKTN mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
894,1472052,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,130540,FLACC1,https://ctdbase.org/detail.go?type=gene&acc=130540,,,130540.0,FLACC1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of FLACC1 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
895,1472053,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2316,FLNA,https://ctdbase.org/detail.go?type=gene&acc=2316,,,2316.0,FLNA,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of FLNA mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
896,1473371,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80144,FRAS1,https://ctdbase.org/detail.go?type=gene&acc=80144,,,80144.0,FRAS1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of FRAS1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
897,1473372,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10023,FRAT1,https://ctdbase.org/detail.go?type=gene&acc=10023,,,10023.0,FRAT1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of FRAT1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
898,1473373,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23401,FRAT2,https://ctdbase.org/detail.go?type=gene&acc=23401,,,23401.0,FRAT2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of FRAT2 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of FRAT2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
899,1473374,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,158326,FREM1,https://ctdbase.org/detail.go?type=gene&acc=158326,,,158326.0,FREM1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of FREM1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
900,1475214,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,163255,ZNF540,https://ctdbase.org/detail.go?type=gene&acc=163255,,,163255.0,ZNF540,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of ZNF540 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
901,1475215,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,147837,ZNF563,https://ctdbase.org/detail.go?type=gene&acc=147837,,,147837.0,ZNF563,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of ZNF563 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
902,1475216,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,148266,ZNF569,https://ctdbase.org/detail.go?type=gene&acc=148266,,,148266.0,ZNF569,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of ZNF569 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
903,1475217,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51042,ZNF593,https://ctdbase.org/detail.go?type=gene&acc=51042,,,51042.0,ZNF593,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of ZNF593 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
904,1475218,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,90850,ZNF598,https://ctdbase.org/detail.go?type=gene&acc=90850,,,90850.0,ZNF598,8049.0,Gadus morhua (Atlantic cod),"Perfluorooctane sulfonic acid results in decreased expression of ZNF598 mrna|[hydrocarbons, chlorinated co-treated with pentabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in decreased expression of ZNF598 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
905,1475219,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23060,ZNF609,https://ctdbase.org/detail.go?type=gene&acc=23060,,,23060.0,ZNF609,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of ZNF609 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
906,1475220,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80110,ZNF614,https://ctdbase.org/detail.go?type=gene&acc=80110,,,80110.0,ZNF614,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of ZNF614 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
907,1475770,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,116151,FAM210B,https://ctdbase.org/detail.go?type=gene&acc=116151,,,116151.0,FAM210B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of FAM210B mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of FAM210B mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of FAM210B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
908,1475771,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,415416,FAM214A,https://ctdbase.org/detail.go?type=gene&acc=415416,,,415416.0,FAM214A,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of FAM214A mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of FAM214A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
909,1475772,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,110437751,FAM214B,https://ctdbase.org/detail.go?type=gene&acc=110437751,,,110437751.0,fam214b,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of FAM214B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
910,1475773,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57184,FAM219B,https://ctdbase.org/detail.go?type=gene&acc=57184,,,57184.0,FAM219B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of FAM219B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
911,1476955,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2145,EZH1,https://ctdbase.org/detail.go?type=gene&acc=2145,,,2145.0,EZH1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of EZH1 mrna|[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of EZH1 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
912,1476956,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2146,EZH2,https://ctdbase.org/detail.go?type=gene&acc=2146,,,2146.0,EZH2,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of EZH2 protein|perfluorooctane sulfonic acid results in increased expression of EZH2 mRNA,,,PMID:25510869,https://www.ncbi.nlm.nih.gov/pubmed/25510869,25510869,,
913,1476957,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7430,EZR,https://ctdbase.org/detail.go?type=gene&acc=7430,,,7430.0,EZR,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of EZR mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
914,1476958,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2159,F10,https://ctdbase.org/detail.go?type=gene&acc=2159,,,2159.0,F10,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of F10 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
915,1390833,74855,Toxin and Toxin Target Database (T3DB),Palladium(II) cyanide,T3D1648,Palladium(II) cyanide,http://www.t3db.ca/toxins/T3D1648,BE0002286,Glutathione peroxidase 6,http://www.t3db.ca/biodb/bio_entities/BE0002286,P59796,Glutathione peroxidase 6,257202.0,GPX6,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
916,1390834,74855,Toxin and Toxin Target Database (T3DB),Palladium(II) cyanide,T3D1648,Palladium(II) cyanide,http://www.t3db.ca/toxins/T3D1648,BE0002289,Glutathione peroxidase 7,http://www.t3db.ca/biodb/bio_entities/BE0002289,Q96SL4,Glutathione peroxidase 7,2882.0,GPX7,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
917,1390835,74855,Toxin and Toxin Target Database (T3DB),Palladium(II) cyanide,T3D1648,Palladium(II) cyanide,http://www.t3db.ca/toxins/T3D1648,BE0000648,"Glutathione reductase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000648,P00390,"Glutathione reductase, mitochondrial",2936.0,GSR,9606.0,Homo sapiens (human),Cyanide inhibits glutathione reductase. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
918,1390836,74855,Toxin and Toxin Target Database (T3DB),Palladium(II) cyanide,T3D1648,Palladium(II) cyanide,http://www.t3db.ca/toxins/T3D1648,BE0000130,Hemoglobin subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0000130,P69905,Hemoglobin subunit alpha,3040.0,HBA2,9606.0,Homo sapiens (human),,,,PMID:10423453,https://www.ncbi.nlm.nih.gov/pubmed/10423453,10423453,,
919,1390837,74855,Toxin and Toxin Target Database (T3DB),Palladium(II) cyanide,T3D1648,Palladium(II) cyanide,http://www.t3db.ca/toxins/T3D1648,BE0000629,Hemoglobin subunit beta,http://www.t3db.ca/biodb/bio_entities/BE0000629,P68871,Hemoglobin subunit beta,3043.0,HBB,9606.0,Homo sapiens (human),,,,PMID:10423453,https://www.ncbi.nlm.nih.gov/pubmed/10423453,10423453,,
920,1390838,74855,Toxin and Toxin Target Database (T3DB),Palladium(II) cyanide,T3D1648,Palladium(II) cyanide,http://www.t3db.ca/toxins/T3D1648,BE0001135,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0001135,P36969,Phospholipid hydroperoxide glutathione peroxidase,2879.0,GPX4,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
921,1390839,74855,Toxin and Toxin Target Database (T3DB),Palladium(II) cyanide,T3D1648,Palladium(II) cyanide,http://www.t3db.ca/toxins/T3D1648,BE0002288,Probable glutathione peroxidase 8,http://www.t3db.ca/biodb/bio_entities/BE0002288,Q8TED1,Probable glutathione peroxidase 8,493869.0,GPX8,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
922,1390840,74855,Toxin and Toxin Target Database (T3DB),Palladium(II) cyanide,T3D1648,Palladium(II) cyanide,http://www.t3db.ca/toxins/T3D1648,BE0000060,Prolyl 4-hydroxylase subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000060,P13674,Prolyl 4-hydroxylase subunit alpha-1,5033.0,P4HA1,9606.0,Homo sapiens (human),"Palladium irreversibly inhibits prolyl hydroxylase by replacing fe2+ in the active site, forming a strong complex with the enzyme. (A242)",,,PMID:177068,https://www.ncbi.nlm.nih.gov/pubmed/177068,177068,,
923,1463496,75928,BindingDB,"3,5-Difluorophenol",26192,"3,5-difluorophenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26192,1229,"Carbonic anhydrase 5B, mitochondrial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1229,Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",11238.0,CA5B,9606.0,Homo sapiens (human),,Ki (nM),98400,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
924,1463497,76302,Toxin and Toxin Target Database (T3DB),"2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane",T3D3858,HPTE,http://www.t3db.ca/toxins/T3D3858,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),,,,PMID:10999957|PMID:10579340|PMID:10774817|PMID:11530281|PMID:15840436|PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/10999957|https://www.ncbi.nlm.nih.gov/pubmed/10579340|https://www.ncbi.nlm.nih.gov/pubmed/10774817|https://www.ncbi.nlm.nih.gov/pubmed/11530281|https://www.ncbi.nlm.nih.gov/pubmed/15840436|https://www.ncbi.nlm.nih.gov/pubmed/23611293,10999957|10579340|10774817|11530281|15840436|23611293,,
925,1463498,76302,Toxin and Toxin Target Database (T3DB),"2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane",T3D3858,HPTE,http://www.t3db.ca/toxins/T3D3858,BE0000792,Estrogen receptor beta,http://www.t3db.ca/biodb/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606.0,Homo sapiens (human),,,,PMID:10999957|PMID:11861976|PMID:10579340|PMID:15840436|PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/10999957|https://www.ncbi.nlm.nih.gov/pubmed/11861976|https://www.ncbi.nlm.nih.gov/pubmed/10579340|https://www.ncbi.nlm.nih.gov/pubmed/15840436|https://www.ncbi.nlm.nih.gov/pubmed/23611293,10999957|11861976|10579340|15840436|23611293,,
926,1463499,76302,Toxin and Toxin Target Database (T3DB),"2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane",T3D3858,HPTE,http://www.t3db.ca/toxins/T3D3858,BE0000132,Androgen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000132,P10275,Androgen receptor,367.0,AR,9606.0,Homo sapiens (human),,,,PMID:10999957|PMID:11861976|PMID:15026081|PMID:15483189|PMID:9705896|PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/10999957|https://www.ncbi.nlm.nih.gov/pubmed/11861976|https://www.ncbi.nlm.nih.gov/pubmed/15026081|https://www.ncbi.nlm.nih.gov/pubmed/15483189|https://www.ncbi.nlm.nih.gov/pubmed/9705896|https://www.ncbi.nlm.nih.gov/pubmed/23611293,10999957|11861976|15026081|15483189|9705896|23611293,,
927,1463500,76302,Toxin and Toxin Target Database (T3DB),"2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane",T3D3858,HPTE,http://www.t3db.ca/toxins/T3D3858,BE0002090,Cytochrome P450 19A1,http://www.t3db.ca/biodb/bio_entities/BE0002090,P11511,Aromatase,1588.0,CYP19A1,9606.0,Homo sapiens (human),,,,PMID:22120136,https://www.ncbi.nlm.nih.gov/pubmed/22120136,22120136,,
928,1463501,76302,Toxin and Toxin Target Database (T3DB),"2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane",T3D3858,HPTE,http://www.t3db.ca/toxins/T3D3858,BE0003848,Nuclear receptor subfamily 1 group I member 3,http://www.t3db.ca/biodb/bio_entities/BE0003848,Q14994,Nuclear receptor subfamily 1 group I member 3 ,9970.0,NR1I3,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
929,1463502,76302,Toxin and Toxin Target Database (T3DB),"2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane",T3D3858,HPTE,http://www.t3db.ca/toxins/T3D3858,BE0000945,5-hydroxytryptamine receptor 6,http://www.t3db.ca/biodb/bio_entities/BE0000945,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
930,1463503,76302,Toxin and Toxin Target Database (T3DB),"2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane",T3D3858,HPTE,http://www.t3db.ca/toxins/T3D3858,BE0002793,Cytochrome P450 2C9,http://www.t3db.ca/biodb/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
931,1463708,77793,Drug Gene Interaction database (DGIdb),4'-Methoxyflavone,,4'-METHOXYFLAVONE,https://www.dgidb.org/drugs/chembl:CHEMBL16312,,HSD17B10,https://www.dgidb.org/genes/hgnc:4800,,,3028.0,HSD17B10,9606.0,Homo sapiens (human),,,,,,,,
932,1463709,77793,Drug Gene Interaction database (DGIdb),4'-Methoxyflavone,,4'-METHOXYFLAVONE,https://www.dgidb.org/drugs/chembl:CHEMBL16312,,SMN2,https://www.dgidb.org/genes/hgnc:11118,,,6607.0,SMN2,9606.0,Homo sapiens (human),,,,,,,,
933,1463710,77793,Comparative Toxicogenomics Database (CTD),4'-Methoxyflavone,C487850,4'-methoxyflavone,https://ctdbase.org/detail.go?type=chem&acc=C487850,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10116.0,Rattus norvegicus (Norway rat),4'-methoxyflavone inhibits the reaction [tetrachlorodibenzodioxin binds to AHR protein]|4'-methoxyflavone binds to and results in increased activity of AHR protein,,,PMID:8866830,https://www.ncbi.nlm.nih.gov/pubmed/8866830,8866830,,
934,1463711,77793,Comparative Toxicogenomics Database (CTD),4'-Methoxyflavone,C487850,4'-methoxyflavone,https://ctdbase.org/detail.go?type=chem&acc=C487850,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),4'-methoxyflavone results in decreased activity of CYP1A1 protein,,,PMID:21053930,https://www.ncbi.nlm.nih.gov/pubmed/21053930,21053930,,
935,1463712,77793,Comparative Toxicogenomics Database (CTD),4'-Methoxyflavone,C487850,4'-methoxyflavone,https://ctdbase.org/detail.go?type=chem&acc=C487850,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),4'-methoxyflavone results in increased expression of CYP1A1 mRNA,,,PMID:8866830,https://www.ncbi.nlm.nih.gov/pubmed/8866830,8866830,,
936,1463713,77793,Comparative Toxicogenomics Database (CTD),4'-Methoxyflavone,C487850,4'-methoxyflavone,https://ctdbase.org/detail.go?type=chem&acc=C487850,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),4'-methoxyflavone results in decreased activity of CYP1A1 protein,,,PMID:19563207,https://www.ncbi.nlm.nih.gov/pubmed/19563207,19563207,,
937,1463714,77793,Comparative Toxicogenomics Database (CTD),4'-Methoxyflavone,C487850,4'-methoxyflavone,https://ctdbase.org/detail.go?type=chem&acc=C487850,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),4'-methoxyflavone results in decreased activity of CYP1A2 protein,,,PMID:21053930,https://www.ncbi.nlm.nih.gov/pubmed/21053930,21053930,,
938,1463715,77793,Comparative Toxicogenomics Database (CTD),4'-Methoxyflavone,C487850,4'-methoxyflavone,https://ctdbase.org/detail.go?type=chem&acc=C487850,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),4'-methoxyflavone results in decreased activity of CYP1A2 protein,,,PMID:19563207,https://www.ncbi.nlm.nih.gov/pubmed/19563207,19563207,,
939,1463716,77793,Comparative Toxicogenomics Database (CTD),4'-Methoxyflavone,C487850,4'-methoxyflavone,https://ctdbase.org/detail.go?type=chem&acc=C487850,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),4'-methoxyflavone binds to and results in decreased activity of CYP1B1 protein,,,PMID:19563207|PMID:21053930,https://www.ncbi.nlm.nih.gov/pubmed/19563207|https://www.ncbi.nlm.nih.gov/pubmed/21053930,19563207|21053930,,
940,1464885,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,653190,ABCC6P1,https://ctdbase.org/detail.go?type=gene&acc=653190,,,653190.0,ABCC6P1,9606.0,Homo sapiens (human),Rosiglitazone results in decreased expression of ABCC6P1 mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
941,1464886,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10060,ABCC9,https://ctdbase.org/detail.go?type=gene&acc=10060,,,10060.0,ABCC9,10090.0,Mus musculus (house mouse),[rosiglitazone co-treated with metformin] results in increased expression of ABCC9 protein alternative form|rosiglitazone results in increased expression of ABCC9 mRNA alternative form|[rosiglitazone co-treated with metformin] results in increased expression of ABCC9 mRNA alternative form|rosiglitazone results in increased expression of ABCC9 protein alternative form,,,PMID:20823565,https://www.ncbi.nlm.nih.gov/pubmed/20823565,20823565,,
942,1464887,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5825,ABCD3,https://ctdbase.org/detail.go?type=gene&acc=5825,,,5825.0,ABCD3,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of ABCD3 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
943,1464888,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,9619,ABCG1,https://ctdbase.org/detail.go?type=gene&acc=9619,,,9619.0,ABCG1,9544.0,Macaca mulatta (Rhesus monkey),[CGA protein co-treated with FSHB protein co-treated with rosiglitazone] results in increased expression of ABCG1 mRNA,,,PMID:20926582,https://www.ncbi.nlm.nih.gov/pubmed/20926582,20926582,,
944,1465041,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,11057,ABHD2,https://ctdbase.org/detail.go?type=gene&acc=11057,,,11057.0,ABHD2,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ABHD2 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
945,1465042,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,51099,ABHD5,https://ctdbase.org/detail.go?type=gene&acc=51099,,,51099.0,ABHD5,10090.0,Mus musculus (house mouse),Rosiglitazone results in increased expression of ABHD5 mRNA,,,PMID:17215164,https://www.ncbi.nlm.nih.gov/pubmed/17215164,17215164,,
946,1465043,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,27,ABL2,https://ctdbase.org/detail.go?type=gene&acc=27,,,27.0,ABL2,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ABL2 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
947,1465044,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3983,ABLIM1,https://ctdbase.org/detail.go?type=gene&acc=3983,,,3983.0,ABLIM1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ABLIM1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
948,1465248,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone inhibits the reaction [[PDGFB protein co-treated with INS1 protein] results in increased expression of MCM6 mrna]|rosiglitazone inhibits the reaction [[PDGFB protein co-treated with INS1 protein] results in increased expression of MCM7 mrna]|rosiglitazone inhibits the reaction [[PDGFB protein co-treated with INS1 protein] results in increased phosphorylation of RB1 protein],,,PMID:12677008,https://www.ncbi.nlm.nih.gov/pubmed/12677008,12677008,,
949,1465249,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of INS1 mRNA,,,PMID:22070604,https://www.ncbi.nlm.nih.gov/pubmed/22070604,22070604,,
950,1465925,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,22801,ITGA11,https://ctdbase.org/detail.go?type=gene&acc=22801,,,22801.0,ITGA11,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ITGA11 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
951,1466561,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,95,ACY1,https://ctdbase.org/detail.go?type=gene&acc=95,,,95.0,ACY1,9606.0,Homo sapiens (human),Rosiglitazone results in decreased expression of ACY1 mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
952,1466562,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,100,ADA,https://ctdbase.org/detail.go?type=gene&acc=100,,,100.0,ADA,9606.0,Homo sapiens (human),Rosiglitazone results in increased expression of ADA mRNA,,,PMID:16982809,https://www.ncbi.nlm.nih.gov/pubmed/16982809,16982809,,
953,1466563,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,8038,ADAM12,https://ctdbase.org/detail.go?type=gene&acc=8038,,,8038.0,ADAM12,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADAM12 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
954,1466564,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,8749,ADAM18,https://ctdbase.org/detail.go?type=gene&acc=8749,,,8749.0,ADAM18,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ADAM18 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
955,1466565,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,8754,ADAM9,https://ctdbase.org/detail.go?type=gene&acc=8754,,,8754.0,ADAM9,9606.0,Homo sapiens (human),[rosiglitazone co-treated with tert-butylhydroperoxide] results in increased expression of ADAM9 mrna|rosiglitazone inhibits the reaction [tert-butylhydroperoxide results in increased expression of ADAM9 mrna],,,PMID:20847119,https://www.ncbi.nlm.nih.gov/pubmed/20847119,20847119,,
956,1466566,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,9510,ADAMTS1,https://ctdbase.org/detail.go?type=gene&acc=9510,,,9510.0,ADAMTS1,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADAMTS1 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
957,1466567,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,9510,ADAMTS1,https://ctdbase.org/detail.go?type=gene&acc=9510,,,9510.0,ADAMTS1,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of ADAMTS1 mRNA,,,PMID:21172411,https://www.ncbi.nlm.nih.gov/pubmed/21172411,21172411,,
958,1466568,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,81792,ADAMTS12,https://ctdbase.org/detail.go?type=gene&acc=81792,,,81792.0,ADAMTS12,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ADAMTS12 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
959,1466569,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,56999,ADAMTS9,https://ctdbase.org/detail.go?type=gene&acc=56999,,,56999.0,ADAMTS9,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ADAMTS9 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
960,1467727,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,79602,ADIPOR2,https://ctdbase.org/detail.go?type=gene&acc=79602,,,79602.0,ADIPOR2,10090.0,Mus musculus (house mouse),"Rosiglitazone inhibits the reaction [linoleic acids, conjugated results in decreased expression of ADIPOR2 mrna]",,,PMID:17322064,https://www.ncbi.nlm.nih.gov/pubmed/17322064,17322064,,
961,1467728,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,79602,ADIPOR2,https://ctdbase.org/detail.go?type=gene&acc=79602,,,79602.0,ADIPOR2,10090.0,Mus musculus (house mouse),Rosiglitazone results in increased expression of ADIPOR2 mRNA,,,PMID:16306350|PMID:16609881,https://www.ncbi.nlm.nih.gov/pubmed/16306350|https://www.ncbi.nlm.nih.gov/pubmed/16609881,16306350|16609881,,
962,1467729,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,79602,ADIPOR2,https://ctdbase.org/detail.go?type=gene&acc=79602,,,79602.0,ADIPOR2,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone affects the reaction [dietary fats affects the expression of ADIPOR2 protein]|rosiglitazone affects the reaction [dietary fats affects the expression of ADIPOR2 mrna],,,PMID:20965162,https://www.ncbi.nlm.nih.gov/pubmed/20965162,20965162,,
963,1467730,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10974,ADIRF,https://ctdbase.org/detail.go?type=gene&acc=10974,,,10974.0,ADIRF,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ADIRF mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
964,1467731,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,55966,AJAP1,https://ctdbase.org/detail.go?type=gene&acc=55966,,,55966.0,AJAP1,9606.0,Homo sapiens (human),Rosiglitazone results in increased expression of AJAP1 mRNA,,,PMID:16982809,https://www.ncbi.nlm.nih.gov/pubmed/16982809,16982809,,
965,1468074,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,155,ADRB3,https://ctdbase.org/detail.go?type=gene&acc=155,,,155.0,ADRB3,10090.0,Mus musculus (house mouse),[rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in increased expression of ADRB3 protein|[rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in increased expression of ADRB3 mRNA,,,PMID:32417366,https://www.ncbi.nlm.nih.gov/pubmed/32417366,32417366,,
966,1468246,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,9606.0,Homo sapiens (human),Rosiglitazone affects the expression of LGALS1 protein,,,PMID:19556978,https://www.ncbi.nlm.nih.gov/pubmed/19556978,19556978,,
967,1468247,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LGALS1 mrna|tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LGALS1 mrna],,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
968,1468248,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3976,LIF,https://ctdbase.org/detail.go?type=gene&acc=3976,,,3976.0,LIF,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of LIF mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
969,1468249,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3977,LIFR,https://ctdbase.org/detail.go?type=gene&acc=3977,,,3977.0,LIFR,10090.0,Mus musculus (house mouse),Rosiglitazone results in increased expression of LIFR mRNA,,,PMID:17321000,https://www.ncbi.nlm.nih.gov/pubmed/17321000,17321000,,
970,1468250,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3977,LIFR,https://ctdbase.org/detail.go?type=gene&acc=3977,,,3977.0,LIFR,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of LIFR mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
971,1468251,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,11024,LILRA1,https://ctdbase.org/detail.go?type=gene&acc=11024,,,11024.0,LILRA1,9606.0,Homo sapiens (human),Rosiglitazone results in increased expression of LILRA1 mRNA,,,PMID:16982809,https://www.ncbi.nlm.nih.gov/pubmed/16982809,16982809,,
972,1468252,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,22998,LIMCH1,https://ctdbase.org/detail.go?type=gene&acc=22998,,,22998.0,LIMCH1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of LIMCH1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
973,1468253,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,8825,LIN7A,https://ctdbase.org/detail.go?type=gene&acc=8825,,,8825.0,LIN7A,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of LIN7A mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
974,1468254,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,339398,LINGO4,https://ctdbase.org/detail.go?type=gene&acc=339398,,,339398.0,LINGO4,9606.0,Homo sapiens (human),Rosiglitazone results in decreased expression of LINGO4 mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
975,1468403,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,9606.0,Homo sapiens (human),"[INS protein co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with rosiglitazone] results in increased expression of AGT mrna|[ins protein co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with rosiglitazone co-treated with 4,4'-hexafluorisopropylidene diphenol] results in increased expression of AGT mRNA",,,PMID:31596606,https://www.ncbi.nlm.nih.gov/pubmed/31596606,31596606,,
976,1468404,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of AGT mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
977,1468822,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,199,AIF1,https://ctdbase.org/detail.go?type=gene&acc=199,,,199.0,AIF1,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of AIF1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
978,1468823,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,84962,AJUBA,https://ctdbase.org/detail.go?type=gene&acc=84962,,,84962.0,AJUBA,9606.0,Homo sapiens (human),[rosiglitazone co-treated with tert-butylhydroperoxide] results in decreased expression of AJUBA mRNA,,,PMID:20847119,https://www.ncbi.nlm.nih.gov/pubmed/20847119,20847119,,
979,1468824,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,205,AK4,https://ctdbase.org/detail.go?type=gene&acc=205,,,205.0,AK4,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of AK4 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
980,1468825,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,9590,AKAP12,https://ctdbase.org/detail.go?type=gene&acc=9590,,,9590.0,AKAP12,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AKAP12 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
981,1468826,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,9590,AKAP12,https://ctdbase.org/detail.go?type=gene&acc=9590,,,9590.0,AKAP12,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of AKAP12 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
982,1468981,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of AKR1B10 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
983,1468982,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,11997,AKR1B7,https://ctdbase.org/detail.go?type=gene&acc=11997,,,11997.0,Akr1b7,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of AKR1B7 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
984,1468983,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,6718,AKR1D1,https://ctdbase.org/detail.go?type=gene&acc=6718,,,6718.0,AKR1D1,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone affects the expression of AKR1D1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
985,1468984,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[rosiglitazone co-treated with IAPP protein] results in increased phosphorylation of AKT1 protein]|[rosiglitazone co-treated with IAPP protein] results in increased phosphorylation of AKT1 protein,,,PMID:16204373,https://www.ncbi.nlm.nih.gov/pubmed/16204373,16204373,,
986,1468985,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [glucose results in decreased phosphorylation of AKT1 protein]]|rosiglitazone inhibits the reaction [glucose results in decreased phosphorylation of AKT1 protein],,,PMID:21333731,https://www.ncbi.nlm.nih.gov/pubmed/21333731,21333731,,
987,1468986,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),PTEN mRNA affects the reaction [rosiglitazone results in decreased phosphorylation of AKT1 protein],,,PMID:17506947,https://www.ncbi.nlm.nih.gov/pubmed/17506947,17506947,,
988,1468987,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),[rosiglitazone co-treated with methamphetamine] results in increased phosphorylation of AKT1 protein,,,PMID:31270305,https://www.ncbi.nlm.nih.gov/pubmed/31270305,31270305,,
989,1469263,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,10090.0,Mus musculus (house mouse),"Rosiglitazone inhibits the reaction [linoleic acids, conjugated results in decreased expression of LPL mrna]",,,PMID:17322064,https://www.ncbi.nlm.nih.gov/pubmed/17322064,17322064,,
990,1469264,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,10090.0,Mus musculus (house mouse),Rosiglitazone promotes the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of LPL mrna],,,PMID:29094436,https://www.ncbi.nlm.nih.gov/pubmed/29094436,29094436,,
991,1469265,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,10090.0,Mus musculus (house mouse),Rosiglitazone results in increased expression of LPL mRNA,,,PMID:11916924|PMID:12021203|PMID:15997096|PMID:22763116|PMID:23322813|PMID:29127035|PMID:29410257|PMID:29787037|PMID:29910772,https://www.ncbi.nlm.nih.gov/pubmed/11916924|https://www.ncbi.nlm.nih.gov/pubmed/12021203|https://www.ncbi.nlm.nih.gov/pubmed/15997096|https://www.ncbi.nlm.nih.gov/pubmed/22763116|https://www.ncbi.nlm.nih.gov/pubmed/23322813|https://www.ncbi.nlm.nih.gov/pubmed/29127035|https://www.ncbi.nlm.nih.gov/pubmed/29410257|https://www.ncbi.nlm.nih.gov/pubmed/29787037|https://www.ncbi.nlm.nih.gov/pubmed/29910772,11916924|12021203|15997096|22763116|23322813|29127035|29410257|29787037|29910772,,
992,1469266,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,10090.0,Mus musculus (house mouse),T 0070907 inhibits the reaction [rosiglitazone results in increased expression of LPL mrna],,,PMID:29787037,https://www.ncbi.nlm.nih.gov/pubmed/29787037,29787037,,
993,1469267,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,9940.0,Ovis aries (sheep),Rosiglitazone results in increased expression of LPL mRNA,,,PMID:19520784,https://www.ncbi.nlm.nih.gov/pubmed/19520784,19520784,,
994,1469268,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of LPL mRNA,,,PMID:15887043|PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/15887043|https://www.ncbi.nlm.nih.gov/pubmed/21515302,15887043|21515302,,
995,1469269,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4026,LPP,https://ctdbase.org/detail.go?type=gene&acc=4026,,,4026.0,LPP,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of LPP mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
996,1469270,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,9227,LRAT,https://ctdbase.org/detail.go?type=gene&acc=9227,,,9227.0,LRAT,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of LRAT mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
997,1469271,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,9860,LRIG2,https://ctdbase.org/detail.go?type=gene&acc=9860,,,9860.0,LRIG2,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of LRIG2 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
998,1469535,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4035,LRP1,https://ctdbase.org/detail.go?type=gene&acc=4035,,,4035.0,LRP1,9606.0,Homo sapiens (human),Rosiglitazone results in increased expression of LRP1 protein|rosiglitazone promotes the reaction [LRP1 protein results in increased uptake of APP protein]|rosiglitazone results in increased expression of LRP1 mrna|rosiglitazone results in increased activity of LRP1 promoter,,,PMID:22040807,https://www.ncbi.nlm.nih.gov/pubmed/22040807,22040807,,
999,1469683,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129.0,ANGPTL4,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mrna]|[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mrna|tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mrna],,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
1000,1469684,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129.0,ANGPTL4,10090.0,Mus musculus (house mouse),Rosiglitazone results in increased expression of ANGPTL4 mRNA,,,PMID:21622945,https://www.ncbi.nlm.nih.gov/pubmed/21622945,21622945,,
1001,1469685,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129.0,ANGPTL4,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of ANGPTL4 mRNA,,,PMID:21172411|PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21172411|https://www.ncbi.nlm.nih.gov/pubmed/21515302,21172411|21515302,,
1002,1469686,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,288,ANK3,https://ctdbase.org/detail.go?type=gene&acc=288,,,288.0,ANK3,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ANK3 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1003,1469950,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4131,MAP1B,https://ctdbase.org/detail.go?type=gene&acc=4131,,,4131.0,MAP1B,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of MAP1B mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1004,1469951,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form],,,PMID:31419397,https://www.ncbi.nlm.nih.gov/pubmed/31419397,31419397,,
1005,1470386,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Rosiglitazone inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein],,,PMID:19451898,https://www.ncbi.nlm.nih.gov/pubmed/19451898,19451898,,
1006,1470387,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9265.0,Didelphidae (opossums),Rosiglitazone results in decreased activity of MAPK3 protein,,,PMID:20113275,https://www.ncbi.nlm.nih.gov/pubmed/20113275,20113275,,
1007,1470388,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Rosiglitazone affects the reaction [methamphetamine affects the phosphorylation of MAPK3 protein],,,PMID:31270305,https://www.ncbi.nlm.nih.gov/pubmed/31270305,31270305,,
1008,1470389,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Rosiglitazone inhibits the reaction [IGF1R protein results in increased phosphorylation of and results in increased activity of MAPK3 protein],,,PMID:18670617,https://www.ncbi.nlm.nih.gov/pubmed/18670617,18670617,,
1009,1470390,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Rosiglitazone promotes the reaction [chlorpyrifos results in increased activity of MAPK3 protein],,,PMID:24793810,https://www.ncbi.nlm.nih.gov/pubmed/24793810,24793810,,
1010,1470391,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Rosiglitazone results in increased phosphorylation of MAPK3 protein,,,PMID:19139119|PMID:25796170,https://www.ncbi.nlm.nih.gov/pubmed/19139119|https://www.ncbi.nlm.nih.gov/pubmed/25796170,19139119|25796170,,
1011,1471912,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4311,MME,https://ctdbase.org/detail.go?type=gene&acc=4311,,,4311.0,MME,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of MME mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1012,1471913,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4319,MMP10,https://ctdbase.org/detail.go?type=gene&acc=4319,,,4319.0,MMP10,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of MMP10 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1013,1471914,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of MMP13 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1014,1472499,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,6182,MRPL12,https://ctdbase.org/detail.go?type=gene&acc=6182,,,6182.0,MRPL12,10090.0,Mus musculus (house mouse),Rosiglitazone affects the expression of MRPL12 mRNA,,,PMID:22013433,https://www.ncbi.nlm.nih.gov/pubmed/22013433,22013433,,
1015,1472648,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,716,C1S,https://ctdbase.org/detail.go?type=gene&acc=716,,,716.0,C1S,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of C1S mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1016,1472649,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,725,C4BPB,https://ctdbase.org/detail.go?type=gene&acc=725,,,725.0,C4BPB,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of C4BPB mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1017,1472905,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,116540,MRPL53,https://ctdbase.org/detail.go?type=gene&acc=116540,,,116540.0,MRPL53,10090.0,Mus musculus (house mouse),Rosiglitazone affects the expression of MRPL53 mRNA,,,PMID:22013433,https://www.ncbi.nlm.nih.gov/pubmed/22013433,22013433,,
1018,1472906,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,128308,MRPL55,https://ctdbase.org/detail.go?type=gene&acc=128308,,,128308.0,MRPL55,10090.0,Mus musculus (house mouse),Rosiglitazone affects the expression of MRPL55 mRNA,,,PMID:22013433,https://www.ncbi.nlm.nih.gov/pubmed/22013433,22013433,,
1019,1472907,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,78988,MRPL57,https://ctdbase.org/detail.go?type=gene&acc=78988,,,78988.0,MRPL57,10090.0,Mus musculus (house mouse),Rosiglitazone affects the expression of MRPL57 mRNA,,,PMID:22013433,https://www.ncbi.nlm.nih.gov/pubmed/22013433,22013433,,
1020,1472908,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,65005,MRPL9,https://ctdbase.org/detail.go?type=gene&acc=65005,,,65005.0,MRPL9,10090.0,Mus musculus (house mouse),Rosiglitazone affects the expression of MRPL9 mRNA,,,PMID:22013433,https://www.ncbi.nlm.nih.gov/pubmed/22013433,22013433,,
1021,1472909,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,64963,MRPS11,https://ctdbase.org/detail.go?type=gene&acc=64963,,,64963.0,MRPS11,10090.0,Mus musculus (house mouse),Rosiglitazone affects the expression of MRPS11 mRNA,,,PMID:22013433,https://www.ncbi.nlm.nih.gov/pubmed/22013433,22013433,,
1022,1472910,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,63931,MRPS14,https://ctdbase.org/detail.go?type=gene&acc=63931,,,63931.0,MRPS14,10090.0,Mus musculus (house mouse),Rosiglitazone affects the expression of MRPS14 mRNA,,,PMID:22013433,https://www.ncbi.nlm.nih.gov/pubmed/22013433,22013433,,
1023,1474917,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of CD14 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1024,1474918,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,909,CD1A,https://ctdbase.org/detail.go?type=gene&acc=909,,,909.0,CD1A,9606.0,Homo sapiens (human),Rosiglitazone results in decreased expression of CD1A protein|[alitretinoin co-treated with rosiglitazone] results in decreased expression of CD1A protein|2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in decreased expression of CD1A protein],,,PMID:17475839,https://www.ncbi.nlm.nih.gov/pubmed/17475839,17475839,,
1025,1479409,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PDGFRB mrna|tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PDGFRB mrna]|egf protein inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PDGFRB mrna],,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
1026,1479410,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,10090.0,Mus musculus (house mouse),Rosiglitazone inhibits the reaction [oxygen deficiency results in increased expression of and results in increased activity of PDGFRB protein],,,PMID:19520921,https://www.ncbi.nlm.nih.gov/pubmed/19520921,19520921,,
1027,1479411,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of PDGFRB mRNA,,,PMID:17713437,https://www.ncbi.nlm.nih.gov/pubmed/17713437,17713437,,
1028,1479412,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of PDGFRB mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1029,1480476,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,283209,PGM2L1,https://ctdbase.org/detail.go?type=gene&acc=283209,,,283209.0,PGM2L1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of PGM2L1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1030,1480477,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10424,PGRMC2,https://ctdbase.org/detail.go?type=gene&acc=10424,,,10424.0,PGRMC2,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of PGRMC2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1031,1480478,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,11331,PHB2,https://ctdbase.org/detail.go?type=gene&acc=11331,,,11331.0,PHB2,10090.0,Mus musculus (house mouse),Rosiglitazone results in increased expression of PHB2 mRNA,,,PMID:30027469,https://www.ncbi.nlm.nih.gov/pubmed/30027469,30027469,,
1032,1480479,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,80012,PHC3,https://ctdbase.org/detail.go?type=gene&acc=80012,,,80012.0,PHC3,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of PHC3 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1033,1480480,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,144717,PHETA1,https://ctdbase.org/detail.go?type=gene&acc=144717,,,144717.0,PHETA1,9606.0,Homo sapiens (human),Rosiglitazone results in decreased expression of PHETA1 mRNA,,,PMID:16982809,https://www.ncbi.nlm.nih.gov/pubmed/16982809,16982809,,
1034,1480481,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of PHLDA1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1035,1480482,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,7262,PHLDA2,https://ctdbase.org/detail.go?type=gene&acc=7262,,,7262.0,PHLDA2,9606.0,Homo sapiens (human),Rosiglitazone results in decreased expression of PHLDA2 mRNA,,,PMID:16982809,https://www.ncbi.nlm.nih.gov/pubmed/16982809,16982809,,
1036,1480483,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,23612,PHLDA3,https://ctdbase.org/detail.go?type=gene&acc=23612,,,23612.0,PHLDA3,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of PHLDA3 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
1037,1392408,79576,Toxin and Toxin Target Database (T3DB),"2-Chloroallylidene-3,3-diacetate",T3D1709,Ranelic acid,http://www.t3db.ca/toxins/T3D1709,BE0002289,Glutathione peroxidase 7,http://www.t3db.ca/biodb/bio_entities/BE0002289,Q96SL4,Glutathione peroxidase 7,2882.0,GPX7,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
1038,1392409,79576,Toxin and Toxin Target Database (T3DB),"2-Chloroallylidene-3,3-diacetate",T3D1709,Ranelic acid,http://www.t3db.ca/toxins/T3D1709,BE0000648,"Glutathione reductase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000648,P00390,"Glutathione reductase, mitochondrial",2936.0,GSR,9606.0,Homo sapiens (human),Cyanide inhibits glutathione reductase. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
1039,1392410,79718,DrugBank,"3,6,9,12,15,18-Hexaoxaicosane-1,20-diol",DB03394,Heptaethylene glycol,https://www.drugbank.ca/drugs/DB03394,BE0003074,Carbonyl reductase [NADPH] 1,https://www.drugbank.ca/bio_entities/BE0003074,P16152,Carbonyl reductase [NADPH] 1,873.0,CBR1,9606.0,Homo sapiens (human),,,,,,,,
1040,1392411,81124,Drug Gene Interaction database (DGIdb),"2-Anilino-1,4-naphthoquinone",,CHEMBL:CHEMBL84010,https://www.dgidb.org/drugs/chembl:CHEMBL84010,,SMAD3,https://www.dgidb.org/genes/hgnc:6769,,,4088.0,SMAD3,9606.0,Homo sapiens (human),,,,,,,,
1041,1392412,81124,Drug Gene Interaction database (DGIdb),"2-Anilino-1,4-naphthoquinone",,CHEMBL:CHEMBL84010,https://www.dgidb.org/drugs/chembl:CHEMBL84010,,MAPK1,https://www.dgidb.org/genes/hgnc:6871,,,5594.0,MAPK1,9606.0,Homo sapiens (human),,,,,,,,
1042,1392413,81124,Drug Gene Interaction database (DGIdb),"2-Anilino-1,4-naphthoquinone",,CHEMBL:CHEMBL84010,https://www.dgidb.org/drugs/chembl:CHEMBL84010,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606.0,Homo sapiens (human),,,,,,,,
1043,1392414,81124,Drug Gene Interaction database (DGIdb),"2-Anilino-1,4-naphthoquinone",,CHEMBL:CHEMBL84010,https://www.dgidb.org/drugs/chembl:CHEMBL84010,,NFKB2,https://www.dgidb.org/genes/hgnc:7795,,,4791.0,NFKB2,9606.0,Homo sapiens (human),,,,,,,,
1044,1392415,81472,BindingDB,ethyl 5-amino-1H-pyrazole-4-carboxylate,14781,Pyrazole carboxylic ester 4,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14781,1575,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B [316-320,321-700,S319G,N320S,N321H,T322M]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1575,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",5142.0,PDE4B,9606.0,Homo sapiens (human),,IC50 (nM),>200000,PMID:15685167|DOI:10.1038/nbt1059,https://www.ncbi.nlm.nih.gov/pubmed/15685167|https://doi.org/10.1038/nbt1059,15685167,10.1038/nbt1059,
1045,1393004,82115,Toxin and Toxin Target Database (T3DB),Trimethylsilyl cyanide,T3D0769,Trimethylsilyl cyanide,http://www.t3db.ca/toxins/T3D0769,BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000176,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",6389.0,SDHA,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
1046,1393005,82115,Toxin and Toxin Target Database (T3DB),Trimethylsilyl cyanide,T3D0769,Trimethylsilyl cyanide,http://www.t3db.ca/toxins/T3D0769,BE0002254,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002254,P21912,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",6390.0,SDHB,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
1047,1393006,82115,Toxin and Toxin Target Database (T3DB),Trimethylsilyl cyanide,T3D0769,Trimethylsilyl cyanide,http://www.t3db.ca/toxins/T3D0769,BE0002257,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002257,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",6391.0,SDHC,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
1048,1393007,82115,Toxin and Toxin Target Database (T3DB),Trimethylsilyl cyanide,T3D0769,Trimethylsilyl cyanide,http://www.t3db.ca/toxins/T3D0769,BE0002390,Superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0002390,P00441,Superoxide dismutase [Cu-Zn],6647.0,SOD1,9606.0,Homo sapiens (human),Cyanide inhibits superoxide dismutase [cu-zn]. (A72),,,PMID:15856906,https://www.ncbi.nlm.nih.gov/pubmed/15856906,15856906,,
1049,1393008,82115,Toxin and Toxin Target Database (T3DB),Trimethylsilyl cyanide,T3D0769,Trimethylsilyl cyanide,http://www.t3db.ca/toxins/T3D0769,BE0000252,Tyrosinase,http://www.t3db.ca/biodb/bio_entities/BE0000252,P14679,Tyrosinase,7299.0,TYR,9606.0,Homo sapiens (human),Cyanide inhibits tyrosinase. (A77),,,PMID:16950829,https://www.ncbi.nlm.nih.gov/pubmed/16950829,16950829,,
1050,1393009,82146,Drug Gene Interaction database (DGIdb),Bexarotene,,BEXAROTENE,https://www.dgidb.org/drugs/rxcui:233272,,RXRG,https://www.dgidb.org/genes/hgnc:10479,,,6258.0,RXRG,9606.0,Homo sapiens (human),,,,,,,,
1051,1393010,82148,IUPHAR/BPS Guide to PHARMACOLOGY,Agomelatine,198,agomelatine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198,288,MT2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=288,P49286,Melatonin receptor type 1B,4544.0,MTNR1B,9606.0,Homo sapiens (human),Full agonist,pKi,9.9 - 10.5,PMID:12764576|PMID:9618428,https://www.ncbi.nlm.nih.gov/pubmed/12764576|https://www.ncbi.nlm.nih.gov/pubmed/9618428,12764576|9618428,,
1052,1475634,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10090.0,Mus musculus (house mouse),Agomelatine results in increased expression of BDNF mRNA,,,PMID:19775499,https://www.ncbi.nlm.nih.gov/pubmed/19775499,19775499,,
1053,1475635,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116.0,Rattus norvegicus (Norway rat),Agomelatine results in increased expression of BDNF protein,,,PMID:22160164,https://www.ncbi.nlm.nih.gov/pubmed/22160164,22160164,,
1054,1475636,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,824,CAPN2,https://ctdbase.org/detail.go?type=gene&acc=824,,,824.0,CAPN2,10116.0,Rattus norvegicus (Norway rat),Agomelatine inhibits the reaction [dietary fats results in increased expression of CAPN2 protein],,,PMID:34081941,https://www.ncbi.nlm.nih.gov/pubmed/34081941,34081941,,
1055,1475637,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,100506742,CASP12,https://ctdbase.org/detail.go?type=gene&acc=100506742,,,100506742.0,CASP12,10116.0,Rattus norvegicus (Norway rat),Agomelatine inhibits the reaction [dietary fats results in increased cleavage of CASP12 protein],,,PMID:34081941,https://www.ncbi.nlm.nih.gov/pubmed/34081941,34081941,,
1056,1475638,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,100506742,CASP12,https://ctdbase.org/detail.go?type=gene&acc=100506742,,,100506742.0,CASP12,10116.0,Rattus norvegicus (Norway rat),Agomelatine inhibits the reaction [galactose results in increased expression of CASP12 protein],,,PMID:34673010,https://www.ncbi.nlm.nih.gov/pubmed/34673010,34673010,,
1057,1475639,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10116.0,Rattus norvegicus (Norway rat),Agomelatine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased expression of CASP8 protein],,,PMID:36356678,https://www.ncbi.nlm.nih.gov/pubmed/36356678,36356678,,
1058,1475640,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),[agomelatine co-treated with methotrexate] results in increased activity of CAT protein,,,PMID:31975554,https://www.ncbi.nlm.nih.gov/pubmed/31975554,31975554,,
1059,1476214,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),Agomelatine inhibits the reaction [methotrexate results in increased expression of NOS2 protein],,,PMID:31975554,https://www.ncbi.nlm.nih.gov/pubmed/31975554,31975554,,
1060,1476215,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507.0,NOX4,10116.0,Rattus norvegicus (Norway rat),Agomelatine inhibits the reaction [galactose results in increased expression of NOX4 protein],,,PMID:34673010,https://www.ncbi.nlm.nih.gov/pubmed/34673010,34673010,,
1061,1476216,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,10090.0,Mus musculus (house mouse),Agomelatine results in increased expression of NR3C1 mRNA,,,PMID:19775499,https://www.ncbi.nlm.nih.gov/pubmed/19775499,19775499,,
1062,1476217,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,84687,PPP1R9B,https://ctdbase.org/detail.go?type=gene&acc=84687,,,84687.0,PPP1R9B,10116.0,Rattus norvegicus (Norway rat),Agomelatine affects the expression of PPP1R9B protein,,,PMID:22160164,https://www.ncbi.nlm.nih.gov/pubmed/22160164,22160164,,
1063,1476218,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Agomelatine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased expression of RELA protein],,,PMID:36356678,https://www.ncbi.nlm.nih.gov/pubmed/36356678,36356678,,
1064,1476219,82148,Comparative Toxicogenomics Database (CTD),Agomelatine,C084711,agomelatine,https://ctdbase.org/detail.go?type=chem&acc=C084711,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,10116.0,Rattus norvegicus (Norway rat),Agomelatine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in decreased expression of SIRT1 protein],,,PMID:36356678,https://www.ncbi.nlm.nih.gov/pubmed/36356678,36356678,,
1065,1394435,82917,Toxin and Toxin Target Database (T3DB),Bis(cyclopentadienyl)vanadium chloride,T3D1641,Vanadocene dichloride,http://www.t3db.ca/toxins/T3D1641,BE0005236,Tyrosine-protein phosphatase non-receptor type 20,http://www.t3db.ca/biodb/bio_entities/BE0005236,Q4JDL3,Tyrosine-protein phosphatase non-receptor type 20,26095.0,PTPN20,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1066,1394436,82917,Toxin and Toxin Target Database (T3DB),Bis(cyclopentadienyl)vanadium chloride,T3D1641,Vanadocene dichloride,http://www.t3db.ca/toxins/T3D1641,BE0005256,Tyrosine-protein phosphatase non-receptor type 21,http://www.t3db.ca/biodb/bio_entities/BE0005256,Q16825,Tyrosine-protein phosphatase non-receptor type 21,11099.0,PTPN21,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1067,1394437,82917,Toxin and Toxin Target Database (T3DB),Bis(cyclopentadienyl)vanadium chloride,T3D1641,Vanadocene dichloride,http://www.t3db.ca/toxins/T3D1641,BE0005254,Tyrosine-protein phosphatase non-receptor type 22,http://www.t3db.ca/biodb/bio_entities/BE0005254,Q9Y2R2,Tyrosine-protein phosphatase non-receptor type 22,26191.0,PTPN22,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1068,1477359,83975,Toxin and Toxin Target Database (T3DB),Tetramethrin,T3D1028,Tetramethrin,http://www.t3db.ca/toxins/T3D1028,BE0003636,Sodium channel subunit beta-2,http://www.t3db.ca/biodb/bio_entities/BE0003636,O60939,Sodium channel subunit beta-2,6327.0,SCN2B,9606.0,Homo sapiens (human),"This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. this pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. type I pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560).",,,PMID:15950969,https://www.ncbi.nlm.nih.gov/pubmed/15950969,15950969,,
1069,1477360,83975,Toxin and Toxin Target Database (T3DB),Tetramethrin,T3D1028,Tetramethrin,http://www.t3db.ca/toxins/T3D1028,BE0003637,Sodium channel subunit beta-3,http://www.t3db.ca/biodb/bio_entities/BE0003637,Q9NY72,Sodium channel subunit beta-3,55800.0,SCN3B,9606.0,Homo sapiens (human),"This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. this pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. type I pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560).",,,PMID:15950969,https://www.ncbi.nlm.nih.gov/pubmed/15950969,15950969,,
1070,1477361,83975,Toxin and Toxin Target Database (T3DB),Tetramethrin,T3D1028,Tetramethrin,http://www.t3db.ca/toxins/T3D1028,BE0003638,Sodium channel subunit beta-4,http://www.t3db.ca/biodb/bio_entities/BE0003638,Q8IWT1,Sodium channel subunit beta-4,6330.0,SCN4B,9606.0,Homo sapiens (human),"This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. this pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. type I pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560).",,,PMID:15950969,https://www.ncbi.nlm.nih.gov/pubmed/15950969,15950969,,
1071,1477362,83975,Toxin and Toxin Target Database (T3DB),Tetramethrin,T3D1028,Tetramethrin,http://www.t3db.ca/toxins/T3D1028,BE0000218,Calcium-transporting ATPase type 2C member 1,http://www.t3db.ca/biodb/bio_entities/BE0000218,P98194,Calcium-transporting ATPase type 2C member 1,27032.0,ATP2C1,9606.0,Homo sapiens (human),"This pyrethroid inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
1072,1477363,83975,Toxin and Toxin Target Database (T3DB),Tetramethrin,T3D1028,Tetramethrin,http://www.t3db.ca/toxins/T3D1028,BE0005014,Calcium-transporting ATPase type 2C member 2,http://www.t3db.ca/biodb/bio_entities/BE0005014,O75185,Calcium-transporting ATPase type 2C member 2,9914.0,ATP2C2,9606.0,Homo sapiens (human),"This pyrethroid inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
1073,1477364,83975,Toxin and Toxin Target Database (T3DB),Tetramethrin,T3D1028,Tetramethrin,http://www.t3db.ca/toxins/T3D1028,BE0003888,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,http://www.t3db.ca/biodb/bio_entities/BE0003888,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 ,487.0,ATP2A1,9606.0,Homo sapiens (human),"This pyrethroid inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
1074,1478428,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,CBX1,https://www.dgidb.org/genes/hgnc:1551,,,10951.0,CBX1,9606.0,Homo sapiens (human),,,,,,,,
1075,1478429,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
1076,1447986,84724,Therapeutic Target Database (TTD),"5-Amino-1,3,4-thiadiazole-2-sulfonamide",D0VD7H,CL-5343,https://idrblab.net/ttd/data/drug/details/D0VD7H,T53378,Carbonic anhydrase IV (CA-IV),https://idrblab.net/ttd/data/target/details/T53378,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1077,1447987,84724,Therapeutic Target Database (TTD),"5-Amino-1,3,4-thiadiazole-2-sulfonamide",D0VD7H,CL-5343,https://idrblab.net/ttd/data/drug/details/D0VD7H,T16987,Carbonic anhydrase XII (CA-XII),https://idrblab.net/ttd/data/target/details/T16987,O43570,Carbonic anhydrase 12,771.0,CA12,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1078,1447988,84724,Therapeutic Target Database (TTD),"5-Amino-1,3,4-thiadiazole-2-sulfonamide",D0VD7H,CL-5343,https://idrblab.net/ttd/data/drug/details/D0VD7H,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1079,1447989,84724,Therapeutic Target Database (TTD),"5-Amino-1,3,4-thiadiazole-2-sulfonamide",D0VD7H,CL-5343,https://idrblab.net/ttd/data/drug/details/D0VD7H,T31992,Carbonic anhydrase XIV (CA-XIV),https://idrblab.net/ttd/data/target/details/T31992,Q9ULX7,Carbonic anhydrase 14,23632.0,CA14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1080,1447990,84724,Therapeutic Target Database (TTD),"5-Amino-1,3,4-thiadiazole-2-sulfonamide",D0VD7H,CL-5343,https://idrblab.net/ttd/data/drug/details/D0VD7H,T64567,Carbonic anhydrase IX (CA-IX),https://idrblab.net/ttd/data/target/details/T64567,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1081,1447991,84724,Therapeutic Target Database (TTD),"5-Amino-1,3,4-thiadiazole-2-sulfonamide",D0VD7H,CL-5343,https://idrblab.net/ttd/data/drug/details/D0VD7H,T06569,Carbonic anhydrase VI (CA-VI),https://idrblab.net/ttd/data/target/details/T06569,P23280,Carbonic anhydrase 6,765.0,CA6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1082,1478430,84979,Comparative Toxicogenomics Database (CTD),Bromate,D001959,Bromates,https://ctdbase.org/detail.go?type=chem&acc=D001959,759,CA1,https://ctdbase.org/detail.go?type=gene&acc=759,,,759.0,CA1,9606.0,Homo sapiens (human),Bromates results in decreased activity of CA1 protein,,,PMID:15664814,https://www.ncbi.nlm.nih.gov/pubmed/15664814,15664814,,
1083,1478431,84979,Comparative Toxicogenomics Database (CTD),Bromate,D001959,Bromates,https://ctdbase.org/detail.go?type=chem&acc=D001959,760,CA2,https://ctdbase.org/detail.go?type=gene&acc=760,,,760.0,CA2,9606.0,Homo sapiens (human),Bromates results in decreased activity of CA2 protein,,,PMID:15664814,https://www.ncbi.nlm.nih.gov/pubmed/15664814,15664814,,
1084,1478432,84979,Comparative Toxicogenomics Database (CTD),Bromate,D001959,Bromates,https://ctdbase.org/detail.go?type=chem&acc=D001959,762,CA4,https://ctdbase.org/detail.go?type=gene&acc=762,,,762.0,CA4,9606.0,Homo sapiens (human),Bromates results in decreased activity of CA4 protein,,,PMID:15664814,https://www.ncbi.nlm.nih.gov/pubmed/15664814,15664814,,
1085,1478813,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,1312,COMT,https://ctdbase.org/detail.go?type=gene&acc=1312,,,1312.0,COMT,9606.0,Homo sapiens (human),Fenbuconazole results in increased expression of COMT mRNA,,,PMID:15942997,https://www.ncbi.nlm.nih.gov/pubmed/15942997,15942997,,
1086,1478814,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,1537,CYC1,https://ctdbase.org/detail.go?type=gene&acc=1537,,,1537.0,CYC1,7955.0,Danio rerio (zebrafish),Fenbuconazole affects the expression of CYC1 mRNA,,,PMID:35218879,https://www.ncbi.nlm.nih.gov/pubmed/35218879,35218879,,
1087,1478815,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,9606.0,Homo sapiens (human),Fenbuconazole results in decreased activity of CYP19A1 protein,,,PMID:16996190,https://www.ncbi.nlm.nih.gov/pubmed/16996190,16996190,,
1088,1478816,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,8022.0,Oncorhynchus mykiss (rainbow trout),Fenbuconazole results in decreased activity of CYP19A1 protein,,,PMID:17081805,https://www.ncbi.nlm.nih.gov/pubmed/17081805,17081805,,
1089,1478817,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,403332,CYP19A2,https://ctdbase.org/detail.go?type=gene&acc=403332,,,403332.0,CYP19A2,8022.0,Oncorhynchus mykiss (rainbow trout),Fenbuconazole results in decreased activity of CYP19A2 protein,,,PMID:17081805,https://www.ncbi.nlm.nih.gov/pubmed/17081805,17081805,,
1090,1478818,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,13088,CYP2B10,https://ctdbase.org/detail.go?type=gene&acc=13088,,,13088.0,Cyp2b10,10090.0,Mus musculus (house mouse),Fenbuconazole binds to and results in increased activity of CYP2B10 protein|fenbuconazole results in increased expression of CYP2B10 protein,,,PMID:16542693,https://www.ncbi.nlm.nih.gov/pubmed/16542693,16542693,,
1091,1478819,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,9606.0,Homo sapiens (human),Fenbuconazole results in decreased expression of CYP7A1 mRNA,,,PMID:15942997,https://www.ncbi.nlm.nih.gov/pubmed/15942997,15942997,,
1092,1478820,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,1915,EEF1A1,https://ctdbase.org/detail.go?type=gene&acc=1915,,,1915.0,EEF1A1,9606.0,Homo sapiens (human),Fenbuconazole results in increased expression of EEF1A1 mRNA,,,PMID:15942997,https://www.ncbi.nlm.nih.gov/pubmed/15942997,15942997,,
1093,1478821,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Fenbuconazole binds to and results in increased activity of ESR1 protein,,,PMID:16626760,https://www.ncbi.nlm.nih.gov/pubmed/16626760,16626760,,
1094,1478822,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Fenbuconazole binds to and results in increased activity of ESR2 protein,,,PMID:16626760,https://www.ncbi.nlm.nih.gov/pubmed/16626760,16626760,,
1095,1478823,86138,Comparative Toxicogenomics Database (CTD),Fenbuconazole,C504383,fenbuconazole,https://ctdbase.org/detail.go?type=chem&acc=C504383,2207,FCER1G,https://ctdbase.org/detail.go?type=gene&acc=2207,,,2207.0,FCER1G,9606.0,Homo sapiens (human),Fenbuconazole results in increased expression of FCER1G mRNA,,,PMID:15942997,https://www.ncbi.nlm.nih.gov/pubmed/15942997,15942997,,
1096,1396302,86354,Comparative Toxicogenomics Database (CTD),Tebufenpyrad,C429623,"4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C429623,9406,ZRANB2,https://ctdbase.org/detail.go?type=gene&acc=9406,,,9406.0,ZRANB2,9606.0,Homo sapiens (human),"4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of ZRANB2 mRNA",,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1097,1448330,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,8894,EIF2S2,https://ctdbase.org/detail.go?type=gene&acc=8894,,,8894.0,EIF2S2,9606.0,Homo sapiens (human),Thifluzamide results in increased expression of EIF2S2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1098,1448331,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606.0,Homo sapiens (human),Thifluzamide results in increased expression of EIF4EBP1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1099,1448332,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,55531,ELMOD1,https://ctdbase.org/detail.go?type=gene&acc=55531,,,55531.0,ELMOD1,9606.0,Homo sapiens (human),Thifluzamide results in decreased expression of ELMOD1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1100,1448333,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,2048,EPHB2,https://ctdbase.org/detail.go?type=gene&acc=2048,,,2048.0,EPHB2,9606.0,Homo sapiens (human),Thifluzamide results in decreased expression of EPHB2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1101,1448334,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,2060,EPS15,https://ctdbase.org/detail.go?type=gene&acc=2060,,,2060.0,EPS15,9606.0,Homo sapiens (human),Thifluzamide results in increased expression of EPS15 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1102,1448335,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,30001,ERO1A,https://ctdbase.org/detail.go?type=gene&acc=30001,,,30001.0,ERO1A,9606.0,Homo sapiens (human),Thifluzamide results in increased expression of ERO1A mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1103,1448336,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,55500,ETNK1,https://ctdbase.org/detail.go?type=gene&acc=55500,,,55500.0,ETNK1,9606.0,Homo sapiens (human),Thifluzamide results in decreased expression of ETNK1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1104,1448337,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,2113,ETS1,https://ctdbase.org/detail.go?type=gene&acc=2113,,,2113.0,ETS1,9606.0,Homo sapiens (human),Thifluzamide results in increased expression of ETS1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1105,1449777,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,57405,SPC25,https://ctdbase.org/detail.go?type=gene&acc=57405,,,57405.0,SPC25,9606.0,Homo sapiens (human),Thifluzamide results in increased expression of SPC25 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1106,1449778,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,25803,SPDEF,https://ctdbase.org/detail.go?type=gene&acc=25803,,,25803.0,SPDEF,9606.0,Homo sapiens (human),Thifluzamide results in decreased expression of SPDEF mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1107,1449779,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,200734,SPRED2,https://ctdbase.org/detail.go?type=gene&acc=200734,,,200734.0,SPRED2,9606.0,Homo sapiens (human),Thifluzamide results in increased expression of SPRED2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1108,1449780,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,10772,SRSF10,https://ctdbase.org/detail.go?type=gene&acc=10772,,,10772.0,SRSF10,9606.0,Homo sapiens (human),Thifluzamide results in increased expression of SRSF10 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1109,1449781,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,6750,SST,https://ctdbase.org/detail.go?type=gene&acc=6750,,,6750.0,SST,9606.0,Homo sapiens (human),Thifluzamide results in decreased expression of SST mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1110,1449782,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,84958,SYTL1,https://ctdbase.org/detail.go?type=gene&acc=84958,,,84958.0,SYTL1,9606.0,Homo sapiens (human),Thifluzamide results in increased expression of SYTL1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1111,1449783,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,6880,TAF9,https://ctdbase.org/detail.go?type=gene&acc=6880,,,6880.0,TAF9,9606.0,Homo sapiens (human),Thifluzamide results in increased expression of TAF9 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1112,1449784,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,6925,TCF4,https://ctdbase.org/detail.go?type=gene&acc=6925,,,6925.0,TCF4,9606.0,Homo sapiens (human),Thifluzamide results in decreased expression of TCF4 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1113,1449785,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,7027,TFDP1,https://ctdbase.org/detail.go?type=gene&acc=7027,,,7027.0,TFDP1,9606.0,Homo sapiens (human),Thifluzamide results in decreased expression of TFDP1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1114,1477955,86398,Comparative Toxicogenomics Database (CTD),Fludioxonil,C108339,fludioxonil,https://ctdbase.org/detail.go?type=chem&acc=C108339,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),[propiconazole co-treated with fludioxonil] results in decreased expression of NR1I3 mrna|[tebuconazole co-treated with fludioxonil] results in decreased expression of NR1I3 mrna|fludioxonil results in decreased expression of NR1I3 mrna|[difenoconazole co-treated with fludioxonil] results in decreased expression of NR1I3 mRNA,,,PMID:33575850,https://www.ncbi.nlm.nih.gov/pubmed/33575850,33575850,,
1115,1477956,86398,Comparative Toxicogenomics Database (CTD),Fludioxonil,C108339,fludioxonil,https://ctdbase.org/detail.go?type=chem&acc=C108339,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,9606.0,Homo sapiens (human),Fludioxonil results in increased expression of NRF1 mRNA,,,PMID:23436777,https://www.ncbi.nlm.nih.gov/pubmed/23436777,23436777,,
1116,1477957,86398,Comparative Toxicogenomics Database (CTD),Fludioxonil,C108339,fludioxonil,https://ctdbase.org/detail.go?type=chem&acc=C108339,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Fludioxonil results in increased expression of PARP1 protein,,,PMID:23052036,https://www.ncbi.nlm.nih.gov/pubmed/23052036,23052036,,
1117,1477958,86398,Comparative Toxicogenomics Database (CTD),Fludioxonil,C108339,fludioxonil,https://ctdbase.org/detail.go?type=chem&acc=C108339,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606.0,Homo sapiens (human),Fludioxonil results in increased expression of PCNA protein,,,PMID:27539251,https://www.ncbi.nlm.nih.gov/pubmed/27539251,27539251,,
1118,1477959,86398,Comparative Toxicogenomics Database (CTD),Fludioxonil,C108339,fludioxonil,https://ctdbase.org/detail.go?type=chem&acc=C108339,27250,PDCD4,https://ctdbase.org/detail.go?type=gene&acc=27250,,,27250.0,PDCD4,9606.0,Homo sapiens (human),Fludioxonil results in decreased expression of PDCD4 protein|mir21 mRNA mutant form inhibits the reaction [fludioxonil results in decreased expression of PDCD4 protein]|fludioxonil results in decreased expression of PDCD4 mRNA,,,PMID:23052036,https://www.ncbi.nlm.nih.gov/pubmed/23052036,23052036,,
1119,1479263,86398,Comparative Toxicogenomics Database (CTD),Fludioxonil,C108339,fludioxonil,https://ctdbase.org/detail.go?type=chem&acc=C108339,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [fludioxonil results in increased expression of CDH2 protein]|fludioxonil results in increased expression of CDH2 protein,,,PMID:27539251,https://www.ncbi.nlm.nih.gov/pubmed/27539251,27539251,,
1120,1479264,86398,Comparative Toxicogenomics Database (CTD),Fludioxonil,C108339,fludioxonil,https://ctdbase.org/detail.go?type=chem&acc=C108339,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Fludioxonil results in decreased expression of CDKN1A protein|fulvestrant inhibits the reaction [fludioxonil results in decreased expression of CDKN1A protein],,,PMID:27539251,https://www.ncbi.nlm.nih.gov/pubmed/27539251,27539251,,
1121,1479265,86398,Comparative Toxicogenomics Database (CTD),Fludioxonil,C108339,fludioxonil,https://ctdbase.org/detail.go?type=chem&acc=C108339,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509.0,CTSD,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [fludioxonil results in increased expression of CTSD protein]|fludioxonil results in increased expression of CTSD protein,,,PMID:27539251,https://www.ncbi.nlm.nih.gov/pubmed/27539251,27539251,,
1122,1396303,86469,Toxin and Toxin Target Database (T3DB),Cupric phosphate,T3D1223,Copper(II) phosphate,http://www.t3db.ca/toxins/T3D1223,BE0001089,Glucose-6-phosphate 1-dehydrogenase,http://www.t3db.ca/biodb/bio_entities/BE0001089,P11413,Glucose-6-phosphate 1-dehydrogenase,2539.0,G6PD,9606.0,Homo sapiens (human),"Excess copper is sequestered within hepatocyte lysosomes, where it is complexed with metallothionein. copper hepatotoxicity is believed to occur when the lysosomes become saturated and copper accumulates in the nucleus, causing nuclear damage. this damage is possibly a result of oxidative damage, including lipid peroxidation. copper inhibits the sulfhydryl group enzymes such as glucose-6-phosphate 1-dehydrogenase, glutathione reductase, and paraoxonases, which protect the cell from free oxygen radicals. it also influences gene expression and is a co-factor for oxidative enzymes such as cytochrome C oxidase and lysyl oxidase. in addition, the oxidative stress induced by copper is thought to activate acid sphingomyelinase, which lead to the production of ceramide, an apoptotic signal, as well as cause hemolytic anemia. (L277, T49, A174, L280)",,,PMID:17697726,https://www.ncbi.nlm.nih.gov/pubmed/17697726,17697726,,
1123,1396304,86469,Toxin and Toxin Target Database (T3DB),Cupric phosphate,T3D1223,Copper(II) phosphate,http://www.t3db.ca/toxins/T3D1223,BE0000648,"Glutathione reductase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000648,P00390,"Glutathione reductase, mitochondrial",2936.0,GSR,9606.0,Homo sapiens (human),"Excess copper is sequestered within hepatocyte lysosomes, where it is complexed with metallothionein. copper hepatotoxicity is believed to occur when the lysosomes become saturated and copper accumulates in the nucleus, causing nuclear damage. this damage is possibly a result of oxidative damage, including lipid peroxidation. copper inhibits the sulfhydryl group enzymes such as glucose-6-phosphate 1-dehydrogenase, glutathione reductase, and paraoxonases, which protect the cell from free oxygen radicals. it also influences gene expression and is a co-factor for oxidative enzymes such as cytochrome C oxidase and lysyl oxidase. in addition, the oxidative stress induced by copper is thought to activate acid sphingomyelinase, which lead to the production of ceramide, an apoptotic signal, as well as cause hemolytic anemia. (L277, T49, A174, L280)",,,PMID:17697726,https://www.ncbi.nlm.nih.gov/pubmed/17697726,17697726,,
1124,1396305,86469,Toxin and Toxin Target Database (T3DB),Cupric phosphate,T3D1223,Copper(II) phosphate,http://www.t3db.ca/toxins/T3D1223,BE0000930,Serum paraoxonase/arylesterase 1,http://www.t3db.ca/biodb/bio_entities/BE0000930,P27169,Serum paraoxonase/arylesterase 1,5444.0,PON1,9606.0,Homo sapiens (human),"Excess copper is sequestered within hepatocyte lysosomes, where it is complexed with metallothionein. copper hepatotoxicity is believed to occur when the lysosomes become saturated and copper accumulates in the nucleus, causing nuclear damage. this damage is possibly a result of oxidative damage, including lipid peroxidation. copper inhibits the sulfhydryl group enzymes such as glucose-6-phosphate 1-dehydrogenase, glutathione reductase, and paraoxonases, which protect the cell from free oxygen radicals. it also influences gene expression and is a co-factor for oxidative enzymes such as cytochrome C oxidase and lysyl oxidase. in addition, the oxidative stress induced by copper is thought to activate acid sphingomyelinase, which lead to the production of ceramide, an apoptotic signal, as well as cause hemolytic anemia. (L277, T49, A174, L280)",,,PMID:17697726,https://www.ncbi.nlm.nih.gov/pubmed/17697726,17697726,,
1125,1396306,86469,Toxin and Toxin Target Database (T3DB),Cupric phosphate,T3D1223,Copper(II) phosphate,http://www.t3db.ca/toxins/T3D1223,BE0003562,Serum paraoxonase/lactonase 3,http://www.t3db.ca/biodb/bio_entities/BE0003562,Q15166,Serum paraoxonase/lactonase 3,5446.0,PON3,9606.0,Homo sapiens (human),"Excess copper is sequestered within hepatocyte lysosomes, where it is complexed with metallothionein. copper hepatotoxicity is believed to occur when the lysosomes become saturated and copper accumulates in the nucleus, causing nuclear damage. this damage is possibly a result of oxidative damage, including lipid peroxidation. copper inhibits the sulfhydryl group enzymes such as glucose-6-phosphate 1-dehydrogenase, glutathione reductase, and paraoxonases, which protect the cell from free oxygen radicals. it also influences gene expression and is a co-factor for oxidative enzymes such as cytochrome C oxidase and lysyl oxidase. in addition, the oxidative stress induced by copper is thought to activate acid sphingomyelinase, which lead to the production of ceramide, an apoptotic signal, as well as cause hemolytic anemia. (L277, T49, A174, L280)",,,PMID:17697726,https://www.ncbi.nlm.nih.gov/pubmed/17697726,17697726,,
1126,1395371,86470,Drug Gene Interaction database (DGIdb),N-Methyldopamine hydrochloride,,CHEMBL:CHEMBL1256484,https://www.dgidb.org/drugs/chembl:CHEMBL1256484,,GFER,https://www.dgidb.org/genes/hgnc:4236,,,2671.0,GFER,9606.0,Homo sapiens (human),,,,,,,,
1127,1386761,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5034,P4HB,https://ctdbase.org/detail.go?type=gene&acc=5034,,,5034.0,P4HB,10116.0,Rattus norvegicus (Norway rat),Nicotine results in decreased expression of P4HB protein,,,PMID:28681937,https://www.ncbi.nlm.nih.gov/pubmed/28681937,28681937,,
1128,1386762,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5062,PAK2,https://ctdbase.org/detail.go?type=gene&acc=5062,,,5062.0,PAK2,10090.0,Mus musculus (house mouse),"[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PAK2 mrna|nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PAK2 mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
1129,1386763,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,79646,PANK3,https://ctdbase.org/detail.go?type=gene&acc=79646,,,79646.0,PANK3,9606.0,Homo sapiens (human),Nicotine results in increased expression of PANK3 mRNA,,,PMID:16949557,https://www.ncbi.nlm.nih.gov/pubmed/16949557,16949557,,
1130,1386764,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,11315,PARK7,https://ctdbase.org/detail.go?type=gene&acc=11315,,,11315.0,PARK7,10090.0,Mus musculus (house mouse),"[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PARK7 mrna|nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PARK7 mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
1131,1386765,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Nicotine inhibits the reaction [aflatoxin B1 results in increased expression of PARP1 protein modified form],,,PMID:22743290,https://www.ncbi.nlm.nih.gov/pubmed/22743290,22743290,,
1132,1387594,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5329,PLAUR,https://ctdbase.org/detail.go?type=gene&acc=5329,,,5329.0,PLAUR,9606.0,Homo sapiens (human),MK-886 inhibits the reaction [nicotine results in increased expression of PLAUR mrna],,,PMID:20061081,https://www.ncbi.nlm.nih.gov/pubmed/20061081,20061081,,
1133,1387595,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5329,PLAUR,https://ctdbase.org/detail.go?type=gene&acc=5329,,,5329.0,PLAUR,9606.0,Homo sapiens (human),Nicotine results in increased expression of PLAUR mRNA,,,PMID:20061081|PMID:22261521,https://www.ncbi.nlm.nih.gov/pubmed/20061081|https://www.ncbi.nlm.nih.gov/pubmed/22261521,20061081|22261521,,
1134,1387596,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,84812,PLCD4,https://ctdbase.org/detail.go?type=gene&acc=84812,,,84812.0,PLCD4,10090.0,Mus musculus (house mouse),Nicotine results in decreased expression of PLCD4 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1135,1387597,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5335,PLCG1,https://ctdbase.org/detail.go?type=gene&acc=5335,,,5335.0,PLCG1,10116.0,Rattus norvegicus (Norway rat),Nicotine results in increased phosphorylation of and results in increased activity of PLCG1 protein,,,PMID:15138183,https://www.ncbi.nlm.nih.gov/pubmed/15138183,15138183,,
1136,1387598,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5337,PLD1,https://ctdbase.org/detail.go?type=gene&acc=5337,,,5337.0,PLD1,9606.0,Homo sapiens (human),Nicotine results in decreased expression of PLD1 mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
1137,1387599,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,57480,PLEKHG1,https://ctdbase.org/detail.go?type=gene&acc=57480,,,57480.0,PLEKHG1,9606.0,Homo sapiens (human),PLEKHG1 gene SNP affects the susceptibility to nicotine,,,PMID:18438686,https://www.ncbi.nlm.nih.gov/pubmed/18438686,18438686,,
1138,1387600,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,57480,PLEKHG1,https://ctdbase.org/detail.go?type=gene&acc=57480,,,57480.0,PLEKHG1,10090.0,Mus musculus (house mouse),Nicotine results in decreased expression of PLEKHG1 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1139,1387601,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123.0,PLIN2,10090.0,Mus musculus (house mouse),Nicotine results in decreased expression of PLIN2 protein,,,PMID:31783125,https://www.ncbi.nlm.nih.gov/pubmed/31783125,31783125,,
1140,1387602,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,10769,PLK2,https://ctdbase.org/detail.go?type=gene&acc=10769,,,10769.0,PLK2,10090.0,Mus musculus (house mouse),Nicotine results in increased expression of PLK2 mRNA,,,PMID:17456735,https://www.ncbi.nlm.nih.gov/pubmed/17456735,17456735,,
1141,1388431,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,56984,PSMG2,https://ctdbase.org/detail.go?type=gene&acc=56984,,,56984.0,PSMG2,10090.0,Mus musculus (house mouse),"Nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PSMG2 mrna]|[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of PSMG2 mRNA",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
1142,1388432,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5724,PTAFR,https://ctdbase.org/detail.go?type=gene&acc=5724,,,5724.0,PTAFR,9606.0,Homo sapiens (human),Nicotine results in decreased expression of PTAFR mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
1143,1388433,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5724,PTAFR,https://ctdbase.org/detail.go?type=gene&acc=5724,,,5724.0,PTAFR,9606.0,Homo sapiens (human),Nicotine results in increased expression of PTAFR mRNA,,,PMID:23825647,https://www.ncbi.nlm.nih.gov/pubmed/23825647,23825647,,
1144,1388434,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,58155,PTBP2,https://ctdbase.org/detail.go?type=gene&acc=58155,,,58155.0,PTBP2,9606.0,Homo sapiens (human),Nicotine results in increased expression of PTBP2 mRNA,,,PMID:16949557,https://www.ncbi.nlm.nih.gov/pubmed/16949557,16949557,,
1145,1388435,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5728,PTEN,https://ctdbase.org/detail.go?type=gene&acc=5728,,,5728.0,PTEN,10116.0,Rattus norvegicus (Norway rat),Nicotine results in increased expression of PTEN mRNA,,,PMID:11478936,https://www.ncbi.nlm.nih.gov/pubmed/11478936,11478936,,
1146,1388436,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,9536,PTGES,https://ctdbase.org/detail.go?type=gene&acc=9536,,,9536.0,PTGES,10090.0,Mus musculus (house mouse),Nicotine results in decreased expression of PTGES protein|nicotine results in decreased expression of PTGES mRNA,,,PMID:24380835,https://www.ncbi.nlm.nih.gov/pubmed/24380835,24380835,,
1147,1388437,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),[4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [nicotine results in increased abundance of dinoprostone]|propranolol inhibits the reaction [nicotine results in increased activity of PTGS2 protein],,,PMID:18805435,https://www.ncbi.nlm.nih.gov/pubmed/18805435,18805435,,
1148,1388438,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6199,RPS6KB2,https://ctdbase.org/detail.go?type=gene&acc=6199,,,6199.0,RPS6KB2,10116.0,Rattus norvegicus (Norway rat),Nicotine results in decreased expression of RPS6KB2 mRNA,,,PMID:11478936,https://www.ncbi.nlm.nih.gov/pubmed/11478936,11478936,,
1149,1388439,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,57521,RPTOR,https://ctdbase.org/detail.go?type=gene&acc=57521,,,57521.0,RPTOR,9606.0,Homo sapiens (human),RPTOR gene SNP affects the susceptibility to nicotine,,,PMID:18438686,https://www.ncbi.nlm.nih.gov/pubmed/18438686,18438686,,
1150,1388564,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),[ICI 118551 binds to and results in decreased activity of ADRB2 protein] inhibits the reaction [nicotine results in increased expression of PTGS2],,,PMID:17369603,https://www.ncbi.nlm.nih.gov/pubmed/17369603,17369603,,
1151,1388565,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),"Lipopolysaccharide, E. coli O26-B6 promotes the reaction [nicotine results in increased expression of PTGS2 mrna]|nicotine promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of PTGS2 mrna]",,,PMID:18986645,https://www.ncbi.nlm.nih.gov/pubmed/18986645,18986645,,
1152,1388566,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),SIRT1 protein inhibits the reaction [[lipopolysaccharides co-treated with nicotine] results in increased expression of PTGS2 protein]|[lipopolysaccharides co-treated with nicotine] results in increased expression of PTGS2 mrna|sirt1 protein inhibits the reaction [[lipopolysaccharides co-treated with nicotine] results in increased expression of PTGS2 mrna]|resveratrol inhibits the reaction [[lipopolysaccharides co-treated with nicotine] results in increased expression of PTGS2 protein]|[lipopolysaccharides co-treated with nicotine] results in increased expression of PTGS2 protein,,,PMID:23199342,https://www.ncbi.nlm.nih.gov/pubmed/23199342,23199342,,
1153,1388567,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Nicotine results in increased activity of PTGS2 protein,,,PMID:17003101|PMID:18805435,https://www.ncbi.nlm.nih.gov/pubmed/17003101|https://www.ncbi.nlm.nih.gov/pubmed/18805435,17003101|18805435,,
1154,1388568,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Nicotine results in increased expression of PTGS2 mRNA,,,PMID:17003101|PMID:17369603|PMID:18986645,https://www.ncbi.nlm.nih.gov/pubmed/17003101|https://www.ncbi.nlm.nih.gov/pubmed/17369603|https://www.ncbi.nlm.nih.gov/pubmed/18986645,17003101|17369603|18986645,,
1155,1388569,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Nicotine results in increased expression of PTGS2 mRNA,,,PMID:16254210|PMID:17456735,https://www.ncbi.nlm.nih.gov/pubmed/16254210|https://www.ncbi.nlm.nih.gov/pubmed/17456735,16254210|17456735,,
1156,1388570,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Ferulic acid inhibits the reaction [nicotine results in increased expression of PTGS2 protein]|acetylcysteine inhibits the reaction [nicotine results in increased expression of PTGS2 protein],,,PMID:18068289,https://www.ncbi.nlm.nih.gov/pubmed/18068289,18068289,,
1157,1388571,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Nicotine results in increased expression of PTGS2 mRNA,,,PMID:19673871,https://www.ncbi.nlm.nih.gov/pubmed/19673871,19673871,,
1158,1389045,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),MK-886 inhibits the reaction [nicotine results in increased expression of RB1 protein modified form]|nicotine results in increased expression of RB1 protein modified form,,,PMID:20061081,https://www.ncbi.nlm.nih.gov/pubmed/20061081,20061081,,
1159,1389046,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),Nicotine inhibits the reaction [RB1 protein binds to BIRC5 promoter],,,PMID:16601104,https://www.ncbi.nlm.nih.gov/pubmed/16601104,16601104,,
1160,1389047,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),Nicotine results in decreased expression of RB1 protein,,,PMID:16011614,https://www.ncbi.nlm.nih.gov/pubmed/16011614,16011614,,
1161,1389048,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),Nicotine results in increased phosphorylation of RB1 protein,,,PMID:16862215|PMID:18448488|PMID:18805435,https://www.ncbi.nlm.nih.gov/pubmed/16862215|https://www.ncbi.nlm.nih.gov/pubmed/18448488|https://www.ncbi.nlm.nih.gov/pubmed/18805435,16862215|18448488|18805435,,
1162,1389049,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,10090.0,Mus musculus (house mouse),Nicotine results in increased phosphorylation of RB1 protein,,,PMID:15574422,https://www.ncbi.nlm.nih.gov/pubmed/15574422,15574422,,
1163,1389050,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5928,RBBP4,https://ctdbase.org/detail.go?type=gene&acc=5928,,,5928.0,RBBP4,10090.0,Mus musculus (house mouse),"Nicotine promotes the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of RBBP4 mrna]|[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RBBP4 mRNA",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
1164,1389051,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5929,RBBP5,https://ctdbase.org/detail.go?type=gene&acc=5929,,,5929.0,RBBP5,10090.0,Mus musculus (house mouse),"[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RBBP5 mrna|nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
1165,1389052,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5930,RBBP6,https://ctdbase.org/detail.go?type=gene&acc=5930,,,5930.0,RBBP6,9606.0,Homo sapiens (human),Tubocurarine inhibits the reaction [nicotine results in decreased expression of RBBP6 mrna]|mecamylamine inhibits the reaction [nicotine results in decreased expression of RBBP6 mrna]|nicotine results in decreased expression of RBBP6 mrna|alpha-cobratoxin inhibits the reaction [nicotine results in decreased expression of RBBP6 mrna],,,PMID:12588870,https://www.ncbi.nlm.nih.gov/pubmed/12588870,12588870,,
1166,1389053,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5930,RBBP6,https://ctdbase.org/detail.go?type=gene&acc=5930,,,5930.0,RBBP6,9606.0,Homo sapiens (human),Nicotine results in increased expression of RBBP6 mRNA,,,PMID:16949557,https://www.ncbi.nlm.nih.gov/pubmed/16949557,16949557,,
1167,1389054,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,10741,RBBP9,https://ctdbase.org/detail.go?type=gene&acc=10741,,,10741.0,RBBP9,10090.0,Mus musculus (house mouse),Nicotine results in increased expression of RBBP9 mRNA,,,PMID:17997037,https://www.ncbi.nlm.nih.gov/pubmed/17997037,17997037,,
1168,1390548,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6615,SNAI1,https://ctdbase.org/detail.go?type=gene&acc=6615,,,6615.0,SNAI1,10116.0,Rattus norvegicus (Norway rat),Nicotine results in increased expression of SNAI1 protein|snai1 protein affects the reaction [nicotine results in increased expression of HDAC1 mrna]|snai1 protein affects the reaction [nicotine results in increased expression of HDAC1 protein]|nicotine results in increased expression of SNAI1 mrna|snai1 protein affects the reaction [nicotine results in increased expression of HDAC2 protein]|snai1 protein affects the reaction [nicotine results in increased expression of HDAC2 mrna],,,PMID:34245815,https://www.ncbi.nlm.nih.gov/pubmed/34245815,34245815,,
1169,1390549,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6591,SNAI2,https://ctdbase.org/detail.go?type=gene&acc=6591,,,6591.0,SNAI2,9606.0,Homo sapiens (human),Nicotine results in increased expression of SNAI2 mRNA,,,PMID:23219715,https://www.ncbi.nlm.nih.gov/pubmed/23219715,23219715,,
1170,1391385,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),CHRNA5 protein affects the reaction [nicotine results in increased phosphorylation of STAT3 protein],,,PMID:35131329,https://www.ncbi.nlm.nih.gov/pubmed/35131329,35131329,,
1171,1391386,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),Propranolol inhibits the reaction [nicotine results in increased phosphorylation of STAT3 protein]|hexamethonium inhibits the reaction [nicotine results in increased phosphorylation of STAT3 protein],,,PMID:18448488|PMID:20106947,https://www.ncbi.nlm.nih.gov/pubmed/18448488|https://www.ncbi.nlm.nih.gov/pubmed/20106947,18448488|20106947,,
1172,1391387,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),Nicotine inhibits the reaction [paclitaxel results in decreased activity of STAT3 protein]|nicotine inhibits the reaction [cisplatin results in decreased activity of STAT3 protein]|nicotine results in increased phosphorylation of and results in increased activity of STAT3 protein|lobeline inhibits the reaction [nicotine results in increased phosphorylation of STAT3 protein],,,PMID:20106947,https://www.ncbi.nlm.nih.gov/pubmed/20106947,20106947,,
1173,1391388,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),[nicotine co-treated with lipopolysaccharides] results in increased phosphorylation of STAT3 protein|nicotine promotes the reaction [STAT3 protein binds to ZFP36 promoter],,,PMID:21606497,https://www.ncbi.nlm.nih.gov/pubmed/21606497,21606497,,
1174,1391389,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),Nicotine results in increased phosphorylation of STAT3 protein,,,PMID:18448488|PMID:35131329,https://www.ncbi.nlm.nih.gov/pubmed/18448488|https://www.ncbi.nlm.nih.gov/pubmed/35131329,18448488|35131329,,
1175,1391390,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),STAT3 results in increased susceptibility to nicotine,,,PMID:20943775,https://www.ncbi.nlm.nih.gov/pubmed/20943775,20943775,,
1176,1391391,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10090.0,Mus musculus (house mouse),STAT3 protein promotes the reaction [[lipopolysaccharides co-treated with nicotine] results in increased expression of ZFP36 mrna]|stat3 protein promotes the reaction [[lipopolysaccharides co-treated with nicotine] results in increased expression of HMOX1 mrna]|stat3 protein results in increased susceptibility to nicotine|zfp36 protein promotes the reaction [nicotine results in increased phosphorylation of STAT3 protein]|stat3 protein promotes the reaction [nicotine inhibits the reaction [lipopolysaccharides results in increased expression of TNF mrna]]|stat3 protein promotes the reaction [nicotine results in increased expression of ZFP36 mrna]|hmox1 protein promotes the reaction [nicotine results in increased phosphorylation of STAT3 protein]|zinc protoporphyrin inhibits the reaction [nicotine results in increased phosphorylation of STAT3 protein],,,PMID:24095726,https://www.ncbi.nlm.nih.gov/pubmed/24095726,24095726,,
1177,1391502,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10116.0,Rattus norvegicus (Norway rat),Nicotine results in increased phosphorylation of STAT3 protein|bungarotoxins inhibits the reaction [nicotine results in increased phosphorylation of STAT3 protein],,,PMID:34153408,https://www.ncbi.nlm.nih.gov/pubmed/34153408,34153408,,
1178,1391503,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10116.0,Rattus norvegicus (Norway rat),Methyllycaconitine inhibits the reaction [[nicotine co-treated with butylhydroxybutylnitrosamine] results in increased expression of STAT3 protein modified form]|[nicotine co-treated with butylhydroxybutylnitrosamine] results in increased expression of STAT3 protein modified form|hexamethonium inhibits the reaction [[nicotine co-treated with butylhydroxybutylnitrosamine] results in increased expression of STAT3 protein modified form],,,PMID:29501575,https://www.ncbi.nlm.nih.gov/pubmed/29501575,29501575,,
1179,1391504,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10116.0,Rattus norvegicus (Norway rat),Nicotine affects the expression of STAT3 mRNA,,,PMID:29155039,https://www.ncbi.nlm.nih.gov/pubmed/29155039,29155039,,
1180,1391618,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,10963,STIP1,https://ctdbase.org/detail.go?type=gene&acc=10963,,,10963.0,STIP1,10090.0,Mus musculus (house mouse),"[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of STIP1 mrna|nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of STIP1 mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
1181,1391619,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,10494,STK25,https://ctdbase.org/detail.go?type=gene&acc=10494,,,10494.0,STK25,9606.0,Homo sapiens (human),Nicotine results in increased expression of STK25 mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
1182,1391620,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,57464,STRIP2,https://ctdbase.org/detail.go?type=gene&acc=57464,,,57464.0,STRIP2,10090.0,Mus musculus (house mouse),Nicotine results in decreased expression of STRIP2 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1183,1391621,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,20909,STX4A,https://ctdbase.org/detail.go?type=gene&acc=20909,,,20909.0,Stx4a,10090.0,Mus musculus (house mouse),"Nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of STX4A mrna]|[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of STX4A mRNA",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
1184,1391622,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,84258,SYT3,https://ctdbase.org/detail.go?type=gene&acc=84258,,,84258.0,SYT3,10116.0,Rattus norvegicus (Norway rat),Nicotine results in increased methylation of SYT3 gene,,,PMID:32994467,https://www.ncbi.nlm.nih.gov/pubmed/32994467,32994467,,
1185,1391623,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6860,SYT4,https://ctdbase.org/detail.go?type=gene&acc=6860,,,6860.0,SYT4,10090.0,Mus musculus (house mouse),"[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of SYT4 mrna|nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SYT4 mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
1186,1391624,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,143425,SYT9,https://ctdbase.org/detail.go?type=gene&acc=143425,,,143425.0,SYT9,10090.0,Mus musculus (house mouse),Nicotine results in decreased expression of SYT9 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1187,1391625,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,10454,TAB1,https://ctdbase.org/detail.go?type=gene&acc=10454,,,10454.0,TAB1,10116.0,Rattus norvegicus (Norway rat),Nicotine results in decreased methylation of TAB1 gene,,,PMID:35026373,https://www.ncbi.nlm.nih.gov/pubmed/35026373,35026373,,
1188,1391626,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6869,TACR1,https://ctdbase.org/detail.go?type=gene&acc=6869,,,6869.0,TACR1,10116.0,Rattus norvegicus (Norway rat),Nicotine results in increased expression of TACR1 protein|methyllycaconitine inhibits the reaction [nicotine results in increased expression of TACR1 mrna]|mecamylamine inhibits the reaction [nicotine results in increased expression of TACR1 mrna]|mecamylamine inhibits the reaction [nicotine results in increased expression of TACR1 protein]|nicotine results in increased expression of TACR1 mrna|methyllycaconitine inhibits the reaction [nicotine results in increased expression of TACR1 protein],,,PMID:26524655,https://www.ncbi.nlm.nih.gov/pubmed/26524655,26524655,,
1189,1393671,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),Nicotine affects the susceptibility to VEGFA,,,PMID:21378373,https://www.ncbi.nlm.nih.gov/pubmed/21378373,21378373,,
1190,1393672,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),Nicotine results in increased expression of VEGFA mRNA,,,PMID:20426880,https://www.ncbi.nlm.nih.gov/pubmed/20426880,20426880,,
1191,1393673,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),Nicotine results in increased expression of VEGFA protein,,,PMID:16499655,https://www.ncbi.nlm.nih.gov/pubmed/16499655,16499655,,
1192,1393674,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),Nicotine results in increased secretion of VEGFA protein,,,PMID:17630920,https://www.ncbi.nlm.nih.gov/pubmed/17630920,17630920,,
1193,1393675,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,9606.0,Homo sapiens (human),Nicotine results in decreased expression of VIM mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
1194,1393676,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,9606.0,Homo sapiens (human),Nicotine results in increased expression of VIM mRNA,,,PMID:23219715,https://www.ncbi.nlm.nih.gov/pubmed/23219715,23219715,,
1195,1393677,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,9606.0,Homo sapiens (human),Nicotine results in increased expression of VIM protein,,,PMID:18844224,https://www.ncbi.nlm.nih.gov/pubmed/18844224,18844224,,
1196,1393678,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,10090.0,Mus musculus (house mouse),Nicotine promotes the reaction [quartz results in increased expression of VIM protein]|staurosporine aglycone inhibits the reaction [[nicotine co-treated with quartz] results in increased expression of VIM protein],,,PMID:36868510,https://www.ncbi.nlm.nih.gov/pubmed/36868510,36868510,,
1197,1393679,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,51160,VPS28,https://ctdbase.org/detail.go?type=gene&acc=51160,,,51160.0,VPS28,10090.0,Mus musculus (house mouse),"[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of VPS28 mrna|nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of VPS28 mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
1198,1393680,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,27072,VPS41,https://ctdbase.org/detail.go?type=gene&acc=27072,,,27072.0,VPS41,10090.0,Mus musculus (house mouse),"[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of VPS41 mrna|nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of VPS41 mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
1199,1393923,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606.0,Homo sapiens (human),Hexamethonium affects the reaction [nicotine results in increased expression of XIAP protein],,,PMID:16601104,https://www.ncbi.nlm.nih.gov/pubmed/16601104,16601104,,
1200,1393924,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606.0,Homo sapiens (human),[nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of XIAP protein,,,PMID:30259641,https://www.ncbi.nlm.nih.gov/pubmed/30259641,30259641,,
1201,1393925,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606.0,Homo sapiens (human),Nicotine results in increased expression of XIAP mRNA,,,PMID:21267677,https://www.ncbi.nlm.nih.gov/pubmed/21267677,21267677,,
1202,1393926,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606.0,Homo sapiens (human),Nicotine results in increased expression of XIAP protein,,,PMID:16601104|PMID:18676776|PMID:20727180|PMID:21267677|PMID:30259641,https://www.ncbi.nlm.nih.gov/pubmed/16601104|https://www.ncbi.nlm.nih.gov/pubmed/18676776|https://www.ncbi.nlm.nih.gov/pubmed/20727180|https://www.ncbi.nlm.nih.gov/pubmed/21267677|https://www.ncbi.nlm.nih.gov/pubmed/30259641,16601104|18676776|20727180|21267677|30259641,,
1203,1393927,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7503,XIST,https://ctdbase.org/detail.go?type=gene&acc=7503,,,7503.0,XIST,9606.0,Homo sapiens (human),Nicotine results in increased expression of XIST mRNA,,,PMID:16949557,https://www.ncbi.nlm.nih.gov/pubmed/16949557,16949557,,
1204,1394157,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,51663,ZFR,https://ctdbase.org/detail.go?type=gene&acc=51663,,,51663.0,ZFR,9606.0,Homo sapiens (human),Nicotine results in decreased expression of ZFR mrna|mecamylamine inhibits the reaction [nicotine results in decreased expression of ZFR mrna]|alpha-cobratoxin inhibits the reaction [nicotine results in decreased expression of ZFR mrna]|tubocurarine inhibits the reaction [nicotine results in decreased expression of ZFR mrna],,,PMID:12588870,https://www.ncbi.nlm.nih.gov/pubmed/12588870,12588870,,
1205,1394158,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7545,ZIC1,https://ctdbase.org/detail.go?type=gene&acc=7545,,,7545.0,ZIC1,10090.0,Mus musculus (house mouse),Nicotine results in increased expression of ZIC1 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1206,1394159,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,23613,ZMYND8,https://ctdbase.org/detail.go?type=gene&acc=23613,,,23613.0,ZMYND8,9606.0,Homo sapiens (human),Nicotine results in increased expression of ZMYND8 mRNA,,,PMID:16949557,https://www.ncbi.nlm.nih.gov/pubmed/16949557,16949557,,
1207,1394160,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,7705,ZNF146,https://ctdbase.org/detail.go?type=gene&acc=7705,,,7705.0,ZNF146,9606.0,Homo sapiens (human),Nicotine results in increased expression of ZNF146 mRNA,,,PMID:16949557,https://www.ncbi.nlm.nih.gov/pubmed/16949557,16949557,,
1208,1450627,89594,DrugBank,Nicotine,DB00184,Nicotine,https://www.drugbank.ca/drugs/DB00184,BE0003549,Cytochrome P450 2B6,https://www.drugbank.ca/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),Substrate,,,PMID:10350185|PMID:11996015,https://www.ncbi.nlm.nih.gov/pubmed/10350185|https://www.ncbi.nlm.nih.gov/pubmed/11996015,10350185|11996015,,
1209,1450628,89594,DrugBank,Nicotine,DB00184,Nicotine,https://www.drugbank.ca/drugs/DB00184,BE0003647,Solute carrier family 22 member 2,https://www.drugbank.ca/bio_entities/BE0003647,O15244,Solute carrier family 22 member 2,6582.0,SLC22A2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:12089365|PMID:9808712|PMID:10082798,https://www.ncbi.nlm.nih.gov/pubmed/12089365|https://www.ncbi.nlm.nih.gov/pubmed/9808712|https://www.ncbi.nlm.nih.gov/pubmed/10082798,12089365|9808712|10082798,,
1210,1395372,89914,BindingDB,4-Tritylaniline,23790,4-(triphenylmethyl)aniline,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23790,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,,,PMID:18266314|DOI:10.1021/jm070606z,https://www.ncbi.nlm.nih.gov/pubmed/18266314|https://doi.org/10.1021/jm070606z,18266314,10.1021/jm070606z,
1211,1394272,90269,BindingDB,3-Methylthiophene-2-carboxylic acid,185154,AC30341 (3),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=185154,7808,Quinolone signal response protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7808,,,,,,,,,,PMID:27082157|DOI:10.1021/acschembio.6b00156,https://www.ncbi.nlm.nih.gov/pubmed/27082157|https://doi.org/10.1021/acschembio.6b00156,27082157,10.1021/acschembio.6b00156,
1212,1479566,91274,Drug Gene Interaction database (DGIdb),Tiagabine Hydrochloride,,TIAGABINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:236875,,SLC6A1,https://www.dgidb.org/genes/hgnc:11042,,,6529.0,SLC6A1,9606.0,Homo sapiens (human),,,,,,,,
1213,1395373,91435,BindingDB,Lactate,50159794,CHEMBL1357,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50159794,10875,Carbonic anhydrase [110-330],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10875,P46510,Carbonic anhydrase,,,4224.0,Flaveria bidentis,,Ki (nM),74100,PMID:23895630|DOI:10.3109/14756366.2013.813942,https://www.ncbi.nlm.nih.gov/pubmed/23895630|https://doi.org/10.3109/14756366.2013.813942,23895630,10.3109/14756366.2013.813942,
1214,1394273,91442,Drug Gene Interaction database (DGIdb),Diethylpropion Hydrochloride,,DIETHYLPROPION HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:81998,,SLC6A2,https://www.dgidb.org/genes/hgnc:11048,,,6530.0,SLC6A2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1215,1479567,91442,ChEMBL,Diethylpropion Hydrochloride,CHEMBL1693,DIETHYLPROPION HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1693/,CHEMBL222,Norepinephrine transporter,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL222/,P23975,Sodium-dependent noradrenaline transporter ,6530.0,SLC6A2,9606.0,Homo sapiens (human),Norepinephrine transporter inhibitor,,,PMID:16767304|PMID:21197148,https://www.ncbi.nlm.nih.gov/pubmed/16767304|https://www.ncbi.nlm.nih.gov/pubmed/21197148,16767304|21197148,,
1216,1395374,91466,Comparative Toxicogenomics Database (CTD),Matrine,D000093842,Matrines,https://ctdbase.org/detail.go?type=chem&acc=D000093842,375790,AGRN,https://ctdbase.org/detail.go?type=gene&acc=375790,,,375790.0,AGRN,9606.0,Homo sapiens (human),Matrines results in decreased expression of AGRN mrna|agrn protein inhibits the reaction [matrines results in decreased expression of MYC protein]|matrines results in decreased expression of AGRN protein|agrn protein inhibits the reaction [matrines results in increased expression of BAX protein]|agrn protein inhibits the reaction [matrines results in decreased expression of CTNNB1 protein]|agrn protein inhibits the reaction [matrines results in decreased expression of BCL2 protein],,,PMID:36620879,https://www.ncbi.nlm.nih.gov/pubmed/36620879,36620879,,
1217,1395375,91466,Comparative Toxicogenomics Database (CTD),Matrine,D000093842,Matrines,https://ctdbase.org/detail.go?type=chem&acc=D000093842,84883,AIFM2,https://ctdbase.org/detail.go?type=gene&acc=84883,,,84883.0,AIFM2,9606.0,Homo sapiens (human),Matrines results in decreased expression of AIFM2 protein,,,PMID:37716422,https://www.ncbi.nlm.nih.gov/pubmed/37716422,37716422,,
1218,1395376,91466,Comparative Toxicogenomics Database (CTD),Matrine,D000093842,Matrines,https://ctdbase.org/detail.go?type=chem&acc=D000093842,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Matrines results in decreased phosphorylation of AKT1 protein,,,PMID:31112718,https://www.ncbi.nlm.nih.gov/pubmed/31112718,31112718,,
1219,1395377,91466,Comparative Toxicogenomics Database (CTD),Matrine,D000093842,Matrines,https://ctdbase.org/detail.go?type=chem&acc=D000093842,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Matrines results in decreased phosphorylation of AKT1 protein,,,PMID:37075934,https://www.ncbi.nlm.nih.gov/pubmed/37075934,37075934,,
1220,1395378,91466,Comparative Toxicogenomics Database (CTD),Matrine,D000093842,Matrines,https://ctdbase.org/detail.go?type=chem&acc=D000093842,55908,ANGPTL8,https://ctdbase.org/detail.go?type=gene&acc=55908,,,55908.0,ANGPTL8,10090.0,Mus musculus (house mouse),Matrines results in increased expression of ANGPTL8 mRNA,,,PMID:36440846,https://www.ncbi.nlm.nih.gov/pubmed/36440846,36440846,,
1221,1395379,91466,Comparative Toxicogenomics Database (CTD),Matrine,D000093842,Matrines,https://ctdbase.org/detail.go?type=chem&acc=D000093842,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),AGRN protein inhibits the reaction [matrines results in increased expression of BAX protein],,,PMID:36620879,https://www.ncbi.nlm.nih.gov/pubmed/36620879,36620879,,
1222,1394274,91467,Drug Gene Interaction database (DGIdb),Streptovitacin A,,RESACTIN A,https://www.dgidb.org/drugs/chembl:CHEMBL509617,,NR2F2,https://www.dgidb.org/genes/hgnc:7976,,,7026.0,NR2F2,9606.0,Homo sapiens (human),,,,,,,,
1223,1394275,91467,Drug Gene Interaction database (DGIdb),Streptovitacin A,,RESACTIN A,https://www.dgidb.org/drugs/chembl:CHEMBL509617,,SMAD3,https://www.dgidb.org/genes/hgnc:6769,,,4088.0,SMAD3,9606.0,Homo sapiens (human),,,,,,,,
1224,1394276,91469,Drug Gene Interaction database (DGIdb),Equol,,AUS-131,https://www.dgidb.org/drugs/chembl:CHEMBL198877,,ESR2,https://www.dgidb.org/genes/hgnc:3468,,,2100.0,ESR2,9606.0,Homo sapiens (human),,,,,,,,
1225,1479568,91477,BindingDB,Cholest-4-en-3-one,92505,4-Cholesten-3-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92505,9153,Ghrelin O-acyltransferase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9153,Q96T53,Ghrelin O-acyltransferase,619373.0,MBOAT4,9606.0,Homo sapiens (human),,IC50 (nM),>1.000e+6,PMID:28134508|DOI:10.1021/acs.biochem.6b01008,https://www.ncbi.nlm.nih.gov/pubmed/28134508|https://doi.org/10.1021/acs.biochem.6b01008,28134508,10.1021/acs.biochem.6b01008,
1226,1394277,91493,DrugBank,6-Phosphogluconic acid,DB02076,6-phospho-D-gluconic acid,https://www.drugbank.ca/drugs/DB02076,BE0003559,"6-phosphogluconate dehydrogenase, decarboxylating",https://www.drugbank.ca/bio_entities/BE0003559,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",5226.0,PGD,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
1227,1394278,91493,DrugBank,6-Phosphogluconic acid,DB02076,6-phospho-D-gluconic acid,https://www.drugbank.ca/drugs/DB02076,BE0001199,Glucose-6-phosphate isomerase,https://www.drugbank.ca/bio_entities/BE0001199,P06744,Glucose-6-phosphate isomerase,2821.0,GPI,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
1228,1394279,91493,DrugBank,6-Phosphogluconic acid,DB02076,6-phospho-D-gluconic acid,https://www.drugbank.ca/drugs/DB02076,BE0001436,Thermoresistant gluconokinase,https://www.drugbank.ca/bio_entities/BE0001436,P46859,Thermoresistant gluconokinase,75202281.0,,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
1229,1394280,91493,Therapeutic Target Database (TTD),6-Phosphogluconic acid,D0E4AN,6-Phosphogluconic Acid,https://idrblab.net/ttd/data/drug/details/D0E4AN,T76497,Phosphogluconate dehydrogenase (PGD),https://idrblab.net/ttd/data/target/details/T76497,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",5226.0,PGD,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1230,1394281,91501,Toxin and Toxin Target Database (T3DB),Cadmium telluride,T3D0387,Cadmium telluride,http://www.t3db.ca/toxins/T3D0387,BE0003789,C-Jun-amino-terminal kinase-interacting protein 1,http://www.t3db.ca/biodb/bio_entities/BE0003789,Q9UQF2,C-Jun-amino-terminal kinase-interacting protein 1,9479.0,MAPK8IP1,9606.0,Homo sapiens (human),Cadmium causes cell apoptosis by activating mitogen-activated protein kinases. (A28),,,PMID:18021293,https://www.ncbi.nlm.nih.gov/pubmed/18021293,18021293,,
1231,1479569,91510,Comparative Toxicogenomics Database (CTD),Maackiain,C001449,inermin,https://ctdbase.org/detail.go?type=chem&acc=C001449,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Inermin results in decreased activity of CYP3A4 protein,,,PMID:29753067,https://www.ncbi.nlm.nih.gov/pubmed/29753067,29753067,,
1232,1479570,91532,Therapeutic Target Database (TTD),Phosphomethylphosphonic acid adenylate ester,D0UG4S,L-betagamma-meATP,https://idrblab.net/ttd/data/drug/details/D0UG4S,T69091,P2X purinoceptor 1 (P2RX1),https://idrblab.net/ttd/data/target/details/T69091,P51575,P2X purinoceptor 1,5023.0,P2RX1,9606.0,Homo sapiens (human),Agonist,,,,,,,
1233,1396561,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),Homocysteine results in increased phosphorylation of TP53 protein,,,PMID:13679428,https://www.ncbi.nlm.nih.gov/pubmed/13679428,13679428,,
1234,1396562,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,7174,TPP2,https://ctdbase.org/detail.go?type=gene&acc=7174,,,7174.0,TPP2,9031.0,Gallus gallus (chicken),Homocysteine results in decreased expression of TPP2 mRNA,,,PMID:17326132,https://www.ncbi.nlm.nih.gov/pubmed/17326132,17326132,,
1235,1396563,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,57113,TRPC7,https://ctdbase.org/detail.go?type=gene&acc=57113,,,57113.0,TRPC7,9031.0,Gallus gallus (chicken),Homocysteine results in decreased expression of TRPC7 mRNA,,,PMID:17326132,https://www.ncbi.nlm.nih.gov/pubmed/17326132,17326132,,
1236,1396564,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,81619,TSPAN14,https://ctdbase.org/detail.go?type=gene&acc=81619,,,81619.0,TSPAN14,9031.0,Gallus gallus (chicken),Homocysteine results in decreased expression of TSPAN14 mRNA,,,PMID:17326132,https://www.ncbi.nlm.nih.gov/pubmed/17326132,17326132,,
1237,1399068,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Staurosporine inhibits the reaction [homocysteine results in increased expression of MMP9 protein]|staurosporine inhibits the reaction [homocysteine results in increased activity of MMP9 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [homocysteine results in increased activity of MMP9 protein]|acetylcysteine inhibits the reaction [homocysteine results in increased activity of MMP9 protein]|homocysteine results in increased activity of MMP9 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [homocysteine results in increased expression of MMP9 protein]|homocysteine results in increased expression of MMP9 protein|acetylcysteine inhibits the reaction [homocysteine results in increased expression of MMP9 protein],,,PMID:16251475,https://www.ncbi.nlm.nih.gov/pubmed/16251475,16251475,,
1238,1399069,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10090.0,Mus musculus (house mouse),Homocysteine results in increased activity of and results in increased expression of MMP9 protein,,,PMID:22326992,https://www.ncbi.nlm.nih.gov/pubmed/22326992,22326992,,
1239,1399297,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),[adenosine co-treated with homocysteine] inhibits the reaction [TNF protein results in increased expression of NFKBIA mrna]|[adenosine co-treated with homocysteine] affects the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]|[adenosine co-treated with homocysteine] results in decreased expression of NFKBIA mRNA,,,PMID:24224954,https://www.ncbi.nlm.nih.gov/pubmed/24224954,24224954,,
1240,1399298,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Homocysteine results in increased degradation of NFKBIA protein,,,PMID:17586618,https://www.ncbi.nlm.nih.gov/pubmed/17586618,17586618,,
1241,1399299,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),[homocysteine results in increased expression of CCL2 protein] which results in increased phosphorylation of NFKBIA protein|[homocysteine results in increased expression of CCL2 protein] which results in increased reduction of NFKBIA mRNA,,,PMID:11356643,https://www.ncbi.nlm.nih.gov/pubmed/11356643,11356643,,
1242,1399300,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,4793,NFKBIB,https://ctdbase.org/detail.go?type=gene&acc=4793,,,4793.0,NFKBIB,9606.0,Homo sapiens (human),Homocysteine results in increased degradation of NFKBIB protein,,,PMID:17586618,https://www.ncbi.nlm.nih.gov/pubmed/17586618,17586618,,
1243,1399301,91552,Comparative Toxicogenomics Database (CTD),L-Homocysteine,D006710,Homocysteine,https://ctdbase.org/detail.go?type=chem&acc=D006710,4820,NKTR,https://ctdbase.org/detail.go?type=gene&acc=4820,,,4820.0,NKTR,9031.0,Gallus gallus (chicken),Homocysteine results in decreased expression of NKTR mRNA,,,PMID:17326132,https://www.ncbi.nlm.nih.gov/pubmed/17326132,17326132,,
1244,1479571,91585,Comparative Toxicogenomics Database (CTD),"3-(1,3-Dihydro-1-oxo-2h-isoindol-2-yl)-2,6-piperidinedione",C001079,"2-(2,6-dioxopiperidin-3-yl)phthalimidine",https://ctdbase.org/detail.go?type=chem&acc=C001079,3676,ITGA4,https://ctdbase.org/detail.go?type=gene&acc=3676,,,3676.0,ITGA4,9483.0,Callithrix jacchus (white-tufted-ear marmoset),"2-(2,6-dioxopiperidin-3-yl)phthalimidine results in decreased expression of ITGA4 protein",,,PMID:8538367,https://www.ncbi.nlm.nih.gov/pubmed/8538367,8538367,,
1245,1479572,91585,Comparative Toxicogenomics Database (CTD),"3-(1,3-Dihydro-1-oxo-2h-isoindol-2-yl)-2,6-piperidinedione",C001079,"2-(2,6-dioxopiperidin-3-yl)phthalimidine",https://ctdbase.org/detail.go?type=chem&acc=C001079,3683,ITGAL,https://ctdbase.org/detail.go?type=gene&acc=3683,,,3683.0,ITGAL,9483.0,Callithrix jacchus (white-tufted-ear marmoset),"2-(2,6-dioxopiperidin-3-yl)phthalimidine results in decreased expression of ITGAL protein",,,PMID:8538367,https://www.ncbi.nlm.nih.gov/pubmed/8538367,8538367,,
1246,1479573,91585,Comparative Toxicogenomics Database (CTD),"3-(1,3-Dihydro-1-oxo-2h-isoindol-2-yl)-2,6-piperidinedione",C001079,"2-(2,6-dioxopiperidin-3-yl)phthalimidine",https://ctdbase.org/detail.go?type=chem&acc=C001079,3688,ITGB1,https://ctdbase.org/detail.go?type=gene&acc=3688,,,3688.0,ITGB1,9483.0,Callithrix jacchus (white-tufted-ear marmoset),"2-(2,6-dioxopiperidin-3-yl)phthalimidine results in decreased expression of ITGB1 protein",,,PMID:8538367,https://www.ncbi.nlm.nih.gov/pubmed/8538367,8538367,,
1247,1451286,91635,Toxin and Toxin Target Database (T3DB),"2,2',3,4,5,6-Hexachlorobiphenyl",T3D0531,"2,2',3,4,5,6-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0531,BE0000792,Estrogen receptor beta,http://www.t3db.ca/biodb/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606.0,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
1248,1451287,91635,Toxin and Toxin Target Database (T3DB),"2,2',3,4,5,6-Hexachlorobiphenyl",T3D0531,"2,2',3,4,5,6-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0531,BE0000951,Estrogen sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000951,P49888,Sulfotransferase 1E1,6783.0,SULT1E1,9606.0,Homo sapiens (human),"Pcbs can cause endocrine disurption by binding to estrogen sulfotransferase, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. (A3, A66)",,,PMID:11386736|PMID:10803601,https://www.ncbi.nlm.nih.gov/pubmed/11386736|https://www.ncbi.nlm.nih.gov/pubmed/10803601,11386736|10803601,,
1249,1451288,91635,Toxin and Toxin Target Database (T3DB),"2,2',3,4,5,6-Hexachlorobiphenyl",T3D0531,"2,2',3,4,5,6-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0531,BE0002151,Aromatic-L-amino-acid decarboxylase,http://www.t3db.ca/biodb/bio_entities/BE0002151,P20711,Aromatic-L-amino-acid decarboxylase,1644.0,DDC,9606.0,Homo sapiens (human),PCB inhibition of aromatic-L-amino-acid decarboxylase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
1250,1451454,91648,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",T3D0596,"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",http://www.t3db.ca/toxins/T3D0596,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
1251,1451455,91648,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",T3D0596,"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",http://www.t3db.ca/toxins/T3D0596,BE0000792,Estrogen receptor beta,http://www.t3db.ca/biodb/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606.0,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
1252,1451456,91648,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",T3D0596,"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",http://www.t3db.ca/toxins/T3D0596,BE0000951,Estrogen sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000951,P49888,Sulfotransferase 1E1,6783.0,SULT1E1,9606.0,Homo sapiens (human),"Pcbs can cause endocrine disurption by binding to estrogen sulfotransferase, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. (A3, A66)",,,PMID:11386736|PMID:10803601,https://www.ncbi.nlm.nih.gov/pubmed/11386736|https://www.ncbi.nlm.nih.gov/pubmed/10803601,11386736|10803601,,
1253,1451457,91648,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",T3D0596,"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",http://www.t3db.ca/toxins/T3D0596,BE0002151,Aromatic-L-amino-acid decarboxylase,http://www.t3db.ca/biodb/bio_entities/BE0002151,P20711,Aromatic-L-amino-acid decarboxylase,1644.0,DDC,9606.0,Homo sapiens (human),PCB inhibition of aromatic-L-amino-acid decarboxylase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
1254,1451458,91648,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",T3D0596,"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",http://www.t3db.ca/toxins/T3D0596,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Dioxin-like pcbs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic phase I and phase II enzymes, especially of the cytochrome P450 family. (A4)",,,PMID:2992927,https://www.ncbi.nlm.nih.gov/pubmed/2992927,2992927,,
1255,1451459,91648,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",T3D0596,"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",http://www.t3db.ca/toxins/T3D0596,BE0000614,Tyrosine 3-monooxygenase,http://www.t3db.ca/biodb/bio_entities/BE0000614,P07101,Tyrosine 3-monooxygenase,7054.0,TH,9606.0,Homo sapiens (human),PCB inhibition of tyrosine 3-monooxygenase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
1256,1479721,91693,Comparative Toxicogenomics Database (CTD),Penconazole,C087058,penconazole,https://ctdbase.org/detail.go?type=chem&acc=C087058,7170,TPM3,https://ctdbase.org/detail.go?type=gene&acc=7170,,,7170.0,TPM3,9606.0,Homo sapiens (human),Penconazole results in increased expression of TPM3 mRNA,,,PMID:23811263,https://www.ncbi.nlm.nih.gov/pubmed/23811263,23811263,,
1257,1479722,91693,Comparative Toxicogenomics Database (CTD),Penconazole,C087058,penconazole,https://ctdbase.org/detail.go?type=chem&acc=C087058,7175,TPR,https://ctdbase.org/detail.go?type=gene&acc=7175,,,7175.0,TPR,9606.0,Homo sapiens (human),Penconazole results in increased expression of TPR mRNA,,,PMID:23811263,https://www.ncbi.nlm.nih.gov/pubmed/23811263,23811263,,
1258,1479723,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,8479.0,Chrysemys picta (Painted turtle),Triflumizol binds to and results in decreased activity of ESR1 protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
1259,1479724,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,8788,DLK1,https://ctdbase.org/detail.go?type=gene&acc=8788,,,8788.0,DLK1,10090.0,Mus musculus (house mouse),Triflumizol results in decreased expression of DLK1 mRNA,,,PMID:23086663,https://www.ncbi.nlm.nih.gov/pubmed/23086663,23086663,,
1260,1479725,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,1735,DIO3,https://ctdbase.org/detail.go?type=gene&acc=1735,,,1735.0,DIO3,9606.0,Homo sapiens (human),Triflumizol results in decreased activity of DIO3 protein,,,PMID:30561685,https://www.ncbi.nlm.nih.gov/pubmed/30561685,30561685,,
1261,1479726,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,317733,ESR2B,https://ctdbase.org/detail.go?type=gene&acc=317733,,,317733.0,esr2b,7955.0,Danio rerio (zebrafish),Triflumizol binds to and results in increased activity of ESR2B protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
1262,1479727,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9606.0,Homo sapiens (human),Triflumizol results in decreased activity of ACHE protein,,,PMID:21251949,https://www.ncbi.nlm.nih.gov/pubmed/21251949,21251949,,
1263,1479893,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),Dihydrotestosterone inhibits the reaction [triflumizol results in increased activity of AR protein],,,PMID:15064155,https://www.ncbi.nlm.nih.gov/pubmed/15064155,15064155,,
1264,1479894,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,399456,AR.L,https://ctdbase.org/detail.go?type=gene&acc=399456,,,399456.0,ar.L,8355.0,Xenopus laevis (African clawed frog),Triflumizol inhibits the reaction [[6-fluorotestosterone co-treated with norgestrel] binds to and results in increased activity of AR.L protein],,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
1265,1479895,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Triflumizol results in decreased expression of CCL2,,,PMID:21788198,https://www.ncbi.nlm.nih.gov/pubmed/21788198,21788198,,
1266,1479896,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,63924,CIDEC,https://ctdbase.org/detail.go?type=gene&acc=63924,,,63924.0,CIDEC,9606.0,Homo sapiens (human),[triflumizol co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in increased expression of CIDEC mrna|[triflumizol co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with indomethacin co-treated with INS protein] results in increased expression of CIDEC mRNA,,,PMID:23086663,https://www.ncbi.nlm.nih.gov/pubmed/23086663,23086663,,
1267,1479897,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,1733,DIO1,https://ctdbase.org/detail.go?type=gene&acc=1733,,,1733.0,DIO1,9606.0,Homo sapiens (human),Triflumizol results in decreased activity of DIO1 protein,,,PMID:29228274|PMID:30561685,https://www.ncbi.nlm.nih.gov/pubmed/29228274|https://www.ncbi.nlm.nih.gov/pubmed/30561685,29228274|30561685,,
1268,1479898,91699,Comparative Toxicogenomics Database (CTD),Triflumizole,C053549,triflumizol,https://ctdbase.org/detail.go?type=chem&acc=C053549,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734.0,DIO2,9606.0,Homo sapiens (human),Triflumizol results in decreased activity of DIO2 protein,,,PMID:30561685,https://www.ncbi.nlm.nih.gov/pubmed/30561685,30561685,,
1269,1401051,91754,Comparative Toxicogenomics Database (CTD),Pyridaben,C428725,pyridaben,https://ctdbase.org/detail.go?type=chem&acc=C428725,1815,DRD4,https://ctdbase.org/detail.go?type=gene&acc=1815,,,1815.0,DRD4,10090.0,Mus musculus (house mouse),Pyridaben results in decreased expression of DRD4 mRNA,,,PMID:22563483,https://www.ncbi.nlm.nih.gov/pubmed/22563483,22563483,,
1270,1401523,91754,Comparative Toxicogenomics Database (CTD),Pyridaben,C428725,pyridaben,https://ctdbase.org/detail.go?type=chem&acc=C428725,92979,MARCHF9,https://ctdbase.org/detail.go?type=gene&acc=92979,,,92979.0,MARCHF9,10090.0,Mus musculus (house mouse),Pyridaben results in decreased expression of MARCHF9 mRNA,,,PMID:22563483,https://www.ncbi.nlm.nih.gov/pubmed/22563483,22563483,,
1271,1401524,91754,Comparative Toxicogenomics Database (CTD),Pyridaben,C428725,pyridaben,https://ctdbase.org/detail.go?type=chem&acc=C428725,129642,MBOAT2,https://ctdbase.org/detail.go?type=gene&acc=129642,,,129642.0,MBOAT2,10090.0,Mus musculus (house mouse),Pyridaben results in increased expression of MBOAT2 mRNA,,,PMID:22563483,https://www.ncbi.nlm.nih.gov/pubmed/22563483,22563483,,
1272,1401525,91754,Comparative Toxicogenomics Database (CTD),Pyridaben,C428725,pyridaben,https://ctdbase.org/detail.go?type=chem&acc=C428725,4188,MDFI,https://ctdbase.org/detail.go?type=gene&acc=4188,,,4188.0,MDFI,10090.0,Mus musculus (house mouse),Pyridaben results in decreased expression of MDFI mRNA,,,PMID:22563483,https://www.ncbi.nlm.nih.gov/pubmed/22563483,22563483,,
1273,1401526,91754,Comparative Toxicogenomics Database (CTD),Pyridaben,C428725,pyridaben,https://ctdbase.org/detail.go?type=chem&acc=C428725,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10090.0,Mus musculus (house mouse),Pyridaben results in increased expression of MPO mRNA,,,PMID:22563483,https://www.ncbi.nlm.nih.gov/pubmed/22563483,22563483,,
1274,1482026,91763,Toxin and Toxin Target Database (T3DB),Halosulfuron-methyl,T3D3856,Halosulfuron-methyl,http://www.t3db.ca/toxins/T3D3856,BE0003554,Nuclear receptor ROR-beta,http://www.t3db.ca/biodb/bio_entities/BE0003554,Q92753,Nuclear receptor ROR-beta,,,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1275,1481271,91766,Comparative Toxicogenomics Database (CTD),Flufenoxuron,C067660,flufenoxuron,https://ctdbase.org/detail.go?type=chem&acc=C067660,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK3 protein]|pyrazolanthrone inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK3 protein]|u 0126 inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK3 protein]|flufenoxuron results in increased phosphorylation of MAPK3 protein,,,PMID:33771252,https://www.ncbi.nlm.nih.gov/pubmed/33771252,33771252,,
1276,1481272,91766,Comparative Toxicogenomics Database (CTD),Flufenoxuron,C067660,flufenoxuron,https://ctdbase.org/detail.go?type=chem&acc=C067660,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10090.0,Mus musculus (house mouse),U 0126 inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK8 protein]|pyrazolanthrone inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK8 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK8 protein]|flufenoxuron results in increased phosphorylation of MAPK8 protein,,,PMID:33771252,https://www.ncbi.nlm.nih.gov/pubmed/33771252,33771252,,
1277,1481273,91766,Comparative Toxicogenomics Database (CTD),Flufenoxuron,C067660,flufenoxuron,https://ctdbase.org/detail.go?type=chem&acc=C067660,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10090.0,Mus musculus (house mouse),Flufenoxuron results in decreased expression of PCNA protein,,,PMID:33771252,https://www.ncbi.nlm.nih.gov/pubmed/33771252,33771252,,
1278,1481274,91766,Comparative Toxicogenomics Database (CTD),Flufenoxuron,C067660,flufenoxuron,https://ctdbase.org/detail.go?type=chem&acc=C067660,55177,RMDN3,https://ctdbase.org/detail.go?type=gene&acc=55177,,,55177.0,RMDN3,10090.0,Mus musculus (house mouse),Flufenoxuron results in increased expression of RMDN3 protein,,,PMID:33771252,https://www.ncbi.nlm.nih.gov/pubmed/33771252,33771252,,
1279,1481275,91766,Comparative Toxicogenomics Database (CTD),Flufenoxuron,C067660,flufenoxuron,https://ctdbase.org/detail.go?type=chem&acc=C067660,6195,RPS6KA1,https://ctdbase.org/detail.go?type=gene&acc=6195,,,6195.0,RPS6KA1,10090.0,Mus musculus (house mouse),Flufenoxuron results in decreased phosphorylation of RPS6KA1 protein|u 0126 inhibits the reaction [flufenoxuron results in decreased phosphorylation of RPS6KA1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [flufenoxuron results in decreased phosphorylation of RPS6KA1 protein],,,PMID:33771252,https://www.ncbi.nlm.nih.gov/pubmed/33771252,33771252,,
1280,1481276,91766,Comparative Toxicogenomics Database (CTD),Flufenoxuron,C067660,flufenoxuron,https://ctdbase.org/detail.go?type=chem&acc=C067660,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,10090.0,Mus musculus (house mouse),Flufenoxuron results in decreased phosphorylation of RPS6KB1 protein|pyrazolanthrone affects the reaction [flufenoxuron results in decreased phosphorylation of RPS6KB1 protein]|u 0126 inhibits the reaction [flufenoxuron results in decreased phosphorylation of RPS6KB1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [flufenoxuron results in decreased phosphorylation of RPS6KB1 protein],,,PMID:33771252,https://www.ncbi.nlm.nih.gov/pubmed/33771252,33771252,,
1281,1453027,91768,Toxin and Toxin Target Database (T3DB),Tau-fluvalinate,T3D1849,Tau-fluvalinate,http://www.t3db.ca/toxins/T3D1849,BE0002084,Sodium channel protein type 8 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0002084,Q9UQD0,Sodium channel protein type 8 subunit alpha,6334.0,SCN8A,9606.0,Homo sapiens (human),"This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. this pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. type I pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560).",,,PMID:15950969,https://www.ncbi.nlm.nih.gov/pubmed/15950969,15950969,,
1282,1453028,91768,Toxin and Toxin Target Database (T3DB),Tau-fluvalinate,T3D1849,Tau-fluvalinate,http://www.t3db.ca/toxins/T3D1849,BE0001143,Sodium channel protein type 9 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0001143,Q15858,Sodium channel protein type 9 subunit alpha,6335.0,SCN9A,9606.0,Homo sapiens (human),"This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. this pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. type I pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560).",,,PMID:15950969,https://www.ncbi.nlm.nih.gov/pubmed/15950969,15950969,,
1283,1453029,91768,Toxin and Toxin Target Database (T3DB),Tau-fluvalinate,T3D1849,Tau-fluvalinate,http://www.t3db.ca/toxins/T3D1849,BE0003635,Sodium channel subunit beta-1,http://www.t3db.ca/biodb/bio_entities/BE0003635,Q07699,Sodium channel subunit beta-1,6324.0,SCN1B,9606.0,Homo sapiens (human),"This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. this pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. type I pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560).",,,PMID:15950969,https://www.ncbi.nlm.nih.gov/pubmed/15950969,15950969,,
1284,1402727,92272,Comparative Toxicogenomics Database (CTD),Monoisobutyl phthalate,C575690,mono-isobutyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C575690,100316868,HOTTIP,https://ctdbase.org/detail.go?type=gene&acc=100316868,,,100316868.0,HOTTIP,9606.0,Homo sapiens (human),Mono-isobutyl phthalate affects the expression of HOTTIP mRNA,,,PMID:29385630,https://www.ncbi.nlm.nih.gov/pubmed/29385630,29385630,,
1285,1402728,92272,Comparative Toxicogenomics Database (CTD),Monoisobutyl phthalate,C575690,mono-isobutyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C575690,3292,HSD17B1,https://ctdbase.org/detail.go?type=gene&acc=3292,,,3292.0,HSD17B1,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of HSD17B1 mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1286,1402729,92272,Comparative Toxicogenomics Database (CTD),Monoisobutyl phthalate,C575690,mono-isobutyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C575690,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of HSD3B1 mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1287,1402730,92272,Comparative Toxicogenomics Database (CTD),Monoisobutyl phthalate,C575690,mono-isobutyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C575690,3973,LHCGR,https://ctdbase.org/detail.go?type=gene&acc=3973,,,3973.0,LHCGR,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of LHCGR mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1288,1402731,92272,Comparative Toxicogenomics Database (CTD),Monoisobutyl phthalate,C575690,mono-isobutyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C575690,406933,MIR141,https://ctdbase.org/detail.go?type=gene&acc=406933,,,406933.0,MIR141,9606.0,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of MIR141 mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
1289,1402732,92272,Comparative Toxicogenomics Database (CTD),Monoisobutyl phthalate,C575690,mono-isobutyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C575690,406960,MIR184,https://ctdbase.org/detail.go?type=gene&acc=406960,,,406960.0,MIR184,9606.0,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MIR184 mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
1290,1402733,92272,Comparative Toxicogenomics Database (CTD),Monoisobutyl phthalate,C575690,mono-isobutyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C575690,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,9606.0,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
1291,1402734,92272,Comparative Toxicogenomics Database (CTD),Monoisobutyl phthalate,C575690,mono-isobutyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C575690,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1292,1402735,92272,Comparative Toxicogenomics Database (CTD),Monoisobutyl phthalate,C575690,mono-isobutyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C575690,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),Mono-isobutyl phthalate binds to NR1I3 protein,,,PMID:25938866,https://www.ncbi.nlm.nih.gov/pubmed/25938866,25938866,,
1293,1481729,92786,Drug Gene Interaction database (DGIdb),Brexanolone,,BREXANOLONE,https://www.dgidb.org/drugs/rxcui:2121777,,GABRG3,https://www.dgidb.org/genes/hgnc:4088,,,2567.0,GABRG3,9606.0,Homo sapiens (human),,,,,,,,
1294,1481730,92974,IUPHAR/BPS Guide to PHARMACOLOGY,Droxidopa,7391,droxidopa,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7391,13,M1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=13,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606.0,Homo sapiens (human),Antagonist,pKi,7.1,PMID:27085897,https://www.ncbi.nlm.nih.gov/pubmed/27085897,27085897,,
1295,1398569,93021,Toxin and Toxin Target Database (T3DB),Manganese acetate tetrahydrate,T3D1149,Manganese triacetate,http://www.t3db.ca/toxins/T3D1149,BE0005211,Iron-responsive element-binding protein 2,http://www.t3db.ca/biodb/bio_entities/BE0005211,P48200,Iron-responsive element-binding protein 2,3658.0,IREB2,9606.0,Homo sapiens (human),"Manganese alters cellular iron homeostasis by stabilizing iron regulatory protein 2. this may occur by manganese competing directly for an iron-binding site on the iron binding protein, disrupting the cellular mechanisms responsible for its iron-dependent degradation. (A159)",,,PMID:17469137,https://www.ncbi.nlm.nih.gov/pubmed/17469137,17469137,,
1296,1398570,93021,Toxin and Toxin Target Database (T3DB),Manganese acetate tetrahydrate,T3D1149,Manganese triacetate,http://www.t3db.ca/toxins/T3D1149,BE0001105,Major prion protein,http://www.t3db.ca/biodb/bio_entities/BE0001105,P04156,Major prion protein,5621.0,PRNP,9606.0,Homo sapiens (human),"Manganese binds to the prion protein, altering its conformation, displacing copper, and altering the redox chemistry of the metal-protein complex. these changes are similar to those associated with prion disease. (A158)",,,PMID:18332141,https://www.ncbi.nlm.nih.gov/pubmed/18332141,18332141,,
1297,1398571,93021,Toxin and Toxin Target Database (T3DB),Manganese acetate tetrahydrate,T3D1149,Manganese triacetate,http://www.t3db.ca/toxins/T3D1149,BE0005209,Putative testis-specific prion protein,http://www.t3db.ca/biodb/bio_entities/BE0005209,Q86SH4,Putative testis-specific prion protein,,,9606.0,Homo sapiens (human),"Manganese binds to the prion protein, altering its conformation, displacing copper, and altering the redox chemistry of the metal-protein complex. these changes are similar to those associated with prion disease. (A158)",,,PMID:18332141,https://www.ncbi.nlm.nih.gov/pubmed/18332141,18332141,,
1298,1398572,93091,Comparative Toxicogenomics Database (CTD),Titanium nitride,C041500,titanium nitride,https://ctdbase.org/detail.go?type=chem&acc=C041500,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,10090.0,Mus musculus (house mouse),"[chromium alloys co-treated with titanium alloy (tial6v4) co-treated with titanium nitride co-treated with silicon dioxide] results in increased expression of IL1A protein|lipopolysaccharide, E coli O55-B5 promotes the reaction [[chromium alloys co-treated with titanium alloy (tial6v4) co-treated with titanium nitride co-treated with silicon dioxide] results in increased expression of IL1A protein]",,,PMID:12168658,https://www.ncbi.nlm.nih.gov/pubmed/12168658,12168658,,
1299,1398573,93091,Comparative Toxicogenomics Database (CTD),Titanium nitride,C041500,titanium nitride,https://ctdbase.org/detail.go?type=chem&acc=C041500,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),"Lipopolysaccharide, E coli O55-B5 promotes the reaction [[chromium alloys co-treated with titanium alloy (tial6v4) co-treated with titanium nitride co-treated with silicon dioxide] results in increased expression of IL1B protein]|[chromium alloys co-treated with titanium alloy (tial6v4) co-treated with titanium nitride co-treated with silicon dioxide] results in increased expression of IL1B protein",,,PMID:12168658,https://www.ncbi.nlm.nih.gov/pubmed/12168658,12168658,,
1300,1398688,93205,IUPHAR/BPS Guide to PHARMACOLOGY,(R)-N-(1-Methyl-2-phenylethyl)adenosine,414,(R)-PIA,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=414,18,A1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=18,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),Full agonist,pKi,6.4 - 8.7,PMID:7798201|PMID:9920910|PMID:8300561|PMID:15476669|PMID:9459566,https://www.ncbi.nlm.nih.gov/pubmed/7798201|https://www.ncbi.nlm.nih.gov/pubmed/9920910|https://www.ncbi.nlm.nih.gov/pubmed/8300561|https://www.ncbi.nlm.nih.gov/pubmed/15476669|https://www.ncbi.nlm.nih.gov/pubmed/9459566,7798201|9920910|8300561|15476669|9459566,,
1301,1386908,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,53827,FXYD5,https://ctdbase.org/detail.go?type=gene&acc=53827,,,53827.0,FXYD5,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FXYD5 mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1302,1386909,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2533,FYB1,https://ctdbase.org/detail.go?type=gene&acc=2533,,,2533.0,FYB1,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of FYB1 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1303,1386910,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,8321,FZD1,https://ctdbase.org/detail.go?type=gene&acc=8321,,,8321.0,FZD1,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of FZD1 mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
1304,1386911,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,8325,FZD8,https://ctdbase.org/detail.go?type=gene&acc=8325,,,8325.0,FZD8,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of FZD8 mRNA",,,PMID:31326446,https://www.ncbi.nlm.nih.gov/pubmed/31326446,31326446,,
1305,1386912,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,8326,FZD9,https://ctdbase.org/detail.go?type=gene&acc=8326,,,8326.0,FZD9,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FZD9 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1306,1386913,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,8326,FZD9,https://ctdbase.org/detail.go?type=gene&acc=8326,,,8326.0,FZD9,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FZD9 mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
1307,1387745,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,79760,GEMIN7,https://ctdbase.org/detail.go?type=gene&acc=79760,,,79760.0,GEMIN7,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of GEMIN7 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1308,1387746,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,348654,GEN1,https://ctdbase.org/detail.go?type=gene&acc=348654,,,348654.0,GEN1,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of GEN1 mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
1309,1387747,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,348654,GEN1,https://ctdbase.org/detail.go?type=gene&acc=348654,,,348654.0,GEN1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of GEN1 mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1310,1387748,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,51608,GET4,https://ctdbase.org/detail.go?type=gene&acc=51608,,,51608.0,GET4,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GET4 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1311,1387749,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of GFAP mRNA",,,PMID:33078273,https://www.ncbi.nlm.nih.gov/pubmed/33078273,33078273,,
1312,1387750,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2671,GFER,https://ctdbase.org/detail.go?type=gene&acc=2671,,,2671.0,GFER,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GFER mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1313,1387751,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2671,GFER,https://ctdbase.org/detail.go?type=gene&acc=2671,,,2671.0,GFER,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of GFER mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1314,1387752,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2673,GFPT1,https://ctdbase.org/detail.go?type=gene&acc=2673,,,2673.0,GFPT1,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of GFPT1 mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
1315,1387753,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2673,GFPT1,https://ctdbase.org/detail.go?type=gene&acc=2673,,,2673.0,GFPT1,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of GFPT1 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1316,1388729,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1880,GPR183,https://ctdbase.org/detail.go?type=gene&acc=1880,,,1880.0,GPR183,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of GPR183 mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
1317,1390688,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of HMGCR mRNA",,,PMID:31173147,https://www.ncbi.nlm.nih.gov/pubmed/31173147,31173147,,
1318,1390689,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of HMGCR mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1319,1390690,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HMGCR mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1320,1390691,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,559054,HMGCRA,https://ctdbase.org/detail.go?type=gene&acc=559054,,,559054.0,hmgcra,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of HMGCRA mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1321,1390692,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3157,HMGCS1,https://ctdbase.org/detail.go?type=gene&acc=3157,,,3157.0,HMGCS1,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HMGCS1 mRNA",,,PMID:30202865,https://www.ncbi.nlm.nih.gov/pubmed/30202865,30202865,,
1322,1390693,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3157,HMGCS1,https://ctdbase.org/detail.go?type=gene&acc=3157,,,3157.0,HMGCS1,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HMGCS1 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1323,1398808,95415,BindingDB,"2-Hydroxy-1,2-bis(4-methoxyphenyl)ethanone",22760,"2-hydroxy-1,2-bis(4-methoxyphenyl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22760,8446,Coagulation factor XII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8446,P00748,Coagulation factor XII,2161.0,F12,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
1324,1398809,95415,BindingDB,"2-Hydroxy-1,2-bis(4-methoxyphenyl)ethanone",22760,"2-hydroxy-1,2-bis(4-methoxyphenyl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22760,7016,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7016,P23141,Liver carboxylesterase 1,1066.0,CES1,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
1325,1398810,95415,BindingDB,"2-Hydroxy-1,2-bis(4-methoxyphenyl)ethanone",22760,"2-hydroxy-1,2-bis(4-methoxyphenyl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22760,2315,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2315,P12337,Liver carboxylesterase 1,100009551.0,CES1,9986.0,Oryctolagus cuniculus (rabbit),,Ki (nM),13900,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
1326,1398811,95415,BindingDB,"2-Hydroxy-1,2-bis(4-methoxyphenyl)ethanone",22760,"2-hydroxy-1,2-bis(4-methoxyphenyl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22760,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
1327,1398812,95415,BindingDB,"2-Hydroxy-1,2-bis(4-methoxyphenyl)ethanone",22760,"2-hydroxy-1,2-bis(4-methoxyphenyl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22760,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
1328,1399158,96430,BindingDB,"4,4'-Dibromobenzil",22733,"1,2-bis(4-bromophenyl)ethane-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22733,8446,Coagulation factor XII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8446,P00748,Coagulation factor XII,2161.0,F12,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
1329,1399159,96430,BindingDB,"4,4'-Dibromobenzil",22733,"1,2-bis(4-bromophenyl)ethane-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22733,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
1330,1403769,97463,Therapeutic Target Database (TTD),"1-(3,4-Dichlorophenyl)-3-hydroxyurea",D09UQM,"1-(3,4-dichlorophenyl)-3-hydroxyurea",https://idrblab.net/ttd/data/drug/details/D09UQM,T64567,Carbonic anhydrase IX (CA-IX),https://idrblab.net/ttd/data/target/details/T64567,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1331,1403770,97463,Therapeutic Target Database (TTD),"1-(3,4-Dichlorophenyl)-3-hydroxyurea",D09UQM,"1-(3,4-dichlorophenyl)-3-hydroxyurea",https://idrblab.net/ttd/data/drug/details/D09UQM,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1332,1399718,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10090.0,Mus musculus (house mouse),Diosgenin results in decreased expression of CTNNB1 mRNA,,,PMID:26408789,https://www.ncbi.nlm.nih.gov/pubmed/26408789,26408789,,
1333,1399719,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,10116.0,Rattus norvegicus (Norway rat),Diosgenin promotes the reaction [dietary fats results in increased expression of CYP27A1 mrna],,,PMID:33383043,https://www.ncbi.nlm.nih.gov/pubmed/33383043,33383043,,
1334,1399720,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,13112,CYP3A11,https://ctdbase.org/detail.go?type=gene&acc=13112,,,13112.0,Cyp3a11,10090.0,Mus musculus (house mouse),Diosgenin results in increased expression of CYP3A11 mRNA,,,PMID:15611112,https://www.ncbi.nlm.nih.gov/pubmed/15611112,15611112,,
1335,1399721,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10116.0,Rattus norvegicus (Norway rat),Diosgenin promotes the reaction [dietary fats results in increased expression of CYP7A1 protein]|diosgenin promotes the reaction [dietary fats results in increased expression of CYP7A1 mrna],,,PMID:33383043,https://www.ncbi.nlm.nih.gov/pubmed/33383043,33383043,,
1336,1399722,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10116.0,Rattus norvegicus (Norway rat),[ethinyl estradiol co-treated with diosgenin] results in increased expression of CYP7A1 mRNA,,,PMID:12963437,https://www.ncbi.nlm.nih.gov/pubmed/12963437,12963437,,
1337,1399723,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,10059,DNM1L,https://ctdbase.org/detail.go?type=gene&acc=10059,,,10059.0,DNM1L,9606.0,Homo sapiens (human),Diosgenin affects the reaction [alpha-chlorohydrin affects the localization of DNM1L protein]|diosgenin inhibits the reaction [alpha-chlorohydrin results in increased expression of DNM1L protein],,,PMID:35149085,https://www.ncbi.nlm.nih.gov/pubmed/35149085,35149085,,
1338,1399724,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606.0,Homo sapiens (human),Diosgenin promotes the reaction [alpha-chlorohydrin results in decreased phosphorylation of EIF4EBP1 protein]|3-methyladenine inhibits the reaction [diosgenin promotes the reaction [alpha-chlorohydrin results in decreased phosphorylation of EIF4EBP1 protein]],,,PMID:35149085,https://www.ncbi.nlm.nih.gov/pubmed/35149085,35149085,,
1339,1399725,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090.0,Mus musculus (house mouse),Diosgenin inhibits the reaction [dietary fats results in decreased expression of ESR2 protein]|diosgenin results in increased expression of ESR2 protein|diosgenin promotes the reaction [RXRA protein binds to ESR2 protein],,,PMID:26408789,https://www.ncbi.nlm.nih.gov/pubmed/26408789,26408789,,
1340,1399832,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Diosgenin inhibits the reaction [dietary fats results in increased expression of IL6 mrna]|diosgenin results in decreased expression of IL6 mRNA,,,PMID:26408789,https://www.ncbi.nlm.nih.gov/pubmed/26408789,26408789,,
1341,1399833,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Diosgenin inhibits the reaction [streptozocin results in increased expression of IL6 mrna]|diosgenin inhibits the reaction [streptozocin results in increased expression of IL6 protein],,,PMID:35305976,https://www.ncbi.nlm.nih.gov/pubmed/35305976,35305976,,
1342,1399834,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),Diosgenin inhibits the reaction [[streptozocin co-treated with dietary fats] results in decreased expression of INS1 protein],,,PMID:24001619,https://www.ncbi.nlm.nih.gov/pubmed/24001619,24001619,,
1343,1399835,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),Diosgenin inhibits the reaction [streptozocin results in decreased expression of INS1 protein],,,PMID:35305976,https://www.ncbi.nlm.nih.gov/pubmed/35305976,35305976,,
1344,1399836,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,3990,LIPC,https://ctdbase.org/detail.go?type=gene&acc=3990,,,3990.0,LIPC,10116.0,Rattus norvegicus (Norway rat),Diosgenin results in increased activity of LIPC protein,,,PMID:20149787,https://www.ncbi.nlm.nih.gov/pubmed/20149787,20149787,,
1345,1399837,99474,Comparative Toxicogenomics Database (CTD),Diosgenin,D004144,Diosgenin,https://ctdbase.org/detail.go?type=chem&acc=D004144,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,9606.0,Homo sapiens (human),Diosgenin results in decreased lipidation of MAP1LC3B protein|[alpha-chlorohydrin co-treated with diosgenin] results in increased lipidation of MAP1LC3B protein|3-methyladenine inhibits the reaction [[alpha-chlorohydrin co-treated with diosgenin] results in increased lipidation of MAP1LC3B protein]|diosgenin promotes the reaction [alpha-chlorohydrin results in increased lipidation of MAP1LC3B protein]|bafilomycin A1 promotes the reaction [[alpha-chlorohydrin co-treated with diosgenin] results in increased lipidation of MAP1LC3B protein]|alpha-chlorohydrin inhibits the reaction [diosgenin results in decreased lipidation of MAP1LC3B protein],,,PMID:35149085,https://www.ncbi.nlm.nih.gov/pubmed/35149085,35149085,,
1346,1391766,99649,Comparative Toxicogenomics Database (CTD),Emodin-8-glucoside,C526172,emodin-8-O-beta-D-glucoside,https://ctdbase.org/detail.go?type=chem&acc=C526172,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Emodin-8-O-beta-D-glucoside results in increased expression of CDKN1A protein,,,PMID:35134436,https://www.ncbi.nlm.nih.gov/pubmed/35134436,35134436,,
1347,1391767,99649,Comparative Toxicogenomics Database (CTD),Emodin-8-glucoside,C526172,emodin-8-O-beta-D-glucoside,https://ctdbase.org/detail.go?type=chem&acc=C526172,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),Emodin-8-O-beta-D-glucoside results in decreased phosphorylation of RB1 protein,,,PMID:35134436,https://www.ncbi.nlm.nih.gov/pubmed/35134436,35134436,,
1348,1391768,99649,Comparative Toxicogenomics Database (CTD),Emodin-8-glucoside,C526172,emodin-8-O-beta-D-glucoside,https://ctdbase.org/detail.go?type=chem&acc=C526172,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Emodin-8-O-beta-D-glucoside inhibits the reaction [TNF protein results in increased abundance of dinoprostone],,,PMID:21245807,https://www.ncbi.nlm.nih.gov/pubmed/21245807,21245807,,
1349,1391769,100046,BindingDB,"4,6-Di-t-butyl-2-(alpha-methyl-4-methoxybenzyl)phenol",34129,"2,4-di-tert-butyl-6-[1-(4-methoxyphenyl)ethyl]phenol, 4b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=34129,50003506,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003506,P04191,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,100037716.0,ATP2A1,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),35300,PMID:19117760|DOI:10.1016/j.bmc.2008.12.010,https://www.ncbi.nlm.nih.gov/pubmed/19117760|https://doi.org/10.1016/j.bmc.2008.12.010,19117760,10.1016/j.bmc.2008.12.010,
1350,1396565,101731,Comparative Toxicogenomics Database (CTD),beta-Patchoulene,C000614835,beta-patchoulene,https://ctdbase.org/detail.go?type=chem&acc=C000614835,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Beta-patchoulene analog inhibits the reaction [ethanol results in increased expression of IL1B protein],,,PMID:29339218,https://www.ncbi.nlm.nih.gov/pubmed/29339218,29339218,,
1351,1396566,101731,Comparative Toxicogenomics Database (CTD),beta-Patchoulene,C000614835,beta-patchoulene,https://ctdbase.org/detail.go?type=chem&acc=C000614835,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10116.0,Rattus norvegicus (Norway rat),Beta-patchoulene analog inhibits the reaction [ethanol results in decreased expression of and results in increased phosphorylation of NFKBIA protein],,,PMID:29339218,https://www.ncbi.nlm.nih.gov/pubmed/29339218,29339218,,
1352,1396567,101731,Comparative Toxicogenomics Database (CTD),beta-Patchoulene,C000614835,beta-patchoulene,https://ctdbase.org/detail.go?type=chem&acc=C000614835,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Beta-patchoulene analog inhibits the reaction [ethanol results in decreased expression of and results in increased phosphorylation of RELA protein],,,PMID:29339218,https://www.ncbi.nlm.nih.gov/pubmed/29339218,29339218,,
1353,1396568,101731,Comparative Toxicogenomics Database (CTD),beta-Patchoulene,C000614835,beta-patchoulene,https://ctdbase.org/detail.go?type=chem&acc=C000614835,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Beta-patchoulene analog inhibits the reaction [ethanol results in increased expression of TNF protein],,,PMID:29339218,https://www.ncbi.nlm.nih.gov/pubmed/29339218,29339218,,
1354,1396569,101798,DrugBank,Methyl alpha-D-mannopyranoside,DB01979,Methyl alpha-D-mannoside,https://www.drugbank.ca/drugs/DB01979,BE0004482,Mannose-binding protein C,https://www.drugbank.ca/bio_entities/BE0004482,P11226,Mannose-binding protein C,4153.0,MBL2,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
1355,1396570,101989,DrugBank,Androstenol,DB01889,"16,17-Androstene-3-Ol",https://www.drugbank.ca/drugs/DB01889,BE0003848,Nuclear receptor subfamily 1 group I member 3,https://www.drugbank.ca/bio_entities/BE0003848,Q14994,Nuclear receptor subfamily 1 group I member 3 ,9970.0,NR1I3,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1356,1396571,104150,Comparative Toxicogenomics Database (CTD),Ethyl Butylacetylaminopropionate,C462400,ethyl-3-(N-n-butyl-N-acetyl)aminopropionate,https://ctdbase.org/detail.go?type=chem&acc=C462400,107038089,OR136,https://ctdbase.org/detail.go?type=gene&acc=107038089,,,107038089.0,,7176.0,Culex quinquefasciatus (southern house mosquito),Ethyl-3-(N-n-butyl-N-acetyl)aminopropionate results in increased activity of [OR136 protein binds to ORCO protein],,,PMID:25349401,https://www.ncbi.nlm.nih.gov/pubmed/25349401,25349401,,
1357,1391902,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10116.0,Rattus norvegicus (Norway rat),Cobalt results in decreased activity of AHR protein,,,PMID:2160969,https://www.ncbi.nlm.nih.gov/pubmed/2160969,2160969,,
1358,1391903,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,50808,AK3,https://ctdbase.org/detail.go?type=gene&acc=50808,,,50808.0,AK3,9606.0,Homo sapiens (human),[tungsten carbide co-treated with cobalt] results in increased expression of AK3 mRNA,,,PMID:18078969,https://www.ncbi.nlm.nih.gov/pubmed/18078969,18078969,,
1359,1391904,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),[tungsten carbide binds to cobalt] which results in decreased expression of AKR1C1 mRNA,,,PMID:20105288,https://www.ncbi.nlm.nih.gov/pubmed/20105288,20105288,,
1360,1391905,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913.0,Bos taurus (cattle),Cobalt binds to ALB protein|myristic acid inhibits the reaction [cobalt binds to ALB protein],,,PMID:22519414,https://www.ncbi.nlm.nih.gov/pubmed/22519414,22519414,,
1361,1391906,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913.0,Bos taurus (cattle),[isoniazid analog binds to cobalt] which binds to ALB protein,,,PMID:22354161,https://www.ncbi.nlm.nih.gov/pubmed/22354161,22354161,,
1362,1391907,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606.0,Homo sapiens (human),Cobalt binds to ALB protein,,,PMID:17274600,https://www.ncbi.nlm.nih.gov/pubmed/17274600,17274600,,
1363,1391908,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606.0,Homo sapiens (human),[naproxen binds to cobalt] which binds to ALB protein,,,PMID:22178666,https://www.ncbi.nlm.nih.gov/pubmed/22178666,22178666,,
1364,1392019,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,216,ALDH1A1,https://ctdbase.org/detail.go?type=gene&acc=216,,,216.0,ALDH1A1,9606.0,Homo sapiens (human),[tungsten carbide binds to cobalt] which results in decreased expression of ALDH1A1 mRNA,,,PMID:20105288,https://www.ncbi.nlm.nih.gov/pubmed/20105288,20105288,,
1365,1392020,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,160428,ALDH1L2,https://ctdbase.org/detail.go?type=gene&acc=160428,,,160428.0,ALDH1L2,9606.0,Homo sapiens (human),[tungsten carbide co-treated with cobalt] results in decreased expression of ALDH1L2 mRNA,,,PMID:18078969,https://www.ncbi.nlm.nih.gov/pubmed/18078969,18078969,,
1366,1392021,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,54890,ALKBH5,https://ctdbase.org/detail.go?type=gene&acc=54890,,,54890.0,ALKBH5,9606.0,Homo sapiens (human),Cobalt results in decreased expression of ALKBH5 protein|cobalt results in increased expression of ALKBH5 mrna|cobalt results in decreased expression of ALKBH5 mRNA,,,PMID:32827984,https://www.ncbi.nlm.nih.gov/pubmed/32827984,32827984,,
1367,1392022,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,115701,ALPK2,https://ctdbase.org/detail.go?type=gene&acc=115701,,,115701.0,ALPK2,9606.0,Homo sapiens (human),[tungsten carbide co-treated with cobalt] results in decreased expression of ALPK2 mRNA,,,PMID:18078969,https://www.ncbi.nlm.nih.gov/pubmed/18078969,18078969,,
1368,1392023,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129.0,ANGPTL4,9606.0,Homo sapiens (human),[tungsten carbide binds to cobalt] which results in increased expression of ANGPTL4 mRNA,,,PMID:20105288,https://www.ncbi.nlm.nih.gov/pubmed/20105288,20105288,,
1369,1392024,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129.0,ANGPTL4,9606.0,Homo sapiens (human),[tungsten carbide co-treated with cobalt] results in increased expression of ANGPTL4 mRNA,,,PMID:18078969,https://www.ncbi.nlm.nih.gov/pubmed/18078969,18078969,,
1370,1392499,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Cobalt results in increased expression of CASP3 mRNA,,,PMID:26378417,https://www.ncbi.nlm.nih.gov/pubmed/26378417,26378417,,
1371,1392500,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),[tungsten co-treated with nickel co-treated with cobalt] results in decreased activity of CASP3 protein,,,PMID:20934443,https://www.ncbi.nlm.nih.gov/pubmed/20934443,20934443,,
1372,1392501,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,7955.0,Danio rerio (zebrafish),Cobalt results in increased expression of CASP9 mRNA,,,PMID:22983774,https://www.ncbi.nlm.nih.gov/pubmed/22983774,22983774,,
1373,1392502,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,7957.0,Carassius auratus (goldfish),Cobalt results in decreased activity of CAT protein,,,PMID:21777937|PMID:21996381,https://www.ncbi.nlm.nih.gov/pubmed/21777937|https://www.ncbi.nlm.nih.gov/pubmed/21996381,21777937|21996381,,
1374,1392503,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,7955.0,Danio rerio (zebrafish),Cobalt results in increased expression of CAT mRNA,,,PMID:22983774,https://www.ncbi.nlm.nih.gov/pubmed/22983774,22983774,,
1375,1392504,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Cobalt results in decreased activity of CAT protein,,,PMID:21968949,https://www.ncbi.nlm.nih.gov/pubmed/21968949,21968949,,
1376,1392505,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Cobalt results in decreased expression of CAT protein,,,PMID:16488005,https://www.ncbi.nlm.nih.gov/pubmed/16488005,16488005,,
1377,1392506,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),CAT protein inhibits the reaction [[tungsten carbide analog co-treated with cobalt analog] results in decreased expression of PDCD4 protein],,,PMID:23758151,https://www.ncbi.nlm.nih.gov/pubmed/23758151,23758151,,
1378,1392507,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),CAT protein inhibits the reaction [[[tungsten carbide co-treated with cobalt] results in increased localization of NFE2L2 protein] which results in increased expression of NQO1 mrna],,,PMID:20528745,https://www.ncbi.nlm.nih.gov/pubmed/20528745,20528745,,
1379,1392735,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,6354,CCL7,https://ctdbase.org/detail.go?type=gene&acc=6354,,,6354.0,CCL7,10090.0,Mus musculus (house mouse),TNF protein promotes the reaction [[zinc co-treated with nickel co-treated with cobalt co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mrna]|[zinc co-treated with nickel co-treated with cobalt co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA,,,PMID:23503329,https://www.ncbi.nlm.nih.gov/pubmed/23503329,23503329,,
1380,1392736,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,6355,CCL8,https://ctdbase.org/detail.go?type=gene&acc=6355,,,6355.0,CCL8,10090.0,Mus musculus (house mouse),TNF protein promotes the reaction [[zinc co-treated with nickel co-treated with cobalt co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in decreased expression of CCL8 mrna]|[zinc co-treated with nickel co-treated with cobalt co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in decreased expression of CCL8 mRNA,,,PMID:23503329,https://www.ncbi.nlm.nih.gov/pubmed/23503329,23503329,,
1381,1392737,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,20308,CCL9,https://ctdbase.org/detail.go?type=gene&acc=20308,,,20308.0,Ccl9,10090.0,Mus musculus (house mouse),[zinc co-treated with nickel co-treated with cobalt co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mrna|tnf protein promotes the reaction [[zinc co-treated with nickel co-treated with cobalt co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mrna],,,PMID:23503329,https://www.ncbi.nlm.nih.gov/pubmed/23503329,23503329,,
1382,1392738,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10116.0,Rattus norvegicus (Norway rat),Cobalt results in decreased expression of CCN2 mRNA,,,PMID:17967803,https://www.ncbi.nlm.nih.gov/pubmed/17967803,17967803,,
1383,1393228,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),TNF protein promotes the reaction [[zinc co-treated with nickel co-treated with cobalt co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL2 mrna]|[zinc co-treated with nickel co-treated with cobalt co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL2 mRNA,,,PMID:23503329,https://www.ncbi.nlm.nih.gov/pubmed/23503329,23503329,,
1384,1393229,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10116.0,Rattus norvegicus (Norway rat),[nickel co-treated with cobalt co-treated with tungsten] results in increased expression of CXCL2 protein,,,PMID:22198552,https://www.ncbi.nlm.nih.gov/pubmed/22198552,22198552,,
1385,1393230,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,6374,CXCL5,https://ctdbase.org/detail.go?type=gene&acc=6374,,,6374.0,CXCL5,10090.0,Mus musculus (house mouse),[zinc co-treated with nickel co-treated with cobalt co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mrna|tnf protein promotes the reaction [[zinc co-treated with nickel co-treated with cobalt co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mrna],,,PMID:23503329,https://www.ncbi.nlm.nih.gov/pubmed/23503329,23503329,,
1386,1393231,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Cobalt results in increased expression of CXCL8 mrna|cobalt results in increased secretion of CXCL8 protein,,,PMID:19132727,https://www.ncbi.nlm.nih.gov/pubmed/19132727,19132727,,
1387,1395104,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [[tungsten carbide co-treated with cobalt] results in increased phosphorylation of and results in increased activity of MAPK3 protein]|[tungsten carbide co-treated with cobalt] results in increased phosphorylation of and results in increased activity of MAPK3 protein,,,PMID:19747498,https://www.ncbi.nlm.nih.gov/pubmed/19747498,19747498,,
1388,1395105,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,9606.0,Homo sapiens (human),Cobalt results in increased expression of MDM2 mrna|tp53 protein affects the reaction [cobalt results in increased expression of MDM2 mrna],,,PMID:24068677,https://www.ncbi.nlm.nih.gov/pubmed/24068677,24068677,,
1389,1395106,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,55384,MEG3,https://ctdbase.org/detail.go?type=gene&acc=55384,,,55384.0,MEG3,10090.0,Mus musculus (house mouse),Cobalt results in increased expression of MEG3 mRNA,,,PMID:34468815,https://www.ncbi.nlm.nih.gov/pubmed/34468815,34468815,,
1390,1395107,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,4233,MET,https://ctdbase.org/detail.go?type=gene&acc=4233,,,4233.0,MET,9606.0,Homo sapiens (human),[tungsten carbide co-treated with cobalt] results in decreased expression of MET mRNA,,,PMID:18078969,https://www.ncbi.nlm.nih.gov/pubmed/18078969,18078969,,
1391,1395108,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,10988,METAP2,https://ctdbase.org/detail.go?type=gene&acc=10988,,,10988.0,METAP2,9606.0,Homo sapiens (human),Cobalt results in increased activity of METAP2 protein,,,PMID:15516829,https://www.ncbi.nlm.nih.gov/pubmed/15516829,15516829,,
1392,1395109,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,10988,METAP2,https://ctdbase.org/detail.go?type=gene&acc=10988,,,10988.0,METAP2,9606.0,Homo sapiens (human),METAP2 protein binds to cobalt,,,PMID:14534293,https://www.ncbi.nlm.nih.gov/pubmed/14534293,14534293,,
1393,1395110,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,56339,METTL3,https://ctdbase.org/detail.go?type=gene&acc=56339,,,56339.0,METTL3,9606.0,Homo sapiens (human),Cobalt results in decreased expression of METTL3 protein|cobalt results in decreased expression of METTL3 mRNA,,,PMID:32827984,https://www.ncbi.nlm.nih.gov/pubmed/32827984,32827984,,
1394,1396833,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),TNF protein promotes the reaction [kainic acid results in increased uptake of cobalt],,,PMID:15869941,https://www.ncbi.nlm.nih.gov/pubmed/15869941,15869941,,
1395,1396834,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),[nickel co-treated with cobalt co-treated with tungsten] results in increased expression of TNF protein,,,PMID:22198552,https://www.ncbi.nlm.nih.gov/pubmed/22198552,22198552,,
1396,1396835,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,7128,TNFAIP3,https://ctdbase.org/detail.go?type=gene&acc=7128,,,7128.0,TNFAIP3,9606.0,Homo sapiens (human),[tungsten carbide co-treated with cobalt] results in increased expression of TNFAIP3 mRNA,,,PMID:18078969,https://www.ncbi.nlm.nih.gov/pubmed/18078969,18078969,,
1397,1396836,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,7130,TNFAIP6,https://ctdbase.org/detail.go?type=gene&acc=7130,,,7130.0,TNFAIP6,9606.0,Homo sapiens (human),[tungsten carbide co-treated with cobalt] results in decreased expression of TNFAIP6 mRNA,,,PMID:18078969,https://www.ncbi.nlm.nih.gov/pubmed/18078969,18078969,,
1398,1396837,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606.0,Homo sapiens (human),[tungsten carbide co-treated with cobalt] results in increased expression of TNFRSF10B mRNA,,,PMID:18078969,https://www.ncbi.nlm.nih.gov/pubmed/18078969,18078969,,
1399,1396838,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,8742,TNFSF12,https://ctdbase.org/detail.go?type=gene&acc=8742,,,8742.0,TNFSF12,9606.0,Homo sapiens (human),[tungsten carbide co-treated with cobalt] results in decreased expression of TNFSF12 mRNA,,,PMID:18078969,https://www.ncbi.nlm.nih.gov/pubmed/18078969,18078969,,
1400,1396839,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,7134,TNNC1,https://ctdbase.org/detail.go?type=gene&acc=7134,,,7134.0,TNNC1,10090.0,Mus musculus (house mouse),Cobalt results in decreased expression of TNNC1 mRNA,,,PMID:34468815,https://www.ncbi.nlm.nih.gov/pubmed/34468815,34468815,,
1401,1397204,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,90637,ZFAND2A,https://ctdbase.org/detail.go?type=gene&acc=90637,,,90637.0,ZFAND2A,9606.0,Homo sapiens (human),[tungsten carbide co-treated with cobalt] results in increased expression of ZFAND2A mRNA,,,PMID:23052192,https://www.ncbi.nlm.nih.gov/pubmed/23052192,23052192,,
1402,1397050,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9075,CLDN2,https://ctdbase.org/detail.go?type=gene&acc=9075,,,9075.0,CLDN2,9606.0,Homo sapiens (human),Fulvestrant results in decreased methylation of CLDN2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1403,1397051,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,7122,CLDN5,https://ctdbase.org/detail.go?type=gene&acc=7122,,,7122.0,CLDN5,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of CLDN5 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1404,1397052,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,23274,CLEC16A,https://ctdbase.org/detail.go?type=gene&acc=23274,,,23274.0,CLEC16A,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of CLEC16A gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1405,1397053,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,51267,CLEC1A,https://ctdbase.org/detail.go?type=gene&acc=51267,,,51267.0,CLEC1A,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of CLEC1A gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1406,1397205,104741,Drug Gene Interaction database (DGIdb),Fulvestrant,,FULVESTRANT,https://www.dgidb.org/drugs/rxcui:282357,,FGFR2,https://www.dgidb.org/genes/hgnc:3689,,,2263.0,FGFR2,9606.0,Homo sapiens (human),,,,,,,,
1407,1397206,104741,Drug Gene Interaction database (DGIdb),Fulvestrant,,FULVESTRANT,https://www.dgidb.org/drugs/rxcui:282357,,PIK3CA,https://www.dgidb.org/genes/hgnc:8975,,,5290.0,PIK3CA,9606.0,Homo sapiens (human),,,,,,,,
1408,1397207,104741,Drug Gene Interaction database (DGIdb),Fulvestrant,,FULVESTRANT,https://www.dgidb.org/drugs/rxcui:282357,,EML4,https://www.dgidb.org/genes/hgnc:1316,,,27436.0,EML4,9606.0,Homo sapiens (human),,,,,,,,
1409,1397208,104741,Drug Gene Interaction database (DGIdb),Fulvestrant,,FULVESTRANT,https://www.dgidb.org/drugs/rxcui:282357,,FGFR2,https://www.dgidb.org/genes/hgnc:3689,,,2263.0,FGFR2,9606.0,Homo sapiens (human),,,,,,,,
1410,1397209,104741,Drug Gene Interaction database (DGIdb),Fulvestrant,,FULVESTRANT,https://www.dgidb.org/drugs/rxcui:282357,,EPHX2,https://www.dgidb.org/genes/hgnc:3402,,,2053.0,EPHX2,9606.0,Homo sapiens (human),,,,,,,,
1411,1397775,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1293,COL6A3,https://ctdbase.org/detail.go?type=gene&acc=1293,,,1293.0,COL6A3,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] affects the methylation of COL6A3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1412,1399435,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,6387,CXCL12,https://ctdbase.org/detail.go?type=gene&acc=6387,,,6387.0,CXCL12,9606.0,Homo sapiens (human),"Fulvestrant inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of CXCL12 mrna]|fulvestrant inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased secretion of CXCL12 protein]",,,PMID:26435001,https://www.ncbi.nlm.nih.gov/pubmed/26435001,26435001,,
1413,1399995,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,140634,CYP1A,https://ctdbase.org/detail.go?type=gene&acc=140634,,,140634.0,cyp1a,56613.0,Poeciliopsis lucida (clearfin livebearer),Fulvestrant results in increased expression of CYP1A mRNA,,,PMID:23064032,https://www.ncbi.nlm.nih.gov/pubmed/23064032,23064032,,
1414,1399996,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Fulvestrant promotes the reaction [biochanin A results in increased expression of CYP1A1 mrna]|fulvestrant promotes the reaction [formononetin results in increased expression of CYP1A1 mrna]|fulvestrant promotes the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 mrna]|fulvestrant inhibits the reaction [genistein results in decreased expression of CYP1A1 mrna]|fulvestrant inhibits the reaction [daidzein results in decreased expression of CYP1A1 mrna],,,PMID:28985473,https://www.ncbi.nlm.nih.gov/pubmed/28985473,28985473,,
1415,1399997,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in decreased expression of CYP1A1 mrna],,,PMID:28985473|PMID:31646340,https://www.ncbi.nlm.nih.gov/pubmed/28985473|https://www.ncbi.nlm.nih.gov/pubmed/31646340,28985473|31646340,,
1416,1399998,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in increased expression of CYP1A1 mrna],,,PMID:10619402|PMID:28618207,https://www.ncbi.nlm.nih.gov/pubmed/10619402|https://www.ncbi.nlm.nih.gov/pubmed/28618207,10619402|28618207,,
1417,1399999,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in increased expression of CYP1A1 protein],,,PMID:28618207,https://www.ncbi.nlm.nih.gov/pubmed/28618207,28618207,,
1418,1400000,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1A1 promoter]],,,PMID:19460354,https://www.ncbi.nlm.nih.gov/pubmed/19460354,19460354,,
1419,1400001,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),"Fulvestrant promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 mrna]",,,PMID:21513769,https://www.ncbi.nlm.nih.gov/pubmed/21513769,21513769,,
1420,1400002,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),[fulvestrant results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA,,,PMID:19901195,https://www.ncbi.nlm.nih.gov/pubmed/19901195,19901195,,
1421,1400474,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10238,DCAF7,https://ctdbase.org/detail.go?type=gene&acc=10238,,,10238.0,DCAF7,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of DCAF7 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1422,1401052,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,8525,DGKZ,https://ctdbase.org/detail.go?type=gene&acc=8525,,,8525.0,DGKZ,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of DGKZ gene|[bisphenol F co-treated with fulvestrant] results in increased methylation of DGKZ gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1423,1401053,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of DHFR gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1424,1401054,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,50846,DHH,https://ctdbase.org/detail.go?type=gene&acc=50846,,,50846.0,DHH,10116.0,Rattus norvegicus (Norway rat),Fulvestrant inhibits the reaction [ethinyl estradiol results in decreased expression of DHH mrna],,,PMID:17109907,https://www.ncbi.nlm.nih.gov/pubmed/17109907,17109907,,
1425,1401055,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9249,DHRS3,https://ctdbase.org/detail.go?type=gene&acc=9249,,,9249.0,DHRS3,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of DHRS3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1426,1401056,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,54505,DHX29,https://ctdbase.org/detail.go?type=gene&acc=54505,,,54505.0,DHX29,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of DHX29 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1427,1401057,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,55760,DHX32,https://ctdbase.org/detail.go?type=gene&acc=55760,,,55760.0,DHX32,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of DHX32 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1428,1401058,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,56919,DHX33,https://ctdbase.org/detail.go?type=gene&acc=56919,,,56919.0,DHX33,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of DHX33 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1429,1401059,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1660,DHX9,https://ctdbase.org/detail.go?type=gene&acc=1660,,,1660.0,DHX9,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of DHX9 mRNA,,,PMID:16514628,https://www.ncbi.nlm.nih.gov/pubmed/16514628,16514628,,
1430,1401060,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1729,DIAPH1,https://ctdbase.org/detail.go?type=gene&acc=1729,,,1729.0,DIAPH1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of DIAPH1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1431,1401061,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,11083,DIDO1,https://ctdbase.org/detail.go?type=gene&acc=11083,,,11083.0,DIDO1,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of DIDO1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1432,1401177,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,79742,DIPK2B,https://ctdbase.org/detail.go?type=gene&acc=79742,,,79742.0,DIPK2B,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of DIPK2B gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1433,1401178,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,54769,DIRAS2,https://ctdbase.org/detail.go?type=gene&acc=54769,,,54769.0,DIRAS2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of DIRAS2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1434,1401179,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,729582,DIRC3,https://ctdbase.org/detail.go?type=gene&acc=729582,,,729582.0,DIRC3,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in decreased methylation of DIRC3 gene|[bisphenol A co-treated with fulvestrant] results in increased methylation of DIRC3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1435,1401180,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,27185,DISC1,https://ctdbase.org/detail.go?type=gene&acc=27185,,,27185.0,DISC1,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in increased methylation of DISC1 gene|[bisphenol A co-treated with fulvestrant] results in increased methylation of DISC1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1436,1401181,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,57540,DISP3,https://ctdbase.org/detail.go?type=gene&acc=57540,,,57540.0,DISP3,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of DISP3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1437,1401182,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,85458,DIXDC1,https://ctdbase.org/detail.go?type=gene&acc=85458,,,85458.0,DIXDC1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of DIXDC1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1438,1401779,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1789,DNMT3B,https://ctdbase.org/detail.go?type=gene&acc=1789,,,1789.0,DNMT3B,10090.0,Mus musculus (house mouse),Fulvestrant inhibits the reaction [bisphenol A results in increased expression of DNMT3B mrna],,,PMID:30892605,https://www.ncbi.nlm.nih.gov/pubmed/30892605,30892605,,
1439,1401780,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,29947,DNMT3L,https://ctdbase.org/detail.go?type=gene&acc=29947,,,29947.0,DNMT3L,10090.0,Mus musculus (house mouse),Fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT3L mrna],,,PMID:22131059,https://www.ncbi.nlm.nih.gov/pubmed/22131059,22131059,,
1440,1401781,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1791,DNTT,https://ctdbase.org/detail.go?type=gene&acc=1791,,,1791.0,DNTT,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in decreased methylation of DNTT gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1441,1401782,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,390213,DOC2GP,https://ctdbase.org/detail.go?type=gene&acc=390213,,,390213.0,DOC2GP,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of DOC2GP gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1442,1401783,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1793,DOCK1,https://ctdbase.org/detail.go?type=gene&acc=1793,,,1793.0,DOCK1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of DOCK1 gene|[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in increased methylation of DOCK1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1443,1401784,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,55619,DOCK10,https://ctdbase.org/detail.go?type=gene&acc=55619,,,55619.0,DOCK10,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of DOCK10 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1444,1401785,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,139818,DOCK11,https://ctdbase.org/detail.go?type=gene&acc=139818,,,139818.0,DOCK11,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of DOCK11 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1445,1401786,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,57572,DOCK6,https://ctdbase.org/detail.go?type=gene&acc=57572,,,57572.0,DOCK6,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in increased methylation of DOCK6 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1446,1401787,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,23348,DOCK9,https://ctdbase.org/detail.go?type=gene&acc=23348,,,23348.0,DOCK9,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of DOCK9 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1447,1401788,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9046,DOK2,https://ctdbase.org/detail.go?type=gene&acc=9046,,,9046.0,DOK2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of DOK2 gene|fulvestrant results in increased methylation of DOK2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1448,1403319,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,60481,ELOVL5,https://ctdbase.org/detail.go?type=gene&acc=60481,,,60481.0,ELOVL5,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ELOVL5 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1449,1403320,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,60481,ELOVL5,https://ctdbase.org/detail.go?type=gene&acc=60481,,,60481.0,ELOVL5,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of ELOVL5 mRNA,,,PMID:16514628,https://www.ncbi.nlm.nih.gov/pubmed/16514628,16514628,,
1450,1403321,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,54859,ELP6,https://ctdbase.org/detail.go?type=gene&acc=54859,,,54859.0,ELP6,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ELP6 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1451,1403322,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,647121,EMBP1,https://ctdbase.org/detail.go?type=gene&acc=647121,,,647121.0,EMBP1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of EMBP1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1452,1403323,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,51705,EMCN,https://ctdbase.org/detail.go?type=gene&acc=51705,,,51705.0,EMCN,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of EMCN gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1453,1403324,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,197342,EME2,https://ctdbase.org/detail.go?type=gene&acc=197342,,,197342.0,EME2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of EME2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1454,1403325,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2009,EML1,https://ctdbase.org/detail.go?type=gene&acc=2009,,,2009.0,EML1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] affects the methylation of EML1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1455,1403326,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,161436,EML5,https://ctdbase.org/detail.go?type=gene&acc=161436,,,161436.0,EML5,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of EML5 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1456,1403327,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,400954,EML6,https://ctdbase.org/detail.go?type=gene&acc=400954,,,400954.0,EML6,9606.0,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in decreased methylation of EML6 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1457,1404128,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Fulvestrant affects the expression of ESR1 mRNA,,,PMID:20543978,https://www.ncbi.nlm.nih.gov/pubmed/20543978,20543978,,
1458,1404129,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Fulvestrant affects the folding of and affects the activity of ESR1 protein,,,PMID:17299137,https://www.ncbi.nlm.nih.gov/pubmed/17299137,17299137,,
1459,1404130,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Fulvestrant binds to and results in decreased activity of ESR1 protein,,,PMID:15537743|PMID:18976723|PMID:20211987|PMID:20362049|PMID:20435135|PMID:23562765|PMID:25012808|PMID:25752796|PMID:26865669,https://www.ncbi.nlm.nih.gov/pubmed/15537743|https://www.ncbi.nlm.nih.gov/pubmed/18976723|https://www.ncbi.nlm.nih.gov/pubmed/20211987|https://www.ncbi.nlm.nih.gov/pubmed/20362049|https://www.ncbi.nlm.nih.gov/pubmed/20435135|https://www.ncbi.nlm.nih.gov/pubmed/23562765|https://www.ncbi.nlm.nih.gov/pubmed/25012808|https://www.ncbi.nlm.nih.gov/pubmed/25752796|https://www.ncbi.nlm.nih.gov/pubmed/26865669,15537743|18976723|20211987|20362049|20435135|23562765|25012808|25752796|26865669,,
1460,1397210,104748,BindingDB,Hydrogen sulfite,26991,CHEMBL1689285,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26991,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),89000000,PMID:19128966|DOI:10.1016/j.bmcl.2008.12.082,https://www.ncbi.nlm.nih.gov/pubmed/19128966|https://doi.org/10.1016/j.bmcl.2008.12.082,19128966,10.1016/j.bmcl.2008.12.082,
1461,1397211,104748,BindingDB,Hydrogen sulfite,26991,CHEMBL1689285,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26991,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),18000000,PMID:19128966|DOI:10.1016/j.bmcl.2008.12.082,https://www.ncbi.nlm.nih.gov/pubmed/19128966|https://doi.org/10.1016/j.bmcl.2008.12.082,19128966,10.1016/j.bmcl.2008.12.082,
1462,1397317,104748,BindingDB,Hydrogen sulfite,26991,CHEMBL1689285,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26991,2930,Carbonic anhydrase 15 [19-324],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2930,Q99N23,Carbonic anhydrase 15,80733.0,Car15,10090.0,Mus musculus (house mouse),,Ki (nM),9700,PMID:19128966|DOI:10.1016/j.bmcl.2008.12.082,https://www.ncbi.nlm.nih.gov/pubmed/19128966|https://doi.org/10.1016/j.bmcl.2008.12.082,19128966,10.1016/j.bmcl.2008.12.082,
1463,1397318,104748,BindingDB,Hydrogen sulfite,26991,CHEMBL1689285,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26991,1247,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1247,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),,Ki (nM),13200000,PMID:19128966|DOI:10.1016/j.bmcl.2008.12.082,https://www.ncbi.nlm.nih.gov/pubmed/19128966|https://doi.org/10.1016/j.bmcl.2008.12.082,19128966,10.1016/j.bmcl.2008.12.082,
1464,1397922,104820,Toxin and Toxin Target Database (T3DB),Arsenocholine,T3D0302,Arsenocholine,http://www.t3db.ca/toxins/T3D0302,BE0001391,Tubulin alpha-4A chain,http://www.t3db.ca/biodb/bio_entities/BE0001391,P68366,Tubulin alpha-4A chain,7277.0,TUBA4A,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
1465,1397923,104820,Toxin and Toxin Target Database (T3DB),Arsenocholine,T3D0302,Arsenocholine,http://www.t3db.ca/toxins/T3D0302,BE0001359,Tubulin alpha-8 chain,http://www.t3db.ca/biodb/bio_entities/BE0001359,Q9NY65,Tubulin alpha-8 chain,51807.0,TUBA8,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
1466,1397924,104820,Toxin and Toxin Target Database (T3DB),Arsenocholine,T3D0302,Arsenocholine,http://www.t3db.ca/toxins/T3D0302,BE0000143,Tubulin beta chain,http://www.t3db.ca/biodb/bio_entities/BE0000143,P07437,Tubulin beta chain,203068.0,TUBB,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
1467,1397925,104820,Toxin and Toxin Target Database (T3DB),Arsenocholine,T3D0302,Arsenocholine,http://www.t3db.ca/toxins/T3D0302,BE0000026,Tubulin beta-1 chain,http://www.t3db.ca/biodb/bio_entities/BE0000026,Q9H4B7,Tubulin beta-1 chain,81027.0,TUBB1,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
1468,1397926,104820,Toxin and Toxin Target Database (T3DB),Arsenocholine,T3D0302,Arsenocholine,http://www.t3db.ca/toxins/T3D0302,BE0003400,Tubulin beta-2A chain,http://www.t3db.ca/biodb/bio_entities/BE0003400,Q13885,Tubulin beta-2A chain,7280.0,TUBB2A,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
1469,1397927,104820,Toxin and Toxin Target Database (T3DB),Arsenocholine,T3D0302,Arsenocholine,http://www.t3db.ca/toxins/T3D0302,BE0003401,Tubulin beta-2B chain,http://www.t3db.ca/biodb/bio_entities/BE0003401,Q9BVA1,Tubulin beta-2B chain,347733.0,TUBB2B,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
1470,1397928,104820,Toxin and Toxin Target Database (T3DB),Arsenocholine,T3D0302,Arsenocholine,http://www.t3db.ca/toxins/T3D0302,BE0001415,Tubulin beta-3 chain,http://www.t3db.ca/biodb/bio_entities/BE0001415,Q13509,Tubulin beta-3 chain,10381.0,TUBB3,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
1471,1398270,104827,Drug Gene Interaction database (DGIdb),Methylene Blue trihydrate,,METHYLENE BLUE,https://www.dgidb.org/drugs/chembl:CHEMBL550495,,RECQL,https://www.dgidb.org/genes/hgnc:9948,,,5965.0,RECQL,9606.0,Homo sapiens (human),,,,,,,,
1472,1398271,104827,Drug Gene Interaction database (DGIdb),Methylene Blue trihydrate,,METHYLENE BLUE,https://www.dgidb.org/drugs/chembl:CHEMBL550495,,ALDH1A1,https://www.dgidb.org/genes/hgnc:402,,,216.0,ALDH1A1,9606.0,Homo sapiens (human),,,,,,,,
1473,1398272,104827,Drug Gene Interaction database (DGIdb),Methylene Blue trihydrate,,METHYLENE BLUE,https://www.dgidb.org/drugs/chembl:CHEMBL550495,,THRB,https://www.dgidb.org/genes/hgnc:11799,,,7068.0,THRB,9606.0,Homo sapiens (human),,,,,,,,
1474,1400904,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,7436,VLDLR,https://ctdbase.org/detail.go?type=gene&acc=7436,,,7436.0,VLDLR,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of VLDLR mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1475,1400905,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,80232,WDR26,https://ctdbase.org/detail.go?type=gene&acc=80232,,,80232.0,WDR26,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of WDR26 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1476,1400906,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,23335,WDR7,https://ctdbase.org/detail.go?type=gene&acc=23335,,,23335.0,WDR7,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in decreased expression of WDR7 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1477,1400907,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,26118,WSB1,https://ctdbase.org/detail.go?type=gene&acc=26118,,,26118.0,WSB1,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of WSB1 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1478,1400908,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,11059,WWP1,https://ctdbase.org/detail.go?type=gene&acc=11059,,,11059.0,WWP1,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of WWP1 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1479,1400909,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,25937,WWTR1,https://ctdbase.org/detail.go?type=gene&acc=25937,,,25937.0,WWTR1,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of WWTR1 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1480,1401622,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1111,CHEK1,https://ctdbase.org/detail.go?type=gene&acc=1111,,,1111.0,CHEK1,9606.0,Homo sapiens (human),Rimonabant results in decreased phosphorylation of CHEK1 protein,,,PMID:19479993,https://www.ncbi.nlm.nih.gov/pubmed/19479993,19479993,,
1481,1401623,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,25932,CLIC4,https://ctdbase.org/detail.go?type=gene&acc=25932,,,25932.0,CLIC4,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of CLIC4 mrna]|rimonabant affects the expression of CLIC4 mRNA,,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1482,1401624,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1213,CLTC,https://ctdbase.org/detail.go?type=gene&acc=1213,,,1213.0,CLTC,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of CLTC mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1483,1401625,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,23019,CNOT1,https://ctdbase.org/detail.go?type=gene&acc=23019,,,23019.0,CNOT1,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of CNOT1 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1484,1402085,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10116.0,Rattus norvegicus (Norway rat),Rimonabant inhibits the reaction [dronabinol results in increased activity of CNR1 protein],,,PMID:11517236,https://www.ncbi.nlm.nih.gov/pubmed/11517236,11517236,,
1485,1402086,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10116.0,Rattus norvegicus (Norway rat),Rimonabant results in decreased activity of CNR1 protein,,,PMID:26558620,https://www.ncbi.nlm.nih.gov/pubmed/26558620,26558620,,
1486,1402087,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,9606.0,Homo sapiens (human),Rimonabant binds to and affects the activity of CNR1 protein,,,PMID:17220538,https://www.ncbi.nlm.nih.gov/pubmed/17220538,17220538,,
1487,1402088,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1525,CXADR,https://ctdbase.org/detail.go?type=gene&acc=1525,,,1525.0,CXADR,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of CXADR mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1488,1402089,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10090.0,Mus musculus (house mouse),"Rimonabant inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CXCL1]",,,PMID:32832534,https://www.ncbi.nlm.nih.gov/pubmed/32832534,32832534,,
1489,1402090,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627.0,CXCL10,10090.0,Mus musculus (house mouse),"Rimonabant inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CXCL10]",,,PMID:32832534,https://www.ncbi.nlm.nih.gov/pubmed/32832534,32832534,,
1490,1402458,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1803,DPP4,https://ctdbase.org/detail.go?type=gene&acc=1803,,,1803.0,DPP4,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of DPP4 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1491,1402459,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1810,DR1,https://ctdbase.org/detail.go?type=gene&acc=1810,,,1810.0,DR1,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of DR1 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1492,1402460,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1781,DYNC1I2,https://ctdbase.org/detail.go?type=gene&acc=1781,,,1781.0,DYNC1I2,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of DYNC1I2 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1493,1402461,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,9695,EDEM1,https://ctdbase.org/detail.go?type=gene&acc=9695,,,9695.0,EDEM1,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of EDEM1 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1494,1402462,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1946,EFNA5,https://ctdbase.org/detail.go?type=gene&acc=1946,,,1946.0,EFNA5,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of EFNA5 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1495,1402463,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,10919,EHMT2,https://ctdbase.org/detail.go?type=gene&acc=10919,,,10919.0,EHMT2,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [ethanol promotes the reaction [EHMT2 protein binds to RAC1 promoter]],,,PMID:30143782,https://www.ncbi.nlm.nih.gov/pubmed/30143782,30143782,,
1496,1402464,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,1982,EIF4G2,https://ctdbase.org/detail.go?type=gene&acc=1982,,,1982.0,EIF4G2,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in increased expression of EIF4G2 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1497,1403040,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,9290,GPR55,https://ctdbase.org/detail.go?type=gene&acc=9290,,,9290.0,GPR55,9606.0,Homo sapiens (human),Rimonabant binds to and results in increased activity of GPR55 protein,,,PMID:17876302,https://www.ncbi.nlm.nih.gov/pubmed/17876302,17876302,,
1498,1403041,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,9606.0,Homo sapiens (human),Rimonabant results in decreased expression of GPT protein,,,PMID:28705172,https://www.ncbi.nlm.nih.gov/pubmed/28705172,28705172,,
1499,1403042,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Rimonabant results in decreased expression of GPT protein,,,PMID:30365523,https://www.ncbi.nlm.nih.gov/pubmed/30365523,30365523,,
1500,1403043,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,2888,GRB14,https://ctdbase.org/detail.go?type=gene&acc=2888,,,2888.0,GRB14,10090.0,Mus musculus (house mouse),Rimonabant affects the expression of GRB14 mrna|rimonabant inhibits the reaction [dietary fats results in increased expression of GRB14 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
1501,1457736,105101,Comparative Toxicogenomics Database (CTD),"2,3,4,5-Tetrachloro-4'-biphenylol",C104006,"2',3',4',5'-tetrachloro-4-biphenylol",https://ctdbase.org/detail.go?type=chem&acc=C104006,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),"2',3',4',5'-tetrachloro-4-biphenylol binds to ESR2 protein|2',3',4',5'-tetrachloro-4-biphenylol promotes the reaction [ESR2 protein binds to NCOA2 protein]|2',3',4',5'-tetrachloro-4-biphenylol promotes the reaction [ESR2 protein binds to NCOA1 protein]|2',3',4',5'-tetrachloro-4-biphenylol inhibits the reaction [estradiol binds to ESR2 protein]",,,PMID:10964929,https://www.ncbi.nlm.nih.gov/pubmed/10964929,10964929,,
1502,1457737,105101,Comparative Toxicogenomics Database (CTD),"2,3,4,5-Tetrachloro-4'-biphenylol",C104006,"2',3',4',5'-tetrachloro-4-biphenylol",https://ctdbase.org/detail.go?type=chem&acc=C104006,8648,NCOA1,https://ctdbase.org/detail.go?type=gene&acc=8648,,,8648.0,NCOA1,9606.0,Homo sapiens (human),"2',3',4',5'-tetrachloro-4-biphenylol promotes the reaction [ESR2 protein binds to NCOA1 protein]",,,PMID:10964929,https://www.ncbi.nlm.nih.gov/pubmed/10964929,10964929,,
1503,1457738,105101,Comparative Toxicogenomics Database (CTD),"2,3,4,5-Tetrachloro-4'-biphenylol",C104006,"2',3',4',5'-tetrachloro-4-biphenylol",https://ctdbase.org/detail.go?type=chem&acc=C104006,10499,NCOA2,https://ctdbase.org/detail.go?type=gene&acc=10499,,,10499.0,NCOA2,9606.0,Homo sapiens (human),"2',3',4',5'-tetrachloro-4-biphenylol promotes the reaction [ESR2 protein binds to NCOA2 protein]",,,PMID:10964929,https://www.ncbi.nlm.nih.gov/pubmed/10964929,10964929,,
1504,1449609,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Glucose results in increased expression of RELA mrna|quercetin inhibits the reaction [glucose results in increased expression of RELA mrna]|quercetin inhibits the reaction [glucose results in increased expression of RELA protein],,,PMID:23770986,https://www.ncbi.nlm.nih.gov/pubmed/23770986,23770986,,
1505,1449938,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,116028,RMI2,https://ctdbase.org/detail.go?type=gene&acc=116028,,,116028.0,RMI2,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in increased expression of RMI2 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1506,1449939,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,64795,RMND5A,https://ctdbase.org/detail.go?type=gene&acc=64795,,,64795.0,RMND5A,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RMND5A mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1507,1449940,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,64777,RMND5B,https://ctdbase.org/detail.go?type=gene&acc=64777,,,64777.0,RMND5B,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of RMND5B mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1508,1449941,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6041,RNASEL,https://ctdbase.org/detail.go?type=gene&acc=6041,,,6041.0,RNASEL,9606.0,Homo sapiens (human),"[2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein] which results in increased uptake of glucose",,,PMID:24651439,https://www.ncbi.nlm.nih.gov/pubmed/24651439,24651439,,
1509,1449942,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,68195,RNASET2B,https://ctdbase.org/detail.go?type=gene&acc=68195,,,68195.0,Rnaset2b,10090.0,Mus musculus (house mouse),[INS protein co-treated with glucose] results in increased expression of RNASET2B mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1510,1449943,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,55298,RNF121,https://ctdbase.org/detail.go?type=gene&acc=55298,,,55298.0,RNF121,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RNF121 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1511,1449944,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,9604,RNF14,https://ctdbase.org/detail.go?type=gene&acc=9604,,,9604.0,RNF14,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RNF14 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1512,1449945,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,9781,RNF144A,https://ctdbase.org/detail.go?type=gene&acc=9781,,,9781.0,RNF144A,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RNF144A mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1513,1450312,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6168,RPL37A,https://ctdbase.org/detail.go?type=gene&acc=6168,,,6168.0,RPL37A,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL37A mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1514,1450313,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6169,RPL38,https://ctdbase.org/detail.go?type=gene&acc=6169,,,6169.0,RPL38,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL38 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1515,1450314,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6124,RPL4,https://ctdbase.org/detail.go?type=gene&acc=6124,,,6124.0,RPL4,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL4 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1516,1450315,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6125,RPL5,https://ctdbase.org/detail.go?type=gene&acc=6125,,,6125.0,RPL5,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL5 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1517,1450316,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6129,RPL7,https://ctdbase.org/detail.go?type=gene&acc=6129,,,6129.0,RPL7,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL7 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1518,1450317,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,194905,RPL9-PS1,https://ctdbase.org/detail.go?type=gene&acc=194905,,,194905.0,Rpl9-ps1,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of RPL9-PS1 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1519,1450318,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6176,RPLP1,https://ctdbase.org/detail.go?type=gene&acc=6176,,,6176.0,RPLP1,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPLP1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1520,1450952,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,20210,SAA3,https://ctdbase.org/detail.go?type=gene&acc=20210,,,20210.0,Saa3,10090.0,Mus musculus (house mouse),Glucose results in increased expression of SAA3 mRNA,,,PMID:16805838,https://www.ncbi.nlm.nih.gov/pubmed/16805838,16805838,,
1521,1451920,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6401,SELE,https://ctdbase.org/detail.go?type=gene&acc=6401,,,6401.0,SELE,9606.0,Homo sapiens (human),Polyphenols inhibits the reaction [glucose results in increased expression of SELE mrna],,,PMID:21682256,https://www.ncbi.nlm.nih.gov/pubmed/21682256,21682256,,
1522,1452673,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,9869,SETDB1,https://ctdbase.org/detail.go?type=gene&acc=9869,,,9869.0,SETDB1,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of SETDB1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1523,1452674,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,10992,SF3B2,https://ctdbase.org/detail.go?type=gene&acc=10992,,,10992.0,SF3B2,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of SF3B2 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1524,1452675,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,10262,SF3B4,https://ctdbase.org/detail.go?type=gene&acc=10262,,,10262.0,SF3B4,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of SF3B4 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1525,1452676,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2810,SFN,https://ctdbase.org/detail.go?type=gene&acc=2810,,,2810.0,SFN,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of SFN mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1526,1452677,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6421,SFPQ,https://ctdbase.org/detail.go?type=gene&acc=6421,,,6421.0,SFPQ,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of SFPQ mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1527,1452678,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6423,SFRP2,https://ctdbase.org/detail.go?type=gene&acc=6423,,,6423.0,SFRP2,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of SFRP2 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1528,1452679,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6441,SFTPD,https://ctdbase.org/detail.go?type=gene&acc=6441,,,6441.0,SFTPD,9606.0,Homo sapiens (human),Glucose results in decreased expression of SFTPD mRNA,,,PMID:32942007,https://www.ncbi.nlm.nih.gov/pubmed/32942007,32942007,,
1529,1452680,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,8910,SGCE,https://ctdbase.org/detail.go?type=gene&acc=8910,,,8910.0,SGCE,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of SGCE mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1530,1452681,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6446,SGK1,https://ctdbase.org/detail.go?type=gene&acc=6446,,,6446.0,SGK1,10090.0,Mus musculus (house mouse),Glucose results in increased expression of SGK1 mRNA,,,PMID:17178593,https://www.ncbi.nlm.nih.gov/pubmed/17178593,17178593,,
1531,1452682,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6446,SGK1,https://ctdbase.org/detail.go?type=gene&acc=6446,,,6446.0,SGK1,10116.0,Rattus norvegicus (Norway rat),Glucose results in decreased expression of SGK1 mrna|glucose results in decreased expression of SGK1 protein,,,PMID:31729781,https://www.ncbi.nlm.nih.gov/pubmed/31729781,31729781,,
1532,1452868,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,10110,SGK2,https://ctdbase.org/detail.go?type=gene&acc=10110,,,10110.0,SGK2,9606.0,Homo sapiens (human),SGK2 mutant form inhibits the reaction [[simvastatin co-treated with NR1I2 protein] results in increased secretion of glucose],,,PMID:24204015,https://www.ncbi.nlm.nih.gov/pubmed/24204015,24204015,,
1533,1452869,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,81537,SGPP1,https://ctdbase.org/detail.go?type=gene&acc=81537,,,81537.0,SGPP1,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of SGPP1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1534,1454298,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606.0,Homo sapiens (human),Glucose results in decreased activity of SIRT1 protein,,,PMID:24894401,https://www.ncbi.nlm.nih.gov/pubmed/24894401,24894401,,
1535,1454299,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,23410,SIRT3,https://ctdbase.org/detail.go?type=gene&acc=23410,,,23410.0,SIRT3,9606.0,Homo sapiens (human),SIRT3 protein inhibits the reaction [glucose results in increased expression of GLB1 protein]|sirt3 protein inhibits the reaction [glucose results in increased expression of CDKN2A protein alternative form]|glucose deficiency results in increased expression of SIRT3 protein|sirt3 protein inhibits the reaction [glucose results in increased expression of SOD2 protein]|sirt3 protein inhibits the reaction [glucose results in increased expression of CAT protein]|sirt3 protein inhibits the reaction [glucose results in increased acetylation of FOXO1 protein],,,PMID:23494737,https://www.ncbi.nlm.nih.gov/pubmed/23494737,23494737,,
1536,1454300,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,23410,SIRT3,https://ctdbase.org/detail.go?type=gene&acc=23410,,,23410.0,SIRT3,9606.0,Homo sapiens (human),Polyethylene glycol loxenatide inhibits the reaction [glucose results in decreased expression of SIRT3 protein]|glucose results in decreased expression of SIRT3 protein,,,PMID:37417536,https://www.ncbi.nlm.nih.gov/pubmed/37417536,37417536,,
1537,1454301,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,23410,SIRT3,https://ctdbase.org/detail.go?type=gene&acc=23410,,,23410.0,SIRT3,10090.0,Mus musculus (house mouse),SIRT3 protein inhibits the reaction [sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of glucose]],,,PMID:25979314,https://www.ncbi.nlm.nih.gov/pubmed/25979314,25979314,,
1538,1454302,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,23409,SIRT4,https://ctdbase.org/detail.go?type=gene&acc=23409,,,23409.0,SIRT4,10116.0,Rattus norvegicus (Norway rat),Glucose affects the expression of SIRT4 protein|glucose results in decreased expression of SIRT4 mRNA,,,PMID:24349266,https://www.ncbi.nlm.nih.gov/pubmed/24349266,24349266,,
1539,1454303,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,51547,SIRT7,https://ctdbase.org/detail.go?type=gene&acc=51547,,,51547.0,SIRT7,10090.0,Mus musculus (house mouse),SIRT7 protein inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of BAX protein]|sirt7 protein inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of BBC3 protein]|[oxygen deficiency co-treated with glucose deficiency] results in increased expression of SIRT7 mrna|sirt7 protein inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased activity of CASP3 protein]|[oxygen deficiency co-treated with glucose deficiency] results in increased expression of SIRT7 protein|sirt7 protein inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of TRP53 protein]|sirt7 protein inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of TRP53 protein modified form],,,PMID:28675767,https://www.ncbi.nlm.nih.gov/pubmed/28675767,28675767,,
1540,1454304,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,27240,SIT1,https://ctdbase.org/detail.go?type=gene&acc=27240,,,27240.0,SIT1,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of SIT1 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1541,1454701,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,26266,SLC13A4,https://ctdbase.org/detail.go?type=gene&acc=26266,,,26266.0,SLC13A4,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of SLC13A4 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1542,1454702,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6565,SLC15A2,https://ctdbase.org/detail.go?type=gene&acc=6565,,,6565.0,SLC15A2,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of SLC15A2 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1543,1454703,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,151473,SLC16A14,https://ctdbase.org/detail.go?type=gene&acc=151473,,,151473.0,SLC16A14,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of SLC16A14 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1544,1454704,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6567,SLC16A2,https://ctdbase.org/detail.go?type=gene&acc=6567,,,6567.0,SLC16A2,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of SLC16A2 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1545,1454705,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,9121,SLC16A5,https://ctdbase.org/detail.go?type=gene&acc=9121,,,9121.0,SLC16A5,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in decreased expression of SLC16A5 mrna]|glucose results in decreased expression of SLC16A5 mrna|glucose results in increased methylation of SLC16A5 gene,,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
1546,1454706,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,10246,SLC17A2,https://ctdbase.org/detail.go?type=gene&acc=10246,,,10246.0,SLC17A2,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of SLC17A2 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1547,1454707,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,246213,SLC17A8,https://ctdbase.org/detail.go?type=gene&acc=246213,,,246213.0,SLC17A8,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of SLC17A8 mrna|[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with herbicides] results in increased expression of SLC17A8 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1548,1454708,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6571,SLC18A2,https://ctdbase.org/detail.go?type=gene&acc=6571,,,6571.0,SLC18A2,10090.0,Mus musculus (house mouse),Glucose results in decreased expression of SLC18A2 mrna|fucoxanthin inhibits the reaction [glucose results in decreased expression of SLC18A2 mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
1549,1454709,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6507,SLC1A3,https://ctdbase.org/detail.go?type=gene&acc=6507,,,6507.0,SLC1A3,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [glucose results in decreased expression of SLC1A3 mrna]|resveratrol inhibits the reaction [glucose results in decreased expression of SLC1A3 protein]|glucose results in decreased expression of SLC1A3 protein|glucose results in decreased expression of SLC1A3 mRNA,,,PMID:26677078,https://www.ncbi.nlm.nih.gov/pubmed/26677078,26677078,,
1550,1458063,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,23642,SNHG1,https://ctdbase.org/detail.go?type=gene&acc=23642,,,23642.0,SNHG1,10090.0,Mus musculus (house mouse),SNHG1 affects the reaction [glucose results in increased expression of CCL2 protein]|snhg1 affects the reaction [glucose results in increased expression of TNF protein]|snhg1 affects the reaction [MIR27B mRNA affects the reaction [glucose results in increased expression of CCL2 protein]]|glucose results in increased expression of SNHG1 mrna|snhg1 affects the reaction [glucose results in increased expression of TNF mrna]|snhg1 affects the reaction [MIR27B mRNA affects the reaction [glucose results in increased expression of TNF protein]]|snhg1 affects the reaction [glucose results in increased expression of CCL2 mrna],,,PMID:36243327,https://www.ncbi.nlm.nih.gov/pubmed/36243327,36243327,,
1551,1458064,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,329369,SNHG7OS,https://ctdbase.org/detail.go?type=gene&acc=329369,,,329369.0,Snhg7os,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of SNHG7OS mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1552,1458065,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,677796,SNORA5C,https://ctdbase.org/detail.go?type=gene&acc=677796,,,677796.0,SNORA5C,10090.0,Mus musculus (house mouse),Glucose results in increased expression of SNORA5C mRNA,,,PMID:31525975,https://www.ncbi.nlm.nih.gov/pubmed/31525975,31525975,,
1553,1461154,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,57464,STRIP2,https://ctdbase.org/detail.go?type=gene&acc=57464,,,57464.0,STRIP2,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in increased expression of STRIP2 mrna]|glucose results in increased expression of STRIP2 mRNA,,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
1554,1461155,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6801,STRN,https://ctdbase.org/detail.go?type=gene&acc=6801,,,6801.0,STRN,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of STRN mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1555,1461156,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,201595,STT3B,https://ctdbase.org/detail.go?type=gene&acc=201595,,,201595.0,STT3B,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of STT3B mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1556,1461157,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,375057,STUM,https://ctdbase.org/detail.go?type=gene&acc=375057,,,375057.0,STUM,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with herbicides] results in increased expression of STUM mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1557,1461158,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,415117,STX19,https://ctdbase.org/detail.go?type=gene&acc=415117,,,415117.0,STX19,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in increased expression of STX19 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1558,1463923,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,9606.0,Homo sapiens (human),Glucose results in decreased expression of TLR4 protein,,,PMID:20200188,https://www.ncbi.nlm.nih.gov/pubmed/20200188,20200188,,
1559,1463924,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,9606.0,Homo sapiens (human),Phytic acid inhibits the reaction [glucose results in increased expression of TLR4 protein]|glucose results in increased expression of TLR4 protein,,,PMID:38000455,https://www.ncbi.nlm.nih.gov/pubmed/38000455,38000455,,
1560,1463925,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10090.0,Mus musculus (house mouse),"TLR4 affects the reaction [lipopolysaccharide, escherichia coli O111 B4 inhibits the reaction [glucose results in increased expression of INS2 mRNA alternative form]]|tlr4 affects the reaction [lipopolysaccharide, escherichia coli O111 B4 inhibits the reaction [glucose results in increased expression of MAFA mrna]]|tlr4 affects the reaction [lipopolysaccharide, escherichia coli O111 B4 inhibits the reaction [glucose results in increased expression of PDX1 mrna]]",,,PMID:22558381,https://www.ncbi.nlm.nih.gov/pubmed/22558381,22558381,,
1561,1463926,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10116.0,Rattus norvegicus (Norway rat),Glucose results in increased expression of TLR4 protein|artesunate inhibits the reaction [glucose results in increased expression of TLR4 protein],,,PMID:30031708,https://www.ncbi.nlm.nih.gov/pubmed/30031708,30031708,,
1562,1464605,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Rutin inhibits the reaction [glucose results in increased expression of TNF mrna]|epigallocatechin gallate inhibits the reaction [glucose results in increased expression of TNF mrna]|catechin inhibits the reaction [glucose results in increased expression of TNF protein]|catechin inhibits the reaction [glucose results in increased expression of TNF mrna]|epigallocatechin gallate inhibits the reaction [glucose results in increased expression of TNF protein]|luteolin inhibits the reaction [glucose results in increased expression of TNF protein]|quercetin inhibits the reaction [glucose results in increased expression of TNF mrna]|quercetin inhibits the reaction [glucose results in increased expression of TNF protein]|rutin inhibits the reaction [glucose results in increased expression of TNF protein]|luteolin inhibits the reaction [glucose results in increased expression of TNF mrna],,,PMID:19557821,https://www.ncbi.nlm.nih.gov/pubmed/19557821,19557821,,
1563,1464606,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Chromic acid inhibits the reaction [[glucose co-treated with tetradecanoylphorbol acetate] results in increased secretion of TNF protein]|[glucose co-treated with tetradecanoylphorbol acetate] results in increased secretion of TNF protein,,,PMID:11726202,https://www.ncbi.nlm.nih.gov/pubmed/11726202,11726202,,
1564,1464607,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Fluorometholone inhibits the reaction [glucose results in increased secretion of TNF protein]|fluorometholone inhibits the reaction [glucose results in increased expression of TNF mrna],,,PMID:35264022,https://www.ncbi.nlm.nih.gov/pubmed/35264022,35264022,,
1565,1464608,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[glucose co-treated with pam(3)csk(4) peptide] results in decreased expression of TNF protein|[glucose co-treated with lipopolysaccharides] results in decreased expression of TNF protein,,,PMID:20200188,https://www.ncbi.nlm.nih.gov/pubmed/20200188,20200188,,
1566,1464609,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Glucose results in increased expression of TNF mRNA,,,PMID:19557821|PMID:24436987|PMID:24513509|PMID:35264022|PMID:36928891,https://www.ncbi.nlm.nih.gov/pubmed/19557821|https://www.ncbi.nlm.nih.gov/pubmed/24436987|https://www.ncbi.nlm.nih.gov/pubmed/24513509|https://www.ncbi.nlm.nih.gov/pubmed/35264022|https://www.ncbi.nlm.nih.gov/pubmed/36928891,19557821|24436987|24513509|35264022|36928891,,
1567,1464610,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Glucose results in increased expression of TNF protein,,,PMID:19557821|PMID:24436987|PMID:24513509|PMID:36928891|PMID:38000455,https://www.ncbi.nlm.nih.gov/pubmed/19557821|https://www.ncbi.nlm.nih.gov/pubmed/24436987|https://www.ncbi.nlm.nih.gov/pubmed/24513509|https://www.ncbi.nlm.nih.gov/pubmed/36928891|https://www.ncbi.nlm.nih.gov/pubmed/38000455,19557821|24436987|24513509|36928891|38000455,,
1568,1464611,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Glucose results in increased secretion of TNF protein,,,PMID:30802477|PMID:33283391|PMID:35264022,https://www.ncbi.nlm.nih.gov/pubmed/30802477|https://www.ncbi.nlm.nih.gov/pubmed/33283391|https://www.ncbi.nlm.nih.gov/pubmed/35264022,30802477|33283391|35264022,,
1569,1464612,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),MIR217 mRNA inhibits the reaction [glucose results in increased secretion of TNF protein],,,PMID:33283391,https://www.ncbi.nlm.nih.gov/pubmed/33283391,33283391,,
1570,1467373,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,22166,TXN1,https://ctdbase.org/detail.go?type=gene&acc=22166,,,22166.0,Txn1,10090.0,Mus musculus (house mouse),[glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein|[[[[glucose results in decreased expression of MIR17 mrna] which results in increased expression of TXNIP mrna] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein|glucose promotes the reaction [TXNIP protein binds to TXN1 protein],,,PMID:26660634,https://www.ncbi.nlm.nih.gov/pubmed/26660634,26660634,,
1571,1467374,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,22166,TXN1,https://ctdbase.org/detail.go?type=gene&acc=22166,,,22166.0,Txn1,10090.0,Mus musculus (house mouse),Glucose results in decreased expression of TXN1 protein,,,PMID:17178593,https://www.ncbi.nlm.nih.gov/pubmed/17178593,17178593,,
1572,1468064,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296.0,TXNRD1,9606.0,Homo sapiens (human),Glucose results in increased expression of TXNRD1 mRNA,,,PMID:32942007,https://www.ncbi.nlm.nih.gov/pubmed/32942007,32942007,,
1573,1468065,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,55236,UBA6,https://ctdbase.org/detail.go?type=gene&acc=55236,,,55236.0,UBA6,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of UBA6 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1574,1468066,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,337867,UBAC2,https://ctdbase.org/detail.go?type=gene&acc=337867,,,337867.0,UBAC2,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of UBAC2 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1575,1468067,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,10537,UBD,https://ctdbase.org/detail.go?type=gene&acc=10537,,,10537.0,UBD,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of UBD mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1576,1468068,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,11065,UBE2C,https://ctdbase.org/detail.go?type=gene&acc=11065,,,11065.0,UBE2C,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of UBE2C mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1577,1468069,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7324,UBE2E1,https://ctdbase.org/detail.go?type=gene&acc=7324,,,7324.0,UBE2E1,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of UBE2E1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1578,1468070,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7329,UBE2I,https://ctdbase.org/detail.go?type=gene&acc=7329,,,7329.0,UBE2I,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of UBE2I mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1579,1468071,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7332,UBE2L3,https://ctdbase.org/detail.go?type=gene&acc=7332,,,7332.0,UBE2L3,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of UBE2L3 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1580,1468072,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,9246,UBE2L6,https://ctdbase.org/detail.go?type=gene&acc=9246,,,9246.0,UBE2L6,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of UBE2L6 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1581,1468073,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,54926,UBE2R2,https://ctdbase.org/detail.go?type=gene&acc=54926,,,54926.0,UBE2R2,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of UBE2R2 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1582,1469125,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,65109,UPF3B,https://ctdbase.org/detail.go?type=gene&acc=65109,,,65109.0,UPF3B,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of UPF3B mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1583,1469126,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,151531,UPP2,https://ctdbase.org/detail.go?type=gene&acc=151531,,,151531.0,UPP2,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in decreased expression of UPP2 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1584,1469127,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7392,USF2,https://ctdbase.org/detail.go?type=gene&acc=7392,,,7392.0,USF2,10090.0,Mus musculus (house mouse),Glucose results in increased activity of USF2 protein,,,PMID:15767253,https://www.ncbi.nlm.nih.gov/pubmed/15767253,15767253,,
1585,1469128,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,10600,USP16,https://ctdbase.org/detail.go?type=gene&acc=10600,,,10600.0,USP16,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of USP16 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1586,1469129,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,57602,USP36,https://ctdbase.org/detail.go?type=gene&acc=57602,,,57602.0,USP36,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of USP36 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1587,1469130,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,84196,USP48,https://ctdbase.org/detail.go?type=gene&acc=84196,,,84196.0,USP48,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of USP48 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1588,1469131,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,8078,USP5,https://ctdbase.org/detail.go?type=gene&acc=8078,,,8078.0,USP5,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of USP5 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1589,1469132,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,8239,USP9X,https://ctdbase.org/detail.go?type=gene&acc=8239,,,8239.0,USP9X,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of USP9X mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1590,1469952,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),[linoleic acid co-treated with glucose] affects the reaction [azoxymethane affects the expression of VEGFA protein],,,PMID:22467055,https://www.ncbi.nlm.nih.gov/pubmed/22467055,22467055,,
1591,1469953,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2277,VEGFD,https://ctdbase.org/detail.go?type=gene&acc=2277,,,2277.0,VEGFD,10090.0,Mus musculus (house mouse),Glucose results in increased expression of VEGFD mRNA,,,PMID:17178593,https://www.ncbi.nlm.nih.gov/pubmed/17178593,17178593,,
1592,1469954,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,389136,VGLL3,https://ctdbase.org/detail.go?type=gene&acc=389136,,,389136.0,VGLL3,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of VGLL3 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1593,1469955,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7428,VHL,https://ctdbase.org/detail.go?type=gene&acc=7428,,,7428.0,VHL,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of VHL mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1594,1469956,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,9606.0,Homo sapiens (human),[glucose co-treated with TGFB1 protein] results in increased expression of VIM protein|mapk14 protein promotes the reaction [glucose results in increased expression of VIM mrna]|glucose results in increased expression of VIM mrna|mapk14 protein promotes the reaction [[glucose co-treated with TGFB1 protein] results in increased expression of VIM protein],,,PMID:21829520,https://www.ncbi.nlm.nih.gov/pubmed/21829520,21829520,,
1595,1469957,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,9606.0,Homo sapiens (human),Glucose deficiency results in increased secretion of VIM protein,,,PMID:24802182,https://www.ncbi.nlm.nih.gov/pubmed/24802182,24802182,,
1596,1469958,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,9606.0,Homo sapiens (human),Glucose results in increased expression of VIM protein,,,PMID:21829520|PMID:33992720|PMID:35445903,https://www.ncbi.nlm.nih.gov/pubmed/21829520|https://www.ncbi.nlm.nih.gov/pubmed/33992720|https://www.ncbi.nlm.nih.gov/pubmed/35445903,21829520|33992720|35445903,,
1597,1469959,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,637004,VMN2R3,https://ctdbase.org/detail.go?type=gene&acc=637004,,,637004.0,Vmn2r3,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in increased expression of VMN2R3 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1598,1469960,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,433070,VMN2R96,https://ctdbase.org/detail.go?type=gene&acc=433070,,,433070.0,Vmn2r96,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of VMN2R96 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1599,1470392,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,116966,WDR17,https://ctdbase.org/detail.go?type=gene&acc=116966,,,116966.0,WDR17,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of WDR17 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1600,1470393,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,57539,WDR35,https://ctdbase.org/detail.go?type=gene&acc=57539,,,57539.0,WDR35,10116.0,Rattus norvegicus (Norway rat),Glucose results in increased expression of WDR35 mrna|wdr35 protein affects the reaction [glucose results in increased activity of CASP3 protein],,,PMID:20224876,https://www.ncbi.nlm.nih.gov/pubmed/20224876,20224876,,
1601,1470394,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,134430,WDR36,https://ctdbase.org/detail.go?type=gene&acc=134430,,,134430.0,WDR36,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of WDR36 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1602,1470395,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,11091,WDR5,https://ctdbase.org/detail.go?type=gene&acc=11091,,,11091.0,WDR5,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of WDR5 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1603,1470396,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,11180,WDR6,https://ctdbase.org/detail.go?type=gene&acc=11180,,,11180.0,WDR6,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of WDR6 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1604,1457739,107649,Toxin and Toxin Target Database (T3DB),Beryllium(2+),T3D0042,Beryllium,http://www.t3db.ca/toxins/T3D0042,BE0005071,"HLA class II histocompatibility antigen, DP(W2) beta chain",http://www.t3db.ca/biodb/bio_entities/BE0005071,P13763,"RecName: Full=HLA class II histocompatibility antigen, DP(W2) beta chain; Short=SB-2-beta; Flags: Precursor",3115.0,HLA-DPB1,9606.0,Homo sapiens (human),"Once in the body, beryllium acts as a hapten and interacts with human leucocyte antigen (HLA) DP presenting cells in the lungs, becoming physically associated with a major histocompatability (MHC) class II molecule. this MHC class II-beryllium-peptide complex is recognized by the T lymphocyte receptor, triggering CD4+ T lymphocyte activation and proliferation. the resulting inflammatory response is a cell-mediated process orchestrated by cytokines and results in the formation of (usually pulmonary) granulomas. (L25, A37)",,,PMID:19191908,https://www.ncbi.nlm.nih.gov/pubmed/19191908,19191908,,
1605,1386490,107702,Comparative Toxicogenomics Database (CTD),Altertoxin II,C050234,altertoxin II,https://ctdbase.org/detail.go?type=chem&acc=C050234,407009,MIR224,https://ctdbase.org/detail.go?type=gene&acc=407009,,,407009.0,MIR224,9606.0,Homo sapiens (human),[altertoxin II co-treated with alternariol] results in increased expression of MIR224 mRNA,,,PMID:28007639,https://www.ncbi.nlm.nih.gov/pubmed/28007639,28007639,,
1606,1386491,107702,Comparative Toxicogenomics Database (CTD),Altertoxin II,C050234,altertoxin II,https://ctdbase.org/detail.go?type=chem&acc=C050234,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),Altertoxin II affects the reaction [alternariol affects the reaction [IL1B protein affects the expression of MMP2 mrna]]|altertoxin II affects the reaction [IL1B protein affects the expression of MMP2 mrna],,,PMID:35405071,https://www.ncbi.nlm.nih.gov/pubmed/35405071,35405071,,
1607,1386492,107702,Comparative Toxicogenomics Database (CTD),Altertoxin II,C050234,altertoxin II,https://ctdbase.org/detail.go?type=chem&acc=C050234,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),[alternariol co-treated with altertoxin II] affects the reaction [IL1B protein affects the expression of MMP9 mrna]|altertoxin II affects the reaction [IL1B protein affects the expression of MMP9 mrna],,,PMID:35405071,https://www.ncbi.nlm.nih.gov/pubmed/35405071,35405071,,
1608,1386493,107702,Comparative Toxicogenomics Database (CTD),Altertoxin II,C050234,altertoxin II,https://ctdbase.org/detail.go?type=chem&acc=C050234,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Altertoxin II affects the localization of NFE2L2 protein|[alternariol co-treated with altertoxin II] affects the localization of NFE2L2 protein|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [altertoxin II affects the localization of NFE2L2 protein]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[alternariol co-treated with altertoxin II] affects the localization of NFE2L2 protein],,,PMID:35405071,https://www.ncbi.nlm.nih.gov/pubmed/35405071,35405071,,
1609,1386494,107702,Comparative Toxicogenomics Database (CTD),Altertoxin II,C050234,altertoxin II,https://ctdbase.org/detail.go?type=chem&acc=C050234,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Altertoxin II results in decreased expression of NFE2L2 mrna|altertoxin II results in increased expression of and affects the localization of NFE2L2 protein,,,PMID:27178040,https://www.ncbi.nlm.nih.gov/pubmed/27178040,27178040,,
1610,1386495,107702,Comparative Toxicogenomics Database (CTD),Altertoxin II,C050234,altertoxin II,https://ctdbase.org/detail.go?type=chem&acc=C050234,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),"Altertoxin II inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of RELA protein]",,,PMID:32022557,https://www.ncbi.nlm.nih.gov/pubmed/32022557,32022557,,
1611,1386496,107702,Comparative Toxicogenomics Database (CTD),Altertoxin II,C050234,altertoxin II,https://ctdbase.org/detail.go?type=chem&acc=C050234,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,9606.0,Homo sapiens (human),Altertoxin II results in increased expression of and affects the localization of TJP1 protein|[alternariol co-treated with altertoxin II] results in increased expression of TJP1 protein|altertoxin II affects the reaction [IL1B protein affects the expression of TJP1 mrna]|[alternariol co-treated with altertoxin II] affects the reaction [IL1B protein affects the expression of TJP1 protein]|[alternariol co-treated with altertoxin II] affects the reaction [IL1B protein affects the expression of TJP1 mrna]|altertoxin II affects the reaction [IL1B protein affects the expression of and affects the localization of TJP1 protein],,,PMID:35405071,https://www.ncbi.nlm.nih.gov/pubmed/35405071,35405071,,
1612,1386606,107736,Comparative Toxicogenomics Database (CTD),"2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadienone",C024709,"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone",https://ctdbase.org/detail.go?type=chem&acc=C024709,60,ACTB,https://ctdbase.org/detail.go?type=gene&acc=60,,,60.0,ACTB,10090.0,Mus musculus (house mouse),"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to ACTB protein",,,PMID:16533022,https://www.ncbi.nlm.nih.gov/pubmed/16533022,16533022,,
1613,1386607,107736,Comparative Toxicogenomics Database (CTD),"2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadienone",C024709,"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone",https://ctdbase.org/detail.go?type=chem&acc=C024709,71,ACTG1,https://ctdbase.org/detail.go?type=gene&acc=71,,,71.0,ACTG1,10090.0,Mus musculus (house mouse),"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to ACTG1 protein",,,PMID:16533022,https://www.ncbi.nlm.nih.gov/pubmed/16533022,16533022,,
1614,1386608,107736,Comparative Toxicogenomics Database (CTD),"2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadienone",C024709,"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone",https://ctdbase.org/detail.go?type=chem&acc=C024709,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306.0,ANXA3,10090.0,Mus musculus (house mouse),"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to ANXA3 protein",,,PMID:16533022,https://www.ncbi.nlm.nih.gov/pubmed/16533022,16533022,,
1615,1386609,107736,Comparative Toxicogenomics Database (CTD),"2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadienone",C024709,"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone",https://ctdbase.org/detail.go?type=chem&acc=C024709,12409,CBR2,https://ctdbase.org/detail.go?type=gene&acc=12409,,,12409.0,Cbr2,10090.0,Mus musculus (house mouse),"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone results in decreased activity of CBR2 protein|2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone inhibits the reaction [CBR2 protein results in increased reduction of 4-oxo-2-nonenal]|2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to CBR2 protein|2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone results in increased alkylation of CBR2 protein",,,PMID:18597497,https://www.ncbi.nlm.nih.gov/pubmed/18597497,18597497,,
1616,1386610,107736,Comparative Toxicogenomics Database (CTD),"2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadienone",C024709,"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone",https://ctdbase.org/detail.go?type=chem&acc=C024709,10694,CCT8,https://ctdbase.org/detail.go?type=gene&acc=10694,,,10694.0,CCT8,10090.0,Mus musculus (house mouse),"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to CCT8 protein",,,PMID:16533022,https://www.ncbi.nlm.nih.gov/pubmed/16533022,16533022,,
1617,1471915,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Perindopril inhibits the reaction [methotrexate results in increased expression of RELA protein],,,PMID:34737150,https://www.ncbi.nlm.nih.gov/pubmed/34737150,34737150,,
1618,1471916,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,5972,REN,https://ctdbase.org/detail.go?type=gene&acc=5972,,,5972.0,REN,9606.0,Homo sapiens (human),Perindopril results in increased activity of REN protein,,,PMID:2549899|PMID:2605800,https://www.ncbi.nlm.nih.gov/pubmed/2549899|https://www.ncbi.nlm.nih.gov/pubmed/2605800,2549899|2605800,,
1619,1471917,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,6262,RYR2,https://ctdbase.org/detail.go?type=gene&acc=6262,,,6262.0,RYR2,10116.0,Rattus norvegicus (Norway rat),Perindopril results in increased expression of RYR2 protein|carvedilol promotes the reaction [perindopril results in increased expression of RYR2 protein]|perindopril promotes the reaction [carvedilol results in increased expression of RYR2 protein],,,PMID:19620082,https://www.ncbi.nlm.nih.gov/pubmed/19620082,19620082,,
1620,1471918,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,6424,SFRP4,https://ctdbase.org/detail.go?type=gene&acc=6424,,,6424.0,SFRP4,9606.0,Homo sapiens (human),Perindopril binds to SFRP4 protein,,,PMID:25019556,https://www.ncbi.nlm.nih.gov/pubmed/25019556,25019556,,
1621,1471919,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,10116.0,Rattus norvegicus (Norway rat),Perindopril inhibits the reaction [methotrexate results in decreased expression of SIRT1 mrna]|perindopril results in increased expression of SIRT1 protein|perindopril inhibits the reaction [methotrexate results in decreased expression of SIRT1 protein]|perindopril results in increased expression of SIRT1 mRNA,,,PMID:34737150,https://www.ncbi.nlm.nih.gov/pubmed/34737150,34737150,,
1622,1471920,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,6564,SLC15A1,https://ctdbase.org/detail.go?type=gene&acc=6564,,,6564.0,SLC15A1,9606.0,Homo sapiens (human),Perindopril inhibits the reaction [SLC15A1 protein results in increased uptake of glycylsarcosine],,,PMID:18713951,https://www.ncbi.nlm.nih.gov/pubmed/18713951,18713951,,
1623,1471921,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,6565,SLC15A2,https://ctdbase.org/detail.go?type=gene&acc=6565,,,6565.0,SLC15A2,10116.0,Rattus norvegicus (Norway rat),Perindopril inhibits the reaction [SLC15A2 protein results in increased uptake of glycylsarcosine],,,PMID:18713951,https://www.ncbi.nlm.nih.gov/pubmed/18713951,18713951,,
1624,1471922,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,10116.0,Rattus norvegicus (Norway rat),Perindopril inhibits the reaction [carbon tetrachloride results in increased expression of SMAD3 protein],,,PMID:16872305,https://www.ncbi.nlm.nih.gov/pubmed/16872305,16872305,,
1625,1386372,107854,Comparative Toxicogenomics Database (CTD),Phorbol-12-myristate,C119222,phorbol-12-myristate,https://ctdbase.org/detail.go?type=chem&acc=C119222,3567,IL5,https://ctdbase.org/detail.go?type=gene&acc=3567,,,3567.0,IL5,9606.0,Homo sapiens (human),[calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL5 protein|fisetin inhibits the reaction [[calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL5 protein],,,PMID:12789233,https://www.ncbi.nlm.nih.gov/pubmed/12789233,12789233,,
1626,1386373,107854,Comparative Toxicogenomics Database (CTD),Phorbol-12-myristate,C119222,phorbol-12-myristate,https://ctdbase.org/detail.go?type=chem&acc=C119222,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),[calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL6 protein,,,PMID:12789233,https://www.ncbi.nlm.nih.gov/pubmed/12789233,12789233,,
1627,1386374,107854,Comparative Toxicogenomics Database (CTD),Phorbol-12-myristate,C119222,phorbol-12-myristate,https://ctdbase.org/detail.go?type=chem&acc=C119222,9611,NCOR1,https://ctdbase.org/detail.go?type=gene&acc=9611,,,9611.0,NCOR1,10090.0,Mus musculus (house mouse),Phorbol-12-myristate promotes the reaction [NR1I2 protein binds to NCOR1 protein],,,PMID:15710363,https://www.ncbi.nlm.nih.gov/pubmed/15710363,15710363,,
1628,1386375,107854,Comparative Toxicogenomics Database (CTD),Phorbol-12-myristate,C119222,phorbol-12-myristate,https://ctdbase.org/detail.go?type=chem&acc=C119222,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,10090.0,Mus musculus (house mouse),Phorbol-12-myristate results in decreased activity of NR1I2 protein|phorbol-12-myristate promotes the reaction [NR1I2 protein binds to NCOR1 protein],,,PMID:15710363,https://www.ncbi.nlm.nih.gov/pubmed/15710363,15710363,,
1629,1386376,107854,Comparative Toxicogenomics Database (CTD),Phorbol-12-myristate,C119222,phorbol-12-myristate,https://ctdbase.org/detail.go?type=chem&acc=C119222,7031,TFF1,https://ctdbase.org/detail.go?type=gene&acc=7031,,,7031.0,TFF1,9606.0,Homo sapiens (human),Phorbol-12-myristate promotes the reaction [ESRRA protein binds to and results in increased expression of TFF1 mrna],,,PMID:16024613,https://www.ncbi.nlm.nih.gov/pubmed/16024613,16024613,,
1630,1386377,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,29974,A1CF,https://ctdbase.org/detail.go?type=gene&acc=29974,,,29974.0,A1CF,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of A1CF mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1631,1386378,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,2,A2M,https://ctdbase.org/detail.go?type=gene&acc=2,,,2.0,A2M,9606.0,Homo sapiens (human),Grape seed proanthocyanidins results in increased expression of A2M mRNA,,,PMID:20471814,https://www.ncbi.nlm.nih.gov/pubmed/20471814,20471814,,
1632,1386379,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of ABCB11 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1633,1386380,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,5825,ABCD3,https://ctdbase.org/detail.go?type=gene&acc=5825,,,5825.0,ABCD3,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of ABCD3 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1634,1386381,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,116983,ACAP3,https://ctdbase.org/detail.go?type=gene&acc=116983,,,116983.0,ACAP3,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of ACAP3 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1635,1452076,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,2330,FMO5,https://ctdbase.org/detail.go?type=gene&acc=2330,,,2330.0,FMO5,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of FMO5 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1636,1452077,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606.0,Homo sapiens (human),Grape seed proanthocyanidins inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]|grape seed proanthocyanidins inhibits the reaction [TGFB1 protein results in increased expression of FN1 mrna]|grape seed proanthocyanidins inhibits the reaction [HMGB1 protein results in increased expression of FN1 protein]|grape seed proanthocyanidins inhibits the reaction [C3 protein alternative form results in increased expression of FN1 protein],,,PMID:31874164,https://www.ncbi.nlm.nih.gov/pubmed/31874164,31874164,,
1637,1452078,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,2294,FOXF1,https://ctdbase.org/detail.go?type=gene&acc=2294,,,2294.0,FOXF1,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of FOXF1 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1638,1452079,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of FOXO3 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1639,1452080,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,27086,FOXP1,https://ctdbase.org/detail.go?type=gene&acc=27086,,,27086.0,FOXP1,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of FOXP1 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1640,1388050,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,4035,LRP1,https://ctdbase.org/detail.go?type=gene&acc=4035,,,4035.0,LRP1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of LRP1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1641,1388051,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,4037,LRP3,https://ctdbase.org/detail.go?type=gene&acc=4037,,,4037.0,LRP3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of LRP3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1642,1388052,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,4038,LRP4,https://ctdbase.org/detail.go?type=gene&acc=4038,,,4038.0,LRP4,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of LRP4 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1643,1388053,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,4041,LRP5,https://ctdbase.org/detail.go?type=gene&acc=4041,,,4041.0,LRP5,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of LRP5 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1644,1388054,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,10128,LRPPRC,https://ctdbase.org/detail.go?type=gene&acc=10128,,,10128.0,LRPPRC,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of LRPPRC mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1645,1388055,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,474354,LRRC18,https://ctdbase.org/detail.go?type=gene&acc=474354,,,474354.0,LRRC18,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of LRRC18 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1646,1388056,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,123355,LRRC28,https://ctdbase.org/detail.go?type=gene&acc=123355,,,123355.0,LRRC28,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of LRRC28 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1647,1388057,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,81543,LRRC3,https://ctdbase.org/detail.go?type=gene&acc=81543,,,81543.0,LRRC3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of LRRC3 mRNA,,,PMID:22334560|PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/22334560|https://www.ncbi.nlm.nih.gov/pubmed/35436446,22334560|35436446,,
1648,1388058,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,127495,LRRC39,https://ctdbase.org/detail.go?type=gene&acc=127495,,,127495.0,LRRC39,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of LRRC39 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1649,1388059,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,57470,LRRC47,https://ctdbase.org/detail.go?type=gene&acc=57470,,,57470.0,LRRC47,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of LRRC47 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1650,1388179,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,11157,LSM6,https://ctdbase.org/detail.go?type=gene&acc=11157,,,11157.0,LSM6,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of LSM6 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1651,1389515,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,84879,MFSD2A,https://ctdbase.org/detail.go?type=gene&acc=84879,,,84879.0,MFSD2A,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MFSD2A mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1652,1389516,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,113655,MFSD3,https://ctdbase.org/detail.go?type=gene&acc=113655,,,113655.0,MFSD3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MFSD3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1653,1389517,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,54842,MFSD6,https://ctdbase.org/detail.go?type=gene&acc=54842,,,54842.0,MFSD6,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MFSD6 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1654,1389518,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,4247,MGAT2,https://ctdbase.org/detail.go?type=gene&acc=4247,,,4247.0,MGAT2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MGAT2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1655,1389519,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,11320,MGAT4A,https://ctdbase.org/detail.go?type=gene&acc=11320,,,11320.0,MGAT4A,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MGAT4A mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1656,1389520,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,71001,MGAT4E,https://ctdbase.org/detail.go?type=gene&acc=71001,,,71001.0,Mgat4e,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MGAT4E mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1657,1389521,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,216864,MGL2,https://ctdbase.org/detail.go?type=gene&acc=216864,,,216864.0,Mgl2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MGL2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1658,1389522,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,11343,MGLL,https://ctdbase.org/detail.go?type=gene&acc=11343,,,11343.0,MGLL,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MGLL mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1659,1390271,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,79590,MRPL24,https://ctdbase.org/detail.go?type=gene&acc=79590,,,79590.0,MRPL24,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of MRPL24 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1660,1390272,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,51264,MRPL27,https://ctdbase.org/detail.go?type=gene&acc=51264,,,51264.0,MRPL27,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MRPL27 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1661,1390273,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,9553,MRPL33,https://ctdbase.org/detail.go?type=gene&acc=9553,,,9553.0,MRPL33,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MRPL33 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1662,1390274,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,64981,MRPL34,https://ctdbase.org/detail.go?type=gene&acc=64981,,,64981.0,MRPL34,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MRPL34 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1663,1390394,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,64978,MRPL38,https://ctdbase.org/detail.go?type=gene&acc=64978,,,64978.0,MRPL38,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MRPL38 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1664,1390395,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,28977,MRPL42,https://ctdbase.org/detail.go?type=gene&acc=28977,,,28977.0,MRPL42,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MRPL42 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1665,1390396,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,26589,MRPL46,https://ctdbase.org/detail.go?type=gene&acc=26589,,,26589.0,MRPL46,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MRPL46 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1666,1390397,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,122704,MRPL52,https://ctdbase.org/detail.go?type=gene&acc=122704,,,122704.0,MRPL52,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MRPL52 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1667,1390398,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,116541,MRPL54,https://ctdbase.org/detail.go?type=gene&acc=116541,,,116541.0,MRPL54,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MRPL54 mRNA,,,PMID:22334560,https://www.ncbi.nlm.nih.gov/pubmed/22334560,22334560,,
1668,1390399,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,128308,MRPL55,https://ctdbase.org/detail.go?type=gene&acc=128308,,,128308.0,MRPL55,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MRPL55 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1669,1390400,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,63931,MRPS14,https://ctdbase.org/detail.go?type=gene&acc=63931,,,63931.0,MRPS14,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MRPS14 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1670,1390401,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,51021,MRPS16,https://ctdbase.org/detail.go?type=gene&acc=51021,,,51021.0,MRPS16,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MRPS16 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1671,1390402,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,28973,MRPS18B,https://ctdbase.org/detail.go?type=gene&acc=28973,,,28973.0,MRPS18B,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of MRPS18B mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1672,1390403,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,28973,MRPS18B,https://ctdbase.org/detail.go?type=gene&acc=28973,,,28973.0,MRPS18B,10116.0,Rattus norvegicus (Norway rat),[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MRPS18B mRNA,,,PMID:29038839,https://www.ncbi.nlm.nih.gov/pubmed/29038839,29038839,,
1673,1391131,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,138151,NACC2,https://ctdbase.org/detail.go?type=gene&acc=138151,,,138151.0,NACC2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of NACC2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1674,1391132,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,65220,NADK,https://ctdbase.org/detail.go?type=gene&acc=65220,,,65220.0,NADK,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of NADK mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1675,1391133,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,55577,NAGK,https://ctdbase.org/detail.go?type=gene&acc=55577,,,55577.0,NAGK,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of NAGK mRNA,,,PMID:22334560,https://www.ncbi.nlm.nih.gov/pubmed/22334560,22334560,,
1676,1391134,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,4669,NAGLU,https://ctdbase.org/detail.go?type=gene&acc=4669,,,4669.0,NAGLU,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of NAGLU mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1677,1391135,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,51172,NAGPA,https://ctdbase.org/detail.go?type=gene&acc=51172,,,51172.0,NAGPA,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of NAGPA mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1678,1393787,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,138883,OR1N1,https://ctdbase.org/detail.go?type=gene&acc=138883,,,138883.0,OR1N1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OR1N1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1679,1393788,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,258457,OR1O11,https://ctdbase.org/detail.go?type=gene&acc=258457,,,258457.0,Or1o11,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OR1O11 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1680,1393789,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,258591,OR2AG13,https://ctdbase.org/detail.go?type=gene&acc=258591,,,258591.0,Or2ag13,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of OR2AG13 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1681,1393790,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,258589,OR2AG19,https://ctdbase.org/detail.go?type=gene&acc=258589,,,258589.0,Or2ag19,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OR2AG19 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1682,1394028,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,258737,OR4F14D,https://ctdbase.org/detail.go?type=gene&acc=258737,,,258737.0,Or4f14d,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OR4F14D mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1683,1394029,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,258257,OR4F60,https://ctdbase.org/detail.go?type=gene&acc=258257,,,258257.0,Or4f60,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OR4F60 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1684,1394030,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,277562,OR4K40,https://ctdbase.org/detail.go?type=gene&acc=277562,,,277562.0,Or4k40,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OR4K40 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1685,1394031,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,258485,OR4L15,https://ctdbase.org/detail.go?type=gene&acc=258485,,,258485.0,Or4l15,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of OR4L15 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1686,1394032,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,258167,OR4P21,https://ctdbase.org/detail.go?type=gene&acc=258167,,,258167.0,Or4p21,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OR4P21 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1687,1394033,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,404330,OR4P23,https://ctdbase.org/detail.go?type=gene&acc=404330,,,404330.0,Or4p23,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of OR4P23 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1688,1394950,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5007,OSBP,https://ctdbase.org/detail.go?type=gene&acc=5007,,,5007.0,OSBP,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OSBP mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1689,1394951,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,9885,OSBPL2,https://ctdbase.org/detail.go?type=gene&acc=9885,,,9885.0,OSBPL2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of OSBPL2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1690,1394952,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,114882,OSBPL8,https://ctdbase.org/detail.go?type=gene&acc=114882,,,114882.0,OSBPL8,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of OSBPL8 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1691,1394953,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,29948,OSGIN1,https://ctdbase.org/detail.go?type=gene&acc=29948,,,29948.0,OSGIN1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OSGIN1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1692,1394954,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,100128731,OST4,https://ctdbase.org/detail.go?type=gene&acc=100128731,,,100128731.0,OST4,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OST4 mRNA,,,PMID:22334560|PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/22334560|https://www.ncbi.nlm.nih.gov/pubmed/35436446,22334560|35436446,,
1693,1394955,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,58505,OSTC,https://ctdbase.org/detail.go?type=gene&acc=58505,,,58505.0,OSTC,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OSTC mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1694,1394956,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,55611,OTUB1,https://ctdbase.org/detail.go?type=gene&acc=55611,,,55611.0,OTUB1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of OTUB1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1695,1394957,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,54491,OTULINL,https://ctdbase.org/detail.go?type=gene&acc=54491,,,54491.0,OTULINL,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of OTULINL mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1696,1395881,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,387521,PEDS1,https://ctdbase.org/detail.go?type=gene&acc=387521,,,387521.0,PEDS1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PEDS1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1697,1395882,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,23089,PEG10,https://ctdbase.org/detail.go?type=gene&acc=23089,,,23089.0,PEG10,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of PEG10 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1698,1395883,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,57162,PELI1,https://ctdbase.org/detail.go?type=gene&acc=57162,,,57162.0,PELI1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PELI1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1699,1395884,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,246330,PELI3,https://ctdbase.org/detail.go?type=gene&acc=246330,,,246330.0,PELI3,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of PELI3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1700,1395885,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5184,PEPD,https://ctdbase.org/detail.go?type=gene&acc=5184,,,5184.0,PEPD,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PEPD mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1701,1395886,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5184,PEPD,https://ctdbase.org/detail.go?type=gene&acc=5184,,,5184.0,PEPD,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of PEPD mRNA,,,PMID:22334560,https://www.ncbi.nlm.nih.gov/pubmed/22334560,22334560,,
1702,1395887,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5187,PER1,https://ctdbase.org/detail.go?type=gene&acc=5187,,,5187.0,PER1,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of PER1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1703,1395998,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5193,PEX12,https://ctdbase.org/detail.go?type=gene&acc=5193,,,5193.0,PEX12,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PEX12 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1704,1395999,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,55670,PEX26,https://ctdbase.org/detail.go?type=gene&acc=55670,,,55670.0,PEX26,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PEX26 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1705,1396000,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5201,PFDN1,https://ctdbase.org/detail.go?type=gene&acc=5201,,,5201.0,PFDN1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of PFDN1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1706,1396001,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5204,PFDN5,https://ctdbase.org/detail.go?type=gene&acc=5204,,,5204.0,PFDN5,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of PFDN5 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1707,1396002,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,10471,PFDN6,https://ctdbase.org/detail.go?type=gene&acc=10471,,,10471.0,PFDN6,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PFDN6 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1708,1396003,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5207,PFKFB1,https://ctdbase.org/detail.go?type=gene&acc=5207,,,5207.0,PFKFB1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PFKFB1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1709,1396004,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5209,PFKFB3,https://ctdbase.org/detail.go?type=gene&acc=5209,,,5209.0,PFKFB3,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of PFKFB3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1710,1396005,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5213,PFKM,https://ctdbase.org/detail.go?type=gene&acc=5213,,,5213.0,PFKM,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of PFKM mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1711,1396006,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5216,PFN1,https://ctdbase.org/detail.go?type=gene&acc=5216,,,5216.0,PFN1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PFN1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1712,1396007,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5217,PFN2,https://ctdbase.org/detail.go?type=gene&acc=5217,,,5217.0,PFN2,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of PFN2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1713,1396830,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,26030,PLEKHG3,https://ctdbase.org/detail.go?type=gene&acc=26030,,,26030.0,PLEKHG3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PLEKHG3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1714,1396831,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,23207,PLEKHM2,https://ctdbase.org/detail.go?type=gene&acc=23207,,,23207.0,PLEKHM2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PLEKHM2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1715,1396832,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,51177,PLEKHO1,https://ctdbase.org/detail.go?type=gene&acc=51177,,,51177.0,PLEKHO1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PLEKHO1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1716,1397309,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5423,POLB,https://ctdbase.org/detail.go?type=gene&acc=5423,,,5423.0,POLB,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of POLB mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1717,1397310,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5424,POLD1,https://ctdbase.org/detail.go?type=gene&acc=5424,,,5424.0,POLD1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of POLD1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1718,1397311,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,11201,POLI,https://ctdbase.org/detail.go?type=gene&acc=11201,,,11201.0,POLI,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of POLI mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1719,1397312,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,64425,POLR1E,https://ctdbase.org/detail.go?type=gene&acc=64425,,,64425.0,POLR1E,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of POLR1E mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1720,1397313,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5431,POLR2B,https://ctdbase.org/detail.go?type=gene&acc=5431,,,5431.0,POLR2B,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of POLR2B mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1721,1397314,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5432,POLR2C,https://ctdbase.org/detail.go?type=gene&acc=5432,,,5432.0,POLR2C,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of POLR2C mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1722,1397315,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5434,POLR2E,https://ctdbase.org/detail.go?type=gene&acc=5434,,,5434.0,POLR2E,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of POLR2E mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1723,1397316,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5437,POLR2H,https://ctdbase.org/detail.go?type=gene&acc=5437,,,5437.0,POLR2H,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of POLR2H mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1724,1552217,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,140823,ROMO1,https://ctdbase.org/detail.go?type=gene&acc=140823,,,140823.0,ROMO1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of ROMO1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1725,1552218,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,83853,ROPN1L,https://ctdbase.org/detail.go?type=gene&acc=83853,,,83853.0,ROPN1L,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of ROPN1L mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1726,1552219,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,4919,ROR1,https://ctdbase.org/detail.go?type=gene&acc=4919,,,4919.0,ROR1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ROR1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1727,1552220,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6095,RORA,https://ctdbase.org/detail.go?type=gene&acc=6095,,,6095.0,RORA,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of RORA mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1728,1552221,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6097,RORC,https://ctdbase.org/detail.go?type=gene&acc=6097,,,6097.0,RORC,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of RORC mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1729,1552222,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6119,RPA3,https://ctdbase.org/detail.go?type=gene&acc=6119,,,6119.0,RPA3,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of RPA3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1730,1552223,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6141,RPL18,https://ctdbase.org/detail.go?type=gene&acc=6141,,,6141.0,RPL18,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of RPL18 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1731,1552224,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6146,RPL22,https://ctdbase.org/detail.go?type=gene&acc=6146,,,6146.0,RPL22,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of RPL22 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1732,1552979,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6239,RREB1,https://ctdbase.org/detail.go?type=gene&acc=6239,,,6239.0,RREB1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of RREB1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1733,1552980,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6240,RRM1,https://ctdbase.org/detail.go?type=gene&acc=6240,,,6240.0,RRM1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of RRM1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1734,1552981,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of RRM2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1735,1552982,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,54700,RRN3,https://ctdbase.org/detail.go?type=gene&acc=54700,,,54700.0,RRN3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of RRN3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1736,1458780,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Epicatechin gallate results in decreased phosphorylation of AKT1 protein,,,PMID:21945981,https://www.ncbi.nlm.nih.gov/pubmed/21945981,21945981,,
1737,1458781,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,9606.0,Homo sapiens (human),Epicatechin gallate results in increased expression of BAD protein,,,PMID:21945981,https://www.ncbi.nlm.nih.gov/pubmed/21945981,21945981,,
1738,1458782,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),Epicatechin gallate inhibits the reaction [benzo(a)pyrene results in increased expression of BCL2 mrna],,,PMID:18656336,https://www.ncbi.nlm.nih.gov/pubmed/18656336,18656336,,
1739,1458783,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),Epicatechin gallate results in increased expression of BCL2L1 protein alternative form,,,PMID:21945981,https://www.ncbi.nlm.nih.gov/pubmed/21945981,21945981,,
1740,1458784,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BDNF protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BDNF protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BDNF protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
1741,1458785,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,406,BMAL1,https://ctdbase.org/detail.go?type=gene&acc=406,,,406.0,BMAL1,9606.0,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of MFN1 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX4 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of UQCRC2 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of CREB1 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of HMOX1 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of FIS1 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of ND1 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BDNF protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of BMAL1 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX2 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BNIP3 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of NDUFS1 mrna]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of AKT1 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of BMAL1 mrna]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of DNM1 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of NQO1 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX6C mrna]],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
1742,1459734,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,10090.0,Mus musculus (house mouse),[sodium glutamate co-treated with gallocatechol co-treated with catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of LEP protein,,,PMID:25663641,https://www.ncbi.nlm.nih.gov/pubmed/25663641,25663641,,
1743,1459735,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Epicatechin gallate results in increased phosphorylation of MAPK1 protein,,,PMID:21945981,https://www.ncbi.nlm.nih.gov/pubmed/21945981,21945981,,
1744,1459736,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Epicatechin gallate results in increased phosphorylation of MAPK3 protein,,,PMID:21945981,https://www.ncbi.nlm.nih.gov/pubmed/21945981,21945981,,
1745,1459737,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,55669,MFN1,https://ctdbase.org/detail.go?type=gene&acc=55669,,,55669.0,MFN1,9606.0,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of MFN1 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of MFN1 protein]],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
1746,1459738,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606.0,Homo sapiens (human),Epicatechin gallate inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of MPO protein]|[epigallocatechin gallate co-treated with gallocatechol co-treated with epicatechin gallate co-treated with catechin analog] inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of MPO protein],,,PMID:26187476,https://www.ncbi.nlm.nih.gov/pubmed/26187476,26187476,,
1747,1459739,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10090.0,Mus musculus (house mouse),Epicatechin gallate inhibits the reaction [benzo(a)pyrene results in increased expression of MYC mrna],,,PMID:18656336,https://www.ncbi.nlm.nih.gov/pubmed/18656336,18656336,,
1748,1387430,107930,IUPHAR/BPS Guide to PHARMACOLOGY,Ecopipam,3304,ecopipam,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3304,214,D1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=214,P21728,D(1A) dopamine receptor,1812.0,DRD1,9606.0,Homo sapiens (human),Antagonist,pKi,8.3,PMID:7862709,https://www.ncbi.nlm.nih.gov/pubmed/7862709,7862709,,
1749,1387431,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,9606.0,Homo sapiens (human),Deguelin results in increased expression of MAP1LC3B mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1750,1387432,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,9606.0,Homo sapiens (human),Deguelin results in decreased expression of MAP2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1751,1387433,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,9606.0,Homo sapiens (human),Deguelin metabolite results in decreased expression of MAP2K1 protein,,,PMID:19139008,https://www.ncbi.nlm.nih.gov/pubmed/19139008,19139008,,
1752,1387434,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,9606.0,Homo sapiens (human),Deguelin results in decreased expression of MAP2K1 protein,,,PMID:19139008|PMID:19336726,https://www.ncbi.nlm.nih.gov/pubmed/19139008|https://www.ncbi.nlm.nih.gov/pubmed/19336726,19139008|19336726,,
1753,1387435,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,5605,MAP2K2,https://ctdbase.org/detail.go?type=gene&acc=5605,,,5605.0,MAP2K2,9606.0,Homo sapiens (human),Deguelin results in decreased expression of MAP2K2 protein,,,PMID:19336726,https://www.ncbi.nlm.nih.gov/pubmed/19336726,19336726,,
1754,1387436,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,5609,MAP2K7,https://ctdbase.org/detail.go?type=gene&acc=5609,,,5609.0,MAP2K7,9606.0,Homo sapiens (human),Deguelin results in decreased expression of MAP2K7 protein,,,PMID:25322282,https://www.ncbi.nlm.nih.gov/pubmed/25322282,25322282,,
1755,1387437,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,4215,MAP3K3,https://ctdbase.org/detail.go?type=gene&acc=4215,,,4215.0,MAP3K3,9606.0,Homo sapiens (human),Deguelin affects the expression of MAP3K3 protein,,,PMID:25322282,https://www.ncbi.nlm.nih.gov/pubmed/25322282,25322282,,
1756,1387438,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,4135,MAP6,https://ctdbase.org/detail.go?type=gene&acc=4135,,,4135.0,MAP6,9606.0,Homo sapiens (human),Deguelin results in decreased expression of MAP6 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1757,1387439,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Deguelin affects the phosphorylation of MAPK1 protein,,,PMID:25322282,https://www.ncbi.nlm.nih.gov/pubmed/25322282,25322282,,
1758,1388885,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),[NPM1 protein mutant form results in increased susceptibility to deguelin] which results in increased cleavage of PARP1 protein,,,PMID:25242579,https://www.ncbi.nlm.nih.gov/pubmed/25242579,25242579,,
1759,1388886,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,10038,PARP2,https://ctdbase.org/detail.go?type=gene&acc=10038,,,10038.0,PARP2,9606.0,Homo sapiens (human),Deguelin results in increased expression of PARP2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1760,1388887,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,55872,PBK,https://ctdbase.org/detail.go?type=gene&acc=55872,,,55872.0,PBK,9606.0,Homo sapiens (human),Deguelin results in increased expression of PBK mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1761,1388888,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,56147,PCDHA1,https://ctdbase.org/detail.go?type=gene&acc=56147,,,56147.0,PCDHA1,9606.0,Homo sapiens (human),Deguelin results in decreased expression of PCDHA1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1762,1388889,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,9752,PCDHA9,https://ctdbase.org/detail.go?type=gene&acc=9752,,,9752.0,PCDHA9,9606.0,Homo sapiens (human),Deguelin results in decreased expression of PCDHA9 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1763,1388890,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,5136,PDE1A,https://ctdbase.org/detail.go?type=gene&acc=5136,,,5136.0,PDE1A,9606.0,Homo sapiens (human),Deguelin results in decreased expression of PDE1A mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1764,1388891,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,5155,PDGFB,https://ctdbase.org/detail.go?type=gene&acc=5155,,,5155.0,PDGFB,9606.0,Homo sapiens (human),Deguelin results in decreased expression of PDGFB mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1765,1388892,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,8050,PDHX,https://ctdbase.org/detail.go?type=gene&acc=8050,,,8050.0,PDHX,9606.0,Homo sapiens (human),Deguelin results in increased expression of PDHX mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1766,1388893,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,5163,PDK1,https://ctdbase.org/detail.go?type=gene&acc=5163,,,5163.0,PDK1,9606.0,Homo sapiens (human),Deguelin metabolite results in decreased expression of PDK1 protein|deguelin results in decreased expression of PDK1 protein,,,PMID:19139008,https://www.ncbi.nlm.nih.gov/pubmed/19139008,19139008,,
1767,1390993,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606.0,Homo sapiens (human),Deguelin results in decreased expression of SULT1A1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1768,1391234,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,7077,TIMP2,https://ctdbase.org/detail.go?type=gene&acc=7077,,,7077.0,TIMP2,9606.0,Homo sapiens (human),Deguelin results in increased expression of TIMP2 protein,,,PMID:25322282,https://www.ncbi.nlm.nih.gov/pubmed/25322282,25322282,,
1769,1391235,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,83877,TM2D2,https://ctdbase.org/detail.go?type=gene&acc=83877,,,83877.0,TM2D2,9606.0,Homo sapiens (human),Deguelin results in decreased expression of TM2D2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1770,1391236,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,56889,TM9SF3,https://ctdbase.org/detail.go?type=gene&acc=56889,,,56889.0,TM9SF3,9606.0,Homo sapiens (human),Deguelin results in decreased expression of TM9SF3 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1771,1391237,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,84233,TMEM126A,https://ctdbase.org/detail.go?type=gene&acc=84233,,,84233.0,TMEM126A,9606.0,Homo sapiens (human),Deguelin results in increased expression of TMEM126A mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1772,1391238,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,153339,TMEM167A,https://ctdbase.org/detail.go?type=gene&acc=153339,,,153339.0,TMEM167A,9606.0,Homo sapiens (human),Deguelin results in decreased expression of TMEM167A mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1773,1391239,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,84548,TMEM185A,https://ctdbase.org/detail.go?type=gene&acc=84548,,,84548.0,TMEM185A,9606.0,Homo sapiens (human),Deguelin results in decreased expression of TMEM185A mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1774,1391240,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,157378,TMEM65,https://ctdbase.org/detail.go?type=gene&acc=157378,,,157378.0,TMEM65,9606.0,Homo sapiens (human),Deguelin results in decreased expression of TMEM65 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1775,1454176,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,26985,AP3M1,https://ctdbase.org/detail.go?type=gene&acc=26985,,,26985.0,AP3M1,9606.0,Homo sapiens (human),Deguelin results in decreased expression of AP3M1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1776,1455297,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,716,C1S,https://ctdbase.org/detail.go?type=gene&acc=716,,,716.0,C1S,9606.0,Homo sapiens (human),Deguelin results in decreased expression of C1S mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1777,1456236,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CDKN1A protein|deguelin metabolite results in decreased expression of CDKN1A protein,,,PMID:19139008,https://www.ncbi.nlm.nih.gov/pubmed/19139008,19139008,,
1778,1456237,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),[deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of CDKN1A protein,,,PMID:25242579,https://www.ncbi.nlm.nih.gov/pubmed/25242579,25242579,,
1779,1456238,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Deguelin results in increased expression of CDKN1A mRNA,,,PMID:29512685,https://www.ncbi.nlm.nih.gov/pubmed/29512685,29512685,,
1780,1457119,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1500,CTNND1,https://ctdbase.org/detail.go?type=gene&acc=1500,,,1500.0,CTNND1,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CTNND1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1781,1457120,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1503,CTPS1,https://ctdbase.org/detail.go?type=gene&acc=1503,,,1503.0,CTPS1,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CTPS1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1782,1457121,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509.0,CTSD,9606.0,Homo sapiens (human),Deguelin results in increased expression of CTSD mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1783,1457122,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1520,CTSS,https://ctdbase.org/detail.go?type=gene&acc=1520,,,1520.0,CTSS,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CTSS mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1784,1459588,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,8342,H2BC14,https://ctdbase.org/detail.go?type=gene&acc=8342,,,8342.0,H2BC14,9606.0,Homo sapiens (human),Deguelin results in increased expression of H2BC14 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1785,1459589,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,8341,H2BC15,https://ctdbase.org/detail.go?type=gene&acc=8341,,,8341.0,H2BC15,9606.0,Homo sapiens (human),Deguelin results in increased expression of H2BC15 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1786,1386755,107969,Comparative Toxicogenomics Database (CTD),Fingolimod Hydrochloride,D000068876,Fingolimod Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000068876,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Fingolimod hydrochloride results in decreased expression of CYP1B1 mRNA,,,PMID:29654831,https://www.ncbi.nlm.nih.gov/pubmed/29654831,29654831,,
1787,1386756,107969,Comparative Toxicogenomics Database (CTD),Fingolimod Hydrochloride,D000068876,Fingolimod Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000068876,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Fingolimod hydrochloride inhibits the reaction [estradiol results in increased expression of ESR1 protein],,,PMID:29654831,https://www.ncbi.nlm.nih.gov/pubmed/29654831,29654831,,
1788,1386757,107969,Comparative Toxicogenomics Database (CTD),Fingolimod Hydrochloride,D000068876,Fingolimod Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000068876,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Fingolimod hydrochloride inhibits the reaction [estradiol results in increased expression of ESR2 protein]|fingolimod hydrochloride results in decreased expression of ESR2 protein,,,PMID:29654831,https://www.ncbi.nlm.nih.gov/pubmed/29654831,29654831,,
1789,1386758,107969,Comparative Toxicogenomics Database (CTD),Fingolimod Hydrochloride,D000068876,Fingolimod Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000068876,63920,FAM200C,https://ctdbase.org/detail.go?type=gene&acc=63920,,,63920.0,FAM200C,9606.0,Homo sapiens (human),Fingolimod hydrochloride results in increased expression of FAM200C mRNA,,,PMID:24356939,https://www.ncbi.nlm.nih.gov/pubmed/24356939,24356939,,
1790,1386759,107969,Comparative Toxicogenomics Database (CTD),Fingolimod Hydrochloride,D000068876,Fingolimod Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000068876,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,10090.0,Mus musculus (house mouse),"[lipopolysaccharide, escherichia coli O111 B4 co-treated with okadaic acid co-treated with fingolimod hydrochloride] results in increased expression of FAS mRNA",,,PMID:33069748,https://www.ncbi.nlm.nih.gov/pubmed/33069748,33069748,,
1791,1386760,107969,Comparative Toxicogenomics Database (CTD),Fingolimod Hydrochloride,D000068876,Fingolimod Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000068876,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090.0,Mus musculus (house mouse),Fingolimod hydrochloride results in increased expression of FOS mRNA,,,PMID:24859201,https://www.ncbi.nlm.nih.gov/pubmed/24859201,24859201,,
1792,1459740,107971,Comparative Toxicogenomics Database (CTD),Daidzin,C013908,daidzin,https://ctdbase.org/detail.go?type=chem&acc=C013908,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116.0,Rattus norvegicus (Norway rat),"Daidzin results in increased expression of ACHE mrna|4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [daidzin results in increased expression of ACHE mrna]|4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [daidzin results in increased expression of and results in increased activity of ACHE protein]|daidzin results in increased expression of and results in increased activity of ACHE protein",,,PMID:31034797,https://www.ncbi.nlm.nih.gov/pubmed/31034797,31034797,,
1793,1459741,107971,Comparative Toxicogenomics Database (CTD),Daidzin,C013908,daidzin,https://ctdbase.org/detail.go?type=chem&acc=C013908,2181,ACSL3,https://ctdbase.org/detail.go?type=gene&acc=2181,,,2181.0,ACSL3,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
1794,1459742,107971,Comparative Toxicogenomics Database (CTD),Daidzin,C013908,daidzin,https://ctdbase.org/detail.go?type=chem&acc=C013908,8854,ALDH1A2,https://ctdbase.org/detail.go?type=gene&acc=8854,,,8854.0,ALDH1A2,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] affects the expression of ALDH1A2 mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
1795,1461751,108052,Comparative Toxicogenomics Database (CTD),Cafestol,C053400,cafestol,https://ctdbase.org/detail.go?type=chem&acc=C053400,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,10114.0,Rattus,Cafestol results in increased activity of MGMT protein|[cafestol co-treated with kahweol] results in increased activity of MGMT protein,,,PMID:12517412,https://www.ncbi.nlm.nih.gov/pubmed/12517412,12517412,,
1796,1461752,108052,Comparative Toxicogenomics Database (CTD),Cafestol,C053400,cafestol,https://ctdbase.org/detail.go?type=chem&acc=C053400,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),[cafestol co-treated with kahweol palmitate] affects the activity of NFE2L2 protein,,,PMID:11309284,https://www.ncbi.nlm.nih.gov/pubmed/11309284,11309284,,
1797,1461753,108052,Comparative Toxicogenomics Database (CTD),Cafestol,C053400,cafestol,https://ctdbase.org/detail.go?type=chem&acc=C053400,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),NFE2L2 protein affects the reaction [[cafestol co-treated with kahweol] results in decreased susceptibility to acrolein]|nfe2l2 protein promotes the reaction [[cafestol co-treated with kahweol] results in increased expression of NQO1 mrna],,,PMID:18028974,https://www.ncbi.nlm.nih.gov/pubmed/18028974,18028974,,
1798,1461754,108052,Comparative Toxicogenomics Database (CTD),Cafestol,C053400,cafestol,https://ctdbase.org/detail.go?type=chem&acc=C053400,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein],,,PMID:17110534,https://www.ncbi.nlm.nih.gov/pubmed/17110534,17110534,,
1799,1461755,108052,Comparative Toxicogenomics Database (CTD),Cafestol,C053400,cafestol,https://ctdbase.org/detail.go?type=chem&acc=C053400,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090.0,Mus musculus (house mouse),[cafestol co-treated with kahweol palmitate] results in increased expression of NQO1 protein,,,PMID:11309284,https://www.ncbi.nlm.nih.gov/pubmed/11309284,11309284,,
1800,1461756,108052,Comparative Toxicogenomics Database (CTD),Cafestol,C053400,cafestol,https://ctdbase.org/detail.go?type=chem&acc=C053400,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090.0,Mus musculus (house mouse),[cafestol co-treated with kahweol] results in increased expression of NQO1 protein|nfe2l2 protein promotes the reaction [[cafestol co-treated with kahweol] results in increased expression of NQO1 mrna]|[cafestol co-treated with kahweol] results in increased expression of NQO1 mRNA,,,PMID:18028974,https://www.ncbi.nlm.nih.gov/pubmed/18028974,18028974,,
1801,1472911,108092,Comparative Toxicogenomics Database (CTD),Tesmilifene,C043062,tesmilifene,https://ctdbase.org/detail.go?type=chem&acc=C043062,942,CD86,https://ctdbase.org/detail.go?type=gene&acc=942,,,942.0,CD86,9606.0,Homo sapiens (human),Tesmilifene results in decreased expression of CD86 protein,,,PMID:11306145,https://www.ncbi.nlm.nih.gov/pubmed/11306145,11306145,,
1802,1472912,108092,Comparative Toxicogenomics Database (CTD),Tesmilifene,C043062,tesmilifene,https://ctdbase.org/detail.go?type=chem&acc=C043062,3676,ITGA4,https://ctdbase.org/detail.go?type=gene&acc=3676,,,3676.0,ITGA4,9606.0,Homo sapiens (human),Tesmilifene results in decreased expression of ITGA4 protein,,,PMID:11556524,https://www.ncbi.nlm.nih.gov/pubmed/11556524,11556524,,
1803,1472913,108092,Comparative Toxicogenomics Database (CTD),Tesmilifene,C043062,tesmilifene,https://ctdbase.org/detail.go?type=chem&acc=C043062,3687,ITGAX,https://ctdbase.org/detail.go?type=gene&acc=3687,,,3687.0,ITGAX,9606.0,Homo sapiens (human),Tesmilifene results in decreased expression of ITGAX protein,,,PMID:11306145|PMID:11556524,https://www.ncbi.nlm.nih.gov/pubmed/11306145|https://www.ncbi.nlm.nih.gov/pubmed/11556524,11306145|11556524,,
1804,1472914,108092,Comparative Toxicogenomics Database (CTD),Tesmilifene,C043062,tesmilifene,https://ctdbase.org/detail.go?type=chem&acc=C043062,4035,LRP1,https://ctdbase.org/detail.go?type=gene&acc=4035,,,4035.0,LRP1,9606.0,Homo sapiens (human),Tesmilifene results in decreased expression of LRP1 protein,,,PMID:11556524,https://www.ncbi.nlm.nih.gov/pubmed/11556524,11556524,,
1805,1472915,108092,Comparative Toxicogenomics Database (CTD),Tesmilifene,C043062,tesmilifene,https://ctdbase.org/detail.go?type=chem&acc=C043062,5788,PTPRC,https://ctdbase.org/detail.go?type=gene&acc=5788,,,5788.0,PTPRC,9606.0,Homo sapiens (human),Tesmilifene results in decreased expression of PTPRC protein,,,PMID:11306145,https://www.ncbi.nlm.nih.gov/pubmed/11306145,11306145,,
1806,1397918,108135,IUPHAR/BPS Guide to PHARMACOLOGY,Tyrosyl-glycyl-glycyl-phenylalanyl-leucyl-arginyl-arginyl-isoleucine,1621,dynorphin A-(1-8),https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1621,318, receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=318,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),Full agonist,pKi,8 - 9.9,PMID:9686407|PMID:7624359|PMID:1967312,https://www.ncbi.nlm.nih.gov/pubmed/9686407|https://www.ncbi.nlm.nih.gov/pubmed/7624359|https://www.ncbi.nlm.nih.gov/pubmed/1967312,9686407|7624359|1967312,,
1807,1388060,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116.0,Rattus norvegicus (Norway rat),BDNF affects the reaction [tamibarotene results in increased phosphorylation of NTRK2 protein]|bdnf affects the reaction [tamibarotene results in increased phosphorylation of MAPK1 protein]|tamibarotene results in increased expression of BDNF mrna|bdnf affects the reaction [tamibarotene results in increased phosphorylation of MAPK3 protein],,,PMID:19457078,https://www.ncbi.nlm.nih.gov/pubmed/19457078,19457078,,
1808,1388180,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,7832,BTG2,https://ctdbase.org/detail.go?type=gene&acc=7832,,,7832.0,BTG2,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of BTG2 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1809,1388181,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,23705,CADM1,https://ctdbase.org/detail.go?type=gene&acc=23705,,,23705.0,CADM1,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of CADM1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1810,1388182,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,8536,CAMK1,https://ctdbase.org/detail.go?type=gene&acc=8536,,,8536.0,CAMK1,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of CAMK1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1811,1388183,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,23125,CAMTA2,https://ctdbase.org/detail.go?type=gene&acc=23125,,,23125.0,CAMTA2,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of CAMTA2 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1812,1388184,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,822,CAPG,https://ctdbase.org/detail.go?type=gene&acc=822,,,822.0,CAPG,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of CAPG mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1813,1388185,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,4076,CAPRIN1,https://ctdbase.org/detail.go?type=gene&acc=4076,,,4076.0,CAPRIN1,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of CAPRIN1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1814,1388186,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of CASP9 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1815,1388187,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,11335,CBX3,https://ctdbase.org/detail.go?type=gene&acc=11335,,,11335.0,CBX3,9606.0,Homo sapiens (human),Tamibarotene affects the expression of CBX3 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1816,1388188,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,28952,CCDC22,https://ctdbase.org/detail.go?type=gene&acc=28952,,,28952.0,CCDC22,9606.0,Homo sapiens (human),Tamibarotene affects the expression of CCDC22 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1817,1388189,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,54520,CCDC93,https://ctdbase.org/detail.go?type=gene&acc=54520,,,54520.0,CCDC93,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of CCDC93 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1818,1388301,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of CCL5 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1819,1388302,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,10090.0,Mus musculus (house mouse),Tamibarotene results in decreased expression of CCL5 mRNA,,,PMID:20861477,https://www.ncbi.nlm.nih.gov/pubmed/20861477,20861477,,
1820,1388303,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,20305,CCL6,https://ctdbase.org/detail.go?type=gene&acc=20305,,,20305.0,Ccl6,10090.0,Mus musculus (house mouse),Tamibarotene results in decreased expression of CCL6 mRNA,,,PMID:20861477,https://www.ncbi.nlm.nih.gov/pubmed/20861477,20861477,,
1821,1388304,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,6355,CCL8,https://ctdbase.org/detail.go?type=gene&acc=6355,,,6355.0,CCL8,10090.0,Mus musculus (house mouse),Tamibarotene results in decreased expression of CCL8 mRNA,,,PMID:20861477,https://www.ncbi.nlm.nih.gov/pubmed/20861477,20861477,,
1822,1388305,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of CCND1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1823,1388306,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,899,CCNF,https://ctdbase.org/detail.go?type=gene&acc=899,,,899.0,CCNF,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of CCNF mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1824,1388307,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,9606.0,Homo sapiens (human),Tamibarotene affects the expression of CCNG1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1825,1388308,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,1230,CCR1,https://ctdbase.org/detail.go?type=gene&acc=1230,,,1230.0,CCR1,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of CCR1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1826,1388309,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,933,CD22,https://ctdbase.org/detail.go?type=gene&acc=933,,,933.0,CD22,9606.0,Homo sapiens (human),Tamibarotene affects the expression of CD22 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1827,1388430,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,972,CD74,https://ctdbase.org/detail.go?type=gene&acc=972,,,972.0,CD74,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of CD74 mRNA,,,PMID:17229644,https://www.ncbi.nlm.nih.gov/pubmed/17229644,17229644,,
1828,1389044,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,667,DST,https://ctdbase.org/detail.go?type=gene&acc=667,,,667.0,DST,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of DST mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1829,1389523,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,10211,FLOT1,https://ctdbase.org/detail.go?type=gene&acc=10211,,,10211.0,FLOT1,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of FLOT1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1830,1389524,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,2354,FOSB,https://ctdbase.org/detail.go?type=gene&acc=2354,,,2354.0,FOSB,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of FOSB mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1831,1389525,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,4303,FOXO4,https://ctdbase.org/detail.go?type=gene&acc=4303,,,4303.0,FOXO4,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of FOXO4 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1832,1390275,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10116.0,Rattus norvegicus (Norway rat),Tamibarotene results in decreased expression of IFNG mRNA,,,PMID:11043609,https://www.ncbi.nlm.nih.gov/pubmed/11043609,11043609,,
1833,1390276,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,3485,IGFBP2,https://ctdbase.org/detail.go?type=gene&acc=3485,,,3485.0,IGFBP2,9606.0,Homo sapiens (human),Tamibarotene affects the expression of IGFBP2 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1834,1390277,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,3486,IGFBP3,https://ctdbase.org/detail.go?type=gene&acc=3486,,,3486.0,IGFBP3,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of IGFBP3 mrna|tamibarotene results in increased expression of IGFBP3 protein,,,PMID:10766424,https://www.ncbi.nlm.nih.gov/pubmed/10766424,10766424,,
1835,1390278,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,3500,IGHG1,https://ctdbase.org/detail.go?type=gene&acc=3500,,,3500.0,IGHG1,9606.0,Homo sapiens (human),Tamibarotene affects the expression of IGHG1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1836,1390279,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,339562,IGKV1OR2-118,https://ctdbase.org/detail.go?type=gene&acc=339562,,,339562.0,IGKV1OR2-118,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of IGKV1OR2-118 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1837,1390280,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,10320,IKZF1,https://ctdbase.org/detail.go?type=gene&acc=10320,,,10320.0,IKZF1,9606.0,Homo sapiens (human),Tamibarotene affects the expression of IKZF1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1838,1391136,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,23499,MACF1,https://ctdbase.org/detail.go?type=gene&acc=23499,,,23499.0,MACF1,9606.0,Homo sapiens (human),Tamibarotene affects the expression of MACF1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1839,1391137,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,90355,MACIR,https://ctdbase.org/detail.go?type=gene&acc=90355,,,90355.0,MACIR,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of MACIR mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1840,1391138,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,11184,MAP4K1,https://ctdbase.org/detail.go?type=gene&acc=11184,,,11184.0,MAP4K1,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of MAP4K1 mRNA,,,PMID:17229644,https://www.ncbi.nlm.nih.gov/pubmed/17229644,17229644,,
1841,1391139,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),[tamibarotene co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] results in decreased phosphorylation of and results in decreased activity of MAPK1 protein|tamibarotene promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in decreased activity of MAPK1 protein],,,PMID:15020266,https://www.ncbi.nlm.nih.gov/pubmed/15020266,15020266,,
1842,1391140,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),BDNF affects the reaction [tamibarotene results in increased phosphorylation of MAPK1 protein]|tamibarotene results in increased phosphorylation of MAPK1 protein,,,PMID:19457078,https://www.ncbi.nlm.nih.gov/pubmed/19457078,19457078,,
1843,1391141,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606.0,Homo sapiens (human),Tamibarotene affects the expression of MAPK14 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1844,1391381,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,4600,MX2,https://ctdbase.org/detail.go?type=gene&acc=4600,,,4600.0,MX2,9606.0,Homo sapiens (human),Tamibarotene affects the expression of MX2 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1845,1391382,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,4602,MYB,https://ctdbase.org/detail.go?type=gene&acc=4602,,,4602.0,MYB,9606.0,Homo sapiens (human),Tamibarotene affects the expression of MYB mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1846,1391383,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of MYC mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1847,1391384,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,4615,MYD88,https://ctdbase.org/detail.go?type=gene&acc=4615,,,4615.0,MYD88,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of MYD88 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1848,1391494,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,4673,NAP1L1,https://ctdbase.org/detail.go?type=gene&acc=4673,,,4673.0,NAP1L1,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of NAP1L1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1849,1391495,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,22916,NCBP2,https://ctdbase.org/detail.go?type=gene&acc=22916,,,22916.0,NCBP2,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of NCBP2 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1850,1391496,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,653361,NCF1,https://ctdbase.org/detail.go?type=gene&acc=653361,,,653361.0,NCF1,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of NCF1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1851,1391497,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,4690,NCK1,https://ctdbase.org/detail.go?type=gene&acc=4690,,,4690.0,NCK1,9606.0,Homo sapiens (human),Tamibarotene affects the expression of NCK1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1852,1391498,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,23054,NCOA6,https://ctdbase.org/detail.go?type=gene&acc=23054,,,23054.0,NCOA6,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of NCOA6 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1853,1391499,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,9612,NCOR2,https://ctdbase.org/detail.go?type=gene&acc=9612,,,9612.0,NCOR2,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of NCOR2 mRNA,,,PMID:17229644,https://www.ncbi.nlm.nih.gov/pubmed/17229644,17229644,,
1854,1391500,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,23306,NEMP1,https://ctdbase.org/detail.go?type=gene&acc=23306,,,23306.0,NEMP1,9606.0,Homo sapiens (human),Tamibarotene results in decreased expression of NEMP1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1855,1391501,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,4778,NFE2,https://ctdbase.org/detail.go?type=gene&acc=4778,,,4778.0,NFE2,9606.0,Homo sapiens (human),Tamibarotene results in increased expression of NFE2 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1856,1391617,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,9606.0,Homo sapiens (human),Tamibarotene results in increased activity of NR1H4 protein|tamibarotene inhibits the reaction [chenodeoxycholic acid results in increased activity of NR1H4 protein],,,PMID:25257666,https://www.ncbi.nlm.nih.gov/pubmed/25257666,25257666,,
1857,1397919,108143,Drug Gene Interaction database (DGIdb),Tamibarotene,,TAMIBAROTENE,https://www.dgidb.org/drugs/ncit:C71025,,RARB,https://www.dgidb.org/genes/hgnc:9865,,,5915.0,RARB,9606.0,Homo sapiens (human),,,,,,,,
1858,1397920,108147,Comparative Toxicogenomics Database (CTD),Senktide,C054724,senktide,https://ctdbase.org/detail.go?type=chem&acc=C054724,6869,TACR1,https://ctdbase.org/detail.go?type=gene&acc=6869,,,6869.0,TACR1,10116.0,Rattus norvegicus (Norway rat),Senktide binds to and results in increased activity of TACR1 protein,,,PMID:11245602,https://www.ncbi.nlm.nih.gov/pubmed/11245602,11245602,,
1859,1397921,108147,Comparative Toxicogenomics Database (CTD),Senktide,C054724,senktide,https://ctdbase.org/detail.go?type=chem&acc=C054724,6870,TACR3,https://ctdbase.org/detail.go?type=gene&acc=6870,,,6870.0,TACR3,10047.0,Meriones unguiculatus (Mongolian gerbil),Senktide binds to and results in increased activity of TACR3 protein,,,PMID:18930726,https://www.ncbi.nlm.nih.gov/pubmed/18930726,18930726,,
1860,1393405,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,5724,PTAFR,https://ctdbase.org/detail.go?type=gene&acc=5724,,,5724.0,PTAFR,10116.0,Rattus norvegicus (Norway rat),Platelet activating factor results in increased expression of PTAFR mRNA,,,PMID:10447766|PMID:9065783,https://www.ncbi.nlm.nih.gov/pubmed/10447766|https://www.ncbi.nlm.nih.gov/pubmed/9065783,10447766|9065783,,
1861,1393406,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,5724,PTAFR,https://ctdbase.org/detail.go?type=gene&acc=5724,,,5724.0,PTAFR,10116.0,Rattus norvegicus (Norway rat),RGS4 protein inhibits the reaction [platelet activating factor results in increased phosphorylation of PTAFR protein]|platelet activating factor results in increased phosphorylation of PTAFR protein,,,PMID:11297424,https://www.ncbi.nlm.nih.gov/pubmed/11297424,11297424,,
1862,1393407,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,9606.0,Homo sapiens (human),Platelet activating factor results in increased expression of PTGS1 mRNA,,,PMID:16386258,https://www.ncbi.nlm.nih.gov/pubmed/16386258,16386258,,
1863,1393408,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Platelet activating factor results in increased expression of PTGS2 mRNA,,,PMID:16386258,https://www.ncbi.nlm.nih.gov/pubmed/16386258,16386258,,
1864,1393409,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Platelet activating factor results in increased expression of PTGS2,,,PMID:15020195,https://www.ncbi.nlm.nih.gov/pubmed/15020195,15020195,,
1865,1393410,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,5820,PVT1,https://ctdbase.org/detail.go?type=gene&acc=5820,,,5820.0,PVT1,9606.0,Homo sapiens (human),[platelet activating factor co-treated with PVT1 mrna] affects the expression of MIR149 mrna|platelet activating factor results in increased expression of PVT1 mrna|pvt1 mRNA affects the reaction [platelet activating factor results in increased secretion of IL6 protein]|pvt1 mRNA affects the reaction [platelet activating factor results in increased expression of MYD88 protein]|pvt1 mRNA affects the reaction [platelet activating factor results in increased secretion of TNF protein]|pvt1 mRNA affects the reaction [platelet activating factor results in increased secretion of IL1B protein],,,PMID:32830409,https://www.ncbi.nlm.nih.gov/pubmed/32830409,32830409,,
1866,1393411,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,5999,RGS4,https://ctdbase.org/detail.go?type=gene&acc=5999,,,5999.0,RGS4,10116.0,Rattus norvegicus (Norway rat),RGS4 protein inhibits the reaction [platelet activating factor results in increased phosphorylation of PTAFR protein],,,PMID:11297424,https://www.ncbi.nlm.nih.gov/pubmed/11297424,11297424,,
1867,1393534,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,6403,SELP,https://ctdbase.org/detail.go?type=gene&acc=6403,,,6403.0,SELP,9606.0,Homo sapiens (human),Foropafant inhibits the reaction [platelet activating factor results in increased expression of SELP protein]|platelet activating factor results in increased expression of SELP protein,,,PMID:11116075,https://www.ncbi.nlm.nih.gov/pubmed/11116075,11116075,,
1868,1393535,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,7079,TIMP4,https://ctdbase.org/detail.go?type=gene&acc=7079,,,7079.0,TIMP4,9606.0,Homo sapiens (human),Platelet activating factor results in increased expression of TIMP4 mRNA,,,PMID:16386258,https://www.ncbi.nlm.nih.gov/pubmed/16386258,16386258,,
1869,1393536,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),PVT1 mRNA affects the reaction [platelet activating factor results in increased secretion of TNF protein]|[platelet activating factor co-treated with MIR149 mrna] affects the secretion of TNF protein,,,PMID:32830409,https://www.ncbi.nlm.nih.gov/pubmed/32830409,32830409,,
1870,1393537,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Platelet activating factor results in increased expression of TNF mRNA,,,PMID:16386258,https://www.ncbi.nlm.nih.gov/pubmed/16386258,16386258,,
1871,1393538,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Platelet activating factor results in increased secretion of TNF protein,,,PMID:16386258|PMID:32830409,https://www.ncbi.nlm.nih.gov/pubmed/16386258|https://www.ncbi.nlm.nih.gov/pubmed/32830409,16386258|32830409,,
1872,1393539,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),BN 50739 inhibits the reaction [platelet activating factor results in increased expression of TNF mrna]|platelet activating factor results in increased expression of TNF mrna|pyrrolidine dithiocarbamic acid inhibits the reaction [platelet activating factor results in increased expression of TNF mrna]|acetylcysteine inhibits the reaction [platelet activating factor results in increased expression of TNF mrna]|vitamin E inhibits the reaction [platelet activating factor results in increased expression of TNF mrna],,,PMID:10921504,https://www.ncbi.nlm.nih.gov/pubmed/10921504,10921504,,
1873,1393540,108156,Comparative Toxicogenomics Database (CTD),Platelet activating factor,D010972,Platelet Activating Factor,https://ctdbase.org/detail.go?type=chem&acc=D010972,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),TNF protein affects the reaction [platelet activating factor results in increased expression of PTAFR mrna],,,PMID:9065783,https://www.ncbi.nlm.nih.gov/pubmed/9065783,9065783,,
1874,1393541,108173,Drug Gene Interaction database (DGIdb),Tocainide Hydrochloride,,TOCAINIDE HYDROCHLORIDE,https://www.dgidb.org/drugs/ncit:C47761,,SCN7A,https://www.dgidb.org/genes/hgnc:10594,,,6332.0,SCN7A,9606.0,Homo sapiens (human),Blocker,,,,,,,
1875,1393542,108173,Drug Gene Interaction database (DGIdb),Tocainide Hydrochloride,,TOCAINIDE HYDROCHLORIDE,https://www.dgidb.org/drugs/ncit:C47761,,SCN2A,https://www.dgidb.org/genes/hgnc:10588,,,6326.0,SCN2A,9606.0,Homo sapiens (human),Blocker,,,,,,,
1876,1393780,108213,Comparative Toxicogenomics Database (CTD),Bifendate,C465548,bifendate,https://ctdbase.org/detail.go?type=chem&acc=C465548,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),Bifendate inhibits the reaction [carbon tetrachloride results in increased phosphorylation of RELA protein],,,PMID:24975834,https://www.ncbi.nlm.nih.gov/pubmed/24975834,24975834,,
1877,1393781,108213,Comparative Toxicogenomics Database (CTD),Bifendate,C465548,bifendate,https://ctdbase.org/detail.go?type=chem&acc=C465548,6667,SP1,https://ctdbase.org/detail.go?type=gene&acc=6667,,,6667.0,SP1,9606.0,Homo sapiens (human),SP1 protein inhibits the reaction [bifendate analog results in decreased expression of ITGAV protein]|bifendate analog inhibits the reaction [SP1 protein binds to ITGAV promoter],,,PMID:31932644,https://www.ncbi.nlm.nih.gov/pubmed/31932644,31932644,,
1878,1393782,108213,Comparative Toxicogenomics Database (CTD),Bifendate,C465548,bifendate,https://ctdbase.org/detail.go?type=chem&acc=C465548,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606.0,Homo sapiens (human),Bifendate analog results in decreased expression of TGFB1 mrna|bifendate analog inhibits the reaction [TGFB1 protein results in increased expression of ITGAV mrna]|bifendate analog results in decreased expression of TGFB1 protein|bifendate analog inhibits the reaction [TGFB1 protein results in increased expression of ITGAV protein]|bifendate analog inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]|itgav protein inhibits the reaction [bifendate analog results in decreased expression of TGFB1 protein]|bifendate analog inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]|bifendate analog inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mrna]|bifendate analog inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mrna],,,PMID:31932644,https://www.ncbi.nlm.nih.gov/pubmed/31932644,31932644,,
1879,1393783,108213,Comparative Toxicogenomics Database (CTD),Bifendate,C465548,bifendate,https://ctdbase.org/detail.go?type=chem&acc=C465548,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606.0,Homo sapiens (human),Bifendate analog inhibits the reaction [TGFB1 protein results in increased expression of TGFB1 mrna],,,PMID:31932644,https://www.ncbi.nlm.nih.gov/pubmed/31932644,31932644|31932644,,
1880,1393784,108213,Comparative Toxicogenomics Database (CTD),Bifendate,C465548,bifendate,https://ctdbase.org/detail.go?type=chem&acc=C465548,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090.0,Mus musculus (house mouse),Bifendate inhibits the reaction [glycosides results in decreased expression of TGFB1 mrna]|bifendate inhibits the reaction [lei gong teng analog results in decreased expression of TGFB1 mrna],,,PMID:26763404,https://www.ncbi.nlm.nih.gov/pubmed/26763404,26763404,,
1881,1393785,108213,Comparative Toxicogenomics Database (CTD),Bifendate,C465548,bifendate,https://ctdbase.org/detail.go?type=chem&acc=C465548,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Bifendate inhibits the reaction [carbon tetrachloride results in increased expression of TNF protein],,,PMID:24975834,https://www.ncbi.nlm.nih.gov/pubmed/24975834,24975834,,
1882,1393786,108213,Comparative Toxicogenomics Database (CTD),Bifendate,C465548,bifendate,https://ctdbase.org/detail.go?type=chem&acc=C465548,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Bifendate inhibits the reaction [glycosides results in increased expression of TNF protein]|bifendate inhibits the reaction [lei gong teng analog results in increased expression of TNF protein],,,PMID:26763404,https://www.ncbi.nlm.nih.gov/pubmed/26763404,26763404,,
1883,1461869,108326,BindingDB,"2-Benzoylimino-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide",16672,"5-Benzoylimino-4-methyl-delta2-1,3,4-thiadiazoline-2-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16672,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),850,PMID:14971907|DOI:10.1021/jm031057+,https://www.ncbi.nlm.nih.gov/pubmed/14971907|https://doi.org/10.1021/jm031057+,14971907,10.1021/jm031057+,
1884,1461870,108326,BindingDB,"2-Benzoylimino-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide",16672,"5-Benzoylimino-4-methyl-delta2-1,3,4-thiadiazoline-2-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16672,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),174,PMID:14971907|DOI:10.1021/jm031057+,https://www.ncbi.nlm.nih.gov/pubmed/14971907|https://doi.org/10.1021/jm031057+,14971907,10.1021/jm031057+,
1885,1462140,110821,Comparative Toxicogenomics Database (CTD),Ephenidine,C000598690,"N-ethyl-1,2-diphenylethylamine",https://ctdbase.org/detail.go?type=chem&acc=C000598690,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),"CYP2C19 protein results in decreased alkylation of N-ethyl-1,2-diphenylethylamine",,,PMID:26276083,https://www.ncbi.nlm.nih.gov/pubmed/26276083,26276083,,
1886,1462141,110821,Comparative Toxicogenomics Database (CTD),Ephenidine,C000598690,"N-ethyl-1,2-diphenylethylamine",https://ctdbase.org/detail.go?type=chem&acc=C000598690,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),"CYP2D6 protein results in decreased alkylation of N-ethyl-1,2-diphenylethylamine",,,PMID:26276083,https://www.ncbi.nlm.nih.gov/pubmed/26276083,26276083,,
1887,1462142,110821,Comparative Toxicogenomics Database (CTD),Ephenidine,C000598690,"N-ethyl-1,2-diphenylethylamine",https://ctdbase.org/detail.go?type=chem&acc=C000598690,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),"CYP3A4 protein results in decreased alkylation of N-ethyl-1,2-diphenylethylamine",,,PMID:26276083,https://www.ncbi.nlm.nih.gov/pubmed/26276083,26276083,,
1888,1462143,111337,BindingDB,"11alpha-Hydroxyandrosta-1,4-diene-3,17-dione",91720,"11alpha-Hydroxyandrost-1,4-dien-3,17-dione, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=91720,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),1.6467e+5,PMID:18728994|DOI:10.1080/14756360802236393,https://www.ncbi.nlm.nih.gov/pubmed/18728994|https://doi.org/10.1080/14756360802236393,18728994,10.1080/14756360802236393,
1889,1461871,111865,Toxin and Toxin Target Database (T3DB),Platinum tetrabromide,T3D1747,Platinum(IV) bromide,http://www.t3db.ca/toxins/T3D1747,BE0005290,Chloride channel protein 1,http://www.t3db.ca/biodb/bio_entities/BE0005290,P35523,Chloride channel protein 1,1180.0,CLCN1,9606.0,Homo sapiens (human),,,,PMID:3047312|PMID:10050002,https://www.ncbi.nlm.nih.gov/pubmed/3047312|https://www.ncbi.nlm.nih.gov/pubmed/10050002,3047312|10050002,,
1890,1461872,111865,Toxin and Toxin Target Database (T3DB),Platinum tetrabromide,T3D1747,Platinum(IV) bromide,http://www.t3db.ca/toxins/T3D1747,BE0002376,Chloride channel protein ClC-Ka,http://www.t3db.ca/biodb/bio_entities/BE0002376,P51800,Chloride channel protein ClC-Ka,1187.0,CLCNKA,9606.0,Homo sapiens (human),,,,PMID:3047312|PMID:10050002,https://www.ncbi.nlm.nih.gov/pubmed/3047312|https://www.ncbi.nlm.nih.gov/pubmed/10050002,3047312|10050002,,
1891,1462144,114429,Drug Gene Interaction database (DGIdb),"(S)-2,3-Dihydro-5,7-dihydroxy-6-methyl-2-phenyl-4-benzopyrone",,STROBOPININ,https://www.dgidb.org/drugs/chembl:CHEMBL1556958,,HSPA5,https://www.dgidb.org/genes/hgnc:5238,,,3309.0,HSPA5,9606.0,Homo sapiens (human),,,,,,,,
1892,1462145,114627,Comparative Toxicogenomics Database (CTD),Neoeriocitrin,C553460,neoeriocitrin,https://ctdbase.org/detail.go?type=chem&acc=C553460,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10090.0,Mus musculus (house mouse),Neoeriocitrin inhibits the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of BGLAP mrna]|neoeriocitrin results in increased expression of BGLAP mRNA,,,PMID:21741227,https://www.ncbi.nlm.nih.gov/pubmed/21741227,21741227,,
1893,1462146,114627,Comparative Toxicogenomics Database (CTD),Neoeriocitrin,C553460,neoeriocitrin,https://ctdbase.org/detail.go?type=chem&acc=C553460,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090.0,Mus musculus (house mouse),Neoeriocitrin inhibits the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of COL1A1 mrna]|neoeriocitrin results in increased expression of COL1A1 mRNA,,,PMID:21741227,https://www.ncbi.nlm.nih.gov/pubmed/21741227,21741227,,
1894,1394572,114856,Toxin and Toxin Target Database (T3DB),Amanullin,T3D3588,Amanullin,http://www.t3db.ca/toxins/T3D3588,BE0005270,"DNA-directed RNA polymerases I, II, and III subunit RPABC3",http://www.t3db.ca/biodb/bio_entities/BE0005270,P52434,"DNA-directed RNA polymerases I, II, and III subunit RPABC3",5437.0,POLR2H,9606.0,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
1895,1394573,114856,Toxin and Toxin Target Database (T3DB),Amanullin,T3D3588,Amanullin,http://www.t3db.ca/toxins/T3D3588,BE0005425,"DNA-directed RNA polymerases I, II, and III subunit RPABC4",http://www.t3db.ca/biodb/bio_entities/BE0005425,P53803,"DNA-directed RNA polymerases I, II, and III subunit RPABC4",5440.0,POLR2K,9606.0,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
1896,1394574,114856,Toxin and Toxin Target Database (T3DB),Amanullin,T3D3588,Amanullin,http://www.t3db.ca/toxins/T3D3588,BE0005271,"DNA-directed RNA polymerases I, II, and III subunit RPABC5",http://www.t3db.ca/biodb/bio_entities/BE0005271,P62875,"DNA-directed RNA polymerases I, II, and III subunit RPABC5",5441.0,POLR2L,9606.0,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
1897,1394575,114858,Comparative Toxicogenomics Database (CTD),Butoxyacetaldehyde,C053320,n-butoxyacetaldehyde,https://ctdbase.org/detail.go?type=chem&acc=C053320,216,ALDH1A1,https://ctdbase.org/detail.go?type=gene&acc=216,,,216.0,ALDH1A1,9606.0,Homo sapiens (human),ALDH1A1 protein results in increased oxidation of n-butoxyacetaldehyde,,,PMID:18940187,https://www.ncbi.nlm.nih.gov/pubmed/18940187,18940187,,
1898,1394576,114858,Comparative Toxicogenomics Database (CTD),Butoxyacetaldehyde,C053320,n-butoxyacetaldehyde,https://ctdbase.org/detail.go?type=chem&acc=C053320,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,9606.0,Homo sapiens (human),ALDH2 protein results in increased oxidation of n-butoxyacetaldehyde,,,PMID:18940187,https://www.ncbi.nlm.nih.gov/pubmed/18940187,18940187,,
1899,1394577,114858,Comparative Toxicogenomics Database (CTD),Butoxyacetaldehyde,C053320,n-butoxyacetaldehyde,https://ctdbase.org/detail.go?type=chem&acc=C053320,218,ALDH3A1,https://ctdbase.org/detail.go?type=gene&acc=218,,,218.0,ALDH3A1,9606.0,Homo sapiens (human),ALDH3A1 protein results in increased oxidation of n-butoxyacetaldehyde,,,PMID:18940187,https://www.ncbi.nlm.nih.gov/pubmed/18940187,18940187,,
1900,1398263,114909,Comparative Toxicogenomics Database (CTD),Tephrosin,C480848,tephrosin,https://ctdbase.org/detail.go?type=chem&acc=C480848,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606.0,Homo sapiens (human),Tephrosin inhibits the reaction [TNF protein results in increased expression of NOS2 protein],,,PMID:18841906,https://www.ncbi.nlm.nih.gov/pubmed/18841906,18841906,,
1901,1398264,114909,Comparative Toxicogenomics Database (CTD),Tephrosin,C480848,tephrosin,https://ctdbase.org/detail.go?type=chem&acc=C480848,3084,NRG1,https://ctdbase.org/detail.go?type=gene&acc=3084,,,3084.0,NRG1,9606.0,Homo sapiens (human),Tephrosin inhibits the reaction [NRG1 protein affects the phosphorylation of AKT1 protein]|tephrosin inhibits the reaction [NRG1 protein affects the phosphorylation of MAPK3 protein]|tephrosin inhibits the reaction [NRG1 protein affects the phosphorylation of ERBB3 protein]|tephrosin inhibits the reaction [NRG1 protein affects the phosphorylation of ERBB2 protein]|tephrosin inhibits the reaction [NRG1 protein affects the phosphorylation of MAPK1 protein],,,PMID:20056314,https://www.ncbi.nlm.nih.gov/pubmed/20056314,20056314,,
1902,1398265,114909,Comparative Toxicogenomics Database (CTD),Tephrosin,C480848,tephrosin,https://ctdbase.org/detail.go?type=chem&acc=C480848,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Tephrosin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein],,,PMID:18841906,https://www.ncbi.nlm.nih.gov/pubmed/18841906,18841906,,
1903,1398266,114909,Comparative Toxicogenomics Database (CTD),Tephrosin,C480848,tephrosin,https://ctdbase.org/detail.go?type=chem&acc=C480848,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Tephrosin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]|tephrosin inhibits the reaction [TNF protein results in increased expression of BIRC3 protein]|tephrosin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]|tephrosin inhibits the reaction [TNF protein results in increased expression of BIRC2 protein]|tephrosin inhibits the reaction [TNF protein results in increased expression of NOS2 protein],,,PMID:18841906,https://www.ncbi.nlm.nih.gov/pubmed/18841906,18841906,,
1904,1398267,114920,Comparative Toxicogenomics Database (CTD),11beta-Hydroxytestosterone,C037914,11-hydroxytestosterone,https://ctdbase.org/detail.go?type=chem&acc=C037914,100067109,CYP3A95,https://ctdbase.org/detail.go?type=gene&acc=100067109,,,100067109.0,,9796.0,Equus caballus (horse),CYP3A95 protein results in increased chemical synthesis of 11-hydroxytestosterone,,,PMID:24479850,https://www.ncbi.nlm.nih.gov/pubmed/24479850,24479850,,
1905,1398268,114920,Comparative Toxicogenomics Database (CTD),11beta-Hydroxytestosterone,C037914,11-hydroxytestosterone,https://ctdbase.org/detail.go?type=chem&acc=C037914,3291,HSD11B2,https://ctdbase.org/detail.go?type=gene&acc=3291,,,3291.0,HSD11B2,7955.0,Danio rerio (zebrafish),HSD11B2 protein results in increased metabolism of 11-hydroxytestosterone,,,PMID:22796344,https://www.ncbi.nlm.nih.gov/pubmed/22796344,22796344,,
1906,1394814,114943,Comparative Toxicogenomics Database (CTD),"5,6-Dihydrodibenzo(a,g)quinolizinium",C009090,protoberberine,https://ctdbase.org/detail.go?type=chem&acc=C009090,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Protoberberine analog inhibits the reaction [[3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate results in increased activity of P2RX7 protein] which results in increased phosphorylation of MAPK3 protein],,,PMID:21320518,https://www.ncbi.nlm.nih.gov/pubmed/21320518,21320518,,
1907,1398269,114982,Comparative Toxicogenomics Database (CTD),Benzyloxyresorufin,C057754,benzyloxyresorufin,https://ctdbase.org/detail.go?type=chem&acc=C057754,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),CYP3A4 protein results in increased oxidation of benzyloxyresorufin,,,PMID:32910235,https://www.ncbi.nlm.nih.gov/pubmed/32910235,32910235,,
1908,1394705,115042,Toxin and Toxin Target Database (T3DB),"Nitric acid, mercury(1+) salt (1:1)",T3D0354,Mercury(II) nitrate,http://www.t3db.ca/toxins/T3D0354,BE0005040,Aquaporin-9,http://www.t3db.ca/biodb/bio_entities/BE0005040,O43315,Aquaporin-9,366.0,AQP9,9606.0,Homo sapiens (human),"Mercury is known to inhibit aquaporins, halting water flow across the cell membrane and resulting in cell injury and death. (A26)",,,PMID:18167118,https://www.ncbi.nlm.nih.gov/pubmed/18167118,18167118,,
1909,1394706,115042,Toxin and Toxin Target Database (T3DB),"Nitric acid, mercury(1+) salt (1:1)",T3D0354,Mercury(II) nitrate,http://www.t3db.ca/toxins/T3D0354,BE0003901,Lens fiber major intrinsic protein,http://www.t3db.ca/biodb/bio_entities/BE0003901,P30301,Lens fiber major intrinsic protein,4284.0,MIP,9606.0,Homo sapiens (human),"Mercury is known to inhibit aquaporins, halting water flow across the cell membrane and resulting in cell injury and death. (A26)",,,PMID:18167118,https://www.ncbi.nlm.nih.gov/pubmed/18167118,18167118,,
1910,1394707,115042,Toxin and Toxin Target Database (T3DB),"Nitric acid, mercury(1+) salt (1:1)",T3D0354,Mercury(II) nitrate,http://www.t3db.ca/toxins/T3D0354,BE0001132,Protein kinase C alpha type,http://www.t3db.ca/biodb/bio_entities/BE0001132,P17252,Protein kinase C alpha type,5578.0,PRKCA,9606.0,Homo sapiens (human),"Mercury affects the nervous system by inhibiting protein kinase C, which impairs brain microvascular formation and function, as well as alters the blood-brain barrier. (L7)",,,,,,,
1911,1394708,115042,Toxin and Toxin Target Database (T3DB),"Nitric acid, mercury(1+) salt (1:1)",T3D0354,Mercury(II) nitrate,http://www.t3db.ca/toxins/T3D0354,BE0000872,Protein kinase C beta type,http://www.t3db.ca/biodb/bio_entities/BE0000872,P05771,Protein kinase C beta type,5579.0,PRKCB,9606.0,Homo sapiens (human),"Mercury affects the nervous system by inhibiting protein kinase C, which impairs brain microvascular formation and function, as well as alters the blood-brain barrier. (L7)",,,,,,,
1912,1394709,115042,Toxin and Toxin Target Database (T3DB),"Nitric acid, mercury(1+) salt (1:1)",T3D0354,Mercury(II) nitrate,http://www.t3db.ca/toxins/T3D0354,BE0002417,Protein kinase C delta type,http://www.t3db.ca/biodb/bio_entities/BE0002417,Q05655,Protein kinase C delta type,5580.0,PRKCD,9606.0,Homo sapiens (human),"Mercury affects the nervous system by inhibiting protein kinase C, which impairs brain microvascular formation and function, as well as alters the blood-brain barrier. (L7)",,,,,,,
1913,1394710,115042,Toxin and Toxin Target Database (T3DB),"Nitric acid, mercury(1+) salt (1:1)",T3D0354,Mercury(II) nitrate,http://www.t3db.ca/toxins/T3D0354,BE0003431,Protein kinase C epsilon type,http://www.t3db.ca/biodb/bio_entities/BE0003431,Q02156,Protein kinase C epsilon type,5581.0,PRKCE,9606.0,Homo sapiens (human),"Mercury affects the nervous system by inhibiting protein kinase C, which impairs brain microvascular formation and function, as well as alters the blood-brain barrier. (L7)",,,,,,,
1914,1394947,115042,Toxin and Toxin Target Database (T3DB),"Nitric acid, mercury(1+) salt (1:1)",T3D0354,Mercury(II) nitrate,http://www.t3db.ca/toxins/T3D0354,BE0001367,Tubulin beta-4B chain,http://www.t3db.ca/biodb/bio_entities/BE0001367,P68371,Tubulin beta-4B chain,10383.0,TUBB4B,9606.0,Homo sapiens (human),"Organic mercury exerts developmental effects by binding to tubulin, preventing microtubule assembly and causing mitotic inhibition. (L7)",,,,,,,
1915,1394948,115042,Toxin and Toxin Target Database (T3DB),"Nitric acid, mercury(1+) salt (1:1)",T3D0354,Mercury(II) nitrate,http://www.t3db.ca/toxins/T3D0354,BE0003402,Tubulin beta-6 chain,http://www.t3db.ca/biodb/bio_entities/BE0003402,Q9BUF5,Tubulin beta-6 chain,84617.0,TUBB6,9606.0,Homo sapiens (human),"Organic mercury exerts developmental effects by binding to tubulin, preventing microtubule assembly and causing mitotic inhibition. (L7)",,,,,,,
1916,1394949,115042,Toxin and Toxin Target Database (T3DB),"Nitric acid, mercury(1+) salt (1:1)",T3D0354,Mercury(II) nitrate,http://www.t3db.ca/toxins/T3D0354,BE0005038,Tubulin beta-8 chain,http://www.t3db.ca/biodb/bio_entities/BE0005038,Q3ZCM7,Tubulin beta-8 chain,347688.0,TUBB8,9606.0,Homo sapiens (human),"Organic mercury exerts developmental effects by binding to tubulin, preventing microtubule assembly and causing mitotic inhibition. (L7)",,,,,,,
1917,1403328,115111,Drug Gene Interaction database (DGIdb),N-tert-Butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide,,PMX53,https://www.dgidb.org/drugs/iuphar.ligand:579,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
1918,1396457,119031,DrugBank,Marimastat,DB00786,Marimastat,https://www.drugbank.ca/drugs/DB00786,BE0003699,Matrix metalloproteinase-24,https://www.drugbank.ca/bio_entities/BE0003699,Q9Y5R2,Matrix metalloproteinase-24,10893.0,MMP24,9606.0,Homo sapiens (human),Inhibitor,,,PMID:10852638|PMID:10669951,https://www.ncbi.nlm.nih.gov/pubmed/10852638|https://www.ncbi.nlm.nih.gov/pubmed/10669951,10852638|10669951,,
1919,1396458,119031,DrugBank,Marimastat,DB00786,Marimastat,https://www.drugbank.ca/drugs/DB00786,BE0009742,Matrix metalloproteinase-25,https://www.drugbank.ca/bio_entities/BE0009742,Q9NPA2,Matrix metalloproteinase-25,64386.0,MMP25,9606.0,Homo sapiens (human),Inhibitor,,,PMID:10852638|PMID:10669951,https://www.ncbi.nlm.nih.gov/pubmed/10852638|https://www.ncbi.nlm.nih.gov/pubmed/10669951,10852638|10669951,,
1920,1396459,119031,DrugBank,Marimastat,DB00786,Marimastat,https://www.drugbank.ca/drugs/DB00786,BE0003701,Matrix metalloproteinase-26,https://www.drugbank.ca/bio_entities/BE0003701,Q9NRE1,Matrix metalloproteinase-26,56547.0,MMP26,9606.0,Homo sapiens (human),Inhibitor,,,PMID:10852638|PMID:10669951,https://www.ncbi.nlm.nih.gov/pubmed/10852638|https://www.ncbi.nlm.nih.gov/pubmed/10669951,10852638|10669951,,
1921,1396460,119031,DrugBank,Marimastat,DB00786,Marimastat,https://www.drugbank.ca/drugs/DB00786,BE0003702,Matrix metalloproteinase-27,https://www.drugbank.ca/bio_entities/BE0003702,Q9H306,Matrix metalloproteinase-27,64066.0,MMP27,9606.0,Homo sapiens (human),Inhibitor,,,PMID:10852638|PMID:10669951,https://www.ncbi.nlm.nih.gov/pubmed/10852638|https://www.ncbi.nlm.nih.gov/pubmed/10669951,10852638|10669951,,
1922,1463787,119055,DrugBank,,DB04400,"L-erythro-7,8-dihydrobiopterin",https://www.drugbank.ca/drugs/DB04400,BE0004555,Pterin-4-alpha-carbinolamine dehydratase,https://www.drugbank.ca/bio_entities/BE0004555,P61457,Pterin-4-alpha-carbinolamine dehydratase,5092.0,PCBD1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
1923,1463788,119055,DrugBank,,DB04400,"L-erythro-7,8-dihydrobiopterin",https://www.drugbank.ca/drugs/DB04400,BE0001289,Dihydroneopterin aldolase,https://www.drugbank.ca/bio_entities/BE0001289,P56740,Dihydroneopterin aldolase,,,1280.0,Staphylococcus aureus,,,,PMID:10896664,https://www.ncbi.nlm.nih.gov/pubmed/10896664,10896664,,
1924,1463493,119086,Comparative Toxicogenomics Database (CTD),"(8R,9S,10R,13S,14S,16R,17S)-16-ethyl-17-(2-hydroxyacetyl)-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one",C020175,"16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione",https://ctdbase.org/detail.go?type=chem&acc=C020175,489,ATP2A3,https://ctdbase.org/detail.go?type=gene&acc=489,,,489.0,ATP2A3,9606.0,Homo sapiens (human),"16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in increased expression of ATP2A3 mRNA",,,PMID:20519331,https://www.ncbi.nlm.nih.gov/pubmed/20519331,20519331,,
1925,1463494,119086,Comparative Toxicogenomics Database (CTD),"(8R,9S,10R,13S,14S,16R,17S)-16-ethyl-17-(2-hydroxyacetyl)-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one",C020175,"16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione",https://ctdbase.org/detail.go?type=chem&acc=C020175,65981,CAPRIN2,https://ctdbase.org/detail.go?type=gene&acc=65981,,,65981.0,CAPRIN2,9606.0,Homo sapiens (human),"16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in increased expression of CAPRIN2 mRNA",,,PMID:20519331,https://www.ncbi.nlm.nih.gov/pubmed/20519331,20519331,,
1926,1463495,119086,Comparative Toxicogenomics Database (CTD),"(8R,9S,10R,13S,14S,16R,17S)-16-ethyl-17-(2-hydroxyacetyl)-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one",C020175,"16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione",https://ctdbase.org/detail.go?type=chem&acc=C020175,113130,CDCA5,https://ctdbase.org/detail.go?type=gene&acc=113130,,,113130.0,CDCA5,9606.0,Homo sapiens (human),"16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in decreased expression of CDCA5 mRNA",,,PMID:20519331,https://www.ncbi.nlm.nih.gov/pubmed/20519331,20519331,,
1927,1463789,119138,DrugBank,Thiodigalactoside,DB04396,Thiodigalactoside,https://www.drugbank.ca/drugs/DB04396,BE0001477,Heat-labile enterotoxin B chain,https://www.drugbank.ca/bio_entities/BE0001477,P32890,Heat-labile enterotoxin B chain,,,562.0,Escherichia coli,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
1928,1463790,119138,DrugBank,Thiodigalactoside,DB04396,Thiodigalactoside,https://www.drugbank.ca/drugs/DB04396,BE0001939,Lactose permease,https://www.drugbank.ca/bio_entities/BE0001939,P02920,Lactose permease,75202506.0,,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
1929,1463791,119138,DrugBank,Thiodigalactoside,DB04396,Thiodigalactoside,https://www.drugbank.ca/drugs/DB04396,BE0004512,Neurocan core protein,https://www.drugbank.ca/bio_entities/BE0004512,O14594,Neurocan core protein,1463.0,NCAN,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
1930,1474592,119373,Comparative Toxicogenomics Database (CTD),Elacridar,C083501,Elacridar,https://ctdbase.org/detail.go?type=chem&acc=C083501,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,10090.0,Mus musculus (house mouse),Elacridar inhibits the reaction [ABCG2 protein results in increased export of zidovudine]|elacridar inhibits the reaction [ABCG2 protein results in increased export of imatinib mesylate]|elacridar inhibits the reaction [ABCG2 protein results in increased export of abacavir]|elacridar inhibits the reaction [ABCG2 protein results in increased export of prazosin],,,PMID:19056916,https://www.ncbi.nlm.nih.gov/pubmed/19056916,19056916,,
1931,1474593,119373,Comparative Toxicogenomics Database (CTD),Elacridar,C083501,Elacridar,https://ctdbase.org/detail.go?type=chem&acc=C083501,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,10116.0,Rattus norvegicus (Norway rat),Elacridar inhibits the reaction [ABCG2 protein affects the transport of nitrofurantoin],,,PMID:18799806,https://www.ncbi.nlm.nih.gov/pubmed/18799806,18799806,,
1932,1474594,119373,Comparative Toxicogenomics Database (CTD),Elacridar,C083501,Elacridar,https://ctdbase.org/detail.go?type=chem&acc=C083501,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,10116.0,Rattus norvegicus (Norway rat),Elacridar results in decreased activity of ABCG2 protein,,,PMID:18799806|PMID:19013229,https://www.ncbi.nlm.nih.gov/pubmed/18799806|https://www.ncbi.nlm.nih.gov/pubmed/19013229,18799806|19013229,,
1933,1404131,119461,Comparative Toxicogenomics Database (CTD),6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C053876,3290,HSD11B1,https://ctdbase.org/detail.go?type=gene&acc=3290,,,3290.0,HSD11B1,9606.0,Homo sapiens (human),6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [butaprost results in increased activity of HSD11B1 protein]|6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [dinoprostone results in increased activity of HSD11B1 protein],,,PMID:17761898,https://www.ncbi.nlm.nih.gov/pubmed/17761898,17761898,,
1934,1404132,119461,Comparative Toxicogenomics Database (CTD),6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C053876,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,9606.0,Homo sapiens (human),[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased expression of IL1R1 protein|[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] inhibits the reaction [[ARRB1 protein modified form binds to SRC protein] which binds to IL1R1 protein],,,PMID:19407222,https://www.ncbi.nlm.nih.gov/pubmed/19407222,19407222,,
1935,1404133,119461,Comparative Toxicogenomics Database (CTD),6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C053876,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased phosphorylation of JUN protein,,,PMID:19407222,https://www.ncbi.nlm.nih.gov/pubmed/19407222,19407222,,
1936,1404134,119461,Comparative Toxicogenomics Database (CTD),6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C053876,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,9606.0,Homo sapiens (human),6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [LEP protein results in increased expression of CYP19A1 protein]|6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [LEP protein results in increased expression of CYP19A1 mrna],,,PMID:28571770,https://www.ncbi.nlm.nih.gov/pubmed/28571770,28571770,,
1937,1404135,119461,Comparative Toxicogenomics Database (CTD),6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C053876,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] inhibits the reaction [GSK3B protein binds to MAPK1 protein binds to MAPK3 protein]|[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased phosphorylation of MAPK1 protein,,,PMID:19407222,https://www.ncbi.nlm.nih.gov/pubmed/19407222,19407222,,
1938,1404136,119461,Comparative Toxicogenomics Database (CTD),6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C053876,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] inhibits the reaction [GSK3B protein binds to MAPK1 protein binds to MAPK3 protein]|[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased phosphorylation of MAPK3 protein,,,PMID:19407222,https://www.ncbi.nlm.nih.gov/pubmed/19407222,19407222,,
1939,1404137,119461,Comparative Toxicogenomics Database (CTD),6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C053876,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased phosphorylation of MYC protein,,,PMID:19407222,https://www.ncbi.nlm.nih.gov/pubmed/19407222,19407222,,
1940,1404138,119461,Comparative Toxicogenomics Database (CTD),6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C053876,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased expression of NFKB1 protein,,,PMID:19407222,https://www.ncbi.nlm.nih.gov/pubmed/19407222,19407222,,
1941,1396696,119570,Toxin and Toxin Target Database (T3DB),Pramipexole,T3D2783,Pramipexole,http://www.t3db.ca/toxins/T3D2783,BE0000020,D(1A) dopamine receptor,http://www.t3db.ca/biodb/bio_entities/BE0000020,P21728,D(1A) dopamine receptor,1812.0,DRD1,9606.0,Homo sapiens (human),,,,PMID:10641988,https://www.ncbi.nlm.nih.gov/pubmed/10641988,10641988,,
1942,1464384,119590,DrugBank,Deramciclane,DB06512,Deramciclane,https://www.drugbank.ca/drugs/DB06512,BE0000533,5-hydroxytryptamine receptor 2C,https://www.drugbank.ca/bio_entities/BE0000533,P28335,5-hydroxytryptamine receptor 2C,3358.0,HTR2C,9606.0,Homo sapiens (human),Inverse agonist,,,PMID:9551765,https://www.ncbi.nlm.nih.gov/pubmed/9551765,9551765,,
1943,1464385,119590,DrugBank,Deramciclane,DB06512,Deramciclane,https://www.drugbank.ca/drugs/DB06512,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606.0,Homo sapiens (human),Inhibitor,,,PMID:14730412,https://www.ncbi.nlm.nih.gov/pubmed/14730412,14730412,,
1944,1464444,119598,Comparative Toxicogenomics Database (CTD),4-(Acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone,C081510,4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C081510,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CCL2 protein,,,PMID:15762874,https://www.ncbi.nlm.nih.gov/pubmed/15762874,15762874,,
1945,1464445,119598,Comparative Toxicogenomics Database (CTD),4-(Acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone,C081510,4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C081510,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CXCL8 protein,,,PMID:15762874,https://www.ncbi.nlm.nih.gov/pubmed/15762874,15762874,,
1946,1464446,119598,Comparative Toxicogenomics Database (CTD),4-(Acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone,C081510,4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C081510,2068,ERCC2,https://ctdbase.org/detail.go?type=gene&acc=2068,,,2068.0,ERCC2,10029.0,Cricetulus griseus (Chinese hamster),ERCC2 protein affects the susceptibility to 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone|ercc2 protein affects the susceptibility to [4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone results in increased mutagenesis of HPRT1 gene],,,PMID:19601657,https://www.ncbi.nlm.nih.gov/pubmed/19601657,19601657,,
1947,1464447,119598,Comparative Toxicogenomics Database (CTD),4-(Acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone,C081510,4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C081510,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9606.0,Homo sapiens (human),4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of and results in increased localization of FOXO3 protein,,,PMID:19380174,https://www.ncbi.nlm.nih.gov/pubmed/19380174,19380174,,
1948,1464448,119598,Comparative Toxicogenomics Database (CTD),4-(Acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone,C081510,4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C081510,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251.0,HPRT1,10029.0,Cricetulus griseus (Chinese hamster),ERCC2 protein affects the susceptibility to [4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone results in increased mutagenesis of HPRT1 gene]|xrcc1 protein affects the susceptibility to [4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone results in increased mutagenesis of HPRT1 gene]|4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone results in increased mutagenesis of HPRT1 gene,,,PMID:19601657,https://www.ncbi.nlm.nih.gov/pubmed/19601657,19601657,,
1949,1464386,119599,Comparative Toxicogenomics Database (CTD),"L-Methioninamide, N-(5-amino-1-oxopentyl)-L-phenylalanyl-L-phenylalanyl-L-prolyl-N-methyl-L-leucyl-",C068032,GR 73632,https://ctdbase.org/detail.go?type=chem&acc=C068032,6863,TAC1,https://ctdbase.org/detail.go?type=gene&acc=6863,,,6863.0,TAC1,10116.0,Rattus norvegicus (Norway rat),"SB 203580 inhibits the reaction [GR 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]]|bisindolylmaleimide I inhibits the reaction [GR 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]]|cp 96345 inhibits the reaction [GR 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]]|pyrazolanthrone promotes the reaction [GR 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]]|gr 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]|u 0126 inhibits the reaction [GR 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]]|1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [GR 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]]|indomethacin inhibits the reaction [GR 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]]|n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [GR 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]]|go 6976 inhibits the reaction [GR 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]]|capsazepine inhibits the reaction [GR 73632 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]]",,,PMID:18809416,https://www.ncbi.nlm.nih.gov/pubmed/18809416,18809416,,
1950,1476820,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,90427,BMF,https://ctdbase.org/detail.go?type=gene&acc=90427,,,90427.0,BMF,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of BMF mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1951,1476821,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,649,BMP1,https://ctdbase.org/detail.go?type=gene&acc=649,,,649.0,BMP1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of BMP1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1952,1476822,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,664,BNIP3,https://ctdbase.org/detail.go?type=gene&acc=664,,,664.0,BNIP3,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of BNIP3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1953,1476823,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,51027,BOLA1,https://ctdbase.org/detail.go?type=gene&acc=51027,,,51027.0,BOLA1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of BOLA1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1954,1476824,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,669,BPGM,https://ctdbase.org/detail.go?type=gene&acc=669,,,669.0,BPGM,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of BPGM mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1955,1477365,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,10576,CCT2,https://ctdbase.org/detail.go?type=gene&acc=10576,,,10576.0,CCT2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of CCT2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1956,1477366,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,7203,CCT3,https://ctdbase.org/detail.go?type=gene&acc=7203,,,7203.0,CCT3,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of CCT3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1957,1480649,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of GULO mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1958,1480650,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,51179,HAO2,https://ctdbase.org/detail.go?type=gene&acc=51179,,,51179.0,HAO2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of HAO2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1959,1480651,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,29915,HCFC2,https://ctdbase.org/detail.go?type=gene&acc=29915,,,29915.0,HCFC2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of HCFC2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1960,1480652,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,79885,HDAC11,https://ctdbase.org/detail.go?type=gene&acc=79885,,,79885.0,HDAC11,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of HDAC11 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1961,1480653,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,3066,HDAC2,https://ctdbase.org/detail.go?type=gene&acc=3066,,,3066.0,HDAC2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of HDAC2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1962,1480654,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,3068,HDGF,https://ctdbase.org/detail.go?type=gene&acc=3068,,,3068.0,HDGF,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of HDGF mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1963,1480655,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of HERPUD1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
1964,1396307,121893,Comparative Toxicogenomics Database (CTD),Protoporphyrinogen,C011539,protoporphyrinogen,https://ctdbase.org/detail.go?type=chem&acc=C011539,1371,CPOX,https://ctdbase.org/detail.go?type=gene&acc=1371,,,1371.0,CPOX,9606.0,Homo sapiens (human),CPOX protein results in increased chemical synthesis of protoporphyrinogen|mercury inhibits the reaction [CPOX protein results in increased chemical synthesis of protoporphyrinogen],,,PMID:19339664,https://www.ncbi.nlm.nih.gov/pubmed/19339664,19339664,,
1965,1396308,121893,Comparative Toxicogenomics Database (CTD),Protoporphyrinogen,C011539,protoporphyrinogen,https://ctdbase.org/detail.go?type=chem&acc=C011539,1371,CPOX,https://ctdbase.org/detail.go?type=gene&acc=1371,,,1371.0,CPOX,9606.0,Homo sapiens (human),CPOX protein results in increased chemical synthesis of protoporphyrinogen|tgfb1 protein promotes the reaction [CPOX protein results in increased chemical synthesis of protoporphyrinogen],,,PMID:11248690,https://www.ncbi.nlm.nih.gov/pubmed/11248690,11248690,,
1966,1396309,121893,Comparative Toxicogenomics Database (CTD),Protoporphyrinogen,C011539,protoporphyrinogen,https://ctdbase.org/detail.go?type=chem&acc=C011539,5498,PPOX,https://ctdbase.org/detail.go?type=gene&acc=5498,,,5498.0,PPOX,7955.0,Danio rerio (zebrafish),PPOX protein affects the oxidation of protoporphyrinogen,,,PMID:18550261,https://www.ncbi.nlm.nih.gov/pubmed/18550261,18550261,,
1967,1396310,121893,Comparative Toxicogenomics Database (CTD),Protoporphyrinogen,C011539,protoporphyrinogen,https://ctdbase.org/detail.go?type=chem&acc=C011539,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606.0,Homo sapiens (human),TGFB1 protein promotes the reaction [CPOX protein results in increased chemical synthesis of protoporphyrinogen],,,PMID:11248690,https://www.ncbi.nlm.nih.gov/pubmed/11248690,11248690,,
1968,1464830,121942,DrugBank,Methyl lactoside,DB04681,BETA-METHYLLACTOSIDE,https://www.drugbank.ca/drugs/DB04681,BE0000214,Histo-blood group ABO system transferase,https://www.drugbank.ca/bio_entities/BE0000214,P16442,Histo-blood group ABO system transferase,28.0,ABO,9606.0,Homo sapiens (human),,,,,,,,
1969,1464831,121945,DrugBank,Dansyllysine,DB04676,Dansyllysine,https://www.drugbank.ca/drugs/DB04676,BE0004610,Ig alpha-2 chain C region,https://www.drugbank.ca/bio_entities/BE0004610,P01877,Immunoglobulin heavy constant alpha 2,,,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1970,1464832,122028,Therapeutic Target Database (TTD),"(2-Amino-4,5-dimethylthiophen-3-yl)(3-(trifluoromethyl)phenyl)methanone",D07HXL,PD-81723,https://idrblab.net/ttd/data/drug/details/D07HXL,T92072,Adenosine A1 receptor (ADORA1),https://idrblab.net/ttd/data/target/details/T92072,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1971,1464833,122077,DrugBank,Lintitript,DB04867,Lintitript,https://www.drugbank.ca/drugs/DB04867,BE0000402,Cholecystokinin receptor type A,https://www.drugbank.ca/bio_entities/BE0000402,P32238,Cholecystokinin receptor type A,886.0,CCKAR,9606.0,Homo sapiens (human),,,,PMID:9712175,https://www.ncbi.nlm.nih.gov/pubmed/9712175,9712175,,
1972,1464834,122187,Therapeutic Target Database (TTD),5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin,D06ROA,UH-301,https://idrblab.net/ttd/data/drug/details/D06ROA,T92609,Adrenergic receptor alpha-1A (ADRA1A),https://idrblab.net/ttd/data/target/details/T92609,P35348,Alpha-1A adrenergic receptor,148.0,ADRA1A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1973,1464835,122187,Therapeutic Target Database (TTD),5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin,D06ROA,UH-301,https://idrblab.net/ttd/data/drug/details/D06ROA,T67162,Dopamine D2 receptor (D2R),https://idrblab.net/ttd/data/target/details/T67162,P14416,D(2) dopamine receptor,1813.0,DRD2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1974,1464836,122187,Therapeutic Target Database (TTD),5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin,D06ROA,UH-301,https://idrblab.net/ttd/data/drug/details/D06ROA,T78709,5-HT 1A receptor (HTR1A),https://idrblab.net/ttd/data/target/details/T78709,P08908,5-hydroxytryptamine receptor 1A,3350.0,HTR1A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1975,1464837,122187,Therapeutic Target Database (TTD),5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin,D06ROA,UH-301,https://idrblab.net/ttd/data/drug/details/D06ROA,T53381,Adrenergic receptor alpha-1D (ADRA1D),https://idrblab.net/ttd/data/target/details/T53381,P25100,Alpha-1D adrenergic receptor,146.0,ADRA1D,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1976,1464838,122187,Therapeutic Target Database (TTD),5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin,D06ROA,UH-301,https://idrblab.net/ttd/data/drug/details/D06ROA,T29500,Adrenergic receptor alpha-1B (ADRA1B),https://idrblab.net/ttd/data/target/details/T29500,P35368,Alpha-1B adrenergic receptor,147.0,ADRA1B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1977,1396311,122324,IUPHAR/BPS Guide to PHARMACOLOGY,"5,6-Dihydroxy-3-phenyl-1-aminomethylisochroman",6077,A68930,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6077,214,D1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=214,P21728,D(1A) dopamine receptor,1812.0,DRD1,9606.0,Homo sapiens (human),Agonist,pEC50,6.82,PMID:16318870,https://www.ncbi.nlm.nih.gov/pubmed/16318870,16318870,,
1978,1396312,122623,Comparative Toxicogenomics Database (CTD),Z-Pro-prolinal,C038541,N-benzyloxycarbonylprolylprolinal,https://ctdbase.org/detail.go?type=chem&acc=C038541,9045,RPL14,https://ctdbase.org/detail.go?type=gene&acc=9045,,,9045.0,RPL14,9606.0,Homo sapiens (human),N-benzyloxycarbonylprolylprolinal results in increased expression of RPL14 mRNA,,,PMID:21487212,https://www.ncbi.nlm.nih.gov/pubmed/21487212,21487212,,
1979,1396924,122806,Drug Gene Interaction database (DGIdb),Olivomycin A,,OLIVOMYCIN I,https://www.dgidb.org/drugs/chembl:CHEMBL576383,,TOP1.00,https://www.dgidb.org/genes/hgnc:11986,,,7150.0,TOP1,9606.0,Homo sapiens (human),,,,,,,,
1980,1396925,122920,Comparative Toxicogenomics Database (CTD),"Butanoic acid, diester with 1,2,3-propanetriol",C063304,dibutyrylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C063304,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),[dibutyrylglycerol analog co-treated with fluorescein-5-isothiocyanate] affects the secretion of IL4 protein,,,PMID:29198882,https://www.ncbi.nlm.nih.gov/pubmed/29198882,29198882,,
1981,1396926,122920,Comparative Toxicogenomics Database (CTD),"Butanoic acid, diester with 1,2,3-propanetriol",C063304,dibutyrylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C063304,8989,TRPA1,https://ctdbase.org/detail.go?type=gene&acc=8989,,,8989.0,TRPA1,9606.0,Homo sapiens (human),Dibutyrylglycerol analog results in increased activity of TRPA1 protein,,,PMID:29198882,https://www.ncbi.nlm.nih.gov/pubmed/29198882,29198882,,
1982,1465464,123339,Comparative Toxicogenomics Database (CTD),2-Methyl-3-phenyloxirane,C509597,phenylpropylene oxide,https://ctdbase.org/detail.go?type=chem&acc=C509597,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,9606.0,Homo sapiens (human),GSTM1 protein affects the metabolism of phenylpropylene oxide,,,PMID:17689871,https://www.ncbi.nlm.nih.gov/pubmed/17689871,17689871,,
1983,1465465,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,58,ACTA1,https://ctdbase.org/detail.go?type=gene&acc=58,,,58.0,ACTA1,8355.0,Xenopus laevis (African clawed frog),Perchlorate results in decreased expression of ACTA1 mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1984,1465466,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,70,ACTC1,https://ctdbase.org/detail.go?type=gene&acc=70,,,70.0,ACTC1,8355.0,Xenopus laevis (African clawed frog),Perchlorate results in increased expression of ACTC1 mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1985,1465467,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,4185,ADAM11,https://ctdbase.org/detail.go?type=gene&acc=4185,,,4185.0,ADAM11,8355.0,Xenopus laevis (African clawed frog),Perchlorate results in decreased expression of ADAM11 mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1986,1465468,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,117,ADCYAP1R1,https://ctdbase.org/detail.go?type=gene&acc=117,,,117.0,ADCYAP1R1,8355.0,Xenopus laevis (African clawed frog),Perchlorate results in decreased expression of ADCYAP1R1 mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1987,1465469,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,127,ADH4,https://ctdbase.org/detail.go?type=gene&acc=127,,,127.0,ADH4,8355.0,Xenopus laevis (African clawed frog),Perchlorate results in decreased expression of ADH4 mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1988,1465470,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,230,ALDOC,https://ctdbase.org/detail.go?type=gene&acc=230,,,230.0,ALDOC,8355.0,Xenopus laevis (African clawed frog),Perchlorate results in increased expression of ALDOC mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1989,1465471,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,8355.0,Xenopus laevis (African clawed frog),Perchlorate results in increased expression of APP mrna|perchlorate results in decreased expression of APP mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1990,1465472,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,358,AQP1,https://ctdbase.org/detail.go?type=gene&acc=358,,,358.0,AQP1,10116.0,Rattus norvegicus (Norway rat),Perchlorate affects the expression of AQP1 mRNA,,,PMID:21623536,https://www.ncbi.nlm.nih.gov/pubmed/21623536,21623536,,
1991,1465473,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,383,ARG1,https://ctdbase.org/detail.go?type=gene&acc=383,,,383.0,ARG1,8355.0,Xenopus laevis (African clawed frog),Perchlorate results in decreased expression of ARG1 mrna|perchlorate results in increased expression of ARG1 mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1992,1465750,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,759,CA1,https://ctdbase.org/detail.go?type=gene&acc=759,,,759.0,CA1,9606.0,Homo sapiens (human),Perchlorate results in decreased activity of CA1 protein,,,PMID:15664814,https://www.ncbi.nlm.nih.gov/pubmed/15664814,15664814,,
1993,1465751,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,760,CA2,https://ctdbase.org/detail.go?type=gene&acc=760,,,760.0,CA2,9606.0,Homo sapiens (human),Perchlorate results in decreased activity of CA2 protein,,,PMID:15664814,https://www.ncbi.nlm.nih.gov/pubmed/15664814,15664814,,
1994,1469390,123351,Comparative Toxicogenomics Database (CTD),Perchlorate,C494474,perchlorate,https://ctdbase.org/detail.go?type=chem&acc=C494474,8531,YBX3,https://ctdbase.org/detail.go?type=gene&acc=8531,,,8531.0,YBX3,8355.0,Xenopus laevis (African clawed frog),Perchlorate results in decreased expression of YBX3 mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1995,1469391,123421,DrugBank,Methyldiazene,DB04361,Methyldiazene,https://www.drugbank.ca/drugs/DB04361,BE0001728,Quinoprotein glucose dehydrogenase B,https://www.drugbank.ca/bio_entities/BE0001728,P13650,Quinoprotein glucose dehydrogenase B,,,471.0,Acinetobacter calcoaceticus,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
1996,1469392,123493,Therapeutic Target Database (TTD),"Ethanedione, bis(3-methoxyphenyl)-",D01VAU,"1,2-Bis-(3-methoxy-phenyl)-ethane-1,2-dione",https://idrblab.net/ttd/data/drug/details/D01VAU,T76369,Liver carboxylesterase (CES1),https://idrblab.net/ttd/data/target/details/T76369,P23141,Liver carboxylesterase 1,1066.0,CES1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1997,1396927,123606,Drug Gene Interaction database (DGIdb),Almotriptan,,ALMOTRIPTAN,https://www.dgidb.org/drugs/rxcui:279645,,HTR1D,https://www.dgidb.org/genes/hgnc:5289,,,3352.0,HTR1D,9606.0,Homo sapiens (human),,,,,,,,
1998,1396928,123606,Drug Gene Interaction database (DGIdb),Almotriptan,,ALMOTRIPTAN,https://www.dgidb.org/drugs/rxcui:279645,,HTR1D,https://www.dgidb.org/genes/hgnc:5289,,,3352.0,HTR1D,9606.0,Homo sapiens (human),,,,,,,,
1999,1469393,123607,ChEMBL,Almotriptan Malate,CHEMBL1200521,ALMOTRIPTAN MALATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200521/,CHEMBL1805,Serotonin 1f (5-HT1f) receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1805/,P30939,5-hydroxytryptamine receptor 1F,3355.0,HTR1F,9606.0,Homo sapiens (human),Serotonin 1f (5-ht1f) receptor agonist,,,,,,,
2000,1400141,123619,Comparative Toxicogenomics Database (CTD),Etoricoxib,D000077613,Etoricoxib,https://ctdbase.org/detail.go?type=chem&acc=D000077613,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),Etoricoxib results in decreased activity of CYP1A2 protein,,,PMID:18816299,https://www.ncbi.nlm.nih.gov/pubmed/18816299,18816299,,
2001,1400142,123619,Comparative Toxicogenomics Database (CTD),Etoricoxib,D000077613,Etoricoxib,https://ctdbase.org/detail.go?type=chem&acc=D000077613,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),CYP3A4 protein results in increased metabolism of etoricoxib,,,PMID:18084859,https://www.ncbi.nlm.nih.gov/pubmed/18084859,18084859,,
2002,1400143,123619,Comparative Toxicogenomics Database (CTD),Etoricoxib,D000077613,Etoricoxib,https://ctdbase.org/detail.go?type=chem&acc=D000077613,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Etoricoxib results in decreased expression of ICAM1 protein|etoricoxib results in decreased expression of ICAM1 mRNA,,,PMID:17931847,https://www.ncbi.nlm.nih.gov/pubmed/17931847,17931847,,
2003,1465296,123628,Drug Gene Interaction database (DGIdb),Glufosfamide,,GLUFOSFAMIDE,https://www.dgidb.org/drugs/ncit:C1612,,SLC2A3,https://www.dgidb.org/genes/hgnc:11007,,,6515.0,SLC2A3,9606.0,Homo sapiens (human),,,,,,,,
2004,1396929,123631,Drug Gene Interaction database (DGIdb),Gefitinib,,GEFITINIB,https://www.dgidb.org/drugs/rxcui:328134,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,,,,,
2005,1396930,123631,Drug Gene Interaction database (DGIdb),Gefitinib,,GEFITINIB,https://www.dgidb.org/drugs/rxcui:328134,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673.0,BRAF,9606.0,Homo sapiens (human),,,,,,,,
2006,1396931,123631,Drug Gene Interaction database (DGIdb),Gefitinib,,GEFITINIB,https://www.dgidb.org/drugs/rxcui:328134,,PTEN,https://www.dgidb.org/genes/hgnc:9588,,,5728.0,PTEN,9606.0,Homo sapiens (human),,,,,,,,
2007,1396932,123631,Drug Gene Interaction database (DGIdb),Gefitinib,,GEFITINIB,https://www.dgidb.org/drugs/rxcui:328134,,RELA,https://www.dgidb.org/genes/hgnc:9955,,,5970.0,RELA,9606.0,Homo sapiens (human),,,,,,,,
2008,1396933,123631,Drug Gene Interaction database (DGIdb),Gefitinib,,GEFITINIB,https://www.dgidb.org/drugs/rxcui:328134,,SIRT2,https://www.dgidb.org/genes/hgnc:10886,,,22933.0,SIRT2,9606.0,Homo sapiens (human),,,,,,,,
2009,1465297,123683,DrugBank,IB-Meca,DB05511,Piclidenoson,https://www.drugbank.ca/drugs/DB05511,BE0000354,Adenosine receptor A3,https://www.drugbank.ca/bio_entities/BE0000354,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,,,,,,,
2010,1469394,123686,BindingDB,1-[2-[[3-(2-Cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea,25748,3-(2-{[3-(2-cyanophenoxy)-2-hydroxypropyl]amino}ethyl)-1-phenylurea,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25748,2890,Beta-3 adrenergic receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2890,P13945,Beta-3 adrenergic receptor,155.0,ADRB3,9606.0,Homo sapiens (human),,,,PMID:15655528|DOI:10.1038/sj.bjp.0706048,https://www.ncbi.nlm.nih.gov/pubmed/15655528|https://doi.org/10.1038/sj.bjp.0706048,15655528,10.1038/sj.bjp.0706048,
2011,1469395,123686,BindingDB,1-[2-[[3-(2-Cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea,25748,3-(2-{[3-(2-cyanophenoxy)-2-hydroxypropyl]amino}ethyl)-1-phenylurea,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25748,2888,Beta-1 adrenergic receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2888,P08588,Beta-1 adrenergic receptor,153.0,ADRB1,9606.0,Homo sapiens (human),,,,PMID:15655528|DOI:10.1038/sj.bjp.0706048,https://www.ncbi.nlm.nih.gov/pubmed/15655528|https://doi.org/10.1038/sj.bjp.0706048,15655528,10.1038/sj.bjp.0706048,
2012,1469396,123686,BindingDB,1-[2-[[3-(2-Cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea,25748,3-(2-{[3-(2-cyanophenoxy)-2-hydroxypropyl]amino}ethyl)-1-phenylurea,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25748,5059,Beta-2 adrenergic receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5059,P07550,Beta-2 adrenergic receptor,154.0,ADRB2,9606.0,Homo sapiens (human),,,,PMID:15655528|DOI:10.1038/sj.bjp.0706048,https://www.ncbi.nlm.nih.gov/pubmed/15655528|https://doi.org/10.1038/sj.bjp.0706048,15655528,10.1038/sj.bjp.0706048,
2013,1397054,123692,Therapeutic Target Database (TTD),1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidine,D07CQD,1-(1-(benzo[b]thiophen-2-yl)cyclohexyl)piperidine,https://idrblab.net/ttd/data/drug/details/D07CQD,T55959,Dopamine transporter (DAT),https://idrblab.net/ttd/data/target/details/T55959,Q01959,Sodium-dependent dopamine transporter ,6531.0,SLC6A3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2014,1465298,123692,Drug Gene Interaction database (DGIdb),1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidine,,CHEMBL:CHEMBL279556,https://www.dgidb.org/drugs/chembl:CHEMBL279556,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
2015,1465299,123695,IUPHAR/BPS Guide to PHARMACOLOGY,Adenophostin a,4124,adenophostin A,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4124,743,IP3R1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=743,Q14643,"Inositol 1,4,5-trisphosphate receptor type 1",3708.0,ITPR1,9606.0,Homo sapiens (human),,,7.72,,,,,
2016,1465300,123695,IUPHAR/BPS Guide to PHARMACOLOGY,Adenophostin a,4124,adenophostin A,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4124,744,IP3R2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=744,Q14571,"Inositol 1,4,5-trisphosphate receptor type 2",3709.0,ITPR2,9606.0,Homo sapiens (human),,,7.72,,,,,
2017,1469397,123698,Comparative Toxicogenomics Database (CTD),Eperisone hydrochloride,C030848,eperisone,https://ctdbase.org/detail.go?type=chem&acc=C030848,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9606.0,Homo sapiens (human),Eperisone results in decreased activity of ACHE protein,,,PMID:33844597,https://www.ncbi.nlm.nih.gov/pubmed/33844597,33844597,,
2018,1469398,123698,Comparative Toxicogenomics Database (CTD),Eperisone hydrochloride,C030848,eperisone,https://ctdbase.org/detail.go?type=chem&acc=C030848,6582,SLC22A2,https://ctdbase.org/detail.go?type=gene&acc=6582,,,6582.0,SLC22A2,9606.0,Homo sapiens (human),Eperisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium],,,PMID:21599003,https://www.ncbi.nlm.nih.gov/pubmed/21599003,21599003,,
2019,1397055,123701,Comparative Toxicogenomics Database (CTD),Octanoylcarnitine,C008698,octanoylcarnitine,https://ctdbase.org/detail.go?type=chem&acc=C008698,54677,CROT,https://ctdbase.org/detail.go?type=gene&acc=54677,,,54677.0,CROT,10090.0,Mus musculus (house mouse),CROT protein results in increased chemical synthesis of octanoylcarnitine,,,PMID:6838215,https://www.ncbi.nlm.nih.gov/pubmed/6838215,6838215,,
2020,1397056,123701,Comparative Toxicogenomics Database (CTD),Octanoylcarnitine,C008698,octanoylcarnitine,https://ctdbase.org/detail.go?type=chem&acc=C008698,171405,SLC22A27,https://ctdbase.org/detail.go?type=gene&acc=171405,,,171405.0,Slc22a27,10090.0,Mus musculus (house mouse),Octanoylcarnitine inhibits the reaction [SLC22A27 protein alternative form results in increased uptake of carnitine],,,PMID:20332632,https://www.ncbi.nlm.nih.gov/pubmed/20332632,20332632,,
2021,1465301,123739,Therapeutic Target Database (TTD),"8-(3,4-Dimethoxyphenyl)-7-methyl-1,3-dipropyl-1H-purine-2,6(3H,7H)-dione",D0O0HR,KF 17837S,https://idrblab.net/ttd/data/drug/details/D0O0HR,T86679,Adenosine A2b receptor (ADORA2B),https://idrblab.net/ttd/data/target/details/T86679,P29275,Adenosine receptor A2b,136.0,ADORA2B,9606.0,Homo sapiens (human),Antagonist,,,,,,,
2022,1397057,123755,Comparative Toxicogenomics Database (CTD),5-Carboxyfluorescein,C045132,4-carboxyfluorescein,https://ctdbase.org/detail.go?type=chem&acc=C045132,9376,SLC22A8,https://ctdbase.org/detail.go?type=gene&acc=9376,,,9376.0,SLC22A8,9606.0,Homo sapiens (human),Quercetin 3'-sulfate inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]|quercetin 3-O-glucuronide inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]|quercetin 3-O-glucuronide analog inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]|slc22a8 protein results in increased transport of 4-carboxyfluorescein,,,PMID:21244849,https://www.ncbi.nlm.nih.gov/pubmed/21244849,21244849,,
2023,1397058,123809,Comparative Toxicogenomics Database (CTD),Modopar,C005177,"benserazide, levodopa drug combination",https://ctdbase.org/detail.go?type=chem&acc=C005177,199,AIF1,https://ctdbase.org/detail.go?type=gene&acc=199,,,199.0,AIF1,10090.0,Mus musculus (house mouse),"Benserazide, levodopa drug combination inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of AIF1 protein]",,,PMID:28185818,https://www.ncbi.nlm.nih.gov/pubmed/28185818,28185818,,
2024,1397059,123809,Comparative Toxicogenomics Database (CTD),Modopar,C005177,"benserazide, levodopa drug combination",https://ctdbase.org/detail.go?type=chem&acc=C005177,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),"Benserazide, levodopa drug combination inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of BAX protein]",,,PMID:28185818,https://www.ncbi.nlm.nih.gov/pubmed/28185818,28185818,,
2025,1397060,123809,Comparative Toxicogenomics Database (CTD),Modopar,C005177,"benserazide, levodopa drug combination",https://ctdbase.org/detail.go?type=chem&acc=C005177,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),"Benserazide, levodopa drug combination inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of BAX mrna]",,,PMID:27053303,https://www.ncbi.nlm.nih.gov/pubmed/27053303,27053303,,
2026,1401943,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,125950,RAVER1,https://ctdbase.org/detail.go?type=gene&acc=125950,,,125950.0,RAVER1,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAVER1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2027,1401944,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,9821,RB1CC1,https://ctdbase.org/detail.go?type=gene&acc=9821,,,9821.0,RB1CC1,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RB1CC1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2028,1401945,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,5928,RBBP4,https://ctdbase.org/detail.go?type=gene&acc=5928,,,5928.0,RBBP4,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP4 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2029,1401946,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,5932,RBBP8,https://ctdbase.org/detail.go?type=gene&acc=5932,,,5932.0,RBBP8,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP8 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2030,1401947,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,10741,RBBP9,https://ctdbase.org/detail.go?type=gene&acc=10741,,,10741.0,RBBP9,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP9 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2031,1401948,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,23543,RBFOX2,https://ctdbase.org/detail.go?type=gene&acc=23543,,,23543.0,RBFOX2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBFOX2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2032,1402900,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,6472,SHMT2,https://ctdbase.org/detail.go?type=gene&acc=6472,,,6472.0,SHMT2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2033,1402901,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,220134,SKA1,https://ctdbase.org/detail.go?type=gene&acc=220134,,,220134.0,SKA1,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2034,1402902,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,348235,SKA2,https://ctdbase.org/detail.go?type=gene&acc=348235,,,348235.0,SKA2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2035,1402903,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,221150,SKA3,https://ctdbase.org/detail.go?type=gene&acc=221150,,,221150.0,SKA3,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA3 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2036,1402904,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,6502,SKP2,https://ctdbase.org/detail.go?type=gene&acc=6502,,,6502.0,SKP2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKP2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2037,1402905,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,7884,SLBP,https://ctdbase.org/detail.go?type=gene&acc=7884,,,7884.0,SLBP,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLBP mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2038,1402906,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,6558,SLC12A2,https://ctdbase.org/detail.go?type=gene&acc=6558,,,6558.0,SLC12A2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2039,1402907,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,6560,SLC12A4,https://ctdbase.org/detail.go?type=gene&acc=6560,,,6560.0,SLC12A4,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC12A4 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2040,1402908,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,84561,SLC12A8,https://ctdbase.org/detail.go?type=gene&acc=84561,,,84561.0,SLC12A8,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A8 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2041,1403614,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,51593,SRRT,https://ctdbase.org/detail.go?type=gene&acc=51593,,,51593.0,SRRT,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRRT mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2042,1403615,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,6426,SRSF1,https://ctdbase.org/detail.go?type=gene&acc=6426,,,6426.0,SRSF1,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRSF1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2043,1403616,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,23635,SSBP2,https://ctdbase.org/detail.go?type=gene&acc=23635,,,23635.0,SSBP2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SSBP2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2044,1404420,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,169200,TMEM64,https://ctdbase.org/detail.go?type=gene&acc=169200,,,169200.0,TMEM64,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM64 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2045,1404421,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,157378,TMEM65,https://ctdbase.org/detail.go?type=gene&acc=157378,,,157378.0,TMEM65,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM65 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2046,1404422,123917,Comparative Toxicogenomics Database (CTD),"3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,27346,TMEM97,https://ctdbase.org/detail.go?type=gene&acc=27346,,,27346.0,TMEM97,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM97 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
2047,1398931,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),CYP27A1 protein results in increased chemical synthesis of 27-hydroxycholesterol,,,PMID:11714861|PMID:12531903|PMID:14622972,https://www.ncbi.nlm.nih.gov/pubmed/11714861|https://www.ncbi.nlm.nih.gov/pubmed/12531903|https://www.ncbi.nlm.nih.gov/pubmed/14622972,11714861|12531903|14622972,,
2048,1398932,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[CYP27A1 protein results in increased hydroxylation of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol|[cyp27a1 protein results in increased oxidation of 27-hydroxycholesterol] which results in increased chemical synthesis of 3-hydroxy-5-cholestenoic acid,,,PMID:9660774,https://www.ncbi.nlm.nih.gov/pubmed/9660774,9660774,,
2049,1398933,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol,,,PMID:11408283|PMID:9215552,https://www.ncbi.nlm.nih.gov/pubmed/11408283|https://www.ncbi.nlm.nih.gov/pubmed/9215552,11408283|9215552,,
2050,1398934,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol] which results in increased activity of HMGCR protein,,,PMID:11408283,https://www.ncbi.nlm.nih.gov/pubmed/11408283,11408283,,
2051,1398935,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[TGFB1 protein results in increased expression of CYP27A1 protein] which results in increased abundance of 27-hydroxycholesterol,,,PMID:15708352,https://www.ncbi.nlm.nih.gov/pubmed/15708352,15708352,,
2052,1398936,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,10116.0,Rattus norvegicus (Norway rat),[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol,,,PMID:8496670,https://www.ncbi.nlm.nih.gov/pubmed/8496670,8496670,,
2053,1398937,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9822.0,Sus,[CYP27A1 protein results in increased hydroxylation of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol,,,PMID:8443234,https://www.ncbi.nlm.nih.gov/pubmed/8443234,8443234,,
2054,1399059,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,9606.0,Homo sapiens (human),CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol,,,PMID:10882719,https://www.ncbi.nlm.nih.gov/pubmed/10882719,10882719,,
2055,1399060,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10036.0,Mesocricetus auratus (golden hamster),27-hydroxycholesterol results in decreased activity of CYP7A1 protein,,,PMID:14614521,https://www.ncbi.nlm.nih.gov/pubmed/14614521,14614521,,
2056,1399061,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,9420,CYP7B1,https://ctdbase.org/detail.go?type=gene&acc=9420,,,9420.0,CYP7B1,9606.0,Homo sapiens (human),CYP7B1 protein results in increased hydroxylation of 27-hydroxycholesterol,,,PMID:10588945,https://www.ncbi.nlm.nih.gov/pubmed/10588945,10588945,,
2057,1399062,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,9420,CYP7B1,https://ctdbase.org/detail.go?type=gene&acc=9420,,,9420.0,CYP7B1,10036.0,Mesocricetus auratus (golden hamster),27-hydroxycholesterol results in decreased activity of CYP7B1 protein,,,PMID:14614521,https://www.ncbi.nlm.nih.gov/pubmed/14614521,14614521,,
2058,1399063,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,9420,CYP7B1,https://ctdbase.org/detail.go?type=gene&acc=9420,,,9420.0,CYP7B1,10090.0,Mus musculus (house mouse),CYP7B1 protein results in increased metabolism of 27-hydroxycholesterol|cyp7b1 gene mutant form results in increased abundance of 27-hydroxycholesterol,,,PMID:10748047,https://www.ncbi.nlm.nih.gov/pubmed/10748047,10748047,,
2059,1399064,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,9420,CYP7B1,https://ctdbase.org/detail.go?type=gene&acc=9420,,,9420.0,CYP7B1,9606.0,Homo sapiens (human),CYP7B1 protein results in increased hydroxylation of 27-hydroxycholesterol,,,PMID:12029625,https://www.ncbi.nlm.nih.gov/pubmed/12029625,12029625,,
2060,1399065,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,9420,CYP7B1,https://ctdbase.org/detail.go?type=gene&acc=9420,,,9420.0,CYP7B1,9606.0,Homo sapiens (human),CYP7B1 protein results in increased metabolism of 27-hydroxycholesterol,,,PMID:17872378|PMID:28739487,https://www.ncbi.nlm.nih.gov/pubmed/17872378|https://www.ncbi.nlm.nih.gov/pubmed/28739487,17872378|28739487,,
2061,1399066,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1582,CYP8B1,https://ctdbase.org/detail.go?type=gene&acc=1582,,,1582.0,CYP8B1,10036.0,Mesocricetus auratus (golden hamster),27-hydroxycholesterol results in decreased activity of CYP8B1 protein,,,PMID:14614521,https://www.ncbi.nlm.nih.gov/pubmed/14614521,14614521,,
2062,1399067,123976,Comparative Toxicogenomics Database (CTD),27-Hydroxycholesterol,C076996,27-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C076996,1869,E2F1,https://ctdbase.org/detail.go?type=gene&acc=1869,,,1869.0,E2F1,9606.0,Homo sapiens (human),27-hydroxycholesterol results in increased expression of E2F1 mRNA,,,PMID:17872378,https://www.ncbi.nlm.nih.gov/pubmed/17872378,17872378,,
2063,1466326,124820,Comparative Toxicogenomics Database (CTD),"(5r)-5-Hydroxy-4-{2-[(2r,4ar,8ar)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5h)-one",C072581,"16-hydroxycleroda-3,13(14)-dien-15,16-olide",https://ctdbase.org/detail.go?type=chem&acc=C072581,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,10090.0,Mus musculus (house mouse),"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in decreased expression of RAC1 protein",,,PMID:23628706,https://www.ncbi.nlm.nih.gov/pubmed/23628706,23628706,,
2064,1466327,124820,Comparative Toxicogenomics Database (CTD),"(5r)-5-Hydroxy-4-{2-[(2r,4ar,8ar)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5h)-one",C072581,"16-hydroxycleroda-3,13(14)-dien-15,16-olide",https://ctdbase.org/detail.go?type=chem&acc=C072581,4087,SMAD2,https://ctdbase.org/detail.go?type=gene&acc=4087,,,4087.0,SMAD2,10090.0,Mus musculus (house mouse),"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in decreased expression of SMAD2 protein",,,PMID:23628706,https://www.ncbi.nlm.nih.gov/pubmed/23628706,23628706,,
2065,1466328,124820,Comparative Toxicogenomics Database (CTD),"(5r)-5-Hydroxy-4-{2-[(2r,4ar,8ar)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5h)-one",C072581,"16-hydroxycleroda-3,13(14)-dien-15,16-olide",https://ctdbase.org/detail.go?type=chem&acc=C072581,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,10090.0,Mus musculus (house mouse),"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in decreased expression of SMAD3 protein",,,PMID:23628706,https://www.ncbi.nlm.nih.gov/pubmed/23628706,23628706,,
2066,1466329,124820,Comparative Toxicogenomics Database (CTD),"(5r)-5-Hydroxy-4-{2-[(2r,4ar,8ar)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5h)-one",C072581,"16-hydroxycleroda-3,13(14)-dien-15,16-olide",https://ctdbase.org/detail.go?type=chem&acc=C072581,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in increased expression of TP53 protein",,,PMID:23628706,https://www.ncbi.nlm.nih.gov/pubmed/23628706,23628706,,
2067,1466330,124820,Comparative Toxicogenomics Database (CTD),"(5r)-5-Hydroxy-4-{2-[(2r,4ar,8ar)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5h)-one",C072581,"16-hydroxycleroda-3,13(14)-dien-15,16-olide",https://ctdbase.org/detail.go?type=chem&acc=C072581,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090.0,Mus musculus (house mouse),"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in increased expression of TRP53 protein",,,PMID:23628706,https://www.ncbi.nlm.nih.gov/pubmed/23628706,23628706,,
2068,1466331,124820,Comparative Toxicogenomics Database (CTD),"(5r)-5-Hydroxy-4-{2-[(2r,4ar,8ar)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5h)-one",C072581,"16-hydroxycleroda-3,13(14)-dien-15,16-olide",https://ctdbase.org/detail.go?type=chem&acc=C072581,7248,TSC1,https://ctdbase.org/detail.go?type=gene&acc=7248,,,7248.0,TSC1,9606.0,Homo sapiens (human),"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in increased expression of TSC1 mRNA",,,PMID:21530604,https://www.ncbi.nlm.nih.gov/pubmed/21530604,21530604,,
2069,1466332,124820,Comparative Toxicogenomics Database (CTD),"(5r)-5-Hydroxy-4-{2-[(2r,4ar,8ar)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5h)-one",C072581,"16-hydroxycleroda-3,13(14)-dien-15,16-olide",https://ctdbase.org/detail.go?type=chem&acc=C072581,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,10090.0,Mus musculus (house mouse),"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in decreased expression of VIM protein",,,PMID:23628706,https://www.ncbi.nlm.nih.gov/pubmed/23628706,23628706,,
2070,1466333,124820,Comparative Toxicogenomics Database (CTD),"(5r)-5-Hydroxy-4-{2-[(2r,4ar,8ar)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5h)-one",C072581,"16-hydroxycleroda-3,13(14)-dien-15,16-olide",https://ctdbase.org/detail.go?type=chem&acc=C072581,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606.0,Homo sapiens (human),"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in decreased expression of XIAP protein",,,PMID:21530604,https://www.ncbi.nlm.nih.gov/pubmed/21530604,21530604,,
2071,1466334,124846,Therapeutic Target Database (TTD),Htfmt,D09UVB,HTMT,https://idrblab.net/ttd/data/drug/details/D09UVB,T26500,Histamine H4 receptor (H4R),https://idrblab.net/ttd/data/target/details/T26500,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606.0,Homo sapiens (human),Agonist,,,,,,,
2072,1470271,124886,DrugBank,Glutathione,DB00143,Glutathione,https://www.drugbank.ca/drugs/DB00143,BE0000815,Glutathione S-transferase omega-1,https://www.drugbank.ca/bio_entities/BE0000815,P78417,Glutathione S-transferase omega-1,9446.0,GSTO1,9606.0,Homo sapiens (human),,,,PMID:17537474|PMID:17617905,https://www.ncbi.nlm.nih.gov/pubmed/17537474|https://www.ncbi.nlm.nih.gov/pubmed/17617905,17537474|17617905,,
2073,1470272,124886,DrugBank,Glutathione,DB00143,Glutathione,https://www.drugbank.ca/drugs/DB00143,BE0000816,Glutathione peroxidase 1,https://www.drugbank.ca/bio_entities/BE0000816,P07203,Glutathione peroxidase 1,2876.0,GPX1,9606.0,Homo sapiens (human),Cofactor,,,PMID:17139284|PMID:17016423|PMID:2742004|PMID:16721761|PMID:15679624,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/2742004|https://www.ncbi.nlm.nih.gov/pubmed/16721761|https://www.ncbi.nlm.nih.gov/pubmed/15679624,17139284|17016423|2742004|16721761|15679624,,
2074,1470273,124886,DrugBank,Glutathione,DB00143,Glutathione,https://www.drugbank.ca/drugs/DB00143,BE0000817,Glutathione peroxidase 2,https://www.drugbank.ca/bio_entities/BE0000817,P18283,Glutathione peroxidase 2,2877.0,GPX2,9606.0,Homo sapiens (human),Cofactor,,,PMID:17510403,https://www.ncbi.nlm.nih.gov/pubmed/17510403,17510403,,
2075,1470274,124886,DrugBank,Glutathione,DB00143,Glutathione,https://www.drugbank.ca/drugs/DB00143,BE0000818,Glutathione S-transferase theta-1,https://www.drugbank.ca/bio_entities/BE0000818,P30711,Glutathione S-transferase theta-1,2952.0,GSTT1,9606.0,Homo sapiens (human),,,,PMID:17381051|PMID:17372252|PMID:17617661|PMID:17653748|PMID:17333241,https://www.ncbi.nlm.nih.gov/pubmed/17381051|https://www.ncbi.nlm.nih.gov/pubmed/17372252|https://www.ncbi.nlm.nih.gov/pubmed/17617661|https://www.ncbi.nlm.nih.gov/pubmed/17653748|https://www.ncbi.nlm.nih.gov/pubmed/17333241,17381051|17372252|17617661|17653748|17333241,,
2076,1471140,124886,DrugBank,Glutathione,DB00143,Glutathione,https://www.drugbank.ca/drugs/DB00143,BE0001061,Canalicular multispecific organic anion transporter 2,https://www.drugbank.ca/bio_entities/BE0001061,O15438,ATP-binding cassette sub-family C member 3,8714.0,ABCC3,9606.0,Homo sapiens (human),Substrate,,,PMID:11581266,https://www.ncbi.nlm.nih.gov/pubmed/11581266,11581266,,
2077,1471141,124886,DrugBank,Glutathione,DB00143,Glutathione,https://www.drugbank.ca/drugs/DB00143,BE0001188,Multidrug resistance-associated protein 4,https://www.drugbank.ca/bio_entities/BE0001188,O15439,Multidrug resistance-associated protein 4,10257.0,ABCC4,9606.0,Homo sapiens (human),Substrate,,,PMID:11802779,https://www.ncbi.nlm.nih.gov/pubmed/11802779,11802779,,
2078,1471142,125414,DrugBank,L-glycero-alpha-D-manno-Heptopyranose,DB04526,L-Glycero-D-Manno-Heptopyranose,https://www.drugbank.ca/drugs/DB04526,BE0001326,Ferrichrome-iron receptor,https://www.drugbank.ca/bio_entities/BE0001326,P06971,Ferrichrome outer membrane transporter/phage receptor,75202035.0,,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
2079,1397413,125468,IUPHAR/BPS Guide to PHARMACOLOGY,"2,3-Dimethylacrylic acid, (E)-",6499,trans-2-methylcrotonic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6499,226,FFA2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=226,O15552,Free fatty acid receptor 2,2867.0,FFAR2,9606.0,Homo sapiens (human),Full agonist,pEC50,3.8,PMID:21220428,https://www.ncbi.nlm.nih.gov/pubmed/21220428,21220428,,
2080,1471143,126154,DrugBank,"(S)-Hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",DB04541,Cyclo(prolylglycyl),https://www.drugbank.ca/drugs/DB04541,BE0001584,Chitinase B,https://www.drugbank.ca/bio_entities/BE0001584,P11797,Chitinase B,,,615.0,Serratia marcescens,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
2081,1471144,126517,Comparative Toxicogenomics Database (CTD),"1,5-Anhydro-D-fructose",C048927,"1,5-anhydrofructose",https://ctdbase.org/detail.go?type=chem&acc=C048927,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10090.0,Mus musculus (house mouse),"1,5-anhydrofructose results in increased secretion of IL10 protein|1,5-anhydrofructose promotes the reaction [lipopolysaccharides results in increased secretion of IL10 protein]",,,PMID:19559007,https://www.ncbi.nlm.nih.gov/pubmed/19559007,19559007,,
2082,1471145,126517,Comparative Toxicogenomics Database (CTD),"1,5-Anhydro-D-fructose",C048927,"1,5-anhydrofructose",https://ctdbase.org/detail.go?type=chem&acc=C048927,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),"1,5-anhydrofructose inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 protein]|1,5-anhydrofructose inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 mrna]",,,PMID:19559007,https://www.ncbi.nlm.nih.gov/pubmed/19559007,19559007,,
2083,1397536,126565,Drug Gene Interaction database (DGIdb),Lestaurtinib,,LESTAURTINIB,https://www.dgidb.org/drugs/ncit:C48402,,FLT3,https://www.dgidb.org/genes/hgnc:3765,,,2322.0,FLT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2084,1397537,126565,Drug Gene Interaction database (DGIdb),Lestaurtinib,,LESTAURTINIB,https://www.dgidb.org/drugs/ncit:C48402,,FLT3,https://www.dgidb.org/genes/hgnc:3765,,,2322.0,FLT3,9606.0,Homo sapiens (human),,,,,,,,
2085,1397538,126565,Drug Gene Interaction database (DGIdb),Lestaurtinib,,LESTAURTINIB,https://www.dgidb.org/drugs/ncit:C48402,,FLT3,https://www.dgidb.org/genes/hgnc:3765,,,2322.0,FLT3,9606.0,Homo sapiens (human),,,,,,,,
2086,1397539,126565,Drug Gene Interaction database (DGIdb),Lestaurtinib,,LESTAURTINIB,https://www.dgidb.org/drugs/ncit:C48402,,NTRK1,https://www.dgidb.org/genes/hgnc:8031,,,4914.0,NTRK1,9606.0,Homo sapiens (human),,,,,,,,
2087,1397540,126894,Comparative Toxicogenomics Database (CTD),Pivaloylcarnitine,C054040,pivaloylcarnitine,https://ctdbase.org/detail.go?type=chem&acc=C054040,6584,SLC22A5,https://ctdbase.org/detail.go?type=gene&acc=6584,,,6584.0,SLC22A5,9606.0,Homo sapiens (human),SLC22A5 protein results in increased transport of pivaloylcarnitine|pivaloylcarnitine binds to SLC22A5 protein|carnitine inhibits the reaction [SLC22A5 protein results in increased transport of pivaloylcarnitine]|pivaloylcarnitine inhibits the reaction [SLC22A5 protein results in increased transport of carnitine],,,PMID:19539806,https://www.ncbi.nlm.nih.gov/pubmed/19539806,19539806,,
2088,1397541,126894,Comparative Toxicogenomics Database (CTD),Pivaloylcarnitine,C054040,pivaloylcarnitine,https://ctdbase.org/detail.go?type=chem&acc=C054040,6584,SLC22A5,https://ctdbase.org/detail.go?type=gene&acc=6584,,,6584.0,SLC22A5,9606.0,Homo sapiens (human),SLC22A5 protein results in increased uptake of pivaloylcarnitine,,,PMID:18762717,https://www.ncbi.nlm.nih.gov/pubmed/18762717,18762717,,
2089,1397542,126894,Comparative Toxicogenomics Database (CTD),Pivaloylcarnitine,C054040,pivaloylcarnitine,https://ctdbase.org/detail.go?type=chem&acc=C054040,6584,SLC22A5,https://ctdbase.org/detail.go?type=gene&acc=6584,,,6584.0,SLC22A5,9823.0,Sus scrofa (pig),Pivaloylcarnitine results in decreased activity of SLC22A5 protein,,,PMID:16826461,https://www.ncbi.nlm.nih.gov/pubmed/16826461,16826461,,
2090,1397543,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,ERCC2,https://www.dgidb.org/genes/hgnc:3434,,,2068.0,ERCC2,9606.0,Homo sapiens (human),,,,,,,,
2091,1397544,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,BIRC5,https://www.dgidb.org/genes/hgnc:593,,,332.0,BIRC5,9606.0,Homo sapiens (human),,,,,,,,
2092,1397545,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,FOLR1,https://www.dgidb.org/genes/hgnc:3791,,,2348.0,FOLR1,9606.0,Homo sapiens (human),,,,,,,,
2093,1397546,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,SLCO1A2,https://www.dgidb.org/genes/hgnc:10956,,,6579.0,SLCO1A2,9606.0,Homo sapiens (human),,,,,,,,
2094,1397656,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,NR1I2,https://www.dgidb.org/genes/hgnc:7968,,,8856.0,NR1I2,9606.0,Homo sapiens (human),,,,,,,,
2095,1397657,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,SPECC1L,https://www.dgidb.org/genes/hgnc:29022,,,23384.0,SPECC1L,9606.0,Homo sapiens (human),,,,,,,,
2096,1397658,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,GSTT1,https://www.dgidb.org/genes/hgnc:4641,,,2952.0,GSTT1,9606.0,Homo sapiens (human),,,,,,,,
2097,1397659,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,NOS3,https://www.dgidb.org/genes/hgnc:7876,,,4846.0,NOS3,9606.0,Homo sapiens (human),,,,,,,,
2098,1397660,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,LINC00251,https://www.dgidb.org/genes/hgnc:31950,,,552859.0,LINC00251,9606.0,Homo sapiens (human),,,,,,,,
2099,1397661,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,FOLH1,https://www.dgidb.org/genes/hgnc:3788,,,2346.0,FOLH1,9606.0,Homo sapiens (human),,,,,,,,
2100,1397662,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,TNFAIP3,https://www.dgidb.org/genes/hgnc:11896,,,7128.0,TNFAIP3,9606.0,Homo sapiens (human),,,,,,,,
2101,1397663,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,CDKN1B,https://www.dgidb.org/genes/hgnc:1785,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),,,,,,,,
2102,1397664,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,ALOX5,https://www.dgidb.org/genes/hgnc:435,,,240.0,ALOX5,9606.0,Homo sapiens (human),,,,,,,,
2103,1397665,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,BAX,https://www.dgidb.org/genes/hgnc:959,,,581.0,BAX,9606.0,Homo sapiens (human),,,,,,,,
2104,1471146,126941,BindingDB,Methotrexate,18050,"2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18050,9726,Dihydrofolate reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9726,P00376,Dihydrofolate reductase ,508809.0,DHFR,9913.0,Bos taurus (cattle),,IC50 (nM),3.4,PMID:19703036|DOI:10.1111/j.1747-0285.2009.00860.x,https://www.ncbi.nlm.nih.gov/pubmed/19703036|https://doi.org/10.1111/j.1747-0285.2009.00860.x,19703036,10.1111/j.1747-0285.2009.00860.x,
2105,1472769,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Pimagedine inhibits the reaction [methotrexate results in increased expression of PTGS2 protein]|methotrexate results in increased expression of PTGS2 mRNA,,,PMID:29935243,https://www.ncbi.nlm.nih.gov/pubmed/29935243,29935243,,
2106,1472770,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Methotrexate results in increased expression of PTGS2 protein,,,PMID:27269004|PMID:28479099|PMID:29935243|PMID:31362085,https://www.ncbi.nlm.nih.gov/pubmed/27269004|https://www.ncbi.nlm.nih.gov/pubmed/28479099|https://www.ncbi.nlm.nih.gov/pubmed/29935243|https://www.ncbi.nlm.nih.gov/pubmed/31362085,27269004|28479099|29935243|31362085,,
2107,1472771,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5746,PTH2R,https://ctdbase.org/detail.go?type=gene&acc=5746,,,5746.0,PTH2R,10116.0,Rattus norvegicus (Norway rat),Methotrexate results in decreased expression of PTH2R mRNA,,,PMID:16005536,https://www.ncbi.nlm.nih.gov/pubmed/16005536,16005536,,
2108,1472772,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5744,PTHLH,https://ctdbase.org/detail.go?type=gene&acc=5744,,,5744.0,PTHLH,9606.0,Homo sapiens (human),Methotrexate results in increased expression of PTHLH mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2109,1472773,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5754,PTK7,https://ctdbase.org/detail.go?type=gene&acc=5754,,,5754.0,PTK7,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of PTK7 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2110,1472774,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5757,PTMA,https://ctdbase.org/detail.go?type=gene&acc=5757,,,5757.0,PTMA,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of PTMA mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2111,1472775,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,53635,PTOV1,https://ctdbase.org/detail.go?type=gene&acc=53635,,,53635.0,PTOV1,9606.0,Homo sapiens (human),PTOV1 protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
2112,1472776,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5782,PTPN12,https://ctdbase.org/detail.go?type=gene&acc=5782,,,5782.0,PTPN12,9606.0,Homo sapiens (human),Methotrexate results in increased expression of PTPN12 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2113,1472777,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,26469,PTPN18,https://ctdbase.org/detail.go?type=gene&acc=26469,,,26469.0,PTPN18,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of PTPN18 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2114,1472778,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,11099,PTPN21,https://ctdbase.org/detail.go?type=gene&acc=11099,,,11099.0,PTPN21,9606.0,Homo sapiens (human),Methotrexate results in increased expression of PTPN21 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2115,1473530,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,146713,RBFOX3,https://ctdbase.org/detail.go?type=gene&acc=146713,,,146713.0,RBFOX3,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of RBFOX3 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2116,1473531,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5933,RBL1,https://ctdbase.org/detail.go?type=gene&acc=5933,,,5933.0,RBL1,9606.0,Homo sapiens (human),Methotrexate results in increased expression of RBL1 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2117,1474307,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,55159,RFWD3,https://ctdbase.org/detail.go?type=gene&acc=55159,,,55159.0,RFWD3,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of RFWD3 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2118,1474308,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,499256,RGD1559600,https://ctdbase.org/detail.go?type=gene&acc=499256,,,499256.0,RGD1559600,10116.0,Rattus norvegicus (Norway rat),Methotrexate results in increased expression of RGD1559600 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2119,1474309,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5996,RGS1,https://ctdbase.org/detail.go?type=gene&acc=5996,,,5996.0,RGS1,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of RGS1 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2120,1474310,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6003,RGS13,https://ctdbase.org/detail.go?type=gene&acc=6003,,,6003.0,RGS13,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of RGS13 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2121,1474311,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5997,RGS2,https://ctdbase.org/detail.go?type=gene&acc=5997,,,5997.0,RGS2,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of RGS2 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2122,1474312,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5999,RGS4,https://ctdbase.org/detail.go?type=gene&acc=5999,,,5999.0,RGS4,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of RGS4 mRNA,,,PMID:17400583|PMID:19192274,https://www.ncbi.nlm.nih.gov/pubmed/17400583|https://www.ncbi.nlm.nih.gov/pubmed/19192274,17400583|19192274,,
2123,1474313,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6000,RGS7,https://ctdbase.org/detail.go?type=gene&acc=6000,,,6000.0,RGS7,9606.0,Homo sapiens (human),Methotrexate results in increased expression of RGS7 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2124,1474314,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,9606.0,Homo sapiens (human),Methotrexate results in increased expression of RHOA mRNA,,,PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/21678067,21678067,,
2125,1477096,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,9120,SLC16A6,https://ctdbase.org/detail.go?type=gene&acc=9120,,,9120.0,SLC16A6,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of SLC16A6 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2126,1481433,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6910,TBX5,https://ctdbase.org/detail.go?type=gene&acc=6910,,,6910.0,TBX5,7955.0,Danio rerio (zebrafish),Folic acid inhibits the reaction [methotrexate results in decreased expression of TBX5 mrna]|methotrexate results in decreased expression of TBX5 mRNA,,,PMID:21215183,https://www.ncbi.nlm.nih.gov/pubmed/21215183,21215183,,
2127,1481434,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6911,TBX6,https://ctdbase.org/detail.go?type=gene&acc=6911,,,6911.0,TBX6,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of TBX6 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2128,1481435,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,403088,TCAF3,https://ctdbase.org/detail.go?type=gene&acc=403088,,,403088.0,Tcaf3,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of TCAF3 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2129,1481436,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6919,TCEA2,https://ctdbase.org/detail.go?type=gene&acc=6919,,,6919.0,TCEA2,9606.0,Homo sapiens (human),Methotrexate results in increased expression of TCEA2 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2130,1481437,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6938,TCF12,https://ctdbase.org/detail.go?type=gene&acc=6938,,,6938.0,TCF12,9606.0,Homo sapiens (human),Methotrexate results in increased expression of TCF12 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2131,1481438,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6938,TCF12,https://ctdbase.org/detail.go?type=gene&acc=6938,,,6938.0,TCF12,9606.0,Homo sapiens (human),TCF12 protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
2132,1481439,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6943,TCF21,https://ctdbase.org/detail.go?type=gene&acc=6943,,,6943.0,TCF21,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of TCF21 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2133,1481440,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,10732,TCFL5,https://ctdbase.org/detail.go?type=gene&acc=10732,,,10732.0,TCFL5,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of TCFL5 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2134,1397776,127198,Comparative Toxicogenomics Database (CTD),Thiosultap,C049599,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",https://ctdbase.org/detail.go?type=chem&acc=C049599,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,7955.0,Danio rerio (zebrafish),"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester results in increased activity of CAT protein",,,PMID:35933024,https://www.ncbi.nlm.nih.gov/pubmed/35933024,35933024,,
2135,1397777,127198,Comparative Toxicogenomics Database (CTD),Thiosultap,C049599,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",https://ctdbase.org/detail.go?type=chem&acc=C049599,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,7955.0,Danio rerio (zebrafish),"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester results in increased expression of COL2A1 mRNA",,,PMID:35933024,https://www.ncbi.nlm.nih.gov/pubmed/35933024,35933024,,
2136,1397778,127198,Comparative Toxicogenomics Database (CTD),Thiosultap,C049599,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",https://ctdbase.org/detail.go?type=chem&acc=C049599,8643,PTCH2,https://ctdbase.org/detail.go?type=gene&acc=8643,,,8643.0,PTCH2,7955.0,Danio rerio (zebrafish),"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester results in increased expression of PTCH2 mRNA",,,PMID:35933024,https://www.ncbi.nlm.nih.gov/pubmed/35933024,35933024,,
2137,1397779,127198,Comparative Toxicogenomics Database (CTD),Thiosultap,C049599,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",https://ctdbase.org/detail.go?type=chem&acc=C049599,30269,SHHA,https://ctdbase.org/detail.go?type=gene&acc=30269,,,30269.0,shha,7955.0,Danio rerio (zebrafish),"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester results in increased expression of SHHA mRNA",,,PMID:35933024,https://www.ncbi.nlm.nih.gov/pubmed/35933024,35933024,,
2138,1397780,127198,Comparative Toxicogenomics Database (CTD),Thiosultap,C049599,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",https://ctdbase.org/detail.go?type=chem&acc=C049599,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,7955.0,Danio rerio (zebrafish),"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester results in increased activity of SOD1 protein",,,PMID:35933024,https://www.ncbi.nlm.nih.gov/pubmed/35933024,35933024,,
2139,1397781,127657,Comparative Toxicogenomics Database (CTD),Triclabendazole sulfoxide,C085104,triclabendazole sulfoxide,https://ctdbase.org/detail.go?type=chem&acc=C085104,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10090.0,Mus musculus (house mouse),Triclabendazole sulfoxide results in increased susceptibility to [ABCB1A protein results in increased transport of xanthenes]|abcb1a protein results in decreased susceptibility to triclabendazole sulfoxide,,,PMID:20513441,https://www.ncbi.nlm.nih.gov/pubmed/20513441,20513441,,
2140,1397782,127657,Comparative Toxicogenomics Database (CTD),Triclabendazole sulfoxide,C085104,triclabendazole sulfoxide,https://ctdbase.org/detail.go?type=chem&acc=C085104,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9913.0,Bos taurus (cattle),Triclabendazole sulfoxide inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride],,,PMID:24389113,https://www.ncbi.nlm.nih.gov/pubmed/24389113,24389113,,
2141,1471147,127716,Comparative Toxicogenomics Database (CTD),"1,4-Dideoxy-1,4-imino-L-arabinitol",C058137,"1,4-dideoxy-1,4-iminoarabinitol",https://ctdbase.org/detail.go?type=chem&acc=C058137,5837,PYGM,https://ctdbase.org/detail.go?type=gene&acc=5837,,,5837.0,PYGM,9986.0,Oryctolagus cuniculus (rabbit),"1,4-dideoxy-1,4-iminoarabinitol inhibits the reaction [[PYGM protein results in increased reduction of sodium arsenate] which results in increased chemical synthesis of arsenite]",,,PMID:17693424,https://www.ncbi.nlm.nih.gov/pubmed/17693424,17693424,,
2142,1397783,127951,Comparative Toxicogenomics Database (CTD),4-Chloro-2-(imidazolin-2-yl)isoindoline,C097364,4-chloro-2-(imidazolin-2-yl)isoindoline,https://ctdbase.org/detail.go?type=chem&acc=C097364,134864,TAAR1,https://ctdbase.org/detail.go?type=gene&acc=134864,,,134864.0,TAAR1,10090.0,Mus musculus (house mouse),4-chloro-2-(imidazolin-2-yl)isoindoline results in increased activity of TAAR1 protein|[4-chloro-2-(imidazolin-2-yl)isoindoline results in increased activity of TAAR1 protein] which results in increased abundance of cyclic AMP,,,PMID:19725810,https://www.ncbi.nlm.nih.gov/pubmed/19725810,19725810,,
2143,1397784,128155,Comparative Toxicogenomics Database (CTD),Stemphyltoxin III,C060436,stemphyltoxin III,https://ctdbase.org/detail.go?type=chem&acc=C060436,7153,TOP2A,https://ctdbase.org/detail.go?type=gene&acc=7153,,,7153.0,TOP2A,9606.0,Homo sapiens (human),Stemphyltoxin III results in decreased activity of TOP2A protein,,,PMID:27682608,https://www.ncbi.nlm.nih.gov/pubmed/27682608,27682608,,
2144,1471148,128174,BindingDB,Mannostatin B,84614,"Mannostatin B, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=84614,4979,Alpha-mannosidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4979,Q24451,Alpha-mannosidase 2,41126.0,alpha-Man-IIa,7227.0,Drosophila melanogaster (fruit fly),,Ki (nM),150,PMID:19101978|DOI:10.1002/cbic.200800538,https://www.ncbi.nlm.nih.gov/pubmed/19101978|https://doi.org/10.1002/cbic.200800538,19101978,10.1002/cbic.200800538,
2145,1471756,130976,Comparative Toxicogenomics Database (CTD),Phlorofucofuroeckol A,C064093,phlorofucofuroeckol A,https://ctdbase.org/detail.go?type=chem&acc=C064093,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),Phlorofucofuroeckol A inhibits the reaction [lipopolysaccharides results in increased phosphorylation of MAPK3 protein],,,PMID:21963823,https://www.ncbi.nlm.nih.gov/pubmed/21963823,21963823,,
2146,1471757,130976,Comparative Toxicogenomics Database (CTD),Phlorofucofuroeckol A,C064093,phlorofucofuroeckol A,https://ctdbase.org/detail.go?type=chem&acc=C064093,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Phlorofucofuroeckol A inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 mrna],,,PMID:21963823,https://www.ncbi.nlm.nih.gov/pubmed/21963823,21963823,,
2147,1471758,130976,Comparative Toxicogenomics Database (CTD),Phlorofucofuroeckol A,C064093,phlorofucofuroeckol A,https://ctdbase.org/detail.go?type=chem&acc=C064093,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Phlorofucofuroeckol A inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 mrna],,,PMID:21963823,https://www.ncbi.nlm.nih.gov/pubmed/21963823,21963823,,
2148,1471759,130976,Comparative Toxicogenomics Database (CTD),Phlorofucofuroeckol A,C064093,phlorofucofuroeckol A,https://ctdbase.org/detail.go?type=chem&acc=C064093,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Phlorofucofuroeckol A inhibits the reaction [lipopolysaccharides results in increased secretion of TNF protein],,,PMID:21963823,https://www.ncbi.nlm.nih.gov/pubmed/21963823,21963823,,
2149,1471760,131153,BindingDB,5-Fluoro-4-oxopentanoic acid,82192,"Substrate analogue, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=82192,4932,Delta-aminolevulinic acid dehydratase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4932,P0ACB2,Delta-aminolevulinic acid dehydratase,83577661.0,,83333.0,Escherichia coli K-12,,Ki (nM),8.5e+4,PMID:11828463|DOI:10.1002/1439-7633(20010504)2,https://www.ncbi.nlm.nih.gov/pubmed/11828463|https://doi.org/10.1002/1439-7633(20010504)2,11828463,10.1002/1439-7633(20010504)2,
2150,1471761,131255,Therapeutic Target Database (TTD),2-(4-Morpholinyl)-4H-1-benzopyran-4-one,D07APP,LY-292223,https://idrblab.net/ttd/data/drug/details/D07APP,T82577,Angiotensin-converting enzyme (ACE),https://idrblab.net/ttd/data/target/details/T82577,P12821,Angiotensin-converting enzyme ,1636.0,ACE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2151,1471762,131255,Therapeutic Target Database (TTD),2-(4-Morpholinyl)-4H-1-benzopyran-4-one,D07APP,LY-292223,https://idrblab.net/ttd/data/drug/details/D07APP,T67849,PI3-kinase delta (PIK3CD),https://idrblab.net/ttd/data/target/details/T67849,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",5293.0,PIK3CD,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2152,1471763,131255,Therapeutic Target Database (TTD),2-(4-Morpholinyl)-4H-1-benzopyran-4-one,D07APP,LY-292223,https://idrblab.net/ttd/data/drug/details/D07APP,T50970,Endothelin-converting enzyme 1 (ECE1),https://idrblab.net/ttd/data/target/details/T50970,P42892,Endothelin-converting enzyme 1,1889.0,ECE1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2153,1471764,131255,Therapeutic Target Database (TTD),2-(4-Morpholinyl)-4H-1-benzopyran-4-one,D07APP,LY-292223,https://idrblab.net/ttd/data/drug/details/D07APP,T95913,PI3-kinase gamma (PIK3CG),https://idrblab.net/ttd/data/target/details/T95913,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2154,1471765,131255,Therapeutic Target Database (TTD),2-(4-Morpholinyl)-4H-1-benzopyran-4-one,D07APP,LY-292223,https://idrblab.net/ttd/data/drug/details/D07APP,T81735,DNA-dependent protein kinase catalytic (PRKDC),https://idrblab.net/ttd/data/target/details/T81735,P78527,DNA-dependent protein kinase catalytic subunit,5591.0,PRKDC,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2155,1398021,131379,Therapeutic Target Database (TTD),Cercosporamide,D0L1YA,(-)-Cercosporamide,https://idrblab.net/ttd/data/drug/details/D0L1YA,T47107,Protein kinase C gamma (PRKCG),https://idrblab.net/ttd/data/target/details/T47107,P05129,Protein kinase C gamma type,5582.0,PRKCG,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2156,1398022,131682,Drug Gene Interaction database (DGIdb),Safinamide,,SAFINAMIDE,https://www.dgidb.org/drugs/rxcui:1922448,,SCN7A,https://www.dgidb.org/genes/hgnc:10594,,,6332.0,SCN7A,9606.0,Homo sapiens (human),,,,,,,,
2157,1398023,131682,Drug Gene Interaction database (DGIdb),Safinamide,,SAFINAMIDE,https://www.dgidb.org/drugs/rxcui:1922448,,SCN8A,https://www.dgidb.org/genes/hgnc:10596,,,6334.0,SCN8A,9606.0,Homo sapiens (human),,,,,,,,
2158,1398024,131682,Drug Gene Interaction database (DGIdb),Safinamide,,SAFINAMIDE,https://www.dgidb.org/drugs/rxcui:1922448,,SCN9A,https://www.dgidb.org/genes/hgnc:10597,,,6335.0,SCN9A,9606.0,Homo sapiens (human),,,,,,,,
2159,1398025,131682,Drug Gene Interaction database (DGIdb),Safinamide,,SAFINAMIDE,https://www.dgidb.org/drugs/rxcui:1922448,,SCN2A,https://www.dgidb.org/genes/hgnc:10588,,,6326.0,SCN2A,9606.0,Homo sapiens (human),,,,,,,,
2160,1398026,132266,IUPHAR/BPS Guide to PHARMACOLOGY,Cyclazosin,486,(+)-cyclazosin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=486,22,1A-adrenoceptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=22,P35348,Alpha-1A adrenergic receptor,148.0,ADRA1A,9606.0,Homo sapiens (human),Antagonist,pKi,7.9,PMID:8917649,https://www.ncbi.nlm.nih.gov/pubmed/8917649,8917649,,
2161,1398027,132266,IUPHAR/BPS Guide to PHARMACOLOGY,Cyclazosin,486,(+)-cyclazosin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=486,23,1B-adrenoceptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=23,P35368,Alpha-1B adrenergic receptor,147.0,ADRA1B,9606.0,Homo sapiens (human),Inverse agonist,pKi,9.9,PMID:8917649,https://www.ncbi.nlm.nih.gov/pubmed/8917649,8917649,,
2162,1398132,132787,Comparative Toxicogenomics Database (CTD),4-(Benzodioxan-5-yl)-1-(indan-2-yl)piperazine,C079549,4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine,https://ctdbase.org/detail.go?type=chem&acc=C079549,3350,HTR1A,https://ctdbase.org/detail.go?type=gene&acc=3350,,,3350.0,HTR1A,9606.0,Homo sapiens (human),4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine binds to and results in increased activity of HTR1A protein,,,PMID:18581099,https://www.ncbi.nlm.nih.gov/pubmed/18581099,18581099,,
2163,1398133,132787,Comparative Toxicogenomics Database (CTD),4-(Benzodioxan-5-yl)-1-(indan-2-yl)piperazine,C079549,4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine,https://ctdbase.org/detail.go?type=chem&acc=C079549,6532,SLC6A4,https://ctdbase.org/detail.go?type=gene&acc=6532,,,6532.0,SLC6A4,10116.0,Rattus norvegicus (Norway rat),SLC6A4 results in increased susceptibility to 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine,,,PMID:18581099,https://www.ncbi.nlm.nih.gov/pubmed/18581099,18581099,,
2164,1398134,132991,IUPHAR/BPS Guide to PHARMACOLOGY,N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,1001,[125I]PD151242,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1001,219,ETA receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=219,P25101,Endothelin-1 receptor,1909.0,EDNRA,9606.0,Homo sapiens (human),Antagonist,pKd,9 - 9.1,PMID:8012722,https://www.ncbi.nlm.nih.gov/pubmed/8012722,8012722,,
2165,1398135,133008,IUPHAR/BPS Guide to PHARMACOLOGY,5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole,3302,L741742,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3302,217,D4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=217,P21917,D(4) dopamine receptor,1815.0,DRD4,9606.0,Homo sapiens (human),Antagonist,pKi,8.5,PMID:8642551,https://www.ncbi.nlm.nih.gov/pubmed/8642551,8642551,,
2166,1398136,133079,IUPHAR/BPS Guide to PHARMACOLOGY,Sonepiprazole,980,sonepiprazole,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=980,217,D4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=217,P30729,D(4) dopamine receptor,,,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,8.7,PMID:15448188,https://www.ncbi.nlm.nih.gov/pubmed/15448188,15448188,,
2167,1398137,133079,IUPHAR/BPS Guide to PHARMACOLOGY,Sonepiprazole,980,sonepiprazole,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=980,217,D4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=217,,,25432.0,Drd4,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,8.7,PMID:15448188,https://www.ncbi.nlm.nih.gov/pubmed/15448188,15448188,,
2168,1551309,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,27243,CHMP2A,https://ctdbase.org/detail.go?type=gene&acc=27243,,,27243.0,CHMP2A,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of CHMP2A protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2169,1551310,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,1211,CLTA,https://ctdbase.org/detail.go?type=gene&acc=1211,,,1211.0,CLTA,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in increased expression of CLTA protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2170,1551509,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,1743,DLST,https://ctdbase.org/detail.go?type=gene&acc=1743,,,1743.0,DLST,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in increased expression of DLST protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2171,1551510,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,10049,DNAJB6,https://ctdbase.org/detail.go?type=gene&acc=10049,,,10049.0,DNAJB6,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of DNAJB6 protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2172,1551511,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,1808,DPYSL2,https://ctdbase.org/detail.go?type=gene&acc=1808,,,1808.0,DPYSL2,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of DPYSL2 protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2173,1551512,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,1809,DPYSL3,https://ctdbase.org/detail.go?type=gene&acc=1809,,,1809.0,DPYSL3,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of DPYSL3 protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2174,1551513,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,10570,DPYSL4,https://ctdbase.org/detail.go?type=gene&acc=10570,,,10570.0,DPYSL4,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of DPYSL4 protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2175,1551514,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,1814,DRD3,https://ctdbase.org/detail.go?type=gene&acc=1814,,,1814.0,DRD3,10116.0,Rattus norvegicus (Norway rat),"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [SK&F 83959 promotes the reaction [CAMK2A protein binds to DRD3 protein]]|sch 23390 inhibits the reaction [SK&F 83959 promotes the reaction [CAMK2A protein binds to DRD3 protein]]|sk&f 83959 promotes the reaction [CAMK2A protein binds to DRD3 protein]",,,PMID:19217379,https://www.ncbi.nlm.nih.gov/pubmed/19217379,19217379,,
2176,1551515,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,1892,ECHS1,https://ctdbase.org/detail.go?type=gene&acc=1892,,,1892.0,ECHS1,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of ECHS1 protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2177,1551516,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,1975,EIF4B,https://ctdbase.org/detail.go?type=gene&acc=1975,,,1975.0,EIF4B,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of EIF4B protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2178,1551709,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,2771,GNAI2,https://ctdbase.org/detail.go?type=gene&acc=2771,,,2771.0,GNAI2,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of GNAI2 protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2179,1551710,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,2775,GNAO1,https://ctdbase.org/detail.go?type=gene&acc=2775,,,2775.0,GNAO1,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 affects the expression of GNAO1 protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2180,1552225,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,9445,ITM2B,https://ctdbase.org/detail.go?type=gene&acc=9445,,,9445.0,ITM2B,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in increased expression of ITM2B protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2181,1552226,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,3927,LASP1,https://ctdbase.org/detail.go?type=gene&acc=3927,,,3927.0,LASP1,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 affects the expression of LASP1 protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2182,1552227,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,3945,LDHB,https://ctdbase.org/detail.go?type=gene&acc=3945,,,3945.0,LDHB,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 affects the expression of LDHB protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2183,1552983,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,5813,PURA,https://ctdbase.org/detail.go?type=gene&acc=5813,,,5813.0,PURA,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in increased expression of PURA protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2184,1552984,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,5814,PURB,https://ctdbase.org/detail.go?type=gene&acc=5814,,,5814.0,PURB,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in increased expression of PURB protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2185,1552985,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,5860,QDPR,https://ctdbase.org/detail.go?type=gene&acc=5860,,,5860.0,QDPR,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of QDPR protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2186,1552986,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,5928,RBBP4,https://ctdbase.org/detail.go?type=gene&acc=5928,,,5928.0,RBBP4,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in increased expression of RBBP4 protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2187,1552987,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,10055,SAE1,https://ctdbase.org/detail.go?type=gene&acc=10055,,,10055.0,SAE1,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of SAE1 protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2188,1552988,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,51540,SCLY,https://ctdbase.org/detail.go?type=gene&acc=51540,,,51540.0,SCLY,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in decreased expression of SCLY protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2189,1552989,133538,Comparative Toxicogenomics Database (CTD),"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",C080703,SK&F 83959,https://ctdbase.org/detail.go?type=chem&acc=C080703,6386,SDCBP,https://ctdbase.org/detail.go?type=gene&acc=6386,,,6386.0,SDCBP,10047.0,Meriones unguiculatus (Mongolian gerbil),SK&F 83959 results in increased expression of SDCBP protein,,,PMID:25852303,https://www.ncbi.nlm.nih.gov/pubmed/25852303,25852303,,
2190,1472768,134601,DrugBank,Aspartame,DB00168,Aspartame,https://www.drugbank.ca/drugs/DB00168,BE0000879,Solute carrier family 22 member 11,https://www.drugbank.ca/bio_entities/BE0000879,Q9NSA0,Solute carrier family 22 member 11,55867.0,SLC22A11,9606.0,Homo sapiens (human),Inhibitor,,,PMID:12063169,https://www.ncbi.nlm.nih.gov/pubmed/12063169,12063169,,
2191,1391241,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),[IL1B protein results in increased expression of and results in increased activity of NOS2 protein] which results in increased chemical synthesis of nitric oxide|rotenone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide],,,PMID:11530235,https://www.ncbi.nlm.nih.gov/pubmed/11530235,11530235,,
2192,1391242,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide,,,PMID:11286988|PMID:18078833|PMID:7519435,https://www.ncbi.nlm.nih.gov/pubmed/11286988|https://www.ncbi.nlm.nih.gov/pubmed/18078833|https://www.ncbi.nlm.nih.gov/pubmed/7519435,11286988|18078833|7519435,,
2193,1391243,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),[indomethacin results in increased activity of NOS2 protein] which results in increased chemical synthesis of nitric oxide,,,PMID:16944022,https://www.ncbi.nlm.nih.gov/pubmed/16944022,16944022,,
2194,1395620,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),[taurocholic acid results in increased expression of NOS2 protein] which results in increased abundance of nitric oxide|resveratrol inhibits the reaction [[taurocholic acid results in increased expression of NOS2 protein] which results in increased abundance of nitric oxide],,,PMID:16389574,https://www.ncbi.nlm.nih.gov/pubmed/16389574,16389574,,
2195,1395621,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),Wuzi yanzong analog inhibits the reaction [[lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide],,,PMID:21893401,https://www.ncbi.nlm.nih.gov/pubmed/21893401,21893401,,
2196,1395622,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9823.0,Sus scrofa (pig),Resveratrol inhibits the reaction [NOS2 protein results in increased chemical synthesis of nitric oxide],,,PMID:20825639,https://www.ncbi.nlm.nih.gov/pubmed/20825639,20825639,,
2197,1395623,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606.0,Homo sapiens (human),"[[IFNG protein co-treated with lipopolysaccharide, escherichia coli O111 B4] results in increased expression of NOS2] which results in increased chemical synthesis of nitric oxide",,,PMID:16307444,https://www.ncbi.nlm.nih.gov/pubmed/16307444,16307444,,
2198,1395624,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606.0,Homo sapiens (human),Manganese promotes the reaction [NOS2 protein results in increased chemical synthesis of nitric oxide],,,PMID:15010209,https://www.ncbi.nlm.nih.gov/pubmed/15010209,15010209,,
2199,1395625,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606.0,Homo sapiens (human),"[N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [TNF protein promotes the reaction [7,8-diacetoxy-4-methylcoumarin results in increased abundance of nitric oxide]]",,,PMID:20188080,https://www.ncbi.nlm.nih.gov/pubmed/20188080,20188080,,
2200,1395626,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606.0,Homo sapiens (human),[NOS2 protein co-treated with sapropterin] results in increased abundance of nitric oxide,,,PMID:7756597,https://www.ncbi.nlm.nih.gov/pubmed/7756597,7756597,,
2201,1402091,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,406991,MIR21,https://ctdbase.org/detail.go?type=gene&acc=406991,,,406991.0,MIR21,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides co-treated with carbon monoxide]] which results in increased expression of MIR21 mrna|[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides]] which results in increased expression of MIR21 mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2202,1402092,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,406992,MIR210,https://ctdbase.org/detail.go?type=gene&acc=406992,,,406992.0,MIR210,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides]] which results in increased expression of MIR210 mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2203,1402093,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,100500809,MIR23C,https://ctdbase.org/detail.go?type=gene&acc=100500809,,,100500809.0,MIR23C,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides]] which results in increased expression of MIR23C mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2204,1402094,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,100422910,MIR2861,https://ctdbase.org/detail.go?type=gene&acc=100422910,,,100422910.0,MIR2861,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides co-treated with carbon monoxide]] which results in increased expression of MIR2861 mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2205,1402095,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,407029,MIR30A,https://ctdbase.org/detail.go?type=gene&acc=407029,,,407029.0,MIR30A,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides]] which results in increased expression of MIR30A mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2206,1402227,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,619552,MIR483,https://ctdbase.org/detail.go?type=gene&acc=619552,,,619552.0,MIR483,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides]] which results in increased expression of MIR483 mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2207,1402228,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,574506,MIR503,https://ctdbase.org/detail.go?type=gene&acc=574506,,,574506.0,MIR503,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides]] which results in increased expression of MIR503 mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2208,1402229,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,693200,MIR615,https://ctdbase.org/detail.go?type=gene&acc=693200,,,693200.0,MIR615,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides co-treated with carbon monoxide]] which results in increased expression of MIR615 mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2209,1402230,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,102465431,MIR6722,https://ctdbase.org/detail.go?type=gene&acc=102465431,,,102465431.0,MIR6722,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides co-treated with carbon monoxide]] which results in increased expression of MIR6722 mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2210,1402231,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,407050,MIR93,https://ctdbase.org/detail.go?type=gene&acc=407050,,,407050.0,MIR93,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides co-treated with carbon monoxide]] which results in increased expression of MIR93 mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2211,1402232,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,406887,MIRLET7E,https://ctdbase.org/detail.go?type=gene&acc=406887,,,406887.0,MIRLET7E,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides]] which results in increased expression of MIRLET7E mrna|[air pollutants results in increased abundance of [particulate matter co-treated with carbon co-treated with sulfur dioxide co-treated with nitrogen oxides co-treated with carbon monoxide]] which results in increased expression of MIRLET7E mRNA,,,PMID:31268311,https://www.ncbi.nlm.nih.gov/pubmed/31268311,31268311,,
2212,1402594,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,7292,TNFSF4,https://ctdbase.org/detail.go?type=gene&acc=7292,,,7292.0,TNFSF4,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [carbon monoxide co-treated with nitrogen oxides co-treated with sulfur dioxide]] which results in increased expression of TNFSF4 mRNA,,,PMID:29621558,https://www.ncbi.nlm.nih.gov/pubmed/29621558,29621558,,
2213,1402595,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Nitrogen oxides inhibits the reaction [benzo(a)pyrene results in increased expression of TP53 protein],,,PMID:16041517,https://www.ncbi.nlm.nih.gov/pubmed/16041517,16041517,,
2214,1402596,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,89870,TRIM15,https://ctdbase.org/detail.go?type=gene&acc=89870,,,89870.0,TRIM15,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of nitrogen oxides] which results in decreased methylation of TRIM15 5' UTR,,,PMID:28843141,https://www.ncbi.nlm.nih.gov/pubmed/28843141,28843141,,
2215,1402597,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009589,Nitrogen Oxides,https://ctdbase.org/detail.go?type=chem&acc=D009589,10413,YAP1,https://ctdbase.org/detail.go?type=gene&acc=10413,,,10413.0,YAP1,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of nitrogen oxides] which affects the methylation of YAP1 gene,,,PMID:34941772,https://www.ncbi.nlm.nih.gov/pubmed/34941772,34941772,,
2216,1402598,145068,Drug Gene Interaction database (DGIdb),Nitric Oxide,,NITRIC OXIDE,https://www.dgidb.org/drugs/rxcui:7442,,GUCY1A2,https://www.dgidb.org/genes/hgnc:4684,,,2977.0,GUCY1A2,9606.0,Homo sapiens (human),,,,,,,,
2217,1402599,145726,Drug Gene Interaction database (DGIdb),"3',4'-Dihydroxyflavone",,CHEMBL:CHEMBL222556,https://www.dgidb.org/drugs/chembl:CHEMBL222556,,POLK,https://www.dgidb.org/genes/hgnc:9183,,,51426.0,POLK,9606.0,Homo sapiens (human),,,,,,,,
2218,1402600,145726,Drug Gene Interaction database (DGIdb),"3',4'-Dihydroxyflavone",,CHEMBL:CHEMBL222556,https://www.dgidb.org/drugs/chembl:CHEMBL222556,,KDM4E,https://www.dgidb.org/genes/hgnc:37098,,,390245.0,KDM4E,9606.0,Homo sapiens (human),,,,,,,,
2219,1402601,145726,Drug Gene Interaction database (DGIdb),"3',4'-Dihydroxyflavone",,CHEMBL:CHEMBL222556,https://www.dgidb.org/drugs/chembl:CHEMBL222556,,ALDH1A1,https://www.dgidb.org/genes/hgnc:402,,,216.0,ALDH1A1,9606.0,Homo sapiens (human),,,,,,,,
2220,1402602,145772,Therapeutic Target Database (TTD),"4,9-dihydro-3H-Pyrido[3,4-b]indole",D0G8BT,"4,9-Dihydro-3H-beta-carboline",https://idrblab.net/ttd/data/drug/details/D0G8BT,T83875,Monoamine oxidase type A (MAO-A),https://idrblab.net/ttd/data/target/details/T83875,P21397,Amine oxidase [flavin-containing] A,4128.0,MAOA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2221,1402603,145772,Therapeutic Target Database (TTD),"4,9-dihydro-3H-Pyrido[3,4-b]indole",D0G8BT,"4,9-Dihydro-3H-beta-carboline",https://idrblab.net/ttd/data/drug/details/D0G8BT,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2222,1402604,145826,Drug Gene Interaction database (DGIdb),"3',4'-Dihydroxyflavonol",,CHEMBL:CHEMBL122701,https://www.dgidb.org/drugs/chembl:CHEMBL122701,,POLK,https://www.dgidb.org/genes/hgnc:9183,,,51426.0,POLK,9606.0,Homo sapiens (human),,,,,,,,
2223,1402725,146285,BindingDB,"4-[(E)-[2,4-diamino-5-methyl-3-[(E)-(4-sulfophenyl)azo]phenyl]azo]benzenesulfonic acid",25320,"4-[(E)-2-{2,6-diamino-3-methyl-5-[(E)-2-(4-sulfophenyl)diazen-1-yl]phenyl}diazen-1-yl]benzene-1-sulfonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25320,2815,ATP phosphoribosyltransferase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2815,P9WMN1,ATP phosphoribosyltransferase,45426096.0,hisG,83332.0,Mycobacterium tuberculosis H37Rv,,,,PMID:18778048|DOI:10.1021/jm800328v,https://www.ncbi.nlm.nih.gov/pubmed/18778048|https://doi.org/10.1021/jm800328v,18778048,10.1021/jm800328v,
2224,1402726,147569,Comparative Toxicogenomics Database (CTD),8-Chloroadenosine,C075440,8-chloroadenosine,https://ctdbase.org/detail.go?type=chem&acc=C075440,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,10090.0,Mus musculus (house mouse),8-chloroadenosine results in decreased expression of ATM mRNA,,,PMID:31778309,https://www.ncbi.nlm.nih.gov/pubmed/31778309,31778309,,
2225,1399302,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,8325,FZD8,https://ctdbase.org/detail.go?type=gene&acc=8325,,,8325.0,FZD8,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in increased expression of FZD8 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2226,1399303,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,2621,GAS6,https://ctdbase.org/detail.go?type=gene&acc=2621,,,2621.0,GAS6,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in increased expression of GAS6 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2227,1399304,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in decreased expression of GCLC mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2228,1399305,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,219970,GLYATL2,https://ctdbase.org/detail.go?type=gene&acc=219970,,,219970.0,GLYATL2,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in increased expression of GLYATL2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2229,1399306,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,2819,GPD1,https://ctdbase.org/detail.go?type=gene&acc=2819,,,2819.0,GPD1,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in decreased expression of GPD1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2230,1399307,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,51495,HACD3,https://ctdbase.org/detail.go?type=gene&acc=51495,,,51495.0,HACD3,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in decreased expression of HACD3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2231,1399425,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),[levofloxacin co-treated with TNF protein] results in increased expression of ICAM1 protein|levofloxacin results in decreased expression of ICAM1 mRNA,,,PMID:32035082,https://www.ncbi.nlm.nih.gov/pubmed/32035082,32035082,,
2232,1399426,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,3422,IDI1,https://ctdbase.org/detail.go?type=gene&acc=3422,,,3422.0,IDI1,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in increased expression of IDI1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2233,1399427,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in increased expression of IFNG,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2234,1399428,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606.0,Homo sapiens (human),Levofloxacin results in increased expression of IL1A mRNA,,,PMID:32816093,https://www.ncbi.nlm.nih.gov/pubmed/32816093,32816093,,
2235,1399429,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),[levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein,,,PMID:30876886,https://www.ncbi.nlm.nih.gov/pubmed/30876886,30876886,,
2236,1399430,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,11009,IL24,https://ctdbase.org/detail.go?type=gene&acc=11009,,,11009.0,IL24,9606.0,Homo sapiens (human),Levofloxacin results in increased expression of IL24 mRNA,,,PMID:32816093,https://www.ncbi.nlm.nih.gov/pubmed/32816093,32816093,,
2237,1399431,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),[levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein,,,PMID:30876886,https://www.ncbi.nlm.nih.gov/pubmed/30876886,30876886,,
2238,1399432,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,3570,IL6R,https://ctdbase.org/detail.go?type=gene&acc=3570,,,3570.0,IL6R,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in increased expression of IL6R mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2239,1399433,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,51447,IP6K2,https://ctdbase.org/detail.go?type=gene&acc=51447,,,51447.0,IP6K2,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in increased expression of IP6K2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2240,1399434,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,10625,IVNS1ABP,https://ctdbase.org/detail.go?type=gene&acc=10625,,,10625.0,IVNS1ABP,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in increased expression of IVNS1ABP mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2241,1400475,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein,,,PMID:30876886,https://www.ncbi.nlm.nih.gov/pubmed/30876886,30876886,,
2242,1400476,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[levofloxacin co-treated with TNF protein] results in increased expression of ICAM1 protein|[levofloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mrna|[levofloxacin co-treated with TNF protein] results in increased expression of NFKBIA mrna|[levofloxacin co-treated with TNF protein] results in increased expression of BIRC2 mRNA,,,PMID:32035082,https://www.ncbi.nlm.nih.gov/pubmed/32035082,32035082,,
2243,1400477,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[TNF protein co-treated with levofloxacin] results in increased lipidation of MAP1LC3B protein|tnf protein promotes the reaction [levofloxacin results in increased expression of MAP1LC3B protein],,,PMID:33609687,https://www.ncbi.nlm.nih.gov/pubmed/33609687,33609687,,
2244,1400478,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,7128,TNFAIP3,https://ctdbase.org/detail.go?type=gene&acc=7128,,,7128.0,TNFAIP3,9606.0,Homo sapiens (human),[levofloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA,,,PMID:32035082,https://www.ncbi.nlm.nih.gov/pubmed/32035082,32035082,,
2245,1400479,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,7130,TNFAIP6,https://ctdbase.org/detail.go?type=gene&acc=7130,,,7130.0,TNFAIP6,9606.0,Homo sapiens (human),Levofloxacin results in decreased expression of TNFAIP6 mRNA,,,PMID:32816093,https://www.ncbi.nlm.nih.gov/pubmed/32816093,32816093,,
2246,1400480,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,3604,TNFRSF9,https://ctdbase.org/detail.go?type=gene&acc=3604,,,3604.0,TNFRSF9,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in decreased expression of TNFRSF9 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2247,1400481,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,10766,TOB2,https://ctdbase.org/detail.go?type=gene&acc=10766,,,10766.0,TOB2,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in increased expression of TOB2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2248,1400482,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,7170,TPM3,https://ctdbase.org/detail.go?type=gene&acc=7170,,,7170.0,TPM3,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in decreased expression of TPM3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2249,1400483,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,1831,TSC22D3,https://ctdbase.org/detail.go?type=gene&acc=1831,,,1831.0,TSC22D3,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in increased expression of TSC22D3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2250,1400484,149096,Comparative Toxicogenomics Database (CTD),Levofloxacin,D064704,Levofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D064704,100130890,TSTD3,https://ctdbase.org/detail.go?type=gene&acc=100130890,,,100130890.0,TSTD3,10116.0,Rattus norvegicus (Norway rat),Levofloxacin results in decreased expression of TSTD3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2251,1551506,150459,Comparative Toxicogenomics Database (CTD),"1-Methyl-4-phenyl-2,3-dihydropyridinium",C044755,"1-methyl-4-phenyl-2,3-dihydropyridinium",https://ctdbase.org/detail.go?type=chem&acc=C044755,4519,CYTB,https://ctdbase.org/detail.go?type=gene&acc=4519,,,4519.0,CYTB,9606.0,Homo sapiens (human),"1-methyl-4-phenyl-2,3-dihydropyridinium results in decreased expression of CYTB mRNA",,,PMID:21856379,https://www.ncbi.nlm.nih.gov/pubmed/21856379,21856379,,
2252,1551507,150459,Comparative Toxicogenomics Database (CTD),"1-Methyl-4-phenyl-2,3-dihydropyridinium",C044755,"1-methyl-4-phenyl-2,3-dihydropyridinium",https://ctdbase.org/detail.go?type=chem&acc=C044755,2896,GRN,https://ctdbase.org/detail.go?type=gene&acc=2896,,,2896.0,GRN,10116.0,Rattus norvegicus (Norway rat),"2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [wortmannin inhibits the reaction [GRN protein results in decreased susceptibility to 1-methyl-4-phenyl-2,3-dihydropyridinium]]|u 0126 promotes the reaction [wortmannin inhibits the reaction [GRN protein results in decreased susceptibility to 1-methyl-4-phenyl-2,3-dihydropyridinium]]|grn protein results in decreased susceptibility to 1-methyl-4-phenyl-2,3-dihydropyridinium|u 0126 inhibits the reaction [GRN protein results in decreased susceptibility to 1-methyl-4-phenyl-2,3-dihydropyridinium]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [GRN protein results in decreased susceptibility to 1-methyl-4-phenyl-2,3-dihydropyridinium]|wortmannin inhibits the reaction [GRN protein results in decreased susceptibility to 1-methyl-4-phenyl-2,3-dihydropyridinium]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [GRN protein results in decreased susceptibility to 1-methyl-4-phenyl-2,3-dihydropyridinium]",,,PMID:21820214,https://www.ncbi.nlm.nih.gov/pubmed/21820214,21820214,,
2253,1551508,150459,Comparative Toxicogenomics Database (CTD),"1-Methyl-4-phenyl-2,3-dihydropyridinium",C044755,"1-methyl-4-phenyl-2,3-dihydropyridinium",https://ctdbase.org/detail.go?type=chem&acc=C044755,3667,IRS1,https://ctdbase.org/detail.go?type=gene&acc=3667,,,3667.0,IRS1,9606.0,Homo sapiens (human),"1-methyl-4-phenyl-2,3-dihydropyridinium results in decreased expression of IRS1 mRNA",,,PMID:21856379,https://www.ncbi.nlm.nih.gov/pubmed/21856379,21856379,,
2254,1403176,150762,Therapeutic Target Database (TTD),Manidipine dihydrochloride,D0I9VY,CV-4093,https://idrblab.net/ttd/data/drug/details/D0I9VY,T24793,Voltage-gated calcium channel alpha Cav1.3 (CACNA1D),https://idrblab.net/ttd/data/target/details/T24793,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D ,776.0,CACNA1D,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2255,1403177,150762,Therapeutic Target Database (TTD),Manidipine dihydrochloride,D0I9VY,CV-4093,https://idrblab.net/ttd/data/drug/details/D0I9VY,T51115,Voltage-gated calcium channel alpha Cav1.2 (CACNA1C),https://idrblab.net/ttd/data/target/details/T51115,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,775.0,CACNA1C,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2256,1403178,150934,BindingDB,N-Methyl-4-toluohydroxamic acid,233170,"N-Hydroxy-4,N-dimethyl-benzamide (9)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=233170,9974,Polyphenol oxidase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9974,Q00024,Polyphenol oxidase 1,,,5341.0,Agaricus bisporus,,IC50 (nM),2.09e+3,PMID:20476840|DOI:10.3109/14756366.2010.482529,https://www.ncbi.nlm.nih.gov/pubmed/20476840|https://doi.org/10.3109/14756366.2010.482529,20476840,10.3109/14756366.2010.482529,
2257,1403179,150950,Comparative Toxicogenomics Database (CTD),Cyclohexyl methylphosphonic acid,C073636,cyclohexyl methylphosphonic acid,https://ctdbase.org/detail.go?type=chem&acc=C073636,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9606.0,Homo sapiens (human),Cyclohexyl methylphosphonic acid analog results in decreased activity of ACHE protein,,,PMID:26965078,https://www.ncbi.nlm.nih.gov/pubmed/26965078,26965078,,
2258,1403914,152234,Therapeutic Target Database (TTD),3-Methoxyamphetamine,D00QSV,2-(3-Methoxy-phenyl)-1-methyl-ethylamine,https://idrblab.net/ttd/data/drug/details/D00QSV,T32060,5-HT 2A receptor (HTR2A),https://idrblab.net/ttd/data/target/details/T32060,P28223,5-hydroxytryptamine receptor 2A,3356.0,HTR2A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2259,1403915,152234,Therapeutic Target Database (TTD),3-Methoxyamphetamine,D00QSV,2-(3-Methoxy-phenyl)-1-methyl-ethylamine,https://idrblab.net/ttd/data/drug/details/D00QSV,T78709,5-HT 1A receptor (HTR1A),https://idrblab.net/ttd/data/target/details/T78709,P08908,5-hydroxytryptamine receptor 1A,3350.0,HTR1A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2260,1403916,152234,Therapeutic Target Database (TTD),3-Methoxyamphetamine,D00QSV,2-(3-Methoxy-phenyl)-1-methyl-ethylamine,https://idrblab.net/ttd/data/drug/details/D00QSV,T11072,5-HT 1D receptor (HTR1D),https://idrblab.net/ttd/data/target/details/T11072,P28221,5-hydroxytryptamine receptor 1D,3352.0,HTR1D,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2261,1403917,152943,Drug Gene Interaction database (DGIdb),Frovatriptan Succinate monohydrate,,FROVATRIPTAN SUCCINATE,https://www.dgidb.org/drugs/rxcui:322249,,HTR1B,https://www.dgidb.org/genes/hgnc:5287,,,3351.0,HTR1B,9606.0,Homo sapiens (human),Agonist,,,,,,,
2262,1403918,152943,Drug Gene Interaction database (DGIdb),Frovatriptan Succinate monohydrate,,FROVATRIPTAN SUCCINATE,https://www.dgidb.org/drugs/rxcui:322249,,HTR1D,https://www.dgidb.org/genes/hgnc:5289,,,3352.0,HTR1D,9606.0,Homo sapiens (human),Agonist,,,,,,,
2263,1404031,154059,DrugBank,Solifenacin,DB01591,Solifenacin,https://www.drugbank.ca/drugs/DB01591,BE0000247,Muscarinic acetylcholine receptor M5,https://www.drugbank.ca/bio_entities/BE0000247,P08912,Muscarinic acetylcholine receptor M5,1133.0,CHRM5,9606.0,Homo sapiens (human),Antagonist,,,PMID:19029429,https://www.ncbi.nlm.nih.gov/pubmed/19029429,19029429,,
2264,1404032,154059,DrugBank,Solifenacin,DB01591,Solifenacin,https://www.drugbank.ca/drugs/DB01591,BE0000092,Muscarinic acetylcholine receptor M1,https://www.drugbank.ca/bio_entities/BE0000092,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606.0,Homo sapiens (human),Antagonist,,,PMID:17139284|PMID:17016423|PMID:20590605|PMID:19029429,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/20590605|https://www.ncbi.nlm.nih.gov/pubmed/19029429,17139284|17016423|20590605|19029429,,
2265,1404033,154059,DrugBank,Solifenacin,DB01591,Solifenacin,https://www.drugbank.ca/drugs/DB01591,BE0003543,Cytochrome P450 1A1,https://www.drugbank.ca/bio_entities/BE0003543,P04798,Cytochrome P450 1A1,1543.0,CYP1A1,9606.0,Homo sapiens (human),Substrate,,,PMID:19566112,https://www.ncbi.nlm.nih.gov/pubmed/19566112,19566112,,
2266,1404034,154059,DrugBank,Solifenacin,DB01591,Solifenacin,https://www.drugbank.ca/drugs/DB01591,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606.0,Homo sapiens (human),Substrate,,,PMID:19566112,https://www.ncbi.nlm.nih.gov/pubmed/19566112,19566112,,
2267,1404035,154059,DrugBank,Solifenacin,DB01591,Solifenacin,https://www.drugbank.ca/drugs/DB01591,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate,,,PMID:19566112|PMID:16867168,https://www.ncbi.nlm.nih.gov/pubmed/19566112|https://www.ncbi.nlm.nih.gov/pubmed/16867168,19566112|16867168,,
2268,1454036,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6790,AURKA,https://ctdbase.org/detail.go?type=gene&acc=6790,,,6790.0,AURKA,9606.0,Homo sapiens (human),"[2,2',4,4'-tetrabromodiphenyl ether co-treated with hexabrominated diphenyl ether 153 co-treated with pentabrominated diphenyl ether 100] results in increased expression of AURKA mrna|pentabrominated diphenyl ether 100 results in increased expression of AURKA mRNA",,,PMID:30796839,https://www.ncbi.nlm.nih.gov/pubmed/30796839,30796839,,
2269,1454037,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9531,BAG3,https://ctdbase.org/detail.go?type=gene&acc=9531,,,9531.0,BAG3,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of BAG3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2270,1454038,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9031,BAZ1B,https://ctdbase.org/detail.go?type=gene&acc=9031,,,9031.0,BAZ1B,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of BAZ1B protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2271,1454039,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,4059,BCAM,https://ctdbase.org/detail.go?type=gene&acc=4059,,,4059.0,BCAM,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of BCAM protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2272,1454040,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10134,BCAP31,https://ctdbase.org/detail.go?type=gene&acc=10134,,,10134.0,BCAP31,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of BCAP31 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2273,1455914,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10540,DCTN2,https://ctdbase.org/detail.go?type=gene&acc=10540,,,10540.0,DCTN2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DCTN2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2274,1455915,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,51181,DCXR,https://ctdbase.org/detail.go?type=gene&acc=51181,,,51181.0,DCXR,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DCXR protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2275,1455916,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1643,DDB2,https://ctdbase.org/detail.go?type=gene&acc=1643,,,1643.0,DDB2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DDB2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2276,1455917,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,65992,DDRGK1,https://ctdbase.org/detail.go?type=gene&acc=65992,,,65992.0,DDRGK1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of DDRGK1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2277,1455918,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1652,DDT,https://ctdbase.org/detail.go?type=gene&acc=1652,,,1652.0,DDT,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DDT protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2278,1455919,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10521,DDX17,https://ctdbase.org/detail.go?type=gene&acc=10521,,,10521.0,DDX17,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DDX17 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2279,1455920,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55308,DDX19A,https://ctdbase.org/detail.go?type=gene&acc=55308,,,55308.0,DDX19A,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DDX19A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2280,1455921,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1654,DDX3X,https://ctdbase.org/detail.go?type=gene&acc=1654,,,1654.0,DDX3X,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DDX3X protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2281,1455922,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1655,DDX5,https://ctdbase.org/detail.go?type=gene&acc=1655,,,1655.0,DDX5,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DDX5 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2282,1457740,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,89846,FGD3,https://ctdbase.org/detail.go?type=gene&acc=89846,,,89846.0,FGD3,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of FGD3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2283,1457741,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2273,FHL1,https://ctdbase.org/detail.go?type=gene&acc=2273,,,2273.0,FHL1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of FHL1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2284,1457742,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,29109,FHOD1,https://ctdbase.org/detail.go?type=gene&acc=29109,,,29109.0,FHOD1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of FHOD1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2285,1457743,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,51024,FIS1,https://ctdbase.org/detail.go?type=gene&acc=51024,,,51024.0,FIS1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of FIS1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2286,1457744,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2286,FKBP2,https://ctdbase.org/detail.go?type=gene&acc=2286,,,2286.0,FKBP2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of FKBP2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2287,1457745,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,80308,FLAD1,https://ctdbase.org/detail.go?type=gene&acc=80308,,,80308.0,FLAD1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of FLAD1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2288,1457746,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2314,FLII,https://ctdbase.org/detail.go?type=gene&acc=2314,,,2314.0,FLII,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of FLII protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2289,1458354,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1687,GSDME,https://ctdbase.org/detail.go?type=gene&acc=1687,,,1687.0,GSDME,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GSDME protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2290,1458355,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2931,GSK3A,https://ctdbase.org/detail.go?type=gene&acc=2931,,,2931.0,GSK3A,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of GSK3A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2291,1458356,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23708,GSPT2,https://ctdbase.org/detail.go?type=gene&acc=23708,,,23708.0,GSPT2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of GSPT2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2292,1458357,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of GSR protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2293,1458358,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,373156,GSTK1,https://ctdbase.org/detail.go?type=gene&acc=373156,,,373156.0,GSTK1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GSTK1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2294,1458359,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2947,GSTM3,https://ctdbase.org/detail.go?type=gene&acc=2947,,,2947.0,GSTM3,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GSTM3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2295,1458360,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2965,GTF2H1,https://ctdbase.org/detail.go?type=gene&acc=2965,,,2965.0,GTF2H1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GTF2H1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2296,1458361,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2967,GTF2H3,https://ctdbase.org/detail.go?type=gene&acc=2967,,,2967.0,GTF2H3,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GTF2H3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2297,1458362,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2968,GTF2H4,https://ctdbase.org/detail.go?type=gene&acc=2968,,,2968.0,GTF2H4,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of GTF2H4 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2298,1458363,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9329,GTF3C4,https://ctdbase.org/detail.go?type=gene&acc=9329,,,9329.0,GTF3C4,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GTF3C4 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2299,1460201,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,127018,LYPLAL1,https://ctdbase.org/detail.go?type=gene&acc=127018,,,127018.0,LYPLAL1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of LYPLAL1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2300,1460202,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,8379,MAD1L1,https://ctdbase.org/detail.go?type=gene&acc=8379,,,8379.0,MAD1L1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MAD1L1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2301,1460203,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,4109,MAGEA10,https://ctdbase.org/detail.go?type=gene&acc=4109,,,4109.0,MAGEA10,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MAGEA10 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2302,1460204,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10916,MAGED2,https://ctdbase.org/detail.go?type=gene&acc=10916,,,10916.0,MAGED2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of MAGED2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2303,1460205,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,4116,MAGOH,https://ctdbase.org/detail.go?type=gene&acc=4116,,,4116.0,MAGOH,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of MAGOH protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2304,1460206,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55201,MAP1S,https://ctdbase.org/detail.go?type=gene&acc=55201,,,55201.0,MAP1S,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MAP1S protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2305,1460207,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5605,MAP2K2,https://ctdbase.org/detail.go?type=gene&acc=5605,,,5605.0,MAP2K2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MAP2K2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2306,1460208,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6416,MAP2K4,https://ctdbase.org/detail.go?type=gene&acc=6416,,,6416.0,MAP2K4,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MAP2K4 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2307,1460209,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,4216,MAP3K4,https://ctdbase.org/detail.go?type=gene&acc=4216,,,4216.0,MAP3K4,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MAP3K4 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2308,1460210,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,4134,MAP4,https://ctdbase.org/detail.go?type=gene&acc=4134,,,4134.0,MAP4,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MAP4 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2309,1460841,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,89853,MVB12B,https://ctdbase.org/detail.go?type=gene&acc=89853,,,89853.0,MVB12B,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MVB12B protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2310,1460842,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10514,MYBBP1A,https://ctdbase.org/detail.go?type=gene&acc=10514,,,10514.0,MYBBP1A,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of MYBBP1A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2311,1460843,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23077,MYCBP2,https://ctdbase.org/detail.go?type=gene&acc=23077,,,23077.0,MYCBP2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MYCBP2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2312,1460844,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,50804,MYEF2,https://ctdbase.org/detail.go?type=gene&acc=50804,,,50804.0,MYEF2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MYEF2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2313,1460845,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,60314,MYG1,https://ctdbase.org/detail.go?type=gene&acc=60314,,,60314.0,MYG1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MYG1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2314,1460846,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,4629,MYH11,https://ctdbase.org/detail.go?type=gene&acc=4629,,,4629.0,MYH11,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of MYH11 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2315,1463792,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9939,RBM8A,https://ctdbase.org/detail.go?type=gene&acc=9939,,,9939.0,RBM8A,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of RBM8A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2316,1463793,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1104,RCC1,https://ctdbase.org/detail.go?type=gene&acc=1104,,,1104.0,RCC1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of RCC1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2317,1463794,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5954,RCN1,https://ctdbase.org/detail.go?type=gene&acc=5954,,,5954.0,RCN1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of RCN1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2318,1463795,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5955,RCN2,https://ctdbase.org/detail.go?type=gene&acc=5955,,,5955.0,RCN2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of RCN2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2319,1463796,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23186,RCOR1,https://ctdbase.org/detail.go?type=gene&acc=23186,,,23186.0,RCOR1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of RCOR1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2320,1463797,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,57665,RDH14,https://ctdbase.org/detail.go?type=gene&acc=57665,,,57665.0,RDH14,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of RDH14 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2321,1464604,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of RTN3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2322,1465118,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6421,SFPQ,https://ctdbase.org/detail.go?type=gene&acc=6421,,,6421.0,SFPQ,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of SFPQ protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2323,1465119,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6441,SFTPD,https://ctdbase.org/detail.go?type=gene&acc=6441,,,6441.0,SFTPD,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of SFTPD protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2324,1465120,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6449,SGTA,https://ctdbase.org/detail.go?type=gene&acc=6449,,,6449.0,SGTA,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of SGTA protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2325,1465121,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6455,SH3GL1,https://ctdbase.org/detail.go?type=gene&acc=6455,,,6455.0,SH3GL1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of SH3GL1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2326,1465122,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,51100,SH3GLB1,https://ctdbase.org/detail.go?type=gene&acc=51100,,,51100.0,SH3GLB1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of SH3GLB1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2327,1465123,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,56904,SH3GLB2,https://ctdbase.org/detail.go?type=gene&acc=56904,,,56904.0,SH3GLB2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of SH3GLB2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2328,1465124,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of SHBG protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2329,1465292,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23347,SMCHD1,https://ctdbase.org/detail.go?type=gene&acc=23347,,,23347.0,SMCHD1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of SMCHD1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2330,1465293,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6611,SMS,https://ctdbase.org/detail.go?type=gene&acc=6611,,,6611.0,SMS,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of SMS protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2331,1465294,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9410,SNRNP40,https://ctdbase.org/detail.go?type=gene&acc=9410,,,9410.0,SNRNP40,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of SNRNP40 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2332,1465295,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6625,SNRNP70,https://ctdbase.org/detail.go?type=gene&acc=6625,,,6625.0,SNRNP70,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of SNRNP70 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2333,1465484,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6629,SNRPB2,https://ctdbase.org/detail.go?type=gene&acc=6629,,,6629.0,SNRPB2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of SNRPB2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2334,1465485,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6632,SNRPD1,https://ctdbase.org/detail.go?type=gene&acc=6632,,,6632.0,SNRPD1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of SNRPD1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2335,1466335,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6876,TAGLN,https://ctdbase.org/detail.go?type=gene&acc=6876,,,6876.0,TAGLN,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of TAGLN protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2336,1466336,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,8407,TAGLN2,https://ctdbase.org/detail.go?type=gene&acc=8407,,,8407.0,TAGLN2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TAGLN2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2337,1466337,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,29114,TAGLN3,https://ctdbase.org/detail.go?type=gene&acc=29114,,,29114.0,TAGLN3,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TAGLN3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2338,1466338,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6888,TALDO1,https://ctdbase.org/detail.go?type=gene&acc=6888,,,6888.0,TALDO1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TALDO1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2339,1466339,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23435,TARDBP,https://ctdbase.org/detail.go?type=gene&acc=23435,,,23435.0,TARDBP,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TARDBP protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2340,1466340,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23061,TBC1D9B,https://ctdbase.org/detail.go?type=gene&acc=23061,,,23061.0,TBC1D9B,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of TBC1D9B protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2341,1466341,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6904,TBCD,https://ctdbase.org/detail.go?type=gene&acc=6904,,,6904.0,TBCD,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TBCD protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2342,1466342,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,285966,TCAF2,https://ctdbase.org/detail.go?type=gene&acc=285966,,,285966.0,TCAF2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of TCAF2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2343,1466343,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6942,TCF20,https://ctdbase.org/detail.go?type=gene&acc=6942,,,6942.0,TCF20,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TCF20 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2344,1466344,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55714,TENM3,https://ctdbase.org/detail.go?type=gene&acc=55714,,,55714.0,TENM3,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of TENM3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2345,1466876,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,7150,TOP1,https://ctdbase.org/detail.go?type=gene&acc=7150,,,7150.0,TOP1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of TOP1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2346,1466877,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,51673,TPPP3,https://ctdbase.org/detail.go?type=gene&acc=51673,,,51673.0,TPPP3,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TPPP3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2347,1466878,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,29896,TRA2A,https://ctdbase.org/detail.go?type=gene&acc=29896,,,29896.0,TRA2A,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TRA2A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2348,1466879,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6434,TRA2B,https://ctdbase.org/detail.go?type=gene&acc=6434,,,6434.0,TRA2B,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TRA2B protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2349,1466880,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,7109,TRAPPC10,https://ctdbase.org/detail.go?type=gene&acc=7109,,,7109.0,TRAPPC10,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of TRAPPC10 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2350,1466881,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10626,TRIM16,https://ctdbase.org/detail.go?type=gene&acc=10626,,,10626.0,TRIM16,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TRIM16 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2351,1466882,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,7706,TRIM25,https://ctdbase.org/detail.go?type=gene&acc=7706,,,7706.0,TRIM25,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TRIM25 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2352,1466883,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9320,TRIP12,https://ctdbase.org/detail.go?type=gene&acc=9320,,,9320.0,TRIP12,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TRIP12 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2353,1467046,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55020,TTC38,https://ctdbase.org/detail.go?type=gene&acc=55020,,,55020.0,TTC38,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of TTC38 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2354,1467047,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,145567,TTC7B,https://ctdbase.org/detail.go?type=gene&acc=145567,,,145567.0,TTC7B,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of TTC7B protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2355,1467048,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23170,TTLL12,https://ctdbase.org/detail.go?type=gene&acc=23170,,,23170.0,TTLL12,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TTLL12 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2356,1467049,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10376,TUBA1B,https://ctdbase.org/detail.go?type=gene&acc=10376,,,10376.0,TUBA1B,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TUBA1B protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2357,1467050,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,51807,TUBA8,https://ctdbase.org/detail.go?type=gene&acc=51807,,,51807.0,TUBA8,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TUBA8 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2358,1467051,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,203068,TUBB,https://ctdbase.org/detail.go?type=gene&acc=203068,,,203068.0,TUBB,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TUBB protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2359,1467052,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,81027,TUBB1,https://ctdbase.org/detail.go?type=gene&acc=81027,,,81027.0,TUBB1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TUBB1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2360,1467053,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,7280,TUBB2A,https://ctdbase.org/detail.go?type=gene&acc=7280,,,7280.0,TUBB2A,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TUBB2A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2361,1467054,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10381,TUBB3,https://ctdbase.org/detail.go?type=gene&acc=10381,,,10381.0,TUBB3,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of TUBB3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2362,1467055,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,84617,TUBB6,https://ctdbase.org/detail.go?type=gene&acc=84617,,,84617.0,TUBB6,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of TUBB6 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2363,1467221,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10422,UBAC1,https://ctdbase.org/detail.go?type=gene&acc=10422,,,10422.0,UBAC1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of UBAC1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2364,1467222,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9690,UBE3C,https://ctdbase.org/detail.go?type=gene&acc=9690,,,9690.0,UBE3C,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of UBE3C protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2365,1467223,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10277,UBE4B,https://ctdbase.org/detail.go?type=gene&acc=10277,,,10277.0,UBE4B,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of UBE4B protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2366,1467565,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,7408,VASP,https://ctdbase.org/detail.go?type=gene&acc=7408,,,7408.0,VASP,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of VASP protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2367,1467566,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,80124,VCPIP1,https://ctdbase.org/detail.go?type=gene&acc=80124,,,80124.0,VCPIP1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of VCPIP1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2368,1467567,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55823,VPS11,https://ctdbase.org/detail.go?type=gene&acc=55823,,,55823.0,VPS11,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of VPS11 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2369,1467568,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,54832,VPS13C,https://ctdbase.org/detail.go?type=gene&acc=54832,,,54832.0,VPS13C,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of VPS13C protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2370,1467569,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,64601,VPS16,https://ctdbase.org/detail.go?type=gene&acc=64601,,,64601.0,VPS16,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of VPS16 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2371,1467570,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,57617,VPS18,https://ctdbase.org/detail.go?type=gene&acc=57617,,,57617.0,VPS18,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of VPS18 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2372,1467571,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,84313,VPS25,https://ctdbase.org/detail.go?type=gene&acc=84313,,,84313.0,VPS25,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of VPS25 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2373,1467572,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9559,VPS26A,https://ctdbase.org/detail.go?type=gene&acc=9559,,,9559.0,VPS26A,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of VPS26A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2374,1468396,154376,Toxin and Toxin Target Database (T3DB),"3,4'-Dibromobiphenyl",T3D1960,"3,4'-Dibromobiphenyl",http://www.t3db.ca/toxins/T3D1960,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Pbbs bind to and activate the aryl hydrocarbon receptor (ahr), which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. this results in the numerous toxic responses characteristic of pbbs. some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)",,,,,,,
2375,1468397,154382,Toxin and Toxin Target Database (T3DB),"2,3,5,6,2',3',5',6'-Octabromobiphenyl",T3D1971,"2,2',3,3',5,5',6,6'-Octabromobiphenyl",http://www.t3db.ca/toxins/T3D1971,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Pbbs bind to and activate the aryl hydrocarbon receptor (ahr), which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. this results in the numerous toxic responses characteristic of pbbs. some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)",,,,,,,
2376,1468398,154383,Toxin and Toxin Target Database (T3DB),"1,1'-Biphenyl, 3,4,4',5-tetrabromo-",T3D1973,"3,4,4',5-Tetrabromobiphenyl",http://www.t3db.ca/toxins/T3D1973,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Pbbs bind to and activate the aryl hydrocarbon receptor (ahr), which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. this results in the numerous toxic responses characteristic of pbbs. some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)",,,,,,,
2377,1468399,154388,Toxin and Toxin Target Database (T3DB),"2,4,4',6-Tetrabromobiphenyl",T3D1978,"2,4,4',6-Tetrabromobiphenyl",http://www.t3db.ca/toxins/T3D1978,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Pbbs bind to and activate the aryl hydrocarbon receptor (ahr), which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. this results in the numerous toxic responses characteristic of pbbs. some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)",,,,,,,
2378,1468400,154389,Toxin and Toxin Target Database (T3DB),"2,4',6-Tribromobiphenyl",T3D1979,"2,4',6-Tribromobiphenyl",http://www.t3db.ca/toxins/T3D1979,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Pbbs bind to and activate the aryl hydrocarbon receptor (ahr), which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. this results in the numerous toxic responses characteristic of pbbs. some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)",,,,,,,
2379,1468401,154390,Toxin and Toxin Target Database (T3DB),"1,1'-Biphenyl, 2,4,4'-tribromo-",T3D1980,"2,4,4'-Tribromobiphenyl",http://www.t3db.ca/toxins/T3D1980,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Pbbs bind to and activate the aryl hydrocarbon receptor (ahr), which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. this results in the numerous toxic responses characteristic of pbbs. some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)",,,,,,,
2380,1468402,154397,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',5,5',6-Nonabromobiphenyl",T3D1992,"2,2',3,3',4,4',5,5',6-Nonabromobiphenyl",http://www.t3db.ca/toxins/T3D1992,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Pbbs bind to and activate the aryl hydrocarbon receptor (ahr), which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. this results in the numerous toxic responses characteristic of pbbs. some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)",,,,,,,
2381,1553530,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,3655,ITGA6,https://ctdbase.org/detail.go?type=gene&acc=3655,,,3655.0,ITGA6,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in increased expression of ITGA6 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2382,1553531,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,3691,ITGB4,https://ctdbase.org/detail.go?type=gene&acc=3691,,,3691.0,ITGB4,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in decreased expression of ITGB4 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2383,1553532,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,3699,ITIH3,https://ctdbase.org/detail.go?type=gene&acc=3699,,,3699.0,ITIH3,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in decreased expression of ITIH3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2384,1553533,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,3704,ITPA,https://ctdbase.org/detail.go?type=gene&acc=3704,,,3704.0,ITPA,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in decreased expression of ITPA protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2385,1553534,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,55677,IWS1,https://ctdbase.org/detail.go?type=gene&acc=55677,,,55677.0,IWS1,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in decreased expression of IWS1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2386,1553535,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,25959,KANK2,https://ctdbase.org/detail.go?type=gene&acc=25959,,,25959.0,KANK2,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in decreased expression of KANK2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2387,1553536,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,56888,KCMF1,https://ctdbase.org/detail.go?type=gene&acc=56888,,,56888.0,KCMF1,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in decreased expression of KCMF1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2388,1553537,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,283219,KCTD21,https://ctdbase.org/detail.go?type=gene&acc=283219,,,283219.0,KCTD21,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in decreased expression of KCTD21 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2389,1554199,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,4057,LTF,https://ctdbase.org/detail.go?type=gene&acc=4057,,,4057.0,LTF,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in increased expression of LTF protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2390,1554200,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,10434,LYPLA1,https://ctdbase.org/detail.go?type=gene&acc=10434,,,10434.0,LYPLA1,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in decreased expression of LYPLA1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2391,1554201,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,127018,LYPLAL1,https://ctdbase.org/detail.go?type=gene&acc=127018,,,127018.0,LYPLAL1,9606.0,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in increased expression of LYPLAL1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2392,1401183,155656,Comparative Toxicogenomics Database (CTD),Tolmetin glucuronide,C056583,tolmetin glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C056583,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Tolmetin glucuronide analog results in increased expression of CXCL8 mRNA,,,PMID:24104198,https://www.ncbi.nlm.nih.gov/pubmed/24104198,24104198,,
2393,1401184,155656,Comparative Toxicogenomics Database (CTD),Tolmetin glucuronide,C056583,tolmetin glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C056583,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Tolmetin glucuronide results in increased expression of CXCL8 mRNA,,,PMID:26528891,https://www.ncbi.nlm.nih.gov/pubmed/26528891,26528891,,
2394,1401185,155656,Comparative Toxicogenomics Database (CTD),Tolmetin glucuronide,C056583,tolmetin glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C056583,3577,CXCR1,https://ctdbase.org/detail.go?type=gene&acc=3577,,,3577.0,CXCR1,9606.0,Homo sapiens (human),Tolmetin glucuronide results in increased expression of CXCR1 mRNA,,,PMID:26528891,https://www.ncbi.nlm.nih.gov/pubmed/26528891,26528891,,
2395,1401186,155656,Comparative Toxicogenomics Database (CTD),Tolmetin glucuronide,C056583,tolmetin glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C056583,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606.0,Homo sapiens (human),Tolmetin glucuronide results in increased expression of IFNG mRNA,,,PMID:26528891,https://www.ncbi.nlm.nih.gov/pubmed/26528891,26528891,,
2396,1401187,155656,Comparative Toxicogenomics Database (CTD),Tolmetin glucuronide,C056583,tolmetin glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C056583,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606.0,Homo sapiens (human),Tolmetin glucuronide results in increased expression of IL1A mRNA,,,PMID:26528891,https://www.ncbi.nlm.nih.gov/pubmed/26528891,26528891,,
2397,1387603,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,59342,SCPEP1,https://ctdbase.org/detail.go?type=gene&acc=59342,,,59342.0,SCPEP1,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of SCPEP1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2398,1387604,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,90507,SCRN2,https://ctdbase.org/detail.go?type=gene&acc=90507,,,90507.0,SCRN2,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of SCRN2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2399,1388572,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,6584,SLC22A5,https://ctdbase.org/detail.go?type=gene&acc=6584,,,6584.0,SLC22A5,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of SLC22A5 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2400,1390550,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,51204,TACO1,https://ctdbase.org/detail.go?type=gene&acc=51204,,,51204.0,TACO1,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of TACO1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2401,1390551,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,9015,TAF1A,https://ctdbase.org/detail.go?type=gene&acc=9015,,,9015.0,TAF1A,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of TAF1A mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2402,1390552,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,9014,TAF1B,https://ctdbase.org/detail.go?type=gene&acc=9014,,,9014.0,TAF1B,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of TAF1B mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2403,1390553,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,79101,TAF1D,https://ctdbase.org/detail.go?type=gene&acc=79101,,,79101.0,TAF1D,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of TAF1D mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2404,1390554,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,6879,TAF7,https://ctdbase.org/detail.go?type=gene&acc=6879,,,6879.0,TAF7,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of TAF7 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2405,1390555,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,6901,TAFAZZIN,https://ctdbase.org/detail.go?type=gene&acc=6901,,,6901.0,TAFAZZIN,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of TAFAZZIN mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2406,1390556,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,132001,TAMM41,https://ctdbase.org/detail.go?type=gene&acc=132001,,,132001.0,TAMM41,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of TAMM41 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2407,1390557,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,55080,TAPBPL,https://ctdbase.org/detail.go?type=gene&acc=55080,,,55080.0,TAPBPL,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of TAPBPL mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2408,1390558,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of TARS1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2409,1392126,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,23087,TRIM35,https://ctdbase.org/detail.go?type=gene&acc=23087,,,23087.0,TRIM35,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of TRIM35 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2410,1392127,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,85363,TRIM5,https://ctdbase.org/detail.go?type=gene&acc=85363,,,85363.0,TRIM5,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of TRIM5 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2411,1392128,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,81786,TRIM7,https://ctdbase.org/detail.go?type=gene&acc=81786,,,81786.0,TRIM7,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of TRIM7 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2412,1392610,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,57544,TXNDC16,https://ctdbase.org/detail.go?type=gene&acc=57544,,,57544.0,TXNDC16,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of TXNDC16 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2413,1392611,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,81567,TXNDC5,https://ctdbase.org/detail.go?type=gene&acc=81567,,,81567.0,TXNDC5,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of TXNDC5 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2414,1392612,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,54957,TXNL4B,https://ctdbase.org/detail.go?type=gene&acc=54957,,,54957.0,TXNL4B,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of TXNL4B mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2415,1392613,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,10587,TXNRD2,https://ctdbase.org/detail.go?type=gene&acc=10587,,,10587.0,TXNRD2,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of TXNRD2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2416,1393917,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,9942,XYLB,https://ctdbase.org/detail.go?type=gene&acc=9942,,,9942.0,XYLB,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of XYLB mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2417,1393918,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,64132,XYLT2,https://ctdbase.org/detail.go?type=gene&acc=64132,,,64132.0,XYLT2,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of XYLT2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2418,1393919,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,57002,YAE1,https://ctdbase.org/detail.go?type=gene&acc=57002,,,57002.0,YAE1,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of YAE1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2419,1393920,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,10413,YAP1,https://ctdbase.org/detail.go?type=gene&acc=10413,,,10413.0,YAP1,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of YAP1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2420,1393921,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,8565,YARS1,https://ctdbase.org/detail.go?type=gene&acc=8565,,,8565.0,YARS1,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of YARS1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2421,1393922,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,8531,YBX3,https://ctdbase.org/detail.go?type=gene&acc=8531,,,8531.0,YBX3,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of YBX3 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2422,1394034,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,150223,YDJC,https://ctdbase.org/detail.go?type=gene&acc=150223,,,150223.0,YDJC,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of YDJC mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2423,1394035,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,54432,YIPF1,https://ctdbase.org/detail.go?type=gene&acc=54432,,,54432.0,YIPF1,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of YIPF1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2424,1394036,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,81555,YIPF5,https://ctdbase.org/detail.go?type=gene&acc=81555,,,81555.0,YIPF5,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of YIPF5 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2425,1394037,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,81576,YJU2B,https://ctdbase.org/detail.go?type=gene&acc=81576,,,81576.0,YJU2B,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of YJU2B mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2426,1394151,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,653121,ZBTB8A,https://ctdbase.org/detail.go?type=gene&acc=653121,,,653121.0,ZBTB8A,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of ZBTB8A mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2427,1394152,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,339487,ZBTB8OS,https://ctdbase.org/detail.go?type=gene&acc=339487,,,339487.0,ZBTB8OS,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of ZBTB8OS mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2428,1394153,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,80149,ZC3H12A,https://ctdbase.org/detail.go?type=gene&acc=80149,,,80149.0,ZC3H12A,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of ZC3H12A mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2429,1394154,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,55906,ZC4H2,https://ctdbase.org/detail.go?type=gene&acc=55906,,,55906.0,ZC4H2,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of ZC4H2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2430,1394155,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,219654,ZCCHC24,https://ctdbase.org/detail.go?type=gene&acc=219654,,,219654.0,ZCCHC24,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of ZCCHC24 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2431,1394156,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,54503,ZDHHC13,https://ctdbase.org/detail.go?type=gene&acc=54503,,,54503.0,ZDHHC13,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of ZDHHC13 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2432,1552105,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,128338,DRAM2,https://ctdbase.org/detail.go?type=gene&acc=128338,,,128338.0,DRAM2,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of DRAM2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2433,1552106,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,1824,DSC2,https://ctdbase.org/detail.go?type=gene&acc=1824,,,1824.0,DSC2,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of DSC2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2434,1552107,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,112487,DTD2,https://ctdbase.org/detail.go?type=gene&acc=112487,,,112487.0,DTD2,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of DTD2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2435,1552108,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,11062,DUS4L,https://ctdbase.org/detail.go?type=gene&acc=11062,,,11062.0,DUS4L,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of DUS4L mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2436,1552109,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,11221,DUSP10,https://ctdbase.org/detail.go?type=gene&acc=11221,,,11221.0,DUSP10,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of DUSP10 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2437,1552110,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,80824,DUSP16,https://ctdbase.org/detail.go?type=gene&acc=80824,,,80824.0,DUSP16,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of DUSP16 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2438,1552487,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,9718,ECE2,https://ctdbase.org/detail.go?type=gene&acc=9718,,,9718.0,ECE2,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of ECE2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2439,1552488,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,1891,ECH1,https://ctdbase.org/detail.go?type=gene&acc=1891,,,1891.0,ECH1,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of ECH1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2440,1552489,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,55268,ECHDC2,https://ctdbase.org/detail.go?type=gene&acc=55268,,,55268.0,ECHDC2,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of ECHDC2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2441,1552490,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,79746,ECHDC3,https://ctdbase.org/detail.go?type=gene&acc=79746,,,79746.0,ECHDC3,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of ECHDC3 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2442,1552491,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,1892,ECHS1,https://ctdbase.org/detail.go?type=gene&acc=1892,,,1892.0,ECHS1,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of ECHS1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2443,1552492,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,10455,ECI2,https://ctdbase.org/detail.go?type=gene&acc=10455,,,10455.0,ECI2,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of ECI2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2444,1552493,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,69123,ECI3,https://ctdbase.org/detail.go?type=gene&acc=69123,,,69123.0,Eci3,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of ECI3 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2445,1552494,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,10913,EDAR,https://ctdbase.org/detail.go?type=gene&acc=10913,,,10913.0,EDAR,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of EDAR mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2446,1554071,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,10144,FAM13A,https://ctdbase.org/detail.go?type=gene&acc=10144,,,10144.0,FAM13A,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of FAM13A mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2447,1554072,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,25854,FAM149A,https://ctdbase.org/detail.go?type=gene&acc=25854,,,25854.0,FAM149A,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of FAM149A mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2448,1554073,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,317662,FAM149B1,https://ctdbase.org/detail.go?type=gene&acc=317662,,,317662.0,FAM149B1,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of FAM149B1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2449,1554074,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,79632,FAM184A,https://ctdbase.org/detail.go?type=gene&acc=79632,,,79632.0,FAM184A,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of FAM184A mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2450,1476090,158385,DrugBank,Motexafin gadolinium,DB05428,Motexafin gadolinium,https://www.drugbank.ca/drugs/DB05428,BE0002450,Ribonucleoside-diphosphate reductase subunit M2,https://www.drugbank.ca/bio_entities/BE0002450,P31350,Ribonucleoside-diphosphate reductase subunit M2,6241.0,RRM2,9606.0,Homo sapiens (human),,,,,,,,
2451,1476091,158795,DrugBank,Tecadenoson,DB04954,Tecadenoson,https://www.drugbank.ca/drugs/DB04954,BE0000013,Adenosine receptor A1,https://www.drugbank.ca/bio_entities/BE0000013,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,,,PMID:16230891|PMID:15956124|PMID:13678937,https://www.ncbi.nlm.nih.gov/pubmed/16230891|https://www.ncbi.nlm.nih.gov/pubmed/15956124|https://www.ncbi.nlm.nih.gov/pubmed/13678937,16230891|15956124|13678937,,
2452,1476092,159273,Comparative Toxicogenomics Database (CTD),Corticosterone-21-hemisuccinate,C067957,corticosterone-21-hemisuccinate,https://ctdbase.org/detail.go?type=chem&acc=C067957,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Corticosterone-21-hemisuccinate results in increased phosphorylation of and results in increased activity of MAPK1 protein,,,PMID:15961565,https://www.ncbi.nlm.nih.gov/pubmed/15961565,15961565,,
2453,1476093,159273,Comparative Toxicogenomics Database (CTD),Corticosterone-21-hemisuccinate,C067957,corticosterone-21-hemisuccinate,https://ctdbase.org/detail.go?type=chem&acc=C067957,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,10116.0,Rattus norvegicus (Norway rat),Corticosterone-21-hemisuccinate results in increased phosphorylation of and results in increased activity of MAPK14 protein,,,PMID:15961565,https://www.ncbi.nlm.nih.gov/pubmed/15961565,15961565,,
2454,1476094,159273,Comparative Toxicogenomics Database (CTD),Corticosterone-21-hemisuccinate,C067957,corticosterone-21-hemisuccinate,https://ctdbase.org/detail.go?type=chem&acc=C067957,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Corticosterone-21-hemisuccinate results in increased phosphorylation of and results in increased activity of MAPK3 protein,,,PMID:15961565,https://www.ncbi.nlm.nih.gov/pubmed/15961565,15961565,,
2455,1476095,159273,Comparative Toxicogenomics Database (CTD),Corticosterone-21-hemisuccinate,C067957,corticosterone-21-hemisuccinate,https://ctdbase.org/detail.go?type=chem&acc=C067957,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10116.0,Rattus norvegicus (Norway rat),Corticosterone-21-hemisuccinate results in increased phosphorylation of and results in increased activity of MAPK8 protein,,,PMID:15961565,https://www.ncbi.nlm.nih.gov/pubmed/15961565,15961565,,
2456,1476096,159278,Comparative Toxicogenomics Database (CTD),Salidroside,C009172,rhodioloside,https://ctdbase.org/detail.go?type=chem&acc=C009172,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,10090.0,Mus musculus (house mouse),[furan co-treated with rhodioloside] results in increased expression of ABCB11 mRNA,,,PMID:32251705,https://www.ncbi.nlm.nih.gov/pubmed/32251705,32251705,,
2457,1476097,159278,Comparative Toxicogenomics Database (CTD),Salidroside,C009172,rhodioloside,https://ctdbase.org/detail.go?type=chem&acc=C009172,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116.0,Rattus norvegicus (Norway rat),Rhodioloside inhibits the reaction [isoflurane results in increased activity of ACHE protein],,,PMID:28084090,https://www.ncbi.nlm.nih.gov/pubmed/28084090,28084090,,
2458,1476098,159278,Comparative Toxicogenomics Database (CTD),Salidroside,C009172,rhodioloside,https://ctdbase.org/detail.go?type=chem&acc=C009172,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [colistin results in decreased phosphorylation of AKT1 protein]]|rhodioloside inhibits the reaction [colistin results in decreased phosphorylation of AKT1 protein],,,PMID:28465020,https://www.ncbi.nlm.nih.gov/pubmed/28465020,28465020,,
2459,1478083,159502,Therapeutic Target Database (TTD),Hydrodolasetron,D01IWD,MDL-74156,https://idrblab.net/ttd/data/drug/details/D01IWD,T20251,Voltage-gated potassium channel Kv11.1 (KCNH2),https://idrblab.net/ttd/data/target/details/T20251,Q12809,Potassium voltage-gated channel subfamily H member 2,3757.0,KCNH2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2460,1447830,159603,IUPHAR/BPS Guide to PHARMACOLOGY,Resiquimod,5051,resiquimod,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5051,1758,TLR8,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1758,Q9NR97,Toll-like receptor 8,51311.0,TLR8,9606.0,Homo sapiens (human),Agonist,pEC50,5.21,PMID:11812998|PMID:12032557|PMID:29152046,https://www.ncbi.nlm.nih.gov/pubmed/11812998|https://www.ncbi.nlm.nih.gov/pubmed/12032557|https://www.ncbi.nlm.nih.gov/pubmed/29152046,11812998|12032557|29152046,,
2461,1447831,159698,Toxin and Toxin Target Database (T3DB),Tin(II) tetrafluoroborate,T3D1236,Tin(II) fluoroborate,http://www.t3db.ca/toxins/T3D1236,BE0000227,Alcohol dehydrogenase 1A,http://www.t3db.ca/biodb/bio_entities/BE0000227,P07327,Alcohol dehydrogenase 1A,124.0,ADH1A,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
2462,1447832,159698,Toxin and Toxin Target Database (T3DB),Tin(II) tetrafluoroborate,T3D1236,Tin(II) fluoroborate,http://www.t3db.ca/toxins/T3D1236,BE0000400,Alcohol dehydrogenase 1B,http://www.t3db.ca/biodb/bio_entities/BE0000400,P00325,All-trans-retinol dehydrogenase [NAD(+)] ADH1B,125.0,ADH1B,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
2463,1447833,159698,Toxin and Toxin Target Database (T3DB),Tin(II) tetrafluoroborate,T3D1236,Tin(II) fluoroborate,http://www.t3db.ca/toxins/T3D1236,BE0000465,Alcohol dehydrogenase 1C,http://www.t3db.ca/biodb/bio_entities/BE0000465,P00326,Alcohol dehydrogenase 1C,126.0,ADH1C,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
2464,1447834,159698,Toxin and Toxin Target Database (T3DB),Tin(II) tetrafluoroborate,T3D1236,Tin(II) fluoroborate,http://www.t3db.ca/toxins/T3D1236,BE0000360,Alcohol dehydrogenase 4,http://www.t3db.ca/biodb/bio_entities/BE0000360,P08319,All-trans-retinol dehydrogenase [NAD(+)] ADH4,127.0,ADH4,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
2465,1447835,159698,Toxin and Toxin Target Database (T3DB),Tin(II) tetrafluoroborate,T3D1236,Tin(II) fluoroborate,http://www.t3db.ca/toxins/T3D1236,BE0003545,Alcohol dehydrogenase 6,http://www.t3db.ca/biodb/bio_entities/BE0003545,P28332,Alcohol dehydrogenase 6,130.0,ADH6,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
2466,1403470,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,3326,HSP90AB1,https://ctdbase.org/detail.go?type=gene&acc=3326,,,3326.0,HSP90AB1,9606.0,Homo sapiens (human),Abrine results in decreased expression of HSP90AB1 protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2467,1403471,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,7184,HSP90B1,https://ctdbase.org/detail.go?type=gene&acc=7184,,,7184.0,HSP90B1,9606.0,Homo sapiens (human),Abrine results in decreased expression of HSP90B1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2468,1403472,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,259217,HSPA12A,https://ctdbase.org/detail.go?type=gene&acc=259217,,,259217.0,HSPA12A,9606.0,Homo sapiens (human),Abrine results in decreased expression of HSPA12A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2469,1403473,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,116835,HSPA12B,https://ctdbase.org/detail.go?type=gene&acc=116835,,,116835.0,HSPA12B,9606.0,Homo sapiens (human),Abrine results in decreased expression of HSPA12B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2470,1403474,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,6782,HSPA13,https://ctdbase.org/detail.go?type=gene&acc=6782,,,6782.0,HSPA13,9606.0,Homo sapiens (human),Abrine results in increased expression of HSPA13 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2471,1448173,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,253639,ZNF620,https://ctdbase.org/detail.go?type=gene&acc=253639,,,253639.0,ZNF620,9606.0,Homo sapiens (human),Abrine results in increased expression of ZNF620 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2472,1448174,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,285268,ZNF621,https://ctdbase.org/detail.go?type=gene&acc=285268,,,285268.0,ZNF621,9606.0,Homo sapiens (human),Abrine results in increased expression of ZNF621 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2473,1448175,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,90441,ZNF622,https://ctdbase.org/detail.go?type=gene&acc=90441,,,90441.0,ZNF622,9606.0,Homo sapiens (human),Abrine results in increased expression of ZNF622 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2474,1448176,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,199692,ZNF627,https://ctdbase.org/detail.go?type=gene&acc=199692,,,199692.0,ZNF627,9606.0,Homo sapiens (human),Abrine results in increased expression of ZNF627 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2475,1448177,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,89887,ZNF628,https://ctdbase.org/detail.go?type=gene&acc=89887,,,89887.0,ZNF628,9606.0,Homo sapiens (human),Abrine results in increased expression of ZNF628 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2476,1448178,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,57232,ZNF630,https://ctdbase.org/detail.go?type=gene&acc=57232,,,57232.0,ZNF630,9606.0,Homo sapiens (human),Abrine results in increased expression of ZNF630 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2477,1448179,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,121274,ZNF641,https://ctdbase.org/detail.go?type=gene&acc=121274,,,121274.0,ZNF641,9606.0,Homo sapiens (human),Abrine results in increased expression of ZNF641 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2478,1448180,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,84146,ZNF644,https://ctdbase.org/detail.go?type=gene&acc=84146,,,84146.0,ZNF644,9606.0,Homo sapiens (human),Abrine results in increased expression of ZNF644 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2479,1448500,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,7552,ZNF711,https://ctdbase.org/detail.go?type=gene&acc=7552,,,7552.0,ZNF711,9606.0,Homo sapiens (human),Abrine results in increased expression of ZNF711 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2480,1470892,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8165,AKAP1,https://ctdbase.org/detail.go?type=gene&acc=8165,,,8165.0,AKAP1,9606.0,Homo sapiens (human),Abrine results in decreased expression of AKAP1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2481,1470893,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,11216,AKAP10,https://ctdbase.org/detail.go?type=gene&acc=11216,,,11216.0,AKAP10,9606.0,Homo sapiens (human),Abrine results in increased expression of AKAP10 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2482,1470894,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,11216,AKAP10,https://ctdbase.org/detail.go?type=gene&acc=11216,,,11216.0,AKAP10,10090.0,Mus musculus (house mouse),Abrine results in decreased expression of AKAP10 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
2483,1470895,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,11215,AKAP11,https://ctdbase.org/detail.go?type=gene&acc=11215,,,11215.0,AKAP11,9606.0,Homo sapiens (human),Abrine results in decreased expression of AKAP11 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2484,1470896,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9590,AKAP12,https://ctdbase.org/detail.go?type=gene&acc=9590,,,9590.0,AKAP12,9606.0,Homo sapiens (human),Abrine results in increased expression of AKAP12 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2485,1470897,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8852,AKAP4,https://ctdbase.org/detail.go?type=gene&acc=8852,,,8852.0,AKAP4,9606.0,Homo sapiens (human),Abrine results in increased expression of AKAP4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2486,1470898,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9495,AKAP5,https://ctdbase.org/detail.go?type=gene&acc=9495,,,9495.0,AKAP5,9606.0,Homo sapiens (human),Abrine results in decreased expression of AKAP5 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2487,1470899,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9465,AKAP7,https://ctdbase.org/detail.go?type=gene&acc=9465,,,9465.0,AKAP7,9606.0,Homo sapiens (human),Abrine results in decreased expression of AKAP7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2488,1471492,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79053,ALG8,https://ctdbase.org/detail.go?type=gene&acc=79053,,,79053.0,ALG8,9606.0,Homo sapiens (human),Abrine results in decreased expression of ALG8 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2489,1471493,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8846,ALKBH1,https://ctdbase.org/detail.go?type=gene&acc=8846,,,8846.0,ALKBH1,9606.0,Homo sapiens (human),Abrine results in increased expression of ALKBH1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2490,1473532,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,200558,APLF,https://ctdbase.org/detail.go?type=gene&acc=200558,,,200558.0,APLF,9606.0,Homo sapiens (human),Abrine results in increased expression of APLF mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2491,1473533,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8862,APLN,https://ctdbase.org/detail.go?type=gene&acc=8862,,,8862.0,APLN,9606.0,Homo sapiens (human),Abrine results in decreased expression of APLN mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2492,1473534,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8862,APLN,https://ctdbase.org/detail.go?type=gene&acc=8862,,,8862.0,APLN,10090.0,Mus musculus (house mouse),Abrine results in decreased expression of APLN mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
2493,1473535,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,57136,APMAP,https://ctdbase.org/detail.go?type=gene&acc=57136,,,57136.0,APMAP,9606.0,Homo sapiens (human),Abrine results in decreased expression of APMAP mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2494,1473536,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9582,APOBEC3B,https://ctdbase.org/detail.go?type=gene&acc=9582,,,9582.0,APOBEC3B,9606.0,Homo sapiens (human),Abrine results in increased expression of APOBEC3B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2495,1473537,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,27350,APOBEC3C,https://ctdbase.org/detail.go?type=gene&acc=27350,,,27350.0,APOBEC3C,9606.0,Homo sapiens (human),Abrine results in decreased expression of APOBEC3C mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2496,1473538,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55911,APOBR,https://ctdbase.org/detail.go?type=gene&acc=55911,,,55911.0,APOBR,9606.0,Homo sapiens (human),Abrine results in increased expression of APOBR mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2497,1473539,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,347,APOD,https://ctdbase.org/detail.go?type=gene&acc=347,,,347.0,APOD,9606.0,Homo sapiens (human),Abrine results in decreased expression of APOD mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2498,1473540,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,350,APOH,https://ctdbase.org/detail.go?type=gene&acc=350,,,350.0,APOH,9606.0,Homo sapiens (human),Abrine results in decreased expression of APOH mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2499,1473833,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,374,AREG,https://ctdbase.org/detail.go?type=gene&acc=374,,,374.0,AREG,9606.0,Homo sapiens (human),Abrine results in increased expression of AREG mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2500,1473834,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,378,ARF4,https://ctdbase.org/detail.go?type=gene&acc=378,,,378.0,ARF4,9606.0,Homo sapiens (human),Abrine results in increased expression of ARF4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2501,1473835,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,382,ARF6,https://ctdbase.org/detail.go?type=gene&acc=382,,,382.0,ARF6,9606.0,Homo sapiens (human),Abrine results in increased expression of ARF6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2502,1473836,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,84364,ARFGAP2,https://ctdbase.org/detail.go?type=gene&acc=84364,,,84364.0,ARFGAP2,9606.0,Homo sapiens (human),Abrine results in increased expression of ARFGAP2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2503,1473837,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,57221,ARFGEF3,https://ctdbase.org/detail.go?type=gene&acc=57221,,,57221.0,ARFGEF3,9606.0,Homo sapiens (human),Abrine results in decreased expression of ARFGEF3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2504,1473838,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23647,ARFIP2,https://ctdbase.org/detail.go?type=gene&acc=23647,,,23647.0,ARFIP2,9606.0,Homo sapiens (human),Abrine results in increased expression of ARFIP2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2505,1473839,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10139,ARFRP1,https://ctdbase.org/detail.go?type=gene&acc=10139,,,10139.0,ARFRP1,9606.0,Homo sapiens (human),Abrine results in increased expression of ARFRP1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2506,1474158,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,343578,ARHGAP40,https://ctdbase.org/detail.go?type=gene&acc=343578,,,343578.0,ARHGAP40,9606.0,Homo sapiens (human),Abrine results in increased expression of ARHGAP40 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2507,1474159,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,143872,ARHGAP42,https://ctdbase.org/detail.go?type=gene&acc=143872,,,143872.0,ARHGAP42,9606.0,Homo sapiens (human),Abrine results in increased expression of ARHGAP42 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2508,1474160,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9912,ARHGAP44,https://ctdbase.org/detail.go?type=gene&acc=9912,,,9912.0,ARHGAP44,9606.0,Homo sapiens (human),Abrine results in decreased expression of ARHGAP44 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2509,1474161,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23526,ARHGAP45,https://ctdbase.org/detail.go?type=gene&acc=23526,,,23526.0,ARHGAP45,9606.0,Homo sapiens (human),Abrine results in decreased expression of ARHGAP45 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2510,1474162,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,64333,ARHGAP9,https://ctdbase.org/detail.go?type=gene&acc=64333,,,64333.0,ARHGAP9,9606.0,Homo sapiens (human),Abrine results in increased expression of ARHGAP9 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2511,1474163,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,9606.0,Homo sapiens (human),Abrine results in decreased expression of ARHGDIB mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2512,1474164,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9138,ARHGEF1,https://ctdbase.org/detail.go?type=gene&acc=9138,,,9138.0,ARHGEF1,9606.0,Homo sapiens (human),Abrine results in decreased expression of ARHGEF1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2513,1475361,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,171023,ASXL1,https://ctdbase.org/detail.go?type=gene&acc=171023,,,171023.0,ASXL1,9606.0,Homo sapiens (human),Abrine results in increased expression of ASXL1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2514,1475362,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,84896,ATAD1,https://ctdbase.org/detail.go?type=gene&acc=84896,,,84896.0,ATAD1,9606.0,Homo sapiens (human),Abrine results in increased expression of ATAD1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2515,1475363,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,29028,ATAD2,https://ctdbase.org/detail.go?type=gene&acc=29028,,,29028.0,ATAD2,9606.0,Homo sapiens (human),Abrine results in decreased expression of ATAD2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2516,1475493,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,60673,ATG101,https://ctdbase.org/detail.go?type=gene&acc=60673,,,60673.0,ATG101,9606.0,Homo sapiens (human),Abrine results in increased expression of ATG101 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2517,1475494,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,22863,ATG14,https://ctdbase.org/detail.go?type=gene&acc=22863,,,22863.0,ATG14,9606.0,Homo sapiens (human),Abrine results in increased expression of ATG14 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2518,1475495,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55054,ATG16L1,https://ctdbase.org/detail.go?type=gene&acc=55054,,,55054.0,ATG16L1,9606.0,Homo sapiens (human),Abrine results in increased expression of ATG16L1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2519,1475496,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23130,ATG2A,https://ctdbase.org/detail.go?type=gene&acc=23130,,,23130.0,ATG2A,9606.0,Homo sapiens (human),Abrine results in increased expression of ATG2A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2520,1475497,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,115201,ATG4A,https://ctdbase.org/detail.go?type=gene&acc=115201,,,115201.0,ATG4A,9606.0,Homo sapiens (human),Abrine results in increased expression of ATG4A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2521,1475498,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23192,ATG4B,https://ctdbase.org/detail.go?type=gene&acc=23192,,,23192.0,ATG4B,9606.0,Homo sapiens (human),Abrine results in increased expression of ATG4B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2522,1475499,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,84938,ATG4C,https://ctdbase.org/detail.go?type=gene&acc=84938,,,84938.0,ATG4C,9606.0,Homo sapiens (human),Abrine results in decreased expression of ATG4C mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2523,1475500,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,84971,ATG4D,https://ctdbase.org/detail.go?type=gene&acc=84971,,,84971.0,ATG4D,9606.0,Homo sapiens (human),Abrine results in increased expression of ATG4D mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2524,1475501,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10533,ATG7,https://ctdbase.org/detail.go?type=gene&acc=10533,,,10533.0,ATG7,9606.0,Homo sapiens (human),Abrine results in increased expression of ATG7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2525,1477817,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,51411,BIN2,https://ctdbase.org/detail.go?type=gene&acc=51411,,,51411.0,BIN2,9606.0,Homo sapiens (human),Abrine results in decreased expression of BIN2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2526,1477818,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55909,BIN3,https://ctdbase.org/detail.go?type=gene&acc=55909,,,55909.0,BIN3,9606.0,Homo sapiens (human),Abrine results in increased expression of BIN3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2527,1477819,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,329,BIRC2,https://ctdbase.org/detail.go?type=gene&acc=329,,,329.0,BIRC2,9606.0,Homo sapiens (human),Abrine results in increased expression of BIRC2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2528,1477820,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,330,BIRC3,https://ctdbase.org/detail.go?type=gene&acc=330,,,330.0,BIRC3,9606.0,Homo sapiens (human),Abrine results in increased expression of BIRC3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2529,1477821,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,54841,BIVM,https://ctdbase.org/detail.go?type=gene&acc=54841,,,54841.0,BIVM,9606.0,Homo sapiens (human),Abrine results in decreased expression of BIVM mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2530,1477822,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,641,BLM,https://ctdbase.org/detail.go?type=gene&acc=641,,,641.0,BLM,9606.0,Homo sapiens (human),Abrine results in decreased expression of BLM mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2531,1477823,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,642,BLMH,https://ctdbase.org/detail.go?type=gene&acc=642,,,642.0,BLMH,9606.0,Homo sapiens (human),Abrine results in decreased expression of BLMH mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2532,1478934,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,284697,BTBD8,https://ctdbase.org/detail.go?type=gene&acc=284697,,,284697.0,BTBD8,9606.0,Homo sapiens (human),Abrine results in decreased expression of BTBD8 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2533,1478935,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,685,BTC,https://ctdbase.org/detail.go?type=gene&acc=685,,,685.0,BTC,9606.0,Homo sapiens (human),Abrine results in decreased expression of BTC mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2534,1478936,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,686,BTD,https://ctdbase.org/detail.go?type=gene&acc=686,,,686.0,BTD,9606.0,Homo sapiens (human),Abrine results in decreased expression of BTD mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2535,1478937,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,689,BTF3,https://ctdbase.org/detail.go?type=gene&acc=689,,,689.0,BTF3,9606.0,Homo sapiens (human),Abrine results in decreased expression of BTF3 protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2536,1478938,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,694,BTG1,https://ctdbase.org/detail.go?type=gene&acc=694,,,694.0,BTG1,9606.0,Homo sapiens (human),Abrine results in increased expression of BTG1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2537,1478939,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,7832,BTG2,https://ctdbase.org/detail.go?type=gene&acc=7832,,,7832.0,BTG2,9606.0,Homo sapiens (human),Abrine results in increased expression of BTG2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2538,1478940,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10950,BTG3,https://ctdbase.org/detail.go?type=gene&acc=10950,,,10950.0,BTG3,9606.0,Homo sapiens (human),Abrine results in increased expression of BTG3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2539,1478941,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,54766,BTG4,https://ctdbase.org/detail.go?type=gene&acc=54766,,,54766.0,BTG4,9606.0,Homo sapiens (human),Abrine results in increased expression of BTG4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2540,1478942,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,11120,BTN2A1,https://ctdbase.org/detail.go?type=gene&acc=11120,,,11120.0,BTN2A1,9606.0,Homo sapiens (human),Abrine results in increased expression of BTN2A1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2541,1479111,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,153579,BTNL9,https://ctdbase.org/detail.go?type=gene&acc=153579,,,153579.0,BTNL9,9606.0,Homo sapiens (human),Abrine results in decreased expression of BTNL9 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2542,1479112,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,701,BUB1B,https://ctdbase.org/detail.go?type=gene&acc=701,,,701.0,BUB1B,9606.0,Homo sapiens (human),Abrine results in decreased expression of BUB1B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2543,1479113,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,84811,BUD13,https://ctdbase.org/detail.go?type=gene&acc=84811,,,84811.0,BUD13,9606.0,Homo sapiens (human),Abrine results in increased expression of BUD13 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2544,1479114,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8896,BUD31,https://ctdbase.org/detail.go?type=gene&acc=8896,,,8896.0,BUD31,9606.0,Homo sapiens (human),Abrine results in increased expression of BUD31 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2545,1479115,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,11149,BVES,https://ctdbase.org/detail.go?type=gene&acc=11149,,,11149.0,BVES,9606.0,Homo sapiens (human),Abrine results in decreased expression of BVES mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2546,1479116,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,705,BYSL,https://ctdbase.org/detail.go?type=gene&acc=705,,,705.0,BYSL,9606.0,Homo sapiens (human),Abrine results in increased expression of BYSL mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2547,1479117,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,414236,C10ORF55,https://ctdbase.org/detail.go?type=gene&acc=414236,,,414236.0,C10orf55,9606.0,Homo sapiens (human),Abrine results in increased expression of C10ORF55 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2548,1479118,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,80007,C10ORF88,https://ctdbase.org/detail.go?type=gene&acc=80007,,,80007.0,C10orf88,9606.0,Homo sapiens (human),Abrine results in increased expression of C10ORF88 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2549,1479119,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,118611,C10ORF90,https://ctdbase.org/detail.go?type=gene&acc=118611,,,118611.0,C10orf90,9606.0,Homo sapiens (human),Abrine results in decreased expression of C10ORF90 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2550,1479120,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79946,C10ORF95,https://ctdbase.org/detail.go?type=gene&acc=79946,,,79946.0,C10orf95,9606.0,Homo sapiens (human),Abrine results in increased expression of C10ORF95 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2551,1481125,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,59284,CACNG7,https://ctdbase.org/detail.go?type=gene&acc=59284,,,59284.0,CACNG7,9606.0,Homo sapiens (human),Abrine results in decreased expression of CACNG7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2552,1481861,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,56109,PCDHGA6,https://ctdbase.org/detail.go?type=gene&acc=56109,,,56109.0,PCDHGA6,9606.0,Homo sapiens (human),Abrine results in decreased expression of PCDHGA6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2553,1481862,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,56108,PCDHGA7,https://ctdbase.org/detail.go?type=gene&acc=56108,,,56108.0,PCDHGA7,9606.0,Homo sapiens (human),Abrine results in decreased expression of PCDHGA7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2554,1481863,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,56104,PCDHGB1,https://ctdbase.org/detail.go?type=gene&acc=56104,,,56104.0,PCDHGB1,9606.0,Homo sapiens (human),Abrine results in decreased expression of PCDHGB1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2555,1481864,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,56103,PCDHGB2,https://ctdbase.org/detail.go?type=gene&acc=56103,,,56103.0,PCDHGB2,9606.0,Homo sapiens (human),Abrine results in decreased expression of PCDHGB2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2556,1395749,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,9495,AKAP5,https://ctdbase.org/detail.go?type=gene&acc=9495,,,9495.0,AKAP5,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of AKAP5 mRNA,,,PMID:16507463,https://www.ncbi.nlm.nih.gov/pubmed/16507463,16507463,,
2557,1395750,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,26993,AKAP8L,https://ctdbase.org/detail.go?type=gene&acc=26993,,,26993.0,AKAP8L,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of AKAP8L protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2558,1395751,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of AKR1B10 mRNA,,,PMID:23876855,https://www.ncbi.nlm.nih.gov/pubmed/23876855,23876855,,
2559,1395752,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,14187,AKR1B8,https://ctdbase.org/detail.go?type=gene&acc=14187,,,14187.0,Akr1b8,10090.0,Mus musculus (house mouse),Monomethylarsonous acid results in decreased expression of AKR1B8 mRNA,,,PMID:20024957,https://www.ncbi.nlm.nih.gov/pubmed/20024957,20024957,,
2560,1395753,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of AKR1C1 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2561,1395754,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of AKR1C2 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2562,1395755,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of AKT1 protein,,,PMID:20045430,https://www.ncbi.nlm.nih.gov/pubmed/20045430,20045430,,
2563,1395756,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Monomethylarsonous acid inhibits the reaction [INS1 protein results in increased phosphorylation of and results in increased activity of AKT1 protein]|monomethylarsonous acid results in decreased phosphorylation of AKT1 protein|akt1 protein modified form inhibits the reaction [monomethylarsonous acid inhibits the reaction [INS1 protein results in increased uptake of glucose]],,,PMID:17520061,https://www.ncbi.nlm.nih.gov/pubmed/17520061,17520061,,
2564,1395757,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Monomethylarsonous acid results in increased expression of AKT1 mRNA,,,PMID:20024957,https://www.ncbi.nlm.nih.gov/pubmed/20024957,20024957,,
2565,1395877,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,57719,ANO8,https://ctdbase.org/detail.go?type=gene&acc=57719,,,57719.0,ANO8,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of ANO8 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2566,1395878,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),APOE protein affects the susceptibility to monomethylarsonous acid|as3mt protein affects the reaction [APOE protein affects the susceptibility to monomethylarsonous acid],,,PMID:28728140,https://www.ncbi.nlm.nih.gov/pubmed/28728140,28728140,,
2567,1395879,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116.0,Rattus norvegicus (Norway rat),Monomethylarsonous acid results in increased expression of APP mRNA,,,PMID:27321306,https://www.ncbi.nlm.nih.gov/pubmed/27321306,27321306,,
2568,1395880,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,374,AREG,https://ctdbase.org/detail.go?type=gene&acc=374,,,374.0,AREG,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of AREG mRNA,,,PMID:20886546,https://www.ncbi.nlm.nih.gov/pubmed/20886546,20886546,,
2569,1395997,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,57412,AS3MT,https://ctdbase.org/detail.go?type=gene&acc=57412,,,57412.0,AS3MT,9606.0,Homo sapiens (human),Unithiol inhibits the reaction [[AS3MT protein results in increased methylation of monomethylarsonous acid] which results in increased chemical synthesis of dimethylarsinous acid]|unithiol inhibits the reaction [AS3MT protein results in increased methylation of monomethylarsonous acid]|[as3mt protein results in increased methylation of arsenite] which results in increased chemical synthesis of monomethylarsonous acid|unithiol inhibits the reaction [[AS3MT protein results in increased methylation of arsenite] which results in increased chemical synthesis of monomethylarsonous acid]|[as3mt protein results in increased methylation of monomethylarsonous acid] which results in increased chemical synthesis of dimethylarsinous acid,,,PMID:25194983,https://www.ncbi.nlm.nih.gov/pubmed/25194983,25194983,,
2570,1396461,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,669,BPGM,https://ctdbase.org/detail.go?type=gene&acc=669,,,669.0,BPGM,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of BPGM protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2571,1396462,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,23774,BRD1,https://ctdbase.org/detail.go?type=gene&acc=23774,,,23774.0,BRD1,9606.0,Homo sapiens (human),[monomethylarsonous acid affects the acetylation of H3-4 protein] which affects the methylation of BRD1 promoter,,,PMID:18448484,https://www.ncbi.nlm.nih.gov/pubmed/18448484,18448484,,
2572,1396463,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,23476,BRD4,https://ctdbase.org/detail.go?type=gene&acc=23476,,,23476.0,BRD4,10090.0,Mus musculus (house mouse),Monomethylarsonous acid results in increased expression of BRD4 mRNA,,,PMID:20024957,https://www.ncbi.nlm.nih.gov/pubmed/20024957,20024957,,
2573,1396464,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1620,BRINP1,https://ctdbase.org/detail.go?type=gene&acc=1620,,,1620.0,BRINP1,9606.0,Homo sapiens (human),[monomethylarsonous acid affects the acetylation of H3-4 protein] which affects the methylation of BRINP1 promoter,,,PMID:18448484,https://www.ncbi.nlm.nih.gov/pubmed/18448484,18448484,,
2574,1396465,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1620,BRINP1,https://ctdbase.org/detail.go?type=gene&acc=1620,,,1620.0,BRINP1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of BRINP1 mRNA,,,PMID:20375083|PMID:22108045,https://www.ncbi.nlm.nih.gov/pubmed/20375083|https://www.ncbi.nlm.nih.gov/pubmed/22108045,20375083|22108045,,
2575,1396466,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,114897,C1QTNF1,https://ctdbase.org/detail.go?type=gene&acc=114897,,,114897.0,C1QTNF1,10090.0,Mus musculus (house mouse),Monomethylarsonous acid results in increased expression of C1QTNF1 mRNA,,,PMID:20024957,https://www.ncbi.nlm.nih.gov/pubmed/20024957,20024957,,
2576,1396467,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,114904,C1QTNF6,https://ctdbase.org/detail.go?type=gene&acc=114904,,,114904.0,C1QTNF6,9606.0,Homo sapiens (human),[monomethylarsonous acid affects the acetylation of H3-4 protein] which affects the methylation of C1QTNF6 promoter,,,PMID:18448484,https://www.ncbi.nlm.nih.gov/pubmed/18448484,18448484,,
2577,1396697,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),CAT protein inhibits the reaction [monomethylarsonous acid results in increased expression of PTGS2 mrna],,,PMID:18588940,https://www.ncbi.nlm.nih.gov/pubmed/18588940,18588940,,
2578,1396698,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Monomethylarsonous acid affects the activity of CAT protein,,,PMID:23353816,https://www.ncbi.nlm.nih.gov/pubmed/23353816,23353816,,
2579,1396699,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),CAT protein inhibits the reaction [monomethylarsonous acid results in decreased activity of TERT protein]|cat protein inhibits the reaction [monomethylarsonous acid results in increased expression of HMOX1 protein],,,PMID:18336854,https://www.ncbi.nlm.nih.gov/pubmed/18336854,18336854,,
2580,1396700,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),CAT protein results in decreased oxidation of monomethylarsonous acid|[cat protein results in decreased oxidation of monomethylarsonous acid] which results in decreased chemical synthesis of monomethylarsonic acid,,,PMID:18619986,https://www.ncbi.nlm.nih.gov/pubmed/18619986,18619986,,
2581,1396701,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,112464,CAVIN3,https://ctdbase.org/detail.go?type=gene&acc=112464,,,112464.0,CAVIN3,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of CAVIN3 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2582,1396702,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,147372,CCBE1,https://ctdbase.org/detail.go?type=gene&acc=147372,,,147372.0,CCBE1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of CCBE1 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2583,1396703,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of CCL2 mRNA,,,PMID:16507463|PMID:22108045,https://www.ncbi.nlm.nih.gov/pubmed/16507463|https://www.ncbi.nlm.nih.gov/pubmed/22108045,16507463|22108045,,
2584,1396704,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of CCN2 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2585,1396705,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),CXCL8 protein affects the reaction [monomethylarsonous acid results in increased expression of CCND1 mrna],,,PMID:22015448,https://www.ncbi.nlm.nih.gov/pubmed/22015448,22015448,,
2586,1396706,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of CCND1 mRNA,,,PMID:19945496|PMID:22015448,https://www.ncbi.nlm.nih.gov/pubmed/19945496|https://www.ncbi.nlm.nih.gov/pubmed/22015448,19945496|22015448,,
2587,1396934,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,993,CDC25A,https://ctdbase.org/detail.go?type=gene&acc=993,,,993.0,CDC25A,10090.0,Mus musculus (house mouse),Monomethylarsonous acid results in increased expression of CDC25A mRNA,,,PMID:20024957,https://www.ncbi.nlm.nih.gov/pubmed/20024957,20024957,,
2588,1397414,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,10488,CREB3,https://ctdbase.org/detail.go?type=gene&acc=10488,,,10488.0,CREB3,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of CREB3 mRNA,,,PMID:20886546,https://www.ncbi.nlm.nih.gov/pubmed/20886546,20886546,,
2589,1397415,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,153222,CREBRF,https://ctdbase.org/detail.go?type=gene&acc=153222,,,153222.0,CREBRF,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of CREBRF mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2590,1397416,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1397,CRIP2,https://ctdbase.org/detail.go?type=gene&acc=1397,,,1397.0,CRIP2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of CRIP2 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2591,1397417,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410.0,CRYAB,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of CRYAB mRNA,,,PMID:25177542,https://www.ncbi.nlm.nih.gov/pubmed/25177542,25177542,,
2592,1397418,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410.0,CRYAB,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of CRYAB mRNA,,,PMID:20886546|PMID:23876855,https://www.ncbi.nlm.nih.gov/pubmed/20886546|https://www.ncbi.nlm.nih.gov/pubmed/23876855,20886546|23876855,,
2593,1397419,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410.0,CRYAB,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of CRYAB protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2594,1397420,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of CSF2 mRNA,,,PMID:20886546,https://www.ncbi.nlm.nih.gov/pubmed/20886546,20886546,,
2595,1397421,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,101928649,CTC-338M12.4,https://ctdbase.org/detail.go?type=gene&acc=101928649,,,101928649.0,CTC-338M12.4,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of CTC-338M12.4 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2596,1397422,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,58190,CTDSP1,https://ctdbase.org/detail.go?type=gene&acc=58190,,,58190.0,CTDSP1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of CTDSP1 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2597,1397423,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1501,CTNND2,https://ctdbase.org/detail.go?type=gene&acc=1501,,,1501.0,CTNND2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of CTNND2 mRNA,,,PMID:22108045,https://www.ncbi.nlm.nih.gov/pubmed/22108045,22108045,,
2598,1398028,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,51635,DHRS7,https://ctdbase.org/detail.go?type=gene&acc=51635,,,51635.0,DHRS7,10090.0,Mus musculus (house mouse),Monomethylarsonous acid results in decreased expression of DHRS7 mRNA,,,PMID:20024957,https://www.ncbi.nlm.nih.gov/pubmed/20024957,20024957,,
2599,1398029,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1730,DIAPH2,https://ctdbase.org/detail.go?type=gene&acc=1730,,,1730.0,DIAPH2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of DIAPH2 mRNA,,,PMID:20886546,https://www.ncbi.nlm.nih.gov/pubmed/20886546,20886546,,
2600,1398030,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,10655,DMRT2,https://ctdbase.org/detail.go?type=gene&acc=10655,,,10655.0,DMRT2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of DMRT2 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2601,1398031,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,23639,DNAAF11,https://ctdbase.org/detail.go?type=gene&acc=23639,,,23639.0,DNAAF11,9606.0,Homo sapiens (human),[monomethylarsonous acid affects the acetylation of H3-4 protein] which affects the methylation of DNAAF11 promoter,,,PMID:18448484,https://www.ncbi.nlm.nih.gov/pubmed/18448484,18448484,,
2602,1398138,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,55332,DRAM1,https://ctdbase.org/detail.go?type=gene&acc=55332,,,55332.0,DRAM1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of DRAM1 mRNA,,,PMID:22108045,https://www.ncbi.nlm.nih.gov/pubmed/22108045,22108045,,
2603,1398139,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,50506,DUOX2,https://ctdbase.org/detail.go?type=gene&acc=50506,,,50506.0,DUOX2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of DUOX2 mRNA,,,PMID:22108045|PMID:25177542,https://www.ncbi.nlm.nih.gov/pubmed/22108045|https://www.ncbi.nlm.nih.gov/pubmed/25177542,22108045|25177542,,
2604,1398140,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1843,DUSP1,https://ctdbase.org/detail.go?type=gene&acc=1843,,,1843.0,DUSP1,9606.0,Homo sapiens (human),Monomethylarsonous acid affects the expression of DUSP1 mRNA,,,PMID:25177542,https://www.ncbi.nlm.nih.gov/pubmed/25177542,25177542,,
2605,1398141,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1843,DUSP1,https://ctdbase.org/detail.go?type=gene&acc=1843,,,1843.0,DUSP1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of DUSP1 mRNA,,,PMID:22108045,https://www.ncbi.nlm.nih.gov/pubmed/22108045,22108045,,
2606,1398142,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,1843,DUSP1,https://ctdbase.org/detail.go?type=gene&acc=1843,,,1843.0,DUSP1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of DUSP1 mRNA,,,PMID:19945496|PMID:20886546,https://www.ncbi.nlm.nih.gov/pubmed/19945496|https://www.ncbi.nlm.nih.gov/pubmed/20886546,19945496|20886546,,
2607,1400003,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,15497,HSD3B6,https://ctdbase.org/detail.go?type=gene&acc=15497,,,15497.0,Hsd3b6,10090.0,Mus musculus (house mouse),Monomethylarsonous acid results in decreased expression of HSD3B6 mRNA,,,PMID:20024957,https://www.ncbi.nlm.nih.gov/pubmed/20024957,20024957,,
2608,1400004,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,3320,HSP90AA1,https://ctdbase.org/detail.go?type=gene&acc=3320,,,3320.0,HSP90AA1,10090.0,Mus musculus (house mouse),Monomethylarsonous acid results in increased expression of HSP90AA1 mRNA,,,PMID:20024957,https://www.ncbi.nlm.nih.gov/pubmed/20024957,20024957,,
2609,1400005,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,3303,HSPA1A,https://ctdbase.org/detail.go?type=gene&acc=3303,,,3303.0,HSPA1A,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of HSPA1A protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2610,1400133,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,3429,IFI27,https://ctdbase.org/detail.go?type=gene&acc=3429,,,3429.0,IFI27,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of IFI27 mRNA,,,PMID:22108045,https://www.ncbi.nlm.nih.gov/pubmed/22108045,22108045,,
2611,1400134,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,10964,IFI44L,https://ctdbase.org/detail.go?type=gene&acc=10964,,,10964.0,IFI44L,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of IFI44L mRNA,,,PMID:22108045|PMID:23876855,https://www.ncbi.nlm.nih.gov/pubmed/22108045|https://www.ncbi.nlm.nih.gov/pubmed/23876855,22108045|23876855,,
2612,1400135,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,2537,IFI6,https://ctdbase.org/detail.go?type=gene&acc=2537,,,2537.0,IFI6,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of IFI6 mRNA,,,PMID:22108045,https://www.ncbi.nlm.nih.gov/pubmed/22108045,22108045,,
2613,1400136,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,2537,IFI6,https://ctdbase.org/detail.go?type=gene&acc=2537,,,2537.0,IFI6,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of IFI6 mRNA,,,PMID:23876855,https://www.ncbi.nlm.nih.gov/pubmed/23876855,23876855,,
2614,1400137,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,3434,IFIT1,https://ctdbase.org/detail.go?type=gene&acc=3434,,,3434.0,IFIT1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of IFIT1 mRNA,,,PMID:22108045|PMID:23876855,https://www.ncbi.nlm.nih.gov/pubmed/22108045|https://www.ncbi.nlm.nih.gov/pubmed/23876855,22108045|23876855,,
2615,1400138,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,3433,IFIT2,https://ctdbase.org/detail.go?type=gene&acc=3433,,,3433.0,IFIT2,9606.0,Homo sapiens (human),Monomethylarsonous acid affects the expression of IFIT2 mRNA,,,PMID:25177542,https://www.ncbi.nlm.nih.gov/pubmed/25177542,25177542,,
2616,1400139,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,3433,IFIT2,https://ctdbase.org/detail.go?type=gene&acc=3433,,,3433.0,IFIT2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of IFIT2 mRNA,,,PMID:22108045,https://www.ncbi.nlm.nih.gov/pubmed/22108045,22108045,,
2617,1400140,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,3433,IFIT2,https://ctdbase.org/detail.go?type=gene&acc=3433,,,3433.0,IFIT2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of IFIT2 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2618,1401332,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,92255,LMBRD2,https://ctdbase.org/detail.go?type=gene&acc=92255,,,92255.0,LMBRD2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of LMBRD2 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2619,1401333,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,29995,LMCD1,https://ctdbase.org/detail.go?type=gene&acc=29995,,,29995.0,LMCD1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of LMCD1 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2620,1401334,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,25802,LMOD1,https://ctdbase.org/detail.go?type=gene&acc=25802,,,25802.0,LMOD1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of LMOD1 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2621,1403919,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,10336,PCGF3,https://ctdbase.org/detail.go?type=gene&acc=10336,,,10336.0,PCGF3,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of PCGF3 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2622,1403920,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,27445,PCLO,https://ctdbase.org/detail.go?type=gene&acc=27445,,,27445.0,PCLO,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of PCLO mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2623,1404036,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,5170,PDPK1,https://ctdbase.org/detail.go?type=gene&acc=5170,,,5170.0,PDPK1,10090.0,Mus musculus (house mouse),Monomethylarsonous acid results in decreased activity of PDPK1 protein,,,PMID:17520061,https://www.ncbi.nlm.nih.gov/pubmed/17520061,17520061,,
2624,1404037,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,9409,PEX16,https://ctdbase.org/detail.go?type=gene&acc=9409,,,9409.0,PEX16,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of PEX16 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2625,1404038,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,25796,PGLS,https://ctdbase.org/detail.go?type=gene&acc=25796,,,25796.0,PGLS,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of PGLS mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2626,1404039,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,57157,PHTF2,https://ctdbase.org/detail.go?type=gene&acc=57157,,,57157.0,PHTF2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased expression of PHTF2 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2627,1404040,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,55367,PIDD1,https://ctdbase.org/detail.go?type=gene&acc=55367,,,55367.0,PIDD1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of PIDD1 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2628,1404041,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,9780,PIEZO1,https://ctdbase.org/detail.go?type=gene&acc=9780,,,9780.0,PIEZO1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in increased methylation of PIEZO1 promoter|monomethylarsonous acid results in decreased expression of PIEZO1 mRNA,,,PMID:20375083,https://www.ncbi.nlm.nih.gov/pubmed/20375083,20375083,,
2629,1404265,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,196051,PLPP4,https://ctdbase.org/detail.go?type=gene&acc=196051,,,196051.0,PLPP4,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of PLPP4 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2630,1404266,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,57088,PLSCR4,https://ctdbase.org/detail.go?type=gene&acc=57088,,,57088.0,PLSCR4,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of PLSCR4 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2631,1404267,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,5361,PLXNA1,https://ctdbase.org/detail.go?type=gene&acc=5361,,,5361.0,PLXNA1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of PLXNA1 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2632,1404268,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,5362,PLXNA2,https://ctdbase.org/detail.go?type=gene&acc=5362,,,5362.0,PLXNA2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of PLXNA2 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
2633,1404269,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,135293,PM20D2,https://ctdbase.org/detail.go?type=gene&acc=135293,,,135293.0,PM20D2,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of PM20D2 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2634,1447652,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005245,Receptor-type tyrosine-protein phosphatase H,http://www.t3db.ca/biodb/bio_entities/BE0005245,Q9HD43,Receptor-type tyrosine-protein phosphatase H,5794.0,PTPRH,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2635,1447653,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005241,Receptor-type tyrosine-protein phosphatase N2,http://www.t3db.ca/biodb/bio_entities/BE0005241,Q92932,Receptor-type tyrosine-protein phosphatase N2,5799.0,PTPRN2,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2636,1447654,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005250,Receptor-type tyrosine-protein phosphatase O,http://www.t3db.ca/biodb/bio_entities/BE0005250,Q16827,Receptor-type tyrosine-protein phosphatase O,5800.0,PTPRO,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2637,1447655,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005251,Receptor-type tyrosine-protein phosphatase R,http://www.t3db.ca/biodb/bio_entities/BE0005251,Q15256,Receptor-type tyrosine-protein phosphatase R,5801.0,PTPRR,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2638,1447656,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0003567,Receptor-type tyrosine-protein phosphatase S,http://www.t3db.ca/biodb/bio_entities/BE0003567,Q13332,Receptor-type tyrosine-protein phosphatase S,5802.0,PTPRS,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2639,1447657,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005252,Receptor-type tyrosine-protein phosphatase T,http://www.t3db.ca/biodb/bio_entities/BE0005252,O14522,Receptor-type tyrosine-protein phosphatase T,11122.0,PTPRT,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2640,1447658,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005229,Receptor-type tyrosine-protein phosphatase U,http://www.t3db.ca/biodb/bio_entities/BE0005229,Q92729,Receptor-type tyrosine-protein phosphatase U,10076.0,PTPRU,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2641,1447659,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005230,Receptor-type tyrosine-protein phosphatase alpha,http://www.t3db.ca/biodb/bio_entities/BE0005230,P18433,Receptor-type tyrosine-protein phosphatase alpha,5786.0,PTPRA,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2642,1447660,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0003769,Receptor-type tyrosine-protein phosphatase beta,http://www.t3db.ca/biodb/bio_entities/BE0003769,P23467,Receptor-type tyrosine-protein phosphatase beta,5787.0,PTPRB,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2643,1447982,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005233,Tyrosine-protein phosphatase non-receptor type 6,http://www.t3db.ca/biodb/bio_entities/BE0005233,P29350,Tyrosine-protein phosphatase non-receptor type 6,5777.0,PTPN6,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2644,1447983,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005228,Tyrosine-protein phosphatase non-receptor type 7,http://www.t3db.ca/biodb/bio_entities/BE0005228,P35236,Tyrosine-protein phosphatase non-receptor type 7,5778.0,PTPN7,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2645,1447984,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005255,Tyrosine-protein phosphatase non-receptor type 9,http://www.t3db.ca/biodb/bio_entities/BE0005255,P43378,Tyrosine-protein phosphatase non-receptor type 9,5780.0,PTPN9,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2646,1447985,167551,BindingDB,Anacardic acid,50240436,2-Hydroxy-6-pentadecyl-benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50240436,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),11040,PMID:32803196|DOI:10.1101/2020.07.17.207019,https://www.ncbi.nlm.nih.gov/pubmed/32803196|https://doi.org/10.1101/2020.07.17.207019,32803196,10.1101/2020.07.17.207019,
2647,1450141,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,40141,ASF1,https://ctdbase.org/detail.go?type=gene&acc=40141,,,40141.0,asf1,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of ASF1 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2648,1450142,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of ATF4 mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2649,1450143,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,38913,ATG18A,https://ctdbase.org/detail.go?type=gene&acc=38913,,,38913.0,Atg18a,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of ATG18A mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2650,1450144,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,475,ATOX1,https://ctdbase.org/detail.go?type=gene&acc=475,,,475.0,ATOX1,10090.0,Mus musculus (house mouse),ATOX1 protein affects the reaction [[bathocuproine sulfonate results in decreased abundance of copper] which results in decreased expression of SLC31A2 mrna]|atox1 protein affects the reaction [[bathocuproine sulfonate results in decreased abundance of copper] which results in decreased expression of SLC31A2 protein],,,PMID:20194531,https://www.ncbi.nlm.nih.gov/pubmed/20194531,20194531,,
2651,1450145,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,538,ATP7A,https://ctdbase.org/detail.go?type=gene&acc=538,,,538.0,ATP7A,9606.0,Homo sapiens (human),Bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]|cupric chloride inhibits the reaction [bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]],,,PMID:11092760,https://www.ncbi.nlm.nih.gov/pubmed/11092760,11092760,,
2652,1450146,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,538,ATP7A,https://ctdbase.org/detail.go?type=gene&acc=538,,,538.0,ATP7A,9606.0,Homo sapiens (human),[penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7A protein],,,PMID:21242307,https://www.ncbi.nlm.nih.gov/pubmed/21242307,21242307,,
2653,1451278,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,1959,EGR2,https://ctdbase.org/detail.go?type=gene&acc=1959,,,1959.0,EGR2,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of EGR2 mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2654,1451279,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,1960,EGR3,https://ctdbase.org/detail.go?type=gene&acc=1960,,,1960.0,EGR3,9606.0,Homo sapiens (human),[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of EGR3 mRNA,,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2655,1451280,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,133418,EMB,https://ctdbase.org/detail.go?type=gene&acc=133418,,,133418.0,EMB,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of EMB mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2656,1451281,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,34953,ENDOGI,https://ctdbase.org/detail.go?type=gene&acc=34953,,,34953.0,EndoGI,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of ENDOGI mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2657,1451282,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,45577,FAA,https://ctdbase.org/detail.go?type=gene&acc=45577,,,45577.0,Faa,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in increased expression of FAA mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2658,1451283,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,9606.0,Homo sapiens (human),Bathocuproine sulfonate inhibits the reaction [copper histidine results in increased expression of FASN mrna],,,PMID:24170205,https://www.ncbi.nlm.nih.gov/pubmed/24170205,24170205,,
2659,1451284,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,44965,FER2LCH,https://ctdbase.org/detail.go?type=gene&acc=44965,,,44965.0,Fer2LCH,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in increased expression of FER2LCH mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2660,1451285,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247.0,FGF2,10090.0,Mus musculus (house mouse),Bathocuproine sulfonate inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]|bathocuproine sulfonate inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein],,,PMID:22842628,https://www.ncbi.nlm.nih.gov/pubmed/22842628,22842628,,
2661,1451450,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,40745,GASP,https://ctdbase.org/detail.go?type=gene&acc=40745,,,40745.0,Gasp,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of GASP mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2662,1451451,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,46008,GEL,https://ctdbase.org/detail.go?type=gene&acc=46008,,,46008.0,Gel,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of GEL mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2663,1451452,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,2675,GFRA2,https://ctdbase.org/detail.go?type=gene&acc=2675,,,2675.0,GFRA2,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of GFRA2 mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2664,1451453,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,41930,GLOB1,https://ctdbase.org/detail.go?type=gene&acc=41930,,,41930.0,glob1,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in increased expression of GLOB1 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2665,1452235,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,42049,IRC,https://ctdbase.org/detail.go?type=gene&acc=42049,,,42049.0,Irc,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of IRC mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2666,1452236,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,43924,JIM,https://ctdbase.org/detail.go?type=gene&acc=43924,,,43924.0,jim,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of JIM mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2667,1453019,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,4494,MT1F,https://ctdbase.org/detail.go?type=gene&acc=4494,,,4494.0,MT1F,9606.0,Homo sapiens (human),[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MT1F mRNA,,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2668,1453020,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,4495,MT1G,https://ctdbase.org/detail.go?type=gene&acc=4495,,,4495.0,MT1G,9606.0,Homo sapiens (human),[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MT1G mRNA,,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2669,1453021,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,4496,MT1H,https://ctdbase.org/detail.go?type=gene&acc=4496,,,4496.0,MT1H,9606.0,Homo sapiens (human),[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MT1H mRNA,,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2670,1453022,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,4501,MT1X,https://ctdbase.org/detail.go?type=gene&acc=4501,,,4501.0,MT1X,9606.0,Homo sapiens (human),[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MT1X mRNA,,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2671,1453023,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,9112,MTA1,https://ctdbase.org/detail.go?type=gene&acc=9112,,,9112.0,MTA1,9606.0,Homo sapiens (human),[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MTA1 mRNA,,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2672,1453024,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,4520,MTF1,https://ctdbase.org/detail.go?type=gene&acc=4520,,,4520.0,MTF1,10090.0,Mus musculus (house mouse),Bathocuproine sulfonate inhibits the reaction [[cobaltiprotoporphyrin co-treated with HPX protein] results in increased expression of MTF1 mrna]|bathocuproine sulfonate inhibits the reaction [[cobaltiprotoporphyrin co-treated with HPX protein] affects the localization of MTF1 protein]|bathocuproine sulfonate inhibits the reaction [[heme co-treated with HPX protein] affects the localization of MTF1 protein],,,PMID:11213479,https://www.ncbi.nlm.nih.gov/pubmed/11213479,11213479,,
2673,1453025,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,41202,MTNA,https://ctdbase.org/detail.go?type=gene&acc=41202,,,41202.0,MtnA,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of MTNA mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2674,1453026,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,42416,MTNC,https://ctdbase.org/detail.go?type=gene&acc=42416,,,42416.0,MtnC,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of MTNC mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2675,1448327,172198,Comparative Toxicogenomics Database (CTD),angiotensin II,D000804,Angiotensin II,https://ctdbase.org/detail.go?type=chem&acc=D000804,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,10090.0,Mus musculus (house mouse),NR1I2 protein affects the susceptibility to angiotensin II,,,PMID:33746155,https://www.ncbi.nlm.nih.gov/pubmed/33746155,33746155,,
2676,1448328,172198,Comparative Toxicogenomics Database (CTD),angiotensin II,D000804,Angiotensin II,https://ctdbase.org/detail.go?type=chem&acc=D000804,5160,PDHA1,https://ctdbase.org/detail.go?type=gene&acc=5160,,,5160.0,PDHA1,10116.0,Rattus norvegicus (Norway rat),PPARA protein promotes the reaction [celastrol methyl ester inhibits the reaction [angiotensin II results in decreased expression of PDHA1 mrna]]|angiotensin II results in decreased expression of PDHA1 mrna|celastrol methyl ester inhibits the reaction [angiotensin II results in decreased expression of PDHA1 mrna],,,PMID:37269933,https://www.ncbi.nlm.nih.gov/pubmed/37269933,37269933,,
2677,1448329,172198,Comparative Toxicogenomics Database (CTD),angiotensin II,D000804,Angiotensin II,https://ctdbase.org/detail.go?type=chem&acc=D000804,5213,PFKM,https://ctdbase.org/detail.go?type=gene&acc=5213,,,5213.0,PFKM,10116.0,Rattus norvegicus (Norway rat),Angiotensin II results in increased expression of PFKM mrna|ppara protein promotes the reaction [celastrol methyl ester inhibits the reaction [angiotensin II results in increased expression of PFKM mrna]]|celastrol methyl ester inhibits the reaction [angiotensin II results in increased expression of PFKM mrna],,,PMID:37269933,https://www.ncbi.nlm.nih.gov/pubmed/37269933,37269933,,
2678,1450629,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1392,CRH,https://ctdbase.org/detail.go?type=gene&acc=1392,,,1392.0,CRH,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [lipopolysaccharides results in increased expression of CRH mrna],,,PMID:21959975,https://www.ncbi.nlm.nih.gov/pubmed/21959975,21959975,,
2679,1450630,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein],,,PMID:17388968,https://www.ncbi.nlm.nih.gov/pubmed/17388968,17388968,,
2680,1450631,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,200186,CRTC2,https://ctdbase.org/detail.go?type=gene&acc=200186,,,200186.0,CRTC2,10090.0,Mus musculus (house mouse),[N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with SB 203580] inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of CRTC2 protein]|sb 203580 inhibits the reaction [perfluorooctane sulfonic acid inhibits the reaction [[CRTC2 protein binds to CREB1 protein modified form] which binds to STAR promoter]]|[n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with SB 203580] inhibits the reaction [perfluorooctane sulfonic acid inhibits the reaction [[CRTC2 protein binds to CREB1 protein modified form] which binds to STAR promoter]]|sb 203580 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of CRTC2 protein],,,PMID:33359577,https://www.ncbi.nlm.nih.gov/pubmed/33359577,33359577,,
2681,1450632,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1436,CSF1R,https://ctdbase.org/detail.go?type=gene&acc=1436,,,1436.0,CSF1R,10090.0,Mus musculus (house mouse),SB 203580 affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of CTSK mrna]]|[sb 203580 co-treated with sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of ATP6V0D2 mrna|[sb 203580 co-treated with sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of CTSK mrna|sb 203580 inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mrna]|sb 203580 inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mrna]|[sb 203580 co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of CTSK mrna|[sb 203580 co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of ATP6V0D2 mrna|sb 203580 affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mrna]],,,PMID:30742845,https://www.ncbi.nlm.nih.gov/pubmed/30742845,30742845,,
2682,1450633,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [particulate matter results in increased secretion of CSF2 protein]|sb 203580 inhibits the reaction [vehicle emissions results in increased secretion of CSF2 protein],,,PMID:10645887,https://www.ncbi.nlm.nih.gov/pubmed/10645887,10645887,,
2683,1450634,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606.0,Homo sapiens (human),"SB 203580 inhibits the reaction [[toluene 2,4-diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]",,,PMID:16908450,https://www.ncbi.nlm.nih.gov/pubmed/16908450,16908450,,
2684,1450635,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),SB 203580 results in decreased phosphorylation of CTNNB1 protein|[cannabidiol co-treated with SB 203580] results in decreased phosphorylation of CTNNB1 protein,,,PMID:32060308,https://www.ncbi.nlm.nih.gov/pubmed/32060308,32060308,,
2685,1451126,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [ADIPOQ protein results in increased expression of CXCL8 protein],,,PMID:28176455,https://www.ncbi.nlm.nih.gov/pubmed/28176455,28176455,,
2686,1451127,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),"SB 203580 inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL8 protein]|sb 203580 inhibits the reaction [arsenic trioxide promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL8 protein]]",,,PMID:21777978,https://www.ncbi.nlm.nih.gov/pubmed/21777978,21777978,,
2687,1451128,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [benzene results in increased expression of CXCL8 mrna]|sb 203580 inhibits the reaction [vehicle emissions results in increased expression of CXCL8 mrna]|sb 203580 inhibits the reaction [benzo(a)pyrene results in increased expression of CXCL8 mrna],,,PMID:11306435,https://www.ncbi.nlm.nih.gov/pubmed/11306435,11306435,,
2688,1451129,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [cadmium chloride results in increased expression of CXCL8 mrna]|sb 203580 inhibits the reaction [cadmium chloride results in increased secretion of CXCL8 protein],,,PMID:28288823,https://www.ncbi.nlm.nih.gov/pubmed/28288823,28288823,,
2689,1451130,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [cadmium sulfate results in increased secretion of CXCL8 protein],,,PMID:22094458,https://www.ncbi.nlm.nih.gov/pubmed/22094458,22094458,,
2690,1451131,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [doxifluridine results in increased expression of CXCL8 mrna]|sb 203580 inhibits the reaction [fluorouracil results in increased expression of CXCL8 mrna]|sb 203580 inhibits the reaction [capecitabine results in increased secretion of CXCL8 protein]|sb 203580 inhibits the reaction [fluorouracil results in increased secretion of CXCL8 protein],,,PMID:35147423,https://www.ncbi.nlm.nih.gov/pubmed/35147423,35147423,,
2691,1451132,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [cobaltous chloride results in increased expression of CXCL8 mrna]|sb 203580 inhibits the reaction [cobaltous chloride results in increased secretion of CXCL8 protein],,,PMID:17082639,https://www.ncbi.nlm.nih.gov/pubmed/17082639,17082639,,
2692,1452081,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [vehicle emissions results in increased secretion of CXCL8 protein],,,PMID:27295300,https://www.ncbi.nlm.nih.gov/pubmed/27295300,27295300,,
2693,1452082,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3579,CXCR2,https://ctdbase.org/detail.go?type=gene&acc=3579,,,3579.0,CXCR2,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [lipopolysaccharides results in decreased expression of CXCR2 protein],,,PMID:10950785,https://www.ncbi.nlm.nih.gov/pubmed/10950785,10950785,,
2694,1452083,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1535,CYBA,https://ctdbase.org/detail.go?type=gene&acc=1535,,,1535.0,CYBA,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [ethanol results in increased expression of CYBA mrna],,,PMID:23978445,https://www.ncbi.nlm.nih.gov/pubmed/23978445,23978445,,
2695,1452084,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [ethanol results in increased expression of CYBB mrna],,,PMID:23978445,https://www.ncbi.nlm.nih.gov/pubmed/23978445,23978445,,
2696,1452085,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [nickel sulfate results in decreased expression of CYP11A1 mrna]|sb 203580 inhibits the reaction [nickel sulfate results in decreased expression of CYP11A1 protein],,,PMID:29567110,https://www.ncbi.nlm.nih.gov/pubmed/29567110,29567110,,
2697,1452086,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 mrna]|sb 203580 inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 protein],,,PMID:29567110,https://www.ncbi.nlm.nih.gov/pubmed/29567110,29567110,,
2698,1452859,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1889,ECE1,https://ctdbase.org/detail.go?type=gene&acc=1889,,,1889.0,ECE1,10116.0,Rattus norvegicus (Norway rat),SB 203580 affects the expression of ECE1 mRNA,,,PMID:21084678,https://www.ncbi.nlm.nih.gov/pubmed/21084678,21084678,,
2699,1452860,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [cobaltous chloride results in increased secretion of EDN1 protein],,,PMID:27297870,https://www.ncbi.nlm.nih.gov/pubmed/27297870,27297870,,
2700,1452861,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [EDN1 protein results in increased expression of PTGS2 mrna]|sb 203580 inhibits the reaction [EDN1 protein results in increased expression of CXCL8 mrna]|sb 203580 inhibits the reaction [EDN1 protein results in increased expression of VCAM1 mrna]|sb 203580 inhibits the reaction [EDN1 protein results in increased expression of IL6 mrna],,,PMID:18457675,https://www.ncbi.nlm.nih.gov/pubmed/18457675,18457675,,
2701,1452862,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [EDN1 protein results in increased expression of EDN1 mrna],,,PMID:18457675,https://www.ncbi.nlm.nih.gov/pubmed/18457675,18457675|18457675,,
2702,1452863,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [glucose results in increased expression of EDN1 mrna],,,PMID:24376792,https://www.ncbi.nlm.nih.gov/pubmed/24376792,24376792,,
2703,1452864,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [EDN1 protein results in increased phosphorylation of CREB1 protein],,,PMID:14741741,https://www.ncbi.nlm.nih.gov/pubmed/14741741,14741741,,
2704,1452865,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [smoke results in increased expression of EDNRA protein],,,PMID:36183783,https://www.ncbi.nlm.nih.gov/pubmed/36183783,36183783,,
2705,1452866,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [cyclosporine results in increased expression of EDNRB protein]|sb 203580 inhibits the reaction [cyclosporine results in increased expression of EDNRB mrna],,,PMID:25772258,https://www.ncbi.nlm.nih.gov/pubmed/25772258,25772258,,
2706,1452867,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [particulate matter results in increased expression of EDNRB mrna],,,PMID:20561571,https://www.ncbi.nlm.nih.gov/pubmed/20561571,20561571,,
2707,1455749,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),[U 0126 co-treated with SB 203580] inhibits the reaction [[nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased expression of HIF1A protein],,,PMID:20600219,https://www.ncbi.nlm.nih.gov/pubmed/20600219,20600219,,
2708,1455750,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,8091,HMGA2,https://ctdbase.org/detail.go?type=gene&acc=8091,,,8091.0,HMGA2,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HMGA2 mrna],,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
2709,1455751,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [silicon dioxide results in increased expression of HMGB1 protein],,,PMID:27616297,https://www.ncbi.nlm.nih.gov/pubmed/27616297,27616297,,
2710,1456544,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [dieldrin results in increased expression of HMOX1 protein],,,PMID:15770161,https://www.ncbi.nlm.nih.gov/pubmed/15770161,15770161,,
2711,1456545,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [farrerol results in increased expression of HMOX1 protein],,,PMID:26111761,https://www.ncbi.nlm.nih.gov/pubmed/26111761,26111761,,
2712,1456546,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein],,,PMID:23290930,https://www.ncbi.nlm.nih.gov/pubmed/23290930,23290930,,
2713,1456547,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [lipoteichoic acid results in increased expression of HMOX1 protein],,,PMID:23500011,https://www.ncbi.nlm.nih.gov/pubmed/23500011,23500011,,
2714,1456548,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [quercetin analog results in increased expression of HMOX1 mrna],,,PMID:27777014,https://www.ncbi.nlm.nih.gov/pubmed/27777014,27777014,,
2715,1456549,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [quercetin results in increased expression of HMOX1 protein],,,PMID:16171798,https://www.ncbi.nlm.nih.gov/pubmed/16171798,16171798,,
2716,1456550,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [ascorbic acid results in increased expression of HMOX1 protein],,,PMID:23022510,https://www.ncbi.nlm.nih.gov/pubmed/23022510,23022510,,
2717,1456551,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [aureusidin results in increased expression of HMOX1 protein],,,PMID:31790703,https://www.ncbi.nlm.nih.gov/pubmed/31790703,31790703,,
2718,1456552,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [diphenylarsinic acid results in increased expression of HMOX1 protein],,,PMID:28087833,https://www.ncbi.nlm.nih.gov/pubmed/28087833,28087833,,
2719,1458624,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mrna],,,PMID:25352548,https://www.ncbi.nlm.nih.gov/pubmed/25352548,25352548,,
2720,1458625,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein],,,PMID:17388968,https://www.ncbi.nlm.nih.gov/pubmed/17388968,17388968,,
2721,1458626,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK3 protein]|sb 203580 inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein]|sb 203580 inhibits the reaction [IL1B protein results in increased expression of IL6 protein]|sb 203580 inhibits the reaction [IL1B protein results in increased secretion of dinoprostone]|sb 203580 inhibits the reaction [IL1B protein results in decreased expression of TNFRSF11B protein],,,PMID:22727857,https://www.ncbi.nlm.nih.gov/pubmed/22727857,22727857,,
2722,1458627,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [IL1B protein results in increased phosphorylation of FOS protein]|sb 203580 inhibits the reaction [IL1B protein results in increased expression of CXCL8 protein]|sb 203580 inhibits the reaction [IL1B protein results in increased expression of CXCL8 mrna],,,PMID:27393034,https://www.ncbi.nlm.nih.gov/pubmed/27393034,27393034,,
2723,1458628,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [IL1B protein results in increased expression of F3 protein],,,PMID:27556861,https://www.ncbi.nlm.nih.gov/pubmed/27556861,27556861,,
2724,1460062,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),SB 203580 results in decreased secretion of IL6 protein,,,PMID:17196171,https://www.ncbi.nlm.nih.gov/pubmed/17196171,17196171,,
2725,1460063,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),"SB 203580 results in decreased susceptibility to [lipopolysaccharide, escherichia coli O111 B4 results in increased secretion of IL6 protein]",,,PMID:12794122,https://www.ncbi.nlm.nih.gov/pubmed/12794122,12794122,,
2726,1460064,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of IL6 mrna],,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
2727,1460067,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [dextran sulfate results in increased expression of IL6 protein],,,PMID:27920472,https://www.ncbi.nlm.nih.gov/pubmed/27920472,27920472,,
2728,1460068,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [fungal polysaccharides results in increased secretion of IL6 protein],,,PMID:28235615,https://www.ncbi.nlm.nih.gov/pubmed/28235615,28235615,,
2729,1460069,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [IL1B protein results in increased expression of IL6 protein],,,PMID:10704466,https://www.ncbi.nlm.nih.gov/pubmed/10704466,10704466,,
2730,1460070,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [lipopolysaccharides results in increased expression of IL6 protein],,,PMID:29906494,https://www.ncbi.nlm.nih.gov/pubmed/29906494,29906494,,
2731,1463717,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,9261,MAPKAPK2,https://ctdbase.org/detail.go?type=gene&acc=9261,,,9261.0,MAPKAPK2,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [sodium fluoride results in increased phosphorylation of MAPKAPK2 protein],,,PMID:19376214,https://www.ncbi.nlm.nih.gov/pubmed/19376214,19376214,,
2732,1463718,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,9261,MAPKAPK2,https://ctdbase.org/detail.go?type=gene&acc=9261,,,9261.0,MAPKAPK2,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [tretinoin results in increased phosphorylation of MAPKAPK2 protein],,,PMID:30709899,https://www.ncbi.nlm.nih.gov/pubmed/30709899,30709899,,
2733,1463719,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,9261,MAPKAPK2,https://ctdbase.org/detail.go?type=gene&acc=9261,,,9261.0,MAPKAPK2,9606.0,Homo sapiens (human),SB 203580 results in decreased phosphorylation of MAPKAPK2 protein,,,PMID:19376214|PMID:30709899,https://www.ncbi.nlm.nih.gov/pubmed/19376214|https://www.ncbi.nlm.nih.gov/pubmed/30709899,19376214|30709899,,
2734,1463720,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,9261,MAPKAPK2,https://ctdbase.org/detail.go?type=gene&acc=9261,,,9261.0,MAPKAPK2,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [sodium arsenite results in increased activity of MAPKAPK2 protein]|sb 203580 affects the reaction [MAPK14 protein affects the reaction [sodium arsenite results in increased activity of MAPKAPK2 protein]],,,PMID:10704466,https://www.ncbi.nlm.nih.gov/pubmed/10704466,10704466,,
2735,1463916,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,7867,MAPKAPK3,https://ctdbase.org/detail.go?type=gene&acc=7867,,,7867.0,MAPKAPK3,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [sodium arsenite results in increased activity of MAPKAPK3 protein],,,PMID:12547826,https://www.ncbi.nlm.nih.gov/pubmed/12547826,12547826,,
2736,1463917,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [acrolein results in increased phosphorylation of MAPT protein],,,PMID:12605413,https://www.ncbi.nlm.nih.gov/pubmed/12605413,12605413,,
2737,1463918,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [cyanoginosin LR results in increased phosphorylation of MAPT protein],,,PMID:23929704,https://www.ncbi.nlm.nih.gov/pubmed/23929704,23929704,,
2738,1463919,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [cyanoginosin LR results in increased localization of MAPT protein]|sb 203580 inhibits the reaction [cyanoginosin LR results in increased phosphorylation of MAPT protein],,,PMID:22000993,https://www.ncbi.nlm.nih.gov/pubmed/22000993,22000993,,
2739,1463920,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4208,MEF2C,https://ctdbase.org/detail.go?type=gene&acc=4208,,,4208.0,MEF2C,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [icariin results in increased expression of MEF2C mrna]|sb 203580 inhibits the reaction [icariin affects the localization of MEF2C protein],,,PMID:18423597,https://www.ncbi.nlm.nih.gov/pubmed/18423597,18423597,,
2740,1463921,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,9606.0,Homo sapiens (human),[[temozolomide results in decreased susceptibility to temozolomide] which results in increased susceptibility to SB 203580] which results in increased expression of MGMT protein|[temozolomide results in decreased susceptibility to temozolomide] inhibits the reaction [SB 203580 results in decreased expression of MGMT protein]|sb 203580 results in decreased expression of MGMT protein,,,PMID:36176197,https://www.ncbi.nlm.nih.gov/pubmed/36176197,36176197,,
2741,1463922,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,406935,MIR143,https://ctdbase.org/detail.go?type=gene&acc=406935,,,406935.0,MIR143,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [TGFB1 protein results in increased expression of MIR143],,,PMID:21712382,https://www.ncbi.nlm.nih.gov/pubmed/21712382,21712382,,
2742,1464278,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4312,MMP1,https://ctdbase.org/detail.go?type=gene&acc=4312,,,4312.0,MMP1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [SB 203580 results in increased expression of MMP1 mrna]|sb 203580 results in increased expression of MMP1 mRNA,,,PMID:11297530,https://www.ncbi.nlm.nih.gov/pubmed/11297530,11297530,,
2743,1464279,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,9606.0,Homo sapiens (human),SB 203580 analog inhibits the reaction [IL1B results in increased expression of MMP13 mrna],,,PMID:19656660,https://www.ncbi.nlm.nih.gov/pubmed/19656660,19656660,,
2744,1464280,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [S100A4 protein results in increased expression of MMP13 protein],,,PMID:16948116,https://www.ncbi.nlm.nih.gov/pubmed/16948116,16948116,,
2745,1464281,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of MMP13 protein],,,PMID:20004183,https://www.ncbi.nlm.nih.gov/pubmed/20004183,20004183,,
2746,1464282,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of MMP13 mrna],,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
2747,1464283,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [gadolinium chloride results in increased expression of MMP13 mrna],,,PMID:12493575,https://www.ncbi.nlm.nih.gov/pubmed/12493575,12493575,,
2748,1464284,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [halofuginone results in increased expression of MMP13 mrna],,,PMID:16489207,https://www.ncbi.nlm.nih.gov/pubmed/16489207,16489207,,
2749,1464285,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),SB 203580 results in decreased expression of mmp2|brazilein promotes the reaction [SB 203580 results in decreased expression of and results in decreased activity of MMP2 protein]|sb 203580 promotes the reaction [brazilein results in decreased expression of and results in decreased activity of MMP2 protein]|sb 203580 results in decreased expression of and results in decreased activity of MMP2 protein,,,PMID:23707804,https://www.ncbi.nlm.nih.gov/pubmed/23707804,23707804,,
2750,1466210,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [glucose results in increased phosphorylation of NFKBIA protein],,,PMID:19132243,https://www.ncbi.nlm.nih.gov/pubmed/19132243,19132243,,
2751,1466211,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [icariin results in increased phosphorylation of and results in increased degradation of NFKBIA protein],,,PMID:18423597,https://www.ncbi.nlm.nih.gov/pubmed/18423597,18423597,,
2752,1466212,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein],,,PMID:23707484,https://www.ncbi.nlm.nih.gov/pubmed/23707484,23707484,,
2753,1466213,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10116.0,Rattus norvegicus (Norway rat),SB 203580 promotes the reaction [iron results in increased phosphorylation of NFKBIA protein]|sb 203580 promotes the reaction [ferrous sulfate results in increased phosphorylation of NFKBIA protein],,,PMID:17172471,https://www.ncbi.nlm.nih.gov/pubmed/17172471,17172471,,
2754,1466214,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4803,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803.0,NGF,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [pentaacetyl geniposide results in increased expression of NGF mrna]|sb 203580 inhibits the reaction [pentaacetyl geniposide results in increased expression of NGF protein],,,PMID:17651887,https://www.ncbi.nlm.nih.gov/pubmed/17651887,17651887,,
2755,1466215,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4803,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803.0,NGF,10116.0,Rattus norvegicus (Norway rat),SB 203580 results in decreased activity of NGF protein,,,PMID:9733710,https://www.ncbi.nlm.nih.gov/pubmed/9733710,9733710,,
2756,1456384,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,55243,KIRREL1,https://ctdbase.org/detail.go?type=gene&acc=55243,,,55243.0,KIRREL1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KIRREL1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2757,1456385,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4254,KITLG,https://ctdbase.org/detail.go?type=gene&acc=4254,,,4254.0,KITLG,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KITLG mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2758,1456386,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10661,KLF1,https://ctdbase.org/detail.go?type=gene&acc=10661,,,10661.0,KLF1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KLF1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2759,1456387,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,7071,KLF10,https://ctdbase.org/detail.go?type=gene&acc=7071,,,7071.0,KLF10,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KLF10 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2760,1456388,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,28999,KLF15,https://ctdbase.org/detail.go?type=gene&acc=28999,,,28999.0,KLF15,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KLF15 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2761,1456389,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314.0,KLF4,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KLF4 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2762,1456390,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,317719,KLHL10,https://ctdbase.org/detail.go?type=gene&acc=317719,,,317719.0,KLHL10,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KLHL10 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2763,1456996,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,3913,LAMB2,https://ctdbase.org/detail.go?type=gene&acc=3913,,,3913.0,LAMB2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LAMB2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2764,1456997,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,3915,LAMC1,https://ctdbase.org/detail.go?type=gene&acc=3915,,,3915.0,LAMC1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LAMC1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2765,1458497,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4306,NR3C2,https://ctdbase.org/detail.go?type=gene&acc=4306,,,4306.0,NR3C2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NR3C2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2766,1458498,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,3164,NR4A1,https://ctdbase.org/detail.go?type=gene&acc=3164,,,3164.0,NR4A1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NR4A1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2767,1458499,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,8013,NR4A3,https://ctdbase.org/detail.go?type=gene&acc=8013,,,8013.0,NR4A3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NR4A3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2768,1458500,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4798,NFRKB,https://ctdbase.org/detail.go?type=gene&acc=4798,,,4798.0,NFRKB,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NFRKB mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2769,1458501,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4802,NFYC,https://ctdbase.org/detail.go?type=gene&acc=4802,,,4802.0,NFYC,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NFYC mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2770,1458502,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,58157,NGB,https://ctdbase.org/detail.go?type=gene&acc=58157,,,58157.0,NGB,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NGB mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2771,1458503,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4811,NID1,https://ctdbase.org/detail.go?type=gene&acc=4811,,,4811.0,NID1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NID1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2772,1458504,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,60491,NIF3L1,https://ctdbase.org/detail.go?type=gene&acc=60491,,,60491.0,NIF3L1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NIF3L1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2773,1459901,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10651,MTX2,https://ctdbase.org/detail.go?type=gene&acc=10651,,,10651.0,MTX2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MTX2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2774,1459902,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,89853,MVB12B,https://ctdbase.org/detail.go?type=gene&acc=89853,,,89853.0,MVB12B,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MVB12B mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2775,1459903,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4601,MXI1,https://ctdbase.org/detail.go?type=gene&acc=4601,,,4601.0,MXI1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MXI1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2776,1459904,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,54587,MXRA8,https://ctdbase.org/detail.go?type=gene&acc=54587,,,54587.0,MXRA8,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MXRA8 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2777,1459905,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4604,MYBPC1,https://ctdbase.org/detail.go?type=gene&acc=4604,,,4604.0,MYBPC1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MYBPC1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2778,1459906,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MYC mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2779,1459907,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4613,MYCN,https://ctdbase.org/detail.go?type=gene&acc=4613,,,4613.0,MYCN,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MYCN mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2780,1459908,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4624,MYH6,https://ctdbase.org/detail.go?type=gene&acc=4624,,,4624.0,MYH6,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MYH6 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2781,1461159,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,28998,MRPL13,https://ctdbase.org/detail.go?type=gene&acc=28998,,,28998.0,MRPL13,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MRPL13 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2782,1461160,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,63875,MRPL17,https://ctdbase.org/detail.go?type=gene&acc=63875,,,63875.0,MRPL17,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MRPL17 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2783,1461161,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10573,MRPL28,https://ctdbase.org/detail.go?type=gene&acc=10573,,,10573.0,MRPL28,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MRPL28 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2784,1461162,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,26589,MRPL46,https://ctdbase.org/detail.go?type=gene&acc=26589,,,26589.0,MRPL46,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MRPL46 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2785,1461429,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4477,MSMB,https://ctdbase.org/detail.go?type=gene&acc=4477,,,4477.0,MSMB,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MSMB mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2786,1461430,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4482,MSRA,https://ctdbase.org/detail.go?type=gene&acc=4482,,,4482.0,MSRA,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MSRA mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2787,1461431,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,118490,MSS51,https://ctdbase.org/detail.go?type=gene&acc=118490,,,118490.0,MSS51,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MSS51 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2788,1461432,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4487,MSX1,https://ctdbase.org/detail.go?type=gene&acc=4487,,,4487.0,MSX1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MSX1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2789,1461433,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4242,MFNG,https://ctdbase.org/detail.go?type=gene&acc=4242,,,4242.0,MFNG,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MFNG mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2790,1461434,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,64747,MFSD1,https://ctdbase.org/detail.go?type=gene&acc=64747,,,64747.0,MFSD1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MFSD1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2791,1461435,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10227,MFSD10,https://ctdbase.org/detail.go?type=gene&acc=10227,,,10227.0,MFSD10,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MFSD10 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2792,1462027,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,1241,LTB4R,https://ctdbase.org/detail.go?type=gene&acc=1241,,,1241.0,LTB4R,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LTB4R mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2793,1462028,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4052,LTBP1,https://ctdbase.org/detail.go?type=gene&acc=4052,,,4052.0,LTBP1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LTBP1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2794,1462029,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,26046,LTN1,https://ctdbase.org/detail.go?type=gene&acc=26046,,,26046.0,LTN1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LTN1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2795,1462030,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,84946,LTV1,https://ctdbase.org/detail.go?type=gene&acc=84946,,,84946.0,LTV1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LTV1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2796,1462461,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,79917,MAGIX,https://ctdbase.org/detail.go?type=gene&acc=79917,,,79917.0,MAGIX,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MAGIX mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2797,1462462,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10892,MALT1,https://ctdbase.org/detail.go?type=gene&acc=10892,,,10892.0,MALT1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MALT1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2798,1462463,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4121,MAN1A1,https://ctdbase.org/detail.go?type=gene&acc=4121,,,4121.0,MAN1A1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MAN1A1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2799,1462464,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4123,MAN2C1,https://ctdbase.org/detail.go?type=gene&acc=4123,,,4123.0,MAN2C1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MAN2C1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2800,1462465,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,79694,MANEA,https://ctdbase.org/detail.go?type=gene&acc=79694,,,79694.0,MANEA,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MANEA mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2801,1462466,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MAP1LC3B mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2802,1462467,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MAP2K1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2803,1462468,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5605,MAP2K2,https://ctdbase.org/detail.go?type=gene&acc=5605,,,5605.0,MAP2K2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MAP2K2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2804,1463351,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,51586,MED15,https://ctdbase.org/detail.go?type=gene&acc=51586,,,51586.0,MED15,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MED15 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2805,1463352,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,219541,MED19,https://ctdbase.org/detail.go?type=gene&acc=219541,,,219541.0,MED19,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MED19 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2806,1463353,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,9439,MED23,https://ctdbase.org/detail.go?type=gene&acc=9439,,,9439.0,MED23,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MED23 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2807,1463354,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,9862,MED24,https://ctdbase.org/detail.go?type=gene&acc=9862,,,9862.0,MED24,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MED24 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2808,1465239,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,79101,TAF1D,https://ctdbase.org/detail.go?type=gene&acc=79101,,,79101.0,TAF1D,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TAF1D mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2809,1465240,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6873,TAF2,https://ctdbase.org/detail.go?type=gene&acc=6873,,,6873.0,TAF2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TAF2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2810,1465241,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6880,TAF9,https://ctdbase.org/detail.go?type=gene&acc=6880,,,6880.0,TAF9,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TAF9 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2811,1465242,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6876,TAGLN,https://ctdbase.org/detail.go?type=gene&acc=6876,,,6876.0,TAGLN,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TAGLN mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2812,1465243,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,160622,TAMALIN,https://ctdbase.org/detail.go?type=gene&acc=160622,,,160622.0,TAMALIN,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TAMALIN mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2813,1465244,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,57551,TAOK1,https://ctdbase.org/detail.go?type=gene&acc=57551,,,57551.0,TAOK1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in increased expression of TAOK1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2814,1465245,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TARS1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2815,1465246,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,80222,TARS2,https://ctdbase.org/detail.go?type=gene&acc=80222,,,80222.0,TARS2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TARS2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2816,1465247,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,387347,TAS2R118,https://ctdbase.org/detail.go?type=gene&acc=387347,,,387347.0,Tas2r118,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TAS2R118 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2817,1465916,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,11022,TDRKH,https://ctdbase.org/detail.go?type=gene&acc=11022,,,11022.0,TDRKH,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TDRKH mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2818,1465917,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,57451,TENM2,https://ctdbase.org/detail.go?type=gene&acc=57451,,,57451.0,TENM2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TENM2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2819,1465918,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,167153,TENT2,https://ctdbase.org/detail.go?type=gene&acc=167153,,,167153.0,TENT2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TENT2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2820,1465919,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,7011,TEP1,https://ctdbase.org/detail.go?type=gene&acc=7011,,,7011.0,TEP1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of TEP1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2821,1465920,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6755,SSTR5,https://ctdbase.org/detail.go?type=gene&acc=6755,,,6755.0,SSTR5,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SSTR5 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2822,1465921,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6768,ST14,https://ctdbase.org/detail.go?type=gene&acc=6768,,,6768.0,ST14,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of ST14 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2823,1465922,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6484,ST3GAL4,https://ctdbase.org/detail.go?type=gene&acc=6484,,,6484.0,ST3GAL4,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of ST3GAL4 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2824,1465923,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,27090,ST6GALNAC4,https://ctdbase.org/detail.go?type=gene&acc=27090,,,27090.0,ST6GALNAC4,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of ST6GALNAC4 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2825,1465924,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,30815,ST6GALNAC6,https://ctdbase.org/detail.go?type=gene&acc=30815,,,30815.0,ST6GALNAC6,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of ST6GALNAC6 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2826,1470569,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,9197,SLC33A1,https://ctdbase.org/detail.go?type=gene&acc=9197,,,9197.0,SLC33A1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SLC33A1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2827,1470570,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10568,SLC34A2,https://ctdbase.org/detail.go?type=gene&acc=10568,,,10568.0,SLC34A2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SLC34A2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2828,1470571,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,54020,SLC37A1,https://ctdbase.org/detail.go?type=gene&acc=54020,,,54020.0,SLC37A1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SLC37A1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2829,1470572,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,54407,SLC38A2,https://ctdbase.org/detail.go?type=gene&acc=54407,,,54407.0,SLC38A2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SLC38A2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2830,1470573,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,27173,SLC39A1,https://ctdbase.org/detail.go?type=gene&acc=27173,,,27173.0,SLC39A1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SLC39A1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2831,1471627,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,8723,SNX4,https://ctdbase.org/detail.go?type=gene&acc=8723,,,8723.0,SNX4,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SNX4 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2832,1471628,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,51375,SNX7,https://ctdbase.org/detail.go?type=gene&acc=51375,,,51375.0,SNX7,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SNX7 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2833,1472490,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,56963,RGMA,https://ctdbase.org/detail.go?type=gene&acc=56963,,,56963.0,RGMA,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RGMA mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2834,1472491,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10636,RGS14,https://ctdbase.org/detail.go?type=gene&acc=10636,,,10636.0,RGS14,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RGS14 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2835,1472492,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5997,RGS2,https://ctdbase.org/detail.go?type=gene&acc=5997,,,5997.0,RGS2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RGS2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2836,1472493,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,8490,RGS5,https://ctdbase.org/detail.go?type=gene&acc=8490,,,8490.0,RGS5,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RGS5 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2837,1472494,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6005,RHAG,https://ctdbase.org/detail.go?type=gene&acc=6005,,,6005.0,RHAG,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RHAG mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2838,1472495,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,64285,RHBDF1,https://ctdbase.org/detail.go?type=gene&acc=64285,,,64285.0,RHBDF1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RHBDF1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2839,1472496,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,57127,RHBG,https://ctdbase.org/detail.go?type=gene&acc=57127,,,57127.0,RHBG,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RHBG mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2840,1472497,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,388,RHOB,https://ctdbase.org/detail.go?type=gene&acc=388,,,388.0,RHOB,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RHOB mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2841,1472498,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,22836,RHOBTB3,https://ctdbase.org/detail.go?type=gene&acc=22836,,,22836.0,RHOBTB3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RHOBTB3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2842,1473091,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,284996,RNF149,https://ctdbase.org/detail.go?type=gene&acc=284996,,,284996.0,RNF149,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RNF149 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2843,1473979,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,83759,RBM4B,https://ctdbase.org/detail.go?type=gene&acc=83759,,,83759.0,RBM4B,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RBM4B mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2844,1473980,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,9939,RBM8A,https://ctdbase.org/detail.go?type=gene&acc=9939,,,9939.0,RBM8A,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RBM8A mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2845,1473981,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5937,RBMS1,https://ctdbase.org/detail.go?type=gene&acc=5937,,,5937.0,RBMS1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RBMS1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2846,1473982,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,27303,RBMS3,https://ctdbase.org/detail.go?type=gene&acc=27303,,,27303.0,RBMS3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RBMS3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2847,1473983,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,11123,RCAN3,https://ctdbase.org/detail.go?type=gene&acc=11123,,,11123.0,RCAN3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RCAN3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2848,1474764,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5446,PON3,https://ctdbase.org/detail.go?type=gene&acc=5446,,,5446.0,PON3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PON3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2849,1474765,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10775,POP4,https://ctdbase.org/detail.go?type=gene&acc=10775,,,10775.0,POP4,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of POP4 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2850,1474766,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,64091,POPDC2,https://ctdbase.org/detail.go?type=gene&acc=64091,,,64091.0,POPDC2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of POPDC2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2851,1474767,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5453,POU3F1,https://ctdbase.org/detail.go?type=gene&acc=5453,,,5453.0,POU3F1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of POU3F1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2852,1474768,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PPARD mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2853,1474769,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,133522,PPARGC1B,https://ctdbase.org/detail.go?type=gene&acc=133522,,,133522.0,PPARGC1B,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PPARGC1B mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2854,1474770,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5473,PPBP,https://ctdbase.org/detail.go?type=gene&acc=5473,,,5473.0,PPBP,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PPBP mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2855,1474771,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,8496,PPFIBP1,https://ctdbase.org/detail.go?type=gene&acc=8496,,,8496.0,PPFIBP1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PPFIBP1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2856,1474772,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5480,PPIC,https://ctdbase.org/detail.go?type=gene&acc=5480,,,5480.0,PPIC,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PPIC mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2857,1475210,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5770,PTPN1,https://ctdbase.org/detail.go?type=gene&acc=5770,,,5770.0,PTPN1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PTPN1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2858,1475211,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5784,PTPN14,https://ctdbase.org/detail.go?type=gene&acc=5784,,,5784.0,PTPN14,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PTPN14 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2859,1475212,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5771,PTPN2,https://ctdbase.org/detail.go?type=gene&acc=5771,,,5771.0,PTPN2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PTPN2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2860,1475213,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,84867,PTPN5,https://ctdbase.org/detail.go?type=gene&acc=84867,,,84867.0,PTPN5,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PTPN5 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2861,1480313,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5125,PCSK5,https://ctdbase.org/detail.go?type=gene&acc=5125,,,5125.0,PCSK5,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PCSK5 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2862,1480797,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5089,PBX2,https://ctdbase.org/detail.go?type=gene&acc=5089,,,5089.0,PBX2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PBX2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2863,1480798,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5094,PCBP2,https://ctdbase.org/detail.go?type=gene&acc=5094,,,5094.0,PCBP2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PCBP2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2864,1480799,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5097,PCDH1,https://ctdbase.org/detail.go?type=gene&acc=5097,,,5097.0,PCDH1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PCDH1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2865,1480800,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5099,PCDH7,https://ctdbase.org/detail.go?type=gene&acc=5099,,,5099.0,PCDH7,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PCDH7 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2866,1480801,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,56130,PCDHB6,https://ctdbase.org/detail.go?type=gene&acc=56130,,,56130.0,PCDHB6,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PCDHB6 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2867,1481720,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,79447,PAGR1,https://ctdbase.org/detail.go?type=gene&acc=79447,,,79447.0,PAGR1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PAGR1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2868,1481721,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5053,PAH,https://ctdbase.org/detail.go?type=gene&acc=5053,,,5053.0,PAH,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PAH mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2869,1481722,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10606,PAICS,https://ctdbase.org/detail.go?type=gene&acc=10606,,,10606.0,PAICS,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PAICS mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2870,1481723,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10605,PAIP1,https://ctdbase.org/detail.go?type=gene&acc=10605,,,10605.0,PAIP1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PAIP1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2871,1481724,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,51247,PAIP2,https://ctdbase.org/detail.go?type=gene&acc=51247,,,51247.0,PAIP2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PAIP2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2872,1481725,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5063,PAK3,https://ctdbase.org/detail.go?type=gene&acc=5063,,,5063.0,PAK3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PAK3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2873,1481726,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,677884,PAKAP,https://ctdbase.org/detail.go?type=gene&acc=677884,,,677884.0,Pakap,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PAKAP mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2874,1481727,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5064,PALM,https://ctdbase.org/detail.go?type=gene&acc=5064,,,5064.0,PALM,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PALM mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2875,1481728,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,5066,PAM,https://ctdbase.org/detail.go?type=gene&acc=5066,,,5066.0,PAM,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PAM mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2876,1398802,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,25937,WWTR1,https://ctdbase.org/detail.go?type=gene&acc=25937,,,25937.0,WWTR1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of WWTR1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2877,1398803,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,25937,WWTR1,https://ctdbase.org/detail.go?type=gene&acc=25937,,,25937.0,WWTR1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of WWTR1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2878,1398804,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,105463123,XACT,https://ctdbase.org/detail.go?type=gene&acc=105463123,,,105463123.0,XACT,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of XACT intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2879,1398805,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54739,XAF1,https://ctdbase.org/detail.go?type=gene&acc=54739,,,54739.0,XAF1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of XAF1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2880,1398806,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,653220,XAGE1A,https://ctdbase.org/detail.go?type=gene&acc=653220,,,653220.0,XAGE1A,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of XAGE1A gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2881,1398807,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,653067,XAGE1B,https://ctdbase.org/detail.go?type=gene&acc=653067,,,653067.0,XAGE1B,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of XAGE1B gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2882,1431260,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,53405,CLIC5,https://ctdbase.org/detail.go?type=gene&acc=53405,,,53405.0,CLIC5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CLIC5 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2883,1431261,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,53405,CLIC5,https://ctdbase.org/detail.go?type=gene&acc=53405,,,53405.0,CLIC5,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CLIC5 mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
2884,1431262,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54102,CLIC6,https://ctdbase.org/detail.go?type=gene&acc=54102,,,54102.0,CLIC6,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CLIC6 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2885,1431263,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6249,CLIP1,https://ctdbase.org/detail.go?type=gene&acc=6249,,,6249.0,CLIP1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CLIP1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2886,1447650,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,22694,ZFP35,https://ctdbase.org/detail.go?type=gene&acc=22694,,,22694.0,Zfp35,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP35 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2887,1447651,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,140482,ZFP358,https://ctdbase.org/detail.go?type=gene&acc=140482,,,140482.0,Zfp358,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZFP358 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2888,1448847,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7545,ZIC1,https://ctdbase.org/detail.go?type=gene&acc=7545,,,7545.0,ZIC1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZIC1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2889,1448848,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7546,ZIC2,https://ctdbase.org/detail.go?type=gene&acc=7546,,,7546.0,ZIC2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ZIC2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2890,1448849,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84107,ZIC4,https://ctdbase.org/detail.go?type=gene&acc=84107,,,84107.0,ZIC4,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZIC4 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2891,1448850,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,85416,ZIC5,https://ctdbase.org/detail.go?type=gene&acc=85416,,,85416.0,ZIC5,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZIC5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2892,1448851,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23619,ZIM2,https://ctdbase.org/detail.go?type=gene&acc=23619,,,23619.0,ZIM2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZIM2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2893,1448852,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,342357,ZKSCAN2,https://ctdbase.org/detail.go?type=gene&acc=342357,,,342357.0,ZKSCAN2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZKSCAN2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2894,1448853,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,80317,ZKSCAN3,https://ctdbase.org/detail.go?type=gene&acc=80317,,,80317.0,ZKSCAN3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZKSCAN3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2895,1448854,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23660,ZKSCAN5,https://ctdbase.org/detail.go?type=gene&acc=23660,,,23660.0,ZKSCAN5,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZKSCAN5 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2896,1448855,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23660,ZKSCAN5,https://ctdbase.org/detail.go?type=gene&acc=23660,,,23660.0,ZKSCAN5,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZKSCAN5 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2897,1448856,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55888,ZKSCAN7,https://ctdbase.org/detail.go?type=gene&acc=55888,,,55888.0,ZKSCAN7,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZKSCAN7 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2898,1449462,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10127,ZNF263,https://ctdbase.org/detail.go?type=gene&acc=10127,,,10127.0,ZNF263,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ZNF263 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2899,1449463,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10308,ZNF267,https://ctdbase.org/detail.go?type=gene&acc=10308,,,10308.0,ZNF267,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ZNF267 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2900,1449464,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10793,ZNF273,https://ctdbase.org/detail.go?type=gene&acc=10793,,,10793.0,ZNF273,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ZNF273 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2901,1449465,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10782,ZNF274,https://ctdbase.org/detail.go?type=gene&acc=10782,,,10782.0,ZNF274,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZNF274 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2902,1449466,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10838,ZNF275,https://ctdbase.org/detail.go?type=gene&acc=10838,,,10838.0,ZNF275,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZNF275 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2903,1449467,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,11179,ZNF277,https://ctdbase.org/detail.go?type=gene&acc=11179,,,11179.0,ZNF277,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of ZNF277 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2904,1449468,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,11179,ZNF277,https://ctdbase.org/detail.go?type=gene&acc=11179,,,11179.0,ZNF277,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZNF277 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2905,1451599,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,284371,ZNF841,https://ctdbase.org/detail.go?type=gene&acc=284371,,,284371.0,ZNF841,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZNF841 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2906,1451600,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,342892,ZNF850,https://ctdbase.org/detail.go?type=gene&acc=342892,,,342892.0,ZNF850,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ZNF850 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2907,1451601,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,344787,ZNF860,https://ctdbase.org/detail.go?type=gene&acc=344787,,,344787.0,ZNF860,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZNF860 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2908,1451602,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,643641,ZNF862,https://ctdbase.org/detail.go?type=gene&acc=643641,,,643641.0,ZNF862,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZNF862 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2909,1451603,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,284459,ZNF875,https://ctdbase.org/detail.go?type=gene&acc=284459,,,284459.0,ZNF875,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZNF875 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2910,1451604,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,81931,ZNF93,https://ctdbase.org/detail.go?type=gene&acc=81931,,,81931.0,ZNF93,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZNF93 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2911,1451605,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57169,ZNFX1,https://ctdbase.org/detail.go?type=gene&acc=57169,,,57169.0,ZNFX1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ZNFX1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2912,1451606,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57169,ZNFX1,https://ctdbase.org/detail.go?type=gene&acc=57169,,,57169.0,ZNFX1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ZNFX1 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2913,1451607,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57169,ZNFX1,https://ctdbase.org/detail.go?type=gene&acc=57169,,,57169.0,ZNFX1,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZNFX1 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2914,1451608,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55871,ZNG1A,https://ctdbase.org/detail.go?type=gene&acc=55871,,,55871.0,ZNG1A,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZNG1A gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2915,1451609,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,150472,ZNG1B,https://ctdbase.org/detail.go?type=gene&acc=150472,,,150472.0,ZNG1B,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZNG1B gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2916,1452372,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,221302,ZUP1,https://ctdbase.org/detail.go?type=gene&acc=221302,,,221302.0,ZUP1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZUP1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2917,1452373,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9183,ZW10,https://ctdbase.org/detail.go?type=gene&acc=9183,,,9183.0,ZW10,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZW10 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2918,1452374,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9183,ZW10,https://ctdbase.org/detail.go?type=gene&acc=9183,,,9183.0,ZW10,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZW10 gene,,,PMID:28458013,https://www.ncbi.nlm.nih.gov/pubmed/28458013,28458013,,
2919,1452375,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55055,ZWILCH,https://ctdbase.org/detail.go?type=gene&acc=55055,,,55055.0,ZWILCH,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ZWILCH protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2920,1452376,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55055,ZWILCH,https://ctdbase.org/detail.go?type=gene&acc=55055,,,55055.0,ZWILCH,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of ZWILCH mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2921,1475774,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23175,LPIN1,https://ctdbase.org/detail.go?type=gene&acc=23175,,,23175.0,LPIN1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of LPIN1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2922,1475775,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4015,LOX,https://ctdbase.org/detail.go?type=gene&acc=4015,,,4015.0,LOX,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of LOX mRNA,,,PMID:21632981|PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/21641981,21632981|21641981,,
2923,1475776,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4015,LOX,https://ctdbase.org/detail.go?type=gene&acc=4015,,,4015.0,LOX,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of LOX gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2924,1475777,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4016,LOXL1,https://ctdbase.org/detail.go?type=gene&acc=4016,,,4016.0,LOXL1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of LOXL1 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2925,1475778,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4017,LOXL2,https://ctdbase.org/detail.go?type=gene&acc=4017,,,4017.0,LOXL2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of LOXL2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2926,1475779,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84171,LOXL4,https://ctdbase.org/detail.go?type=gene&acc=84171,,,84171.0,LOXL4,9031.0,Gallus gallus (chicken),Aflatoxin B1 results in decreased expression of LOXL4 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
2927,1475780,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84171,LOXL4,https://ctdbase.org/detail.go?type=gene&acc=84171,,,84171.0,LOXL4,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of LOXL4 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2928,1476664,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,145581,LRFN5,https://ctdbase.org/detail.go?type=gene&acc=145581,,,145581.0,LRFN5,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of LRFN5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2929,1476665,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,116844,LRG1,https://ctdbase.org/detail.go?type=gene&acc=116844,,,116844.0,LRG1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of LRG1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2930,1476666,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,116844,LRG1,https://ctdbase.org/detail.go?type=gene&acc=116844,,,116844.0,LRG1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of LRG1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2931,1476667,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26018,LRIG1,https://ctdbase.org/detail.go?type=gene&acc=26018,,,26018.0,LRIG1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of LRIG1 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2932,1476668,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26018,LRIG1,https://ctdbase.org/detail.go?type=gene&acc=26018,,,26018.0,LRIG1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of LRIG1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2933,1476669,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9860,LRIG2,https://ctdbase.org/detail.go?type=gene&acc=9860,,,9860.0,LRIG2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of LRIG2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2934,1477087,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26020,LRP10,https://ctdbase.org/detail.go?type=gene&acc=26020,,,26020.0,LRP10,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of LRP10 mRNA,,,PMID:21632981|PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/21641981,21632981|21641981,,
2935,1477088,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84918,LRP11,https://ctdbase.org/detail.go?type=gene&acc=84918,,,84918.0,LRP11,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of LRP11 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2936,1477089,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84918,LRP11,https://ctdbase.org/detail.go?type=gene&acc=84918,,,84918.0,LRP11,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of LRP11 gene,,,PMID:28458013,https://www.ncbi.nlm.nih.gov/pubmed/28458013,28458013,,
2937,1477090,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,29967,LRP12,https://ctdbase.org/detail.go?type=gene&acc=29967,,,29967.0,LRP12,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of LRP12 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2938,1477091,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,29967,LRP12,https://ctdbase.org/detail.go?type=gene&acc=29967,,,29967.0,LRP12,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of LRP12 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2939,1477092,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,53353,LRP1B,https://ctdbase.org/detail.go?type=gene&acc=53353,,,53353.0,LRP1B,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of LRP1B intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2940,1477093,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,53353,LRP1B,https://ctdbase.org/detail.go?type=gene&acc=53353,,,53353.0,LRP1B,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of LRP1B mRNA,,,PMID:22100608|PMID:31555880|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/31555880|https://www.ncbi.nlm.nih.gov/pubmed/32234424,22100608|31555880|32234424,,
2941,1477094,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,53353,LRP1B,https://ctdbase.org/detail.go?type=gene&acc=53353,,,53353.0,LRP1B,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of LRP1B promoter,,,PMID:31555880,https://www.ncbi.nlm.nih.gov/pubmed/31555880,31555880,,
2942,1477095,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4041,LRP5,https://ctdbase.org/detail.go?type=gene&acc=4041,,,4041.0,LRP5,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of LRP5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2943,1479255,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4057,LTF,https://ctdbase.org/detail.go?type=gene&acc=4057,,,4057.0,LTF,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of LTF mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2944,1479256,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,220064,LTO1,https://ctdbase.org/detail.go?type=gene&acc=220064,,,220064.0,LTO1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of LTO1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2945,1479257,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100506895,LUARIS,https://ctdbase.org/detail.go?type=gene&acc=100506895,,,100506895.0,LUARIS,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of LUARIS mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2946,1479258,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100506895,LUARIS,https://ctdbase.org/detail.go?type=gene&acc=100506895,,,100506895.0,LUARIS,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of LUARIS promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2947,1479259,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51631,LUC7L2,https://ctdbase.org/detail.go?type=gene&acc=51631,,,51631.0,LUC7L2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of LUC7L2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2948,1479260,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51631,LUC7L2,https://ctdbase.org/detail.go?type=gene&acc=51631,,,51631.0,LUC7L2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of LUC7L2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2949,1479261,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51747,LUC7L3,https://ctdbase.org/detail.go?type=gene&acc=51747,,,51747.0,LUC7L3,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of LUC7L3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2950,1479262,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100505994,LUCAT1,https://ctdbase.org/detail.go?type=gene&acc=100505994,,,100505994.0,LUCAT1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of LUCAT1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2951,1481604,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,260425,MAGI3,https://ctdbase.org/detail.go?type=gene&acc=260425,,,260425.0,MAGI3,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of MAGI3 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2952,1481605,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,260425,MAGI3,https://ctdbase.org/detail.go?type=gene&acc=260425,,,260425.0,MAGI3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of MAGI3 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2953,1481606,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,260425,MAGI3,https://ctdbase.org/detail.go?type=gene&acc=260425,,,260425.0,MAGI3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MAGI3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2954,1481607,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4116,MAGOH,https://ctdbase.org/detail.go?type=gene&acc=4116,,,4116.0,MAGOH,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of MAGOH mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2955,1481608,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55110,MAGOHB,https://ctdbase.org/detail.go?type=gene&acc=55110,,,55110.0,MAGOHB,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MAGOHB promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2956,1481865,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,283129,MAJIN,https://ctdbase.org/detail.go?type=gene&acc=283129,,,283129.0,MAJIN,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MAJIN gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2957,1481866,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84549,MAK16,https://ctdbase.org/detail.go?type=gene&acc=84549,,,84549.0,MAK16,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of MAK16 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2958,1481867,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4118,MAL,https://ctdbase.org/detail.go?type=gene&acc=4118,,,4118.0,MAL,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of MAL mRNA,,,PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/25378103,25378103,,
2959,1481868,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,340895,MALRD1,https://ctdbase.org/detail.go?type=gene&acc=340895,,,340895.0,MALRD1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of MALRD1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2960,1481869,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,340895,MALRD1,https://ctdbase.org/detail.go?type=gene&acc=340895,,,340895.0,MALRD1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MALRD1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2961,1481870,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10892,MALT1,https://ctdbase.org/detail.go?type=gene&acc=10892,,,10892.0,MALT1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of MALT1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2962,1481871,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10892,MALT1,https://ctdbase.org/detail.go?type=gene&acc=10892,,,10892.0,MALT1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of MALT1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2963,1447790,262695,BindingDB,"1-Piperidin-1-ylmethyl-1H-indole-2,3-dione",22840,"1-(piperidin-1-ylmethyl)-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22840,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
2964,1447791,262695,BindingDB,"1-Piperidin-1-ylmethyl-1H-indole-2,3-dione",22840,"1-(piperidin-1-ylmethyl)-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22840,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
2965,1447792,262696,BindingDB,"1-Morpholin-4-ylmethyl-1H-indole-2,3-dione",22841,"1-(morpholin-4-ylmethyl)-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22841,8446,Coagulation factor XII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8446,P00748,Coagulation factor XII,2161.0,F12,9606.0,Homo sapiens (human),,Ki (nM),22500,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
2966,1447793,262696,BindingDB,"1-Morpholin-4-ylmethyl-1H-indole-2,3-dione",22841,"1-(morpholin-4-ylmethyl)-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22841,7016,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7016,P23141,Liver carboxylesterase 1,1066.0,CES1,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
2967,1448669,278492,Toxin and Toxin Target Database (T3DB),Nickel(II) bromide,T3D0691,Nickel bromide,http://www.t3db.ca/toxins/T3D0691,BE0002219,Egl nine homolog 3,http://www.t3db.ca/biodb/bio_entities/BE0002219,Q9H6Z9,Prolyl hydroxylase EGLN3,112399.0,EGLN3,9606.0,Homo sapiens (human),"Nickel substitutes for iron in hypoxia-inducible factor prolyl hydroxylases, inhibiting their enzyme activity. this results in the accumulation of hypoxia inducible factor 1 alpha, causing hypoxia-mimic stress. (A109)",,,PMID:19096759,https://www.ncbi.nlm.nih.gov/pubmed/19096759,19096759,,
2968,1448670,278492,Toxin and Toxin Target Database (T3DB),Nickel(II) bromide,T3D0691,Nickel bromide,http://www.t3db.ca/toxins/T3D0691,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000795,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
2969,1448992,278492,Toxin and Toxin Target Database (T3DB),Nickel(II) bromide,T3D0691,Nickel bromide,http://www.t3db.ca/toxins/T3D0691,BE0005155,Histone H2A.J,http://www.t3db.ca/biodb/bio_entities/BE0005155,Q9BTM1,Histone H2A.J,55766.0,H2AJ,9606.0,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
2970,1448993,278492,Toxin and Toxin Target Database (T3DB),Nickel(II) bromide,T3D0691,Nickel bromide,http://www.t3db.ca/toxins/T3D0691,BE0005154,Histone H2A.V,http://www.t3db.ca/biodb/bio_entities/BE0005154,Q71UI9,Histone H2A.V,94239.0,H2AZ2,9606.0,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
2971,1448994,278492,Toxin and Toxin Target Database (T3DB),Nickel(II) bromide,T3D0691,Nickel bromide,http://www.t3db.ca/toxins/T3D0691,BE0005151,Histone H2A.Z,http://www.t3db.ca/biodb/bio_entities/BE0005151,P0C0S5,Histone H2A.Z,3015.0,H2AZ1,9606.0,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
2972,1448995,278492,Toxin and Toxin Target Database (T3DB),Nickel(II) bromide,T3D0691,Nickel bromide,http://www.t3db.ca/toxins/T3D0691,BE0005146,Histone H2A.x,http://www.t3db.ca/biodb/bio_entities/BE0005146,P16104,Histone H2AX,3014.0,H2AX,9606.0,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
2973,1551405,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,9606.0,Homo sapiens (human),Wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased phosphorylation of CREB1 protein],,,PMID:23626723,https://www.ncbi.nlm.nih.gov/pubmed/23626723,23626723,,
2974,1551406,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,9606.0,Homo sapiens (human),Wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of CREB1 protein],,,PMID:15608143,https://www.ncbi.nlm.nih.gov/pubmed/15608143,15608143,,
2975,1551407,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10090.0,Mus musculus (house mouse),Wortmannin inhibits the reaction [resveratrol inhibits the reaction [lipopolysaccharides results in increased phosphorylation of CREB1 protein]],,,PMID:22952890,https://www.ncbi.nlm.nih.gov/pubmed/22952890,22952890,,
2976,1551408,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,9606.0,Homo sapiens (human),Wortmannin inhibits the reaction [vehicle emissions analog results in increased expression of CRP mrna]|wortmannin inhibits the reaction [dust analog results in increased expression of CRP mrna]|wortmannin inhibits the reaction [particulate matter analog results in increased expression of CRP mrna]|wortmannin inhibits the reaction [particulate matter results in increased expression of CRP mrna]|wortmannin inhibits the reaction [dust results in increased expression of CRP mrna]|wortmannin inhibits the reaction [vehicle emissions results in increased expression of CRP mrna],,,PMID:16263508,https://www.ncbi.nlm.nih.gov/pubmed/16263508,16263508,,
2977,1551409,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606.0,Homo sapiens (human),Wortmannin inhibits the reaction [[IL3 protein co-treated with CSF2 protein co-treated with FLT3LG protein co-treated with KITLG protein] results in increased phosphorylation of RPS6 protein]|wortmannin inhibits the reaction [[IL3 protein co-treated with CSF2 protein co-treated with FLT3LG protein co-treated with KITLG protein] results in increased phosphorylation of AKT1 protein]|wortmannin inhibits the reaction [[IL3 protein co-treated with CSF2 protein co-treated with FLT3LG protein co-treated with KITLG protein] results in increased expression of LAT2 protein],,,PMID:23001822,https://www.ncbi.nlm.nih.gov/pubmed/23001822,23001822,,
2978,1551410,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Wortmannin inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CTNNB1 protein],,,PMID:28321046,https://www.ncbi.nlm.nih.gov/pubmed/28321046,28321046,,
2979,1551411,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Wortmannin results in increased phosphorylation of CTNNB1 protein|wortmannin inhibits the reaction [testosterone results in decreased phosphorylation of CTNNB1 protein]|wortmannin inhibits the reaction [hydroxyflutamide results in decreased phosphorylation of CTNNB1 protein],,,PMID:28163245,https://www.ncbi.nlm.nih.gov/pubmed/28163245,28163245,,
2980,1457217,332208,Comparative Toxicogenomics Database (CTD),"2-(3,4,5-Trimethoxyphenyl)-4H-chromen-4-one",C441202,"3',4',5'-trimethoxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C441202,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9823.0,Sus scrofa (pig),"3',4',5'-trimethoxyflavone analog inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 mrna]",,,PMID:26180592,https://www.ncbi.nlm.nih.gov/pubmed/26180592,26180592,,
2981,1457218,332208,Comparative Toxicogenomics Database (CTD),"2-(3,4,5-Trimethoxyphenyl)-4H-chromen-4-one",C441202,"3',4',5'-trimethoxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C441202,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9823.0,Sus scrofa (pig),"3',4',5'-trimethoxyflavone analog inhibits the reaction [lipopolysaccharides results in increased expression of TNF mrna]",,,PMID:26180592,https://www.ncbi.nlm.nih.gov/pubmed/26180592,26180592,,
2982,1457219,334409,Drug Gene Interaction database (DGIdb),"7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine",,CHEMBL:CHEMBL353764,https://www.dgidb.org/drugs/chembl:CHEMBL353764,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606.0,Homo sapiens (human),,,,,,,,
2983,1457220,334409,Drug Gene Interaction database (DGIdb),"7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine",,CHEMBL:CHEMBL353764,https://www.dgidb.org/drugs/chembl:CHEMBL353764,,RAD52,https://www.dgidb.org/genes/hgnc:9824,,,5893.0,RAD52,9606.0,Homo sapiens (human),,,,,,,,
2984,1457221,334409,Drug Gene Interaction database (DGIdb),"7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine",,CHEMBL:CHEMBL353764,https://www.dgidb.org/drugs/chembl:CHEMBL353764,,RAD54L,https://www.dgidb.org/genes/hgnc:9826,,,8438.0,RAD54L,9606.0,Homo sapiens (human),,,,,,,,
2985,1455166,337359,Therapeutic Target Database (TTD),Sorbinil,D02CGC,Sorbinil,https://idrblab.net/ttd/data/drug/details/D02CGC,T26623,Aldose reductase (AKR1B1),https://idrblab.net/ttd/data/target/details/T26623,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2986,1455167,339226,BindingDB,"4-Thiazolidinone, 3-(2-benzothiazolyl)-2-(2-chloro-6-fluorophenyl)-",237342,3-(Benzo[d]thiazol-2-yl)-2-(2-chloro-6-fluorophenyl)thiazolidin-4-one (2),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=237342,239,Gag-Pol polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=239,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,IC50 (nM),>4.0e+4,PMID:22380777|DOI:10.3109/14756366.2011.636362,https://www.ncbi.nlm.nih.gov/pubmed/22380777|https://doi.org/10.3109/14756366.2011.636362,22380777,10.3109/14756366.2011.636362,
2987,1455168,339455,Comparative Toxicogenomics Database (CTD),Pyrazoloacridine,C064541,NSC 366140,https://ctdbase.org/detail.go?type=chem&acc=C064541,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606.0,Homo sapiens (human),XIAP protein results in increased susceptibility to NSC 366140,,,PMID:10815900,https://www.ncbi.nlm.nih.gov/pubmed/10815900,10815900,,
2988,1457222,339455,Drug Gene Interaction database (DGIdb),Pyrazoloacridine,,PYRAZOLOACRIDINE,https://www.dgidb.org/drugs/ncit:C1564,,TOP2A,https://www.dgidb.org/genes/hgnc:11989,,,7153.0,TOP2A,9606.0,Homo sapiens (human),,,,,,,,
2989,1455169,340661,Drug Gene Interaction database (DGIdb),5-Naphthalen-2-yl-3-(5-naphthalen-2-yloxazol-3-yl)oxazole,,CHEMBL:CHEMBL1288106,https://www.dgidb.org/drugs/chembl:CHEMBL1288106,,CYP1A2,https://www.dgidb.org/genes/hgnc:2596,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,,,,,
2990,1455170,344131,Drug Gene Interaction database (DGIdb),"1,2-Naphthalenedione, 4-(phenylamino)-",,CHEMBL:CHEMBL299853,https://www.dgidb.org/drugs/chembl:CHEMBL299853,,ATXN2,https://www.dgidb.org/genes/hgnc:10555,,,6311.0,ATXN2,9606.0,Homo sapiens (human),,,,,,,,
2991,1455171,344131,Drug Gene Interaction database (DGIdb),"1,2-Naphthalenedione, 4-(phenylamino)-",,CHEMBL:CHEMBL299853,https://www.dgidb.org/drugs/chembl:CHEMBL299853,,CASP3,https://www.dgidb.org/genes/hgnc:1504,,,836.0,CASP3,9606.0,Homo sapiens (human),,,,,,,,
2992,1455172,344131,Drug Gene Interaction database (DGIdb),"1,2-Naphthalenedione, 4-(phenylamino)-",,CHEMBL:CHEMBL299853,https://www.dgidb.org/drugs/chembl:CHEMBL299853,,NPSR1,https://www.dgidb.org/genes/hgnc:23631,,,387129.0,NPSR1,9606.0,Homo sapiens (human),,,,,,,,
2993,1457223,346926,Therapeutic Target Database (TTD),"4-(2-Amino-1,3-thiazol-4-yl)phenol",D01KOI,"4-(2-amino-1,3-thiazol-4-yl)phenol",https://idrblab.net/ttd/data/drug/details/D01KOI,T03691,Leukotriene A-4 hydrolase (LTA4H),https://idrblab.net/ttd/data/target/details/T03691,P09960,Leukotriene A-4 hydrolase,4048.0,LTA4H,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2994,1456391,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of CD14 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2995,1456392,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,157313,CDCA2,https://ctdbase.org/detail.go?type=gene&acc=157313,,,157313.0,CDCA2,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of CDCA2 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2996,1456393,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,55143,CDCA8,https://ctdbase.org/detail.go?type=gene&acc=55143,,,55143.0,CDCA8,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of CDCA8 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2997,1456394,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),NSC668394 results in increased expression of CDKN1A mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2998,1459099,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,23645,PPP1R15A,https://ctdbase.org/detail.go?type=gene&acc=23645,,,23645.0,PPP1R15A,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PPP1R15A mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2999,1459100,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,10650,PRELID3A,https://ctdbase.org/detail.go?type=gene&acc=10650,,,10650.0,PRELID3A,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PRELID3A mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3000,1459101,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5558,PRIM2,https://ctdbase.org/detail.go?type=gene&acc=5558,,,5558.0,PRIM2,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PRIM2 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3001,1459102,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,29968,PSAT1,https://ctdbase.org/detail.go?type=gene&acc=29968,,,29968.0,PSAT1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PSAT1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3002,1459103,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5713,PSMD7,https://ctdbase.org/detail.go?type=gene&acc=5713,,,5713.0,PSMD7,10090.0,Mus musculus (house mouse),NSC668394 results in decreased expression of PSMD7 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3003,1459104,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,84722,PSRC1,https://ctdbase.org/detail.go?type=gene&acc=84722,,,84722.0,PSRC1,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of PSRC1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3004,1459105,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5732,PTGER2,https://ctdbase.org/detail.go?type=gene&acc=5732,,,5732.0,PTGER2,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of PTGER2 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3005,1459106,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PTGS2 mrna|ezr protein affects the reaction [NSC668394 results in increased expression of PTGS2 mrna],,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3006,1459441,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,390,RND3,https://ctdbase.org/detail.go?type=gene&acc=390,,,390.0,RND3,9606.0,Homo sapiens (human),NSC668394 results in increased expression of RND3 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3007,1459442,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,26871,RNU1-1,https://ctdbase.org/detail.go?type=gene&acc=26871,,,26871.0,RNU1-1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of RNU1-1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3008,1459443,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,26869,RNU1-3,https://ctdbase.org/detail.go?type=gene&acc=26869,,,26869.0,RNU1-3,9606.0,Homo sapiens (human),NSC668394 results in increased expression of RNU1-3 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3009,1459444,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,26863,RNVU1-18,https://ctdbase.org/detail.go?type=gene&acc=26863,,,26863.0,RNVU1-18,9606.0,Homo sapiens (human),NSC668394 results in increased expression of RNVU1-18 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3010,1459445,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,26864,RNVU1-7,https://ctdbase.org/detail.go?type=gene&acc=26864,,,26864.0,RNVU1-7,9606.0,Homo sapiens (human),NSC668394 results in increased expression of RNVU1-7 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3011,1459446,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,1901,S1PR1,https://ctdbase.org/detail.go?type=gene&acc=1901,,,1901.0,S1PR1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of S1PR1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3012,1459447,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,23753,SDF2L1,https://ctdbase.org/detail.go?type=gene&acc=23753,,,23753.0,SDF2L1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of SDF2L1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3013,1459448,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,23231,SEL1L3,https://ctdbase.org/detail.go?type=gene&acc=23231,,,23231.0,SEL1L3,9606.0,Homo sapiens (human),NSC668394 results in increased expression of SEL1L3 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3014,1459449,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of SERPINE1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3015,1459450,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,56256,SERTAD4,https://ctdbase.org/detail.go?type=gene&acc=56256,,,56256.0,SERTAD4,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of SERTAD4 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3016,1460328,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,7286,TUFT1,https://ctdbase.org/detail.go?type=gene&acc=7286,,,7286.0,TUFT1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of TUFT1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3017,1460329,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296.0,TXNRD1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of TXNRD1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3018,1460330,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,7307,U2AF1,https://ctdbase.org/detail.go?type=gene&acc=7307,,,7307.0,U2AF1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of U2AF1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3019,1460331,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,7328,UBE2H,https://ctdbase.org/detail.go?type=gene&acc=7328,,,7328.0,UBE2H,9606.0,Homo sapiens (human),NSC668394 results in increased expression of UBE2H mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3020,1460332,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,7358,UGDH,https://ctdbase.org/detail.go?type=gene&acc=7358,,,7358.0,UGDH,9606.0,Homo sapiens (human),NSC668394 results in increased expression of UGDH mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3021,1460333,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,80329,ULBP1,https://ctdbase.org/detail.go?type=gene&acc=80329,,,80329.0,ULBP1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of ULBP1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3022,1460334,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,80328,ULBP2,https://ctdbase.org/detail.go?type=gene&acc=80328,,,80328.0,ULBP2,9606.0,Homo sapiens (human),NSC668394 results in increased expression of ULBP2 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3023,1460335,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),NSC668394 results in increased expression of VEGFA mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
3024,1462738,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),ATF3 results in increased susceptibility to bortezomib|bortezomib results in increased expression of ATF3 protein|atf3 mutant form promotes the reaction [bortezomib results in increased expression of PMAIP1 mrna],,,PMID:20022965,https://www.ncbi.nlm.nih.gov/pubmed/20022965,20022965,,
3025,1462739,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Bortezomib results in increased expression of ATF3,,,PMID:21762082,https://www.ncbi.nlm.nih.gov/pubmed/21762082,21762082,,
3026,1462740,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Bortezomib results in increased expression of ATF3 mRNA,,,PMID:17898295,https://www.ncbi.nlm.nih.gov/pubmed/17898295,17898295,,
3027,1462741,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),[BRCA1 mutant form results in increased susceptibility to bortezomib] which results in increased expression of ATF3 mRNA,,,PMID:25522274,https://www.ncbi.nlm.nih.gov/pubmed/25522274,25522274,,
3028,1462742,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,10090.0,Mus musculus (house mouse),Bortezomib results in increased expression of ATF3 protein|bortezomib results in increased expression of ATF3 mRNA,,,PMID:20830808,https://www.ncbi.nlm.nih.gov/pubmed/20830808,20830808,,
3029,1462743,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Bortezomib results in increased activity of ATF3 protein,,,PMID:19164757,https://www.ncbi.nlm.nih.gov/pubmed/19164757,19164757,,
3030,1462744,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,9606.0,Homo sapiens (human),"Bortezomib results in increased expression of ATF4 protein|1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt inhibits the reaction [bortezomib results in increased expression of ATF4 protein]",,,PMID:15509775,https://www.ncbi.nlm.nih.gov/pubmed/15509775,15509775,,
3031,1462745,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,9606.0,Homo sapiens (human),Dactinomycin inhibits the reaction [bortezomib results in increased expression of ATF4 mrna]|atf4 results in decreased susceptibility to bortezomib|nupr1 mutant form promotes the reaction [bortezomib results in increased expression of ATF4 mrna]|atf4 mutant form inhibits the reaction [bortezomib results in increased expression of PMAIP1 mrna]|dactinomycin inhibits the reaction [bortezomib results in increased expression of ATF4 protein]|atf4 mutant form inhibits the reaction [bortezomib results in increased expression of PMAIP1 protein]|bortezomib promotes the reaction [ATF4 protein binds to PMAIP1 promoter],,,PMID:20022965,https://www.ncbi.nlm.nih.gov/pubmed/20022965,20022965,,
3032,1462891,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,8992,ATP6V0E1,https://ctdbase.org/detail.go?type=gene&acc=8992,,,8992.0,ATP6V0E1,9606.0,Homo sapiens (human),Bortezomib results in increased expression of ATP6V0E1 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3033,1462892,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,567,B2M,https://ctdbase.org/detail.go?type=gene&acc=567,,,567.0,B2M,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of B2M protein,,,PMID:17204182,https://www.ncbi.nlm.nih.gov/pubmed/17204182,17204182,,
3034,1449775,390798,Comparative Toxicogenomics Database (CTD),"7,8-Diacetoxy-4-methylcoumarin",C114369,"7,8-diacetoxy-4-methylcoumarin",https://ctdbase.org/detail.go?type=chem&acc=C114369,811,CALR,https://ctdbase.org/detail.go?type=gene&acc=811,,,811.0,CALR,9606.0,Homo sapiens (human),"CALR protein affects the reaction [TNF protein promotes the reaction [7,8-diacetoxy-4-methylcoumarin results in increased abundance of nitric oxide]]|7,8-diacetoxy-4-methylcoumarin results in increased activity of CALR protein",,,PMID:20188080,https://www.ncbi.nlm.nih.gov/pubmed/20188080,20188080,,
3035,1449776,390798,Comparative Toxicogenomics Database (CTD),"7,8-Diacetoxy-4-methylcoumarin",C114369,"7,8-diacetoxy-4-methylcoumarin",https://ctdbase.org/detail.go?type=chem&acc=C114369,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),"7,8-diacetoxy-4-methylcoumarin results in increased activity of CASP3 protein",,,PMID:19061872,https://www.ncbi.nlm.nih.gov/pubmed/19061872,19061872,,
3036,1450147,392622,Drug Gene Interaction database (DGIdb),Ritonavir,,RITONAVIR,https://www.dgidb.org/drugs/rxcui:85762,,UGT1A1,https://www.dgidb.org/genes/hgnc:12530,,,54658.0,UGT1A1,9606.0,Homo sapiens (human),,,,,,,,
3037,1464286,394180,BindingDB,Methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methoxycarbonyl-phenyl)-5-methoxy-5-oxo-pent-1-enyl]-2-methoxy-benzoate,2838,Alkenyldiarylmethane (ADAM) 5c,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2838,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,IC50 (nM),>100000,PMID:10579849|DOI:10.1021/jm990343b,https://www.ncbi.nlm.nih.gov/pubmed/10579849|https://doi.org/10.1021/jm990343b,10579849,10.1021/jm990343b,
3038,1464673,395754,BindingDB,(2S)-2-[[4-[[(2R)-2-amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid,50067584,(S)-2-{[5-((R)-2-Amino-3-mercapto-propylamino)-biphenyl-2-carbonyl]-amino}-4-methylsulfanyl-butyric acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50067584,50004255,Protein farnesyltransferase alpha subunit/subunit beta,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50004255,,,,,,,,IC50 (nM),10.0,PMID:22233543|DOI:10.3109/14756366.2011.643302,https://www.ncbi.nlm.nih.gov/pubmed/22233543|https://doi.org/10.3109/14756366.2011.643302,22233543,10.3109/14756366.2011.643302,
3039,1464669,395769,BindingDB,"6-Azido-3,3-dichloro-4,4-dimethoxy-5,5-bis(methoxycarbonyl)-1,1-diphenyl-1-hexene",2841,"6-Azido-3,3-dichloro-4,4-dimethoxy-5,5-bis(methoxycarbonyl)-1,1-diphenyl-1-hexene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2841,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,IC50 (nM),1300,PMID:10579849|DOI:10.1021/jm990343b,https://www.ncbi.nlm.nih.gov/pubmed/10579849|https://doi.org/10.1021/jm990343b,10579849,10.1021/jm990343b,
3040,1464670,395769,BindingDB,"6-Azido-3,3-dichloro-4,4-dimethoxy-5,5-bis(methoxycarbonyl)-1,1-diphenyl-1-hexene",2841,"6-Azido-3,3-dichloro-4,4-dimethoxy-5,5-bis(methoxycarbonyl)-1,1-diphenyl-1-hexene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2841,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,IC50 (nM),800,PMID:10579849|DOI:10.1021/jm990343b,https://www.ncbi.nlm.nih.gov/pubmed/10579849|https://doi.org/10.1021/jm990343b,10579849,10.1021/jm990343b,
3041,1464671,395770,BindingDB,Methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methoxycarbonyl-phenyl)-6-(ethylcarbamoyloxy)hex-1-enyl]-2-methoxy-benzoate,2842,"5,5-Dichloro-4,4-dimethoxy-5,5-bis(methoxycarbonyl)-6,6-diphenyl-5-hexen-1-yl N-Ethylcarbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2842,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,IC50 (nM),3200,PMID:10579849|DOI:10.1021/jm990343b,https://www.ncbi.nlm.nih.gov/pubmed/10579849|https://doi.org/10.1021/jm990343b,10579849,10.1021/jm990343b,
3042,1464672,395770,BindingDB,Methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methoxycarbonyl-phenyl)-6-(ethylcarbamoyloxy)hex-1-enyl]-2-methoxy-benzoate,2842,"5,5-Dichloro-4,4-dimethoxy-5,5-bis(methoxycarbonyl)-6,6-diphenyl-5-hexen-1-yl N-Ethylcarbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2842,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,IC50 (nM),1200,PMID:10579849|DOI:10.1021/jm990343b,https://www.ncbi.nlm.nih.gov/pubmed/10579849|https://doi.org/10.1021/jm990343b,10579849,10.1021/jm990343b,
3043,1464674,396360,BindingDB,"4,4-Dimethoxy-3,3-di(methoxycarbonyl)-5,5-dimethyl-1,1-diphenyl-1-heptene",2765,"4,4-Dimethoxy-3,3-di(methoxycarbonyl)-5,5-dimethyl-1,1-diphenyl-1-heptene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2765,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,IC50 (nM),1000,PMID:11708913|DOI:10.1021/jm010212m,https://www.ncbi.nlm.nih.gov/pubmed/11708913|https://doi.org/10.1021/jm010212m,11708913,10.1021/jm010212m,
3044,1451921,396412,BindingDB,"2,3-Dimethoxy-7,12-dihydro-9-(trifluoromethyl)indolo[3,2-d][1]benzazepine-6(5H)-one",7270,"2,3-dimethoxy-9-trifluoromethylpaullone",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7270,91,Cyclin-dependent kinase 1/G2/mitotic-specific cyclin-B,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=91,Q9DGD3,Cyclin-dependent kinase 1,100049478.0,cdk1,8090.0,Oryzias latipes (Japanese medaka),,IC50 (nM),280,PMID:10998059|DOI:10.1046/j.1432-1327.2000.01673.x,https://www.ncbi.nlm.nih.gov/pubmed/10998059|https://doi.org/10.1046/j.1432-1327.2000.01673.x,10998059,10.1046/j.1432-1327.2000.01673.x,
3045,1451922,396571,BindingDB,"2-Bromo-9-(trifluoromethyl)-7,12-dihydroindolo[3,2-d][1]benzazepine-6(5H)-one",7298,2-bromo-9-trifluoromethylpaullone,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7298,91,Cyclin-dependent kinase 1/G2/mitotic-specific cyclin-B,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=91,Q9DGD3,Cyclin-dependent kinase 1,100049478.0,cdk1,8090.0,Oryzias latipes (Japanese medaka),,IC50 (nM),240,PMID:10998059|DOI:10.1046/j.1432-1327.2000.01673.x,https://www.ncbi.nlm.nih.gov/pubmed/10998059|https://doi.org/10.1046/j.1432-1327.2000.01673.x,10998059,10.1046/j.1432-1327.2000.01673.x,
3046,1451923,396571,BindingDB,"2-Bromo-9-(trifluoromethyl)-7,12-dihydroindolo[3,2-d][1]benzazepine-6(5H)-one",7298,2-bromo-9-trifluoromethylpaullone,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7298,105,Cyclin-dependent kinase 5 activator 1 [99-307],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=105,Q15078,Cyclin-dependent kinase 5 activator 1,8851.0,CDK5R1,9606.0,Homo sapiens (human),,IC50 (nM),3000,PMID:10998059|DOI:10.1046/j.1432-1327.2000.01673.x,https://www.ncbi.nlm.nih.gov/pubmed/10998059|https://doi.org/10.1046/j.1432-1327.2000.01673.x,10998059,10.1046/j.1432-1327.2000.01673.x,
3047,1451924,396571,BindingDB,"2-Bromo-9-(trifluoromethyl)-7,12-dihydroindolo[3,2-d][1]benzazepine-6(5H)-one",7298,2-bromo-9-trifluoromethylpaullone,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7298,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),2000,PMID:10998059|DOI:10.1046/j.1432-1327.2000.01673.x,https://www.ncbi.nlm.nih.gov/pubmed/10998059|https://doi.org/10.1046/j.1432-1327.2000.01673.x,10998059,10.1046/j.1432-1327.2000.01673.x,
3048,1451925,396572,BindingDB,"8,10-Dichloropaullone",7306,"13,15-dichloro-8,18-diazatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2,4,6,12(17),13,15-heptaen-9-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7306,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),5000,PMID:10998059|DOI:10.1046/j.1432-1327.2000.01673.x,https://www.ncbi.nlm.nih.gov/pubmed/10998059|https://doi.org/10.1046/j.1432-1327.2000.01673.x,10998059,10.1046/j.1432-1327.2000.01673.x,
3049,1451926,396572,BindingDB,"8,10-Dichloropaullone",7306,"13,15-dichloro-8,18-diazatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2,4,6,12(17),13,15-heptaen-9-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7306,105,Cyclin-dependent kinase 5 activator 1 [99-307],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=105,Q15078,Cyclin-dependent kinase 5 activator 1,8851.0,CDK5R1,9606.0,Homo sapiens (human),,IC50 (nM),350000,PMID:10998059|DOI:10.1046/j.1432-1327.2000.01673.x,https://www.ncbi.nlm.nih.gov/pubmed/10998059|https://doi.org/10.1046/j.1432-1327.2000.01673.x,10998059,10.1046/j.1432-1327.2000.01673.x,
3050,1451927,396572,BindingDB,"8,10-Dichloropaullone",7306,"13,15-dichloro-8,18-diazatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2,4,6,12(17),13,15-heptaen-9-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7306,91,Cyclin-dependent kinase 1/G2/mitotic-specific cyclin-B,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=91,Q9DGD3,Cyclin-dependent kinase 1,100049478.0,cdk1,8090.0,Oryzias latipes (Japanese medaka),,IC50 (nM),2500,PMID:10998059|DOI:10.1046/j.1432-1327.2000.01673.x,https://www.ncbi.nlm.nih.gov/pubmed/10998059|https://doi.org/10.1046/j.1432-1327.2000.01673.x,10998059,10.1046/j.1432-1327.2000.01673.x,
3051,1450148,396813,Comparative Toxicogenomics Database (CTD),"4-(5-Fluoro-1,3-benzothiazol-2-yl)-2-methylaniline",C425784,2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole,https://ctdbase.org/detail.go?type=chem&acc=C425784,54905,CYP2W1,https://ctdbase.org/detail.go?type=gene&acc=54905,,,54905.0,CYP2W1,9606.0,Homo sapiens (human),CYP2W1 protein results in increased oxidation of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole|[cyp2w1 protein results in increased oxidation of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole] which results in increased chemical synthesis of hydroxylamine,,,PMID:22734839,https://www.ncbi.nlm.nih.gov/pubmed/22734839,22734839,,
3052,1450149,396813,Comparative Toxicogenomics Database (CTD),"4-(5-Fluoro-1,3-benzothiazol-2-yl)-2-methylaniline",C425784,2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole,https://ctdbase.org/detail.go?type=chem&acc=C425784,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053.0,EPHX2,9606.0,Homo sapiens (human),2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in decreased expression of EPHX2 mRNA,,,PMID:25781201,https://www.ncbi.nlm.nih.gov/pubmed/25781201,25781201,,
3053,1450150,396813,Comparative Toxicogenomics Database (CTD),"4-(5-Fluoro-1,3-benzothiazol-2-yl)-2-methylaniline",C425784,2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole,https://ctdbase.org/detail.go?type=chem&acc=C425784,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606.0,Homo sapiens (human),2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of GPX2 mRNA,,,PMID:25781201,https://www.ncbi.nlm.nih.gov/pubmed/25781201,25781201,,
3054,1464977,404291,Comparative Toxicogenomics Database (CTD),Mequindox,C545385,Mequindox,https://ctdbase.org/detail.go?type=chem&acc=C545385,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116.0,Rattus norvegicus (Norway rat),Mequindox affects the expression of ACE mRNA,,,PMID:20553828,https://www.ncbi.nlm.nih.gov/pubmed/20553828,20553828,,
3055,1464978,404291,Comparative Toxicogenomics Database (CTD),Mequindox,C545385,Mequindox,https://ctdbase.org/detail.go?type=chem&acc=C545385,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),Mequindox results in increased expression of AGT mRNA,,,PMID:20553828,https://www.ncbi.nlm.nih.gov/pubmed/20553828,20553828,,
3056,1464979,404291,Comparative Toxicogenomics Database (CTD),Mequindox,C545385,Mequindox,https://ctdbase.org/detail.go?type=chem&acc=C545385,11607,AGTR1A,https://ctdbase.org/detail.go?type=gene&acc=11607,,,11607.0,Agtr1a,10116.0,Rattus norvegicus (Norway rat),Mequindox results in increased expression of AGTR1A mRNA,,,PMID:20553828,https://www.ncbi.nlm.nih.gov/pubmed/20553828,20553828,,
3057,1464980,404291,Comparative Toxicogenomics Database (CTD),Mequindox,C545385,Mequindox,https://ctdbase.org/detail.go?type=chem&acc=C545385,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10116.0,Rattus norvegicus (Norway rat),Mequindox results in increased expression of AHR mRNA,,,PMID:21377486,https://www.ncbi.nlm.nih.gov/pubmed/21377486,21377486,,
3058,1464981,404291,Comparative Toxicogenomics Database (CTD),Mequindox,C545385,Mequindox,https://ctdbase.org/detail.go?type=chem&acc=C545385,283,ANG,https://ctdbase.org/detail.go?type=gene&acc=283,,,283.0,ANG,10116.0,Rattus norvegicus (Norway rat),Mequindox results in increased expression of ANG mRNA,,,PMID:20553828,https://www.ncbi.nlm.nih.gov/pubmed/20553828,20553828,,
3059,1450798,408043,Drug Gene Interaction database (DGIdb),"1-[3-(2,5-Dichlorophenyl)sulfanylpropyl]piperazine",,CHEMBL:CHEMBL189724,https://www.dgidb.org/drugs/chembl:CHEMBL189724,,CYP1A2,https://www.dgidb.org/genes/hgnc:2596,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,,,,,
3060,1389697,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1299,COL9A3,https://ctdbase.org/detail.go?type=gene&acc=1299,,,1299.0,COL9A3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of COL9A3 mRNA,,,PMID:23179753|PMID:26272509|PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/34089799,23179753|26272509|34089799,,
3061,1389698,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1299,COL9A3,https://ctdbase.org/detail.go?type=gene&acc=1299,,,1299.0,COL9A3,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL9A3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3062,1389699,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,81035,COLEC12,https://ctdbase.org/detail.go?type=gene&acc=81035,,,81035.0,COLEC12,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of COLEC12 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3063,1389700,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,81035,COLEC12,https://ctdbase.org/detail.go?type=gene&acc=81035,,,81035.0,COLEC12,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of COLEC12 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
3064,1389701,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51122,COMMD2,https://ctdbase.org/detail.go?type=gene&acc=51122,,,51122.0,COMMD2,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of COMMD2 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3065,1389702,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51122,COMMD2,https://ctdbase.org/detail.go?type=gene&acc=51122,,,51122.0,COMMD2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of COMMD2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3066,1389703,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,54939,COMMD4,https://ctdbase.org/detail.go?type=gene&acc=54939,,,54939.0,COMMD4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of COMMD4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3067,1389704,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,185428,COMP-1,https://ctdbase.org/detail.go?type=gene&acc=185428,,,185428.0,comp-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of COMP-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3068,1395747,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23406,COTL1,https://ctdbase.org/detail.go?type=gene&acc=23406,,,23406.0,COTL1,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3069,1395748,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4512,COX1,https://ctdbase.org/detail.go?type=gene&acc=4512,,,4512.0,COX1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of COX1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3070,1447794,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,7262,PHLDA2,https://ctdbase.org/detail.go?type=gene&acc=7262,,,7262.0,PHLDA2,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3071,1447795,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23612,PHLDA3,https://ctdbase.org/detail.go?type=gene&acc=23612,,,23612.0,PHLDA3,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of PHLDA3 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3072,1447796,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,493911,PHOSPHO2,https://ctdbase.org/detail.go?type=gene&acc=493911,,,493911.0,PHOSPHO2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PHOSPHO2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3073,1447797,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,35322,PHR6-4,https://ctdbase.org/detail.go?type=gene&acc=35322,,,35322.0,phr6-4,7227.0,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of PHR6-4 mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
3074,1447798,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,57157,PHTF2,https://ctdbase.org/detail.go?type=gene&acc=57157,,,57157.0,PHTF2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PHTF2 mrna|methylmercuric chloride results in increased expression of PHTF2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3075,1447799,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,32857,PHTM,https://ctdbase.org/detail.go?type=gene&acc=32857,,,32857.0,phtm,7227.0,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of PHTM mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
3076,1448660,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23236,PLCB1,https://ctdbase.org/detail.go?type=gene&acc=23236,,,23236.0,PLCB1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PLCB1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3077,1448661,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5332,PLCB4,https://ctdbase.org/detail.go?type=gene&acc=5332,,,5332.0,PLCB4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PLCB4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3078,1448662,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23007,PLCH1,https://ctdbase.org/detail.go?type=gene&acc=23007,,,23007.0,PLCH1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PLCH1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3079,1448663,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23228,PLCL2,https://ctdbase.org/detail.go?type=gene&acc=23228,,,23228.0,PLCL2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PLCL2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3080,1448664,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,257068,PLCXD2,https://ctdbase.org/detail.go?type=gene&acc=257068,,,257068.0,PLCXD2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PLCXD2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3081,1448665,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5338,PLD2,https://ctdbase.org/detail.go?type=gene&acc=5338,,,5338.0,PLD2,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of PLD2 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3082,1448666,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,200150,PLD5,https://ctdbase.org/detail.go?type=gene&acc=200150,,,200150.0,PLD5,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PLD5 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3083,1448667,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,201164,PLD6,https://ctdbase.org/detail.go?type=gene&acc=201164,,,201164.0,PLD6,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of PLD6 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3084,1448668,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,22874,PLEKHA6,https://ctdbase.org/detail.go?type=gene&acc=22874,,,22874.0,PLEKHA6,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of PLEKHA6 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3085,1448985,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,54886,PLPPR1,https://ctdbase.org/detail.go?type=gene&acc=54886,,,54886.0,PLPPR1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of PLPPR1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3086,1448986,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9890,PLPPR4,https://ctdbase.org/detail.go?type=gene&acc=9890,,,9890.0,PLPPR4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PLPPR4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3087,1448987,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174710,PLPR-1,https://ctdbase.org/detail.go?type=gene&acc=174710,,,174710.0,plpr-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of PLPR-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3088,1448988,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5357,PLS1,https://ctdbase.org/detail.go?type=gene&acc=5357,,,5357.0,PLS1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PLS1 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3089,1448989,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5358,PLS3,https://ctdbase.org/detail.go?type=gene&acc=5358,,,5358.0,PLS3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of PLS3 mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
3090,1448990,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5359,PLSCR1,https://ctdbase.org/detail.go?type=gene&acc=5359,,,5359.0,PLSCR1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PLSCR1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3091,1448991,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,57125,PLXDC1,https://ctdbase.org/detail.go?type=gene&acc=57125,,,57125.0,PLXDC1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of PLXDC1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3092,1453697,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,83716,CRISPLD2,https://ctdbase.org/detail.go?type=gene&acc=83716,,,83716.0,CRISPLD2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of CRISPLD2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3093,1453698,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9244,CRLF1,https://ctdbase.org/detail.go?type=gene&acc=9244,,,9244.0,CRLF1,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of CRLF1 mRNA,,,PMID:31378766,https://www.ncbi.nlm.nih.gov/pubmed/31378766,31378766,,
3094,1453699,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,436923,CRLF1A,https://ctdbase.org/detail.go?type=gene&acc=436923,,,436923.0,crlf1a,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of CRLF1A mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3095,1455441,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,179823,CUT-2,https://ctdbase.org/detail.go?type=gene&acc=179823,,,179823.0,cut-2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUT-2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3096,1455442,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174347,CUT-3,https://ctdbase.org/detail.go?type=gene&acc=174347,,,174347.0,cut-3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUT-3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3097,1455443,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,187677,CUT-5,https://ctdbase.org/detail.go?type=gene&acc=187677,,,187677.0,cut-5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUT-5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3098,1455444,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,253039,CUTALP,https://ctdbase.org/detail.go?type=gene&acc=253039,,,253039.0,CUTALP,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CUTALP mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3099,1455445,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188066,CUTL-11,https://ctdbase.org/detail.go?type=gene&acc=188066,,,188066.0,cutl-11,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUTL-11 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3100,1455446,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,171637,CUTL-13,https://ctdbase.org/detail.go?type=gene&acc=171637,,,171637.0,cutl-13,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUTL-13 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3101,1455923,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51503,CWC15,https://ctdbase.org/detail.go?type=gene&acc=51503,,,51503.0,CWC15,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of CWC15 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3102,1455924,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10283,CWC27,https://ctdbase.org/detail.go?type=gene&acc=10283,,,10283.0,CWC27,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of CWC27 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3103,1456553,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1528,CYB5A,https://ctdbase.org/detail.go?type=gene&acc=1528,,,1528.0,CYB5A,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CYB5A mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3104,1456554,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80777,CYB5B,https://ctdbase.org/detail.go?type=gene&acc=80777,,,80777.0,CYB5B,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CYB5B mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3105,1458216,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51571,CYRIB,https://ctdbase.org/detail.go?type=gene&acc=51571,,,51571.0,CYRIB,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CYRIB mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3106,1458217,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,259617,CYSL-3,https://ctdbase.org/detail.go?type=gene&acc=259617,,,259617.0,cysl-3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CYSL-3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3107,1458218,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186587,CYSL-4,https://ctdbase.org/detail.go?type=gene&acc=186587,,,186587.0,cysl-4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of CYSL-4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3108,1458219,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,183954,D2062.4,https://ctdbase.org/detail.go?type=gene&acc=183954,,,183954.0,D2062.4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of D2062.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3109,1458220,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84418,CYSTM1,https://ctdbase.org/detail.go?type=gene&acc=84418,,,84418.0,CYSTM1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CYSTM1 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3110,1458786,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23002,DAAM1,https://ctdbase.org/detail.go?type=gene&acc=23002,,,23002.0,DAAM1,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of DAAM1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3111,1458787,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23002,DAAM1,https://ctdbase.org/detail.go?type=gene&acc=23002,,,23002.0,DAAM1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DAAM1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3112,1458986,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174561,F52H3.6,https://ctdbase.org/detail.go?type=gene&acc=174561,,,174561.0,F52H3.6,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F52H3.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3113,1458987,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181117,F53A9.3,https://ctdbase.org/detail.go?type=gene&acc=181117,,,181117.0,F53A9.3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F53A9.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3114,1458988,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181118,F53A9.8,https://ctdbase.org/detail.go?type=gene&acc=181118,,,181118.0,F53A9.8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F53A9.8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3115,1459898,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,780,DDR1,https://ctdbase.org/detail.go?type=gene&acc=780,,,780.0,DDR1,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride affects the expression of DDR1 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
3116,1459899,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4921,DDR2,https://ctdbase.org/detail.go?type=gene&acc=4921,,,4921.0,DDR2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of DDR2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3117,1459900,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1653,DDX1,https://ctdbase.org/detail.go?type=gene&acc=1653,,,1653.0,DDX1,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of DDX1 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3118,1460071,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186398,F56F4.3,https://ctdbase.org/detail.go?type=gene&acc=186398,,,186398.0,F56F4.3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F56F4.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3119,1460072,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186411,F56H1.3,https://ctdbase.org/detail.go?type=gene&acc=186411,,,186411.0,F56H1.3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F56H1.3 mrna|f56h1.3 protein results in increased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3120,1460073,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186412,F56H6.1,https://ctdbase.org/detail.go?type=gene&acc=186412,,,186412.0,F56H6.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F56H6.1 mrna|f56h6.1 protein results in increased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3121,1460074,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186413,F56H6.2,https://ctdbase.org/detail.go?type=gene&acc=186413,,,186413.0,F56H6.2,6239.0,Caenorhabditis elegans,F56H6.2 protein results in decreased susceptibility to methylmercuric chloride|methylmercuric chloride results in increased expression of F56H6.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3122,1460075,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,179805,F57B1.6,https://ctdbase.org/detail.go?type=gene&acc=179805,,,179805.0,F57B1.6,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F57B1.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3123,1460076,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186440,F57B9.3,https://ctdbase.org/detail.go?type=gene&acc=186440,,,186440.0,F57B9.3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F57B9.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3124,1460077,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,175967,F57B9.8,https://ctdbase.org/detail.go?type=gene&acc=175967,,,175967.0,F57B9.8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F57B9.8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3125,1460484,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186542,F58G1.9,https://ctdbase.org/detail.go?type=gene&acc=186542,,,186542.0,F58G1.9,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F58G1.9 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3126,1460485,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,179635,F58H1.5,https://ctdbase.org/detail.go?type=gene&acc=179635,,,179635.0,F58H1.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F58H1.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3127,1461436,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,175108,DHS-8,https://ctdbase.org/detail.go?type=gene&acc=175108,,,175108.0,dhs-8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of DHS-8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3128,1461437,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,90957,DHX57,https://ctdbase.org/detail.go?type=gene&acc=90957,,,90957.0,DHX57,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DHX57 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3129,1461438,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1659,DHX8,https://ctdbase.org/detail.go?type=gene&acc=1659,,,1659.0,DHX8,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of DHX8 mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
3130,1461439,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1660,DHX9,https://ctdbase.org/detail.go?type=gene&acc=1660,,,1660.0,DHX9,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of DHX9 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
3131,1462031,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1742,DLG4,https://ctdbase.org/detail.go?type=gene&acc=1742,,,1742.0,DLG4,9483.0,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride results in increased expression of DLG4 protein,,,PMID:27012723,https://www.ncbi.nlm.nih.gov/pubmed/27012723,27012723,,
3132,1462032,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,649446,DLGAP1-AS1,https://ctdbase.org/detail.go?type=gene&acc=649446,,,649446.0,DLGAP1-AS1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of DLGAP1-AS1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3133,1462033,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84777,DLGAP1-AS2,https://ctdbase.org/detail.go?type=gene&acc=84777,,,84777.0,DLGAP1-AS2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of DLGAP1-AS2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3134,1462034,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,22839,DLGAP4,https://ctdbase.org/detail.go?type=gene&acc=22839,,,22839.0,DLGAP4,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of DLGAP4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3135,1462035,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188808,DLHD-1,https://ctdbase.org/detail.go?type=gene&acc=188808,,,188808.0,dlhd-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of DLHD-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3136,1462036,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8788,DLK1,https://ctdbase.org/detail.go?type=gene&acc=8788,,,8788.0,DLK1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of DLK1 mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
3137,1462037,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,28514,DLL1,https://ctdbase.org/detail.go?type=gene&acc=28514,,,28514.0,DLL1,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of DLL1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3138,1463205,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23549,DNPEP,https://ctdbase.org/detail.go?type=gene&acc=23549,,,23549.0,DNPEP,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of DNPEP mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3139,1463206,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1793,DOCK1,https://ctdbase.org/detail.go?type=gene&acc=1793,,,1793.0,DOCK1,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of DOCK1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3140,1463207,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9732,DOCK4,https://ctdbase.org/detail.go?type=gene&acc=9732,,,9732.0,DOCK4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DOCK4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3141,1463344,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188182,FBXA-199,https://ctdbase.org/detail.go?type=gene&acc=188182,,,188182.0,fbxa-199,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of FBXA-199 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3142,1463345,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189038,FBXA-202,https://ctdbase.org/detail.go?type=gene&acc=189038,,,189038.0,fbxa-202,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of FBXA-202 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3143,1463346,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189629,FBXA-211,https://ctdbase.org/detail.go?type=gene&acc=189629,,,189629.0,fbxa-211,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of FBXA-211 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3144,1463347,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,190002,FBXA-217,https://ctdbase.org/detail.go?type=gene&acc=190002,,,190002.0,fbxa-217,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of FBXA-217 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3145,1463348,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176670,FBXA-218,https://ctdbase.org/detail.go?type=gene&acc=176670,,,176670.0,fbxa-218,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of FBXA-218 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3146,1463349,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,190489,FBXA-220,https://ctdbase.org/detail.go?type=gene&acc=190489,,,190489.0,fbxa-220,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXA-220 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3147,1463350,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191196,FBXA-223,https://ctdbase.org/detail.go?type=gene&acc=191196,,,191196.0,fbxa-223,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of FBXA-223 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3148,1463665,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,22845,DOLK,https://ctdbase.org/detail.go?type=gene&acc=22845,,,22845.0,DOLK,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of DOLK mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3149,1463666,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23033,DOP1A,https://ctdbase.org/detail.go?type=gene&acc=23033,,,23033.0,DOP1A,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DOP1A mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3150,1463667,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186905,DOS-3,https://ctdbase.org/detail.go?type=gene&acc=186905,,,186905.0,dos-3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of DOS-3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3151,1463668,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186332,DOT-1.4,https://ctdbase.org/detail.go?type=gene&acc=186332,,,186332.0,dot-1.4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of DOT-1.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3152,1463669,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,25911,DPCD,https://ctdbase.org/detail.go?type=gene&acc=25911,,,25911.0,DPCD,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DPCD mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3153,1463670,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51611,DPH5,https://ctdbase.org/detail.go?type=gene&acc=51611,,,51611.0,DPH5,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DPH5 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3154,1463671,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,89978,DPH6,https://ctdbase.org/detail.go?type=gene&acc=89978,,,89978.0,DPH6,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DPH6 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3155,1463672,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,54344,DPM3,https://ctdbase.org/detail.go?type=gene&acc=54344,,,54344.0,DPM3,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DPM3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3156,1463673,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,57628,DPP10,https://ctdbase.org/detail.go?type=gene&acc=57628,,,57628.0,DPP10,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DPP10 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3157,1463855,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,29952,DPP7,https://ctdbase.org/detail.go?type=gene&acc=29952,,,29952.0,DPP7,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DPP7 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3158,1463856,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,54878,DPP8,https://ctdbase.org/detail.go?type=gene&acc=54878,,,54878.0,DPP8,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of DPP8 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3159,1463857,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,151871,DPPA2,https://ctdbase.org/detail.go?type=gene&acc=151871,,,151871.0,DPPA2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of DPPA2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3160,1463858,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55211,DPPA4,https://ctdbase.org/detail.go?type=gene&acc=55211,,,55211.0,DPPA4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DPPA4 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3161,1463859,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,172410,DPY-14,https://ctdbase.org/detail.go?type=gene&acc=172410,,,172410.0,dpy-14,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of DPY-14 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3162,1463860,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,175696,DPY-17,https://ctdbase.org/detail.go?type=gene&acc=175696,,,175696.0,dpy-17,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of DPY-17 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3163,1463861,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,283417,DPY19L2,https://ctdbase.org/detail.go?type=gene&acc=283417,,,283417.0,DPY19L2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DPY19L2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3164,1464154,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184178,FBXB-105,https://ctdbase.org/detail.go?type=gene&acc=184178,,,184178.0,fbxb-105,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-105 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3165,1464155,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173619,FBXB-107,https://ctdbase.org/detail.go?type=gene&acc=173619,,,173619.0,fbxb-107,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-107 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3166,1464156,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184177,FBXB-108,https://ctdbase.org/detail.go?type=gene&acc=184177,,,184177.0,fbxb-108,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-108 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3167,1464157,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173623,FBXB-111,https://ctdbase.org/detail.go?type=gene&acc=173623,,,173623.0,fbxb-111,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-111 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3168,1464158,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,183048,FBXB-114,https://ctdbase.org/detail.go?type=gene&acc=183048,,,183048.0,fbxb-114,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-114 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3169,1464159,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188949,FBXB-116,https://ctdbase.org/detail.go?type=gene&acc=188949,,,188949.0,fbxb-116,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-116 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3170,1464160,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186289,FBXB-117,https://ctdbase.org/detail.go?type=gene&acc=186289,,,186289.0,fbxb-117,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-117 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3171,1464161,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173535,FBXB-15,https://ctdbase.org/detail.go?type=gene&acc=173535,,,173535.0,fbxb-15,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-15 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3172,1464162,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186510,FBXB-17,https://ctdbase.org/detail.go?type=gene&acc=186510,,,186510.0,fbxb-17,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-17 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3173,1464163,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186514,FBXB-19,https://ctdbase.org/detail.go?type=gene&acc=186514,,,186514.0,fbxb-19,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-19 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3174,1464522,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176852,DSC-4,https://ctdbase.org/detail.go?type=gene&acc=176852,,,176852.0,dsc-4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of DSC-4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3175,1464523,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,92126,DSEL,https://ctdbase.org/detail.go?type=gene&acc=92126,,,92126.0,DSEL,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of DSEL mrna|methylmercuric chloride results in decreased expression of DSEL mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3176,1464524,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,13510,DSG1A,https://ctdbase.org/detail.go?type=gene&acc=13510,,,13510.0,Dsg1a,10090.0,Mus musculus (house mouse),Methylmercuric chloride results in decreased expression of DSG1A mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
3177,1464525,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1829,DSG2,https://ctdbase.org/detail.go?type=gene&acc=1829,,,1829.0,DSG2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DSG2 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3178,1464526,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173894,DSH-1,https://ctdbase.org/detail.go?type=gene&acc=173894,,,173894.0,dsh-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of DSH-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3179,1464527,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176939,DSL-1,https://ctdbase.org/detail.go?type=gene&acc=176939,,,176939.0,dsl-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of DSL-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3180,1464528,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176938,DSL-2,https://ctdbase.org/detail.go?type=gene&acc=176938,,,176938.0,dsl-2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of DSL-2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3181,1464529,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176970,DSL-3,https://ctdbase.org/detail.go?type=gene&acc=176970,,,176970.0,dsl-3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of DSL-3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3182,1464530,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178063,DSL-6,https://ctdbase.org/detail.go?type=gene&acc=178063,,,178063.0,dsl-6,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of DSL-6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3183,1465906,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6605,SMARCE1,https://ctdbase.org/detail.go?type=gene&acc=6605,,,6605.0,SMARCE1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SMARCE1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3184,1465907,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6605,SMARCE1,https://ctdbase.org/detail.go?type=gene&acc=6605,,,6605.0,SMARCE1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SMARCE1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3185,1465908,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9126,SMC3,https://ctdbase.org/detail.go?type=gene&acc=9126,,,9126.0,SMC3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SMC3 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3186,1465909,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,79677,SMC6,https://ctdbase.org/detail.go?type=gene&acc=79677,,,79677.0,SMC6,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of SMC6 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3187,1465910,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,140775,SMCR8,https://ctdbase.org/detail.go?type=gene&acc=140775,,,140775.0,SMCR8,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SMCR8 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3188,1465911,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,140775,SMCR8,https://ctdbase.org/detail.go?type=gene&acc=140775,,,140775.0,SMCR8,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SMCR8 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
3189,1465912,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,140775,SMCR8,https://ctdbase.org/detail.go?type=gene&acc=140775,,,140775.0,SMCR8,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMCR8 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3190,1465913,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100380293,SMEK2,https://ctdbase.org/detail.go?type=gene&acc=100380293,,,100380293.0,,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SMEK2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3191,1465914,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23049,SMG1,https://ctdbase.org/detail.go?type=gene&acc=23049,,,23049.0,SMG1,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of SMG1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3192,1465915,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23049,SMG1,https://ctdbase.org/detail.go?type=gene&acc=23049,,,23049.0,SMG1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SMG1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
3193,1466074,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100129361,SMIM10L1,https://ctdbase.org/detail.go?type=gene&acc=100129361,,,100129361.0,SMIM10L1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SMIM10L1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3194,1466075,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,201895,SMIM14,https://ctdbase.org/detail.go?type=gene&acc=201895,,,201895.0,SMIM14,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of SMIM14 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3195,1466076,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100129250,SMIM27,https://ctdbase.org/detail.go?type=gene&acc=100129250,,,100129250.0,SMIM27,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SMIM27 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3196,1466077,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,85027,SMIM3,https://ctdbase.org/detail.go?type=gene&acc=85027,,,85027.0,SMIM3,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SMIM3 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3197,1466078,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,132332,SMIM43,https://ctdbase.org/detail.go?type=gene&acc=132332,,,132332.0,SMIM43,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SMIM43 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3198,1466079,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,57150,SMIM8,https://ctdbase.org/detail.go?type=gene&acc=57150,,,57150.0,SMIM8,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SMIM8 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3199,1466080,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100287482,SMKR1,https://ctdbase.org/detail.go?type=gene&acc=100287482,,,100287482.0,SMKR1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SMKR1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3200,1466081,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,64093,SMOC1,https://ctdbase.org/detail.go?type=gene&acc=64093,,,64093.0,SMOC1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SMOC1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3201,1466091,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2222,FDFT1,https://ctdbase.org/detail.go?type=gene&acc=2222,,,2222.0,FDFT1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of FDFT1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3202,1466092,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2230,FDX1,https://ctdbase.org/detail.go?type=gene&acc=2230,,,2230.0,FDX1,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of FDX1 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
3203,1466093,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10116,FEM1B,https://ctdbase.org/detail.go?type=gene&acc=10116,,,10116.0,FEM1B,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of FEM1B mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3204,1466094,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2241,FER,https://ctdbase.org/detail.go?type=gene&acc=2241,,,2241.0,FER,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of FER mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3205,1466216,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of EDNRA mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3206,1466217,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of EDNRB mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
3207,1466218,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8726,EED,https://ctdbase.org/detail.go?type=gene&acc=8726,,,8726.0,EED,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of EED mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3208,1466219,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173922,EEED8.12,https://ctdbase.org/detail.go?type=gene&acc=173922,,,173922.0,EEED8.12,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of EEED8.12 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3209,1466220,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173924,EEED8.15,https://ctdbase.org/detail.go?type=gene&acc=173924,,,173924.0,EEED8.15,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of EEED8.15 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3210,1466221,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173923,EEED8.2,https://ctdbase.org/detail.go?type=gene&acc=173923,,,173923.0,EEED8.2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of EEED8.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3211,1466222,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1915,EEF1A1,https://ctdbase.org/detail.go?type=gene&acc=1915,,,1915.0,EEF1A1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of EEF1A1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3212,1466223,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,196483,EEF2KMT,https://ctdbase.org/detail.go?type=gene&acc=196483,,,196483.0,EEF2KMT,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of EEF2KMT mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3213,1466224,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,284611,EEIG2,https://ctdbase.org/detail.go?type=gene&acc=284611,,,284611.0,EEIG2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of EEIG2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3214,1466225,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100130771,EFCAB10,https://ctdbase.org/detail.go?type=gene&acc=100130771,,,100130771.0,EFCAB10,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of EFCAB10 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3215,1466438,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9892,SNAP91,https://ctdbase.org/detail.go?type=gene&acc=9892,,,9892.0,SNAP91,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SNAP91 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3216,1466439,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6617,SNAPC1,https://ctdbase.org/detail.go?type=gene&acc=6617,,,6617.0,SNAPC1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SNAPC1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3217,1466440,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6619,SNAPC3,https://ctdbase.org/detail.go?type=gene&acc=6619,,,6619.0,SNAPC3,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SNAPC3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3218,1466441,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23557,SNAPIN,https://ctdbase.org/detail.go?type=gene&acc=23557,,,23557.0,SNAPIN,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SNAPIN mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3219,1466442,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84455,EFCAB7,https://ctdbase.org/detail.go?type=gene&acc=84455,,,84455.0,EFCAB7,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of EFCAB7 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3220,1466443,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2202,EFEMP1,https://ctdbase.org/detail.go?type=gene&acc=2202,,,2202.0,EFEMP1,10116.0,Rattus norvegicus (Norway rat),"[hydrocarbons, chlorinated co-treated with polychlorinated biphenyls co-treated with methylmercuric chloride] results in increased expression of EFEMP1 mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
3221,1466444,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,30008,EFEMP2,https://ctdbase.org/detail.go?type=gene&acc=30008,,,30008.0,EFEMP2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of EFEMP2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3222,1466445,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174334,EFF-1,https://ctdbase.org/detail.go?type=gene&acc=174334,,,174334.0,eff-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of EFF-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3223,1466446,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,151651,EFHB,https://ctdbase.org/detail.go?type=gene&acc=151651,,,151651.0,EFHB,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of EFHB mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3224,1466447,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,114327,EFHC1,https://ctdbase.org/detail.go?type=gene&acc=114327,,,114327.0,EFHC1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of EFHC1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3225,1466448,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80258,EFHC2,https://ctdbase.org/detail.go?type=gene&acc=80258,,,80258.0,EFHC2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of EFHC2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3226,1466449,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,175073,EFHD-1,https://ctdbase.org/detail.go?type=gene&acc=175073,,,175073.0,efhd-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of EFHD-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3227,1466450,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80303,EFHD1,https://ctdbase.org/detail.go?type=gene&acc=80303,,,80303.0,EFHD1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of EFHD1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3228,1466451,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176882,EFN-4,https://ctdbase.org/detail.go?type=gene&acc=176882,,,176882.0,efn-4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of EFN-4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3229,1468395,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100286489,SPAS2,https://ctdbase.org/detail.go?type=gene&acc=100286489,,,100286489.0,,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of SPAS2 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3230,1469388,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2521,FUS,https://ctdbase.org/detail.go?type=gene&acc=2521,,,2521.0,FUS,7227.0,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of FUS mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
3231,1469389,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2523,FUT1,https://ctdbase.org/detail.go?type=gene&acc=2523,,,2523.0,FUT1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of FUT1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3232,1470121,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2559,GABRA6,https://ctdbase.org/detail.go?type=gene&acc=2559,,,2559.0,GABRA6,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA6 protein binds to GABRB2 protein binds to GABRG2 protein]]|bicuculline inhibits the reaction [methylmercuric chloride promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA6 protein binds to GABRB2 protein binds to GABRG2 protein]]],,,PMID:27720918,https://www.ncbi.nlm.nih.gov/pubmed/27720918,27720918,,
3233,1470122,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2561,GABRB2,https://ctdbase.org/detail.go?type=gene&acc=2561,,,2561.0,GABRB2,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA6 protein binds to GABRB2 protein binds to GABRG2 protein]]|bicuculline inhibits the reaction [methylmercuric chloride promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA6 protein binds to GABRB2 protein binds to GABRG2 protein]]]|bicuculline inhibits the reaction [methylmercuric chloride promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]]|methylmercuric chloride promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]],,,PMID:27720918,https://www.ncbi.nlm.nih.gov/pubmed/27720918,27720918,,
3234,1470123,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2562,GABRB3,https://ctdbase.org/detail.go?type=gene&acc=2562,,,2562.0,GABRB3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of GABRB3 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
3235,1470124,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2562,GABRB3,https://ctdbase.org/detail.go?type=gene&acc=2562,,,2562.0,GABRB3,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GABRB3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3236,1470736,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191473,SRLF-34,https://ctdbase.org/detail.go?type=gene&acc=191473,,,191473.0,srlf-34,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SRLF-34 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3237,1470737,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,187826,SRLF-35,https://ctdbase.org/detail.go?type=gene&acc=187826,,,187826.0,srlf-35,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SRLF-35 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3238,1470738,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191335,SRLF-36,https://ctdbase.org/detail.go?type=gene&acc=191335,,,191335.0,srlf-36,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SRLF-36 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3239,1470739,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,185899,SRM-4,https://ctdbase.org/detail.go?type=gene&acc=185899,,,185899.0,srm-4,6239.0,Caenorhabditis elegans,SRM-4 protein results in increased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3240,1470740,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,41944,SRP,https://ctdbase.org/detail.go?type=gene&acc=41944,,,41944.0,srp,7227.0,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of SRP mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
3241,1470741,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191962,SRP-10,https://ctdbase.org/detail.go?type=gene&acc=191962,,,191962.0,srp-10,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SRP-10 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3242,1470742,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6728,SRP19,https://ctdbase.org/detail.go?type=gene&acc=6728,,,6728.0,SRP19,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SRP19 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3243,1470743,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191960,SRP-8,https://ctdbase.org/detail.go?type=gene&acc=191960,,,191960.0,srp-8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SRP-8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3244,1470744,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191961,SRP-9,https://ctdbase.org/detail.go?type=gene&acc=191961,,,191961.0,srp-9,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SRP-9 mrna|srp-9 protein results in increased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3245,1470745,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,63826,SRR,https://ctdbase.org/detail.go?type=gene&acc=63826,,,63826.0,SRR,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SRR mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3246,1471334,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2118,ETV4,https://ctdbase.org/detail.go?type=gene&acc=2118,,,2118.0,ETV4,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of ETV4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3247,1471494,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191963,SSP-32,https://ctdbase.org/detail.go?type=gene&acc=191963,,,191963.0,ssp-32,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SSP-32 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3248,1471495,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177811,SSP-36,https://ctdbase.org/detail.go?type=gene&acc=177811,,,177811.0,ssp-36,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SSP-36 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3249,1471496,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177264,SSP-9,https://ctdbase.org/detail.go?type=gene&acc=177264,,,177264.0,ssp-9,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SSP-9 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3250,1471497,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177835,SSQ-1,https://ctdbase.org/detail.go?type=gene&acc=177835,,,177835.0,ssq-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SSQ-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3251,1471498,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177265,SSQ-2,https://ctdbase.org/detail.go?type=gene&acc=177265,,,177265.0,ssq-2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SSQ-2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3252,1471499,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191964,SSQ-3,https://ctdbase.org/detail.go?type=gene&acc=191964,,,191964.0,ssq-3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SSQ-3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3253,1471500,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177269,SSQ-4,https://ctdbase.org/detail.go?type=gene&acc=177269,,,177269.0,ssq-4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SSQ-4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3254,1471501,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6745,SSR1,https://ctdbase.org/detail.go?type=gene&acc=6745,,,6745.0,SSR1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SSR1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3255,1471502,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6746,SSR2,https://ctdbase.org/detail.go?type=gene&acc=6746,,,6746.0,SSR2,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of SSR2 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3256,1472054,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,134429,STARD4,https://ctdbase.org/detail.go?type=gene&acc=134429,,,134429.0,STARD4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of STARD4 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3257,1472055,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,134429,STARD4,https://ctdbase.org/detail.go?type=gene&acc=134429,,,134429.0,STARD4,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of STARD4 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
3258,1472056,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of STAT1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3259,1472057,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10090.0,Mus musculus (house mouse),Methylmercuric chloride promotes the reaction [LEP protein results in increased phosphorylation of STAT3 protein]|methylmercuric chloride results in increased expression of STAT3 mRNA,,,PMID:33338554,https://www.ncbi.nlm.nih.gov/pubmed/33338554,33338554,,
3260,1472058,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6781,STC1,https://ctdbase.org/detail.go?type=gene&acc=6781,,,6781.0,STC1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of STC1 mrna|methylmercuric chloride results in decreased expression of STC1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3261,1472059,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,393511,STC1L,https://ctdbase.org/detail.go?type=gene&acc=393511,,,393511.0,stc1l,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of STC1L mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3262,1472060,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8614,STC2,https://ctdbase.org/detail.go?type=gene&acc=8614,,,8614.0,STC2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of STC2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3263,1472186,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174438,GCS-1,https://ctdbase.org/detail.go?type=gene&acc=174438,,,174438.0,gcs-1,6239.0,Caenorhabditis elegans,GCS-1 protein results in decreased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3264,1472187,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174438,GCS-1,https://ctdbase.org/detail.go?type=gene&acc=174438,,,174438.0,gcs-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of GCS-1 mRNA,,,PMID:21692103,https://www.ncbi.nlm.nih.gov/pubmed/21692103,21692103,,
3265,1472188,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173902,GCY-12,https://ctdbase.org/detail.go?type=gene&acc=173902,,,173902.0,gcy-12,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of GCY-12 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3266,1472189,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191640,GCY-2,https://ctdbase.org/detail.go?type=gene&acc=191640,,,191640.0,gcy-2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of GCY-2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3267,1472190,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191655,GCY-31,https://ctdbase.org/detail.go?type=gene&acc=191655,,,191655.0,gcy-31,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of GCY-31 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3268,1472191,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,54834,GDAP2,https://ctdbase.org/detail.go?type=gene&acc=54834,,,54834.0,GDAP2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of GDAP2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3269,1472328,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184142,F07E5.4,https://ctdbase.org/detail.go?type=gene&acc=184142,,,184142.0,F07E5.4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F07E5.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3270,1472329,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184145,F07E5.8,https://ctdbase.org/detail.go?type=gene&acc=184145,,,184145.0,F07E5.8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F07E5.8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3271,1472330,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184146,F07E5.9,https://ctdbase.org/detail.go?type=gene&acc=184146,,,184146.0,F07E5.9,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F07E5.9 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3272,1472640,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,81551,STMN4,https://ctdbase.org/detail.go?type=gene&acc=81551,,,81551.0,STMN4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of STMN4 mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
3273,1472641,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,79991,STN1,https://ctdbase.org/detail.go?type=gene&acc=79991,,,79991.0,STN1,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of STN1 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3274,1472642,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,79991,STN1,https://ctdbase.org/detail.go?type=gene&acc=79991,,,79991.0,STN1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of STN1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3275,1472643,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191966,STO-3,https://ctdbase.org/detail.go?type=gene&acc=191966,,,191966.0,sto-3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of STO-3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3276,1472644,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9399,STOML1,https://ctdbase.org/detail.go?type=gene&acc=9399,,,9399.0,STOML1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of STOML1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3277,1472645,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,11037,STON1,https://ctdbase.org/detail.go?type=gene&acc=11037,,,11037.0,STON1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of STON1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3278,1472646,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,85439,STON2,https://ctdbase.org/detail.go?type=gene&acc=85439,,,85439.0,STON2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of STON2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
3279,1472647,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,219736,STOX1,https://ctdbase.org/detail.go?type=gene&acc=219736,,,219736.0,STOX1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of STOX1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3280,1473215,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8675,STX16,https://ctdbase.org/detail.go?type=gene&acc=8675,,,8675.0,STX16,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of STX16 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
3281,1473216,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8675,STX16,https://ctdbase.org/detail.go?type=gene&acc=8675,,,8675.0,STX16,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STX16 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3282,1473217,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55014,STX17,https://ctdbase.org/detail.go?type=gene&acc=55014,,,55014.0,STX17,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of STX17 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3283,1473218,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6804,STX1A,https://ctdbase.org/detail.go?type=gene&acc=6804,,,6804.0,STX1A,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of STX1A mrna|fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of STX1A mrna],,,PMID:30890323,https://www.ncbi.nlm.nih.gov/pubmed/30890323,30890323,,
3284,1473219,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2054,STX2,https://ctdbase.org/detail.go?type=gene&acc=2054,,,2054.0,STX2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of STX2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3285,1473220,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6809,STX3,https://ctdbase.org/detail.go?type=gene&acc=6809,,,6809.0,STX3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of STX3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3286,1473221,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,56389,STX5A,https://ctdbase.org/detail.go?type=gene&acc=56389,,,56389.0,Stx5a,10090.0,Mus musculus (house mouse),Methylmercuric chloride results in decreased expression of STX5A mRNA,,,PMID:29261810,https://www.ncbi.nlm.nih.gov/pubmed/29261810,29261810,,
3287,1473222,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6812,STXBP1,https://ctdbase.org/detail.go?type=gene&acc=6812,,,6812.0,STXBP1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of STXBP1 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
3288,1474074,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51292,GMPR2,https://ctdbase.org/detail.go?type=gene&acc=51292,,,51292.0,GMPR2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of GMPR2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3289,1474075,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8833,GMPS,https://ctdbase.org/detail.go?type=gene&acc=8833,,,8833.0,GMPS,9483.0,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride results in decreased expression of GMPS protein,,,PMID:25809596,https://www.ncbi.nlm.nih.gov/pubmed/25809596,25809596,,
3290,1474076,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8833,GMPS,https://ctdbase.org/detail.go?type=gene&acc=8833,,,8833.0,GMPS,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of GMPS mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3291,1474155,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23224,SYNE2,https://ctdbase.org/detail.go?type=gene&acc=23224,,,23224.0,SYNE2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SYNE2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3292,1474156,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8867,SYNJ1,https://ctdbase.org/detail.go?type=gene&acc=8867,,,8867.0,SYNJ1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SYNJ1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3293,1474157,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8871,SYNJ2,https://ctdbase.org/detail.go?type=gene&acc=8871,,,8871.0,SYNJ2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SYNJ2 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
3294,1474595,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23208,SYT11,https://ctdbase.org/detail.go?type=gene&acc=23208,,,23208.0,SYT11,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SYT11 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3295,1474596,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51760,SYT17,https://ctdbase.org/detail.go?type=gene&acc=51760,,,51760.0,SYT17,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SYT17 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3296,1474597,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,143425,SYT9,https://ctdbase.org/detail.go?type=gene&acc=143425,,,143425.0,SYT9,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SYT9 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3297,1474598,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,54843,SYTL2,https://ctdbase.org/detail.go?type=gene&acc=54843,,,54843.0,SYTL2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SYTL2 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
3298,1474599,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,54843,SYTL2,https://ctdbase.org/detail.go?type=gene&acc=54843,,,54843.0,SYTL2,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYTL2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3299,1474600,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,94121,SYTL4,https://ctdbase.org/detail.go?type=gene&acc=94121,,,94121.0,SYTL4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SYTL4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3300,1474601,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,94122,SYTL5,https://ctdbase.org/detail.go?type=gene&acc=94122,,,94122.0,SYTL5,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SYTL5 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
3301,1474602,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84447,SYVN1,https://ctdbase.org/detail.go?type=gene&acc=84447,,,84447.0,SYVN1,10090.0,Mus musculus (house mouse),Methylmercuric chloride results in increased expression of SYVN1 protein,,,PMID:33454823,https://www.ncbi.nlm.nih.gov/pubmed/33454823,33454823,,
3302,1474773,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3565980,T01C3.11,https://ctdbase.org/detail.go?type=gene&acc=3565980,,,3565980.0,T01C3.11,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of T01C3.11 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3303,1474774,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,187974,T01H10.4,https://ctdbase.org/detail.go?type=gene&acc=187974,,,187974.0,T01H10.4,6239.0,Caenorhabditis elegans,T01H10.4 protein results in increased susceptibility to methylmercuric chloride|methylmercuric chloride results in increased expression of T01H10.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3304,1475074,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184915,F25B3.4,https://ctdbase.org/detail.go?type=gene&acc=184915,,,184915.0,F25B3.4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F25B3.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3305,1475075,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184916,F25B3.5,https://ctdbase.org/detail.go?type=gene&acc=184916,,,184916.0,F25B3.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F25B3.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3306,1475076,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3565479,F25E5.5,https://ctdbase.org/detail.go?type=gene&acc=3565479,,,3565479.0,F25E5.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F25E5.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3307,1475077,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184927,F25E5.8,https://ctdbase.org/detail.go?type=gene&acc=184927,,,184927.0,F25E5.8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F25E5.8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3308,1475078,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,175589,F25F2.1,https://ctdbase.org/detail.go?type=gene&acc=175589,,,175589.0,F25F2.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F25F2.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3309,1475911,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,54329,GPR85,https://ctdbase.org/detail.go?type=gene&acc=54329,,,54329.0,GPR85,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of GPR85 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3310,1475912,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55890,GPRC5C,https://ctdbase.org/detail.go?type=gene&acc=55890,,,55890.0,GPRC5C,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of GPRC5C mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3311,1475913,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55890,GPRC5C,https://ctdbase.org/detail.go?type=gene&acc=55890,,,55890.0,GPRC5C,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of GPRC5C mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3312,1475914,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,26086,GPSM1,https://ctdbase.org/detail.go?type=gene&acc=26086,,,26086.0,GPSM1,10116.0,Rattus norvegicus (Norway rat),"[hydrocarbons, chlorinated co-treated with polychlorinated biphenyls co-treated with methylmercuric chloride] results in decreased expression of GPSM1 mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
3313,1475915,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Eleostearic acid inhibits the reaction [methylmercuric chloride results in increased activity of GPT protein]|alpha-linolenic acid inhibits the reaction [methylmercuric chloride results in increased activity of GPT protein]|methylmercuric chloride results in increased activity of GPT protein,,,PMID:22269903,https://www.ncbi.nlm.nih.gov/pubmed/22269903,22269903,,
3314,1475916,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84706,GPT2,https://ctdbase.org/detail.go?type=gene&acc=84706,,,84706.0,GPT2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of GPT2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3315,1476220,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174096,T19D12.4,https://ctdbase.org/detail.go?type=gene&acc=174096,,,174096.0,T19D12.4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of T19D12.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3316,1476221,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188608,T19D12.5,https://ctdbase.org/detail.go?type=gene&acc=188608,,,188608.0,T19D12.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of T19D12.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3317,1476222,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,171977,T20F5.4,https://ctdbase.org/detail.go?type=gene&acc=171977,,,171977.0,T20F5.4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of T20F5.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3318,1476223,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188656,T20F5.5,https://ctdbase.org/detail.go?type=gene&acc=188656,,,188656.0,T20F5.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of T20F5.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3319,1476224,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188662,T20G5.12,https://ctdbase.org/detail.go?type=gene&acc=188662,,,188662.0,T20G5.12,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of T20G5.12 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3320,1476373,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,175482,F34D10.8,https://ctdbase.org/detail.go?type=gene&acc=175482,,,175482.0,F34D10.8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F34D10.8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3321,1476374,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173612,F34D6.1,https://ctdbase.org/detail.go?type=gene&acc=173612,,,173612.0,F34D6.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F34D6.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3322,1476375,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,185250,F35A5.5,https://ctdbase.org/detail.go?type=gene&acc=185250,,,185250.0,F35A5.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F35A5.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3323,1476376,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,185271,F35C11.2,https://ctdbase.org/detail.go?type=gene&acc=185271,,,185271.0,F35C11.2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F35C11.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3324,1476510,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191662,GRD-8,https://ctdbase.org/detail.go?type=gene&acc=191662,,,191662.0,grd-8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of GRD-8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3325,1476511,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,191663,GRD-9,https://ctdbase.org/detail.go?type=gene&acc=191663,,,191663.0,grd-9,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of GRD-9 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3326,1476512,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of GREB1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3327,1476513,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,26585,GREM1,https://ctdbase.org/detail.go?type=gene&acc=26585,,,26585.0,GREM1,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of GREM1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3328,1476514,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,26585,GREM1,https://ctdbase.org/detail.go?type=gene&acc=26585,,,26585.0,GREM1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of GREM1 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
3329,1476515,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,26585,GREM1,https://ctdbase.org/detail.go?type=gene&acc=26585,,,26585.0,GREM1,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GREM1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3330,1476516,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,29841,GRHL1,https://ctdbase.org/detail.go?type=gene&acc=29841,,,29841.0,GRHL1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of GRHL1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3331,1476517,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9380,GRHPR,https://ctdbase.org/detail.go?type=gene&acc=9380,,,9380.0,GRHPR,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of GRHPR mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3332,1476814,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188825,T24A6.7,https://ctdbase.org/detail.go?type=gene&acc=188825,,,188825.0,T24A6.7,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of T24A6.7 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3333,1476815,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188843,T24C4.2,https://ctdbase.org/detail.go?type=gene&acc=188843,,,188843.0,T24C4.2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of T24C4.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3334,1476816,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188845,T24C4.4,https://ctdbase.org/detail.go?type=gene&acc=188845,,,188845.0,T24C4.4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of T24C4.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3335,1476817,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188873,T25B2.1,https://ctdbase.org/detail.go?type=gene&acc=188873,,,188873.0,T25B2.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of T25B2.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3336,1476818,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188882,T25B9.4,https://ctdbase.org/detail.go?type=gene&acc=188882,,,188882.0,T25B9.4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of T25B9.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3337,1476819,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188884,T25B9.6,https://ctdbase.org/detail.go?type=gene&acc=188884,,,188884.0,T25B9.6,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of T25B9.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3338,1476959,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2902,GRIN1,https://ctdbase.org/detail.go?type=gene&acc=2902,,,2902.0,GRIN1,10116.0,Rattus norvegicus (Norway rat),Thioctic acid inhibits the reaction [methylmercuric chloride results in decreased expression of GRIN1 protein]|thioctic acid inhibits the reaction [methylmercuric chloride results in decreased expression of GRIN1 mrna],,,PMID:32061141,https://www.ncbi.nlm.nih.gov/pubmed/32061141,32061141,,
3339,1476960,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of GRIN2A mRNA,,,PMID:19409459|PMID:22223486|PMID:32061141,https://www.ncbi.nlm.nih.gov/pubmed/19409459|https://www.ncbi.nlm.nih.gov/pubmed/22223486|https://www.ncbi.nlm.nih.gov/pubmed/32061141,19409459|22223486|32061141,,
3340,1476961,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of GRIN2A protein,,,PMID:22223486|PMID:32061141,https://www.ncbi.nlm.nih.gov/pubmed/22223486|https://www.ncbi.nlm.nih.gov/pubmed/32061141,22223486|32061141,,
3341,1476962,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,10116.0,Rattus norvegicus (Norway rat),Polyphenols inhibits the reaction [methylmercuric chloride results in decreased expression of GRIN2A protein]|polyphenols inhibits the reaction [methylmercuric chloride results in decreased expression of GRIN2A mrna],,,PMID:22223486,https://www.ncbi.nlm.nih.gov/pubmed/22223486,22223486,,
3342,1476963,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,10116.0,Rattus norvegicus (Norway rat),Thioctic acid inhibits the reaction [methylmercuric chloride results in decreased expression of GRIN2A mrna]|thioctic acid inhibits the reaction [methylmercuric chloride results in decreased expression of GRIN2A protein],,,PMID:32061141,https://www.ncbi.nlm.nih.gov/pubmed/32061141,32061141,,
3343,1476964,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,9483.0,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride affects the expression of GRIN2B protein,,,PMID:27012723,https://www.ncbi.nlm.nih.gov/pubmed/27012723,27012723,,
3344,1476965,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of GRIN2B mRNA,,,PMID:19409459|PMID:22223486|PMID:32061141,https://www.ncbi.nlm.nih.gov/pubmed/19409459|https://www.ncbi.nlm.nih.gov/pubmed/22223486|https://www.ncbi.nlm.nih.gov/pubmed/32061141,19409459|22223486|32061141,,
3345,1477667,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6882,TAF11,https://ctdbase.org/detail.go?type=gene&acc=6882,,,6882.0,TAF11,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of TAF11 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3346,1477668,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6884,TAF13,https://ctdbase.org/detail.go?type=gene&acc=6884,,,6884.0,TAF13,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TAF13 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3347,1477669,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8148,TAF15,https://ctdbase.org/detail.go?type=gene&acc=8148,,,8148.0,TAF15,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of TAF15 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3348,1477960,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,185508,F40A3.6,https://ctdbase.org/detail.go?type=gene&acc=185508,,,185508.0,F40A3.6,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F40A3.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3349,1477961,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181090,F40B5.2,https://ctdbase.org/detail.go?type=gene&acc=181090,,,181090.0,F40B5.2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F40B5.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3350,1477962,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,185514,F40C5.1,https://ctdbase.org/detail.go?type=gene&acc=185514,,,185514.0,F40C5.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F40C5.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3351,1477963,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,185515,F40C5.2,https://ctdbase.org/detail.go?type=gene&acc=185515,,,185515.0,F40C5.2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F40C5.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3352,1477964,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,185537,F40E12.2,https://ctdbase.org/detail.go?type=gene&acc=185537,,,185537.0,F40E12.2,6239.0,Caenorhabditis elegans,F40E12.2 protein results in decreased susceptibility to methylmercuric chloride|methylmercuric chloride results in increased expression of F40E12.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3353,1478433,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,202020,TAPT1-AS1,https://ctdbase.org/detail.go?type=gene&acc=202020,,,202020.0,TAPT1-AS1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TAPT1-AS1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3354,1478434,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23435,TARDBP,https://ctdbase.org/detail.go?type=gene&acc=23435,,,23435.0,TARDBP,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of TARDBP mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3355,1478435,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23435,TARDBP,https://ctdbase.org/detail.go?type=gene&acc=23435,,,23435.0,TARDBP,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TARDBP mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3356,1478436,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23435,TARDBP,https://ctdbase.org/detail.go?type=gene&acc=23435,,,23435.0,TARDBP,9606.0,Homo sapiens (human),[methylmercuric chloride results in increased abundance of mercury] which affects the localization of TARDBP protein|methylmercuric chloride results in increased expression of TARDBP mrna|methylmercuric chloride results in increased activity of TARDBP protein,,,PMID:30371865,https://www.ncbi.nlm.nih.gov/pubmed/30371865,30371865,,
3357,1478437,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TARS1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3358,1478633,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,11138,TBC1D8,https://ctdbase.org/detail.go?type=gene&acc=11138,,,11138.0,TBC1D8,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TBC1D8 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3359,1478932,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of GSTM2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3360,1478933,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116.0,Rattus norvegicus (Norway rat),"[hydrocarbons, chlorinated co-treated with polychlorinated biphenyls co-treated with methylmercuric chloride co-treated with dibenzofurans, polychlorinated co-treated with polychlorinated dibenzodioxins] results in increased expression of GSTM2 mrna|[hydrocarbons, chlorinated co-treated with polychlorinated biphenyls co-treated with methylmercuric chloride] results in increased expression of GSTM2 mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
3361,1479563,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,7010,TEK,https://ctdbase.org/detail.go?type=gene&acc=7010,,,7010.0,TEK,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TEK mRNA,,,PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,26272509|28001369,,
3362,1479564,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,27285,TEKT2,https://ctdbase.org/detail.go?type=gene&acc=27285,,,27285.0,TEKT2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TEKT2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3363,1479565,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9894,TELO2,https://ctdbase.org/detail.go?type=gene&acc=9894,,,9894.0,TELO2,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of TELO2 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3364,1480031,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186677,H03G16.7,https://ctdbase.org/detail.go?type=gene&acc=186677,,,186677.0,H03G16.7,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of H03G16.7 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3365,1480032,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,172575,H05L14.1,https://ctdbase.org/detail.go?type=gene&acc=172575,,,172575.0,H05L14.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of H05L14.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3366,1480033,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186696,H06A10.1,https://ctdbase.org/detail.go?type=gene&acc=186696,,,186696.0,H06A10.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of H06A10.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3367,1480034,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,175411,H06I04.5,https://ctdbase.org/detail.go?type=gene&acc=175411,,,175411.0,H06I04.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of H06I04.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3368,1480035,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,175412,H06I04.6,https://ctdbase.org/detail.go?type=gene&acc=175412,,,175412.0,H06I04.6,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of H06I04.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3369,1480303,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186748,H16D19.4,https://ctdbase.org/detail.go?type=gene&acc=186748,,,186748.0,H16D19.4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of H16D19.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3370,1480304,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,283120,H19,https://ctdbase.org/detail.go?type=gene&acc=283120,,,283120.0,H19,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of H19 mRNA,,,PMID:31378766,https://www.ncbi.nlm.nih.gov/pubmed/31378766,31378766,,
3371,1480305,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,50709,H1F4,https://ctdbase.org/detail.go?type=gene&acc=50709,,,50709.0,H1f4,10116.0,Rattus norvegicus (Norway rat),"[hydrocarbons, chlorinated co-treated with polychlorinated biphenyls co-treated with methylmercuric chloride] results in decreased expression of H1F4 mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
3372,1480306,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173770,H20J04.1,https://ctdbase.org/detail.go?type=gene&acc=173770,,,173770.0,H20J04.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of H20J04.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3373,1480307,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186791,H27M09.5,https://ctdbase.org/detail.go?type=gene&acc=186791,,,186791.0,H27M09.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of H27M09.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3374,1480308,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8330,H2AC15,https://ctdbase.org/detail.go?type=gene&acc=8330,,,8330.0,H2AC15,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of H2AC15 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3375,1480309,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8336,H2AC17,https://ctdbase.org/detail.go?type=gene&acc=8336,,,8336.0,H2AC17,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of H2AC17 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3376,1480310,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,94239,H2AZ2,https://ctdbase.org/detail.go?type=gene&acc=94239,,,94239.0,H2AZ2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of H2AZ2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3377,1480311,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,54145,H2BC12L,https://ctdbase.org/detail.go?type=gene&acc=54145,,,54145.0,H2BC12L,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of H2BC12L mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3378,1480312,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8343,H2BC7,https://ctdbase.org/detail.go?type=gene&acc=8343,,,8343.0,H2BC7,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of H2BC7 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3379,1480953,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,26520,TIMM9,https://ctdbase.org/detail.go?type=gene&acc=26520,,,26520.0,TIMM9,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of TIMM9 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3380,1480954,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TIMP1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3381,1480955,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of TIMP1 mRNA,,,PMID:31378766,https://www.ncbi.nlm.nih.gov/pubmed/31378766,31378766,,
3382,1480956,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of TIMP1 protein,,,PMID:28526320,https://www.ncbi.nlm.nih.gov/pubmed/28526320,28526320,,
3383,1480957,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,7077,TIMP2,https://ctdbase.org/detail.go?type=gene&acc=7077,,,7077.0,TIMP2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TIMP2 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
3384,1480958,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,359835,TIMP2A,https://ctdbase.org/detail.go?type=gene&acc=359835,,,359835.0,timp2a,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of TIMP2A mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3385,1480959,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,406650,TIMP2B,https://ctdbase.org/detail.go?type=gene&acc=406650,,,406650.0,timp2b,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of TIMP2B mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3386,1480960,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,7078,TIMP3,https://ctdbase.org/detail.go?type=gene&acc=7078,,,7078.0,TIMP3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TIMP3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3387,1480961,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,25976,TIPARP,https://ctdbase.org/detail.go?type=gene&acc=25976,,,25976.0,TIPARP,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TIPARP mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3388,1482019,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10430,TMEM147,https://ctdbase.org/detail.go?type=gene&acc=10430,,,10430.0,TMEM147,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of TMEM147 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3389,1482020,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,129303,TMEM150A,https://ctdbase.org/detail.go?type=gene&acc=129303,,,129303.0,TMEM150A,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TMEM150A mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3390,1482021,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,25907,TMEM158,https://ctdbase.org/detail.go?type=gene&acc=25907,,,25907.0,TMEM158,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TMEM158 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3391,1482022,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,153396,TMEM161B,https://ctdbase.org/detail.go?type=gene&acc=153396,,,153396.0,TMEM161B,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TMEM161B mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3392,1482023,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,153339,TMEM167A,https://ctdbase.org/detail.go?type=gene&acc=153339,,,153339.0,TMEM167A,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TMEM167A mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3393,1482024,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,64418,TMEM168,https://ctdbase.org/detail.go?type=gene&acc=64418,,,64418.0,TMEM168,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TMEM168 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3394,1482025,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,92691,TMEM169,https://ctdbase.org/detail.go?type=gene&acc=92691,,,92691.0,TMEM169,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TMEM169 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3395,1551901,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177066,Y54G2A.15,https://ctdbase.org/detail.go?type=gene&acc=177066,,,177066.0,Y54G2A.15,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y54G2A.15 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3396,1551902,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177076,Y54G2A.24,https://ctdbase.org/detail.go?type=gene&acc=177076,,,177076.0,Y54G2A.24,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y54G2A.24 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3397,1552648,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,190507,Y67A10A.3,https://ctdbase.org/detail.go?type=gene&acc=190507,,,190507.0,Y67A10A.3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y67A10A.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3398,1552844,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,190554,Y69E1A.8,https://ctdbase.org/detail.go?type=gene&acc=190554,,,190554.0,Y69E1A.8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y69E1A.8 mrna|y69e1a.8 protein results in decreased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3399,1552845,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,190555,Y69F12A.1,https://ctdbase.org/detail.go?type=gene&acc=190555,,,190555.0,Y69F12A.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y69F12A.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3400,1552846,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,180221,Y69H2.3,https://ctdbase.org/detail.go?type=gene&acc=180221,,,180221.0,Y69H2.3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y69H2.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3401,1552847,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189367,Y6B3B.3,https://ctdbase.org/detail.go?type=gene&acc=189367,,,189367.0,Y6B3B.3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y6B3B.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3402,1552848,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173262,Y71A12B.11,https://ctdbase.org/detail.go?type=gene&acc=173262,,,173262.0,Y71A12B.11,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of Y71A12B.11 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3403,1552849,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3565560,Y71A12B.15,https://ctdbase.org/detail.go?type=gene&acc=3565560,,,3565560.0,Y71A12B.15,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of Y71A12B.15 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3404,1552850,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,171863,Y71F9AL.2,https://ctdbase.org/detail.go?type=gene&acc=171863,,,171863.0,Y71F9AL.2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y71F9AL.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3405,1553255,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178622,Y75B7B.2,https://ctdbase.org/detail.go?type=gene&acc=178622,,,178622.0,Y75B7B.2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y75B7B.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3406,1553256,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,190709,Y75B8A.23,https://ctdbase.org/detail.go?type=gene&acc=190709,,,190709.0,Y75B8A.23,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y75B8A.23 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3407,1553257,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3565445,Y75B8A.37,https://ctdbase.org/detail.go?type=gene&acc=3565445,,,3565445.0,Y75B8A.37,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y75B8A.37 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3408,1553258,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176998,Y76B12C.4,https://ctdbase.org/detail.go?type=gene&acc=176998,,,176998.0,Y76B12C.4,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y76B12C.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3409,1553259,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181666,Y7A5A.1,https://ctdbase.org/detail.go?type=gene&acc=181666,,,181666.0,Y7A5A.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of Y7A5A.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3410,1553260,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189382,Y7A5A.3,https://ctdbase.org/detail.go?type=gene&acc=189382,,,189382.0,Y7A5A.3,6239.0,Caenorhabditis elegans,Y7A5A.3 protein results in increased susceptibility to methylmercuric chloride|methylmercuric chloride results in increased expression of Y7A5A.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3411,1553261,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189395,Y7A9C.1,https://ctdbase.org/detail.go?type=gene&acc=189395,,,189395.0,Y7A9C.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of Y7A9C.1 mrna|methylmercuric chloride results in increased expression of Y7A9C.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3412,1553262,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178455,Y7A9D.1,https://ctdbase.org/detail.go?type=gene&acc=178455,,,178455.0,Y7A9D.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of Y7A9D.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3413,1553263,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,180237,Y80D3A.8,https://ctdbase.org/detail.go?type=gene&acc=180237,,,180237.0,Y80D3A.8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y80D3A.8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3414,1553264,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,175302,Y82E9BR.1,https://ctdbase.org/detail.go?type=gene&acc=175302,,,175302.0,Y82E9BR.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of Y82E9BR.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3415,1608517,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,29893,PSMC3IP,https://ctdbase.org/detail.go?type=gene&acc=29893,,,29893.0,PSMC3IP,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of PSMC3IP mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3416,1450799,416923,Comparative Toxicogenomics Database (CTD),Acetyldiethylcholine,C033680,acetyldiethylcholine,https://ctdbase.org/detail.go?type=chem&acc=C033680,1128,CHRM1,https://ctdbase.org/detail.go?type=gene&acc=1128,,,1128.0,CHRM1,9606.0,Homo sapiens (human),Acetyldiethylcholine results in increased activity of CHRM1 protein,,,PMID:31830555,https://www.ncbi.nlm.nih.gov/pubmed/31830555,31830555,,
3417,1450800,416923,Comparative Toxicogenomics Database (CTD),Acetyldiethylcholine,C033680,acetyldiethylcholine,https://ctdbase.org/detail.go?type=chem&acc=C033680,1131,CHRM3,https://ctdbase.org/detail.go?type=gene&acc=1131,,,1131.0,CHRM3,9606.0,Homo sapiens (human),Acetyldiethylcholine results in increased activity of CHRM3 protein,,,PMID:31830555,https://www.ncbi.nlm.nih.gov/pubmed/31830555,31830555,,
3418,1450488,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,177619,VIT-6,https://ctdbase.org/detail.go?type=gene&acc=177619,,,177619.0,vit-6,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of VIT-6 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
3419,1450489,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,7441,VPREB1,https://ctdbase.org/detail.go?type=gene&acc=7441,,,7441.0,VPREB1,10090.0,Mus musculus (house mouse),Lithium chloride results in increased expression of VPREB1 mRNA,,,PMID:27226553,https://www.ncbi.nlm.nih.gov/pubmed/27226553,27226553,,
3420,1450490,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,178069,WHT-2,https://ctdbase.org/detail.go?type=gene&acc=178069,,,178069.0,wht-2,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of WHT-2 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
3421,1450491,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,175528,WHT-3,https://ctdbase.org/detail.go?type=gene&acc=175528,,,175528.0,wht-3,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of WHT-3 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
3422,1450492,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,178182,WHT-5,https://ctdbase.org/detail.go?type=gene&acc=178182,,,178182.0,wht-5,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of WHT-5 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
3423,1450493,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,188911,WHT-6,https://ctdbase.org/detail.go?type=gene&acc=188911,,,188911.0,wht-6,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of WHT-6 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
3424,1453207,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,990,CDC6,https://ctdbase.org/detail.go?type=gene&acc=990,,,990.0,CDC6,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of CDC6 mRNA,,,PMID:22493441,https://www.ncbi.nlm.nih.gov/pubmed/22493441,22493441,,
3425,1453208,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,8317,CDC7,https://ctdbase.org/detail.go?type=gene&acc=8317,,,8317.0,CDC7,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of CDC7 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3426,1453209,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),"Lithium chloride inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in increased expression of CDH1 protein]",,,PMID:35985571,https://www.ncbi.nlm.nih.gov/pubmed/35985571,35985571,,
3427,1453210,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [tetrachlorodibenzodioxin results in decreased expression of CDH1 protein],,,PMID:22134133,https://www.ncbi.nlm.nih.gov/pubmed/22134133,22134133,,
3428,1453211,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [thymoquinone results in increased expression of CDH1 protein],,,PMID:32112862,https://www.ncbi.nlm.nih.gov/pubmed/32112862,32112862,,
3429,1453212,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),[lithium chloride results in decreased degradation of SNAI1 protein] which affects the expression of CDH1 protein,,,PMID:20348013,https://www.ncbi.nlm.nih.gov/pubmed/20348013,20348013,,
3430,1453567,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,10116.0,Rattus norvegicus (Norway rat),[lithium chloride co-treated with pilocarpine] affects the reaction [dexamethasone results in increased expression of CEBPA mrna],,,PMID:32494933,https://www.ncbi.nlm.nih.gov/pubmed/32494933,32494933,,
3431,1453568,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1052,CEBPD,https://ctdbase.org/detail.go?type=gene&acc=1052,,,1052.0,CEBPD,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of CEBPD mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3432,1453569,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,10659,CELF2,https://ctdbase.org/detail.go?type=gene&acc=10659,,,10659.0,CELF2,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of CELF2 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3433,1453570,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1063,CENPF,https://ctdbase.org/detail.go?type=gene&acc=1063,,,1063.0,CENPF,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of CENPF mRNA,,,PMID:15711924|PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/15711924|https://www.ncbi.nlm.nih.gov/pubmed/23527032,15711924|23527032,,
3434,1453571,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,11190,CEP250,https://ctdbase.org/detail.go?type=gene&acc=11190,,,11190.0,CEP250,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of CEP250 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3435,1454030,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,10664,CTCF,https://ctdbase.org/detail.go?type=gene&acc=10664,,,10664.0,CTCF,10116.0,Rattus norvegicus (Norway rat),Lithium chloride results in increased expression of CTCF mRNA,,,PMID:19285016,https://www.ncbi.nlm.nih.gov/pubmed/19285016,19285016,,
3436,1454031,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,7955.0,Danio rerio (zebrafish),Lithium chloride results in increased expression of CTNNB1 protein|lithium chloride affects the localization of CTNNB1 protein,,,PMID:22975441,https://www.ncbi.nlm.nih.gov/pubmed/22975441,22975441,,
3437,1454032,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Arsenic trioxide inhibits the reaction [lithium chloride results in increased expression of CTNNB1 protein],,,PMID:28901456,https://www.ncbi.nlm.nih.gov/pubmed/28901456,28901456,,
3438,1454033,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),CTNNB1 protein affects the reaction [[lithium chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 protein],,,PMID:19274078,https://www.ncbi.nlm.nih.gov/pubmed/19274078,19274078,,
3439,1454034,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),CTNNB1 protein promotes the reaction [lithium chloride results in increased expression of POU5F1 protein]|ctnnb1 protein promotes the reaction [lithium chloride results in increased expression of POU5F1 mrna],,,PMID:20074550,https://www.ncbi.nlm.nih.gov/pubmed/20074550,20074550,,
3440,1454035,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Hexachlorophene inhibits the reaction [lithium chloride results in increased expression of CTNNB1 protein],,,PMID:16735606,https://www.ncbi.nlm.nih.gov/pubmed/16735606,16735606,,
3441,1454463,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [tetrachlorodibenzodioxin results in decreased expression of CTNNB1 protein],,,PMID:22134133,https://www.ncbi.nlm.nih.gov/pubmed/22134133,22134133,,
3442,1454464,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [thymoquinone results in decreased expression of and results in increased phosphorylation of CTNNB1 protein],,,PMID:32112862,https://www.ncbi.nlm.nih.gov/pubmed/32112862,32112862,,
3443,1454465,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [wogonin results in decreased expression of CTNNB1 protein]|[lithium chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1,,,PMID:23872260,https://www.ncbi.nlm.nih.gov/pubmed/23872260,23872260,,
3444,1454466,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Lithium chloride results in decreased phosphorylation of CTNNB1 protein,,,PMID:16076840,https://www.ncbi.nlm.nih.gov/pubmed/16076840,16076840,,
3445,1454467,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [lithium chloride results in increased activity of [TCF4 protein co-treated with CTNNB1 protein]]|lithium chloride results in increased activity of [TCF4 protein co-treated with CTNNB1 protein],,,PMID:22935447,https://www.ncbi.nlm.nih.gov/pubmed/22935447,22935447,,
3446,1454468,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of and results in decreased phosphorylation of CTNNB1 protein,,,PMID:19228266,https://www.ncbi.nlm.nih.gov/pubmed/19228266,19228266,,
3447,1455752,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,187093,CYP-35B2,https://ctdbase.org/detail.go?type=gene&acc=187093,,,187093.0,cyp-35B2,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of CYP-35B2 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
3448,1455753,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,179885,CYP-35C1,https://ctdbase.org/detail.go?type=gene&acc=179885,,,179885.0,cyp-35C1,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of CYP-35C1 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
3449,1455754,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,183193,CYP-36A1,https://ctdbase.org/detail.go?type=gene&acc=183193,,,183193.0,cyp-36A1,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of CYP-36A1 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
3450,1455755,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,180236,CYP-42A1,https://ctdbase.org/detail.go?type=gene&acc=180236,,,180236.0,cyp-42A1,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of CYP-42A1 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
3451,1455756,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,183957,D2063.1,https://ctdbase.org/detail.go?type=gene&acc=183957,,,183957.0,D2063.1,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of D2063.1 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
3452,1455757,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10116.0,Rattus norvegicus (Norway rat),Lithium chloride promotes the reaction [cadmium results in increased expression of DDIT3 protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,
3453,1455758,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,42313,DELTA,https://ctdbase.org/detail.go?type=gene&acc=42313,,,42313.0,Delta,7668.0,Strongylocentrotus purpuratus (purple sea urchin),Lithium chloride results in increased expression of DELTA mRNA,,,PMID:17506889,https://www.ncbi.nlm.nih.gov/pubmed/17506889,17506889,,
3454,1455759,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,9077,DIRAS3,https://ctdbase.org/detail.go?type=gene&acc=9077,,,9077.0,DIRAS3,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of DIRAS3 mRNA,,,PMID:15711924,https://www.ncbi.nlm.nih.gov/pubmed/15711924,15711924,,
3455,1456987,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2902,GRIN1,https://ctdbase.org/detail.go?type=gene&acc=2902,,,2902.0,GRIN1,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of GRIN1 mRNA,,,PMID:34748853,https://www.ncbi.nlm.nih.gov/pubmed/34748853,34748853,,
3456,1456988,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2902,GRIN1,https://ctdbase.org/detail.go?type=gene&acc=2902,,,2902.0,GRIN1,10090.0,Mus musculus (house mouse),[lithium chloride co-treated with estradiol] results in decreased expression of GRIN1 mrna|lithium chloride results in decreased expression of GRIN1 mrna|[[lithium chloride co-treated with estradiol] results in decreased expression of GRIN1 mrna] which affects the susceptibility to excitatory amino acid agonists,,,PMID:19285052,https://www.ncbi.nlm.nih.gov/pubmed/19285052,19285052,,
3457,1456989,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2911,GRM1,https://ctdbase.org/detail.go?type=gene&acc=2911,,,2911.0,GRM1,10116.0,Rattus norvegicus (Norway rat),[dexamethasone co-treated with lithium chloride co-treated with pilocarpine] affects the expression of GRM1 mRNA,,,PMID:32494933,https://www.ncbi.nlm.nih.gov/pubmed/32494933,32494933,,
3458,1456990,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2896,GRN,https://ctdbase.org/detail.go?type=gene&acc=2896,,,2896.0,GRN,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of GRN mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3459,1456991,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,145258,GSC,https://ctdbase.org/detail.go?type=gene&acc=145258,,,145258.0,GSC,7668.0,Strongylocentrotus purpuratus (purple sea urchin),Lithium chloride results in decreased expression of GSC mRNA,,,PMID:17506889,https://www.ncbi.nlm.nih.gov/pubmed/17506889,17506889,,
3460,1456992,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2931,GSK3A,https://ctdbase.org/detail.go?type=gene&acc=2931,,,2931.0,GSK3A,10116.0,Rattus norvegicus (Norway rat),Lithium chloride promotes the reaction [cadmium results in increased phosphorylation of GSK3A protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,
3461,1456993,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2931,GSK3A,https://ctdbase.org/detail.go?type=gene&acc=2931,,,2931.0,GSK3A,9606.0,Homo sapiens (human),Lithium chloride results in decreased activity of [GSK3A protein binds to GSK3B protein],,,PMID:16076840,https://www.ncbi.nlm.nih.gov/pubmed/16076840,16076840,,
3462,1456994,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9913.0,Bos taurus (cattle),Lithium chloride results in decreased activity of GSK3B protein|[lithium chloride results in decreased activity of GSK3B protein] which results in increased expression of SCN9A mRNA,,,PMID:19486905,https://www.ncbi.nlm.nih.gov/pubmed/19486905,19486905,,
3463,1456995,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),CTNNB1 protein affects the reaction [[lithium chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 protein]|[lithium chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 protein|[lithium chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 mRNA,,,PMID:19274078,https://www.ncbi.nlm.nih.gov/pubmed/19274078,19274078,,
3464,1460653,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,4359,MPZ,https://ctdbase.org/detail.go?type=gene&acc=4359,,,4359.0,MPZ,10090.0,Mus musculus (house mouse),Lithium chloride results in increased expression of MPZ protein|lithium chloride inhibits the reaction [paraquat results in decreased expression of MPZ mrna]|lithium chloride results in increased expression of MPZ mrna|lithium chloride inhibits the reaction [paraquat results in decreased expression of MPZ protein],,,PMID:27788593,https://www.ncbi.nlm.nih.gov/pubmed/27788593,27788593,,
3465,1461304,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Lithium chloride affects the reaction [triptolide affects the expression of NFE2L2 protein],,,PMID:30926361,https://www.ncbi.nlm.nih.gov/pubmed/30926361,30926361,,
3466,1461305,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [[1-methyl-4-phenylpyridinium co-treated with puerarin] results in increased activity of NFE2L2 protein],,,PMID:32763437,https://www.ncbi.nlm.nih.gov/pubmed/32763437,32763437,,
3467,1461306,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [matrines results in decreased expression of NFE2L2 protein],,,PMID:37075934,https://www.ncbi.nlm.nih.gov/pubmed/37075934,37075934,,
3468,1461307,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Lithium chloride results in increased degradation of NFKBIA protein,,,PMID:24085292,https://www.ncbi.nlm.nih.gov/pubmed/24085292,24085292,,
3469,1461308,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,33167,NHE1,https://ctdbase.org/detail.go?type=gene&acc=33167,,,33167.0,Nhe1,10116.0,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [citronellal inhibits the reaction [doxorubicin results in increased expression of NHE1 protein]],,,PMID:34813134,https://www.ncbi.nlm.nih.gov/pubmed/34813134,34813134,,
3470,1461309,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,4807,NHLH1,https://ctdbase.org/detail.go?type=gene&acc=4807,,,4807.0,NHLH1,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of NHLH1 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3471,1461310,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,85407,NKD1,https://ctdbase.org/detail.go?type=gene&acc=85407,,,85407.0,NKD1,9606.0,Homo sapiens (human),Niclosamide inhibits the reaction [lithium chloride results in increased expression of NKD1 mrna]|lithium chloride results in increased expression of NKD1 mrna|xav939 inhibits the reaction [lithium chloride results in increased expression of NKD1 mrna],,,PMID:24534281,https://www.ncbi.nlm.nih.gov/pubmed/24534281,24534281,,
3472,1461311,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,4821,NKX2-2,https://ctdbase.org/detail.go?type=gene&acc=4821,,,4821.0,NKX2-2,7668.0,Strongylocentrotus purpuratus (purple sea urchin),Lithium chloride results in decreased expression of NKX2-2 mRNA,,,PMID:17506889,https://www.ncbi.nlm.nih.gov/pubmed/17506889,17506889,,
3473,1462593,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,55703,POLR3B,https://ctdbase.org/detail.go?type=gene&acc=55703,,,55703.0,POLR3B,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of POLR3B mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3474,1462594,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,64208,POPDC3,https://ctdbase.org/detail.go?type=gene&acc=64208,,,64208.0,POPDC3,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of POPDC3 mRNA,,,PMID:15711924,https://www.ncbi.nlm.nih.gov/pubmed/15711924,15711924,,
3475,1462595,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606.0,Homo sapiens (human),CTNNB1 protein promotes the reaction [lithium chloride results in increased expression of POU5F1 protein]|lithium chloride results in increased expression of POU5F1 protein|ctnnb1 protein promotes the reaction [lithium chloride results in increased expression of POU5F1 mrna],,,PMID:20074550,https://www.ncbi.nlm.nih.gov/pubmed/20074550,20074550,,
3476,1462596,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [proanthocyanidins results in decreased expression of POU5F1 protein],,,PMID:37551626,https://www.ncbi.nlm.nih.gov/pubmed/37551626,37551626,,
3477,1462597,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of POU5F1 mRNA,,,PMID:20069066|PMID:20074550,https://www.ncbi.nlm.nih.gov/pubmed/20069066|https://www.ncbi.nlm.nih.gov/pubmed/20074550,20069066|20074550,,
3478,1463035,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,29942,PURG,https://ctdbase.org/detail.go?type=gene&acc=29942,,,29942.0,PURG,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of PURG mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3479,1463036,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,5829,PXN,https://ctdbase.org/detail.go?type=gene&acc=5829,,,5829.0,PXN,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of PXN mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3480,1463037,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,29108,PYCARD,https://ctdbase.org/detail.go?type=gene&acc=29108,,,29108.0,PYCARD,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of PYCARD mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3481,1463038,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,51715,RAB23,https://ctdbase.org/detail.go?type=gene&acc=51715,,,51715.0,RAB23,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of RAB23 mRNA,,,PMID:15711924,https://www.ncbi.nlm.nih.gov/pubmed/15711924,15711924,,
3482,1447519,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,5829,PXN,https://ctdbase.org/detail.go?type=gene&acc=5829,,,5829.0,PXN,10116.0,Rattus norvegicus (Norway rat),Mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [AGT protein results in increased phosphorylation of PXN protein]],,,PMID:22306966,https://www.ncbi.nlm.nih.gov/pubmed/22306966,22306966,,
3483,1447520,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,9913.0,Bos taurus (cattle),Mevalonic acid inhibits the reaction [simvastatin results in increased activity of RAC1 protein],,,PMID:19332549,https://www.ncbi.nlm.nih.gov/pubmed/19332549,19332549,,
3484,1447521,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,9606.0,Homo sapiens (human),Mevalonic acid inhibits the reaction [lovastatin affects the localization of RAC1 protein],,,PMID:12933658,https://www.ncbi.nlm.nih.gov/pubmed/12933658,12933658,,
3485,1447522,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,10116.0,Rattus norvegicus (Norway rat),Mevalonic acid inhibits the reaction [simvastatin results in increased expression of RAC1 protein],,,PMID:16698853,https://www.ncbi.nlm.nih.gov/pubmed/16698853,16698853,,
3486,1447523,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,5906,RAP1A,https://ctdbase.org/detail.go?type=gene&acc=5906,,,5906.0,RAP1A,9606.0,Homo sapiens (human),Mevalonic acid affects the reaction [menthol results in increased expression of RAP1A protein]|mevalonic acid affects the reaction [perillaldehyde results in increased expression of RAP1A protein]|mevalonic acid affects the reaction [menthol analog results in increased expression of RAP1A protein]|mevalonic acid affects the reaction [myrtenol results in increased expression of RAP1A protein]|mevalonic acid affects the reaction [perillyl alcohol results in increased expression of RAP1A protein],,,PMID:12671036,https://www.ncbi.nlm.nih.gov/pubmed/12671036,12671036,,
3487,1447524,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,5906,RAP1A,https://ctdbase.org/detail.go?type=gene&acc=5906,,,5906.0,RAP1A,9606.0,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin results in decreased geranoylation of RAP1A protein]|mevalonic acid inhibits the reaction [cerivastatin results in decreased geranoylation of RAP1A protein],,,PMID:25578243,https://www.ncbi.nlm.nih.gov/pubmed/25578243,25578243,,
3488,1447525,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),"Mevalonic acid inhibits the reaction [asbestos, crocidolite affects the localization of RELA protein]",,,PMID:17322126,https://www.ncbi.nlm.nih.gov/pubmed/17322126,17322126,,
3489,1451775,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),[GW 274150 results in decreased activity of NOS2 protein] which results in increased susceptibility to norepinephrine|nos2 protein affects the susceptibility to norepinephrine,,,PMID:16424707,https://www.ncbi.nlm.nih.gov/pubmed/16424707,16424707,,
3490,1451776,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,9615.0,Canis lupus familiaris (dog),Norepinephrine results in increased expression of NPPA protein,,,PMID:8952593,https://www.ncbi.nlm.nih.gov/pubmed/8952593,8952593,,
3491,1453700,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116.0,Rattus norvegicus (Norway rat),Trans-sodium crocetinate inhibits the reaction [norepinephrine results in increased activity of MMP2 protein]|trans-sodium crocetinate inhibits the reaction [norepinephrine results in increased expression of MMP2 mrna]|norepinephrine results in increased activity of MMP2 protein,,,PMID:16864425,https://www.ncbi.nlm.nih.gov/pubmed/16864425,16864425,,
3492,1453701,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116.0,Rattus norvegicus (Norway rat),Norepinephrine results in increased expression of MMP2 mRNA,,,PMID:14577597|PMID:15326086|PMID:16864425,https://www.ncbi.nlm.nih.gov/pubmed/14577597|https://www.ncbi.nlm.nih.gov/pubmed/15326086|https://www.ncbi.nlm.nih.gov/pubmed/16864425,14577597|15326086|16864425,,
3493,1453702,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [norepinephrine results in increased expression of MMP9 mrna]|propranolol inhibits the reaction [norepinephrine results in increased activity of MMP9 protein]|norepinephrine results in increased expression of MMP9 mrna|quercetin 3-O-glucuronide inhibits the reaction [norepinephrine results in increased expression of MMP9 mrna]|tanshinone inhibits the reaction [norepinephrine results in increased expression of MMP9 mrna]|propranolol inhibits the reaction [norepinephrine results in increased expression of MMP9 mrna]|sr 11302 inhibits the reaction [norepinephrine results in increased expression of MMP9 mrna]|norepinephrine results in increased activity of MMP9 protein|quercetin 3-O-glucuronide inhibits the reaction [norepinephrine results in increased activity of MMP9 protein],,,PMID:24929186,https://www.ncbi.nlm.nih.gov/pubmed/24929186,24929186,,
3494,1453703,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10116.0,Rattus norvegicus (Norway rat),Trans-sodium crocetinate inhibits the reaction [norepinephrine results in increased expression of MMP9 mrna]|norepinephrine results in increased activity of MMP9 protein|norepinephrine results in increased expression of MMP9 mRNA,,,PMID:16864425,https://www.ncbi.nlm.nih.gov/pubmed/16864425,16864425,,
3495,1453704,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10116.0,Rattus norvegicus (Norway rat),[EGF protein co-treated with norepinephrine] results in increased expression of MYC mRNA,,,PMID:12632255,https://www.ncbi.nlm.nih.gov/pubmed/12632255,12632255,,
3496,1453705,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10116.0,Rattus norvegicus (Norway rat),Norepinephrine results in increased expression of MYC,,,PMID:7605896,https://www.ncbi.nlm.nih.gov/pubmed/7605896,7605896,,
3497,1453706,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4624,MYH6,https://ctdbase.org/detail.go?type=gene&acc=4624,,,4624.0,MYH6,10116.0,Rattus norvegicus (Norway rat),Norepinephrine results in decreased expression of MYH6 mRNA,,,PMID:17592507,https://www.ncbi.nlm.nih.gov/pubmed/17592507,17592507,,
3498,1453707,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4625,MYH7,https://ctdbase.org/detail.go?type=gene&acc=4625,,,4625.0,MYH7,10116.0,Rattus norvegicus (Norway rat),Norepinephrine affects the expression of MYH7 mRNA,,,PMID:25437044,https://www.ncbi.nlm.nih.gov/pubmed/25437044,25437044,,
3499,1454998,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,155,ADRB3,https://ctdbase.org/detail.go?type=gene&acc=155,,,155.0,ADRB3,9606.0,Homo sapiens (human),Norepinephrine binds to and results in increased activity of ADRB3 protein,,,PMID:14730417|PMID:1682311,https://www.ncbi.nlm.nih.gov/pubmed/14730417|https://www.ncbi.nlm.nih.gov/pubmed/1682311,14730417|1682311,,
3500,1454999,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,155,ADRB3,https://ctdbase.org/detail.go?type=gene&acc=155,,,155.0,ADRB3,9606.0,Homo sapiens (human),[norepinephrine binds to and results in increased activity of ADRB3 protein] which results in increased abundance of cyclic amp|norepinephrine inhibits the reaction [cyanopindolol binds to ADRB3 protein],,,PMID:14730417,https://www.ncbi.nlm.nih.gov/pubmed/14730417,14730417,,
3501,1455000,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,155,ADRB3,https://ctdbase.org/detail.go?type=gene&acc=155,,,155.0,ADRB3,9606.0,Homo sapiens (human),Octopamine inhibits the reaction [norepinephrine binds to ADRB3 protein],,,PMID:10344530,https://www.ncbi.nlm.nih.gov/pubmed/10344530,10344530,,
3502,1455602,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,10116.0,Rattus norvegicus (Norway rat),Norepinephrine results in increased activity of CASP2 protein,,,PMID:14732211|PMID:15158148|PMID:17041759,https://www.ncbi.nlm.nih.gov/pubmed/14732211|https://www.ncbi.nlm.nih.gov/pubmed/15158148|https://www.ncbi.nlm.nih.gov/pubmed/17041759,14732211|15158148|17041759,,
3503,1455603,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [norepinephrine results in increased activity of and results in increased cleavage of CASP3 protein]|norepinephrine results in increased activity of and results in increased cleavage of CASP3 protein,,,PMID:17136323,https://www.ncbi.nlm.nih.gov/pubmed/17136323,17136323,,
3504,1455604,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Acetylcysteine inhibits the reaction [norepinephrine results in increased activity of CASP3 protein],,,PMID:15158148|PMID:17041759,https://www.ncbi.nlm.nih.gov/pubmed/15158148|https://www.ncbi.nlm.nih.gov/pubmed/17041759,15158148|17041759,,
3505,1455605,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased activity of CASP3 protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
3506,1455606,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea inhibits the reaction [norepinephrine results in increased expression of CASP3 protein]|norepinephrine results in increased expression of CASP3 protein,,,PMID:20374255,https://www.ncbi.nlm.nih.gov/pubmed/20374255,20374255,,
3507,1455607,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Norepinephrine inhibits the reaction [okadaic acid results in increased activity of CASP3 protein],,,PMID:11099166,https://www.ncbi.nlm.nih.gov/pubmed/11099166,11099166,,
3508,1456086,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,9606.0,Homo sapiens (human),Norepinephrine results in increased secretion of CCL5 protein|prazosin inhibits the reaction [norepinephrine results in increased secretion of CCL5 protein],,,PMID:16782692,https://www.ncbi.nlm.nih.gov/pubmed/16782692,16782692,,
3509,1456087,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,10090.0,Mus musculus (house mouse),Norepinephrine results in increased expression of CCN1 mRNA,,,PMID:15117851,https://www.ncbi.nlm.nih.gov/pubmed/15117851,15117851,,
3510,1456088,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,9606.0,Homo sapiens (human),Norepinephrine affects the expression of CNR1 mRNA,,,PMID:29650773,https://www.ncbi.nlm.nih.gov/pubmed/29650773,29650773,,
3511,1456089,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090.0,Mus musculus (house mouse),FPS-ZM1 inhibits the reaction [norepinephrine results in increased expression of COL1A1 mrna]|norepinephrine results in increased expression of COL1A1 mrna|[clorgyline co-treated with selegiline] inhibits the reaction [norepinephrine results in increased expression of COL1A1 mrna],,,PMID:34609854,https://www.ncbi.nlm.nih.gov/pubmed/34609854,34609854,,
3512,1456090,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [norepinephrine results in increased expression of COL1A1 mrna],,,PMID:10722803|PMID:19575289,https://www.ncbi.nlm.nih.gov/pubmed/10722803|https://www.ncbi.nlm.nih.gov/pubmed/19575289,10722803|19575289,,
3513,1456091,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10116.0,Rattus norvegicus (Norway rat),Doxazosin inhibits the reaction [norepinephrine results in increased expression of COL1A1 mrna],,,PMID:19575289,https://www.ncbi.nlm.nih.gov/pubmed/19575289,19575289,,
3514,1456092,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10116.0,Rattus norvegicus (Norway rat),Norepinephrine results in increased expression of COL1A1 mRNA,,,PMID:10722803|PMID:14577597|PMID:19575289,https://www.ncbi.nlm.nih.gov/pubmed/10722803|https://www.ncbi.nlm.nih.gov/pubmed/14577597|https://www.ncbi.nlm.nih.gov/pubmed/19575289,10722803|14577597|19575289,,
3515,1456093,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,10090.0,Mus musculus (house mouse),Carnosine inhibits the reaction [norepinephrine results in increased expression of COL3A1 mrna]|[clorgyline co-treated with selegiline] inhibits the reaction [norepinephrine results in increased expression of COL3A1 mrna]|norepinephrine results in increased expression of COL3A1 mrna|fps-ZM1 inhibits the reaction [norepinephrine results in increased expression of COL3A1 mrna],,,PMID:34609854,https://www.ncbi.nlm.nih.gov/pubmed/34609854,34609854,,
3516,1456094,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [norepinephrine results in increased expression of COL3A1 mrna],,,PMID:10722803,https://www.ncbi.nlm.nih.gov/pubmed/10722803,10722803,,
3517,1480154,439507,DrugBank,D-Allose,DB03989,D-Allopyranose,https://www.drugbank.ca/drugs/DB03989,BE0001663,D-allose-binding periplasmic protein,https://www.drugbank.ca/bio_entities/BE0001663,P39265,D-allose-binding periplasmic protein,948604.0,alsB,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
3518,1480155,439507,Comparative Toxicogenomics Database (CTD),D-Allose,C002055,allose,https://ctdbase.org/detail.go?type=chem&acc=C002055,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,9606.0,Homo sapiens (human),Allose results in decreased expression of CCNA2 mRNA,,,PMID:18930000,https://www.ncbi.nlm.nih.gov/pubmed/18930000,18930000,,
3519,1480156,439507,Comparative Toxicogenomics Database (CTD),D-Allose,C002055,allose,https://ctdbase.org/detail.go?type=chem&acc=C002055,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Fluorouracil promotes the reaction [allose results in decreased expression of CCND1 mrna]|[allose co-treated with fluorouracil] results in decreased expression of CCND1 protein|allose results in decreased expression of CCND1 mRNA,,,PMID:18930000,https://www.ncbi.nlm.nih.gov/pubmed/18930000,18930000,,
3520,1480157,439507,Comparative Toxicogenomics Database (CTD),D-Allose,C002055,allose,https://ctdbase.org/detail.go?type=chem&acc=C002055,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),Allose results in decreased expression of CCNE1 mRNA,,,PMID:18930000,https://www.ncbi.nlm.nih.gov/pubmed/18930000,18930000,,
3521,1480158,439507,Comparative Toxicogenomics Database (CTD),D-Allose,C002055,allose,https://ctdbase.org/detail.go?type=chem&acc=C002055,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),Allose results in increased expression of CDKN1B protein,,,PMID:18930000,https://www.ncbi.nlm.nih.gov/pubmed/18930000,18930000,,
3522,1480159,439507,Comparative Toxicogenomics Database (CTD),D-Allose,C002055,allose,https://ctdbase.org/detail.go?type=chem&acc=C002055,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Fluorouracil promotes the reaction [allose results in increased expression of TP53 protein]|allose results in increased expression of TP53 mrna|allose results in increased expression of TP53 protein,,,PMID:18930000,https://www.ncbi.nlm.nih.gov/pubmed/18930000,18930000,,
3523,1480160,439507,Comparative Toxicogenomics Database (CTD),D-Allose,C002055,allose,https://ctdbase.org/detail.go?type=chem&acc=C002055,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),Allose results in increased expression of TXNIP protein|allose results in increased expression of TXNIP mrna|fluorouracil promotes the reaction [allose results in increased expression of TXNIP mrna]|[allose co-treated with fluorouracil] results in increased expression of TXNIP protein,,,PMID:18930000,https://www.ncbi.nlm.nih.gov/pubmed/18930000,18930000,,
3524,1480161,439509,DrugBank,L-Xylopyranose,DB03911,L-Xylopyranose,https://www.drugbank.ca/drugs/DB03911,BE0001225,Xylose isomerase,https://www.drugbank.ca/bio_entities/BE0001225,P24300,Xylose isomerase,,,1929.0,Streptomyces rubiginosus,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
3525,1464746,439530,Drug Gene Interaction database (DGIdb),Puromycin,,PUROMYCIN,https://www.dgidb.org/drugs/ncit:C787,,HSPA4,https://www.dgidb.org/genes/hgnc:5237,,,3308.0,HSPA4,9606.0,Homo sapiens (human),,,,,,,,
3526,1480162,439533,Drug Gene Interaction database (DGIdb),Taxifolin,,TAXIFOLIN,https://www.dgidb.org/drugs/drugbank:DB02224,,KDM4E,https://www.dgidb.org/genes/hgnc:37098,,,390245.0,KDM4E,9606.0,Homo sapiens (human),,,,,,,,
3527,1480163,439533,BindingDB,Taxifolin,212435,"(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212435,3579,Amyloid-beta precursor protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3579,P05067,Amyloid-beta precursor protein,351.0,APP,9606.0,Homo sapiens (human),,IC50 (nM),3.30e+4,PMID:23792961|DOI:10.1074/jbc.M113.464222,https://www.ncbi.nlm.nih.gov/pubmed/23792961|https://doi.org/10.1074/jbc.M113.464222,23792961,10.1074/jbc.M113.464222,
3528,1464982,439924,Comparative Toxicogenomics Database (CTD),Nicotinamide riboside,C018613,nicotinamide-beta-riboside,https://ctdbase.org/detail.go?type=chem&acc=C018613,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606.0,Homo sapiens (human),Nicotinamide-beta-riboside results in increased activity of SIRT1 protein,,,PMID:17652729,https://www.ncbi.nlm.nih.gov/pubmed/17652729,17652729,,
3529,1464983,440656,Comparative Toxicogenomics Database (CTD),Epimelibiose,D008553,Melibiose,https://ctdbase.org/detail.go?type=chem&acc=D008553,9531,BAG3,https://ctdbase.org/detail.go?type=gene&acc=9531,,,9531.0,BAG3,10090.0,Mus musculus (house mouse),Melibiose results in increased expression of BAG3 mRNA,,,PMID:30335591,https://www.ncbi.nlm.nih.gov/pubmed/30335591,30335591,,
3530,1464984,440656,Comparative Toxicogenomics Database (CTD),Epimelibiose,D008553,Melibiose,https://ctdbase.org/detail.go?type=chem&acc=D008553,26353,HSPB8,https://ctdbase.org/detail.go?type=gene&acc=26353,,,26353.0,HSPB8,10090.0,Mus musculus (house mouse),Melibiose results in increased expression of HSPB8 mRNA,,,PMID:30335591,https://www.ncbi.nlm.nih.gov/pubmed/30335591,30335591,,
3531,1464985,440656,Comparative Toxicogenomics Database (CTD),Epimelibiose,D008553,Melibiose,https://ctdbase.org/detail.go?type=chem&acc=D008553,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,10090.0,Mus musculus (house mouse),Melibiose results in increased expression of MAP1LC3B mRNA,,,PMID:30335591,https://www.ncbi.nlm.nih.gov/pubmed/30335591,30335591,,
3532,1464986,440656,Comparative Toxicogenomics Database (CTD),Epimelibiose,D008553,Melibiose,https://ctdbase.org/detail.go?type=chem&acc=D008553,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10090.0,Mus musculus (house mouse),Melibiose results in increased expression of SQSTM1 mRNA,,,PMID:30335591,https://www.ncbi.nlm.nih.gov/pubmed/30335591,30335591,,
3533,1464987,440656,Comparative Toxicogenomics Database (CTD),Epimelibiose,D008553,Melibiose,https://ctdbase.org/detail.go?type=chem&acc=D008553,7942,TFEB,https://ctdbase.org/detail.go?type=gene&acc=7942,,,7942.0,TFEB,10090.0,Mus musculus (house mouse),Melibiose affects the localization of TFEB protein|cyclosporine inhibits the reaction [melibiose affects the localization of TFEB protein],,,PMID:30335591,https://www.ncbi.nlm.nih.gov/pubmed/30335591,30335591,,
3534,1448846,440908,Comparative Toxicogenomics Database (CTD),Nivalenol,C038405,nivalenol,https://ctdbase.org/detail.go?type=chem&acc=C038405,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9823.0,Sus scrofa (pig),Nivalenol promotes the reaction [deoxynivalenol results in increased expression of IL1A mrna]|deoxynivalenol promotes the reaction [nivalenol results in increased expression of IL1A mrna],,,PMID:27915442,https://www.ncbi.nlm.nih.gov/pubmed/27915442,27915442,,
3535,1449280,440908,Comparative Toxicogenomics Database (CTD),Nivalenol,C038405,nivalenol,https://ctdbase.org/detail.go?type=chem&acc=C038405,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9823.0,Sus scrofa (pig),[deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of TNF mrna|[nivalenol co-treated with fumonisin B1] results in increased expression of TNF mrna|nivalenol results in increased expression of TNF mrna|[deoxynivalenol co-treated with nivalenol] results in increased expression of TNF mrna|[deoxynivalenol co-treated with nivalenol co-treated with zearalenone co-treated with fumonisin B1] results in increased expression of TNF mrna|[nivalenol co-treated with zearalenone co-treated with fumonisin B1] results in increased expression of TNF mrna|[deoxynivalenol co-treated with nivalenol co-treated with zearalenone] results in increased expression of TNF mrna|[nivalenol co-treated with zearalenone] results in increased expression of TNF mRNA,,,PMID:23688591,https://www.ncbi.nlm.nih.gov/pubmed/23688591,23688591,,
3536,1449281,440908,Comparative Toxicogenomics Database (CTD),Nivalenol,C038405,nivalenol,https://ctdbase.org/detail.go?type=chem&acc=C038405,22974,TPX2,https://ctdbase.org/detail.go?type=gene&acc=22974,,,22974.0,TPX2,10090.0,Mus musculus (house mouse),Nivalenol results in increased expression of TPX2 mRNA,,,PMID:35016910,https://www.ncbi.nlm.nih.gov/pubmed/35016910,35016910,,
3537,1449282,440908,Comparative Toxicogenomics Database (CTD),Nivalenol,C038405,nivalenol,https://ctdbase.org/detail.go?type=chem&acc=C038405,10376,TUBA1B,https://ctdbase.org/detail.go?type=gene&acc=10376,,,10376.0,TUBA1B,10090.0,Mus musculus (house mouse),Nivalenol results in decreased acetylation of TUBA1B protein,,,PMID:35016910,https://www.ncbi.nlm.nih.gov/pubmed/35016910,35016910,,
3538,1449283,440908,Comparative Toxicogenomics Database (CTD),Nivalenol,C038405,nivalenol,https://ctdbase.org/detail.go?type=chem&acc=C038405,123720,WHAMM,https://ctdbase.org/detail.go?type=gene&acc=123720,,,123720.0,WHAMM,10090.0,Mus musculus (house mouse),Nivalenol results in increased expression of WHAMM mRNA,,,PMID:35016910,https://www.ncbi.nlm.nih.gov/pubmed/35016910,35016910,,
3539,1452226,440936,Comparative Toxicogenomics Database (CTD),Arbutin,D001104,Arbutin,https://ctdbase.org/detail.go?type=chem&acc=D001104,8189,SYMPK,https://ctdbase.org/detail.go?type=gene&acc=8189,,,8189.0,SYMPK,9606.0,Homo sapiens (human),Arbutin results in decreased expression of SYMPK mRNA,,,PMID:17103032,https://www.ncbi.nlm.nih.gov/pubmed/17103032,17103032,,
3540,1452227,440936,Comparative Toxicogenomics Database (CTD),Arbutin,D001104,Arbutin,https://ctdbase.org/detail.go?type=chem&acc=D001104,6886,TAL1,https://ctdbase.org/detail.go?type=gene&acc=6886,,,6886.0,TAL1,9606.0,Homo sapiens (human),Arbutin results in decreased expression of TAL1 mRNA,,,PMID:17103032,https://www.ncbi.nlm.nih.gov/pubmed/17103032,17103032,,
3541,1452228,440936,Comparative Toxicogenomics Database (CTD),Arbutin,D001104,Arbutin,https://ctdbase.org/detail.go?type=chem&acc=D001104,23435,TARDBP,https://ctdbase.org/detail.go?type=gene&acc=23435,,,23435.0,TARDBP,9606.0,Homo sapiens (human),Arbutin results in increased expression of TARDBP mRNA,,,PMID:17103032,https://www.ncbi.nlm.nih.gov/pubmed/17103032,17103032,,
3542,1452229,440936,Comparative Toxicogenomics Database (CTD),Arbutin,D001104,Arbutin,https://ctdbase.org/detail.go?type=chem&acc=D001104,6938,TCF12,https://ctdbase.org/detail.go?type=gene&acc=6938,,,6938.0,TCF12,9606.0,Homo sapiens (human),Arbutin results in increased expression of TCF12 mRNA,,,PMID:17103032,https://www.ncbi.nlm.nih.gov/pubmed/17103032,17103032,,
3543,1452230,440936,Comparative Toxicogenomics Database (CTD),Arbutin,D001104,Arbutin,https://ctdbase.org/detail.go?type=chem&acc=D001104,6947,TCN1,https://ctdbase.org/detail.go?type=gene&acc=6947,,,6947.0,TCN1,9606.0,Homo sapiens (human),Arbutin results in decreased expression of TCN1 mRNA,,,PMID:17103032,https://www.ncbi.nlm.nih.gov/pubmed/17103032,17103032,,
3544,1452231,440936,Comparative Toxicogenomics Database (CTD),Arbutin,D001104,Arbutin,https://ctdbase.org/detail.go?type=chem&acc=D001104,26136,TES,https://ctdbase.org/detail.go?type=gene&acc=26136,,,26136.0,TES,9606.0,Homo sapiens (human),Arbutin results in increased expression of TES mRNA,,,PMID:17103032,https://www.ncbi.nlm.nih.gov/pubmed/17103032,17103032,,
3545,1452232,440936,Comparative Toxicogenomics Database (CTD),Arbutin,D001104,Arbutin,https://ctdbase.org/detail.go?type=chem&acc=D001104,56156,TEX13B,https://ctdbase.org/detail.go?type=gene&acc=56156,,,56156.0,TEX13B,9606.0,Homo sapiens (human),Arbutin results in decreased expression of TEX13B mRNA,,,PMID:17103032,https://www.ncbi.nlm.nih.gov/pubmed/17103032,17103032,,
3546,1452233,440936,Comparative Toxicogenomics Database (CTD),Arbutin,D001104,Arbutin,https://ctdbase.org/detail.go?type=chem&acc=D001104,7043,TGFB3,https://ctdbase.org/detail.go?type=gene&acc=7043,,,7043.0,TGFB3,9606.0,Homo sapiens (human),Arbutin results in decreased expression of TGFB3 mRNA,,,PMID:17103032,https://www.ncbi.nlm.nih.gov/pubmed/17103032,17103032,,
3547,1452234,440936,Comparative Toxicogenomics Database (CTD),Arbutin,D001104,Arbutin,https://ctdbase.org/detail.go?type=chem&acc=D001104,7092,TLL1,https://ctdbase.org/detail.go?type=gene&acc=7092,,,7092.0,TLL1,9606.0,Homo sapiens (human),Arbutin results in decreased expression of TLL1 mRNA,,,PMID:17103032,https://www.ncbi.nlm.nih.gov/pubmed/17103032,17103032,,
3548,1449284,441036,Comparative Toxicogenomics Database (CTD),D-Psicose,C003243,psicose,https://ctdbase.org/detail.go?type=chem&acc=C003243,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Psicose inhibits the reaction [glucose results in increased expression of CCL2 protein]|psicose inhibits the reaction [glucose results in increased expression of CCL2 mrna],,,PMID:17655880,https://www.ncbi.nlm.nih.gov/pubmed/17655880,17655880,,
3549,1465612,441335,DrugBank,Mometasone,DB00764,Mometasone,https://www.drugbank.ca/drugs/DB00764,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15601807|PMID:27424662,https://www.ncbi.nlm.nih.gov/pubmed/15601807|https://www.ncbi.nlm.nih.gov/pubmed/27424662,15601807|27424662,,
3550,1465613,441335,DrugBank,Mometasone,DB00764,Mometasone,https://www.drugbank.ca/drugs/DB00764,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate|Inducer,,,PMID:17165278|PMID:11511026|PMID:20482443,https://www.ncbi.nlm.nih.gov/pubmed/17165278|https://www.ncbi.nlm.nih.gov/pubmed/11511026|https://www.ncbi.nlm.nih.gov/pubmed/20482443,17165278|11511026|20482443,,
3551,1465614,441335,DrugBank,Mometasone,DB00764,Mometasone,https://www.drugbank.ca/drugs/DB00764,BE0002362,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),Inducer,,,PMID:20482443,https://www.ncbi.nlm.nih.gov/pubmed/20482443,20482443,,
3552,1465615,441344,Drug Gene Interaction database (DGIdb),Dicyclomine Hydrochloride,,DICYCLOMINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:152021,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
3553,1465616,441347,Drug Gene Interaction database (DGIdb),Reglan,,METOCLOPRAMIDE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:267036,,IL2,https://www.dgidb.org/genes/hgnc:6001,,,3558.0,IL2,9606.0,Homo sapiens (human),,,,,,,,
3554,1465617,441350,DrugBank,Metyrosine,DB00765,Metyrosine,https://www.drugbank.ca/drugs/DB00765,BE0000614,Tyrosine 3-monooxygenase,https://www.drugbank.ca/bio_entities/BE0000614,P07101,Tyrosine 3-monooxygenase,7054.0,TH,9606.0,Homo sapiens (human),Binder,,,PMID:17374|PMID:15710413|PMID:1168577|PMID:7409209|PMID:11752352,https://www.ncbi.nlm.nih.gov/pubmed/17374|https://www.ncbi.nlm.nih.gov/pubmed/15710413|https://www.ncbi.nlm.nih.gov/pubmed/1168577|https://www.ncbi.nlm.nih.gov/pubmed/7409209|https://www.ncbi.nlm.nih.gov/pubmed/11752352,17374|15710413|1168577|7409209|11752352,,
3555,1465618,441351,Drug Gene Interaction database (DGIdb),Rocuronium Bromide,,ROCURONIUM BROMIDE,https://www.dgidb.org/drugs/rxcui:32521,,CHRNE,https://www.dgidb.org/genes/hgnc:1966,,,1145.0,CHRNE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3556,1454578,441371,ChEMBL,Erythromycin Estolate,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2218877/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG55,50S ribosomal protein L6,83578268.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:20876130,https://www.ncbi.nlm.nih.gov/pubmed/20876130,20876130,,
3557,1465619,441404,Comparative Toxicogenomics Database (CTD),Testosterone Cypionate,C016131,testosterone 17 beta-cypionate,https://ctdbase.org/detail.go?type=chem&acc=C016131,51,ACOX1,https://ctdbase.org/detail.go?type=gene&acc=51,,,51.0,ACOX1,10090.0,Mus musculus (house mouse),[testosterone 17 beta-cypionate co-treated with dietary fats] results in increased expression of ACOX1 mrna|testosterone 17 beta-cypionate results in increased expression of ACOX1 mRNA,,,PMID:29704577,https://www.ncbi.nlm.nih.gov/pubmed/29704577,29704577,,
3558,1465620,441404,Comparative Toxicogenomics Database (CTD),Testosterone Cypionate,C016131,testosterone 17 beta-cypionate,https://ctdbase.org/detail.go?type=chem&acc=C016131,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Testosterone 17 beta-cypionate promotes the reaction [dietary fats results in decreased activity of CAT protein],,,PMID:29704577,https://www.ncbi.nlm.nih.gov/pubmed/29704577,29704577,,
3559,1451766,441726,Toxin and Toxin Target Database (T3DB),Delphinine,T3D3077,Delphinine,http://www.t3db.ca/toxins/T3D3077,BE0003637,Sodium channel subunit beta-3,http://www.t3db.ca/biodb/bio_entities/BE0003637,Q9NY72,Sodium channel subunit beta-3,55800.0,SCN3B,9606.0,Homo sapiens (human),Delphinine acts as an allosteric modulator of voltage gated sodium channels. (L1234),,,,,,,
3560,1451767,441726,Toxin and Toxin Target Database (T3DB),Delphinine,T3D3077,Delphinine,http://www.t3db.ca/toxins/T3D3077,BE0003638,Sodium channel subunit beta-4,http://www.t3db.ca/biodb/bio_entities/BE0003638,Q8IWT1,Sodium channel subunit beta-4,6330.0,SCN4B,9606.0,Homo sapiens (human),Delphinine acts as an allosteric modulator of voltage gated sodium channels. (L1234),,,,,,,
3561,1451768,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9615.0,Canis lupus familiaris (dog),[verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of mesaconitine|[cyclosporine results in decreased activity of ABCB1 protein] which results in decreased transport of mesaconitine|abcb1 protein results in increased transport of mesaconitine,,,PMID:23200901,https://www.ncbi.nlm.nih.gov/pubmed/23200901,23200901,,
3562,1451769,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Mesaconitine inhibits the reaction [ABCB11 protein results in increased transport of taurodeoxycholic acid],,,PMID:35101544,https://www.ncbi.nlm.nih.gov/pubmed/35101544,35101544,,
3563,1451770,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10090.0,Mus musculus (house mouse),[ABCB1A protein affects the susceptibility to mesaconitine] which affects the expression of S100B protein|abcb1a protein affects the susceptibility to mesaconitine,,,PMID:33171190,https://www.ncbi.nlm.nih.gov/pubmed/33171190,33171190,,
3564,1451771,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606.0,Homo sapiens (human),[verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of mesaconitine,,,PMID:23200901,https://www.ncbi.nlm.nih.gov/pubmed/23200901,23200901,,
3565,1451772,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9615.0,Canis lupus familiaris (dog),"[3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] which results in decreased transport of mesaconitine|abcg2 protein results in increased transport of mesaconitine",,,PMID:23200901,https://www.ncbi.nlm.nih.gov/pubmed/23200901,23200901,,
3566,1451773,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,10090.0,Mus musculus (house mouse),ABCG2 protein affects the susceptibility to mesaconitine,,,PMID:33171190,https://www.ncbi.nlm.nih.gov/pubmed/33171190,33171190,,
3567,1451774,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,235674,ACAA1B,https://ctdbase.org/detail.go?type=gene&acc=235674,,,235674.0,Acaa1b,10116.0,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of ACAA1B protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
3568,1454828,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,11252,PACSIN2,https://ctdbase.org/detail.go?type=gene&acc=11252,,,11252.0,PACSIN2,10116.0,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of PACSIN2 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
3569,1454829,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,5064,PALM,https://ctdbase.org/detail.go?type=gene&acc=5064,,,5064.0,PALM,10116.0,Rattus norvegicus (Norway rat),Mesaconitine results in decreased expression of PALM protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
3570,1454830,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,5137,PDE1C,https://ctdbase.org/detail.go?type=gene&acc=5137,,,5137.0,PDE1C,10116.0,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of PDE1C protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
3571,1454831,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,27295,PDLIM3,https://ctdbase.org/detail.go?type=gene&acc=27295,,,27295.0,PDLIM3,10116.0,Rattus norvegicus (Norway rat),Mesaconitine results in decreased expression of PDLIM3 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
3572,1454832,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,54704,PDP1,https://ctdbase.org/detail.go?type=gene&acc=54704,,,54704.0,PDP1,10116.0,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of PDP1 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
3573,1454833,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,5214,PFKP,https://ctdbase.org/detail.go?type=gene&acc=5214,,,5214.0,PFKP,10116.0,Rattus norvegicus (Norway rat),Mesaconitine results in decreased expression of PFKP protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
3574,1454834,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,5217,PFN2,https://ctdbase.org/detail.go?type=gene&acc=5217,,,5217.0,PFN2,10116.0,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of PFN2 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
3575,1454835,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,10424,PGRMC2,https://ctdbase.org/detail.go?type=gene&acc=10424,,,10424.0,PGRMC2,10116.0,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of PGRMC2 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
3576,1454836,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,5306,PITPNA,https://ctdbase.org/detail.go?type=gene&acc=5306,,,5306.0,PITPNA,10116.0,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of PITPNA protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
3577,1466082,441959,Comparative Toxicogenomics Database (CTD),Biflorin,C522781,biflorin,https://ctdbase.org/detail.go?type=chem&acc=C522781,7298,TYMS,https://ctdbase.org/detail.go?type=gene&acc=7298,,,7298.0,TYMS,9606.0,Homo sapiens (human),Biflorin affects the expression of TYMS mRNA,,,PMID:27079618,https://www.ncbi.nlm.nih.gov/pubmed/27079618,27079618,,
3578,1466083,442089,Comparative Toxicogenomics Database (CTD),Stevioside,C012043,stevioside,https://ctdbase.org/detail.go?type=chem&acc=C012043,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),Stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mrna],,,PMID:25554529,https://www.ncbi.nlm.nih.gov/pubmed/25554529,25554529,,
3579,1466084,442089,Comparative Toxicogenomics Database (CTD),Stevioside,C012043,stevioside,https://ctdbase.org/detail.go?type=chem&acc=C012043,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Stevioside results in decreased expression of PTGS2 mRNA,,,PMID:31655124,https://www.ncbi.nlm.nih.gov/pubmed/31655124,31655124,,
3580,1466085,442089,Comparative Toxicogenomics Database (CTD),Stevioside,C012043,stevioside,https://ctdbase.org/detail.go?type=chem&acc=C012043,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10090.0,Mus musculus (house mouse),Stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mrna],,,PMID:25554529,https://www.ncbi.nlm.nih.gov/pubmed/25554529,25554529,,
3581,1466086,442089,Comparative Toxicogenomics Database (CTD),Stevioside,C012043,stevioside,https://ctdbase.org/detail.go?type=chem&acc=C012043,6401,SELE,https://ctdbase.org/detail.go?type=gene&acc=6401,,,6401.0,SELE,9606.0,Homo sapiens (human),Stevioside results in decreased expression of SELE mRNA,,,PMID:31655124,https://www.ncbi.nlm.nih.gov/pubmed/31655124,31655124,,
3582,1466087,442089,Comparative Toxicogenomics Database (CTD),Stevioside,C012043,stevioside,https://ctdbase.org/detail.go?type=chem&acc=C012043,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,10090.0,Mus musculus (house mouse),Stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mrna],,,PMID:25554529,https://www.ncbi.nlm.nih.gov/pubmed/25554529,25554529,,
3583,1466088,442089,Comparative Toxicogenomics Database (CTD),Stevioside,C012043,stevioside,https://ctdbase.org/detail.go?type=chem&acc=C012043,376497,SLC27A1,https://ctdbase.org/detail.go?type=gene&acc=376497,,,376497.0,SLC27A1,10090.0,Mus musculus (house mouse),Stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mrna],,,PMID:25554529,https://www.ncbi.nlm.nih.gov/pubmed/25554529,25554529,,
3584,1466089,442089,Comparative Toxicogenomics Database (CTD),Stevioside,C012043,stevioside,https://ctdbase.org/detail.go?type=chem&acc=C012043,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,10090.0,Mus musculus (house mouse),Stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mrna],,,PMID:25554529,https://www.ncbi.nlm.nih.gov/pubmed/25554529,25554529,,
3585,1466090,442089,Comparative Toxicogenomics Database (CTD),Stevioside,C012043,stevioside,https://ctdbase.org/detail.go?type=chem&acc=C012043,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10090.0,Mus musculus (house mouse),Stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS1 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARA mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PLIN2 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of MTOR mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKB1 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of G6PC1 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKBIA mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CPT1A mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS2 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of INSR mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FOXO1 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SOD2 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of LIPC mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACOX1 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CAT mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PCK1 mrna]|stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mrna],,,PMID:25554529,https://www.ncbi.nlm.nih.gov/pubmed/25554529,25554529,,
3586,1481277,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129.0,ANGPTL4,10090.0,Mus musculus (house mouse),Genipin inhibits the reaction [lipopolysaccharides results in increased expression of ANGPTL4 mrna],,,PMID:22687549,https://www.ncbi.nlm.nih.gov/pubmed/22687549,22687549,,
3587,1481278,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Genipin results in increased expression of BAX mRNA,,,PMID:22245672,https://www.ncbi.nlm.nih.gov/pubmed/22245672,22245672,,
3588,1481279,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,10286,BCAS2,https://ctdbase.org/detail.go?type=gene&acc=10286,,,10286.0,BCAS2,10090.0,Mus musculus (house mouse),Genipin inhibits the reaction [lipopolysaccharides results in increased expression of BCAS2 mrna],,,PMID:22687549,https://www.ncbi.nlm.nih.gov/pubmed/22687549,22687549,,
3589,1481280,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Genipin results in decreased expression of BCL2 mRNA,,,PMID:22245672,https://www.ncbi.nlm.nih.gov/pubmed/22245672,22245672,,
3590,1481281,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,330,BIRC3,https://ctdbase.org/detail.go?type=gene&acc=330,,,330.0,BIRC3,10090.0,Mus musculus (house mouse),Genipin inhibits the reaction [lipopolysaccharides results in increased expression of BIRC3 mrna],,,PMID:22687549,https://www.ncbi.nlm.nih.gov/pubmed/22687549,22687549,,
3591,1457548,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60422,50S ribosomal protein L2,947811.0,rpsS,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
3592,1457549,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60438,50S ribosomal protein L3,84234841.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
3593,1457550,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60624,50S ribosomal protein L24,944759.0,rpsT,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
3594,1457551,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60723,50S ribosomal protein L4,83578037.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
3595,1457552,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P61175,50S ribosomal protein L22,947874.0,rpsB,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
3596,1457342,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7S9,30S ribosomal protein S13,75204609.0,rpmE,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3597,1457343,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7T3,30S ribosomal protein S16,944960.0,ykgM,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3598,1457344,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7T7,30S ribosomal protein S18,945657.0,rpmF,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3599,1457345,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7U3,30S ribosomal protein S19,84236347.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3600,1457346,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7U7,30S ribosomal protein S20,946318.0,rpmG,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3601,1457347,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V0,30S ribosomal protein S2,8913847.0,rpmG,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3602,1457348,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V3,30S ribosomal protein S3,948216.0,rpmH,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3603,1457349,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V8,30S ribosomal protein S4,84238873.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3604,1457553,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7W1,30S ribosomal protein S5,946349.0,rpmI,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3605,1457554,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7W7,30S ribosomal protein S8,84236820.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3606,1457555,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7X3,30S ribosomal protein S9,947805.0,rpmJ,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3607,1457556,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AA10,50S ribosomal protein L13,84234858.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3608,1457557,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0ADY3,50S ribosomal protein L14,947816.0,rpsJ,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
3609,1448490,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51742,ARID4B,https://ctdbase.org/detail.go?type=gene&acc=51742,,,51742.0,ARID4B,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ARID4B mRNA,,,PMID:17879257,https://www.ncbi.nlm.nih.gov/pubmed/17879257,17879257,,
3610,1448491,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51742,ARID4B,https://ctdbase.org/detail.go?type=gene&acc=51742,,,51742.0,ARID4B,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ARID4B mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3611,1448492,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84159,ARID5B,https://ctdbase.org/detail.go?type=gene&acc=84159,,,84159.0,ARID5B,9606.0,Homo sapiens (human),[sodium arsenite co-treated with sodium arsenite deficiency] results in decreased methylation of ARID5B promoter,,,PMID:28336213,https://www.ncbi.nlm.nih.gov/pubmed/28336213,28336213,,
3612,1448493,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84159,ARID5B,https://ctdbase.org/detail.go?type=gene&acc=84159,,,84159.0,ARID5B,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ARID5B mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3613,1448494,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84159,ARID5B,https://ctdbase.org/detail.go?type=gene&acc=84159,,,84159.0,ARID5B,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of ARID5B mRNA,,,PMID:16014739,https://www.ncbi.nlm.nih.gov/pubmed/16014739,16014739,,
3614,1448495,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,405859,ARIH1L,https://ctdbase.org/detail.go?type=gene&acc=405859,,,405859.0,arih1l,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ARIH1L mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3615,1448496,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10425,ARIH2,https://ctdbase.org/detail.go?type=gene&acc=10425,,,10425.0,ARIH2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ARIH2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3616,1448497,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494470,ARK2C,https://ctdbase.org/detail.go?type=gene&acc=494470,,,494470.0,ARK2C,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ARK2C mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3617,1448498,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,285598,ARL10,https://ctdbase.org/detail.go?type=gene&acc=285598,,,285598.0,ARL10,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ARL10 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3618,1448499,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,200894,ARL13B,https://ctdbase.org/detail.go?type=gene&acc=200894,,,200894.0,ARL13B,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ARL13B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3619,1449132,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100006005,ARRDC1A,https://ctdbase.org/detail.go?type=gene&acc=100006005,,,100006005.0,arrdc1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ARRDC1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3620,1449133,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,27106,ARRDC2,https://ctdbase.org/detail.go?type=gene&acc=27106,,,27106.0,ARRDC2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ARRDC2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3621,1449134,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,91947,ARRDC4,https://ctdbase.org/detail.go?type=gene&acc=91947,,,91947.0,ARRDC4,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ARRDC4 mRNA,,,PMID:29301061|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/29301061|https://www.ncbi.nlm.nih.gov/pubmed/34032870,29301061|34032870,,
3622,1449135,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,411,ARSB,https://ctdbase.org/detail.go?type=gene&acc=411,,,411.0,ARSB,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of ARSB mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3623,1449136,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,414,ARSD,https://ctdbase.org/detail.go?type=gene&acc=414,,,414.0,ARSD,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of ARSD gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3624,1449137,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,414,ARSD,https://ctdbase.org/detail.go?type=gene&acc=414,,,414.0,ARSD,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ARSD mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3625,1449138,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,416,ARSF,https://ctdbase.org/detail.go?type=gene&acc=416,,,416.0,ARSF,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ARSF mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3626,1449139,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,340075,ARSI,https://ctdbase.org/detail.go?type=gene&acc=340075,,,340075.0,ARSI,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ARSI mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3627,1449140,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,153642,ARSK,https://ctdbase.org/detail.go?type=gene&acc=153642,,,153642.0,ARSK,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of ARSK mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3628,1449141,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,417,ART1,https://ctdbase.org/detail.go?type=gene&acc=417,,,417.0,ART1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ART1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3629,1449610,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51666,ASB4,https://ctdbase.org/detail.go?type=gene&acc=51666,,,51666.0,ASB4,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ASB4 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3630,1449611,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51666,ASB4,https://ctdbase.org/detail.go?type=gene&acc=51666,,,51666.0,ASB4,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of ASB4 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3631,1449612,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51666,ASB4,https://ctdbase.org/detail.go?type=gene&acc=51666,,,51666.0,ASB4,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ASB4 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3632,1449613,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,140458,ASB5,https://ctdbase.org/detail.go?type=gene&acc=140458,,,140458.0,ASB5,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ASB5 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3633,1449614,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,550449,ASB5B,https://ctdbase.org/detail.go?type=gene&acc=550449,,,550449.0,asb5b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ASB5B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3634,1449615,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,140462,ASB9,https://ctdbase.org/detail.go?type=gene&acc=140462,,,140462.0,ASB9,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ASB9 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3635,1449616,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51008,ASCC1,https://ctdbase.org/detail.go?type=gene&acc=51008,,,51008.0,ASCC1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ASCC1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3636,1449617,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84164,ASCC2,https://ctdbase.org/detail.go?type=gene&acc=84164,,,84164.0,ASCC2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ASCC2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3637,1449618,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84164,ASCC2,https://ctdbase.org/detail.go?type=gene&acc=84164,,,84164.0,ASCC2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ASCC2 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
3638,1449619,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10973,ASCC3,https://ctdbase.org/detail.go?type=gene&acc=10973,,,10973.0,ASCC3,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ASCC3 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
3639,1449946,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ASNS protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
3640,1449947,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,9606.0,Homo sapiens (human),Sodium arsenite results in decreased methylation of ASNS intron,,,PMID:32844245,https://www.ncbi.nlm.nih.gov/pubmed/32844245,32844245,,
3641,1450319,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,79915,ATAD5,https://ctdbase.org/detail.go?type=gene&acc=79915,,,79915.0,ATAD5,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATAD5 mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
3642,1450320,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,79969,ATAT1,https://ctdbase.org/detail.go?type=gene&acc=79969,,,79969.0,ATAT1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ATAT1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3643,1450321,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,69678,ATCAYOS,https://ctdbase.org/detail.go?type=gene&acc=69678,,,69678.0,Atcayos,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of ATCAYOS mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3644,1450322,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,466,ATF1,https://ctdbase.org/detail.go?type=gene&acc=466,,,466.0,ATF1,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of ATF1 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3645,1450790,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406514,ATF4A,https://ctdbase.org/detail.go?type=gene&acc=406514,,,406514.0,atf4a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATF4A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3646,1450791,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,22809,ATF5,https://ctdbase.org/detail.go?type=gene&acc=22809,,,22809.0,ATF5,9606.0,Homo sapiens (human),ATF5 protein affects the reaction [sodium arsenite results in increased expression of DDIT3 protein],,,PMID:20654631,https://www.ncbi.nlm.nih.gov/pubmed/20654631,20654631,,
3647,1450792,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,22809,ATF5,https://ctdbase.org/detail.go?type=gene&acc=22809,,,22809.0,ATF5,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATF5 mrna|sodium arsenite results in increased expression of ATF5 protein,,,PMID:18055463,https://www.ncbi.nlm.nih.gov/pubmed/18055463,18055463,,
3648,1450793,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,566223,ATF5A,https://ctdbase.org/detail.go?type=gene&acc=566223,,,566223.0,atf5a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATF5A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3649,1450794,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,7955.0,Danio rerio (zebrafish),[sodium arsenite co-treated with ethanol] results in increased expression of ATF6 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3650,1450795,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,7955.0,Danio rerio (zebrafish),[sodium arsenite results in increased abundance of arsenic] which results in increased expression of ATF6 mRNA,,,PMID:33147493,https://www.ncbi.nlm.nih.gov/pubmed/33147493,33147493,,
3651,1450796,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ATF6 mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
3652,1450797,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,10090.0,Mus musculus (house mouse),Sodium arsenite affects the localization of ATF6 protein|sodium arsenite results in increased expression of ATF6 protein|acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ATF6 protein],,,PMID:21911445,https://www.ncbi.nlm.nih.gov/pubmed/21911445,21911445,,
3653,1452377,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10775,POP4,https://ctdbase.org/detail.go?type=gene&acc=10775,,,10775.0,POP4,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of POP4 mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
3654,1452378,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10248,POP7,https://ctdbase.org/detail.go?type=gene&acc=10248,,,10248.0,POP7,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of POP7 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3655,1452379,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64091,POPDC2,https://ctdbase.org/detail.go?type=gene&acc=64091,,,64091.0,POPDC2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of POPDC2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3656,1452380,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64208,POPDC3,https://ctdbase.org/detail.go?type=gene&acc=64208,,,64208.0,POPDC3,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of POPDC3 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3657,1452381,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64208,POPDC3,https://ctdbase.org/detail.go?type=gene&acc=64208,,,64208.0,POPDC3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of POPDC3 mRNA,,,PMID:25493608|PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/25493608|https://www.ncbi.nlm.nih.gov/pubmed/29301061,25493608|29301061,,
3658,1452513,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,490,ATP2B1,https://ctdbase.org/detail.go?type=gene&acc=490,,,490.0,ATP2B1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of ATP2B1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3659,1452514,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,378746,ATP2B1A,https://ctdbase.org/detail.go?type=gene&acc=378746,,,378746.0,atp2b1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ATP2B1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3660,1452515,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,338758,ATP2B1-AS1,https://ctdbase.org/detail.go?type=gene&acc=338758,,,338758.0,ATP2B1-AS1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ATP2B1-AS1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3661,1452516,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,491,ATP2B2,https://ctdbase.org/detail.go?type=gene&acc=491,,,491.0,ATP2B2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATP2B2 protein,,,PMID:30137596,https://www.ncbi.nlm.nih.gov/pubmed/30137596,30137596,,
3662,1452517,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,492,ATP2B3,https://ctdbase.org/detail.go?type=gene&acc=492,,,492.0,ATP2B3,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of ATP2B3 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
3663,1452518,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,493,ATP2B4,https://ctdbase.org/detail.go?type=gene&acc=493,,,493.0,ATP2B4,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ATP2B4 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3664,1452519,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,495,ATP4A,https://ctdbase.org/detail.go?type=gene&acc=495,,,495.0,ATP4A,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of ATP4A gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3665,1452520,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,498,ATP5F1A,https://ctdbase.org/detail.go?type=gene&acc=498,,,498.0,ATP5F1A,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of ATP5F1A gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3666,1452521,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,498,ATP5F1A,https://ctdbase.org/detail.go?type=gene&acc=498,,,498.0,ATP5F1A,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATP5F1A protein,,,PMID:27908234,https://www.ncbi.nlm.nih.gov/pubmed/27908234,27908234,,
3667,1453861,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9550,ATP6V1G1,https://ctdbase.org/detail.go?type=gene&acc=9550,,,9550.0,ATP6V1G1,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of ATP6V1G1 protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
3668,1453862,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51606,ATP6V1H,https://ctdbase.org/detail.go?type=gene&acc=51606,,,51606.0,ATP6V1H,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP6V1H mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3669,1453863,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51606,ATP6V1H,https://ctdbase.org/detail.go?type=gene&acc=51606,,,51606.0,ATP6V1H,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of ATP6V1H mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
3670,1453864,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,538,ATP7A,https://ctdbase.org/detail.go?type=gene&acc=538,,,538.0,ATP7A,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP7A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3671,1453865,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,538,ATP7A,https://ctdbase.org/detail.go?type=gene&acc=538,,,538.0,ATP7A,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ATP7A mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3672,1453866,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,540,ATP7B,https://ctdbase.org/detail.go?type=gene&acc=540,,,540.0,ATP7B,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP7B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3673,1453867,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,540,ATP7B,https://ctdbase.org/detail.go?type=gene&acc=540,,,540.0,ATP7B,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of ATP7B gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3674,1453868,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,540,ATP7B,https://ctdbase.org/detail.go?type=gene&acc=540,,,540.0,ATP7B,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of ATP7B mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3675,1454990,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5515,PPP2CA,https://ctdbase.org/detail.go?type=gene&acc=5515,,,5515.0,PPP2CA,9606.0,Homo sapiens (human),PPP2CA protein affects the reaction [sodium arsenite results in decreased phosphorylation of TFE3 protein],,,PMID:29945972,https://www.ncbi.nlm.nih.gov/pubmed/29945972,29945972,,
3676,1454991,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5515,PPP2CA,https://ctdbase.org/detail.go?type=gene&acc=5515,,,5515.0,PPP2CA,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PPP2CA protein,,,PMID:21268130,https://www.ncbi.nlm.nih.gov/pubmed/21268130,21268130,,
3677,1454992,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5516,PPP2CB,https://ctdbase.org/detail.go?type=gene&acc=5516,,,5516.0,PPP2CB,9606.0,Homo sapiens (human),PPP2CB protein affects the reaction [sodium arsenite results in decreased phosphorylation of TFE3 protein],,,PMID:29945972,https://www.ncbi.nlm.nih.gov/pubmed/29945972,29945972,,
3678,1454993,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5516,PPP2CB,https://ctdbase.org/detail.go?type=gene&acc=5516,,,5516.0,PPP2CB,9606.0,Homo sapiens (human),Sodium arsenite promotes the reaction [PPP2CB protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
3679,1454994,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5518,PPP2R1A,https://ctdbase.org/detail.go?type=gene&acc=5518,,,5518.0,PPP2R1A,9606.0,Homo sapiens (human),PPP2R1A protein affects the reaction [sodium arsenite results in decreased phosphorylation of TFE3 protein],,,PMID:29945972,https://www.ncbi.nlm.nih.gov/pubmed/29945972,29945972,,
3680,1454995,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5518,PPP2R1A,https://ctdbase.org/detail.go?type=gene&acc=5518,,,5518.0,PPP2R1A,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PPP2R1A mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3681,1454996,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5518,PPP2R1A,https://ctdbase.org/detail.go?type=gene&acc=5518,,,5518.0,PPP2R1A,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of PPP2R1A protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3682,1454997,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,449548,PPP2R1BB,https://ctdbase.org/detail.go?type=gene&acc=449548,,,449548.0,ppp2r1bb,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PPP2R1BB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3683,1456239,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,9606.0,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenite] which results in increased expression of PRDX1 mRNA,,,PMID:32076005,https://www.ncbi.nlm.nih.gov/pubmed/32076005,32076005,,
3684,1456240,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PRDX1 mRNA,,,PMID:28229933|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28229933|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28229933|34032870,,
3685,1456241,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PRDX1 protein,,,PMID:15899475,https://www.ncbi.nlm.nih.gov/pubmed/15899475,15899475,,
3686,1456242,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRDX1 mRNA,,,PMID:16322246,https://www.ncbi.nlm.nih.gov/pubmed/16322246,16322246,,
3687,1456243,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,266858,PRDX-2,https://ctdbase.org/detail.go?type=gene&acc=266858,,,266858.0,prdx-2,6239.0,Caenorhabditis elegans,NSY-1 mRNA promotes the reaction [sodium arsenite promotes the reaction [PRDX-2 gene mutant form results in increased expression of GCS-1 protein]]|csn-2 mRNA promotes the reaction [sodium arsenite promotes the reaction [PRDX-2 gene mutant form results in increased expression of GCS-1 protein]]|sodium arsenite promotes the reaction [PRDX-2 gene mutant form results in increased expression of GCS-1 protein]|csn-4 mRNA promotes the reaction [sodium arsenite promotes the reaction [PRDX-2 gene mutant form results in increased expression of GCS-1 protein]]|tir-1 mRNA promotes the reaction [sodium arsenite promotes the reaction [PRDX-2 gene mutant form results in increased expression of GCS-1 protein]]|csn-5 mRNA promotes the reaction [sodium arsenite promotes the reaction [PRDX-2 gene mutant form results in increased expression of GCS-1 protein]],,,PMID:25204677,https://www.ncbi.nlm.nih.gov/pubmed/25204677,25204677,,
3688,1456244,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,266858,PRDX-2,https://ctdbase.org/detail.go?type=gene&acc=266858,,,266858.0,prdx-2,6239.0,Caenorhabditis elegans,[PRDX-2 protein affects the localization of and results in decreased activity of DAF-16 protein] which results in increased susceptibility to sodium arsenite|[prdx-2 protein affects the localization of and results in decreased activity of SKN-1 protein] which results in increased susceptibility to sodium arsenite|prdx-2 protein results in increased susceptibility to sodium arsenite,,,PMID:25808059,https://www.ncbi.nlm.nih.gov/pubmed/25808059,25808059,,
3689,1456245,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7001,PRDX2,https://ctdbase.org/detail.go?type=gene&acc=7001,,,7001.0,PRDX2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PRDX2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3690,1456246,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7001,PRDX2,https://ctdbase.org/detail.go?type=gene&acc=7001,,,7001.0,PRDX2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PRDX2 protein,,,PMID:29207610,https://www.ncbi.nlm.nih.gov/pubmed/29207610,29207610,,
3691,1457123,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5563,PRKAA2,https://ctdbase.org/detail.go?type=gene&acc=5563,,,5563.0,PRKAA2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PRKAA2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3692,1457124,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,436905,PRKAB1A,https://ctdbase.org/detail.go?type=gene&acc=436905,,,436905.0,prkab1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PRKAB1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3693,1457125,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,335232,PRKAB1B,https://ctdbase.org/detail.go?type=gene&acc=335232,,,335232.0,prkab1b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PRKAB1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3694,1457126,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5565,PRKAB2,https://ctdbase.org/detail.go?type=gene&acc=5565,,,5565.0,PRKAB2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PRKAB2 mRNA,,,PMID:28595984|PMID:29301061|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/29301061|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|29301061|34032870,,
3695,1457127,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5566,PRKACA,https://ctdbase.org/detail.go?type=gene&acc=5566,,,5566.0,PRKACA,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PRKACA mrna|sodium arsenite results in decreased expression of PRKACA protein,,,PMID:12760830,https://www.ncbi.nlm.nih.gov/pubmed/12760830,12760830,,
3696,1457128,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5566,PRKACA,https://ctdbase.org/detail.go?type=gene&acc=5566,,,5566.0,PRKACA,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PRKACA mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3697,1457129,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5566,PRKACA,https://ctdbase.org/detail.go?type=gene&acc=5566,,,5566.0,PRKACA,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRKACA mRNA,,,PMID:16014739,https://www.ncbi.nlm.nih.gov/pubmed/16014739,16014739,,
3698,1458221,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100534685,MAST3A,https://ctdbase.org/detail.go?type=gene&acc=100534685,,,100534685.0,mast3a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MAST3A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3699,1458222,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,375449,MAST4,https://ctdbase.org/detail.go?type=gene&acc=375449,,,375449.0,MAST4,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of MAST4 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3700,1458223,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84930,MASTL,https://ctdbase.org/detail.go?type=gene&acc=84930,,,84930.0,MASTL,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MASTL mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3701,1458224,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4143,MAT1A,https://ctdbase.org/detail.go?type=gene&acc=4143,,,4143.0,MAT1A,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of MAT1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3702,1458225,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4143,MAT1A,https://ctdbase.org/detail.go?type=gene&acc=4143,,,4143.0,MAT1A,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MAT1A mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3703,1458226,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,678634,MAT2AL,https://ctdbase.org/detail.go?type=gene&acc=678634,,,678634.0,mat2al,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MAT2AL mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3704,1458364,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,19112,PRL8A6,https://ctdbase.org/detail.go?type=gene&acc=19112,,,19112.0,Prl8a6,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRL8A6 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3705,1458494,443495,Toxin and Toxin Target Database (T3DB),Sodium arsenite,T3D0243,Sodium arsenite,http://www.t3db.ca/toxins/T3D0243,BE0003402,Tubulin beta-6 chain,http://www.t3db.ca/biodb/bio_entities/BE0003402,Q9BUF5,Tubulin beta-6 chain,84617.0,TUBB6,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
3706,1458495,443495,Toxin and Toxin Target Database (T3DB),Sodium arsenite,T3D0243,Sodium arsenite,http://www.t3db.ca/toxins/T3D0243,BE0005038,Tubulin beta-8 chain,http://www.t3db.ca/biodb/bio_entities/BE0005038,Q3ZCM7,Tubulin beta-8 chain,347688.0,TUBB8,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
3707,1458496,443495,Toxin and Toxin Target Database (T3DB),Sodium arsenite,T3D0243,Sodium arsenite,http://www.t3db.ca/toxins/T3D0243,BE0005087,Tubulin beta-8 chain-like protein LOC260334,http://www.t3db.ca/biodb/bio_entities/BE0005087,A6NNZ2,Tubulin beta 8B,,,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
3708,1458979,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4159,MC3R,https://ctdbase.org/detail.go?type=gene&acc=4159,,,4159.0,MC3R,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MC3R mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3709,1458980,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4160,MC4R,https://ctdbase.org/detail.go?type=gene&acc=4160,,,4160.0,MC4R,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased methylation of MC4R gene,,,PMID:32068019,https://www.ncbi.nlm.nih.gov/pubmed/32068019,32068019,,
3710,1458981,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4162,MCAM,https://ctdbase.org/detail.go?type=gene&acc=4162,,,4162.0,MCAM,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MCAM mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3711,1458982,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,338313,MCAMB,https://ctdbase.org/detail.go?type=gene&acc=338313,,,338313.0,mcamb,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of MCAMB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3712,1458983,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4163,MCC,https://ctdbase.org/detail.go?type=gene&acc=4163,,,4163.0,MCC,9606.0,Homo sapiens (human),[sodium arsenite co-treated with cadmium chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MCC mRNA,,,PMID:12634122,https://www.ncbi.nlm.nih.gov/pubmed/12634122,12634122,,
3713,1458984,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4163,MCC,https://ctdbase.org/detail.go?type=gene&acc=4163,,,4163.0,MCC,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MCC mRNA,,,PMID:17879257,https://www.ncbi.nlm.nih.gov/pubmed/17879257,17879257,,
3714,1458985,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64087,MCCC2,https://ctdbase.org/detail.go?type=gene&acc=64087,,,64087.0,MCCC2,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of MCCC2 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3715,1459434,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5634,PRPS2,https://ctdbase.org/detail.go?type=gene&acc=5634,,,5634.0,PRPS2,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRPS2 mRNA,,,PMID:16322246,https://www.ncbi.nlm.nih.gov/pubmed/16322246,16322246,,
3716,1459435,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5636,PRPSAP2,https://ctdbase.org/detail.go?type=gene&acc=5636,,,5636.0,PRPSAP2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PRPSAP2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3717,1459436,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,557848,PRR12B,https://ctdbase.org/detail.go?type=gene&acc=557848,,,557848.0,prr12b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PRR12B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3718,1459437,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,78994,PRR14,https://ctdbase.org/detail.go?type=gene&acc=78994,,,78994.0,PRR14,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PRR14 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3719,1459438,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,222171,PRR15,https://ctdbase.org/detail.go?type=gene&acc=222171,,,222171.0,PRR15,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PRR15 mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
3720,1459439,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,163154,PRR22,https://ctdbase.org/detail.go?type=gene&acc=163154,,,163154.0,PRR22,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PRR22 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3721,1459440,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,729627,PRR23A,https://ctdbase.org/detail.go?type=gene&acc=729627,,,729627.0,PRR23A,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of and affects the splicing of PRR23A mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
3722,1460336,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,195827,PRXL2C,https://ctdbase.org/detail.go?type=gene&acc=195827,,,195827.0,PRXL2C,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PRXL2C mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3723,1460337,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5660,PSAP,https://ctdbase.org/detail.go?type=gene&acc=5660,,,5660.0,PSAP,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PSAP mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3724,1460338,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5660,PSAP,https://ctdbase.org/detail.go?type=gene&acc=5660,,,5660.0,PSAP,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of PSAP mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3725,1460476,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,9986.0,Oryctolagus cuniculus (rabbit),Sodium arsenite inhibits the reaction [S-nitroso-N-acetylpenicillamine results in increased metabolism of [GAPDH protein binds to GAPDH protein binds to GAPDH protein binds to GAPDH protein]]|[sodium arsenite co-treated with dithiothreitol] inhibits the reaction [S-nitroso-N-acetylpenicillamine results in decreased activity of [GAPDH protein binds to GAPDH protein binds to GAPDH protein binds to GAPDH protein]]|[sodium arsenite co-treated with dithiothreitol] inhibits the reaction [hydrogen peroxide results in decreased activity of [GAPDH protein binds to GAPDH protein binds to GAPDH protein binds to GAPDH protein]]|[sodium arsenite co-treated with dithiothreitol] inhibits the reaction [nitroprusside results in decreased activity of [GAPDH protein binds to GAPDH protein binds to GAPDH protein binds to GAPDH protein]],,,PMID:10403526,https://www.ncbi.nlm.nih.gov/pubmed/10403526,10403526,,
3726,1460477,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2613,GAPDHP71,https://ctdbase.org/detail.go?type=gene&acc=2613,,,2613.0,GAPDHP71,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GAPDHP71 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3727,1460478,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26330,GAPDHS,https://ctdbase.org/detail.go?type=gene&acc=26330,,,26330.0,GAPDHS,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of GAPDHS mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3728,1460479,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26130,GAPVD1,https://ctdbase.org/detail.go?type=gene&acc=26130,,,26130.0,GAPVD1,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of GAPVD1 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3729,1460480,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,54433,GAR1,https://ctdbase.org/detail.go?type=gene&acc=54433,,,54433.0,GAR1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of GAR1 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
3730,1460481,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64762,GAREM1,https://ctdbase.org/detail.go?type=gene&acc=64762,,,64762.0,GAREM1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GAREM1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3731,1460482,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,150946,GAREM2,https://ctdbase.org/detail.go?type=gene&acc=150946,,,150946.0,GAREM2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GAREM2 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3732,1460483,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,346653,GARIN1A,https://ctdbase.org/detail.go?type=gene&acc=346653,,,346653.0,GARIN1A,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GARIN1A mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3733,1461016,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,9606.0,Homo sapiens (human),GATA3 protein inhibits the reaction [sodium arsenite results in increased expression of FOXA1 mrna]|sodium arsenite results in decreased expression of GATA3 protein|gata3 protein inhibits the reaction [sodium arsenite results in increased expression of CDH1 mrna],,,PMID:37269932,https://www.ncbi.nlm.nih.gov/pubmed/37269932,37269932,,
3734,1461017,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of GATA3 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3735,1461018,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GATA3 mRNA,,,PMID:12634122|PMID:25493608|PMID:37269932,https://www.ncbi.nlm.nih.gov/pubmed/12634122|https://www.ncbi.nlm.nih.gov/pubmed/25493608|https://www.ncbi.nlm.nih.gov/pubmed/37269932,12634122|25493608|37269932,,
3736,1461019,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,9606.0,Homo sapiens (human),Sodium arsenite results in increased stability of GATA3 mRNA,,,PMID:25493608,https://www.ncbi.nlm.nih.gov/pubmed/25493608,25493608,,
3737,1461020,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GATA3 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3738,1461873,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5718,PSMD12,https://ctdbase.org/detail.go?type=gene&acc=5718,,,5718.0,PSMD12,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PSMD12 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3739,1461874,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5718,PSMD12,https://ctdbase.org/detail.go?type=gene&acc=5718,,,5718.0,PSMD12,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of PSMD12 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
3740,1461875,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5718,PSMD12,https://ctdbase.org/detail.go?type=gene&acc=5718,,,5718.0,PSMD12,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of PSMD12 protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
3741,1461876,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5718,PSMD12,https://ctdbase.org/detail.go?type=gene&acc=5718,,,5718.0,PSMD12,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of PSMD12 mRNA,,,PMID:19072884,https://www.ncbi.nlm.nih.gov/pubmed/19072884,19072884,,
3742,1461877,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5719,PSMD13,https://ctdbase.org/detail.go?type=gene&acc=5719,,,5719.0,PSMD13,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PSMD13 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3743,1461878,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5719,PSMD13,https://ctdbase.org/detail.go?type=gene&acc=5719,,,5719.0,PSMD13,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of PSMD13 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3744,1461879,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5719,PSMD13,https://ctdbase.org/detail.go?type=gene&acc=5719,,,5719.0,PSMD13,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PSMD13 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3745,1462147,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9833,MELK,https://ctdbase.org/detail.go?type=gene&acc=9833,,,9833.0,MELK,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MELK mrna|sodium arsenite inhibits the reaction [E2F1 protein binds to MELK promoter]|sodium arsenite promotes the reaction [E2F4 protein binds to MELK promoter],,,PMID:17998272,https://www.ncbi.nlm.nih.gov/pubmed/17998272,17998272,,
3746,1462148,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9833,MELK,https://ctdbase.org/detail.go?type=gene&acc=9833,,,9833.0,MELK,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MELK mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3747,1462149,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4241,MELTF,https://ctdbase.org/detail.go?type=gene&acc=4241,,,4241.0,MELTF,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of MELTF gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3748,1462150,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4241,MELTF,https://ctdbase.org/detail.go?type=gene&acc=4241,,,4241.0,MELTF,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MELTF mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3749,1462291,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenic] inhibits the reaction [NFE2L1 protein alternative form results in decreased expression of GCLC mrna],,,PMID:32188015,https://www.ncbi.nlm.nih.gov/pubmed/32188015,32188015,,
3750,1462292,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenic] which results in increased expression of GCLC mRNA,,,PMID:33434570,https://www.ncbi.nlm.nih.gov/pubmed/33434570,33434570,,
3751,1462293,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenic] which results in increased expression of GCLC protein,,,PMID:32188015|PMID:33434570,https://www.ncbi.nlm.nih.gov/pubmed/32188015|https://www.ncbi.nlm.nih.gov/pubmed/33434570,32188015|33434570,,
3752,1462294,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenite] which results in increased expression of GCLC mRNA,,,PMID:32076005,https://www.ncbi.nlm.nih.gov/pubmed/32076005,32076005,,
3753,1462295,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),Sodium arsenite results in increased activity of GCLC protein,,,PMID:12441363,https://www.ncbi.nlm.nih.gov/pubmed/12441363,12441363,,
3754,1462296,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GCLC mRNA,,,PMID:12441363|PMID:20100676|PMID:20805060|PMID:20886546|PMID:23699174|PMID:24516582|PMID:25201354|PMID:26535918|PMID:27068294|PMID:28125038|PMID:28229933|PMID:28713220|PMID:30186748,https://www.ncbi.nlm.nih.gov/pubmed/12441363|https://www.ncbi.nlm.nih.gov/pubmed/20100676|https://www.ncbi.nlm.nih.gov/pubmed/20805060|https://www.ncbi.nlm.nih.gov/pubmed/20886546|https://www.ncbi.nlm.nih.gov/pubmed/23699174|https://www.ncbi.nlm.nih.gov/pubmed/24516582|https://www.ncbi.nlm.nih.gov/pubmed/25201354|https://www.ncbi.nlm.nih.gov/pubmed/26535918|https://www.ncbi.nlm.nih.gov/pubmed/27068294|https://www.ncbi.nlm.nih.gov/pubmed/28125038|https://www.ncbi.nlm.nih.gov/pubmed/28229933|https://www.ncbi.nlm.nih.gov/pubmed/28713220|https://www.ncbi.nlm.nih.gov/pubmed/30186748,12441363|20100676|20805060|20886546|23699174|24516582|25201354|26535918|27068294|28125038|28229933|28713220|30186748,,
3755,1462297,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GCLC protein,,,PMID:25201354|PMID:28713220,https://www.ncbi.nlm.nih.gov/pubmed/25201354|https://www.ncbi.nlm.nih.gov/pubmed/28713220,25201354|28713220,,
3756,1462298,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),SQSTM1 protein promotes the reaction [sodium arsenite results in increased expression of GCLC mrna],,,PMID:28125038,https://www.ncbi.nlm.nih.gov/pubmed/28125038,28125038,,
3757,1462469,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10090.0,Mus musculus (house mouse),[GCLM co-treated with GCLC] inhibits the reaction [sodium arsenite results in increased activity of CASP9 protein]|[gclm co-treated with GCLC] inhibits the reaction [sodium arsenite results in increased activity of and results in increased cleavage of CASP3 protein],,,PMID:20006689,https://www.ncbi.nlm.nih.gov/pubmed/20006689,20006689,,
3758,1462470,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of GCLC mRNA,,,PMID:16014739|PMID:21396911|PMID:26371860|PMID:26473898|PMID:26631322|PMID:28549828,https://www.ncbi.nlm.nih.gov/pubmed/16014739|https://www.ncbi.nlm.nih.gov/pubmed/21396911|https://www.ncbi.nlm.nih.gov/pubmed/26371860|https://www.ncbi.nlm.nih.gov/pubmed/26473898|https://www.ncbi.nlm.nih.gov/pubmed/26631322|https://www.ncbi.nlm.nih.gov/pubmed/28549828,16014739|21396911|26371860|26473898|26631322|28549828,,
3759,1464664,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23395,LARS2,https://ctdbase.org/detail.go?type=gene&acc=23395,,,23395.0,LARS2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of LARS2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3760,1464665,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23395,LARS2,https://ctdbase.org/detail.go?type=gene&acc=23395,,,23395.0,LARS2,9606.0,Homo sapiens (human),Sodium arsenite promotes the reaction [LARS2 protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
3761,1464666,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23395,LARS2,https://ctdbase.org/detail.go?type=gene&acc=23395,,,23395.0,LARS2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LARS2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3762,1464667,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23395,LARS2,https://ctdbase.org/detail.go?type=gene&acc=23395,,,23395.0,LARS2,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of LARS2 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3763,1464668,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3927,LASP1,https://ctdbase.org/detail.go?type=gene&acc=3927,,,3927.0,LASP1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of LASP1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3764,1464889,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9113,LATS1,https://ctdbase.org/detail.go?type=gene&acc=9113,,,9113.0,LATS1,9606.0,Homo sapiens (human),Sodium arsenite promotes the reaction [LATS1 protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
3765,1464890,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,54900,LAX1,https://ctdbase.org/detail.go?type=gene&acc=54900,,,54900.0,LAX1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LAX1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3766,1464891,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,54900,LAX1,https://ctdbase.org/detail.go?type=gene&acc=54900,,,54900.0,LAX1,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of LAX1 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3767,1464892,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,81606,LBH,https://ctdbase.org/detail.go?type=gene&acc=81606,,,81606.0,LBH,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LBH mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3768,1464893,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,81606,LBH,https://ctdbase.org/detail.go?type=gene&acc=81606,,,81606.0,LBH,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of LBH mRNA,,,PMID:16322246,https://www.ncbi.nlm.nih.gov/pubmed/16322246,16322246,,
3769,1465045,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,54810,GIPC2,https://ctdbase.org/detail.go?type=gene&acc=54810,,,54810.0,GIPC2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GIPC2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3770,1465046,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,793882,GIT2A,https://ctdbase.org/detail.go?type=gene&acc=793882,,,793882.0,git2a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GIT2A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3771,1465047,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GJA1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3772,1465048,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of and results in decreased activity of GJA1 protein,,,PMID:35750204,https://www.ncbi.nlm.nih.gov/pubmed/35750204,35750204,,
3773,1465049,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GJA1 mRNA,,,PMID:12727804|PMID:16507463|PMID:19615344,https://www.ncbi.nlm.nih.gov/pubmed/12727804|https://www.ncbi.nlm.nih.gov/pubmed/16507463|https://www.ncbi.nlm.nih.gov/pubmed/19615344,12727804|16507463|19615344,,
3774,1465602,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406899,MIR106A,https://ctdbase.org/detail.go?type=gene&acc=406899,,,406899.0,MIR106A,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MIR106A mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3775,1465603,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406900,MIR106B,https://ctdbase.org/detail.go?type=gene&acc=406900,,,406900.0,MIR106B,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MIR106B mRNA,,,PMID:28972549,https://www.ncbi.nlm.nih.gov/pubmed/28972549,28972549,,
3776,1465604,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406900,MIR106B,https://ctdbase.org/detail.go?type=gene&acc=406900,,,406900.0,MIR106B,10090.0,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenic] which results in increased expression of MIR106B mRNA,,,PMID:34952004,https://www.ncbi.nlm.nih.gov/pubmed/34952004,34952004,,
3777,1465605,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406903,MIR10B,https://ctdbase.org/detail.go?type=gene&acc=406903,,,406903.0,MIR10B,9031.0,Gallus gallus (chicken),Sodium arsenite results in decreased expression of MIR10B mRNA,,,PMID:21503876,https://www.ncbi.nlm.nih.gov/pubmed/21503876,21503876,,
3778,1465606,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406903,MIR10B,https://ctdbase.org/detail.go?type=gene&acc=406903,,,406903.0,MIR10B,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR10B mRNA,,,PMID:24431212,https://www.ncbi.nlm.nih.gov/pubmed/24431212,24431212,,
3779,1465607,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406903,MIR10B,https://ctdbase.org/detail.go?type=gene&acc=406903,,,406903.0,MIR10B,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MIR10B mRNA,,,PMID:32068019,https://www.ncbi.nlm.nih.gov/pubmed/32068019,32068019,,
3780,1465608,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406904,MIR1-1,https://ctdbase.org/detail.go?type=gene&acc=406904,,,406904.0,MIR1-1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR1-1 mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
3781,1465609,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100302209,MIR1185-2,https://ctdbase.org/detail.go?type=gene&acc=100302209,,,100302209.0,MIR1185-2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MIR1185-2 mRNA,,,PMID:28972549,https://www.ncbi.nlm.nih.gov/pubmed/28972549,28972549,,
3782,1465610,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100316805,MIR1190,https://ctdbase.org/detail.go?type=gene&acc=100316805,,,100316805.0,Mir1190,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MIR1190 mRNA,,,PMID:32068019,https://www.ncbi.nlm.nih.gov/pubmed/32068019,32068019,,
3783,1465611,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100302250,MIR1197,https://ctdbase.org/detail.go?type=gene&acc=100302250,,,100302250.0,MIR1197,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MIR1197 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3784,1465762,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3939,LDHA,https://ctdbase.org/detail.go?type=gene&acc=3939,,,3939.0,LDHA,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased activity of LDHA protein,,,PMID:37120063,https://www.ncbi.nlm.nih.gov/pubmed/37120063,37120063,,
3785,1465763,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3939,LDHA,https://ctdbase.org/detail.go?type=gene&acc=3939,,,3939.0,LDHA,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of LDHA protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3786,1465764,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,442013,LDHAP3,https://ctdbase.org/detail.go?type=gene&acc=442013,,,442013.0,LDHAP3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LDHAP3 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3787,1465765,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,158222,LDHAP4,https://ctdbase.org/detail.go?type=gene&acc=158222,,,158222.0,LDHAP4,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LDHAP4 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3788,1465766,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3945,LDHB,https://ctdbase.org/detail.go?type=gene&acc=3945,,,3945.0,LDHB,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LDHB mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3789,1465767,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3945,LDHB,https://ctdbase.org/detail.go?type=gene&acc=3945,,,3945.0,LDHB,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of LDHB protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3790,1465768,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3945,LDHB,https://ctdbase.org/detail.go?type=gene&acc=3945,,,3945.0,LDHB,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of LDHB mRNA,,,PMID:21297353,https://www.ncbi.nlm.nih.gov/pubmed/21297353,21297353,,
3791,1465769,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,436747,LDHBB,https://ctdbase.org/detail.go?type=gene&acc=436747,,,436747.0,ldhbb,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of LDHBB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3792,1466570,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of and results in decreased activity of GLUL protein,,,PMID:22020379,https://www.ncbi.nlm.nih.gov/pubmed/22020379,22020379,,
3793,1466738,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,181427,GMAP-2,https://ctdbase.org/detail.go?type=gene&acc=181427,,,181427.0,gmap-2,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of GMAP-2 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
3794,1466739,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,182266,GMAP-3,https://ctdbase.org/detail.go?type=gene&acc=182266,,,182266.0,gmap-3,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of GMAP-3 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
3795,1466740,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100508120,GMDS-DT,https://ctdbase.org/detail.go?type=gene&acc=100508120,,,100508120.0,GMDS-DT,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GMDS-DT mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3796,1466741,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10691,GMEB1,https://ctdbase.org/detail.go?type=gene&acc=10691,,,10691.0,GMEB1,9606.0,Homo sapiens (human),Sodium arsenite results in increased stability of GMEB1 mRNA,,,PMID:25493608,https://www.ncbi.nlm.nih.gov/pubmed/25493608,25493608,,
3797,1466742,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51053,GMNN,https://ctdbase.org/detail.go?type=gene&acc=51053,,,51053.0,GMNN,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GMNN mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3798,1466743,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51053,GMNN,https://ctdbase.org/detail.go?type=gene&acc=51053,,,51053.0,GMNN,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GMNN mRNA,,,PMID:16014739,https://www.ncbi.nlm.nih.gov/pubmed/16014739,16014739,,
3799,1466744,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,29926,GMPPA,https://ctdbase.org/detail.go?type=gene&acc=29926,,,29926.0,GMPPA,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GMPPA mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
3800,1466745,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,29926,GMPPA,https://ctdbase.org/detail.go?type=gene&acc=29926,,,29926.0,GMPPA,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of GMPPA mRNA,,,PMID:32068019,https://www.ncbi.nlm.nih.gov/pubmed/32068019,32068019,,
3801,1467912,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26468,LHX6,https://ctdbase.org/detail.go?type=gene&acc=26468,,,26468.0,LHX6,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of LHX6 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3802,1467913,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,11019,LIAS,https://ctdbase.org/detail.go?type=gene&acc=11019,,,11019.0,LIAS,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of LIAS mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3803,1467914,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3976,LIF,https://ctdbase.org/detail.go?type=gene&acc=3976,,,3976.0,LIF,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of LIF mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3804,1467915,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3976,LIF,https://ctdbase.org/detail.go?type=gene&acc=3976,,,3976.0,LIF,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LIF mRNA,,,PMID:12760830|PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/12760830|https://www.ncbi.nlm.nih.gov/pubmed/29301061,12760830|29301061,,
3805,1467916,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3977,LIFR,https://ctdbase.org/detail.go?type=gene&acc=3977,,,3977.0,LIFR,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LIFR mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3806,1467917,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3977,LIFR,https://ctdbase.org/detail.go?type=gene&acc=3977,,,3977.0,LIFR,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of LIFR mRNA,,,PMID:28370166,https://www.ncbi.nlm.nih.gov/pubmed/28370166,28370166,,
3807,1467918,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,565104,LIFRB,https://ctdbase.org/detail.go?type=gene&acc=565104,,,565104.0,lifrb,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of LIFRB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3808,1468535,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2239,GPC4,https://ctdbase.org/detail.go?type=gene&acc=2239,,,2239.0,GPC4,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GPC4 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3809,1468536,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2262,GPC5,https://ctdbase.org/detail.go?type=gene&acc=2262,,,2262.0,GPC5,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GPC5 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3810,1468537,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100873969,GPC5-AS1,https://ctdbase.org/detail.go?type=gene&acc=100873969,,,100873969.0,GPC5-AS1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GPC5-AS1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3811,1468705,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2852,GPER1,https://ctdbase.org/detail.go?type=gene&acc=2852,,,2852.0,GPER1,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of GPER1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3812,1468706,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10243,GPHN,https://ctdbase.org/detail.go?type=gene&acc=10243,,,10243.0,GPHN,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of GPHN protein,,,PMID:19072884,https://www.ncbi.nlm.nih.gov/pubmed/19072884,19072884,,
3813,1468707,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2821,GPI,https://ctdbase.org/detail.go?type=gene&acc=2821,,,2821.0,GPI,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GPI mRNA,,,PMID:23648393|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/23648393|https://www.ncbi.nlm.nih.gov/pubmed/34032870,23648393|34032870,,
3814,1468708,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,246094,GPIA,https://ctdbase.org/detail.go?type=gene&acc=246094,,,246094.0,gpia,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of GPIA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3815,1468709,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,246095,GPIB,https://ctdbase.org/detail.go?type=gene&acc=246095,,,246095.0,gpib,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GPIB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3816,1468710,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,338328,GPIHBP1,https://ctdbase.org/detail.go?type=gene&acc=338328,,,338328.0,GPIHBP1,10090.0,Mus musculus (house mouse),Sodium arsenite affects the expression of GPIHBP1,,,PMID:25367288,https://www.ncbi.nlm.nih.gov/pubmed/25367288,25367288,,
3817,1469122,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23314,SATB2,https://ctdbase.org/detail.go?type=gene&acc=23314,,,23314.0,SATB2,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of SATB2 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3818,1469123,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23314,SATB2,https://ctdbase.org/detail.go?type=gene&acc=23314,,,23314.0,SATB2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SATB2 mRNA,,,PMID:22714537|PMID:29603397,https://www.ncbi.nlm.nih.gov/pubmed/22714537|https://www.ncbi.nlm.nih.gov/pubmed/29603397,22714537|29603397,,
3819,1469124,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55776,SAYSD1,https://ctdbase.org/detail.go?type=gene&acc=55776,,,55776.0,SAYSD1,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of SAYSD1 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3820,1469687,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,81491,GPR63,https://ctdbase.org/detail.go?type=gene&acc=81491,,,81491.0,GPR63,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of GPR63 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3821,1469688,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,81491,GPR63,https://ctdbase.org/detail.go?type=gene&acc=81491,,,81491.0,GPR63,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GPR63 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3822,1469689,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8111,GPR68,https://ctdbase.org/detail.go?type=gene&acc=8111,,,8111.0,GPR68,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GPR68 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3823,1469690,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,27197,GPR82,https://ctdbase.org/detail.go?type=gene&acc=27197,,,27197.0,GPR82,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of GPR82 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3824,1469691,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10888,GPR83,https://ctdbase.org/detail.go?type=gene&acc=10888,,,10888.0,GPR83,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of GPR83 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3825,1469692,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,54112,GPR88,https://ctdbase.org/detail.go?type=gene&acc=54112,,,54112.0,GPR88,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GPR88 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3826,1469693,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,80823,GPRASP3,https://ctdbase.org/detail.go?type=gene&acc=80823,,,80823.0,GPRASP3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GPRASP3 mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
3827,1470889,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,196996,GRAMD2A,https://ctdbase.org/detail.go?type=gene&acc=196996,,,196996.0,GRAMD2A,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of GRAMD2A mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3828,1470890,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,65983,GRAMD2B,https://ctdbase.org/detail.go?type=gene&acc=65983,,,65983.0,GRAMD2B,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of GRAMD2B gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3829,1470891,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23151,GRAMD4,https://ctdbase.org/detail.go?type=gene&acc=23151,,,23151.0,GRAMD4,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GRAMD4 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3830,1471335,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,57410,SCYL1,https://ctdbase.org/detail.go?type=gene&acc=57410,,,57410.0,SCYL1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of SCYL1 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
3831,1471336,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,157489,SDAD1P1,https://ctdbase.org/detail.go?type=gene&acc=157489,,,157489.0,SDAD1P1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of SDAD1P1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3832,1471337,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6382,SDC1,https://ctdbase.org/detail.go?type=gene&acc=6382,,,6382.0,SDC1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SDC1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3833,1471338,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6382,SDC1,https://ctdbase.org/detail.go?type=gene&acc=6382,,,6382.0,SDC1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of SDC1 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
3834,1471339,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,181341,SDC-2,https://ctdbase.org/detail.go?type=gene&acc=181341,,,181341.0,sdc-2,6239.0,Caenorhabditis elegans,SDC-2 mRNA promotes the reaction [sodium arsenite results in increased expression of GCS-1 protein]|sdc-2 mRNA results in decreased susceptibility to sodium arsenite,,,PMID:25204677,https://www.ncbi.nlm.nih.gov/pubmed/25204677,25204677,,
3835,1471340,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6383,SDC2,https://ctdbase.org/detail.go?type=gene&acc=6383,,,6383.0,SDC2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of and affects the splicing of SDC2 mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
3836,1471341,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6383,SDC2,https://ctdbase.org/detail.go?type=gene&acc=6383,,,6383.0,SDC2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SDC2 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3837,1471342,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6383,SDC2,https://ctdbase.org/detail.go?type=gene&acc=6383,,,6383.0,SDC2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SDC2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3838,1471343,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6385,SDC4,https://ctdbase.org/detail.go?type=gene&acc=6385,,,6385.0,SDC4,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of SDC4 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
3839,1471344,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6385,SDC4,https://ctdbase.org/detail.go?type=gene&acc=6385,,,6385.0,SDC4,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SDC4 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3840,1472192,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GRIN2B protein,,,PMID:31712840|PMID:32194376,https://www.ncbi.nlm.nih.gov/pubmed/31712840|https://www.ncbi.nlm.nih.gov/pubmed/32194376,31712840|32194376,,
3841,1472193,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2905,GRIN2C,https://ctdbase.org/detail.go?type=gene&acc=2905,,,2905.0,GRIN2C,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of GRIN2C mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3842,1472194,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2906,GRIN2D,https://ctdbase.org/detail.go?type=gene&acc=2906,,,2906.0,GRIN2D,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GRIN2D mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3843,1472195,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2906,GRIN2D,https://ctdbase.org/detail.go?type=gene&acc=2906,,,2906.0,GRIN2D,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GRIN2D mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3844,1472196,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,116443,GRIN3A,https://ctdbase.org/detail.go?type=gene&acc=116443,,,116443.0,GRIN3A,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of GRIN3A mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
3845,1472489,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,407041,MIR34B,https://ctdbase.org/detail.go?type=gene&acc=407041,,,407041.0,MIR34B,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR34B mRNA,,,PMID:27054085|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/27054085|https://www.ncbi.nlm.nih.gov/pubmed/34032870,27054085|34032870,,
3846,1473081,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,442913,MIR376C,https://ctdbase.org/detail.go?type=gene&acc=442913,,,442913.0,MIR376C,10090.0,Mus musculus (house mouse),[sodium arsenite co-treated with cadmium chloride co-treated with lead acetate] results in increased expression of MIR376C mRNA,,,PMID:24080485,https://www.ncbi.nlm.nih.gov/pubmed/24080485,24080485,,
3847,1473082,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494327,MIR378A,https://ctdbase.org/detail.go?type=gene&acc=494327,,,494327.0,MIR378A,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR378A mRNA,,,PMID:29207610,https://www.ncbi.nlm.nih.gov/pubmed/29207610,29207610,,
3848,1473083,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494327,MIR378A,https://ctdbase.org/detail.go?type=gene&acc=494327,,,494327.0,MIR378A,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MIR378A mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3849,1473084,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100422867,MIR378C,https://ctdbase.org/detail.go?type=gene&acc=100422867,,,100422867.0,MIR378C,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of MIR378C mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3850,1473085,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100616498,MIR378E,https://ctdbase.org/detail.go?type=gene&acc=100616498,,,100616498.0,MIR378E,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR378E mRNA,,,PMID:29207610,https://www.ncbi.nlm.nih.gov/pubmed/29207610,29207610,,
3851,1473086,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100616321,MIR378G,https://ctdbase.org/detail.go?type=gene&acc=100616321,,,100616321.0,MIR378G,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR378G mRNA,,,PMID:29207610,https://www.ncbi.nlm.nih.gov/pubmed/29207610,29207610,,
3852,1473087,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100616259,MIR378I,https://ctdbase.org/detail.go?type=gene&acc=100616259,,,100616259.0,MIR378I,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR378I mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3853,1473088,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100616259,MIR378I,https://ctdbase.org/detail.go?type=gene&acc=100616259,,,100616259.0,MIR378I,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MIR378I mRNA,,,PMID:29207610,https://www.ncbi.nlm.nih.gov/pubmed/29207610,29207610,,
3854,1473089,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494328,MIR379,https://ctdbase.org/detail.go?type=gene&acc=494328,,,494328.0,MIR379,10090.0,Mus musculus (house mouse),[sodium arsenite co-treated with cadmium chloride co-treated with lead acetate] results in increased expression of MIR379 mRNA,,,PMID:24080485,https://www.ncbi.nlm.nih.gov/pubmed/24080485,24080485,,
3855,1473090,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494330,MIR381,https://ctdbase.org/detail.go?type=gene&acc=494330,,,494330.0,MIR381,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR381 mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
3856,1473375,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GSK3B protein modified form,,,PMID:16054901,https://www.ncbi.nlm.nih.gov/pubmed/16054901,16054901,,
3857,1473376,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),Wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of GSK3B protein]|sodium arsenite results in increased phosphorylation of and results in increased activity of GSK3B protein,,,PMID:12614848,https://www.ncbi.nlm.nih.gov/pubmed/12614848,12614848,,
3858,1473377,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),Sodium arsenite results in increased phosphorylation of GSK3B protein,,,PMID:17849503|PMID:22859221|PMID:26220687,https://www.ncbi.nlm.nih.gov/pubmed/17849503|https://www.ncbi.nlm.nih.gov/pubmed/22859221|https://www.ncbi.nlm.nih.gov/pubmed/26220687,17849503|22859221|26220687,,
3859,1473378,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased phosphorylation of GSK3B protein,,,PMID:12529330,https://www.ncbi.nlm.nih.gov/pubmed/12529330,12529330,,
3860,1473379,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116.0,Rattus norvegicus (Norway rat),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [curcumin inhibits the reaction [sodium arsenite results in decreased phosphorylation of GSK3B protein]],,,PMID:29723552,https://www.ncbi.nlm.nih.gov/pubmed/29723552,29723552,,
3861,1473380,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090.0,Mus musculus (house mouse),Salvin inhibits the reaction [sodium arsenite results in decreased activity of GSR protein],,,PMID:29854073,https://www.ncbi.nlm.nih.gov/pubmed/29854073,29854073,,
3862,1473381,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116.0,Rattus norvegicus (Norway rat),"IL1RN protein inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of GSK3B protein]|[sodium arsenite results in increased abundance of arsenic] which results in increased expression of GSK3B protein|4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of GSK3B protein]",,,PMID:35993674,https://www.ncbi.nlm.nih.gov/pubmed/35993674,35993674,,
3863,1473690,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,693122,MIR421,https://ctdbase.org/detail.go?type=gene&acc=693122,,,693122.0,MIR421,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MIR421 mRNA,,,PMID:29207610|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/29207610|https://www.ncbi.nlm.nih.gov/pubmed/34032870,29207610|34032870,,
3864,1473691,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494334,MIR422A,https://ctdbase.org/detail.go?type=gene&acc=494334,,,494334.0,MIR422A,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MIR422A mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3865,1473692,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494335,MIR423,https://ctdbase.org/detail.go?type=gene&acc=494335,,,494335.0,MIR423,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MIR423 mRNA,,,PMID:28972549|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28972549|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28972549|34032870,,
3866,1473693,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494335,MIR423,https://ctdbase.org/detail.go?type=gene&acc=494335,,,494335.0,MIR423,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of MIR423 mRNA,,,PMID:25625412,https://www.ncbi.nlm.nih.gov/pubmed/25625412,25625412,,
3867,1473694,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494336,MIR424,https://ctdbase.org/detail.go?type=gene&acc=494336,,,494336.0,MIR424,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR424 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3868,1473695,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494337,MIR425,https://ctdbase.org/detail.go?type=gene&acc=494337,,,494337.0,MIR425,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of MIR425 mRNA,,,PMID:25625412,https://www.ncbi.nlm.nih.gov/pubmed/25625412,25625412,,
3869,1473696,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100422898,MIR4255,https://ctdbase.org/detail.go?type=gene&acc=100422898,,,100422898.0,MIR4255,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR4255 mRNA,,,PMID:28972549,https://www.ncbi.nlm.nih.gov/pubmed/28972549,28972549,,
3870,1473840,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10512,SEMA3C,https://ctdbase.org/detail.go?type=gene&acc=10512,,,10512.0,SEMA3C,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SEMA3C mRNA,,,PMID:12634122,https://www.ncbi.nlm.nih.gov/pubmed/12634122,12634122,,
3871,1473841,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10512,SEMA3C,https://ctdbase.org/detail.go?type=gene&acc=10512,,,10512.0,SEMA3C,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SEMA3C mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3872,1473842,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10512,SEMA3C,https://ctdbase.org/detail.go?type=gene&acc=10512,,,10512.0,SEMA3C,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of SEMA3C mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
3873,1473843,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,223117,SEMA3D,https://ctdbase.org/detail.go?type=gene&acc=223117,,,223117.0,SEMA3D,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SEMA3D mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3874,1474305,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Lead acetate promotes the reaction [sodium arsenite results in decreased activity of GSR protein]|sodium arsenite promotes the reaction [lead acetate results in decreased activity of GSR protein],,,PMID:30510688,https://www.ncbi.nlm.nih.gov/pubmed/30510688,30510688,,
3875,1474306,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Lithium carbonate promotes the reaction [sodium arsenite results in decreased activity of GSR protein]|sodium arsenite promotes the reaction [lithium carbonate results in decreased activity of GSR protein],,,PMID:28988373,https://www.ncbi.nlm.nih.gov/pubmed/28988373,28988373,,
3876,1474454,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,124404,SEPTIN12,https://ctdbase.org/detail.go?type=gene&acc=124404,,,124404.0,SEPTIN12,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SEPTIN12 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3877,1474455,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,151354,LRATD1,https://ctdbase.org/detail.go?type=gene&acc=151354,,,151354.0,LRATD1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of LRATD1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3878,1474456,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,987,LRBA,https://ctdbase.org/detail.go?type=gene&acc=987,,,987.0,LRBA,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of LRBA mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3879,1474457,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23143,LRCH1,https://ctdbase.org/detail.go?type=gene&acc=23143,,,23143.0,LRCH1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of LRCH1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3880,1474458,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,57631,LRCH2,https://ctdbase.org/detail.go?type=gene&acc=57631,,,57631.0,LRCH2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of LRCH2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3881,1474459,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,57631,LRCH2,https://ctdbase.org/detail.go?type=gene&acc=57631,,,57631.0,LRCH2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of LRCH2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3882,1474460,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84859,LRCH3,https://ctdbase.org/detail.go?type=gene&acc=84859,,,84859.0,LRCH3,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of LRCH3 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
3883,1474461,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,116844,LRG1,https://ctdbase.org/detail.go?type=gene&acc=116844,,,116844.0,LRG1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of LRG1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3884,1474462,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,116844,LRG1,https://ctdbase.org/detail.go?type=gene&acc=116844,,,116844.0,LRG1,10090.0,Mus musculus (house mouse),Sodium arsenite affects the expression of LRG1 mRNA,,,PMID:17450228,https://www.ncbi.nlm.nih.gov/pubmed/17450228,17450228,,
3885,1474463,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55791,LRIF1,https://ctdbase.org/detail.go?type=gene&acc=55791,,,55791.0,LRIF1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of LRIF1 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
3886,1474464,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55791,LRIF1,https://ctdbase.org/detail.go?type=gene&acc=55791,,,55791.0,LRIF1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of LRIF1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3887,1474909,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4041,LRP5,https://ctdbase.org/detail.go?type=gene&acc=4041,,,4041.0,LRP5,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of LRP5 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
3888,1474910,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4040,LRP6,https://ctdbase.org/detail.go?type=gene&acc=4040,,,4040.0,LRP6,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LRP6 mRNA alternative form|lrp6 mRNA alternative form promotes the reaction [sodium arsenite results in decreased expression of CDH1 protein]|lrp6 mRNA alternative form promotes the reaction [sodium arsenite results in increased expression of VIM protein]|lrp6 mRNA alternative form promotes the reaction [sodium arsenite results in increased expression of ZEB1 protein],,,PMID:29216394,https://www.ncbi.nlm.nih.gov/pubmed/29216394,29216394,,
3889,1474911,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7804,LRP8,https://ctdbase.org/detail.go?type=gene&acc=7804,,,7804.0,LRP8,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of LRP8 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3890,1474912,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7804,LRP8,https://ctdbase.org/detail.go?type=gene&acc=7804,,,7804.0,LRP8,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of LRP8 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3891,1474913,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7804,LRP8,https://ctdbase.org/detail.go?type=gene&acc=7804,,,7804.0,LRP8,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LRP8 mRNA,,,PMID:25493608,https://www.ncbi.nlm.nih.gov/pubmed/25493608,25493608,,
3892,1474914,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4043,LRPAP1,https://ctdbase.org/detail.go?type=gene&acc=4043,,,4043.0,LRPAP1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LRPAP1 mrna|[sodium arsenite co-treated with cadmium chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of LRPAP1 mRNA,,,PMID:12634122,https://www.ncbi.nlm.nih.gov/pubmed/12634122,12634122,,
3893,1474915,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10128,LRPPRC,https://ctdbase.org/detail.go?type=gene&acc=10128,,,10128.0,LRPPRC,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of LRPPRC mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3894,1474916,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10128,LRPPRC,https://ctdbase.org/detail.go?type=gene&acc=10128,,,10128.0,LRPPRC,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of LRPPRC mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3895,1475353,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,145264,SERPINA12,https://ctdbase.org/detail.go?type=gene&acc=145264,,,145264.0,SERPINA12,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of SERPINA12 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3896,1475354,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,20700,SERPINA1A,https://ctdbase.org/detail.go?type=gene&acc=20700,,,20700.0,Serpina1a,10090.0,Mus musculus (house mouse),Sodium arsenite affects the expression of SERPINA1A mRNA,,,PMID:17450228,https://www.ncbi.nlm.nih.gov/pubmed/17450228,17450228,,
3897,1475355,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,20700,SERPINA1A,https://ctdbase.org/detail.go?type=gene&acc=20700,,,20700.0,Serpina1a,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SERPINA1A mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3898,1475356,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,20701,SERPINA1B,https://ctdbase.org/detail.go?type=gene&acc=20701,,,20701.0,Serpina1b,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of SERPINA1B mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3899,1475357,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,20701,SERPINA1B,https://ctdbase.org/detail.go?type=gene&acc=20701,,,20701.0,Serpina1b,10090.0,Mus musculus (house mouse),Sodium arsenite affects the expression of SERPINA1B mRNA,,,PMID:17450228,https://www.ncbi.nlm.nih.gov/pubmed/17450228,17450228,,
3900,1475358,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,20701,SERPINA1B,https://ctdbase.org/detail.go?type=gene&acc=20701,,,20701.0,Serpina1b,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SERPINA1B mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3901,1475359,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,20702,SERPINA1C,https://ctdbase.org/detail.go?type=gene&acc=20702,,,20702.0,Serpina1c,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SERPINA1C mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3902,1475360,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,20703,SERPINA1D,https://ctdbase.org/detail.go?type=gene&acc=20703,,,20703.0,Serpina1d,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SERPINA1D mRNA,,,PMID:17350061|PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/17350061|https://www.ncbi.nlm.nih.gov/pubmed/37682722,17350061|37682722,,
3903,1475491,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of GSTM1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3904,1475492,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of GSTM2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3905,1476088,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,654429,LRTM2,https://ctdbase.org/detail.go?type=gene&acc=654429,,,654429.0,LRTM2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of LRTM2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3906,1476089,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,222229,LRWD1,https://ctdbase.org/detail.go?type=gene&acc=222229,,,222229.0,LRWD1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of LRWD1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3907,1476670,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SERPINE1 protein|sodium arsenite inhibits the reaction [oxygen deficiency results in increased expression of SERPINE1 protein]|oxygen deficiency inhibits the reaction [sodium arsenite results in increased expression of SERPINE1 protein],,,PMID:27286880,https://www.ncbi.nlm.nih.gov/pubmed/27286880,27286880,,
3908,1476671,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),[sodium arsenite co-treated with tetradecanoylphorbol acetate] results in increased secretion of SERPINE1 protein,,,PMID:35001170,https://www.ncbi.nlm.nih.gov/pubmed/35001170,35001170,,
3909,1476672,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenite] which results in increased expression of SERPINE1 mRNA,,,PMID:32076005,https://www.ncbi.nlm.nih.gov/pubmed/32076005,32076005,,
3910,1476673,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SERPINE1 mRNA,,,PMID:26535918|PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/26535918|https://www.ncbi.nlm.nih.gov/pubmed/29301061,26535918|29301061,,
3911,1476674,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10090.0,Mus musculus (house mouse),Sodium arsenite affects the expression of SERPINE1 mrna|sodium arsenite results in increased expression of SERPINE1 protein,,,PMID:16507464,https://www.ncbi.nlm.nih.gov/pubmed/16507464,16507464,,
3912,1477356,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2987,GUK1,https://ctdbase.org/detail.go?type=gene&acc=2987,,,2987.0,GUK1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GUK1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3913,1477357,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of GULO mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3914,1477358,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of GULO protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
3915,1477510,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51454,GULP1,https://ctdbase.org/detail.go?type=gene&acc=51454,,,51454.0,GULP1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of GULP1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3916,1477511,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51454,GULP1,https://ctdbase.org/detail.go?type=gene&acc=51454,,,51454.0,GULP1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GULP1 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3917,1477512,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2990,GUSB,https://ctdbase.org/detail.go?type=gene&acc=2990,,,2990.0,GUSB,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of GUSB mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3918,1477513,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,118126072,GUSBP9,https://ctdbase.org/detail.go?type=gene&acc=118126072,,,118126072.0,GUSBP9,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GUSBP9 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3919,1477514,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,283464,GXYLT1,https://ctdbase.org/detail.go?type=gene&acc=283464,,,283464.0,GXYLT1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GXYLT1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3920,1477515,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,727936,GXYLT2,https://ctdbase.org/detail.go?type=gene&acc=727936,,,727936.0,GXYLT2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GXYLT2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3921,1477516,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,727936,GXYLT2,https://ctdbase.org/detail.go?type=gene&acc=727936,,,727936.0,GXYLT2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GXYLT2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3922,1477517,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,37419,GYG,https://ctdbase.org/detail.go?type=gene&acc=37419,,,37419.0,Gyg,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GYG mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3923,1477518,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406831,GYG1A,https://ctdbase.org/detail.go?type=gene&acc=406831,,,406831.0,gyg1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GYG1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3924,1477519,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2995,GYPC,https://ctdbase.org/detail.go?type=gene&acc=2995,,,2995.0,GYPC,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GYPC mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3925,1477520,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2997,GYS1,https://ctdbase.org/detail.go?type=gene&acc=2997,,,2997.0,GYS1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GYS1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3926,1477670,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2998,GYS2,https://ctdbase.org/detail.go?type=gene&acc=2998,,,2998.0,GYS2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GYS2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3927,1477671,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2998,GYS2,https://ctdbase.org/detail.go?type=gene&acc=2998,,,2998.0,GYS2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GYS2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3928,1477672,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2998,GYS2,https://ctdbase.org/detail.go?type=gene&acc=2998,,,2998.0,GYS2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GYS2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3929,1477673,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64412,GZF1,https://ctdbase.org/detail.go?type=gene&acc=64412,,,64412.0,GZF1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of GZF1 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3930,1477674,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3002,GZMB,https://ctdbase.org/detail.go?type=gene&acc=3002,,,3002.0,GZMB,10090.0,Mus musculus (house mouse),Immune checkpoint inhibitors inhibits the reaction [sodium arsenite results in decreased expression of GZMB protein]|sodium arsenite results in decreased expression of GZMB protein,,,PMID:34166680,https://www.ncbi.nlm.nih.gov/pubmed/34166680,34166680,,
3931,1477675,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3002,GZMB,https://ctdbase.org/detail.go?type=gene&acc=3002,,,3002.0,GZMB,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of GZMB mRNA,,,PMID:21297353,https://www.ncbi.nlm.nih.gov/pubmed/21297353,21297353,,
3932,1477676,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,14940,GZMC,https://ctdbase.org/detail.go?type=gene&acc=14940,,,14940.0,Gzmc,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of GZMC mRNA,,,PMID:21297353,https://www.ncbi.nlm.nih.gov/pubmed/21297353,21297353,,
3933,1477677,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,14941,GZMD,https://ctdbase.org/detail.go?type=gene&acc=14941,,,14941.0,Gzmd,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GZMD mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3934,1477813,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8971,H1-10,https://ctdbase.org/detail.go?type=gene&acc=8971,,,8971.0,H1-10,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of H1-10 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3935,1477814,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,339942,H1-10-AS1,https://ctdbase.org/detail.go?type=gene&acc=339942,,,339942.0,H1-10-AS1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of H1-10-AS1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3936,1477815,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3007,H1-3,https://ctdbase.org/detail.go?type=gene&acc=3007,,,3007.0,H1-3,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of H1-3 mRNA,,,PMID:24516582,https://www.ncbi.nlm.nih.gov/pubmed/24516582,24516582,,
3937,1477816,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3008,H1-4,https://ctdbase.org/detail.go?type=gene&acc=3008,,,3008.0,H1-4,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of H1-4 mRNA,,,PMID:24516582,https://www.ncbi.nlm.nih.gov/pubmed/24516582,24516582,,
3938,1478084,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4066,LYL1,https://ctdbase.org/detail.go?type=gene&acc=4066,,,4066.0,LYL1,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of LYL1 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3939,1478085,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4067,LYN,https://ctdbase.org/detail.go?type=gene&acc=4067,,,4067.0,LYN,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of LYN mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3940,1478086,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4067,LYN,https://ctdbase.org/detail.go?type=gene&acc=4067,,,4067.0,LYN,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of LYN mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3941,1478087,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,66004,LYNX1,https://ctdbase.org/detail.go?type=gene&acc=66004,,,66004.0,LYNX1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LYNX1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3942,1478088,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,116372,LYPD1,https://ctdbase.org/detail.go?type=gene&acc=116372,,,116372.0,LYPD1,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of LYPD1 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3943,1478089,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,210155,LYPD11,https://ctdbase.org/detail.go?type=gene&acc=210155,,,210155.0,Lypd11,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of LYPD11 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3944,1478090,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,137797,LYPD2,https://ctdbase.org/detail.go?type=gene&acc=137797,,,137797.0,LYPD2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LYPD2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3945,1478091,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,27076,LYPD3,https://ctdbase.org/detail.go?type=gene&acc=27076,,,27076.0,LYPD3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LYPD3 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3946,1478092,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,284348,LYPD5,https://ctdbase.org/detail.go?type=gene&acc=284348,,,284348.0,LYPD5,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of LYPD5 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3947,1478093,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,130574,LYPD6,https://ctdbase.org/detail.go?type=gene&acc=130574,,,130574.0,LYPD6,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of LYPD6 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3948,1478255,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6424,SFRP4,https://ctdbase.org/detail.go?type=gene&acc=6424,,,6424.0,SFRP4,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SFRP4 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3949,1478256,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6424,SFRP4,https://ctdbase.org/detail.go?type=gene&acc=6424,,,6424.0,SFRP4,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of SFRP4 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3950,1478257,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6424,SFRP4,https://ctdbase.org/detail.go?type=gene&acc=6424,,,6424.0,SFRP4,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SFRP4 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3951,1478258,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6425,SFRP5,https://ctdbase.org/detail.go?type=gene&acc=6425,,,6425.0,SFRP5,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SFRP5 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3952,1478259,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6425,SFRP5,https://ctdbase.org/detail.go?type=gene&acc=6425,,,6425.0,SFRP5,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SFRP5 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3953,1478260,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6425,SFRP5,https://ctdbase.org/detail.go?type=gene&acc=6425,,,6425.0,SFRP5,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of SFRP5 mRNA,,,PMID:31170414,https://www.ncbi.nlm.nih.gov/pubmed/31170414,31170414,,
3954,1478261,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,113402,SFT2D1,https://ctdbase.org/detail.go?type=gene&acc=113402,,,113402.0,SFT2D1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SFT2D1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3955,1478262,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,375035,SFT2D2,https://ctdbase.org/detail.go?type=gene&acc=375035,,,375035.0,SFT2D2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SFT2D2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3956,1479121,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4085,MAD2L1,https://ctdbase.org/detail.go?type=gene&acc=4085,,,4085.0,MAD2L1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MAD2L1 mRNA,,,PMID:16014739|PMID:17998272,https://www.ncbi.nlm.nih.gov/pubmed/16014739|https://www.ncbi.nlm.nih.gov/pubmed/17998272,16014739|17998272,,
3957,1480164,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6464,SHC1,https://ctdbase.org/detail.go?type=gene&acc=6464,,,6464.0,SHC1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SHC1 protein|folic acid inhibits the reaction [sodium arsenite results in increased expression of SHC1 protein]|shc1 protein affects the reaction [sodium arsenite results in decreased expression of GDF1 protein],,,PMID:26537450,https://www.ncbi.nlm.nih.gov/pubmed/26537450,26537450,,
3958,1480473,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4121,MAN1A1,https://ctdbase.org/detail.go?type=gene&acc=4121,,,4121.0,MAN1A1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MAN1A1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3959,1480474,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4121,MAN1A1,https://ctdbase.org/detail.go?type=gene&acc=4121,,,4121.0,MAN1A1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MAN1A1 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3960,1480475,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,11253,MAN1B1,https://ctdbase.org/detail.go?type=gene&acc=11253,,,11253.0,MAN1B1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MAN1B1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3961,1480645,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,152573,SHISA3,https://ctdbase.org/detail.go?type=gene&acc=152573,,,152573.0,SHISA3,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SHISA3 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3962,1480646,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,149345,SHISA4,https://ctdbase.org/detail.go?type=gene&acc=149345,,,149345.0,SHISA4,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SHISA4 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3963,1480647,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51246,SHISA5,https://ctdbase.org/detail.go?type=gene&acc=51246,,,51246.0,SHISA5,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of SHISA5 mRNA,,,PMID:20477944,https://www.ncbi.nlm.nih.gov/pubmed/20477944,20477944,,
3964,1480648,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,440829,SHISA8,https://ctdbase.org/detail.go?type=gene&acc=440829,,,440829.0,SHISA8,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SHISA8 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3965,1480802,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,131076,MIX23,https://ctdbase.org/detail.go?type=gene&acc=131076,,,131076.0,MIX23,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MIX23 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3966,1480803,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of MKI67 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3967,1480804,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MKI67 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3968,1480805,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MKI67 protein,,,PMID:37668303,https://www.ncbi.nlm.nih.gov/pubmed/37668303,37668303,,
3969,1480806,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10116.0,Rattus norvegicus (Norway rat),Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of MKI67 protein]|sodium arsenite results in decreased expression of MKI67 protein,,,PMID:21964460,https://www.ncbi.nlm.nih.gov/pubmed/21964460,21964460,,
3970,1480807,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100136944,MKK6A,https://ctdbase.org/detail.go?type=gene&acc=100136944,,,100136944.0,,8030.0,Salmo salar (Atlantic salmon),Sodium arsenite results in increased activity of MKK6A protein|sodium arsenite promotes the reaction [MKK6A protein results in increased phosphorylation of and results in increased activity of P38A protein],,,PMID:18754769,https://www.ncbi.nlm.nih.gov/pubmed/18754769,18754769,,
3971,1481609,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100330105,MAP1LC3CL,https://ctdbase.org/detail.go?type=gene&acc=100330105,,,100330105.0,map1lc3cl,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MAP1LC3CL mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3972,1481610,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55201,MAP1S,https://ctdbase.org/detail.go?type=gene&acc=55201,,,55201.0,MAP1S,9606.0,Homo sapiens (human),Sodium arsenite promotes the reaction [MAP1S protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
3973,1481611,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55201,MAP1S,https://ctdbase.org/detail.go?type=gene&acc=55201,,,55201.0,MAP1S,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MAP1S mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3974,1481612,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,562808,MAP1SA,https://ctdbase.org/detail.go?type=gene&acc=562808,,,562808.0,map1sa,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MAP1SA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3975,1481613,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MAP2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3976,1481614,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MAP2 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3977,1551299,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,15122,HBA-A1,https://ctdbase.org/detail.go?type=gene&acc=15122,,,15122.0,Hba-a1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of HBA-A1 protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
3978,1551300,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,15122,HBA-A1,https://ctdbase.org/detail.go?type=gene&acc=15122,,,15122.0,Hba-a1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of HBA-A1 mRNA,,,PMID:19072884,https://www.ncbi.nlm.nih.gov/pubmed/19072884,19072884,,
3979,1551301,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,15126,HBA-X,https://ctdbase.org/detail.go?type=gene&acc=15126,,,15126.0,Hba-x,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of HBA-X mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3980,1551302,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3043,HBB,https://ctdbase.org/detail.go?type=gene&acc=3043,,,3043.0,HBB,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of HBB mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3981,1551303,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3043,HBB,https://ctdbase.org/detail.go?type=gene&acc=3043,,,3043.0,HBB,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of HBB mRNA,,,PMID:19072884,https://www.ncbi.nlm.nih.gov/pubmed/19072884,19072884,,
3982,1551304,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3043,HBB,https://ctdbase.org/detail.go?type=gene&acc=3043,,,3043.0,HBB,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of HBB protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3983,1551305,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,15129,HBB-B1,https://ctdbase.org/detail.go?type=gene&acc=15129,,,15129.0,Hbb-b1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of HBB-B1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3984,1551306,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,15135,HBB-Y,https://ctdbase.org/detail.go?type=gene&acc=15135,,,15135.0,Hbb-y,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of HBB-Y mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3985,1551307,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3046,HBE1,https://ctdbase.org/detail.go?type=gene&acc=3046,,,3046.0,HBE1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of HBE1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3986,1551308,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1839,HBEGF,https://ctdbase.org/detail.go?type=gene&acc=1839,,,1839.0,HBEGF,9606.0,Homo sapiens (human),HBEGF protein affects the reaction [sodium arsenite results in increased phosphorylation of EGFR protein]|sodium arsenite results in increased expression of HBEGF protein,,,PMID:32695675,https://www.ncbi.nlm.nih.gov/pubmed/32695675,32695675,,
3987,1551818,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598.0,MVK,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of MVK mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3988,1551819,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598.0,MVK,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MVK protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
3989,1551825,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3059,HCLS1,https://ctdbase.org/detail.go?type=gene&acc=3059,,,3059.0,HCLS1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of HCLS1 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3990,1551826,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3059,HCLS1,https://ctdbase.org/detail.go?type=gene&acc=3059,,,3059.0,HCLS1,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of HCLS1 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3991,1551827,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,610,HCN2,https://ctdbase.org/detail.go?type=gene&acc=610,,,610.0,HCN2,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of HCN2 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3992,1551828,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,610,HCN2,https://ctdbase.org/detail.go?type=gene&acc=610,,,610.0,HCN2,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of HCN2 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
3993,1551993,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,83933,HDAC10,https://ctdbase.org/detail.go?type=gene&acc=83933,,,83933.0,HDAC10,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of HDAC10 mRNA,,,PMID:32844245,https://www.ncbi.nlm.nih.gov/pubmed/32844245,32844245,,
3994,1551994,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,79885,HDAC11,https://ctdbase.org/detail.go?type=gene&acc=79885,,,79885.0,HDAC11,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of HDAC11 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3995,1551995,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3066,HDAC2,https://ctdbase.org/detail.go?type=gene&acc=3066,,,3066.0,HDAC2,9606.0,Homo sapiens (human),Estradiol inhibits the reaction [sodium arsenite results in increased expression of HDAC2 mrna]|sodium arsenite results in increased expression of HDAC2 mRNA,,,PMID:22952798,https://www.ncbi.nlm.nih.gov/pubmed/22952798,22952798,,
3996,1551996,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3066,HDAC2,https://ctdbase.org/detail.go?type=gene&acc=3066,,,3066.0,HDAC2,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of HDAC2 mRNA,,,PMID:19822182,https://www.ncbi.nlm.nih.gov/pubmed/19822182,19822182,,
3997,1551997,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,101927768,HDAC2-AS2,https://ctdbase.org/detail.go?type=gene&acc=101927768,,,101927768.0,HDAC2-AS2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of HDAC2-AS2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3998,1551998,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8841,HDAC3,https://ctdbase.org/detail.go?type=gene&acc=8841,,,8841.0,HDAC3,9606.0,Homo sapiens (human),Estradiol inhibits the reaction [sodium arsenite results in increased expression of HDAC3 mrna]|sodium arsenite results in increased expression of HDAC3 mRNA,,,PMID:22952798,https://www.ncbi.nlm.nih.gov/pubmed/22952798,22952798,,
3999,1551999,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8841,HDAC3,https://ctdbase.org/detail.go?type=gene&acc=8841,,,8841.0,HDAC3,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of HDAC3 mRNA,,,PMID:32844245,https://www.ncbi.nlm.nih.gov/pubmed/32844245,32844245,,
4000,1552000,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8841,HDAC3,https://ctdbase.org/detail.go?type=gene&acc=8841,,,8841.0,HDAC3,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of HDAC3 mRNA,,,PMID:19822182,https://www.ncbi.nlm.nih.gov/pubmed/19822182,19822182,,
4001,1552001,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8841,HDAC3,https://ctdbase.org/detail.go?type=gene&acc=8841,,,8841.0,HDAC3,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of HDAC3 protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
4002,1552002,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9759,HDAC4,https://ctdbase.org/detail.go?type=gene&acc=9759,,,9759.0,HDAC4,9031.0,Gallus gallus (chicken),Sodium arsenite results in increased expression of HDAC4 mRNA,,,PMID:21503876,https://www.ncbi.nlm.nih.gov/pubmed/21503876,21503876,,
4003,1552735,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23593,HEBP2,https://ctdbase.org/detail.go?type=gene&acc=23593,,,23593.0,HEBP2,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of HEBP2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4004,1553426,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4628,MYH10,https://ctdbase.org/detail.go?type=gene&acc=4628,,,4628.0,MYH10,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MYH10 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4005,1553427,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4628,MYH10,https://ctdbase.org/detail.go?type=gene&acc=4628,,,4628.0,MYH10,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MYH10 mRNA,,,PMID:31170414,https://www.ncbi.nlm.nih.gov/pubmed/31170414,31170414,,
4006,1553428,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4628,MYH10,https://ctdbase.org/detail.go?type=gene&acc=4628,,,4628.0,MYH10,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of MYH10 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
4007,1463862,443879,Drug Gene Interaction database (DGIdb),Tolterodine,,TOLTERODINE,https://www.dgidb.org/drugs/rxcui:119565,,CHRM5,https://www.dgidb.org/genes/hgnc:1954,,,1133.0,CHRM5,9606.0,Homo sapiens (human),,,,,,,,
4008,1463863,443928,ChEMBL,Paramethasone Acetate,CHEMBL1200342,PARAMETHASONE ACETATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200342/,CHEMBL2034,Glucocorticoid receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2034/,P04150,Glucocorticoid receptor,2908.0,NR3C1,9606.0,Homo sapiens (human),Glucocorticoid receptor agonist,,,PMID:4862587,https://www.ncbi.nlm.nih.gov/pubmed/4862587,4862587,,
4009,1463864,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,C506643,liposomal doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=C506643,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Liposomal doxorubicin results in decreased expression of CCND1 protein,,,PMID:27923599,https://www.ncbi.nlm.nih.gov/pubmed/27923599,27923599,,
4010,1464029,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,C506643,liposomal doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=C506643,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,9606.0,Homo sapiens (human),Liposomal doxorubicin results in increased phosphorylation of CHEK2 protein,,,PMID:27923599,https://www.ncbi.nlm.nih.gov/pubmed/27923599,27923599,,
4011,1464030,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,C506643,liposomal doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=C506643,140628,GATA5,https://ctdbase.org/detail.go?type=gene&acc=140628,,,140628.0,GATA5,7955.0,Danio rerio (zebrafish),Liposomal doxorubicin results in decreased expression of GATA5 mRNA,,,PMID:24853142,https://www.ncbi.nlm.nih.gov/pubmed/24853142,24853142,,
4012,1464031,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,C506643,liposomal doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=C506643,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),Liposomal doxorubicin results in increased phosphorylation of H2AX protein,,,PMID:27923599,https://www.ncbi.nlm.nih.gov/pubmed/27923599,27923599,,
4013,1464032,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,C506643,liposomal doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=C506643,9464,HAND2,https://ctdbase.org/detail.go?type=gene&acc=9464,,,9464.0,HAND2,7955.0,Danio rerio (zebrafish),Liposomal doxorubicin results in decreased expression of HAND2 mRNA,,,PMID:24853142,https://www.ncbi.nlm.nih.gov/pubmed/24853142,24853142,,
4014,1464033,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,C506643,liposomal doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=C506643,3037,HAS2,https://ctdbase.org/detail.go?type=gene&acc=3037,,,3037.0,HAS2,7955.0,Danio rerio (zebrafish),Liposomal doxorubicin results in decreased expression of HAS2 mRNA,,,PMID:24853142,https://www.ncbi.nlm.nih.gov/pubmed/24853142,24853142,,
4015,1464217,443939,Drug Gene Interaction database (DGIdb),Doxorubicin Hydrochloride,,DOXORUBICIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:142433,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
4016,1464218,443939,Drug Gene Interaction database (DGIdb),Doxorubicin Hydrochloride,,DOXORUBICIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:142433,,CYP1A1,https://www.dgidb.org/genes/hgnc:2595,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),,,,,,,,
4017,1464219,443939,Drug Gene Interaction database (DGIdb),Doxorubicin Hydrochloride,,DOXORUBICIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:142433,,SP3,https://www.dgidb.org/genes/hgnc:11208,,,6670.0,SP3,9606.0,Homo sapiens (human),,,,,,,,
4018,1464220,443939,Drug Gene Interaction database (DGIdb),Doxorubicin Hydrochloride,,DOXORUBICIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:142433,,TGM2,https://www.dgidb.org/genes/hgnc:11778,,,7052.0,TGM2,9606.0,Homo sapiens (human),,,,,,,,
4019,1464221,443939,Drug Gene Interaction database (DGIdb),Doxorubicin Hydrochloride,,DOXORUBICIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:142433,,FCGR3A,https://www.dgidb.org/genes/hgnc:3619,,,2214.0,FCGR3A,9606.0,Homo sapiens (human),,,,,,,,
4020,1464222,443939,Drug Gene Interaction database (DGIdb),Doxorubicin Hydrochloride,,DOXORUBICIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:142433,,PIK3CB,https://www.dgidb.org/genes/hgnc:8976,,,5291.0,PIK3CB,9606.0,Homo sapiens (human),,,,,,,,
4021,1464223,443939,Drug Gene Interaction database (DGIdb),Doxorubicin Hydrochloride,,DOXORUBICIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:142433,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
4022,1464224,443951,IUPHAR/BPS Guide to PHARMACOLOGY,Terguride,56,terguride,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,8,5-HT2C receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=8,P28335,5-hydroxytryptamine receptor 2C,3358.0,HTR2C,9606.0,Homo sapiens (human),Antagonist,pKi,7.3,PMID:12388666,https://www.ncbi.nlm.nih.gov/pubmed/12388666,12388666,,
4023,1464225,443958,Drug Gene Interaction database (DGIdb),Amcinonide,,AMCINONIDE,https://www.dgidb.org/drugs/rxcui:17652,,NR3C1,https://www.dgidb.org/genes/hgnc:7978,,,2908.0,NR3C1,9606.0,Homo sapiens (human),Agonist,,,,,,,
4024,1464226,443958,ChEMBL,Amcinonide,CHEMBL1200732,AMCINONIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200732/,CHEMBL2034,Glucocorticoid receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2034/,P04150,Glucocorticoid receptor,2908.0,NR3C1,9606.0,Homo sapiens (human),Glucocorticoid receptor agonist,,,PMID:16895953,https://www.ncbi.nlm.nih.gov/pubmed/16895953,16895953,,
4025,1464387,443967,Drug Gene Interaction database (DGIdb),Betamethasone Acetate,,BETAMETHASONE ACETATE,https://www.dgidb.org/drugs/rxcui:1516,,NR3C1,https://www.dgidb.org/genes/hgnc:7978,,,2908.0,NR3C1,9606.0,Homo sapiens (human),Agonist,,,,,,,
4026,1464388,443980,ChEMBL,Flumethasone Pivalate,CHEMBL1200877,FLUMETHASONE PIVALATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200877/,CHEMBL2034,Glucocorticoid receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2034/,P04150,Glucocorticoid receptor,2908.0,NR3C1,9606.0,Homo sapiens (human),Glucocorticoid receptor agonist,,,PMID:3212030,https://www.ncbi.nlm.nih.gov/pubmed/3212030,3212030,,
4027,1464389,444020,Drug Gene Interaction database (DGIdb),Voglibose,,VOGLIBOSE,https://www.dgidb.org/drugs/ncit:C95221,,SI,https://www.dgidb.org/genes/hgnc:10856,,,6476.0,SI,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4028,1464390,444020,Comparative Toxicogenomics Database (CTD),Voglibose,C102817,voglibose,https://ctdbase.org/detail.go?type=chem&acc=C102817,248,ALPI,https://ctdbase.org/detail.go?type=gene&acc=248,,,248.0,ALPI,10116.0,Rattus norvegicus (Norway rat),Voglibose results in increased activity of ALPI protein,,,PMID:12560160,https://www.ncbi.nlm.nih.gov/pubmed/12560160,12560160,,
4029,1464391,444020,Comparative Toxicogenomics Database (CTD),Voglibose,C102817,voglibose,https://ctdbase.org/detail.go?type=chem&acc=C102817,1803,DPP4,https://ctdbase.org/detail.go?type=gene&acc=1803,,,1803.0,DPP4,10090.0,Mus musculus (house mouse),Voglibose results in decreased expression of and results in decreased activity of DPP4 protein,,,PMID:19208898,https://www.ncbi.nlm.nih.gov/pubmed/19208898,19208898,,
4030,1464392,444020,Comparative Toxicogenomics Database (CTD),Voglibose,C102817,voglibose,https://ctdbase.org/detail.go?type=chem&acc=C102817,2548,GAA,https://ctdbase.org/detail.go?type=gene&acc=2548,,,2548.0,GAA,9606.0,Homo sapiens (human),Voglibose results in decreased activity of GAA protein,,,PMID:12560160,https://www.ncbi.nlm.nih.gov/pubmed/12560160,12560160,,
4031,1464393,444020,Comparative Toxicogenomics Database (CTD),Voglibose,C102817,voglibose,https://ctdbase.org/detail.go?type=chem&acc=C102817,2641,GCG,https://ctdbase.org/detail.go?type=gene&acc=2641,,,2641.0,GCG,10090.0,Mus musculus (house mouse),Voglibose results in increased secretion of GCG protein|voglibose results in increased expression of GCG mrna|voglibose results in increased expression of GCG protein,,,PMID:19208898,https://www.ncbi.nlm.nih.gov/pubmed/19208898,19208898,,
4032,1480951,444539,Comparative Toxicogenomics Database (CTD),Cinnamic Acid,C029010,cinnamic acid,https://ctdbase.org/detail.go?type=chem&acc=C029010,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Cinnamic acid inhibits the reaction [cyclophosphamide affects the activity of CAT protein],,,PMID:22285266,https://www.ncbi.nlm.nih.gov/pubmed/22285266,22285266,,
4033,1480952,444539,Comparative Toxicogenomics Database (CTD),Cinnamic Acid,C029010,cinnamic acid,https://ctdbase.org/detail.go?type=chem&acc=C029010,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Cinnamic acid inhibits the reaction [cisplatin results in decreased activity of CAT protein],,,PMID:23959918,https://www.ncbi.nlm.nih.gov/pubmed/23959918,23959918,,
4034,1457224,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8405,SPOP,https://ctdbase.org/detail.go?type=gene&acc=8405,,,8405.0,SPOP,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPOP mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4035,1457225,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8405,SPOP,https://ctdbase.org/detail.go?type=gene&acc=8405,,,8405.0,SPOP,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SPOP mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4036,1457226,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4037,1457227,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SPP1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4038,1457907,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5552,SRGN,https://ctdbase.org/detail.go?type=gene&acc=5552,,,5552.0,SRGN,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SRGN mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
4039,1457908,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6729,SRP54,https://ctdbase.org/detail.go?type=gene&acc=6729,,,6729.0,SRP54,9606.0,Homo sapiens (human),Trichostatin A affects the expression of SRP54 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4040,1457909,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6734,SRPRA,https://ctdbase.org/detail.go?type=gene&acc=6734,,,6734.0,SRPRA,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SRPRA mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4041,1457910,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,58477,SRPRB,https://ctdbase.org/detail.go?type=gene&acc=58477,,,58477.0,SRPRB,9606.0,Homo sapiens (human),Trichostatin A affects the expression of SRPRB mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4042,1457911,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8406,SRPX,https://ctdbase.org/detail.go?type=gene&acc=8406,,,8406.0,SRPX,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRPX mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4043,1457912,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8406,SRPX,https://ctdbase.org/detail.go?type=gene&acc=8406,,,8406.0,SRPX,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SRPX mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4044,1457913,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84530,SRRM4,https://ctdbase.org/detail.go?type=gene&acc=84530,,,84530.0,SRRM4,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRRM4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4045,1457914,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84530,SRRM4,https://ctdbase.org/detail.go?type=gene&acc=84530,,,84530.0,SRRM4,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SRRM4 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4046,1457915,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6429,SRSF4,https://ctdbase.org/detail.go?type=gene&acc=6429,,,6429.0,SRSF4,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SRSF4 mRNA,,,PMID:33770205,https://www.ncbi.nlm.nih.gov/pubmed/33770205,33770205,,
4047,1463556,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,64786,TBC1D15,https://ctdbase.org/detail.go?type=gene&acc=64786,,,64786.0,TBC1D15,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TBC1D15 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4048,1464438,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6925,TCF4,https://ctdbase.org/detail.go?type=gene&acc=6925,,,6925.0,TCF4,9606.0,Homo sapiens (human),Trichostatin A inhibits the reaction [dibutyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]|trichostatin A inhibits the reaction [butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]],,,PMID:22552774,https://www.ncbi.nlm.nih.gov/pubmed/22552774,22552774,,
4049,1464439,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6925,TCF4,https://ctdbase.org/detail.go?type=gene&acc=6925,,,6925.0,TCF4,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TCF4 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4050,1464440,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6934,TCF7L2,https://ctdbase.org/detail.go?type=gene&acc=6934,,,6934.0,TCF7L2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TCF7L2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4051,1464441,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6934,TCF7L2,https://ctdbase.org/detail.go?type=gene&acc=6934,,,6934.0,TCF7L2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TCF7L2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4052,1464442,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,56892,TCIM,https://ctdbase.org/detail.go?type=gene&acc=56892,,,56892.0,TCIM,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TCIM mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4053,1464443,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,56892,TCIM,https://ctdbase.org/detail.go?type=gene&acc=56892,,,56892.0,TCIM,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TCIM mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4054,1464839,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,157695,TDRP,https://ctdbase.org/detail.go?type=gene&acc=157695,,,157695.0,TDRP,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of TDRP mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4055,1464840,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7003,TEAD1,https://ctdbase.org/detail.go?type=gene&acc=7003,,,7003.0,TEAD1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TEAD1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4056,1465752,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7022,TFAP2C,https://ctdbase.org/detail.go?type=gene&acc=7022,,,7022.0,TFAP2C,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4057,1465753,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7022,TFAP2C,https://ctdbase.org/detail.go?type=gene&acc=7022,,,7022.0,TFAP2C,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of TFAP2C mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4058,1465754,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7023,TFAP4,https://ctdbase.org/detail.go?type=gene&acc=7023,,,7023.0,TFAP4,9606.0,Homo sapiens (human),Trichostatin A affects the expression of TFAP4 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4059,1465755,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,29842,TFCP2L1,https://ctdbase.org/detail.go?type=gene&acc=29842,,,29842.0,TFCP2L1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of TFCP2L1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4060,1465756,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7027,TFDP1,https://ctdbase.org/detail.go?type=gene&acc=7027,,,7027.0,TFDP1,9606.0,Homo sapiens (human),Trichostatin A affects the expression of TFDP1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4061,1465757,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7029,TFDP2,https://ctdbase.org/detail.go?type=gene&acc=7029,,,7029.0,TFDP2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4062,1465758,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7029,TFDP2,https://ctdbase.org/detail.go?type=gene&acc=7029,,,7029.0,TFDP2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TFDP2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4063,1465759,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7031,TFF1,https://ctdbase.org/detail.go?type=gene&acc=7031,,,7031.0,TFF1,9606.0,Homo sapiens (human),[decitabine co-treated with trichostatin A] affects the expression of TFF1 mRNA,,,PMID:18264725,https://www.ncbi.nlm.nih.gov/pubmed/18264725,18264725,,
4064,1465760,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7031,TFF1,https://ctdbase.org/detail.go?type=gene&acc=7031,,,7031.0,TFF1,9606.0,Homo sapiens (human),[decitabine co-treated with trichostatin A] results in increased expression of TFF1 mRNA,,,PMID:17533736,https://www.ncbi.nlm.nih.gov/pubmed/17533736,17533736,,
4065,1465761,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7031,TFF1,https://ctdbase.org/detail.go?type=gene&acc=7031,,,7031.0,TFF1,9606.0,Homo sapiens (human),Trichostatin A inhibits the reaction [[raloxifene hydrochloride co-treated with estradiol] results in increased expression of TFF1 mrna]|[raloxifene hydrochloride co-treated with trichostatin A] results in decreased expression of TFF1 mrna|trichostatin A results in decreased expression of TFF1 mRNA,,,PMID:22476901,https://www.ncbi.nlm.nih.gov/pubmed/22476901,22476901,,
4066,1467908,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9874,TLK1,https://ctdbase.org/detail.go?type=gene&acc=9874,,,9874.0,TLK1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TLK1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4067,1467909,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11011,TLK2,https://ctdbase.org/detail.go?type=gene&acc=11011,,,11011.0,TLK2,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of TLK2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4068,1467910,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11011,TLK2,https://ctdbase.org/detail.go?type=gene&acc=11011,,,11011.0,TLK2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TLK2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4069,1467911,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11011,TLK2,https://ctdbase.org/detail.go?type=gene&acc=11011,,,11011.0,TLK2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TLK2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4070,1469814,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,169200,TMEM64,https://ctdbase.org/detail.go?type=gene&acc=169200,,,169200.0,TMEM64,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM64 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4071,1469815,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,169200,TMEM64,https://ctdbase.org/detail.go?type=gene&acc=169200,,,169200.0,TMEM64,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of TMEM64 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4072,1469816,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,137695,TMEM68,https://ctdbase.org/detail.go?type=gene&acc=137695,,,137695.0,TMEM68,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TMEM68 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4073,1471149,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51330,TNFRSF12A,https://ctdbase.org/detail.go?type=gene&acc=51330,,,51330.0,TNFRSF12A,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of TNFRSF12A mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4074,1471766,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,100003572,TNNT3B,https://ctdbase.org/detail.go?type=gene&acc=100003572,,,100003572.0,tnnt3b,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of TNNT3B mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4075,1473687,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9830,TRIM14,https://ctdbase.org/detail.go?type=gene&acc=9830,,,9830.0,TRIM14,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM14 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4076,1473688,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9830,TRIM14,https://ctdbase.org/detail.go?type=gene&acc=9830,,,9830.0,TRIM14,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of TRIM14 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4077,1473689,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,373,TRIM23,https://ctdbase.org/detail.go?type=gene&acc=373,,,373.0,TRIM23,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRIM23 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4078,1475917,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,284900,TTC28-AS1,https://ctdbase.org/detail.go?type=gene&acc=284900,,,284900.0,TTC28-AS1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TTC28-AS1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4079,1475918,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,83894,TTC29,https://ctdbase.org/detail.go?type=gene&acc=83894,,,83894.0,TTC29,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of TTC29 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4080,1475919,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7267,TTC3,https://ctdbase.org/detail.go?type=gene&acc=7267,,,7267.0,TTC3,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4081,1475920,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7267,TTC3,https://ctdbase.org/detail.go?type=gene&acc=7267,,,7267.0,TTC3,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of TTC3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4082,1476518,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23318,TUT4,https://ctdbase.org/detail.go?type=gene&acc=23318,,,23318.0,TUT4,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TUT4 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4083,1476519,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,780776,TVP23A,https://ctdbase.org/detail.go?type=gene&acc=780776,,,780776.0,TVP23A,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TVP23A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4084,1476520,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,780776,TVP23A,https://ctdbase.org/detail.go?type=gene&acc=780776,,,780776.0,TVP23A,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of TVP23A mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4085,1477223,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7325,UBE2E2,https://ctdbase.org/detail.go?type=gene&acc=7325,,,7325.0,UBE2E2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2E2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4086,1477224,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7325,UBE2E2,https://ctdbase.org/detail.go?type=gene&acc=7325,,,7325.0,UBE2E2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of UBE2E2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4087,1477225,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10477,UBE2E3,https://ctdbase.org/detail.go?type=gene&acc=10477,,,10477.0,UBE2E3,9606.0,Homo sapiens (human),Trichostatin A affects the expression of UBE2E3 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4088,1477226,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,140739,UBE2F,https://ctdbase.org/detail.go?type=gene&acc=140739,,,140739.0,UBE2F,9606.0,Homo sapiens (human),Trichostatin A affects the expression of UBE2F mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4089,1477227,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7328,UBE2H,https://ctdbase.org/detail.go?type=gene&acc=7328,,,7328.0,UBE2H,9606.0,Homo sapiens (human),Trichostatin A affects the expression of UBE2H mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4090,1477228,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7328,UBE2H,https://ctdbase.org/detail.go?type=gene&acc=7328,,,7328.0,UBE2H,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of UBE2H mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4091,1477229,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51366,UBR5,https://ctdbase.org/detail.go?type=gene&acc=51366,,,51366.0,UBR5,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of UBR5 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4092,1477230,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7329,UBE2I,https://ctdbase.org/detail.go?type=gene&acc=7329,,,7329.0,UBE2I,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2I mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4093,1477231,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7329,UBE2I,https://ctdbase.org/detail.go?type=gene&acc=7329,,,7329.0,UBE2I,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of UBE2I mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4094,1479413,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84101,USP44,https://ctdbase.org/detail.go?type=gene&acc=84101,,,84101.0,USP44,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of USP44 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4095,1479414,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,85015,USP45,https://ctdbase.org/detail.go?type=gene&acc=85015,,,85015.0,USP45,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of USP45 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4096,1479415,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55031,USP47,https://ctdbase.org/detail.go?type=gene&acc=55031,,,55031.0,USP47,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of USP47 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4097,1479416,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25862,USP49,https://ctdbase.org/detail.go?type=gene&acc=25862,,,25862.0,USP49,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP49 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4098,1479417,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25862,USP49,https://ctdbase.org/detail.go?type=gene&acc=25862,,,25862.0,USP49,9606.0,Homo sapiens (human),Trichostatin A affects the expression of USP49 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4099,1479418,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25862,USP49,https://ctdbase.org/detail.go?type=gene&acc=25862,,,25862.0,USP49,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of USP49 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4100,1479419,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54532,USP53,https://ctdbase.org/detail.go?type=gene&acc=54532,,,54532.0,USP53,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of USP53 mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
4101,1480025,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606.0,Homo sapiens (human),Trichostatin A inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein],,,PMID:19281832,https://www.ncbi.nlm.nih.gov/pubmed/19281832,19281832,,
4102,1480026,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of VCAM1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4103,1480027,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1462,VCAN,https://ctdbase.org/detail.go?type=gene&acc=1462,,,1462.0,VCAN,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VCAN mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4104,1480028,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1462,VCAN,https://ctdbase.org/detail.go?type=gene&acc=1462,,,1462.0,VCAN,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of VCAN mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4105,1480029,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7414,VCL,https://ctdbase.org/detail.go?type=gene&acc=7414,,,7414.0,VCL,9606.0,Homo sapiens (human),Trichostatin A affects the expression of VCL mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4106,1480030,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7414,VCL,https://ctdbase.org/detail.go?type=gene&acc=7414,,,7414.0,VCL,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of VCL mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4107,1481430,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,338917,VSX2,https://ctdbase.org/detail.go?type=gene&acc=338917,,,338917.0,VSX2,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of VSX2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4108,1481431,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,79679,VTCN1,https://ctdbase.org/detail.go?type=gene&acc=79679,,,79679.0,VTCN1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of VTCN1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4109,1481432,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,403026,VTNB,https://ctdbase.org/detail.go?type=gene&acc=403026,,,403026.0,vtnb,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of VTNB mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4110,1551711,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54677,CROT,https://ctdbase.org/detail.go?type=gene&acc=54677,,,54677.0,CROT,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of CROT mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4111,1551712,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55118,CRTAC1,https://ctdbase.org/detail.go?type=gene&acc=55118,,,55118.0,CRTAC1,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of CRTAC1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4112,1551713,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10491,CRTAP,https://ctdbase.org/detail.go?type=gene&acc=10491,,,10491.0,CRTAP,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRTAP mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4113,1551714,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10491,CRTAP,https://ctdbase.org/detail.go?type=gene&acc=10491,,,10491.0,CRTAP,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of CRTAP mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4114,1551715,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,64784,CRTC3,https://ctdbase.org/detail.go?type=gene&acc=64784,,,64784.0,CRTC3,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of CRTC3 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4115,1551716,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1406,CRX,https://ctdbase.org/detail.go?type=gene&acc=1406,,,1406.0,CRX,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of CRX mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4116,1551717,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,373653,CRX.S,https://ctdbase.org/detail.go?type=gene&acc=373653,,,373653.0,crx.S,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of CRX.S mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4117,1551718,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1407,CRY1,https://ctdbase.org/detail.go?type=gene&acc=1407,,,1407.0,CRY1,9606.0,Homo sapiens (human),Trichostatin A affects the expression of CRY1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4118,1552638,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,767676,CTDSPLB,https://ctdbase.org/detail.go?type=gene&acc=767676,,,767676.0,ctdsplb,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of CTDSPLB mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4119,1552639,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,100194970,CTGF,https://ctdbase.org/detail.go?type=gene&acc=100194970,,,100194970.0,,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of CTGF mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
4120,1552640,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,115908,CTHRC1,https://ctdbase.org/detail.go?type=gene&acc=115908,,,115908.0,CTHRC1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTHRC1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4121,1552641,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,115908,CTHRC1,https://ctdbase.org/detail.go?type=gene&acc=115908,,,115908.0,CTHRC1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of CTHRC1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4122,1552642,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1493,CTLA4,https://ctdbase.org/detail.go?type=gene&acc=1493,,,1493.0,CTLA4,10090.0,Mus musculus (house mouse),Trichostatin A results in increased expression of CTLA4 protein,,,PMID:19545742,https://www.ncbi.nlm.nih.gov/pubmed/19545742,19545742,,
4123,1552643,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),[3-deazaneplanocin co-treated with trichostatin A] affects the expression of CTNNB1 protein,,,PMID:18538736,https://www.ncbi.nlm.nih.gov/pubmed/18538736,18538736,,
4124,1552644,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTNNB1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4125,1552645,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Trichostatin A inhibits the reaction [butylbenzyl phthalate affects the localization of CTNNB1 protein]|trichostatin A inhibits the reaction [dibutyl phthalate affects the localization of CTNNB1 protein],,,PMID:22552774,https://www.ncbi.nlm.nih.gov/pubmed/22552774,22552774,,
4126,1552646,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of CTNNB1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4127,1552647,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10090.0,Mus musculus (house mouse),[estradiol dipropionate co-treated with trichostatin A] results in decreased expression of CTNNB1 protein,,,PMID:15930180,https://www.ncbi.nlm.nih.gov/pubmed/15930180,15930180,,
4128,1552840,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1075,CTSC,https://ctdbase.org/detail.go?type=gene&acc=1075,,,1075.0,CTSC,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTSC mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4129,1552841,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1075,CTSC,https://ctdbase.org/detail.go?type=gene&acc=1075,,,1075.0,CTSC,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of CTSC mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4130,1552842,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1515,CTSV,https://ctdbase.org/detail.go?type=gene&acc=1515,,,1515.0,CTSV,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTSV mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4131,1552843,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1515,CTSV,https://ctdbase.org/detail.go?type=gene&acc=1515,,,1515.0,CTSV,9606.0,Homo sapiens (human),Trichostatin A affects the expression of CTSV mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4132,1553642,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,352944,CXCL12A,https://ctdbase.org/detail.go?type=gene&acc=352944,,,352944.0,cxcl12a,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of CXCL12A mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4133,1553643,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9547,CXCL14,https://ctdbase.org/detail.go?type=gene&acc=9547,,,9547.0,CXCL14,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4134,1553644,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9547,CXCL14,https://ctdbase.org/detail.go?type=gene&acc=9547,,,9547.0,CXCL14,9606.0,Homo sapiens (human),Trichostatin A results in decreased acetylation of CXCL14 protein,,,PMID:20562917,https://www.ncbi.nlm.nih.gov/pubmed/20562917,20562917,,
4135,1553645,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9547,CXCL14,https://ctdbase.org/detail.go?type=gene&acc=9547,,,9547.0,CXCL14,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of CXCL14 mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
4136,1553646,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9547,CXCL14,https://ctdbase.org/detail.go?type=gene&acc=9547,,,9547.0,CXCL14,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of CXCL14 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4137,1553647,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of CXCL2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4138,1553648,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6374,CXCL5,https://ctdbase.org/detail.go?type=gene&acc=6374,,,6374.0,CXCL5,9606.0,Homo sapiens (human),Trichostatin A results in decreased acetylation of CXCL5 protein,,,PMID:20562917,https://www.ncbi.nlm.nih.gov/pubmed/20562917,20562917,,
4139,1553649,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6374,CXCL5,https://ctdbase.org/detail.go?type=gene&acc=6374,,,6374.0,CXCL5,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of CXCL5 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4140,1553650,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6372,CXCL6,https://ctdbase.org/detail.go?type=gene&acc=6372,,,6372.0,CXCL6,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of CXCL6 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4141,1553651,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Trichostatin A promotes the reaction [lipopolysaccharides results in increased expression of and results in increased secretion of CXCL8 protein],,,PMID:12470611,https://www.ncbi.nlm.nih.gov/pubmed/12470611,12470611,,
4142,1517817,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2720,GLB1,https://ctdbase.org/detail.go?type=gene&acc=2720,,,2720.0,GLB1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GLB1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4143,1517818,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,89944,GLB1L2,https://ctdbase.org/detail.go?type=gene&acc=89944,,,89944.0,GLB1L2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GLB1L2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4144,1551610,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10234,LRRC17,https://ctdbase.org/detail.go?type=gene&acc=10234,,,10234.0,LRRC17,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of LRRC17 mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
4145,1551611,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,126364,LRRC25,https://ctdbase.org/detail.go?type=gene&acc=126364,,,126364.0,LRRC25,9606.0,Homo sapiens (human),Tretinoin results in increased expression of LRRC25 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4146,1552348,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,51691,LSM8,https://ctdbase.org/detail.go?type=gene&acc=51691,,,51691.0,LSM8,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of LSM8 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4147,1552349,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,4046,LSP1,https://ctdbase.org/detail.go?type=gene&acc=4046,,,4046.0,LSP1,9606.0,Homo sapiens (human),[tretinoin co-treated with arsenic trioxide] results in increased expression of LSP1 mRNA,,,PMID:15894607,https://www.ncbi.nlm.nih.gov/pubmed/15894607,15894607,,
4148,1552350,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,4046,LSP1,https://ctdbase.org/detail.go?type=gene&acc=4046,,,4046.0,LSP1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of LSP1 mRNA,,,PMID:12875902|PMID:15498508|PMID:15894607,https://www.ncbi.nlm.nih.gov/pubmed/12875902|https://www.ncbi.nlm.nih.gov/pubmed/15498508|https://www.ncbi.nlm.nih.gov/pubmed/15894607,12875902|15498508|15894607,,
4149,1552351,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,4046,LSP1,https://ctdbase.org/detail.go?type=gene&acc=4046,,,4046.0,LSP1,10090.0,Mus musculus (house mouse),[bisphenol F co-treated with tretinoin] results in decreased expression of LSP1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
4150,1552352,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,4046,LSP1,https://ctdbase.org/detail.go?type=gene&acc=4046,,,4046.0,LSP1,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of LSP1 mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
4151,1552736,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,683,BST1,https://ctdbase.org/detail.go?type=gene&acc=683,,,683.0,BST1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of BST1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4152,1552737,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,684,BST2,https://ctdbase.org/detail.go?type=gene&acc=684,,,684.0,BST2,9606.0,Homo sapiens (human),Tretinoin affects the expression of BST2 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
4153,1552738,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,684,BST2,https://ctdbase.org/detail.go?type=gene&acc=684,,,684.0,BST2,9606.0,Homo sapiens (human),[tretinoin co-treated with arsenic trioxide] results in increased expression of BST2 mRNA,,,PMID:15894607,https://www.ncbi.nlm.nih.gov/pubmed/15894607,15894607,,
4154,1552739,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,684,BST2,https://ctdbase.org/detail.go?type=gene&acc=684,,,684.0,BST2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of BST2 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4155,1552740,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,684,BST2,https://ctdbase.org/detail.go?type=gene&acc=684,,,684.0,BST2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of BST2 mRNA,,,PMID:15894607|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/15894607|https://www.ncbi.nlm.nih.gov/pubmed/33167477,15894607|33167477,,
4156,1552741,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,684,BST2,https://ctdbase.org/detail.go?type=gene&acc=684,,,684.0,BST2,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of BST2 mRNA,,,PMID:20488242|PMID:22664269,https://www.ncbi.nlm.nih.gov/pubmed/20488242|https://www.ncbi.nlm.nih.gov/pubmed/22664269,20488242|22664269,,
4157,1552742,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,685,BTC,https://ctdbase.org/detail.go?type=gene&acc=685,,,685.0,BTC,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of BTC mRNA,,,PMID:16470170,https://www.ncbi.nlm.nih.gov/pubmed/16470170,16470170,,
4158,1552743,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,689,BTF3,https://ctdbase.org/detail.go?type=gene&acc=689,,,689.0,BTF3,9606.0,Homo sapiens (human),Tretinoin affects the expression of BTF3 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
4159,1552744,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,689,BTF3,https://ctdbase.org/detail.go?type=gene&acc=689,,,689.0,BTF3,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of BTF3 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4160,1552745,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,694,BTG1,https://ctdbase.org/detail.go?type=gene&acc=694,,,694.0,BTG1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of BTG1 mRNA,,,PMID:12875902|PMID:16129123,https://www.ncbi.nlm.nih.gov/pubmed/12875902|https://www.ncbi.nlm.nih.gov/pubmed/16129123,12875902|16129123,,
4161,1553801,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9935,MAFB,https://ctdbase.org/detail.go?type=gene&acc=9935,,,9935.0,MAFB,7955.0,Danio rerio (zebrafish),Tretinoin results in increased expression of MAFB mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
4162,1553802,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9935,MAFB,https://ctdbase.org/detail.go?type=gene&acc=9935,,,9935.0,MAFB,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of MAFB mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
4163,1553803,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9935,MAFB,https://ctdbase.org/detail.go?type=gene&acc=9935,,,9935.0,MAFB,9606.0,Homo sapiens (human),Tretinoin results in increased expression of MAFB mRNA,,,PMID:21934132|PMID:23724009|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/23724009|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|23724009|33167477,,
4164,1553804,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9935,MAFB,https://ctdbase.org/detail.go?type=gene&acc=9935,,,9935.0,MAFB,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of MAFB mRNA,,,PMID:20488242|PMID:22664269,https://www.ncbi.nlm.nih.gov/pubmed/20488242|https://www.ncbi.nlm.nih.gov/pubmed/22664269,20488242|22664269,,
4165,1553805,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,114463,MAFBB,https://ctdbase.org/detail.go?type=gene&acc=114463,,,114463.0,mafbb,7955.0,Danio rerio (zebrafish),Tretinoin results in increased expression of MAFBB mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
4166,1553806,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23764,MAFF,https://ctdbase.org/detail.go?type=gene&acc=23764,,,23764.0,MAFF,9606.0,Homo sapiens (human),Tretinoin results in increased expression of MAFF mRNA,,,PMID:21934132|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/23724009,21934132|23724009,,
4167,1553807,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,4097,MAFG,https://ctdbase.org/detail.go?type=gene&acc=4097,,,4097.0,MAFG,9606.0,Homo sapiens (human),Tretinoin results in increased expression of MAFG mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4168,1465169,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,240,ALOX5,https://ctdbase.org/detail.go?type=gene&acc=240,,,240.0,ALOX5,9606.0,Homo sapiens (human),[zileuton results in decreased activity of ALOX5 protein] which affects the abundance of arachidonic acid,,,PMID:9495842,https://www.ncbi.nlm.nih.gov/pubmed/9495842,9495842,,
4169,1465170,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,240,ALOX5,https://ctdbase.org/detail.go?type=gene&acc=240,,,240.0,ALOX5,9606.0,Homo sapiens (human),[zileuton results in decreased activity of ALOX5 protein] which results in decreased susceptibility to arachidonic acid,,,PMID:7592874,https://www.ncbi.nlm.nih.gov/pubmed/7592874,7592874,,
4170,1465171,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,240,ALOX5,https://ctdbase.org/detail.go?type=gene&acc=240,,,240.0,ALOX5,9606.0,Homo sapiens (human),ALOX5 protein affects the metabolism of arachidonic acid,,,PMID:22613217,https://www.ncbi.nlm.nih.gov/pubmed/22613217,22613217,,
4171,1465172,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,240,ALOX5,https://ctdbase.org/detail.go?type=gene&acc=240,,,240.0,ALOX5,9606.0,Homo sapiens (human),ALOX5 protein results in increased metabolism of arachidonic acid,,,PMID:18951527,https://www.ncbi.nlm.nih.gov/pubmed/18951527,18951527,,
4172,1465173,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,42127,ALT,https://ctdbase.org/detail.go?type=gene&acc=42127,,,42127.0,alt,10090.0,Mus musculus (house mouse),"Plant extracts inhibits the reaction [[arachidonic acid co-treated with iron] results in increased expression of ALT protein]|drugs, chinese herbal inhibits the reaction [[arachidonic acid co-treated with iron] results in increased expression of ALT protein]",,,PMID:27916511,https://www.ncbi.nlm.nih.gov/pubmed/27916511,27916511,,
4173,1465174,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),Arachidonic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of phospholipids]]|arachidonic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]],,,PMID:16118212,https://www.ncbi.nlm.nih.gov/pubmed/16118212,16118212,,
4174,1465175,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),Arachidonic acid results in decreased expression of APOA1 mRNA,,,PMID:7983038,https://www.ncbi.nlm.nih.gov/pubmed/7983038,7983038,,
4175,1466873,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,10682,EBP,https://ctdbase.org/detail.go?type=gene&acc=10682,,,10682.0,EBP,9606.0,Homo sapiens (human),Arachidonic acid results in decreased expression of EBP mRNA,,,PMID:16704987,https://www.ncbi.nlm.nih.gov/pubmed/16704987,16704987,,
4176,1466874,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,9913.0,Bos taurus (cattle),[EDN1 protein co-treated with arachidonic acid] results in decreased abundance of 6-ketoprostaglandin F1 alpha|arachidonic acid promotes the reaction [EDN1 protein inhibits the reaction [LHB protein results in increased chemical synthesis of progesterone]]|[edn1 protein co-treated with arachidonic acid] results in increased abundance of dinoprost,,,PMID:18809207,https://www.ncbi.nlm.nih.gov/pubmed/18809207,18809207,,
4177,1466875,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10116.0,Rattus norvegicus (Norway rat),"5,8,11,14-eicosatetraynoic acid inhibits the reaction [arachidonic acid results in increased phosphorylation of and results in increased activity of EGFR protein]",,,PMID:15525798,https://www.ncbi.nlm.nih.gov/pubmed/15525798,15525798,,
4178,1467224,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),"MAP2K1 protein inhibits the reaction [arachidonic acid results in increased expression of FAS protein]|arachidonic acid results in increased expression of FAS protein|jun protein affects the reaction [arachidonic acid results in increased expression of FAS protein]|acetylcysteine inhibits the reaction [arachidonic acid results in increased expression of FAS protein]|arachidonic acid results in increased expression of FAS mrna|fos protein affects the reaction [MAP2K1 protein inhibits the reaction [arachidonic acid results in increased expression of FAS protein]]|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [arachidonic acid results in increased expression of FAS protein]|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [arachidonic acid results in increased expression of FAS protein]",,,PMID:19720122,https://www.ncbi.nlm.nih.gov/pubmed/19720122,19720122,,
4179,1467225,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,3422,IDI1,https://ctdbase.org/detail.go?type=gene&acc=3422,,,3422.0,IDI1,9606.0,Homo sapiens (human),Arachidonic acid results in decreased expression of IDI1 mRNA,,,PMID:16704987,https://www.ncbi.nlm.nih.gov/pubmed/16704987,16704987,,
4180,1467226,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,51668,IFT25,https://ctdbase.org/detail.go?type=gene&acc=51668,,,51668.0,IFT25,9606.0,Homo sapiens (human),Arachidonic acid results in decreased expression of IFT25 mRNA,,,PMID:16704987,https://www.ncbi.nlm.nih.gov/pubmed/16704987,16704987,,
4181,1467227,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,3490,IGFBP7,https://ctdbase.org/detail.go?type=gene&acc=3490,,,3490.0,IGFBP7,9606.0,Homo sapiens (human),Arachidonic acid results in decreased expression of IGFBP7 mRNA,,,PMID:16704987,https://www.ncbi.nlm.nih.gov/pubmed/16704987,16704987,,
4182,1467228,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,9606.0,Homo sapiens (human),"MAP2K1 protein inhibits the reaction [arachidonic acid results in increased expression of FASLG protein]|arachidonic acid results in increased expression of FASLG protein|acetylcysteine inhibits the reaction [arachidonic acid results in increased expression of FASLG protein]|fos protein affects the reaction [MAP2K1 protein inhibits the reaction [arachidonic acid results in increased expression of FASLG protein]]|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [arachidonic acid results in increased expression of FASLG protein]|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [arachidonic acid results in increased expression of FASLG protein]|jun protein affects the reaction [arachidonic acid results in increased expression of FASLG protein]|arachidonic acid results in increased expression of FASLG mRNA",,,PMID:19720122,https://www.ncbi.nlm.nih.gov/pubmed/19720122,19720122,,
4183,1467229,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,10090.0,Mus musculus (house mouse),Arachidonic acid results in decreased expression of FASN mRNA,,,PMID:19159447,https://www.ncbi.nlm.nih.gov/pubmed/19159447,19159447,,
4184,1467230,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2230,FDX1,https://ctdbase.org/detail.go?type=gene&acc=2230,,,2230.0,FDX1,9606.0,Homo sapiens (human),[CYP2C8 protein modified form co-treated with FDX1 protein co-treated with FDXR protein] results in increased metabolism of arachidonic acid,,,PMID:25160618,https://www.ncbi.nlm.nih.gov/pubmed/25160618,25160618,,
4185,1467231,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2232,FDXR,https://ctdbase.org/detail.go?type=gene&acc=2232,,,2232.0,FDXR,9606.0,Homo sapiens (human),[CYP2C8 protein modified form co-treated with FDX1 protein co-treated with FDXR protein] results in increased metabolism of arachidonic acid,,,PMID:25160618,https://www.ncbi.nlm.nih.gov/pubmed/25160618,25160618,,
4186,1467375,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2261,FGFR3,https://ctdbase.org/detail.go?type=gene&acc=2261,,,2261.0,FGFR3,9606.0,Homo sapiens (human),Arachidonic acid results in decreased expression of FGFR3 mRNA,,,PMID:16704987,https://www.ncbi.nlm.nih.gov/pubmed/16704987,16704987,,
4187,1467376,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),Arachidonic acid inhibits the reaction [quercetin results in increased expression of FOS protein]|[arachidonic acid co-treated with quercetin co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of FOS protein,,,PMID:20551291,https://www.ncbi.nlm.nih.gov/pubmed/20551291,20551291,,
4188,1467377,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),FOS protein affects the reaction [MAP2K1 protein inhibits the reaction [arachidonic acid results in increased expression of FAS protein]]|arachidonic acid results in decreased phosphorylation of FOS protein|fos protein affects the reaction [MAP2K1 protein inhibits the reaction [arachidonic acid results in increased expression of FASLG protein]],,,PMID:19720122,https://www.ncbi.nlm.nih.gov/pubmed/19720122,19720122,,
4189,1467378,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),Arachidonic acid results in increased expression of FOS mRNA,,,PMID:10864209|PMID:15878913|PMID:16704987,https://www.ncbi.nlm.nih.gov/pubmed/10864209|https://www.ncbi.nlm.nih.gov/pubmed/15878913|https://www.ncbi.nlm.nih.gov/pubmed/16704987,10864209|15878913|16704987,,
4190,1467379,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [arachidonic acid results in increased expression of FOS mrna]|flurbiprofen inhibits the reaction [arachidonic acid results in increased expression of FOS mrna],,,PMID:10864209,https://www.ncbi.nlm.nih.gov/pubmed/10864209,10864209,,
4191,1467380,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090.0,Mus musculus (house mouse),Arachidonic acid results in increased expression of FOS mRNA,,,PMID:8764118,https://www.ncbi.nlm.nih.gov/pubmed/8764118,8764118,,
4192,1467381,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,8061,FOSL1,https://ctdbase.org/detail.go?type=gene&acc=8061,,,8061.0,FOSL1,9606.0,Homo sapiens (human),Arachidonic acid results in increased expression of FOSL1 mRNA,,,PMID:16704987,https://www.ncbi.nlm.nih.gov/pubmed/16704987,16704987,,
4193,1467382,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2596,GAP43,https://ctdbase.org/detail.go?type=gene&acc=2596,,,2596.0,GAP43,10090.0,Mus musculus (house mouse),Arachidonic acid results in increased phosphorylation of GAP43 protein,,,PMID:9852580,https://www.ncbi.nlm.nih.gov/pubmed/9852580,9852580,,
4194,1467383,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),Arachidonic acid results in increased activity of GCLC protein,,,PMID:17092368,https://www.ncbi.nlm.nih.gov/pubmed/17092368,17092368,,
4195,1467732,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),NFE2L2 gene mutant form inhibits the reaction [arachidonic acid metabolite results in increased expression of HMOX1 protein]|arachidonic acid metabolite results in increased expression of HMOX1 mrna|arachidonic acid metabolite results in increased expression of HMOX1 protein,,,PMID:27012417,https://www.ncbi.nlm.nih.gov/pubmed/27012417,27012417,,
4196,1467733,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),HMOX1 protein results in decreased susceptibility to arachidonic acid,,,PMID:15036350,https://www.ncbi.nlm.nih.gov/pubmed/15036350,15036350,,
4197,1467734,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),HMOX1 protein results in decreased metabolism of arachidonic acid,,,PMID:16316349,https://www.ncbi.nlm.nih.gov/pubmed/16316349,16316349,,
4198,1467735,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,9653,HS2ST1,https://ctdbase.org/detail.go?type=gene&acc=9653,,,9653.0,HS2ST1,9606.0,Homo sapiens (human),Arachidonic acid results in decreased expression of HS2ST1 mRNA,,,PMID:16704987,https://www.ncbi.nlm.nih.gov/pubmed/16704987,16704987,,
4199,1467736,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,3326,HSP90AB1,https://ctdbase.org/detail.go?type=gene&acc=3326,,,3326.0,HSP90AB1,10090.0,Mus musculus (house mouse),Arachidonic acid results in decreased expression of HSP90AB1 mRNA,,,PMID:16623957,https://www.ncbi.nlm.nih.gov/pubmed/16623957,16623957,,
4200,1467737,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,3350,HTR1A,https://ctdbase.org/detail.go?type=gene&acc=3350,,,3350.0,HTR1A,9606.0,Homo sapiens (human),Arachidonic acid metabolite inhibits the reaction [HTR1A protein inhibits the reaction [colforsin results in increased abundance of cyclic AMP]],,,PMID:11356925,https://www.ncbi.nlm.nih.gov/pubmed/11356925,11356925,,
4201,1470125,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),[nimesulide results in decreased expression of PTGS2] which results in increased abundance of arachidonic acid,,,PMID:17624748,https://www.ncbi.nlm.nih.gov/pubmed/17624748,17624748,,
4202,1470126,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),PTGS2 results in increased susceptibility to arachidonic acid,,,PMID:15863457,https://www.ncbi.nlm.nih.gov/pubmed/15863457,15863457,,
4203,1470127,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,8090.0,Oryzias latipes (Japanese medaka),Arachidonic acid results in increased expression of PTGS2 mRNA,,,PMID:20801906,https://www.ncbi.nlm.nih.gov/pubmed/20801906,20801906,,
4204,1470128,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9940.0,Ovis aries (sheep),Arachidonic acid results in increased activity of PTGS2 protein|ibuprofen analog inhibits the reaction [arachidonic acid results in increased activity of PTGS2 protein]|naproxen inhibits the reaction [arachidonic acid results in increased activity of PTGS2 protein]|indomethacin inhibits the reaction [arachidonic acid results in increased activity of PTGS2 protein],,,PMID:11755111,https://www.ncbi.nlm.nih.gov/pubmed/11755111,11755111,,
4205,1470129,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Arachidonic acid results in increased expression of PTGS2 protein,,,PMID:22476691,https://www.ncbi.nlm.nih.gov/pubmed/22476691,22476691,,
4206,1470130,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),PTGS2 protein affects the metabolism of arachidonic acid,,,PMID:12902868|PMID:22613217,https://www.ncbi.nlm.nih.gov/pubmed/12902868|https://www.ncbi.nlm.nih.gov/pubmed/22613217,12902868|22613217,,
4207,1470131,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),PTGS2 protein results in increased metabolism of arachidonic acid,,,PMID:21857970|PMID:21916491|PMID:9266823,https://www.ncbi.nlm.nih.gov/pubmed/21857970|https://www.ncbi.nlm.nih.gov/pubmed/21916491|https://www.ncbi.nlm.nih.gov/pubmed/9266823,21857970|21916491|9266823,,
4208,1470275,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,9693,RAPGEF2,https://ctdbase.org/detail.go?type=gene&acc=9693,,,9693.0,RAPGEF2,9606.0,Homo sapiens (human),Arachidonic acid results in increased expression of RAPGEF2 mRNA,,,PMID:16704987,https://www.ncbi.nlm.nih.gov/pubmed/16704987,16704987,,
4209,1470276,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,56729,RETN,https://ctdbase.org/detail.go?type=gene&acc=56729,,,56729.0,RETN,9606.0,Homo sapiens (human),Arachidonic acid results in decreased expression of RETN mRNA,,,PMID:15949695,https://www.ncbi.nlm.nih.gov/pubmed/15949695,15949695,,
4210,1470277,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,9606.0,Homo sapiens (human),Arachidonic acid promotes the reaction [quercetin results in decreased phosphorylation of RPS6KB1 protein],,,PMID:20551291,https://www.ncbi.nlm.nih.gov/pubmed/20551291,20551291,,
4211,1470278,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Arachidonic acid binds to RXRA protein,,,PMID:16258897,https://www.ncbi.nlm.nih.gov/pubmed/16258897,16258897,,
4212,1470279,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,6319,SCD,https://ctdbase.org/detail.go?type=gene&acc=6319,,,6319.0,SCD,9606.0,Homo sapiens (human),Arachidonic acid results in increased expression of SCD mRNA,,,PMID:21457203,https://www.ncbi.nlm.nih.gov/pubmed/21457203,21457203,,
4213,1470280,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,6403,SELP,https://ctdbase.org/detail.go?type=gene&acc=6403,,,6403.0,SELP,9606.0,Homo sapiens (human),Arachidonic acid results in increased expression of SELP protein,,,PMID:18413191|PMID:23249183,https://www.ncbi.nlm.nih.gov/pubmed/18413191|https://www.ncbi.nlm.nih.gov/pubmed/23249183,18413191|23249183,,
4214,1470281,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,6403,SELP,https://ctdbase.org/detail.go?type=gene&acc=6403,,,6403.0,SELP,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [arachidonic acid results in increased expression of SELP protein],,,PMID:17543677|PMID:18413191,https://www.ncbi.nlm.nih.gov/pubmed/17543677|https://www.ncbi.nlm.nih.gov/pubmed/18413191,17543677|18413191,,
4215,1470746,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,6794,STK11,https://ctdbase.org/detail.go?type=gene&acc=6794,,,6794.0,STK11,9606.0,Homo sapiens (human),STK11 protein affects the reaction [resveratrol results in decreased susceptibility to [arachidonic acid co-treated with iron]],,,PMID:19620254,https://www.ncbi.nlm.nih.gov/pubmed/19620254,19620254,,
4216,1471139,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10090.0,Mus musculus (house mouse),CYP2C23 mRNA promotes the reaction [[arachidonic acid co-treated with VEGFA protein] results in increased phosphorylation of MAPK3 protein]|cyp2c23 mRNA promotes the reaction [[arachidonic acid co-treated with VEGFA protein] results in increased phosphorylation of MAPK1 protein]|[arachidonic acid co-treated with VEGFA protein] results in increased phosphorylation of MAPK3 protein|[arachidonic acid co-treated with VEGFA protein] results in increased phosphorylation of MAPK1 protein,,,PMID:19464254,https://www.ncbi.nlm.nih.gov/pubmed/19464254,19464254,,
4217,1475630,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,23536,ADAT1,https://ctdbase.org/detail.go?type=gene&acc=23536,,,23536.0,ADAT1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of ADAT1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4218,1475631,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,134637,ADAT2,https://ctdbase.org/detail.go?type=gene&acc=134637,,,134637.0,ADAT2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of ADAT2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4219,1475632,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,113179,ADAT3,https://ctdbase.org/detail.go?type=gene&acc=113179,,,113179.0,ADAT3,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ADAT3 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4220,1475633,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,196883,ADCY4,https://ctdbase.org/detail.go?type=gene&acc=196883,,,196883.0,ADCY4,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in increased expression of ADCY4 mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
4221,1476377,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [bisphenol A results in decreased expression of ADIPOQ protein],,,PMID:37570835,https://www.ncbi.nlm.nih.gov/pubmed/37570835,37570835,,
4222,1476378,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [fructose results in decreased expression of ADIPOQ mrna],,,PMID:26973390,https://www.ncbi.nlm.nih.gov/pubmed/26973390,26973390,,
4223,1476379,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [palmitic acid results in decreased expression of ADIPOQ mrna]|resveratrol inhibits the reaction [fructose results in decreased expression of ADIPOQ protein],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
4224,1476380,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of ADIPOQ protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
4225,1476381,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in increased expression of ADIPOQ protein,,,PMID:19356108|PMID:21439372|PMID:23824959,https://www.ncbi.nlm.nih.gov/pubmed/19356108|https://www.ncbi.nlm.nih.gov/pubmed/21439372|https://www.ncbi.nlm.nih.gov/pubmed/23824959,19356108|21439372|23824959,,
4226,1476382,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in increased secretion of ADIPOQ protein,,,PMID:23824959,https://www.ncbi.nlm.nih.gov/pubmed/23824959,23824959,,
4227,1476383,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,51094,ADIPOR1,https://ctdbase.org/detail.go?type=gene&acc=51094,,,51094.0,ADIPOR1,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of ADIPOR1 mrna|ethanol promotes the reaction [resveratrol results in increased expression of ADIPOR1 mrna],,,PMID:18755807,https://www.ncbi.nlm.nih.gov/pubmed/18755807,18755807,,
4228,1477222,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [AGT protein results in increased abundance of reactive oxygen species]|resveratrol inhibits the reaction [AGT protein results in increased expression of EDN1 mrna],,,PMID:15878161,https://www.ncbi.nlm.nih.gov/pubmed/15878161,15878161,,
4229,1478252,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [bisphenol A results in increased expression of AHR protein],,,PMID:31489946,https://www.ncbi.nlm.nih.gov/pubmed/31489946,31489946,,
4230,1478253,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),Resveratrol binds to and results in decreased activity of AHR protein,,,PMID:11018766|PMID:16359657|PMID:17959153|PMID:18282621|PMID:18708364|PMID:22197621|PMID:22471748|PMID:23419638|PMID:24136580|PMID:24247421,https://www.ncbi.nlm.nih.gov/pubmed/11018766|https://www.ncbi.nlm.nih.gov/pubmed/16359657|https://www.ncbi.nlm.nih.gov/pubmed/17959153|https://www.ncbi.nlm.nih.gov/pubmed/18282621|https://www.ncbi.nlm.nih.gov/pubmed/18708364|https://www.ncbi.nlm.nih.gov/pubmed/22197621|https://www.ncbi.nlm.nih.gov/pubmed/22471748|https://www.ncbi.nlm.nih.gov/pubmed/23419638|https://www.ncbi.nlm.nih.gov/pubmed/24136580|https://www.ncbi.nlm.nih.gov/pubmed/24247421,11018766|16359657|17959153|18282621|18708364|22197621|22471748|23419638|24136580|24247421,,
4231,1478254,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [tetrachlorodibenzodioxin results in increased activity of AHR protein],,,PMID:14646185,https://www.ncbi.nlm.nih.gov/pubmed/14646185,14646185,,
4232,1478634,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,9606.0,Homo sapiens (human),PD 150606 inhibits the reaction [resveratrol affects the localization of AIFM1 protein],,,PMID:20484155,https://www.ncbi.nlm.nih.gov/pubmed/20484155,20484155,,
4233,1478635,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of AIFM1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4234,1478636,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,9606.0,Homo sapiens (human),Resveratrol affects the localization of AIFM1 protein,,,PMID:16617056|PMID:16759640|PMID:17636462|PMID:18276737|PMID:20484155,https://www.ncbi.nlm.nih.gov/pubmed/16617056|https://www.ncbi.nlm.nih.gov/pubmed/16759640|https://www.ncbi.nlm.nih.gov/pubmed/17636462|https://www.ncbi.nlm.nih.gov/pubmed/18276737|https://www.ncbi.nlm.nih.gov/pubmed/20484155,16617056|16759640|17636462|18276737|20484155,,
4235,1478637,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [GBA1 protein mutant form results in increased expression of AIFM1 protein],,,PMID:26027833,https://www.ncbi.nlm.nih.gov/pubmed/26027833,26027833,,
4236,1478638,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [tert-butylhydroperoxide results in increased expression of AIFM1 protein],,,PMID:25522270,https://www.ncbi.nlm.nih.gov/pubmed/25522270,25522270,,
4237,1478639,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [1-methyl-4-phenylpyridinium affects the localization of AIFM1 protein],,,PMID:19466539,https://www.ncbi.nlm.nih.gov/pubmed/19466539,19466539,,
4238,1478640,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,7965,AIMP2,https://ctdbase.org/detail.go?type=gene&acc=7965,,,7965.0,AIMP2,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of AIMP2 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4239,1478641,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,326,AIRE,https://ctdbase.org/detail.go?type=gene&acc=326,,,326.0,AIRE,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of AIRE mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4240,1478642,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,55966,AJAP1,https://ctdbase.org/detail.go?type=gene&acc=55966,,,55966.0,AJAP1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of AJAP1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4241,1478643,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,204,AK2,https://ctdbase.org/detail.go?type=gene&acc=204,,,204.0,AK2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of AK2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4242,1479717,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [streptozocin results in decreased expression of AKT1 mrna]|[resveratrol co-treated with streptozocin] results in decreased phosphorylation of AKT1 protein,,,PMID:26071184,https://www.ncbi.nlm.nih.gov/pubmed/26071184,26071184,,
4243,1479718,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein],,,PMID:15849355|PMID:16626303,https://www.ncbi.nlm.nih.gov/pubmed/15849355|https://www.ncbi.nlm.nih.gov/pubmed/16626303,15849355|16626303,,
4244,1479719,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [glucose results in increased phosphorylation of AKT1 protein],,,PMID:24971582,https://www.ncbi.nlm.nih.gov/pubmed/24971582,24971582,,
4245,1479720,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased phosphorylation of and results in decreased activity of AKT1 protein|resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein],,,PMID:16626303,https://www.ncbi.nlm.nih.gov/pubmed/16626303,16626303,,
4246,1479888,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein],,,PMID:19738051,https://www.ncbi.nlm.nih.gov/pubmed/19738051,19738051,,
4247,1479889,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,84335,AKT1S1,https://ctdbase.org/detail.go?type=gene&acc=84335,,,84335.0,AKT1S1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of AKT1S1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4248,1479890,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,84335,AKT1S1,https://ctdbase.org/detail.go?type=gene&acc=84335,,,84335.0,AKT1S1,9606.0,Homo sapiens (human),Resveratrol results in decreased phosphorylation of AKT1S1 protein,,,PMID:25311616,https://www.ncbi.nlm.nih.gov/pubmed/25311616,25311616,,
4249,1479891,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,84335,AKT1S1,https://ctdbase.org/detail.go?type=gene&acc=84335,,,84335.0,AKT1S1,10090.0,Mus musculus (house mouse),Resveratrol results in decreased phosphorylation of AKT1S1 protein|resveratrol inhibits the reaction [sirolimus inhibits the reaction [TSC2 gene mutant form results in decreased phosphorylation of AKT1S1 protein]]|[sirolimus co-treated with resveratrol] results in decreased phosphorylation of AKT1S1 protein|[resveratrol co-treated with sirolimus] results in decreased phosphorylation of AKT1S1 protein|resveratrol promotes the reaction [TSC2 gene mutant form results in decreased phosphorylation of AKT1S1 protein],,,PMID:24304514,https://www.ncbi.nlm.nih.gov/pubmed/24304514,24304514,,
4250,1479892,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,208,AKT2,https://ctdbase.org/detail.go?type=gene&acc=208,,,208.0,AKT2,9606.0,Homo sapiens (human),[doxorubicin co-treated with resveratrol] affects the expression of AKT2 mrna|resveratrol results in decreased expression of AKT2 mRNA,,,PMID:26969377,https://www.ncbi.nlm.nih.gov/pubmed/26969377,26969377,,
4251,1481116,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,269,AMHR2,https://ctdbase.org/detail.go?type=gene&acc=269,,,269.0,AMHR2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of AMHR2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4252,1481117,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,57463,AMIGO1,https://ctdbase.org/detail.go?type=gene&acc=57463,,,57463.0,AMIGO1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of AMIGO1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4253,1481118,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,347902,AMIGO2,https://ctdbase.org/detail.go?type=gene&acc=347902,,,347902.0,AMIGO2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of AMIGO2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4254,1481119,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9949,AMMECR1,https://ctdbase.org/detail.go?type=gene&acc=9949,,,9949.0,AMMECR1,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of AMMECR1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4255,1481120,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,83607,AMMECR1L,https://ctdbase.org/detail.go?type=gene&acc=83607,,,83607.0,AMMECR1L,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of AMMECR1L mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4256,1481121,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,154810,AMOTL1,https://ctdbase.org/detail.go?type=gene&acc=154810,,,154810.0,AMOTL1,9606.0,Homo sapiens (human),Resveratrol results in increased expression of AMOTL1 mRNA,,,PMID:23750556,https://www.ncbi.nlm.nih.gov/pubmed/23750556,23750556,,
4257,1481122,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,11722,AMY1,https://ctdbase.org/detail.go?type=gene&acc=11722,,,11722.0,Amy1,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [bisphenol A results in increased expression of AMY1 protein],,,PMID:37570835,https://www.ncbi.nlm.nih.gov/pubmed/37570835,37570835,,
4258,1481123,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,279,AMY2A,https://ctdbase.org/detail.go?type=gene&acc=279,,,279.0,AMY2A,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of AMY2A mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4259,1481124,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,280,AMY2B,https://ctdbase.org/detail.go?type=gene&acc=280,,,280.0,AMY2B,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of AMY2B mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4260,1496797,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,19134,PRPF4B,https://ctdbase.org/detail.go?type=gene&acc=19134,,,19134.0,Prpf4b,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased expression of PRPF4B mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
4261,1496798,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,24148,PRPF6,https://ctdbase.org/detail.go?type=gene&acc=24148,,,24148.0,PRPF6,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of PRPF6 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4262,1496799,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,24148,PRPF6,https://ctdbase.org/detail.go?type=gene&acc=24148,,,24148.0,PRPF6,10090.0,Mus musculus (house mouse),Resveratrol results in decreased expression of PRPF6 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4263,1496800,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10594,PRPF8,https://ctdbase.org/detail.go?type=gene&acc=10594,,,10594.0,PRPF8,10090.0,Mus musculus (house mouse),Resveratrol results in decreased expression of PRPF8 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4264,1517819,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,11325,DDX42,https://ctdbase.org/detail.go?type=gene&acc=11325,,,11325.0,DDX42,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of DDX42 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4265,1517820,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,11325,DDX42,https://ctdbase.org/detail.go?type=gene&acc=11325,,,11325.0,DDX42,10090.0,Mus musculus (house mouse),Resveratrol results in decreased expression of DDX42 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4266,1530925,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9700,ESPL1,https://ctdbase.org/detail.go?type=gene&acc=9700,,,9700.0,ESPL1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ESPL1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4267,1530926,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,83715,ESPN,https://ctdbase.org/detail.go?type=gene&acc=83715,,,83715.0,ESPN,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ESPN mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4268,1530927,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,83715,ESPN,https://ctdbase.org/detail.go?type=gene&acc=83715,,,83715.0,ESPN,9606.0,Homo sapiens (human),Resveratrol results in increased expression of ESPN mRNA,,,PMID:19371625,https://www.ncbi.nlm.nih.gov/pubmed/19371625,19371625,,
4269,1530928,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,339768,ESPNL,https://ctdbase.org/detail.go?type=gene&acc=339768,,,339768.0,ESPNL,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ESPNL mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4270,1530929,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,284729,ESPNP,https://ctdbase.org/detail.go?type=gene&acc=284729,,,284729.0,ESPNP,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ESPNP mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4271,1551820,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,958,CD40,https://ctdbase.org/detail.go?type=gene&acc=958,,,958.0,CD40,10116.0,Rattus norvegicus (Norway rat),"Resveratrol inhibits the reaction [cholesterol, dietary results in increased expression of CD40 protein]",,,PMID:21574786,https://www.ncbi.nlm.nih.gov/pubmed/21574786,21574786,,
4272,1551821,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,959,CD40LG,https://ctdbase.org/detail.go?type=gene&acc=959,,,959.0,CD40LG,10116.0,Rattus norvegicus (Norway rat),"Resveratrol inhibits the reaction [cholesterol, dietary results in increased expression of CD40LG protein]",,,PMID:21574786,https://www.ncbi.nlm.nih.gov/pubmed/21574786,21574786,,
4273,1551822,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of CD44 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4274,1551823,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mrna]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to etoposide]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mrna]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to doxorubicin]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mrna]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to doxorubicin]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to etoposide]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mrna],,,PMID:19047049,https://www.ncbi.nlm.nih.gov/pubmed/19047049,19047049,,
4275,1551824,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of CD44 protein,,,PMID:22692956,https://www.ncbi.nlm.nih.gov/pubmed/22692956,22692956,,
4276,1551992,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116.0,Rattus norvegicus (Norway rat),Fulvestrant inhibits the reaction [resveratrol results in decreased expression of MPO protein],,,PMID:18277952,https://www.ncbi.nlm.nih.gov/pubmed/18277952,18277952,,
4277,1552342,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2820,GPD2,https://ctdbase.org/detail.go?type=gene&acc=2820,,,2820.0,GPD2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of GPD2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4278,1552343,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2820,GPD2,https://ctdbase.org/detail.go?type=gene&acc=2820,,,2820.0,GPD2,9823.0,Sus scrofa (pig),[dietary fats co-treated with resveratrol] results in increased expression of GPD2 mRNA,,,PMID:21852083,https://www.ncbi.nlm.nih.gov/pubmed/21852083,21852083,,
4279,1552344,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2852,GPER1,https://ctdbase.org/detail.go?type=gene&acc=2852,,,2852.0,GPER1,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in decreased expression of GPER1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4280,1552345,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,338328,GPIHBP1,https://ctdbase.org/detail.go?type=gene&acc=338328,,,338328.0,GPIHBP1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of GPIHBP1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4281,1552346,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2822,GPLD1,https://ctdbase.org/detail.go?type=gene&acc=2822,,,2822.0,GPLD1,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of GPLD1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
4282,1552347,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2824,GPM6B,https://ctdbase.org/detail.go?type=gene&acc=2824,,,2824.0,GPM6B,52904.0,Scophthalmus maximus (turbot),Resveratrol results in decreased expression of GPM6B mRNA,,,PMID:23419489,https://www.ncbi.nlm.nih.gov/pubmed/23419489,23419489,,
4283,1553142,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090.0,Mus musculus (house mouse),Resveratrol affects the reaction [cisplatin results in increased activity of GPT protein],,,PMID:28606469,https://www.ncbi.nlm.nih.gov/pubmed/28606469,28606469,,
4284,1553143,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [carbon tetrachloride results in increased expression of GPT protein]|[raspberry ketone co-treated with resveratrol] inhibits the reaction [carbon tetrachloride results in increased expression of GPT protein],,,PMID:37009719,https://www.ncbi.nlm.nih.gov/pubmed/37009719,37009719,,
4285,1553144,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Resveratrol analog inhibits the reaction [bisphenol A results in increased activity of GPT protein],,,PMID:34067838,https://www.ncbi.nlm.nih.gov/pubmed/34067838,34067838,,
4286,1553145,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),[resveratrol co-treated with niacinamide] inhibits the reaction [[aflatoxin B1 co-treated with ethanol] results in increased expression of GPT protein]|resveratrol inhibits the reaction [[aflatoxin B1 co-treated with ethanol] results in increased expression of GPT protein],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
4287,1553146,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[2-cyano-N-((ethylamino)carbonyl)-2-(methoxyimino)acetamide co-treated with mancozeb] results in increased expression of GPT protein],,,PMID:37009748,https://www.ncbi.nlm.nih.gov/pubmed/37009748,37009748,,
4288,1553147,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [chromium hexavalent ion results in increased activity of GPT protein],,,PMID:35024197,https://www.ncbi.nlm.nih.gov/pubmed/35024197,35024197,,
4289,1553148,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [diazinon results in increased expression of GPT protein],,,PMID:35403302,https://www.ncbi.nlm.nih.gov/pubmed/35403302,35403302,,
4290,1553149,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [methotrexate results in increased expression of GPT protein],,,PMID:23424212,https://www.ncbi.nlm.nih.gov/pubmed/23424212,23424212,,
4291,1553150,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [streptozocin results in increased expression of GPT protein],,,PMID:26071184,https://www.ncbi.nlm.nih.gov/pubmed/26071184,26071184,,
4292,1553151,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in increased expression of GPT protein,,,PMID:15748624,https://www.ncbi.nlm.nih.gov/pubmed/15748624,15748624,,
4293,1553418,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,740,MRPL49,https://ctdbase.org/detail.go?type=gene&acc=740,,,740.0,MRPL49,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of MRPL49 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4294,1553419,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,740,MRPL49,https://ctdbase.org/detail.go?type=gene&acc=740,,,740.0,MRPL49,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of MRPL49 mRNA,,,PMID:22610192,https://www.ncbi.nlm.nih.gov/pubmed/22610192,22610192,,
4295,1553420,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,78988,MRPL57,https://ctdbase.org/detail.go?type=gene&acc=78988,,,78988.0,MRPL57,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of MRPL57 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4296,1553421,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,64963,MRPS11,https://ctdbase.org/detail.go?type=gene&acc=64963,,,64963.0,MRPS11,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of MRPS11 mRNA,,,PMID:22610192,https://www.ncbi.nlm.nih.gov/pubmed/22610192,22610192,,
4297,1553422,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,6183,MRPS12,https://ctdbase.org/detail.go?type=gene&acc=6183,,,6183.0,MRPS12,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of MRPS12 mRNA,,,PMID:22610192,https://www.ncbi.nlm.nih.gov/pubmed/22610192,22610192,,
4298,1553423,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,63931,MRPS14,https://ctdbase.org/detail.go?type=gene&acc=63931,,,63931.0,MRPS14,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of MRPS14 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4299,1553424,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,64960,MRPS15,https://ctdbase.org/detail.go?type=gene&acc=64960,,,64960.0,MRPS15,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of MRPS15 mRNA,,,PMID:22610192,https://www.ncbi.nlm.nih.gov/pubmed/22610192,22610192,,
4300,1553425,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,51021,MRPS16,https://ctdbase.org/detail.go?type=gene&acc=51021,,,51021.0,MRPS16,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of MRPS16 mRNA,,,PMID:22610192,https://www.ncbi.nlm.nih.gov/pubmed/22610192,22610192,,
4301,1553797,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2885,GRB2,https://ctdbase.org/detail.go?type=gene&acc=2885,,,2885.0,GRB2,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of GRB2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
4302,1553798,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of GREB1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4303,1553799,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Resveratrol promotes the reaction [NCOA3 protein binds to GREB1 enhancer]|fulvestrant inhibits the reaction [resveratrol results in increased expression of GREB1 mrna]|resveratrol promotes the reaction [ESR1 protein binds to GREB1 enhancer]|resveratrol results in increased expression of GREB1 mRNA,,,PMID:20846786,https://www.ncbi.nlm.nih.gov/pubmed/20846786,20846786,,
4304,1553800,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Resveratrol promotes the reaction [NCOA2 protein binds to GREB1 gene]|resveratrol promotes the reaction [ESR1 protein binds to GREB1 gene],,,PMID:24771768,https://www.ncbi.nlm.nih.gov/pubmed/24771768,24771768,,
4305,1553933,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased expression of CDK2 protein,,,PMID:20972827,https://www.ncbi.nlm.nih.gov/pubmed/20972827,20972827,,
4306,1551903,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1592,CYP26A1,https://ctdbase.org/detail.go?type=gene&acc=1592,,,1592.0,CYP26A1,9606.0,Homo sapiens (human),[palmitic acid co-treated with oleic acid] results in increased expression of CYP26A1 mrna|[palmitic acid co-treated with oleic acid co-treated with TNF protein] results in increased expression of CYP26A1 mRNA,,,PMID:30547786,https://www.ncbi.nlm.nih.gov/pubmed/30547786,30547786,,
4307,1551904,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,56603,CYP26B1,https://ctdbase.org/detail.go?type=gene&acc=56603,,,56603.0,CYP26B1,9606.0,Homo sapiens (human),[palmitic acid co-treated with oleic acid] results in increased expression of CYP26B1 mRNA,,,PMID:30547786,https://www.ncbi.nlm.nih.gov/pubmed/30547786,30547786,,
4308,1551905,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606.0,Homo sapiens (human),Oleic acid results in increased expression of CYP2A6 mrna|oleic acid results in increased expression of CYP2A6 protein,,,PMID:28555106,https://www.ncbi.nlm.nih.gov/pubmed/28555106,28555106,,
4309,1551906,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1869,E2F1,https://ctdbase.org/detail.go?type=gene&acc=1869,,,1869.0,E2F1,9606.0,Homo sapiens (human),Oleic acid results in decreased expression of E2F1 protein,,,PMID:16027227,https://www.ncbi.nlm.nih.gov/pubmed/16027227,16027227,,
4310,1551907,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1891,ECH1,https://ctdbase.org/detail.go?type=gene&acc=1891,,,1891.0,ECH1,9606.0,Homo sapiens (human),[GW 4064 co-treated with oleic acid] results in decreased expression of ECH1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
4311,1551908,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,9451,EIF2AK3,https://ctdbase.org/detail.go?type=gene&acc=9451,,,9451.0,EIF2AK3,9606.0,Homo sapiens (human),[palmitic acid co-treated with oleic acid] affects the expression of EIF2AK3 mRNA,,,PMID:30547786,https://www.ncbi.nlm.nih.gov/pubmed/30547786,30547786,,
4312,1551909,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606.0,Homo sapiens (human),"[GW 7647 co-treated with oleic acid] results in decreased expression of CYP2B6 mrna|farnesol analog inhibits the reaction [oleic acid results in decreased expression of CYP2B6 mrna]|[gw 4064 co-treated with oleic acid] results in decreased expression of CYP2B6 mrna|[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with oleic acid] results in increased expression of CYP2B6 mrna|oleic acid results in decreased expression of CYP2B6 mrna|[farnesol analog co-treated with oleic acid] results in increased expression of CYP2B6 mRNA",,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
4313,1551910,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606.0,Homo sapiens (human),[oleic acid co-treated with troglitazone] results in increased expression of CYP2B6 mrna|[oleic acid co-treated with rosiglitazone] results in increased expression of CYP2B6 mRNA,,,PMID:24534255,https://www.ncbi.nlm.nih.gov/pubmed/24534255,24534255,,
4314,1551911,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,72303,CYP2C65,https://ctdbase.org/detail.go?type=gene&acc=72303,,,72303.0,Cyp2c65,10090.0,Mus musculus (house mouse),PPARA protein promotes the reaction [oleic acid results in increased expression of CYP2C65 mrna],,,PMID:18489776,https://www.ncbi.nlm.nih.gov/pubmed/18489776,18489776,,
4315,1552100,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1579,CYP4A11,https://ctdbase.org/detail.go?type=gene&acc=1579,,,1579.0,CYP4A11,9606.0,Homo sapiens (human),[GW 4064 co-treated with oleic acid] results in decreased expression of CYP4A11 mrna|[gw 7647 co-treated with oleic acid] results in increased expression of CYP4A11 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
4316,1552101,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,70101,CYP4F16,https://ctdbase.org/detail.go?type=gene&acc=70101,,,70101.0,Cyp4f16,10090.0,Mus musculus (house mouse),PPARA protein promotes the reaction [oleic acid results in increased expression of CYP4F16 mrna],,,PMID:18489776,https://www.ncbi.nlm.nih.gov/pubmed/18489776,18489776,,
4317,1552102,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10116.0,Rattus norvegicus (Norway rat),Oleic acid results in decreased expression of CYP7A1 mRNA,,,PMID:32738331,https://www.ncbi.nlm.nih.gov/pubmed/32738331,32738331,,
4318,1552103,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,9606.0,Homo sapiens (human),"3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[palmitic acid co-treated with oleic acid] results in increased expression of DDIT3 mrna]|[palmitic acid co-treated with oleic acid] results in increased expression of DDIT3 mRNA",,,PMID:32369900,https://www.ncbi.nlm.nih.gov/pubmed/32369900,32369900,,
4319,1552104,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),MIR497 affects the reaction [SNHG14 affects the reaction [[oleic acid co-treated with palmitic acid] results in increased expression of DDIT3 protein]]|[oleic acid co-treated with palmitic acid] results in increased expression of DDIT3 protein|bace1 protein affects the reaction [SNHG14 affects the reaction [[oleic acid co-treated with palmitic acid] results in increased expression of DDIT3 protein]]|snhg14 affects the reaction [[oleic acid co-treated with palmitic acid] results in increased expression of DDIT3 protein],,,PMID:37009739,https://www.ncbi.nlm.nih.gov/pubmed/37009739,37009739,,
4320,1552484,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,1962,EHHADH,https://ctdbase.org/detail.go?type=gene&acc=1962,,,1962.0,EHHADH,9606.0,Homo sapiens (human),[GW 4064 co-treated with oleic acid] results in decreased expression of EHHADH mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
4321,1552485,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,9451,EIF2AK3,https://ctdbase.org/detail.go?type=gene&acc=9451,,,9451.0,EIF2AK3,9606.0,Homo sapiens (human),"3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[palmitic acid co-treated with oleic acid] results in increased expression of EIF2AK3 mrna]|[palmitic acid co-treated with oleic acid] results in increased expression of EIF2AK3 mRNA",,,PMID:32369900,https://www.ncbi.nlm.nih.gov/pubmed/32369900,32369900,,
4322,1552486,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071.0,ELOVL6,9606.0,Homo sapiens (human),[GW 4064 co-treated with oleic acid] results in decreased expression of ELOVL6 mrna|[farnesol analog co-treated with oleic acid] results in increased expression of ELOVL6 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
4323,1553265,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,10211,FLOT1,https://ctdbase.org/detail.go?type=gene&acc=10211,,,10211.0,FLOT1,9606.0,Homo sapiens (human),[palmitic acid co-treated with oleic acid co-treated with TNF protein] results in increased expression of FLOT1 mRNA,,,PMID:30547786,https://www.ncbi.nlm.nih.gov/pubmed/30547786,30547786,,
4324,1553652,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,84803,GPAT3,https://ctdbase.org/detail.go?type=gene&acc=84803,,,84803.0,GPAT3,9606.0,Homo sapiens (human),[GW 4064 co-treated with oleic acid] results in decreased expression of GPAT3 mrna|[gw 7647 co-treated with oleic acid] results in increased expression of GPAT3 mrna|oleic acid results in increased expression of GPAT3 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
4325,1496801,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,51284,TLR7,https://ctdbase.org/detail.go?type=gene&acc=51284,,,51284.0,TLR7,9031.0,Gallus gallus (chicken),[resiquimod co-treated with N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide] results in increased expression of TLR7 mRNA,,,PMID:23405061,https://www.ncbi.nlm.nih.gov/pubmed/23405061,23405061,,
4326,1496802,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with TNF protein] results in decreased expression of SIRT1 protein,,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
4327,1496803,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [dieldrin results in increased expression of TNF mrna],,,PMID:31068361,https://www.ncbi.nlm.nih.gov/pubmed/31068361,31068361,,
4328,1551602,752709,Drug Gene Interaction database (DGIdb),"5-(5-Bromofuran-2-yl)-3-pyridin-2-yl-1,2,4-oxadiazole",,CHEMBL:CHEMBL429335,https://www.dgidb.org/drugs/chembl:CHEMBL429335,,PKM,https://www.dgidb.org/genes/hgnc:9021,,,5315.0,PKM,9606.0,Homo sapiens (human),,,,,,,,
4329,1551603,752709,Drug Gene Interaction database (DGIdb),"5-(5-Bromofuran-2-yl)-3-pyridin-2-yl-1,2,4-oxadiazole",,CHEMBL:CHEMBL429335,https://www.dgidb.org/drugs/chembl:CHEMBL429335,,SMN2,https://www.dgidb.org/genes/hgnc:11118,,,6607.0,SMN2,9606.0,Homo sapiens (human),,,,,,,,
4330,1551604,846186,Drug Gene Interaction database (DGIdb),"2'-Methyl-1H,1'H-[2,5']bibenzoimidazolyl-5-ylamine",,CHEMBL:CHEMBL525103,https://www.dgidb.org/drugs/chembl:CHEMBL525103,,POLB,https://www.dgidb.org/genes/hgnc:9174,,,5423.0,POLB,9606.0,Homo sapiens (human),,,,,,,,
4331,1551605,854389,Comparative Toxicogenomics Database (CTD),"1,1-Diethylthiourea",C035318,diethylthiourea,https://ctdbase.org/detail.go?type=chem&acc=C035318,361523,CYP2B2,https://ctdbase.org/detail.go?type=gene&acc=361523,,,361523.0,Cyp2b2,10116.0,Rattus norvegicus (Norway rat),Diethylthiourea results in increased expression of CYP2B2 protein,,,PMID:10190572,https://www.ncbi.nlm.nih.gov/pubmed/10190572,10190572,,
4332,1551606,854389,Comparative Toxicogenomics Database (CTD),"1,1-Diethylthiourea",C035318,diethylthiourea,https://ctdbase.org/detail.go?type=chem&acc=C035318,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10116.0,Rattus norvegicus (Norway rat),Diethylthiourea results in increased expression of CYP2E1 protein,,,PMID:10190572,https://www.ncbi.nlm.nih.gov/pubmed/10190572,10190572,,
4333,1551607,854389,Comparative Toxicogenomics Database (CTD),"1,1-Diethylthiourea",C035318,diethylthiourea,https://ctdbase.org/detail.go?type=chem&acc=C035318,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,10116.0,Rattus norvegicus (Norway rat),Diethylthiourea results in increased expression of EPHX1 mrna|diethylthiourea results in increased expression of EPHX1 protein,,,PMID:10190572,https://www.ncbi.nlm.nih.gov/pubmed/10190572,10190572,,
4334,1551608,854389,Comparative Toxicogenomics Database (CTD),"1,1-Diethylthiourea",C035318,diethylthiourea,https://ctdbase.org/detail.go?type=chem&acc=C035318,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10116.0,Rattus norvegicus (Norway rat),Diethylthiourea results in increased expression of GSTA2 protein|diethylthiourea results in increased expression of GSTA2 mRNA,,,PMID:10190572,https://www.ncbi.nlm.nih.gov/pubmed/10190572,10190572,,
4335,1551609,854389,Comparative Toxicogenomics Database (CTD),"1,1-Diethylthiourea",C035318,diethylthiourea,https://ctdbase.org/detail.go?type=chem&acc=C035318,51203,NUSAP1,https://ctdbase.org/detail.go?type=gene&acc=51203,,,51203.0,NUSAP1,10116.0,Rattus norvegicus (Norway rat),Diethylthiourea results in increased expression of NUSAP1 mRNA,,,PMID:22584684,https://www.ncbi.nlm.nih.gov/pubmed/22584684,22584684,,
4336,1551402,1794427,Therapeutic Target Database (TTD),Chlorogenic Acid,D02HCQ,Chlorogenic acid,https://idrblab.net/ttd/data/drug/details/D02HCQ,T47306,Glucose-6-phosphate translocase (SLC37A4),https://idrblab.net/ttd/data/target/details/T47306,O43826,Glucose-6-phosphate exchanger SLC37A4,2542.0,SLC37A4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4337,1551403,1871549,BindingDB,"4-[(4S)-4-[(3-chlorophenyl)carbamoyl]-6-oxo-1,4,5,6-tetrahydropyrimidin-2-yl]-1-methylpiperazin-1-ium",28360,"4-[(4S)-4-[(3-chlorophenyl)carbamoyl]-6-oxo-1,4,5,6-tetrahydropyrimidin-2-yl]-1-methylpiperazin-1-ium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28360,3417,Trypanothione reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3417,P28593,Trypanothione reductase,,,5693.0,Trypanosoma cruzi,,IC50 (nM),>100000,PMID:19296695|DOI:10.1021/jm801306g,https://www.ncbi.nlm.nih.gov/pubmed/19296695|https://doi.org/10.1021/jm801306g,19296695,10.1021/jm801306g,
4338,1551404,1871549,BindingDB,"4-[(4S)-4-[(3-chlorophenyl)carbamoyl]-6-oxo-1,4,5,6-tetrahydropyrimidin-2-yl]-1-methylpiperazin-1-ium",28360,"4-[(4S)-4-[(3-chlorophenyl)carbamoyl]-6-oxo-1,4,5,6-tetrahydropyrimidin-2-yl]-1-methylpiperazin-1-ium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28360,3418,Trypanothione reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3418,P39051,Trypanothione reductase,,,5702.0,Trypanosoma brucei brucei,,IC50 (nM),>100000,PMID:19296695|DOI:10.1021/jm801306g,https://www.ncbi.nlm.nih.gov/pubmed/19296695|https://doi.org/10.1021/jm801306g,19296695,10.1021/jm801306g,
4339,1553538,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),"Fructose results in increased secretion of CCL2 protein|khk protein promotes the reaction [fructose results in increased secretion of CCL2 protein]|allopurinol inhibits the reaction [fructose results in increased secretion of CCL2 protein]|acetylcysteine inhibits the reaction [fructose results in increased secretion of CCL2 protein]|allopurinol inhibits the reaction [[fructose co-treated with uric acid] results in increased secretion of CCL2 protein]|acetovanillone inhibits the reaction [fructose results in increased secretion of CCL2 protein]|[fructose co-treated with uric acid] results in increased secretion of CCL2 protein|glucose inhibits the reaction [fructose results in increased secretion of CCL2 protein]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [fructose results in increased secretion of CCL2 protein]|superoxides affects the reaction [fructose results in increased secretion of CCL2 protein]",,,PMID:19158351,https://www.ncbi.nlm.nih.gov/pubmed/19158351,19158351,,
4340,1553539,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Fructose results in increased expression of CCL2 mRNA,,,PMID:31655124,https://www.ncbi.nlm.nih.gov/pubmed/31655124,31655124,,
4341,1553923,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10090.0,Mus musculus (house mouse),[FGF21 gene mutant form results in increased susceptibility to fructose] which results in increased expression of CCL3 mRNA,,,PMID:28123933,https://www.ncbi.nlm.nih.gov/pubmed/28123933,28123933,,
4342,1553924,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,6354,CCL7,https://ctdbase.org/detail.go?type=gene&acc=6354,,,6354.0,CCL7,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of CCL7 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4343,1553925,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,20308,CCL9,https://ctdbase.org/detail.go?type=gene&acc=20308,,,20308.0,Ccl9,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of CCL9 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4344,1553926,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10116.0,Rattus norvegicus (Norway rat),Betanin inhibits the reaction [fructose results in increased expression of CCN2 protein]|fructose results in increased expression of CCN2 protein,,,PMID:25559852,https://www.ncbi.nlm.nih.gov/pubmed/25559852,25559852,,
4345,1553927,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of CCNB1 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4346,1553928,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,1235,CCR6,https://ctdbase.org/detail.go?type=gene&acc=1235,,,1235.0,CCR6,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with herbicides] results in decreased expression of CCR6 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4347,1553929,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,1236,CCR7,https://ctdbase.org/detail.go?type=gene&acc=1236,,,1236.0,CCR7,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of CCR7 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4348,1553930,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,9332,CD163,https://ctdbase.org/detail.go?type=gene&acc=9332,,,9332.0,CD163,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of CD163 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4349,1553931,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,9332,CD163,https://ctdbase.org/detail.go?type=gene&acc=9332,,,9332.0,CD163,10116.0,Rattus norvegicus (Norway rat),[gadolinium chloride co-treated with fructose co-treated with copper deficiency] results in decreased expression of CD163 mRNA,,,PMID:25813056,https://www.ncbi.nlm.nih.gov/pubmed/25813056,25813056,,
4350,1553932,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,930,CD19,https://ctdbase.org/detail.go?type=gene&acc=930,,,930.0,CD19,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in decreased expression of CD19 mrna|[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of CD19 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4351,1554075,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,69142,CD209F,https://ctdbase.org/detail.go?type=gene&acc=69142,,,69142.0,Cd209f,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in increased expression of CD209F mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4352,1554076,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,10666,CD226,https://ctdbase.org/detail.go?type=gene&acc=10666,,,10666.0,CD226,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of CD226 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4353,1554077,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,919,CD247,https://ctdbase.org/detail.go?type=gene&acc=919,,,919.0,CD247,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of CD247 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4354,1554078,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,11314,CD300A,https://ctdbase.org/detail.go?type=gene&acc=11314,,,11314.0,CD300A,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of CD300A mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4355,1554079,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,124599,CD300LB,https://ctdbase.org/detail.go?type=gene&acc=124599,,,124599.0,CD300LB,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of CD300LB mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
4356,1554080,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10090.0,Mus musculus (house mouse),Fructose results in decreased expression of CD36 protein,,,PMID:28257781,https://www.ncbi.nlm.nih.gov/pubmed/28257781,28257781,,
4357,1554081,2723872,Comparative Toxicogenomics Database (CTD),D-Fructose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10116.0,Rattus norvegicus (Norway rat),[fructose co-treated with dietary fats] results in increased expression of CD36 protein|[atorvastatin co-treated with dapagliflozin] inhibits the reaction [[fructose co-treated with dietary fats] results in increased expression of CD36 protein]|dapagliflozin inhibits the reaction [[fructose co-treated with dietary fats] results in increased expression of CD36 protein],,,PMID:32259528,https://www.ncbi.nlm.nih.gov/pubmed/32259528,32259528,,
4358,1608511,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,3596,IL13,https://ctdbase.org/detail.go?type=gene&acc=3596,,,3596.0,IL13,10090.0,Mus musculus (house mouse),N-acetylcysteinamide inhibits the reaction [ovalbumin results in increased expression of IL13 protein],,,PMID:18160846,https://www.ncbi.nlm.nih.gov/pubmed/18160846,18160846,,
4359,1608512,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,3596,IL13,https://ctdbase.org/detail.go?type=gene&acc=3596,,,3596.0,IL13,10090.0,Mus musculus (house mouse),"[nanotubes, carbon co-treated with ovalbumin] results in increased expression of IL13 protein|stat1 protein affects the reaction [ovalbumin results in increased expression of IL13 protein]|stat1 protein affects the reaction [[nanotubes, carbon co-treated with ovalbumin] results in increased expression of IL13 protein]",,,PMID:25807359,https://www.ncbi.nlm.nih.gov/pubmed/25807359,25807359,,
4360,1608513,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,3596,IL13,https://ctdbase.org/detail.go?type=gene&acc=3596,,,3596.0,IL13,10090.0,Mus musculus (house mouse),[ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL13 protein,,,PMID:30803854,https://www.ncbi.nlm.nih.gov/pubmed/30803854,30803854,,
4361,1608514,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,3596,IL13,https://ctdbase.org/detail.go?type=gene&acc=3596,,,3596.0,IL13,10090.0,Mus musculus (house mouse),[ovalbumin co-treated with aluminum hydroxide] results in increased expression of IL13 protein,,,PMID:35481609|PMID:36029577,https://www.ncbi.nlm.nih.gov/pubmed/35481609|https://www.ncbi.nlm.nih.gov/pubmed/36029577,35481609|36029577,,
4362,1608515,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,3596,IL13,https://ctdbase.org/detail.go?type=gene&acc=3596,,,3596.0,IL13,10090.0,Mus musculus (house mouse),[ovalbumin co-treated with benzo(a)pyrene] results in increased secretion of IL13 protein,,,PMID:37267060,https://www.ncbi.nlm.nih.gov/pubmed/37267060,37267060,,
4363,1608516,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,3596,IL13,https://ctdbase.org/detail.go?type=gene&acc=3596,,,3596.0,IL13,10090.0,Mus musculus (house mouse),Ovalbumin results in increased expression of and results in increased secretion of IL13 protein|[ovalbumin co-treated with bisphenol A] results in increased expression of and results in increased secretion of IL13 protein,,,PMID:29737898,https://www.ncbi.nlm.nih.gov/pubmed/29737898,29737898,,
4364,2012951,11634973,Drug Gene Interaction database (DGIdb),Epelsiban,,EPELSIBAN,https://www.dgidb.org/drugs/ncit:C99151,,OXTR,https://www.dgidb.org/genes/hgnc:8529,,,5021.0,OXTR,9606.0,Homo sapiens (human),,,,,,,,
4365,2012952,11641076,IUPHAR/BPS Guide to PHARMACOLOGY,4-(4-(Hydroxydiphenylmethyl)piperidin-1-yl)-1-(4-propylphenyl)butan-1-one,8832,compound 4 [PMID: 16495056],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8832,1332,CYP2J2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1332,P51589,Cytochrome P450 2J2,1573.0,CYP2J2,9606.0,Homo sapiens (human),Inhibition,pIC50,6.8,PMID:16495056,https://www.ncbi.nlm.nih.gov/pubmed/16495056,16495056,,
4366,2012953,11643451,Therapeutic Target Database (TTD),"1,3-Di(berberine-9-O-yl)ethane dibromide",D0P5BT,"1,3-Di(berberine-9-O-yl)ethane dibromide",https://idrblab.net/ttd/data/drug/details/D0P5BT,T30082,Acetylcholinesterase (AChE),https://idrblab.net/ttd/data/target/details/T30082,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4367,2012954,11643451,Therapeutic Target Database (TTD),"1,3-Di(berberine-9-O-yl)ethane dibromide",D0P5BT,"1,3-Di(berberine-9-O-yl)ethane dibromide",https://idrblab.net/ttd/data/drug/details/D0P5BT,T99799,Cholinesterase (BCHE),https://idrblab.net/ttd/data/target/details/T99799,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4368,2012955,11644688,Therapeutic Target Database (TTD),5-(1-Methyl-pyrrolidin-2-yl)-2-phenethyl-pyridine,D03ZVM,5-(1-Methyl-pyrrolidin-2-yl)-2-phenethyl-pyridine,https://idrblab.net/ttd/data/drug/details/D03ZVM,T55815,Neuronal acetylcholine receptor alpha-2 (CHRNA2),https://idrblab.net/ttd/data/target/details/T55815,Q15822,Neuronal acetylcholine receptor subunit alpha-2,1135.0,CHRNA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4369,2012956,11646328,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 6",35557,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35557,5408,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5408,P26663,Genome polyprotein,,,11105.0,Hepatitis C virus (isolate BK),,IC50 (nM),190,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
4370,2012957,11646328,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 6",35557,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35557,4292,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4292,P26661,Genome polyprotein,,,11115.0,Hepatitis C virus isolate HC-J8,,IC50 (nM),300,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
4371,2012958,11646514,BindingDB,"3-ethyl-1-[7-(3-fluoropyridin-2-yl)-5-(pyridin-3-yl)-1H-1,3-benzodiazol-2-yl]urea",24611,"3-ethyl-1-[7-(3-fluoropyridin-2-yl)-5-(pyridin-3-yl)-1H-1,3-benzodiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24611,206,DNA gyrase subunit A/B,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=206,P20831,DNA gyrase subunit A,,,1280.0,Staphylococcus aureus,,Ki (nM),14,PMID:18690678|DOI:10.1021/jm800318d,https://www.ncbi.nlm.nih.gov/pubmed/18690678|https://doi.org/10.1021/jm800318d,18690678,10.1021/jm800318d,
4372,2012959,11646514,BindingDB,"3-ethyl-1-[7-(3-fluoropyridin-2-yl)-5-(pyridin-3-yl)-1H-1,3-benzodiazol-2-yl]urea",24611,"3-ethyl-1-[7-(3-fluoropyridin-2-yl)-5-(pyridin-3-yl)-1H-1,3-benzodiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24611,208,DNA gyrase subunit A/B,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=208,P0AES4,DNA gyrase subunit A,946614.0,gyrA,83333.0,Escherichia coli K-12,,Ki (nM),<4,PMID:18690678|DOI:10.1021/jm800318d,https://www.ncbi.nlm.nih.gov/pubmed/18690678|https://doi.org/10.1021/jm800318d,18690678,10.1021/jm800318d,
4373,2014092,11673720,Drug Gene Interaction database (DGIdb),CID 11673720,,CHEMBL:CHEMBL1077391,https://www.dgidb.org/drugs/chembl:CHEMBL1077391,,GABRB3,https://www.dgidb.org/genes/hgnc:4083,,,2562.0,GABRB3,9606.0,Homo sapiens (human),,,,,,,,
4374,2014093,11681998,IUPHAR/BPS Guide to PHARMACOLOGY,(S)-methyl 4-(2-(4-isopropoxyphenoxy)thiazol-5-yl)but-3-yn-2-ylcarbamate,10669,A-908292,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10669,1264,Acetyl-CoA carboxylase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1264,O00763,Acetyl-CoA carboxylase 2,32.0,ACACB,9606.0,Homo sapiens (human),Inhibition,pIC50,7.64,PMID:18025247,https://www.ncbi.nlm.nih.gov/pubmed/18025247,18025247,,
4375,2014094,11690090,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 14",35565,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 14",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35565,5408,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5408,P26663,Genome polyprotein,,,11105.0,Hepatitis C virus (isolate BK),,IC50 (nM),1600,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
4376,2014095,11690090,BindingDB,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 14",35565,"1H-benzo[de]isoquinoline-1,3(2H)-dione, 14",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35565,4292,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4292,P26661,Genome polyprotein,,,11115.0,Hepatitis C virus isolate HC-J8,,IC50 (nM),>50000,PMID:19877603|DOI:10.1021/jm900517t,https://www.ncbi.nlm.nih.gov/pubmed/19877603|https://doi.org/10.1021/jm900517t,19877603,10.1021/jm900517t,
4377,2014096,11691484,IUPHAR/BPS Guide to PHARMACOLOGY,Isopropyl 4-((5-methoxy-6-((2-methyl-6-(methylsulfonyl)pyridin-3-yl)amino)pyrimidin-4-yl)oxy)piperidine-1-carboxylate,5727,JNJ-38431055,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5727,126,GPR119,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=126,Q8TDV5,Glucose-dependent insulinotropic receptor,139760.0,GPR119,9606.0,Homo sapiens (human),Agonist,pEC50,7.3,PMID:22264481,https://www.ncbi.nlm.nih.gov/pubmed/22264481,22264481,,
4378,2014097,11695129,Therapeutic Target Database (TTD),N-(3-chlorophenyl)-6-nitroquinazolin-4-amine,D0UN6P,N-(3-chlorophenyl)-6-nitroquinazolin-4-amine,https://idrblab.net/ttd/data/drug/details/D0UN6P,T99347,Metabotropic glutamate receptor 5 (mGluR5),https://idrblab.net/ttd/data/target/details/T99347,P41594,Metabotropic glutamate receptor 5,2915.0,GRM5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4379,2014098,11696674,IUPHAR/BPS Guide to PHARMACOLOGY,3-(3-Fluorophenyl)sulfonyl-8-(4-methylpiperazin-1-yl)quinoline,8430,[11C]GSK215083,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8430,11,5-HT6 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=11,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),Antagonist,pKi,9.8,PMID:22223878,https://www.ncbi.nlm.nih.gov/pubmed/22223878,22223878,,
4380,2014099,11697676,Drug Gene Interaction database (DGIdb),"3,4-Dihydro-7-(4-(4-(1-naphthyl)piperazino)butoxy)-1,8-naphthyridine-2(1H)-one",,PF-00217830,https://www.dgidb.org/drugs/drugbank:DB12998,,DRD2,https://www.dgidb.org/genes/hgnc:3023,,,1813.0,DRD2,9606.0,Homo sapiens (human),Agonist,,,,,,,
4381,2014100,11702450,Therapeutic Target Database (TTD),"5-[(8Z,11Z)-pentadeca-8,11-dien-1-yl]benzene-1,3-diol",D04WLH,"5-{8(Z),11(Z)-pentadecadienyl}resorcinol",https://idrblab.net/ttd/data/drug/details/D04WLH,T97035,Tyrosinase (TYR),https://idrblab.net/ttd/data/target/details/T97035,P14679,Tyrosinase,7299.0,TYR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4382,2014101,11705608,IUPHAR/BPS Guide to PHARMACOLOGY,"isopropyl 4-(1-(2-fluoro-4-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)piperidine-1-carboxylate",12151,APD668,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12151,126,GPR119,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=126,Q8TDV5,Glucose-dependent insulinotropic receptor,139760.0,GPR119,9606.0,Homo sapiens (human),Agonist,pEC50,8.57,PMID:21444206,https://www.ncbi.nlm.nih.gov/pubmed/21444206,21444206,,
4383,2014059,12934390,Comparative Toxicogenomics Database (CTD),7-hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde,C000625876,4-methylumbelliferone 8-carbaldehyde,https://ctdbase.org/detail.go?type=chem&acc=C000625876,7494,XBP1,https://ctdbase.org/detail.go?type=gene&acc=7494,,,7494.0,XBP1,10090.0,Mus musculus (house mouse),4-methylumbelliferone 8-carbaldehyde affects the reaction [glucosamine results in increased expression of XBP1 protein alternative form]|4-methylumbelliferone 8-carbaldehyde inhibits the reaction [glucosamine results in increased splicing of XBP1 mrna],,,PMID:30602124,https://www.ncbi.nlm.nih.gov/pubmed/30602124,30602124,,
4384,2014060,12934390,Comparative Toxicogenomics Database (CTD),7-hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde,C000625876,4-methylumbelliferone 8-carbaldehyde,https://ctdbase.org/detail.go?type=chem&acc=C000625876,7494,XBP1,https://ctdbase.org/detail.go?type=gene&acc=7494,,,7494.0,XBP1,10090.0,Mus musculus (house mouse),4-methylumbelliferone 8-carbaldehyde inhibits the reaction [cyanoginosin LR results in increased expression of XBP1 protein alternative form],,,PMID:33290805,https://www.ncbi.nlm.nih.gov/pubmed/33290805,33290805,,
4385,2014061,12934390,Comparative Toxicogenomics Database (CTD),7-hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde,C000625876,4-methylumbelliferone 8-carbaldehyde,https://ctdbase.org/detail.go?type=chem&acc=C000625876,7494,XBP1,https://ctdbase.org/detail.go?type=gene&acc=7494,,,7494.0,XBP1,10090.0,Mus musculus (house mouse),4-methylumbelliferone 8-carbaldehyde inhibits the reaction [palmitic acid results in increased expression of XBP1 mRNA alternative form]|4-methylumbelliferone 8-carbaldehyde inhibits the reaction [palmitic acid results in increased expression of XBP1 protein alternative form],,,PMID:36030031,https://www.ncbi.nlm.nih.gov/pubmed/36030031,36030031,,
4386,2014062,12963076,Therapeutic Target Database (TTD),"Dimetindene, (R)-",D0H8XV,R-dimethindene,https://idrblab.net/ttd/data/drug/details/D0H8XV,T20251,Voltage-gated potassium channel Kv11.1 (KCNH2),https://idrblab.net/ttd/data/target/details/T20251,Q12809,Potassium voltage-gated channel subfamily H member 2,3757.0,KCNH2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4387,2014063,12963076,Therapeutic Target Database (TTD),"Dimetindene, (R)-",D0H8XV,R-dimethindene,https://idrblab.net/ttd/data/drug/details/D0H8XV,T28893,Muscarinic acetylcholine receptor M1 (CHRM1),https://idrblab.net/ttd/data/target/details/T28893,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4388,2014064,12963076,Therapeutic Target Database (TTD),"Dimetindene, (R)-",D0H8XV,R-dimethindene,https://idrblab.net/ttd/data/drug/details/D0H8XV,T77913,Histamine H1 receptor (H1R),https://idrblab.net/ttd/data/target/details/T77913,P35367,Histamine H1 receptor,3269.0,HRH1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4389,2014065,12985714,Therapeutic Target Database (TTD),6-Ketoestrone,D03BZT,6-oxo-estrone,https://idrblab.net/ttd/data/drug/details/D03BZT,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4390,2014066,12999626,BindingDB,"5,7-Diallyloxy-4-phenyl-chromen-2-one",93221,"Neoflavonoid derivative, 6c",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=93221,5408,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5408,P26663,Genome polyprotein,,,11105.0,Hepatitis C virus (isolate BK),,IC50 (nM),3.03e+4,PMID:23311976|DOI:10.1111/cbdd.12105,https://www.ncbi.nlm.nih.gov/pubmed/23311976|https://doi.org/10.1111/cbdd.12105,23311976,10.1111/cbdd.12105,
4391,2014067,13066250,BindingDB,"2-N,2-N,6-N,6-N-tetrakis(2-ethoxyethyl)-4,8-bis(piperidin-1-yl)pyrimido[5,4-d][1,3]diazine-2,6-diamine",23695,"2-N,2-N,6-N,6-N-tetrakis(2-ethoxyethyl)-4,8-bis(piperidin-1-yl)pyrimido[5,4-d][1,3]diazine-2,6-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23695,2421,Equilibrative nucleoside transporter 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2421,Q99808,Equilibrative nucleoside transporter 1,2030.0,SLC29A1,9606.0,Homo sapiens (human),,,,PMID:17636949|DOI:10.1021/jm070311l,https://www.ncbi.nlm.nih.gov/pubmed/17636949|https://doi.org/10.1021/jm070311l,17636949,10.1021/jm070311l,
4392,2013295,13904714,Therapeutic Target Database (TTD),3-(2-Phenyl-2-(piperazin-1-yl)ethyl)phenol,D0T8BU,3-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol,https://idrblab.net/ttd/data/drug/details/D0T8BU,T55959,Dopamine transporter (DAT),https://idrblab.net/ttd/data/target/details/T55959,Q01959,Sodium-dependent dopamine transporter ,6531.0,SLC6A3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4393,2013300,13904714,Therapeutic Target Database (TTD),3-(2-Phenyl-2-(piperazin-1-yl)ethyl)phenol,D0T8BU,3-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol,https://idrblab.net/ttd/data/drug/details/D0T8BU,T21945,Norepinephrine transporter (NET),https://idrblab.net/ttd/data/target/details/T21945,P23975,Sodium-dependent noradrenaline transporter ,6530.0,SLC6A2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4394,2037459,13943297,Comparative Toxicogenomics Database (CTD),Astragaloside IV,C052064,astragaloside A,https://ctdbase.org/detail.go?type=chem&acc=C052064,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Astragaloside A results in increased expression of HMOX1 protein|[astragaloside A co-treated with ginsenoside rg1 co-treated with ginsenoside rb1 co-treated with notoginsenoside R1] results in increased expression of HMOX1 protein|astragaloside A results in increased expression of HMOX1 mrna|[astragaloside A co-treated with ginsenoside rg1 co-treated with ginsenoside rb1 co-treated with notoginsenoside R1] results in increased expression of HMOX1 mRNA,,,PMID:25422538,https://www.ncbi.nlm.nih.gov/pubmed/25422538,25422538,,
4395,2037460,13943297,Comparative Toxicogenomics Database (CTD),Astragaloside IV,C052064,astragaloside A,https://ctdbase.org/detail.go?type=chem&acc=C052064,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Astragaloside A inhibits the reaction [cisplatin results in increased expression of IL1B protein],,,PMID:30842369,https://www.ncbi.nlm.nih.gov/pubmed/30842369,30842369,,
4396,2037461,13943297,Comparative Toxicogenomics Database (CTD),Astragaloside IV,C052064,astragaloside A,https://ctdbase.org/detail.go?type=chem&acc=C052064,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Astragaloside A inhibits the reaction [taurocholic acid results in increased expression of IL1B protein]|astragaloside A inhibits the reaction [taurocholic acid results in increased expression of IL1B mrna],,,PMID:25604657,https://www.ncbi.nlm.nih.gov/pubmed/25604657,25604657,,
4397,2037462,13943297,Comparative Toxicogenomics Database (CTD),Astragaloside IV,C052064,astragaloside A,https://ctdbase.org/detail.go?type=chem&acc=C052064,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),[paeonol co-treated with icariin co-treated with nobiletin co-treated with ginsenosides co-treated with astragaloside A] results in decreased secretion of IL1B protein,,,PMID:32344236,https://www.ncbi.nlm.nih.gov/pubmed/32344236,32344236,,
4398,2013292,14314897,Drug Gene Interaction database (DGIdb),"alpha,beta-Dehydrocurvularin",,CHEMBL:CHEMBL482050,https://www.dgidb.org/drugs/chembl:CHEMBL482050,,POLK,https://www.dgidb.org/genes/hgnc:9183,,,51426.0,POLK,9606.0,Homo sapiens (human),,,,,,,,
4399,2013293,14314897,Drug Gene Interaction database (DGIdb),"alpha,beta-Dehydrocurvularin",,CHEMBL:CHEMBL482050,https://www.dgidb.org/drugs/chembl:CHEMBL482050,,NPSR1,https://www.dgidb.org/genes/hgnc:23631,,,387129.0,NPSR1,9606.0,Homo sapiens (human),,,,,,,,
4400,2013294,14343211,IUPHAR/BPS Guide to PHARMACOLOGY,5-Methyl-2-(phenylethynyl)pyridine,1419,5-MPEP,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1419,293,mGlu5 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=293,P31424,Metabotropic glutamate receptor 5,24418.0,Grm5,10116.0,Rattus norvegicus (Norway rat),Neutral,pKi,6.4,PMID:16155210,https://www.ncbi.nlm.nih.gov/pubmed/16155210,16155210,,
4401,2013301,14407285,IUPHAR/BPS Guide to PHARMACOLOGY,ethyl (E)-3-[3-amino-2-cyano-1-[(E)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate,11560,compound III [PMID: 29351497],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11560,2801,regulator of G-protein signaling 17,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2801,Q9UGC6,Regulator of G-protein signaling 17,26575.0,RGS17,9606.0,Homo sapiens (human),Inhibition,pIC50,4.84,PMID:29351497,https://www.ncbi.nlm.nih.gov/pubmed/29351497,29351497,,
4402,2013296,14487390,IUPHAR/BPS Guide to PHARMACOLOGY,"N-ethyl,N-methyl EM-A",1447,ME36,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1447,297,motilin receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=297,O43193,Motilin receptor,2862.0,MLNR,9606.0,Homo sapiens (human),Full agonist,pIC50,4.7,PMID:15764739,https://www.ncbi.nlm.nih.gov/pubmed/15764739,15764739,,
4403,2013297,14533720,Drug Gene Interaction database (DGIdb),7-Methoxy-1-naphthylpiperazine,,S-15535,https://www.dgidb.org/drugs/iuphar.ligand:26,,HTR1A,https://www.dgidb.org/genes/hgnc:5286,,,3350.0,HTR1A,9606.0,Homo sapiens (human),,,,,,,,
4404,2013298,14539800,Drug Gene Interaction database (DGIdb),Rapastinel,,RAPASTINEL,https://www.dgidb.org/drugs/ncit:C152156,,GRIN1,https://www.dgidb.org/genes/hgnc:4584,,,2902.0,GRIN1,9606.0,Homo sapiens (human),Agonist,,,,,,,
4405,2013299,14571158,Therapeutic Target Database (TTD),1-(p-Toluenesulfonyl)tryptamine,D08SMK,2-(1-tosyl-1H-indol-3-yl)ethanamine,https://idrblab.net/ttd/data/drug/details/D08SMK,T16691,5-HT 6 receptor (HTR6),https://idrblab.net/ttd/data/target/details/T16691,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4406,2013302,14624081,BindingDB,"2-(2-Chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-chromen-4-one",50079331,"2-(2-Chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50079331,93,Cyclin-dependent kinase 4/G1/S-specific cyclin-D1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=93,P11802,Cyclin-dependent kinase 4,1019.0,CDK4,9606.0,Homo sapiens (human),,IC50 (nM),155,PMID:16242653|DOI:10.1016/j.chembiol.2005.08.008,https://www.ncbi.nlm.nih.gov/pubmed/16242653|https://doi.org/10.1016/j.chembiol.2005.08.008,16242653,10.1016/j.chembiol.2005.08.008,
4407,2013313,14624081,BindingDB,"2-(2-Chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-chromen-4-one",50079331,"2-(2-Chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50079331,311,Cyclin-dependent kinase 6/G1/S-specific cyclin-D3,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=311,Q00534,Cyclin-dependent kinase 6,1021.0,CDK6,9606.0,Homo sapiens (human),,IC50 (nM),663,PMID:16242653|DOI:10.1016/j.chembiol.2005.08.008,https://www.ncbi.nlm.nih.gov/pubmed/16242653|https://doi.org/10.1016/j.chembiol.2005.08.008,16242653,10.1016/j.chembiol.2005.08.008,
4408,2013314,14624081,BindingDB,"2-(2-Chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-chromen-4-one",50079331,"2-(2-Chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50079331,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),221,PMID:16242653|DOI:10.1016/j.chembiol.2005.08.008,https://www.ncbi.nlm.nih.gov/pubmed/16242653|https://doi.org/10.1016/j.chembiol.2005.08.008,16242653,10.1016/j.chembiol.2005.08.008,
4409,2014012,14624081,BindingDB,"2-(2-Chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-chromen-4-one",50079331,"2-(2-Chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50079331,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),485,PMID:16242653|DOI:10.1016/j.chembiol.2005.08.008,https://www.ncbi.nlm.nih.gov/pubmed/16242653|https://doi.org/10.1016/j.chembiol.2005.08.008,16242653,10.1016/j.chembiol.2005.08.008,
4410,2013315,14728930,Comparative Toxicogenomics Database (CTD),7-Isoleucine-aiii,C056764,"angiotensin III, Ile(7)-",https://ctdbase.org/detail.go?type=chem&acc=C056764,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),"Angiotensin III, ile(7)- results in decreased activity of AGT protein modified form",,,PMID:9176287,https://www.ncbi.nlm.nih.gov/pubmed/9176287,9176287,,
4411,2013316,14824655,Drug Gene Interaction database (DGIdb),Talaroflavone,,TALAROFLAVONE,https://www.dgidb.org/drugs/chembl:CHEMBL408995,,POLL,https://www.dgidb.org/genes/hgnc:9184,,,27343.0,POLL,9606.0,Homo sapiens (human),,,,,,,,
4412,2013317,14956545,Therapeutic Target Database (TTD),"5-Butyl-6-chloro-1,2,3,4-tetrahydropyrimidine-2,4-dione",D0RE9X,"5-butyl-6-chloropyrimidine-2,4(1H,3H)-dione",https://idrblab.net/ttd/data/drug/details/D0RE9X,T59929,Thymidine phosphorylase (TYMP),https://idrblab.net/ttd/data/target/details/T59929,P19971,Thymidine phosphorylase,1890.0,TYMP,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4413,2013318,14973220,Comparative Toxicogenomics Database (CTD),1H-Indole-5-carboxamide,C514526,indole-5-carboxamide,https://ctdbase.org/detail.go?type=chem&acc=C514526,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Indole-5-carboxamide inhibits the reaction [ozone results in increased expression of IL1B mrna],,,PMID:18926814,https://www.ncbi.nlm.nih.gov/pubmed/18926814,18926814,,
4414,2013319,14973220,Comparative Toxicogenomics Database (CTD),1H-Indole-5-carboxamide,C514526,indole-5-carboxamide,https://ctdbase.org/detail.go?type=chem&acc=C514526,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Indole-5-carboxamide inhibits the reaction [ozone results in increased expression of IL6 mrna],,,PMID:18926814,https://www.ncbi.nlm.nih.gov/pubmed/18926814,18926814,,
4415,2013320,14973220,Comparative Toxicogenomics Database (CTD),1H-Indole-5-carboxamide,C514526,indole-5-carboxamide,https://ctdbase.org/detail.go?type=chem&acc=C514526,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606.0,Homo sapiens (human),Indole-5-carboxamide results in decreased activity of MAPK14 protein,,,PMID:15363871,https://www.ncbi.nlm.nih.gov/pubmed/15363871,15363871,,
4416,2013321,14973220,Comparative Toxicogenomics Database (CTD),1H-Indole-5-carboxamide,C514526,indole-5-carboxamide,https://ctdbase.org/detail.go?type=chem&acc=C514526,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),Indole-5-carboxamide promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK8 protein],,,PMID:16818652,https://www.ncbi.nlm.nih.gov/pubmed/16818652,16818652,,
4417,2013352,14973220,Comparative Toxicogenomics Database (CTD),1H-Indole-5-carboxamide,C514526,indole-5-carboxamide,https://ctdbase.org/detail.go?type=chem&acc=C514526,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606.0,Homo sapiens (human),Indole-5-carboxamide promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK9 protein],,,PMID:16818652,https://www.ncbi.nlm.nih.gov/pubmed/16818652,16818652,,
4418,2013353,14973220,Comparative Toxicogenomics Database (CTD),1H-Indole-5-carboxamide,C514526,indole-5-carboxamide,https://ctdbase.org/detail.go?type=chem&acc=C514526,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Indole-5-carboxamide inhibits the reaction [ozone results in increased expression of PTGS2 mrna],,,PMID:18926814,https://www.ncbi.nlm.nih.gov/pubmed/18926814,18926814,,
4419,2014225,15071517,Therapeutic Target Database (TTD),"(5R,6S)-6-(benzyloxy)-5-methoxycyclohex-2-enone",D04TWU,"(5R,6S)-6-(benzyloxy)-5-methoxycyclohex-2-enone",https://idrblab.net/ttd/data/drug/details/D04TWU,T99840,Gamma-secretase (GS),https://idrblab.net/ttd/data/target/details/T99840,Q92542,Nicastrin,23385.0,NCSTN,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4420,2014226,15071517,Therapeutic Target Database (TTD),"(5R,6S)-6-(benzyloxy)-5-methoxycyclohex-2-enone",D04TWU,"(5R,6S)-6-(benzyloxy)-5-methoxycyclohex-2-enone",https://idrblab.net/ttd/data/drug/details/D04TWU,T99840,Gamma-secretase (GS),https://idrblab.net/ttd/data/target/details/T99840,P49768,Presenilin-1,5663.0,PSEN1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4421,2013354,15110210,BindingDB,"(2,5-Bis[[(benzyloxy)carbonyl]amino]-1,2,5,6-tetradeoxy-1,6-di-1h-indol-3-yl-l-iditol)",429252,acs.jmedchem.1c00409_ST.146,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=429252,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,Ki (nM),340,PMID:26878082|DOI:10.1021/acs.jmedchem.5b01461,https://www.ncbi.nlm.nih.gov/pubmed/26878082|https://doi.org/10.1021/acs.jmedchem.5b01461,26878082,10.1021/acs.jmedchem.5b01461,
4422,2014227,15110210,BindingDB,"(2,5-Bis[[(benzyloxy)carbonyl]amino]-1,2,5,6-tetradeoxy-1,6-di-1h-indol-3-yl-l-iditol)",429252,acs.jmedchem.1c00409_ST.146,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=429252,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,Ki (nM),340,PMID:32852058|DOI:10.1002/med.21724,https://www.ncbi.nlm.nih.gov/pubmed/32852058|https://doi.org/10.1002/med.21724,32852058,10.1002/med.21724,
4423,2013355,15281645,Therapeutic Target Database (TTD),N-[4-(2-aminoethyl)phenyl]Benzenesulfonamide,D0D6FC,N-(4-(2-aminoethyl)phenyl)benzenesulfonamide,https://idrblab.net/ttd/data/drug/details/D0D6FC,T16691,5-HT 6 receptor (HTR6),https://idrblab.net/ttd/data/target/details/T16691,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4424,2013356,15294091,Comparative Toxicogenomics Database (CTD),Ankaflavin,C499916,ankaflavin,https://ctdbase.org/detail.go?type=chem&acc=C499916,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,10090.0,Mus musculus (house mouse),Ankaflavin results in increased expression of NR1H4 mRNA,,,PMID:24275089,https://www.ncbi.nlm.nih.gov/pubmed/24275089,24275089,,
4425,2013357,15294091,Comparative Toxicogenomics Database (CTD),Ankaflavin,C499916,ankaflavin,https://ctdbase.org/detail.go?type=chem&acc=C499916,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10090.0,Mus musculus (house mouse),Ankaflavin binds to and results in increased activity of PPARA protein|ankaflavin results in increased expression of PPARA mrna|ankaflavin affects the reaction [PPARA protein affects the oxidation of fatty acids],,,PMID:24275089,https://www.ncbi.nlm.nih.gov/pubmed/24275089,24275089,,
4426,2013358,15294091,Comparative Toxicogenomics Database (CTD),Ankaflavin,C499916,ankaflavin,https://ctdbase.org/detail.go?type=chem&acc=C499916,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),Ankaflavin results in increased expression of PPARGC1A mRNA,,,PMID:24275089,https://www.ncbi.nlm.nih.gov/pubmed/24275089,24275089,,
4427,2013359,15409414,Therapeutic Target Database (TTD),c(-GRGDfL-),D0B4JU,C(-GRGDfL-),https://idrblab.net/ttd/data/drug/details/D0B4JU,T67103,Integrin alpha-V (ITGAV),https://idrblab.net/ttd/data/target/details/T67103,P06756,Integrin alpha-V ,3685.0,ITGAV,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4428,2013360,15409414,Therapeutic Target Database (TTD),c(-GRGDfL-),D0B4JU,C(-GRGDfL-),https://idrblab.net/ttd/data/drug/details/D0B4JU,T01851,Integrin beta-1 (ITGB1),https://idrblab.net/ttd/data/target/details/T01851,P05556,Integrin beta-1,3688.0,ITGB1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4429,2013361,15409414,Therapeutic Target Database (TTD),c(-GRGDfL-),D0B4JU,C(-GRGDfL-),https://idrblab.net/ttd/data/drug/details/D0B4JU,T29879,Integrin alpha-5 (ITGA5),https://idrblab.net/ttd/data/target/details/T29879,P08648,Integrin alpha-5,3678.0,ITGA5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4430,2014011,15409414,Therapeutic Target Database (TTD),c(-GRGDfL-),D0B4JU,C(-GRGDfL-),https://idrblab.net/ttd/data/drug/details/D0B4JU,T23355,ITGB3 messenger RNA (ITGB3 mRNA),https://idrblab.net/ttd/data/target/details/T23355,P05106,Integrin beta-3,3690.0,ITGB3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
4431,2012812,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,354,KLK3,https://ctdbase.org/detail.go?type=gene&acc=354,,,354.0,KLK3,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of KLK3 mRNA,,,PMID:32184358|PMID:33932781,https://www.ncbi.nlm.nih.gov/pubmed/32184358|https://www.ncbi.nlm.nih.gov/pubmed/33932781,32184358|33932781,,
4432,2012813,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,354,KLK3,https://ctdbase.org/detail.go?type=gene&acc=354,,,354.0,KLK3,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of KLK3 protein,,,PMID:19359544|PMID:32184358|PMID:32805266|PMID:37019376,https://www.ncbi.nlm.nih.gov/pubmed/19359544|https://www.ncbi.nlm.nih.gov/pubmed/32184358|https://www.ncbi.nlm.nih.gov/pubmed/32805266|https://www.ncbi.nlm.nih.gov/pubmed/37019376,19359544|32184358|32805266|37019376,,
4433,2012814,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,354,KLK3,https://ctdbase.org/detail.go?type=gene&acc=354,,,354.0,KLK3,9606.0,Homo sapiens (human),Enzalutamide results in increased expression of KLK3 mRNA,,,PMID:23704919,https://www.ncbi.nlm.nih.gov/pubmed/23704919,23704919,,
4434,2012815,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,354,KLK3,https://ctdbase.org/detail.go?type=gene&acc=354,,,354.0,KLK3,9606.0,Homo sapiens (human),KDM1A protein promotes the reaction [enzalutamide results in decreased expression of KLK3 protein],,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4435,2012816,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,354,KLK3,https://ctdbase.org/detail.go?type=gene&acc=354,,,354.0,KLK3,9606.0,Homo sapiens (human),[nirogacestat results in increased susceptibility to enzalutamide] which results in decreased expression of KLK3 protein,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4436,2012817,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,3880,KRT19,https://ctdbase.org/detail.go?type=gene&acc=3880,,,3880.0,KRT19,9606.0,Homo sapiens (human),Enzalutamide affects the expression of KRT19 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4437,2012818,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,3932,LCK,https://ctdbase.org/detail.go?type=gene&acc=3932,,,3932.0,LCK,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of LCK mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4438,2012819,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,3936,LCP1,https://ctdbase.org/detail.go?type=gene&acc=3936,,,3936.0,LCP1,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of LCP1 mrna|kdm1a protein promotes the reaction [enzalutamide results in decreased expression of LCP1 mrna],,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4439,2012820,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4094,MAF,https://ctdbase.org/detail.go?type=gene&acc=4094,,,4094.0,MAF,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of MAF mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4440,2012821,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,9794,MAML1,https://ctdbase.org/detail.go?type=gene&acc=9794,,,9794.0,MAML1,9606.0,Homo sapiens (human),Enzalutamide affects the expression of MAML1 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4441,2012822,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,55534,MAML3,https://ctdbase.org/detail.go?type=gene&acc=55534,,,55534.0,MAML3,9606.0,Homo sapiens (human),Enzalutamide affects the expression of MAML3 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4442,2012823,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,9606.0,Homo sapiens (human),[enzalutamide co-treated with GSK-2816126] results in increased expression of MAP1LC3B protein modified form,,,PMID:32805266,https://www.ncbi.nlm.nih.gov/pubmed/32805266,32805266,,
4443,2012824,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of MAP2 mrna|kdm1a protein promotes the reaction [enzalutamide results in decreased expression of MAP2 mrna],,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4444,2012825,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4192,MDK,https://ctdbase.org/detail.go?type=gene&acc=4192,,,4192.0,MDK,9606.0,Homo sapiens (human),Enzalutamide affects the expression of MDK mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4445,2012826,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,57534,MIB1,https://ctdbase.org/detail.go?type=gene&acc=57534,,,57534.0,MIB1,9606.0,Homo sapiens (human),Enzalutamide affects the expression of MIB1 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4446,2012827,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,142678,MIB2,https://ctdbase.org/detail.go?type=gene&acc=142678,,,142678.0,MIB2,9606.0,Homo sapiens (human),Enzalutamide affects the expression of MIB2 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4447,2012828,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,9606.0,Homo sapiens (human),Enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of MKI67 protein],,,PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/32184358,32184358,,
4448,2012829,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4477,MSMB,https://ctdbase.org/detail.go?type=gene&acc=4477,,,4477.0,MSMB,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of MSMB mRNA,,,PMID:33932781,https://www.ncbi.nlm.nih.gov/pubmed/33932781,33932781,,
4449,2012830,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),Enzalutamide affects the expression of MYC mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4450,2012831,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of MYC protein|enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of MYC protein]|[enzalutamide co-treated with NVP-BHG712] results in decreased expression of MYC protein,,,PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/32184358,32184358,,
4451,2012832,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),Enzalutamide inhibits the reaction [dihydrotestosterone results in decreased expression of MYC protein]|enzalutamide inhibits the reaction [dihydrotestosterone results in decreased expression of MYC mrna]|enzalutamide inhibits the reaction [dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]],,,PMID:24759320,https://www.ncbi.nlm.nih.gov/pubmed/24759320,24759320,,
4452,2012833,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),Enzalutamide promotes the reaction [niclosamide results in decreased expression of MYC protein],,,PMID:25970160,https://www.ncbi.nlm.nih.gov/pubmed/25970160,25970160,,
4453,2012834,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4430,MYO1B,https://ctdbase.org/detail.go?type=gene&acc=4430,,,4430.0,MYO1B,9606.0,Homo sapiens (human),KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MYO1B mrna]|enzalutamide results in decreased expression of MYO1B mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4454,2012835,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,23385,NCSTN,https://ctdbase.org/detail.go?type=gene&acc=23385,,,23385.0,NCSTN,9606.0,Homo sapiens (human),Enzalutamide affects the expression of NCSTN mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4455,2012836,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,54492,NEURL1B,https://ctdbase.org/detail.go?type=gene&acc=54492,,,54492.0,NEURL1B,9606.0,Homo sapiens (human),Enzalutamide affects the expression of NEURL1B mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4456,2012837,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,79576,NKAP,https://ctdbase.org/detail.go?type=gene&acc=79576,,,79576.0,NKAP,9606.0,Homo sapiens (human),Enzalutamide affects the expression of NKAP mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4457,2012838,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4824,NKX3-1,https://ctdbase.org/detail.go?type=gene&acc=4824,,,4824.0,NKX3-1,9606.0,Homo sapiens (human),NVP-BHG712 promotes the reaction [enzalutamide results in decreased expression of NKX3-1 mrna]|enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of NKX3-1 mrna],,,PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/32184358,32184358,,
4458,2012839,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4824,NKX3-1,https://ctdbase.org/detail.go?type=gene&acc=4824,,,4824.0,NKX3-1,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of NKX3-1 mRNA,,,PMID:29581250|PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/29581250|https://www.ncbi.nlm.nih.gov/pubmed/32184358,29581250|32184358,,
4459,2012840,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,54475,NLE1,https://ctdbase.org/detail.go?type=gene&acc=54475,,,54475.0,NLE1,9606.0,Homo sapiens (human),Enzalutamide affects the expression of NLE1 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4460,2012841,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4851,NOTCH1,https://ctdbase.org/detail.go?type=gene&acc=4851,,,4851.0,NOTCH1,9606.0,Homo sapiens (human),[NOTCH1 protein affects the susceptibility to enzalutamide] which affects the cleavage of PARP1 protein|enzalutamide affects the expression of NOTCH1 mrna|notch1 protein affects the susceptibility to enzalutamide,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4461,2012842,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4853,NOTCH2,https://ctdbase.org/detail.go?type=gene&acc=4853,,,4853.0,NOTCH2,9606.0,Homo sapiens (human),Enzalutamide affects the expression of NOTCH2 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4462,2012843,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Enzalutamide promotes the reaction [NVP-BHG712 results in increased cleavage of PARP1 protein]|ephb4 protein affects the reaction [enzalutamide results in decreased cleavage of PARP1 protein]|enzalutamide results in decreased cleavage of PARP1 protein,,,PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/32184358,32184358,,
4463,2012844,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),[nirogacestat results in increased susceptibility to enzalutamide] which results in increased cleavage of PARP1 protein|[notch1 protein affects the susceptibility to enzalutamide] which affects the cleavage of PARP1 protein,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4464,2012845,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,64065,PERP,https://ctdbase.org/detail.go?type=gene&acc=64065,,,64065.0,PERP,9606.0,Homo sapiens (human),Enzalutamide affects the expression of PERP mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4465,2012846,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,5322,PLA2G5,https://ctdbase.org/detail.go?type=gene&acc=5322,,,5322.0,PLA2G5,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of PLA2G5 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4466,2012847,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,5347,PLK1,https://ctdbase.org/detail.go?type=gene&acc=5347,,,5347.0,PLK1,9606.0,Homo sapiens (human),[enzalutamide co-treated with NVP-BHG712] results in decreased expression of PLK1 protein|[enzalutamide co-treated with NVP-BHG712] results in decreased expression of PLK1 mrna|enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of PLK1 mrna],,,PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/32184358,32184358,,
4467,2012848,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,5352,PLOD2,https://ctdbase.org/detail.go?type=gene&acc=5352,,,5352.0,PLOD2,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of PLOD2 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4468,2012849,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,23509,POFUT1,https://ctdbase.org/detail.go?type=gene&acc=23509,,,23509.0,POFUT1,9606.0,Homo sapiens (human),Enzalutamide affects the expression of POFUT1 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4469,2012850,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,5663,PSEN1,https://ctdbase.org/detail.go?type=gene&acc=5663,,,5663.0,PSEN1,9606.0,Homo sapiens (human),Enzalutamide affects the expression of PSEN1 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4470,2012861,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,6400,SEL1L,https://ctdbase.org/detail.go?type=gene&acc=6400,,,6400.0,SEL1L,9606.0,Homo sapiens (human),Enzalutamide affects the expression of SEL1L mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4471,2012862,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,6414,SELENOP,https://ctdbase.org/detail.go?type=gene&acc=6414,,,6414.0,SELENOP,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of SELENOP mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4472,2012863,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,6581,SLC22A3,https://ctdbase.org/detail.go?type=gene&acc=6581,,,6581.0,SLC22A3,9606.0,Homo sapiens (human),KDM1A protein promotes the reaction [enzalutamide results in decreased expression of SLC22A3 mrna]|enzalutamide results in decreased expression of SLC22A3 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4473,2012864,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,22938,SNW1,https://ctdbase.org/detail.go?type=gene&acc=22938,,,22938.0,SNW1,9606.0,Homo sapiens (human),Enzalutamide affects the expression of SNW1 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4474,2012865,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,8835,SOCS2,https://ctdbase.org/detail.go?type=gene&acc=8835,,,8835.0,SOCS2,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of SOCS2 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4475,2012866,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,9606.0,Homo sapiens (human),Enzalutamide affects the expression of SOX9 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4476,2012867,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,23013,SPEN,https://ctdbase.org/detail.go?type=gene&acc=23013,,,23013.0,SPEN,9606.0,Homo sapiens (human),Enzalutamide affects the expression of SPEN mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4477,2012868,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,6695,SPOCK1,https://ctdbase.org/detail.go?type=gene&acc=6695,,,6695.0,SPOCK1,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of SPOCK1 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4478,2012869,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,55808,ST6GALNAC1,https://ctdbase.org/detail.go?type=gene&acc=55808,,,55808.0,ST6GALNAC1,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of ST6GALNAC1 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4479,2012870,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),Niclosamide inhibits the reaction [STAT3 protein results in decreased susceptibility to enzalutamide]|enzalutamide promotes the reaction [niclosamide results in decreased phosphorylation of and results in decreased activity of STAT3 protein]|stat3 protein results in decreased susceptibility to enzalutamide,,,PMID:25970160,https://www.ncbi.nlm.nih.gov/pubmed/25970160,25970160,,
4480,2012871,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,26032,SUSD5,https://ctdbase.org/detail.go?type=gene&acc=26032,,,26032.0,SUSD5,9606.0,Homo sapiens (human),Enzalutamide affects the expression of SUSD5 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4481,2012872,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,23512,SUZ12,https://ctdbase.org/detail.go?type=gene&acc=23512,,,23512.0,SUZ12,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of SUZ12 protein|[enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]|enzalutamide promotes the reaction [GSK-2816126 results in decreased expression of SUZ12 protein]|gsk-2816126 promotes the reaction [enzalutamide results in decreased expression of SUZ12 protein],,,PMID:32805266,https://www.ncbi.nlm.nih.gov/pubmed/32805266,32805266,,
4482,2012873,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,10178,TENM1,https://ctdbase.org/detail.go?type=gene&acc=10178,,,10178.0,TENM1,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of TENM1 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4483,2012874,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,57458,TMCC3,https://ctdbase.org/detail.go?type=gene&acc=57458,,,57458.0,TMCC3,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of TMCC3 mrna|kdm1a protein promotes the reaction [enzalutamide results in decreased expression of TMCC3 mrna],,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4484,2012875,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,7113,TMPRSS2,https://ctdbase.org/detail.go?type=gene&acc=7113,,,7113.0,TMPRSS2,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of TMPRSS2 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4485,2012876,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,7163,TPD52,https://ctdbase.org/detail.go?type=gene&acc=7163,,,7163.0,TPD52,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of TPD52 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4486,2012877,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,79054,TRPM8,https://ctdbase.org/detail.go?type=gene&acc=79054,,,79054.0,TRPM8,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of TRPM8 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4487,2012878,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,7311,UBA52,https://ctdbase.org/detail.go?type=gene&acc=7311,,,7311.0,UBA52,9606.0,Homo sapiens (human),Enzalutamide affects the expression of UBA52 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4488,2012879,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,7314,UBB,https://ctdbase.org/detail.go?type=gene&acc=7314,,,7314.0,UBB,9606.0,Homo sapiens (human),Enzalutamide affects the expression of UBB mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4489,2012880,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,7316,UBC,https://ctdbase.org/detail.go?type=gene&acc=7316,,,7316.0,UBC,9606.0,Homo sapiens (human),Enzalutamide affects the expression of UBC mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4490,2012881,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,11065,UBE2C,https://ctdbase.org/detail.go?type=gene&acc=11065,,,11065.0,UBE2C,9606.0,Homo sapiens (human),[enzalutamide co-treated with NVP-BHG712] results in decreased expression of UBE2C mRNA,,,PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/32184358,32184358,,
4491,2012882,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,55759,WDR12,https://ctdbase.org/detail.go?type=gene&acc=55759,,,55759.0,WDR12,9606.0,Homo sapiens (human),Enzalutamide affects the expression of WDR12 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
4492,2012883,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,25937,WWTR1,https://ctdbase.org/detail.go?type=gene&acc=25937,,,25937.0,WWTR1,9606.0,Homo sapiens (human),Enzalutamide results in decreased expression of WWTR1 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
4493,2012884,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4179,CD46,https://ctdbase.org/detail.go?type=gene&acc=4179,,,4179.0,CD46,9606.0,Homo sapiens (human),Enzalutamide results in increased expression of CD46 protein,,,PMID:30185663,https://www.ncbi.nlm.nih.gov/pubmed/30185663,30185663,,
4494,2012885,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3127,HLA-DRB5,https://ctdbase.org/detail.go?type=gene&acc=3127,,,3127.0,HLA-DRB5,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HLA-DRB5 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4495,2012886,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3133,HLA-E,https://ctdbase.org/detail.go?type=gene&acc=3133,,,3133.0,HLA-E,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HLA-E mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4496,2012887,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,9455,HOMER2,https://ctdbase.org/detail.go?type=gene&acc=9455,,,9455.0,HOMER2,10090.0,Mus musculus (house mouse),HOMER2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4497,2012888,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84525,HOPX,https://ctdbase.org/detail.go?type=gene&acc=84525,,,84525.0,HOPX,10090.0,Mus musculus (house mouse),HOPX results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4498,2012889,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3198,HOXA1,https://ctdbase.org/detail.go?type=gene&acc=3198,,,3198.0,HOXA1,10090.0,Mus musculus (house mouse),HOXA1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4499,2012890,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,221883,HOXA11-AS,https://ctdbase.org/detail.go?type=gene&acc=221883,,,221883.0,HOXA11-AS,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HOXA11-AS mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4500,2012891,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3201,HOXA4,https://ctdbase.org/detail.go?type=gene&acc=3201,,,3201.0,HOXA4,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HOXA4 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4501,2012892,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3202,HOXA5,https://ctdbase.org/detail.go?type=gene&acc=3202,,,3202.0,HOXA5,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HOXA5 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4502,2012893,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3204,HOXA7,https://ctdbase.org/detail.go?type=gene&acc=3204,,,3204.0,HOXA7,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HOXA7 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4503,2012894,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3205,HOXA9,https://ctdbase.org/detail.go?type=gene&acc=3205,,,3205.0,HOXA9,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HOXA9 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4504,2012895,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3225,HOXC9,https://ctdbase.org/detail.go?type=gene&acc=3225,,,3225.0,HOXC9,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HOXC9 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4505,2012896,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,51478,HSD17B7,https://ctdbase.org/detail.go?type=gene&acc=51478,,,51478.0,HSD17B7,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HSD17B7 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4506,2012897,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,158160,HSD17B7P2,https://ctdbase.org/detail.go?type=gene&acc=158160,,,158160.0,HSD17B7P2,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HSD17B7P2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4507,2012898,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,259217,HSPA12A,https://ctdbase.org/detail.go?type=gene&acc=259217,,,259217.0,HSPA12A,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HSPA12A mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4508,2012899,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,259217,HSPA12A,https://ctdbase.org/detail.go?type=gene&acc=259217,,,259217.0,HSPA12A,10090.0,Mus musculus (house mouse),HSPA12A results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4509,2012900,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10553,HTATIP2,https://ctdbase.org/detail.go?type=gene&acc=10553,,,10553.0,HTATIP2,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of HTATIP2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4510,2012901,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5654,HTRA1,https://ctdbase.org/detail.go?type=gene&acc=5654,,,5654.0,HTRA1,10090.0,Mus musculus (house mouse),HTRA1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4511,2012902,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,285148,IAH1,https://ctdbase.org/detail.go?type=gene&acc=285148,,,285148.0,IAH1,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of IAH1 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4512,2012903,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3398,ID2,https://ctdbase.org/detail.go?type=gene&acc=3398,,,3398.0,ID2,10090.0,Mus musculus (house mouse),ID2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4513,2012904,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3399,ID3,https://ctdbase.org/detail.go?type=gene&acc=3399,,,3399.0,ID3,10090.0,Mus musculus (house mouse),ID3 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4514,2012905,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,414328,IDNK,https://ctdbase.org/detail.go?type=gene&acc=414328,,,414328.0,IDNK,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of IDNK mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4515,2012906,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,8870,IER3,https://ctdbase.org/detail.go?type=gene&acc=8870,,,8870.0,IER3,10090.0,Mus musculus (house mouse),IER3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4516,2012907,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,51278,IER5,https://ctdbase.org/detail.go?type=gene&acc=51278,,,51278.0,IER5,10090.0,Mus musculus (house mouse),IER5 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4517,2012908,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,126917,IFFO2,https://ctdbase.org/detail.go?type=gene&acc=126917,,,126917.0,IFFO2,10090.0,Mus musculus (house mouse),IFFO2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4518,2012909,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,26388,IFI202B,https://ctdbase.org/detail.go?type=gene&acc=26388,,,26388.0,Ifi202b,10090.0,Mus musculus (house mouse),IFI202B results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4519,2012910,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,15950,IFI203,https://ctdbase.org/detail.go?type=gene&acc=15950,,,15950.0,Ifi203,10090.0,Mus musculus (house mouse),IFI203 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4520,2012911,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10561,IFI44,https://ctdbase.org/detail.go?type=gene&acc=10561,,,10561.0,IFI44,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of IFI44 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4521,2012912,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,15953,IFI47,https://ctdbase.org/detail.go?type=gene&acc=15953,,,15953.0,Ifi47,10090.0,Mus musculus (house mouse),IFI47 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4522,2012913,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3434,IFIT1,https://ctdbase.org/detail.go?type=gene&acc=3434,,,3434.0,IFIT1,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of IFIT1 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4523,2012924,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3482,IGF2R,https://ctdbase.org/detail.go?type=gene&acc=3482,,,3482.0,IGF2R,10090.0,Mus musculus (house mouse),IGF2R results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4524,2012925,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3490,IGFBP7,https://ctdbase.org/detail.go?type=gene&acc=3490,,,3490.0,IGFBP7,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of IGFBP7 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4525,2012926,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3490,IGFBP7,https://ctdbase.org/detail.go?type=gene&acc=3490,,,3490.0,IGFBP7,10090.0,Mus musculus (house mouse),IGFBP7 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4526,2012927,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,16061,IGH-VJ558,https://ctdbase.org/detail.go?type=gene&acc=16061,,,16061.0,Igh-VJ558,10090.0,Mus musculus (house mouse),IGH-VJ558 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4527,2012928,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3597,IL13RA1,https://ctdbase.org/detail.go?type=gene&acc=3597,,,3597.0,IL13RA1,10090.0,Mus musculus (house mouse),IL13RA1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4528,2012929,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3598,IL13RA2,https://ctdbase.org/detail.go?type=gene&acc=3598,,,3598.0,IL13RA2,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of IL13RA2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4529,2012930,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3556,IL1RAP,https://ctdbase.org/detail.go?type=gene&acc=3556,,,3556.0,IL1RAP,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of IL1RAP mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4530,2012931,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3556,IL1RAP,https://ctdbase.org/detail.go?type=gene&acc=3556,,,3556.0,IL1RAP,10090.0,Mus musculus (house mouse),IL1RAP results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4531,2012932,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,11009,IL24,https://ctdbase.org/detail.go?type=gene&acc=11009,,,11009.0,IL24,10090.0,Mus musculus (house mouse),IL24 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4532,2012933,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,90865,IL33,https://ctdbase.org/detail.go?type=gene&acc=90865,,,90865.0,IL33,10090.0,Mus musculus (house mouse),IL33 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4533,2012934,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),IL6 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4534,2012935,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,16194,IL6RA,https://ctdbase.org/detail.go?type=gene&acc=16194,,,16194.0,Il6ra,10090.0,Mus musculus (house mouse),IL6RA results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4535,2012936,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,286676,ILDR1,https://ctdbase.org/detail.go?type=gene&acc=286676,,,286676.0,ILDR1,10090.0,Mus musculus (house mouse),ILDR1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4536,2012937,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10994,ILVBL,https://ctdbase.org/detail.go?type=gene&acc=10994,,,10994.0,ILVBL,10090.0,Mus musculus (house mouse),ILVBL results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4537,2012938,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,642938,INSYN2A,https://ctdbase.org/detail.go?type=gene&acc=642938,,,642938.0,INSYN2A,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of INSYN2A mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4538,2012939,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3659,IRF1,https://ctdbase.org/detail.go?type=gene&acc=3659,,,3659.0,IRF1,10090.0,Mus musculus (house mouse),IRF1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4539,2012940,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,345611,IRGM,https://ctdbase.org/detail.go?type=gene&acc=345611,,,345611.0,IRGM,10090.0,Mus musculus (house mouse),IRGM results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4540,2012941,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3705,ITPK1,https://ctdbase.org/detail.go?type=gene&acc=3705,,,3705.0,ITPK1,10090.0,Mus musculus (house mouse),ITPK1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4541,2012942,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,25959,KANK2,https://ctdbase.org/detail.go?type=gene&acc=25959,,,25959.0,KANK2,10090.0,Mus musculus (house mouse),KANK2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4542,2012943,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,9920,KBTBD11,https://ctdbase.org/detail.go?type=gene&acc=9920,,,9920.0,KBTBD11,10090.0,Mus musculus (house mouse),KBTBD11 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4543,2012944,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3751,KCND2,https://ctdbase.org/detail.go?type=gene&acc=3751,,,3751.0,KCND2,9606.0,Homo sapiens (human),MRK 003 results in increased expression of KCND2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4544,2012945,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3770,KCNJ14,https://ctdbase.org/detail.go?type=gene&acc=3770,,,3770.0,KCNJ14,10090.0,Mus musculus (house mouse),KCNJ14 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4545,2012946,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3776,KCNK2,https://ctdbase.org/detail.go?type=gene&acc=3776,,,3776.0,KCNK2,10090.0,Mus musculus (house mouse),KCNK2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4546,2012947,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,8645,KCNK5,https://ctdbase.org/detail.go?type=gene&acc=8645,,,8645.0,KCNK5,9606.0,Homo sapiens (human),MRK 003 results in increased expression of KCNK5 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4547,2012948,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3778,KCNMA1,https://ctdbase.org/detail.go?type=gene&acc=3778,,,3778.0,KCNMA1,10090.0,Mus musculus (house mouse),KCNMA1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4548,2012949,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,27345,KCNMB4,https://ctdbase.org/detail.go?type=gene&acc=27345,,,27345.0,KCNMB4,10090.0,Mus musculus (house mouse),KCNMB4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4549,2012950,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3783,KCNN4,https://ctdbase.org/detail.go?type=gene&acc=3783,,,3783.0,KCNN4,10090.0,Mus musculus (house mouse),KCNN4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4550,2012960,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3785,KCNQ2,https://ctdbase.org/detail.go?type=gene&acc=3785,,,3785.0,KCNQ2,9606.0,Homo sapiens (human),MRK 003 results in increased expression of KCNQ2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4551,2012961,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,386618,KCTD4,https://ctdbase.org/detail.go?type=gene&acc=386618,,,386618.0,KCTD4,10090.0,Mus musculus (house mouse),KCTD4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4552,2012962,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3800,KIF5C,https://ctdbase.org/detail.go?type=gene&acc=3800,,,3800.0,KIF5C,10090.0,Mus musculus (house mouse),KIF5C results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4553,2012963,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3801,KIFC3,https://ctdbase.org/detail.go?type=gene&acc=3801,,,3801.0,KIFC3,10090.0,Mus musculus (house mouse),KIFC3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4554,2012964,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,17311,KITL,https://ctdbase.org/detail.go?type=gene&acc=17311,,,17311.0,Kitl,10090.0,Mus musculus (house mouse),KITL results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4555,2012965,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,28999,KLF15,https://ctdbase.org/detail.go?type=gene&acc=28999,,,28999.0,KLF15,10090.0,Mus musculus (house mouse),KLF15 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4556,2012966,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,126823,KLHDC9,https://ctdbase.org/detail.go?type=gene&acc=126823,,,126823.0,KLHDC9,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of KLHDC9 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4557,2012967,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,16627,KLRA1,https://ctdbase.org/detail.go?type=gene&acc=16627,,,16627.0,Klra1,10090.0,Mus musculus (house mouse),KLRA1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4558,2012968,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,16630,KLRA12,https://ctdbase.org/detail.go?type=gene&acc=16630,,,16630.0,Klra12,10090.0,Mus musculus (house mouse),KLRA12 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4559,2012969,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,16631,KLRA13-PS,https://ctdbase.org/detail.go?type=gene&acc=16631,,,16631.0,Klra13-ps,10090.0,Mus musculus (house mouse),KLRA13-PS results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4560,2012970,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,27423,KLRA15,https://ctdbase.org/detail.go?type=gene&acc=27423,,,27423.0,Klra15,10090.0,Mus musculus (house mouse),KLRA15 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4561,2012971,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,27424,KLRA16,https://ctdbase.org/detail.go?type=gene&acc=27424,,,27424.0,Klra16,10090.0,Mus musculus (house mouse),KLRA16 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4562,2012972,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,93968,KLRA21,https://ctdbase.org/detail.go?type=gene&acc=93968,,,93968.0,Klra21,10090.0,Mus musculus (house mouse),KLRA21 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4563,2012973,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,93969,KLRA22,https://ctdbase.org/detail.go?type=gene&acc=93969,,,93969.0,Klra22,10090.0,Mus musculus (house mouse),KLRA22 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4564,2012974,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,79410,KLRA23,https://ctdbase.org/detail.go?type=gene&acc=79410,,,79410.0,Klra23,10090.0,Mus musculus (house mouse),KLRA23 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4565,2012975,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,16635,KLRA4,https://ctdbase.org/detail.go?type=gene&acc=16635,,,16635.0,Klra4,10090.0,Mus musculus (house mouse),KLRA4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4566,2012976,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,16638,KLRA7,https://ctdbase.org/detail.go?type=gene&acc=16638,,,16638.0,Klra7,10090.0,Mus musculus (house mouse),KLRA7 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4567,2012977,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3861,KRT14,https://ctdbase.org/detail.go?type=gene&acc=3861,,,3861.0,KRT14,10090.0,Mus musculus (house mouse),KRT14 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4568,2012978,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3880,KRT19,https://ctdbase.org/detail.go?type=gene&acc=3880,,,3880.0,KRT19,10090.0,Mus musculus (house mouse),KRT19 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4569,2012979,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3855,KRT7,https://ctdbase.org/detail.go?type=gene&acc=3855,,,3855.0,KRT7,10090.0,Mus musculus (house mouse),KRT7 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4570,2012980,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,200634,KRTCAP3,https://ctdbase.org/detail.go?type=gene&acc=200634,,,200634.0,KRTCAP3,10090.0,Mus musculus (house mouse),KRTCAP3 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4571,2012981,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3910,LAMA4,https://ctdbase.org/detail.go?type=gene&acc=3910,,,3910.0,LAMA4,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of LAMA4 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4572,2012982,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,24141,LAMP5,https://ctdbase.org/detail.go?type=gene&acc=24141,,,24141.0,LAMP5,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of LAMP5 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4573,2012983,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,67718,LCE1H,https://ctdbase.org/detail.go?type=gene&acc=67718,,,67718.0,Lce1h,10090.0,Mus musculus (house mouse),LCE1H results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4574,2012984,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10637,LEFTY1,https://ctdbase.org/detail.go?type=gene&acc=10637,,,10637.0,LEFTY1,10090.0,Mus musculus (house mouse),LEFTY1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4575,2012985,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,10090.0,Mus musculus (house mouse),LGALS1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4576,2012986,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3958,LGALS3,https://ctdbase.org/detail.go?type=gene&acc=3958,,,3958.0,LGALS3,10090.0,Mus musculus (house mouse),LGALS3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4577,2012987,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55203,LGI2,https://ctdbase.org/detail.go?type=gene&acc=55203,,,55203.0,LGI2,10090.0,Mus musculus (house mouse),LGI2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4578,2012988,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5641,LGMN,https://ctdbase.org/detail.go?type=gene&acc=5641,,,5641.0,LGMN,10090.0,Mus musculus (house mouse),LGMN results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4579,2012989,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,59352,LGR6,https://ctdbase.org/detail.go?type=gene&acc=59352,,,59352.0,LGR6,9606.0,Homo sapiens (human),MRK 003 results in increased expression of LGR6 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4580,2012990,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,79168,LILRA6,https://ctdbase.org/detail.go?type=gene&acc=79168,,,79168.0,LILRA6,10090.0,Mus musculus (house mouse),LILRA6 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4581,2012991,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,11006,LILRB4,https://ctdbase.org/detail.go?type=gene&acc=11006,,,11006.0,LILRB4,10090.0,Mus musculus (house mouse),LILRB4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4582,2012992,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,9388,LIPG,https://ctdbase.org/detail.go?type=gene&acc=9388,,,9388.0,LIPG,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of LIPG mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4583,2012993,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,643418,LIPN,https://ctdbase.org/detail.go?type=gene&acc=643418,,,643418.0,LIPN,10090.0,Mus musculus (house mouse),LIPN results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4584,2012994,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,29995,LMCD1,https://ctdbase.org/detail.go?type=gene&acc=29995,,,29995.0,LMCD1,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of LMCD1 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4585,2012995,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,29995,LMCD1,https://ctdbase.org/detail.go?type=gene&acc=29995,,,29995.0,LMCD1,10090.0,Mus musculus (house mouse),LMCD1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4586,2013005,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4005,LMO2,https://ctdbase.org/detail.go?type=gene&acc=4005,,,4005.0,LMO2,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of LMO2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4587,2013006,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,1902,LPAR1,https://ctdbase.org/detail.go?type=gene&acc=1902,,,1902.0,LPAR1,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of LPAR1 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4588,2013007,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,26018,LRIG1,https://ctdbase.org/detail.go?type=gene&acc=26018,,,26018.0,LRIG1,10090.0,Mus musculus (house mouse),LRIG1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4589,2013008,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84918,LRP11,https://ctdbase.org/detail.go?type=gene&acc=84918,,,84918.0,LRP11,10090.0,Mus musculus (house mouse),LRP11 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4590,2013009,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,29967,LRP12,https://ctdbase.org/detail.go?type=gene&acc=29967,,,29967.0,LRP12,10090.0,Mus musculus (house mouse),LRP12 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4591,2013010,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,16995,LTB4R1,https://ctdbase.org/detail.go?type=gene&acc=16995,,,16995.0,Ltb4r1,10090.0,Mus musculus (house mouse),LTB4R1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4592,2013011,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4053,LTBP2,https://ctdbase.org/detail.go?type=gene&acc=4053,,,4053.0,LTBP2,10090.0,Mus musculus (house mouse),LTBP2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4593,2013012,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,23643,LY96,https://ctdbase.org/detail.go?type=gene&acc=23643,,,23643.0,LY96,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of LY96 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4594,2013013,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,17105,LYZ2,https://ctdbase.org/detail.go?type=gene&acc=17105,,,17105.0,Lyz2,10090.0,Mus musculus (house mouse),LYZ2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4595,2013014,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,9935,MAFB,https://ctdbase.org/detail.go?type=gene&acc=9935,,,9935.0,MAFB,10090.0,Mus musculus (house mouse),MAFB results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4596,2013015,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4128,MAOA,https://ctdbase.org/detail.go?type=gene&acc=4128,,,4128.0,MAOA,10090.0,Mus musculus (house mouse),MAOA results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4597,2013016,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5603,MAPK13,https://ctdbase.org/detail.go?type=gene&acc=5603,,,5603.0,MAPK13,10090.0,Mus musculus (house mouse),MAPK13 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4598,2013017,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7867,MAPKAPK3,https://ctdbase.org/detail.go?type=gene&acc=7867,,,7867.0,MAPKAPK3,10090.0,Mus musculus (house mouse),MAPKAPK3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4599,2013018,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,441061,MARCHF11,https://ctdbase.org/detail.go?type=gene&acc=441061,,,441061.0,MARCHF11,10090.0,Mus musculus (house mouse),MARCHF11 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4600,2013019,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,153562,MARVELD2,https://ctdbase.org/detail.go?type=gene&acc=153562,,,153562.0,MARVELD2,10090.0,Mus musculus (house mouse),MARVELD2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4601,2013020,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,23263,MCF2L,https://ctdbase.org/detail.go?type=gene&acc=23263,,,23263.0,MCF2L,10090.0,Mus musculus (house mouse),MCF2L results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4602,2013021,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4173,MCM4,https://ctdbase.org/detail.go?type=gene&acc=4173,,,4173.0,MCM4,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of MCM4 protein,,,PMID:19318552,https://www.ncbi.nlm.nih.gov/pubmed/19318552,19318552,,
4603,2013022,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4175,MCM6,https://ctdbase.org/detail.go?type=gene&acc=4175,,,4175.0,MCM6,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of MCM6 protein,,,PMID:19318552,https://www.ncbi.nlm.nih.gov/pubmed/19318552,19318552,,
4604,2013023,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,17225,MCPT2,https://ctdbase.org/detail.go?type=gene&acc=17225,,,17225.0,Mcpt2,10090.0,Mus musculus (house mouse),MCPT2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4605,2013024,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,17227,MCPT4,https://ctdbase.org/detail.go?type=gene&acc=17227,,,17227.0,Mcpt4,10090.0,Mus musculus (house mouse),MCPT4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4606,2013025,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55013,MCUB,https://ctdbase.org/detail.go?type=gene&acc=55013,,,55013.0,MCUB,10090.0,Mus musculus (house mouse),MCUB results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4607,2013026,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4200,ME2,https://ctdbase.org/detail.go?type=gene&acc=4200,,,4200.0,ME2,10090.0,Mus musculus (house mouse),ME2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4608,2013027,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84466,MEGF10,https://ctdbase.org/detail.go?type=gene&acc=84466,,,84466.0,MEGF10,10090.0,Mus musculus (house mouse),MEGF10 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4609,2013028,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84465,MEGF11,https://ctdbase.org/detail.go?type=gene&acc=84465,,,84465.0,MEGF11,10090.0,Mus musculus (house mouse),MEGF11 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4610,2013029,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,284207,METRNL,https://ctdbase.org/detail.go?type=gene&acc=284207,,,284207.0,METRNL,10090.0,Mus musculus (house mouse),METRNL results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4611,2013030,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84206,MEX3B,https://ctdbase.org/detail.go?type=gene&acc=84206,,,84206.0,MEX3B,10090.0,Mus musculus (house mouse),MEX3B results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4612,2013031,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,9258,MFHAS1,https://ctdbase.org/detail.go?type=gene&acc=9258,,,9258.0,MFHAS1,10090.0,Mus musculus (house mouse),MFHAS1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4613,2013032,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4242,MFNG,https://ctdbase.org/detail.go?type=gene&acc=4242,,,4242.0,MFNG,9606.0,Homo sapiens (human),MRK 003 results in increased expression of MFNG mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4614,2013033,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,100194875,MFSD2,https://ctdbase.org/detail.go?type=gene&acc=100194875,,,100194875.0,,10090.0,Mus musculus (house mouse),MFSD2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4615,2013034,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54842,MFSD6,https://ctdbase.org/detail.go?type=gene&acc=54842,,,54842.0,MFSD6,10090.0,Mus musculus (house mouse),MFSD6 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4616,2013035,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4249,MGAT5,https://ctdbase.org/detail.go?type=gene&acc=4249,,,4249.0,MGAT5,10090.0,Mus musculus (house mouse),MGAT5 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4617,2013036,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,11343,MGLL,https://ctdbase.org/detail.go?type=gene&acc=11343,,,11343.0,MGLL,10090.0,Mus musculus (house mouse),MGLL results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4618,2013037,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,8190,MIA,https://ctdbase.org/detail.go?type=gene&acc=8190,,,8190.0,MIA,10090.0,Mus musculus (house mouse),MIA results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4619,2013038,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,100507436,MICA,https://ctdbase.org/detail.go?type=gene&acc=100507436,,,100507436.0,MICA,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of MICA mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4620,2013039,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,399959,MIR100HG,https://ctdbase.org/detail.go?type=gene&acc=399959,,,399959.0,MIR100HG,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of MIR100HG mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4621,2013040,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10090.0,Mus musculus (house mouse),MRK 003 results in decreased expression of MKI67 protein,,,PMID:20197467,https://www.ncbi.nlm.nih.gov/pubmed/20197467,20197467,,
4622,2013050,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,79083,MLPH,https://ctdbase.org/detail.go?type=gene&acc=79083,,,79083.0,MLPH,10090.0,Mus musculus (house mouse),MLPH results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4623,2013051,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,326625,MMAB,https://ctdbase.org/detail.go?type=gene&acc=326625,,,326625.0,MMAB,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of MMAB mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4624,2013052,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4321,MMP12,https://ctdbase.org/detail.go?type=gene&acc=4321,,,4321.0,MMP12,10090.0,Mus musculus (house mouse),MMP12 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4625,2013053,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4327,MMP19,https://ctdbase.org/detail.go?type=gene&acc=4327,,,4327.0,MMP19,10090.0,Mus musculus (house mouse),MMP19 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4626,2013054,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4314,MMP3,https://ctdbase.org/detail.go?type=gene&acc=4314,,,4314.0,MMP3,10090.0,Mus musculus (house mouse),MMP3 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4627,2013055,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4317,MMP8,https://ctdbase.org/detail.go?type=gene&acc=4317,,,4317.0,MMP8,10090.0,Mus musculus (house mouse),MMP8 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4628,2013056,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55329,MNS1,https://ctdbase.org/detail.go?type=gene&acc=55329,,,55329.0,MNS1,10090.0,Mus musculus (house mouse),MNS1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4629,2013057,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55034,MOCOS,https://ctdbase.org/detail.go?type=gene&acc=55034,,,55034.0,MOCOS,10090.0,Mus musculus (house mouse),MOCOS results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4630,2013058,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4360,MRC1,https://ctdbase.org/detail.go?type=gene&acc=4360,,,4360.0,MRC1,10090.0,Mus musculus (house mouse),MRC1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4631,2013084,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,64968,MRPS6,https://ctdbase.org/detail.go?type=gene&acc=64968,,,64968.0,MRPS6,10090.0,Mus musculus (house mouse),MRPS6 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4632,2013085,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,51338,MS4A4A,https://ctdbase.org/detail.go?type=gene&acc=51338,,,51338.0,MS4A4A,10090.0,Mus musculus (house mouse),MS4A4A results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4633,2013086,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,73656,MS4A6C,https://ctdbase.org/detail.go?type=gene&acc=73656,,,73656.0,Ms4a6c,10090.0,Mus musculus (house mouse),MS4A6C results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4634,2013087,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,68774,MS4A6D,https://ctdbase.org/detail.go?type=gene&acc=68774,,,68774.0,Ms4a6d,10090.0,Mus musculus (house mouse),MS4A6D results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4635,2013088,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,64381,MS4A8A,https://ctdbase.org/detail.go?type=gene&acc=64381,,,64381.0,Ms4a8a,10090.0,Mus musculus (house mouse),MS4A8A results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4636,2013089,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10232,MSLN,https://ctdbase.org/detail.go?type=gene&acc=10232,,,10232.0,MSLN,10090.0,Mus musculus (house mouse),MSLN results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4637,2013090,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6307,MSMO1,https://ctdbase.org/detail.go?type=gene&acc=6307,,,6307.0,MSMO1,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of MSMO1 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4638,2013091,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4481,MSR1,https://ctdbase.org/detail.go?type=gene&acc=4481,,,4481.0,MSR1,10090.0,Mus musculus (house mouse),MSR1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4639,2013092,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4482,MSRA,https://ctdbase.org/detail.go?type=gene&acc=4482,,,4482.0,MSRA,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of MSRA mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4640,2013102,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10903,MTMR11,https://ctdbase.org/detail.go?type=gene&acc=10903,,,10903.0,MTMR11,10090.0,Mus musculus (house mouse),MTMR11 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4641,2013103,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,10090.0,Mus musculus (house mouse),MRK 003 affects the activity of MTOR protein,,,PMID:19246562,https://www.ncbi.nlm.nih.gov/pubmed/19246562,19246562,,
4642,2013104,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54587,MXRA8,https://ctdbase.org/detail.go?type=gene&acc=54587,,,54587.0,MXRA8,10090.0,Mus musculus (house mouse),MXRA8 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4643,2013105,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of MYC mRNA,,,PMID:21127729,https://www.ncbi.nlm.nih.gov/pubmed/21127729,21127729,,
4644,2013106,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of MYC protein,,,PMID:17646409|PMID:19318552|PMID:21127729,https://www.ncbi.nlm.nih.gov/pubmed/17646409|https://www.ncbi.nlm.nih.gov/pubmed/19318552|https://www.ncbi.nlm.nih.gov/pubmed/21127729,17646409|19318552|21127729,,
4645,2013107,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),[MRK 003 results in decreased expression of MYC protein] inhibits the reaction [MYC binds to CDKN2D promoter],,,PMID:19318552,https://www.ncbi.nlm.nih.gov/pubmed/19318552,19318552,,
4646,2013108,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10090.0,Mus musculus (house mouse),MRK 003 results in decreased expression of MYC mRNA,,,PMID:19246562|PMID:20197467,https://www.ncbi.nlm.nih.gov/pubmed/19246562|https://www.ncbi.nlm.nih.gov/pubmed/20197467,19246562|20197467,,
4647,2013109,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4613,MYCN,https://ctdbase.org/detail.go?type=gene&acc=4613,,,4613.0,MYCN,9606.0,Homo sapiens (human),MRK 003 results in increased expression of MYCN mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4648,2013110,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4646,MYO6,https://ctdbase.org/detail.go?type=gene&acc=4646,,,4646.0,MYO6,10090.0,Mus musculus (house mouse),MYO6 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4649,2013128,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55728,N4BP2,https://ctdbase.org/detail.go?type=gene&acc=55728,,,55728.0,N4BP2,10090.0,Mus musculus (house mouse),N4BP2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4650,2013129,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4665,NAB2,https://ctdbase.org/detail.go?type=gene&acc=4665,,,4665.0,NAB2,10090.0,Mus musculus (house mouse),NAB2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4651,2013130,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,89796,NAV1,https://ctdbase.org/detail.go?type=gene&acc=89796,,,89796.0,NAV1,10090.0,Mus musculus (house mouse),NAV1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4652,2013131,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,89795,NAV3,https://ctdbase.org/detail.go?type=gene&acc=89795,,,89795.0,NAV3,10090.0,Mus musculus (house mouse),NAV3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4653,2013132,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,65009,NDRG4,https://ctdbase.org/detail.go?type=gene&acc=65009,,,65009.0,NDRG4,10090.0,Mus musculus (house mouse),NDRG4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4654,2013133,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4695,NDUFA2,https://ctdbase.org/detail.go?type=gene&acc=4695,,,4695.0,NDUFA2,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of NDUFA2 protein,,,PMID:19775282,https://www.ncbi.nlm.nih.gov/pubmed/19775282,19775282,,
4655,2013134,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4747,NEFL,https://ctdbase.org/detail.go?type=gene&acc=4747,,,4747.0,NEFL,10090.0,Mus musculus (house mouse),NEFL results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4656,2013135,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4741,NEFM,https://ctdbase.org/detail.go?type=gene&acc=4741,,,4741.0,NEFM,10090.0,Mus musculus (house mouse),NEFM results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4657,2013136,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4756,NEO1,https://ctdbase.org/detail.go?type=gene&acc=4756,,,4756.0,NEO1,10090.0,Mus musculus (house mouse),NEO1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4658,2013154,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,150372,NFAM1,https://ctdbase.org/detail.go?type=gene&acc=150372,,,150372.0,NFAM1,10090.0,Mus musculus (house mouse),NFAM1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4659,2013155,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4772,NFATC1,https://ctdbase.org/detail.go?type=gene&acc=4772,,,4772.0,NFATC1,10090.0,Mus musculus (house mouse),NFATC1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4660,2013156,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4773,NFATC2,https://ctdbase.org/detail.go?type=gene&acc=4773,,,4773.0,NFATC2,10090.0,Mus musculus (house mouse),NFATC2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4661,2013157,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,9603,NFE2L3,https://ctdbase.org/detail.go?type=gene&acc=9603,,,9603.0,NFE2L3,10090.0,Mus musculus (house mouse),NFE2L3 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4662,2013158,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,25791,NGEF,https://ctdbase.org/detail.go?type=gene&acc=25791,,,25791.0,NGEF,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of NGEF mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4663,2013159,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,25791,NGEF,https://ctdbase.org/detail.go?type=gene&acc=25791,,,25791.0,NGEF,10090.0,Mus musculus (house mouse),NGEF results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4664,2013160,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55768,NGLY1,https://ctdbase.org/detail.go?type=gene&acc=55768,,,55768.0,NGLY1,10090.0,Mus musculus (house mouse),NGLY1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4665,2013161,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,57224,NHSL1,https://ctdbase.org/detail.go?type=gene&acc=57224,,,57224.0,NHSL1,10090.0,Mus musculus (house mouse),NHSL1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4666,2013162,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,116496,NIBAN1,https://ctdbase.org/detail.go?type=gene&acc=116496,,,116496.0,NIBAN1,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of NIBAN1 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4667,2013172,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4814,NINJ1,https://ctdbase.org/detail.go?type=gene&acc=4814,,,4814.0,NINJ1,10090.0,Mus musculus (house mouse),NINJ1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4668,2013173,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,152519,NIPAL1,https://ctdbase.org/detail.go?type=gene&acc=152519,,,152519.0,NIPAL1,10090.0,Mus musculus (house mouse),NIPAL1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4669,2013174,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,57185,NIPAL3,https://ctdbase.org/detail.go?type=gene&acc=57185,,,57185.0,NIPAL3,10090.0,Mus musculus (house mouse),NIPAL3 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4670,2013175,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,8508,NIPSNAP1,https://ctdbase.org/detail.go?type=gene&acc=8508,,,8508.0,NIPSNAP1,10090.0,Mus musculus (house mouse),NIPSNAP1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4671,2013176,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,85409,NKD2,https://ctdbase.org/detail.go?type=gene&acc=85409,,,85409.0,NKD2,10090.0,Mus musculus (house mouse),NKD2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4672,2013177,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,114548,NLRP3,https://ctdbase.org/detail.go?type=gene&acc=114548,,,114548.0,NLRP3,10090.0,Mus musculus (house mouse),NLRP3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4673,2013178,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4851,NOTCH1,https://ctdbase.org/detail.go?type=gene&acc=4851,,,4851.0,NOTCH1,9606.0,Homo sapiens (human),MRK 003 inhibits the reaction [resveratrol results in increased activity of NOTCH1],,,PMID:21743969,https://www.ncbi.nlm.nih.gov/pubmed/21743969,21743969,,
4674,2013179,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4851,NOTCH1,https://ctdbase.org/detail.go?type=gene&acc=4851,,,4851.0,NOTCH1,9606.0,Homo sapiens (human),MRK 003 results in decreased cleavage of NOTCH1 protein,,,PMID:17646409|PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/17646409|https://www.ncbi.nlm.nih.gov/pubmed/21169257,17646409|21169257,,
4675,2013180,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4851,NOTCH1,https://ctdbase.org/detail.go?type=gene&acc=4851,,,4851.0,NOTCH1,9606.0,Homo sapiens (human),NOTCH1 protein modified form inhibits the reaction [MRK 003 results in decreased phosphorylation of and results in increased activity of RB1 protein],,,PMID:19318552,https://www.ncbi.nlm.nih.gov/pubmed/19318552,19318552,,
4676,2013189,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4851,NOTCH1,https://ctdbase.org/detail.go?type=gene&acc=4851,,,4851.0,NOTCH1,10090.0,Mus musculus (house mouse),MRK 003 results in decreased expression of NOTCH1 protein,,,PMID:19246562,https://www.ncbi.nlm.nih.gov/pubmed/19246562,19246562,,
4677,2013190,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4853,NOTCH2,https://ctdbase.org/detail.go?type=gene&acc=4853,,,4853.0,NOTCH2,9606.0,Homo sapiens (human),NOTCH2 inhibits the reaction [MRK 003 results in increased expression of GLI1 mrna],,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4678,2013191,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4854,NOTCH3,https://ctdbase.org/detail.go?type=gene&acc=4854,,,4854.0,NOTCH3,9606.0,Homo sapiens (human),NOTCH3 protein modified form results in decreased susceptibility to MRK 003,,,PMID:21994468,https://www.ncbi.nlm.nih.gov/pubmed/21994468,21994468,,
4679,2013192,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4854,NOTCH3,https://ctdbase.org/detail.go?type=gene&acc=4854,,,4854.0,NOTCH3,9606.0,Homo sapiens (human),NOTCH3 results in increased susceptibility to MRK 003,,,PMID:17804716,https://www.ncbi.nlm.nih.gov/pubmed/17804716,17804716,,
4680,2013193,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4855,NOTCH4,https://ctdbase.org/detail.go?type=gene&acc=4855,,,4855.0,NOTCH4,10090.0,Mus musculus (house mouse),NOTCH4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4681,2013194,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,80896,NPL,https://ctdbase.org/detail.go?type=gene&acc=80896,,,80896.0,NPL,10090.0,Mus musculus (house mouse),NPL results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4682,2013195,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,4879,NPPB,https://ctdbase.org/detail.go?type=gene&acc=4879,,,4879.0,NPPB,10090.0,Mus musculus (house mouse),NPPB results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4683,2013196,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7025,NR2F1,https://ctdbase.org/detail.go?type=gene&acc=7025,,,7025.0,NR2F1,10090.0,Mus musculus (house mouse),NR2F1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4684,2013197,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,67169,NRADD,https://ctdbase.org/detail.go?type=gene&acc=67169,,,67169.0,Nradd,10090.0,Mus musculus (house mouse),NRADD results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4685,2013207,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,340371,NRBP2,https://ctdbase.org/detail.go?type=gene&acc=340371,,,340371.0,NRBP2,10090.0,Mus musculus (house mouse),NRBP2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4686,2013208,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84628,NTNG2,https://ctdbase.org/detail.go?type=gene&acc=84628,,,84628.0,NTNG2,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of NTNG2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4687,2013209,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,220323,OAF,https://ctdbase.org/detail.go?type=gene&acc=220323,,,220323.0,OAF,10090.0,Mus musculus (house mouse),OAF results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4688,2013210,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,132299,OCIAD2,https://ctdbase.org/detail.go?type=gene&acc=132299,,,132299.0,OCIAD2,10090.0,Mus musculus (house mouse),OCIAD2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4689,2013211,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10439,OLFM1,https://ctdbase.org/detail.go?type=gene&acc=10439,,,10439.0,OLFM1,10090.0,Mus musculus (house mouse),OLFM1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4690,2013212,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,169611,OLFML2A,https://ctdbase.org/detail.go?type=gene&acc=169611,,,169611.0,OLFML2A,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of OLFML2A mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4691,2013213,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54491,OTULINL,https://ctdbase.org/detail.go?type=gene&acc=54491,,,54491.0,OTULINL,10090.0,Mus musculus (house mouse),OTULINL results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4692,2013214,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5031,P2RY6,https://ctdbase.org/detail.go?type=gene&acc=5031,,,5031.0,P2RY6,10090.0,Mus musculus (house mouse),P2RY6 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4693,2013215,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,51702,PADI3,https://ctdbase.org/detail.go?type=gene&acc=51702,,,51702.0,PADI3,10090.0,Mus musculus (house mouse),PADI3 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4694,2013216,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5058,PAK1,https://ctdbase.org/detail.go?type=gene&acc=5058,,,5058.0,PAK1,10090.0,Mus musculus (house mouse),PAK1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4695,2013217,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,677884,PAKAP,https://ctdbase.org/detail.go?type=gene&acc=677884,,,677884.0,Pakap,10090.0,Mus musculus (house mouse),PAKAP results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4696,2013218,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,9060,PAPSS2,https://ctdbase.org/detail.go?type=gene&acc=9060,,,9060.0,PAPSS2,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PAPSS2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4697,2013219,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),MRK 003 results in increased cleavage of PARP1 protein,,,PMID:17804716,https://www.ncbi.nlm.nih.gov/pubmed/17804716,17804716,,
4698,2013220,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,79668,PARP8,https://ctdbase.org/detail.go?type=gene&acc=79668,,,79668.0,PARP8,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PARP8 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4699,2013221,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10207,PATJ,https://ctdbase.org/detail.go?type=gene&acc=10207,,,10207.0,PATJ,10090.0,Mus musculus (house mouse),PATJ results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4700,2013222,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5087,PBX1,https://ctdbase.org/detail.go?type=gene&acc=5087,,,5087.0,PBX1,10090.0,Mus musculus (house mouse),PBX1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4701,2013223,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54510,PCDH18,https://ctdbase.org/detail.go?type=gene&acc=54510,,,54510.0,PCDH18,10090.0,Mus musculus (house mouse),PCDH18 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4702,2013224,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,56133,PCDHB2,https://ctdbase.org/detail.go?type=gene&acc=56133,,,56133.0,PCDHB2,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PCDHB2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4703,2013225,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,93891,PCDHB20,https://ctdbase.org/detail.go?type=gene&acc=93891,,,93891.0,Pcdhb20,10090.0,Mus musculus (house mouse),PCDHB20 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4704,2013226,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,56129,PCDHB7,https://ctdbase.org/detail.go?type=gene&acc=56129,,,56129.0,PCDHB7,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PCDHB7 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4705,2013227,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,56103,PCDHGB2,https://ctdbase.org/detail.go?type=gene&acc=56103,,,56103.0,PCDHGB2,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PCDHGB2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4706,2013228,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5106,PCK2,https://ctdbase.org/detail.go?type=gene&acc=5106,,,5106.0,PCK2,10090.0,Mus musculus (house mouse),PCK2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4707,2013229,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5046,PCSK6,https://ctdbase.org/detail.go?type=gene&acc=5046,,,5046.0,PCSK6,10090.0,Mus musculus (house mouse),PCSK6 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4708,2013230,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,18563,PCX,https://ctdbase.org/detail.go?type=gene&acc=18563,,,18563.0,Pcx,10090.0,Mus musculus (house mouse),PCX results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4709,2013231,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5130,PCYT1A,https://ctdbase.org/detail.go?type=gene&acc=5130,,,5130.0,PCYT1A,10090.0,Mus musculus (house mouse),PCYT1A results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4710,2013232,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10846,PDE10A,https://ctdbase.org/detail.go?type=gene&acc=10846,,,10846.0,PDE10A,10090.0,Mus musculus (house mouse),PDE10A results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4711,2013233,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5156,PDGFRA,https://ctdbase.org/detail.go?type=gene&acc=5156,,,5156.0,PDGFRA,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PDGFRA mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4712,2013256,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10630,PDPN,https://ctdbase.org/detail.go?type=gene&acc=10630,,,10630.0,PDPN,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PDPN mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4713,2013257,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10630,PDPN,https://ctdbase.org/detail.go?type=gene&acc=10630,,,10630.0,PDPN,10090.0,Mus musculus (house mouse),PDPN results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4714,2013258,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,23024,PDZRN3,https://ctdbase.org/detail.go?type=gene&acc=23024,,,23024.0,PDZRN3,10090.0,Mus musculus (house mouse),PDZRN3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4715,2013259,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5178,PEG3,https://ctdbase.org/detail.go?type=gene&acc=5178,,,5178.0,PEG3,9606.0,Homo sapiens (human),MRK 003 results in increased expression of PEG3 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4716,2013260,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5178,PEG3,https://ctdbase.org/detail.go?type=gene&acc=5178,,,5178.0,PEG3,10090.0,Mus musculus (house mouse),PEG3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4717,2013261,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,64065,PERP,https://ctdbase.org/detail.go?type=gene&acc=64065,,,64065.0,PERP,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PERP mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4718,2013262,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5196,PF4,https://ctdbase.org/detail.go?type=gene&acc=5196,,,5196.0,PF4,10090.0,Mus musculus (house mouse),PF4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4719,2013263,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84302,PGAP4,https://ctdbase.org/detail.go?type=gene&acc=84302,,,84302.0,PGAP4,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PGAP4 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4720,2013264,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,23187,PHLDB1,https://ctdbase.org/detail.go?type=gene&acc=23187,,,23187.0,PHLDB1,10090.0,Mus musculus (house mouse),PHLDB1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4721,2013265,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,18689,PHXR4,https://ctdbase.org/detail.go?type=gene&acc=18689,,,18689.0,Phxr4,10090.0,Mus musculus (house mouse),PHXR4 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4722,2013266,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,113791,PIK3IP1,https://ctdbase.org/detail.go?type=gene&acc=113791,,,113791.0,PIK3IP1,10090.0,Mus musculus (house mouse),PIK3IP1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4723,2013267,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,30849,PIK3R4,https://ctdbase.org/detail.go?type=gene&acc=30849,,,30849.0,PIK3R4,10090.0,Mus musculus (house mouse),PIK3R4 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4724,2013268,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,29992,PILRA,https://ctdbase.org/detail.go?type=gene&acc=29992,,,29992.0,PILRA,10090.0,Mus musculus (house mouse),PILRA results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4725,2013269,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,18722,PIRA1,https://ctdbase.org/detail.go?type=gene&acc=18722,,,18722.0,Pira1,10090.0,Mus musculus (house mouse),PIRA1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4726,2013270,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,18725,PIRA2,https://ctdbase.org/detail.go?type=gene&acc=18725,,,18725.0,Pira2,10090.0,Mus musculus (house mouse),PIRA2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4727,2013271,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,18727,PIRA4,https://ctdbase.org/detail.go?type=gene&acc=18727,,,18727.0,Pira4,10090.0,Mus musculus (house mouse),PIRA4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4728,2013272,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,18728,PIRA5,https://ctdbase.org/detail.go?type=gene&acc=18728,,,18728.0,Pira5,10090.0,Mus musculus (house mouse),PIRA5 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4729,2013273,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,18730,PIRA7,https://ctdbase.org/detail.go?type=gene&acc=18730,,,18730.0,Pira7,10090.0,Mus musculus (house mouse),PIRA7 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4730,2013283,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,83394,PITPNM3,https://ctdbase.org/detail.go?type=gene&acc=83394,,,83394.0,PITPNM3,10090.0,Mus musculus (house mouse),PITPNM3 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4731,2013284,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55124,PIWIL2,https://ctdbase.org/detail.go?type=gene&acc=55124,,,55124.0,PIWIL2,10090.0,Mus musculus (house mouse),PIWIL2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4732,2013285,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5569,PKIA,https://ctdbase.org/detail.go?type=gene&acc=5569,,,5569.0,PKIA,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PKIA mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4733,2013286,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5570,PKIB,https://ctdbase.org/detail.go?type=gene&acc=5570,,,5570.0,PKIB,10090.0,Mus musculus (house mouse),PKIB results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4734,2013287,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7941,PLA2G7,https://ctdbase.org/detail.go?type=gene&acc=7941,,,7941.0,PLA2G7,10090.0,Mus musculus (house mouse),PLA2G7 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4735,2013288,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5327,PLAT,https://ctdbase.org/detail.go?type=gene&acc=5327,,,5327.0,PLAT,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PLAT mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4736,2013289,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5327,PLAT,https://ctdbase.org/detail.go?type=gene&acc=5327,,,5327.0,PLAT,10090.0,Mus musculus (house mouse),PLAT results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4737,2013290,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,79887,PLBD1,https://ctdbase.org/detail.go?type=gene&acc=79887,,,79887.0,PLBD1,10090.0,Mus musculus (house mouse),PLBD1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4738,2013291,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5338,PLD2,https://ctdbase.org/detail.go?type=gene&acc=5338,,,5338.0,PLD2,10090.0,Mus musculus (house mouse),PLD2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4739,2013322,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5341,PLEK,https://ctdbase.org/detail.go?type=gene&acc=5341,,,5341.0,PLEK,10090.0,Mus musculus (house mouse),PLEK results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4740,2013323,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,59339,PLEKHA2,https://ctdbase.org/detail.go?type=gene&acc=59339,,,59339.0,PLEKHA2,10090.0,Mus musculus (house mouse),PLEKHA2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4741,2013324,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,22874,PLEKHA6,https://ctdbase.org/detail.go?type=gene&acc=22874,,,22874.0,PLEKHA6,10090.0,Mus musculus (house mouse),PLEKHA6 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4742,2013325,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,450095,PLF,https://ctdbase.org/detail.go?type=gene&acc=450095,,,450095.0,PLF,10090.0,Mus musculus (house mouse),PLF results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4743,2013326,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123.0,PLIN2,10090.0,Mus musculus (house mouse),PLIN2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4744,2013327,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,8612,PLPP2,https://ctdbase.org/detail.go?type=gene&acc=8612,,,8612.0,PLPP2,10090.0,Mus musculus (house mouse),PLPP2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4745,2013328,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5357,PLS1,https://ctdbase.org/detail.go?type=gene&acc=5357,,,5357.0,PLS1,10090.0,Mus musculus (house mouse),PLS1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4746,2013329,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,57047,PLSCR2,https://ctdbase.org/detail.go?type=gene&acc=57047,,,57047.0,PLSCR2,10090.0,Mus musculus (house mouse),PLSCR2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4747,2013330,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,91584,PLXNA4,https://ctdbase.org/detail.go?type=gene&acc=91584,,,91584.0,PLXNA4,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PLXNA4 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4748,2013377,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5364,PLXNB1,https://ctdbase.org/detail.go?type=gene&acc=5364,,,5364.0,PLXNB1,10090.0,Mus musculus (house mouse),PLXNB1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4749,2013378,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376.0,PMP22,10090.0,Mus musculus (house mouse),PMP22 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4750,2013379,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,79883,PODNL1,https://ctdbase.org/detail.go?type=gene&acc=79883,,,79883.0,PODNL1,10090.0,Mus musculus (house mouse),PODNL1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4751,2013380,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,57804,POLD4,https://ctdbase.org/detail.go?type=gene&acc=57804,,,57804.0,POLD4,10090.0,Mus musculus (house mouse),POLD4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4752,2013381,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,10090.0,Mus musculus (house mouse),PPARD results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4753,2013382,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),PPARGC1A results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4754,2013383,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,133522,PPARGC1B,https://ctdbase.org/detail.go?type=gene&acc=133522,,,133522.0,PPARGC1B,9606.0,Homo sapiens (human),MRK 003 results in increased expression of PPARGC1B mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4755,2013384,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5473,PPBP,https://ctdbase.org/detail.go?type=gene&acc=5473,,,5473.0,PPBP,10090.0,Mus musculus (house mouse),PPBP results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4756,2013385,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5480,PPIC,https://ctdbase.org/detail.go?type=gene&acc=5480,,,5480.0,PPIC,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PPIC mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4757,2013386,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5480,PPIC,https://ctdbase.org/detail.go?type=gene&acc=5480,,,5480.0,PPIC,10090.0,Mus musculus (house mouse),PPIC results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4758,2013387,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,79660,PPP1R3B,https://ctdbase.org/detail.go?type=gene&acc=79660,,,79660.0,PPP1R3B,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PPP1R3B mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4759,2013388,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5521,PPP2R2B,https://ctdbase.org/detail.go?type=gene&acc=5521,,,5521.0,PPP2R2B,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PPP2R2B mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4760,2013389,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5521,PPP2R2B,https://ctdbase.org/detail.go?type=gene&acc=5521,,,5521.0,PPP2R2B,10090.0,Mus musculus (house mouse),PPP2R2B results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4761,2013390,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,59336,PRDM13,https://ctdbase.org/detail.go?type=gene&acc=59336,,,59336.0,PRDM13,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PRDM13 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4762,2013391,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5613,PRKX,https://ctdbase.org/detail.go?type=gene&acc=5613,,,5613.0,PRKX,9606.0,Homo sapiens (human),MRK 003 results in increased expression of PRKX mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4763,2013392,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,18812,PRL2C3,https://ctdbase.org/detail.go?type=gene&acc=18812,,,18812.0,Prl2c3,10090.0,Mus musculus (house mouse),PRL2C3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4764,2013393,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,26421,PRL2C4,https://ctdbase.org/detail.go?type=gene&acc=26421,,,26421.0,Prl2c4,10090.0,Mus musculus (house mouse),PRL2C4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4765,2013394,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3275,PRMT2,https://ctdbase.org/detail.go?type=gene&acc=3275,,,3275.0,PRMT2,10090.0,Mus musculus (house mouse),PRMT2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4766,2013425,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544.0,PROCR,10090.0,Mus musculus (house mouse),PROCR results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4767,2013426,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5627,PROS1,https://ctdbase.org/detail.go?type=gene&acc=5627,,,5627.0,PROS1,10090.0,Mus musculus (house mouse),PROS1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4768,2013427,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54458,PRR13,https://ctdbase.org/detail.go?type=gene&acc=54458,,,54458.0,PRR13,10090.0,Mus musculus (house mouse),PRR13 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4769,2013428,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,80758,PRR7,https://ctdbase.org/detail.go?type=gene&acc=80758,,,80758.0,PRR7,10090.0,Mus musculus (house mouse),PRR7 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4770,2013429,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5396,PRRX1,https://ctdbase.org/detail.go?type=gene&acc=5396,,,5396.0,PRRX1,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PRRX1 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4771,2013430,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5644,PRSS1,https://ctdbase.org/detail.go?type=gene&acc=5644,,,5644.0,PRSS1,10090.0,Mus musculus (house mouse),PRSS1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4772,2013431,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,158471,PRUNE2,https://ctdbase.org/detail.go?type=gene&acc=158471,,,158471.0,PRUNE2,10090.0,Mus musculus (house mouse),PRUNE2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4773,2013432,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5764,PTN,https://ctdbase.org/detail.go?type=gene&acc=5764,,,5764.0,PTN,10090.0,Mus musculus (house mouse),PTN results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4774,2013433,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10076,PTPRU,https://ctdbase.org/detail.go?type=gene&acc=10076,,,10076.0,PTPRU,10090.0,Mus musculus (house mouse),PTPRU results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4775,2013434,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,139221,PWWP3B,https://ctdbase.org/detail.go?type=gene&acc=139221,,,139221.0,PWWP3B,10090.0,Mus musculus (house mouse),PWWP3B results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4776,2013435,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7837,PXDN,https://ctdbase.org/detail.go?type=gene&acc=7837,,,7837.0,PXDN,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of PXDN mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4777,2013436,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,29108,PYCARD,https://ctdbase.org/detail.go?type=gene&acc=29108,,,29108.0,PYCARD,10090.0,Mus musculus (house mouse),PYCARD results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4778,2013437,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836.0,PYGL,10090.0,Mus musculus (house mouse),PYGL results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4779,2013438,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10981,RAB32,https://ctdbase.org/detail.go?type=gene&acc=10981,,,10981.0,RAB32,10090.0,Mus musculus (house mouse),RAB32 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4780,2013439,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,23682,RAB38,https://ctdbase.org/detail.go?type=gene&acc=23682,,,23682.0,RAB38,10090.0,Mus musculus (house mouse),RAB38 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4781,2013440,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5866,RAB3IL1,https://ctdbase.org/detail.go?type=gene&acc=5866,,,5866.0,RAB3IL1,10090.0,Mus musculus (house mouse),RAB3IL1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4782,2013441,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,9910,RABGAP1L,https://ctdbase.org/detail.go?type=gene&acc=9910,,,9910.0,RABGAP1L,10090.0,Mus musculus (house mouse),RABGAP1L results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4783,2013442,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,26064,RAI14,https://ctdbase.org/detail.go?type=gene&acc=26064,,,26064.0,RAI14,10090.0,Mus musculus (house mouse),RAI14 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4784,2013454,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10267,RAMP1,https://ctdbase.org/detail.go?type=gene&acc=10267,,,10267.0,RAMP1,10090.0,Mus musculus (house mouse),RAMP1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4785,2013455,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10411,RAPGEF3,https://ctdbase.org/detail.go?type=gene&acc=10411,,,10411.0,RAPGEF3,10090.0,Mus musculus (house mouse),RAPGEF3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4786,2013456,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,10090.0,Mus musculus (house mouse),RARB results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4787,2013457,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,9462,RASAL2,https://ctdbase.org/detail.go?type=gene&acc=9462,,,9462.0,RASAL2,10090.0,Mus musculus (house mouse),RASAL2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4788,2013458,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,221002,RASGEF1A,https://ctdbase.org/detail.go?type=gene&acc=221002,,,221002.0,RASGEF1A,10090.0,Mus musculus (house mouse),RASGEF1A results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4789,2013459,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10633,RASL10A,https://ctdbase.org/detail.go?type=gene&acc=10633,,,10633.0,RASL10A,10090.0,Mus musculus (house mouse),RASL10A results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4790,2013460,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,83853,ROPN1L,https://ctdbase.org/detail.go?type=gene&acc=83853,,,83853.0,ROPN1L,10090.0,Mus musculus (house mouse),ROPN1L results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4791,2013461,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),"2-bromo-12,13-dihydro-5-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione promotes the reaction [MRK 003 results in decreased phosphorylation of and results in increased activity of RB1 protein]|[mrk 003 results in increased expression of CDKN2D protein] which results in decreased phosphorylation of and results in increased activity of RB1 protein|mrk 003 results in decreased phosphorylation of and results in increased activity of RB1 protein|notch1 protein modified form inhibits the reaction [MRK 003 results in decreased phosphorylation of and results in increased activity of RB1 protein]",,,PMID:19318552,https://www.ncbi.nlm.nih.gov/pubmed/19318552,19318552,,
4792,2013473,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of RB1 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4793,2013474,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5947,RBP1,https://ctdbase.org/detail.go?type=gene&acc=5947,,,5947.0,RBP1,10090.0,Mus musculus (house mouse),RBP1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4794,2013475,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,5950,RBP4,https://ctdbase.org/detail.go?type=gene&acc=5950,,,5950.0,RBP4,10090.0,Mus musculus (house mouse),RBP4 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4795,2013476,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3516,RBPJ,https://ctdbase.org/detail.go?type=gene&acc=3516,,,3516.0,RBPJ,10090.0,Mus musculus (house mouse),RBPJ results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4796,2013477,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,348093,RBPMS2,https://ctdbase.org/detail.go?type=gene&acc=348093,,,348093.0,RBPMS2,10090.0,Mus musculus (house mouse),RBPMS2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4797,2013487,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,401190,RGS7BP,https://ctdbase.org/detail.go?type=gene&acc=401190,,,401190.0,RGS7BP,10090.0,Mus musculus (house mouse),RGS7BP results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4798,2013488,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,171177,RHOV,https://ctdbase.org/detail.go?type=gene&acc=171177,,,171177.0,RHOV,10090.0,Mus musculus (house mouse),RHOV results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4799,2013489,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54453,RIN2,https://ctdbase.org/detail.go?type=gene&acc=54453,,,54453.0,RIN2,10090.0,Mus musculus (house mouse),RIN2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4800,2013490,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54101,RIPK4,https://ctdbase.org/detail.go?type=gene&acc=54101,,,54101.0,RIPK4,10090.0,Mus musculus (house mouse),RIPK4 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4801,2013491,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,26994,RNF11,https://ctdbase.org/detail.go?type=gene&acc=26994,,,26994.0,RNF11,10090.0,Mus musculus (house mouse),RNF11 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4802,2013492,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6091,ROBO1,https://ctdbase.org/detail.go?type=gene&acc=6091,,,6091.0,ROBO1,10090.0,Mus musculus (house mouse),ROBO1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4803,2013493,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6146,RPL22,https://ctdbase.org/detail.go?type=gene&acc=6146,,,6146.0,RPL22,10090.0,Mus musculus (house mouse),RPL22 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4804,2013494,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,116832,RPL39L,https://ctdbase.org/detail.go?type=gene&acc=116832,,,116832.0,RPL39L,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of RPL39L mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4805,2013495,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,140032,RPS4Y2,https://ctdbase.org/detail.go?type=gene&acc=140032,,,140032.0,RPS4Y2,9606.0,Homo sapiens (human),MRK 003 results in increased expression of RPS4Y2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4806,2013496,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,10090.0,Mus musculus (house mouse),MRK 003 results in decreased phosphorylation of RPS6 protein,,,PMID:19246562|PMID:20197467,https://www.ncbi.nlm.nih.gov/pubmed/19246562|https://www.ncbi.nlm.nih.gov/pubmed/20197467,19246562|20197467,,
4807,2013497,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,10090.0,Mus musculus (house mouse),MRK 003 results in decreased phosphorylation of RPS6KB1 protein|mrk 003 results in decreased activity of RPS6KB1 protein|mrk 003 promotes the reaction [sirolimus results in decreased activity of RPS6KB1 protein]|sirolimus promotes the reaction [MRK 003 results in decreased activity of RPS6KB1 protein],,,PMID:19246562,https://www.ncbi.nlm.nih.gov/pubmed/19246562,19246562,,
4808,2013498,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,219790,RTKN2,https://ctdbase.org/detail.go?type=gene&acc=219790,,,219790.0,RTKN2,10090.0,Mus musculus (house mouse),RTKN2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4809,2013499,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,64108,RTP4,https://ctdbase.org/detail.go?type=gene&acc=64108,,,64108.0,RTP4,10090.0,Mus musculus (house mouse),RTP4 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4810,2013500,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10900,RUNDC3A,https://ctdbase.org/detail.go?type=gene&acc=10900,,,10900.0,RUNDC3A,10090.0,Mus musculus (house mouse),RUNDC3A results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4811,2013501,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6282,S100A11,https://ctdbase.org/detail.go?type=gene&acc=6282,,,6282.0,S100A11,10090.0,Mus musculus (house mouse),S100A11 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4812,2013502,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6275,S100A4,https://ctdbase.org/detail.go?type=gene&acc=6275,,,6275.0,S100A4,10090.0,Mus musculus (house mouse),S100A4 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4813,2013503,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6279,S100A8,https://ctdbase.org/detail.go?type=gene&acc=6279,,,6279.0,S100A8,10090.0,Mus musculus (house mouse),S100A8 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4814,2013534,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10560,SLC19A2,https://ctdbase.org/detail.go?type=gene&acc=10560,,,10560.0,SLC19A2,10090.0,Mus musculus (house mouse),SLC19A2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4815,2013535,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6575,SLC20A2,https://ctdbase.org/detail.go?type=gene&acc=6575,,,6575.0,SLC20A2,10090.0,Mus musculus (house mouse),SLC20A2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4816,2013536,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,9606.0,Homo sapiens (human),[MRK 003 results in decreased expression of SLC2A1 protein] which results in decreased uptake of fluorodeoxyglucose F18|MRK 003 results in decreased expression of SLC2A1 protein,,,PMID:20197467,https://www.ncbi.nlm.nih.gov/pubmed/20197467,20197467,,
4817,2013537,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,9606.0,Homo sapiens (human),MRK 003 results in increased expression of SLC2A4 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4818,2013538,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6518,SLC2A5,https://ctdbase.org/detail.go?type=gene&acc=6518,,,6518.0,SLC2A5,10090.0,Mus musculus (house mouse),SLC2A5 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4819,2013539,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55630,SLC39A4,https://ctdbase.org/detail.go?type=gene&acc=55630,,,55630.0,SLC39A4,10090.0,Mus musculus (house mouse),SLC39A4 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4820,2013540,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,30061,SLC40A1,https://ctdbase.org/detail.go?type=gene&acc=30061,,,30061.0,SLC40A1,10090.0,Mus musculus (house mouse),SLC40A1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4821,2013541,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84102,SLC41A2,https://ctdbase.org/detail.go?type=gene&acc=84102,,,84102.0,SLC41A2,10090.0,Mus musculus (house mouse),SLC41A2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4822,2013542,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,204962,SLC44A5,https://ctdbase.org/detail.go?type=gene&acc=204962,,,204962.0,SLC44A5,10090.0,Mus musculus (house mouse),SLC44A5 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4823,2013543,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,85414,SLC45A3,https://ctdbase.org/detail.go?type=gene&acc=85414,,,85414.0,SLC45A3,10090.0,Mus musculus (house mouse),SLC45A3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4824,2013554,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6649,SOD3,https://ctdbase.org/detail.go?type=gene&acc=6649,,,6649.0,SOD3,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of SOD3 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4825,2013555,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10580,SORBS1,https://ctdbase.org/detail.go?type=gene&acc=10580,,,10580.0,SORBS1,10090.0,Mus musculus (house mouse),SORBS1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4826,2013556,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,22986,SORCS3,https://ctdbase.org/detail.go?type=gene&acc=22986,,,22986.0,SORCS3,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of SORCS3 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4827,2013557,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,345079,SOWAHB,https://ctdbase.org/detail.go?type=gene&acc=345079,,,345079.0,SOWAHB,10090.0,Mus musculus (house mouse),SOWAHB results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4828,2013558,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6664,SOX11,https://ctdbase.org/detail.go?type=gene&acc=6664,,,6664.0,SOX11,10090.0,Mus musculus (house mouse),SOX11 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4829,2013559,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,347689,SOX2-OT,https://ctdbase.org/detail.go?type=gene&acc=347689,,,347689.0,SOX2-OT,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of SOX2-OT mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4830,2013560,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6672,SP100,https://ctdbase.org/detail.go?type=gene&acc=6672,,,6672.0,SP100,10090.0,Mus musculus (house mouse),SP100 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4831,2013561,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,11092,SPACA9,https://ctdbase.org/detail.go?type=gene&acc=11092,,,11092.0,SPACA9,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of SPACA9 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4832,2013562,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,221178,SPATA13,https://ctdbase.org/detail.go?type=gene&acc=221178,,,221178.0,SPATA13,10090.0,Mus musculus (house mouse),SPATA13 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4833,2013563,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,92521,SPECC1,https://ctdbase.org/detail.go?type=gene&acc=92521,,,92521.0,SPECC1,10090.0,Mus musculus (house mouse),SPECC1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4834,2013564,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,75657,SPEER4A1,https://ctdbase.org/detail.go?type=gene&acc=75657,,,75657.0,Speer4a1,10090.0,Mus musculus (house mouse),SPEER4A1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4835,2013565,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,100502967,SPEER4C1,https://ctdbase.org/detail.go?type=gene&acc=100502967,,,100502967.0,Speer4c1,10090.0,Mus musculus (house mouse),SPEER4C1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4836,2013566,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,360220,SPEER4D,https://ctdbase.org/detail.go?type=gene&acc=360220,,,360220.0,Speer4d,10090.0,Mus musculus (house mouse),SPEER4D results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4837,2013567,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,624245,SPEER4E1,https://ctdbase.org/detail.go?type=gene&acc=624245,,,624245.0,Speer4e1,10090.0,Mus musculus (house mouse),SPEER4E1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4838,2013568,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,70935,SPEER4F1,https://ctdbase.org/detail.go?type=gene&acc=70935,,,70935.0,Speer4f1,10090.0,Mus musculus (house mouse),SPEER4F1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4839,2013569,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,70365,SPEER5-PS1,https://ctdbase.org/detail.go?type=gene&acc=70365,,,70365.0,Speer5-ps1,10090.0,Mus musculus (house mouse),SPEER5-PS1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4840,2013570,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10653,SPINT2,https://ctdbase.org/detail.go?type=gene&acc=10653,,,10653.0,SPINT2,10090.0,Mus musculus (house mouse),SPINT2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4841,2013571,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of SPP1 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4842,2013572,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10090.0,Mus musculus (house mouse),SPP1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4843,2013573,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,58472,SQOR,https://ctdbase.org/detail.go?type=gene&acc=58472,,,58472.0,SQOR,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of SQOR mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4844,2013574,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6426,SRSF1,https://ctdbase.org/detail.go?type=gene&acc=6426,,,6426.0,SRSF1,10090.0,Mus musculus (house mouse),SRSF1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4845,2013582,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,90627,STARD13,https://ctdbase.org/detail.go?type=gene&acc=90627,,,90627.0,STARD13,10090.0,Mus musculus (house mouse),STARD13 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4846,2013583,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,261729,STEAP2,https://ctdbase.org/detail.go?type=gene&acc=261729,,,261729.0,STEAP2,10090.0,Mus musculus (house mouse),STEAP2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4847,2013584,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,282974,STK32C,https://ctdbase.org/detail.go?type=gene&acc=282974,,,282974.0,STK32C,10090.0,Mus musculus (house mouse),STK32C results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4848,2013585,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,85439,STON2,https://ctdbase.org/detail.go?type=gene&acc=85439,,,85439.0,STON2,10090.0,Mus musculus (house mouse),STON2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4849,2013586,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55359,STYK1,https://ctdbase.org/detail.go?type=gene&acc=55359,,,55359.0,STYK1,10090.0,Mus musculus (house mouse),STYK1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4850,2013587,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,6840,SVIL,https://ctdbase.org/detail.go?type=gene&acc=6840,,,6840.0,SVIL,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of SVIL mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4851,2013588,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84144,SYDE2,https://ctdbase.org/detail.go?type=gene&acc=84144,,,84144.0,SYDE2,10090.0,Mus musculus (house mouse),SYDE2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4852,2013603,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,56849,TCEAL7,https://ctdbase.org/detail.go?type=gene&acc=56849,,,56849.0,TCEAL7,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of TCEAL7 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4853,2013604,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,90843,TCEAL8,https://ctdbase.org/detail.go?type=gene&acc=90843,,,90843.0,TCEAL8,10090.0,Mus musculus (house mouse),TCEAL8 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4854,2013605,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,83439,TCF7L1,https://ctdbase.org/detail.go?type=gene&acc=83439,,,83439.0,TCF7L1,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of TCF7L1 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4855,2013606,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,79867,TCTN2,https://ctdbase.org/detail.go?type=gene&acc=79867,,,79867.0,TCTN2,10090.0,Mus musculus (house mouse),TCTN2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4856,2013607,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,23424,TDRD7,https://ctdbase.org/detail.go?type=gene&acc=23424,,,23424.0,TDRD7,10090.0,Mus musculus (house mouse),TDRD7 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4857,2013608,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54997,TESC,https://ctdbase.org/detail.go?type=gene&acc=54997,,,54997.0,TESC,9606.0,Homo sapiens (human),MRK 003 results in increased expression of TESC mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4858,2013609,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,80312,TET1,https://ctdbase.org/detail.go?type=gene&acc=80312,,,80312.0,TET1,10090.0,Mus musculus (house mouse),TET1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4859,2013610,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7029,TFDP2,https://ctdbase.org/detail.go?type=gene&acc=7029,,,7029.0,TFDP2,10090.0,Mus musculus (house mouse),TFDP2 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4860,2013611,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,22797,TFEC,https://ctdbase.org/detail.go?type=gene&acc=22797,,,22797.0,TFEC,10090.0,Mus musculus (house mouse),TFEC results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4861,2013612,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7045,TGFBI,https://ctdbase.org/detail.go?type=gene&acc=7045,,,7045.0,TGFBI,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of TGFBI mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4862,2013613,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7049,TGFBR3,https://ctdbase.org/detail.go?type=gene&acc=7049,,,7049.0,TGFBR3,10090.0,Mus musculus (house mouse),TGFBR3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4863,2013622,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84866,TMEM25,https://ctdbase.org/detail.go?type=gene&acc=84866,,,84866.0,TMEM25,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of TMEM25 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4864,2013623,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,140738,TMEM37,https://ctdbase.org/detail.go?type=gene&acc=140738,,,140738.0,TMEM37,10090.0,Mus musculus (house mouse),TMEM37 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4865,2013624,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55287,TMEM40,https://ctdbase.org/detail.go?type=gene&acc=55287,,,55287.0,TMEM40,10090.0,Mus musculus (house mouse),TMEM40 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4866,2013625,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,169200,TMEM64,https://ctdbase.org/detail.go?type=gene&acc=169200,,,169200.0,TMEM64,10090.0,Mus musculus (house mouse),TMEM64 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4867,2013626,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,26022,TMEM98,https://ctdbase.org/detail.go?type=gene&acc=26022,,,26022.0,TMEM98,10090.0,Mus musculus (house mouse),TMEM98 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4868,2013627,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,28983,TMPRSS11E,https://ctdbase.org/detail.go?type=gene&acc=28983,,,28983.0,TMPRSS11E,10090.0,Mus musculus (house mouse),TMPRSS11E results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4869,2013628,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7127,TNFAIP2,https://ctdbase.org/detail.go?type=gene&acc=7127,,,7127.0,TNFAIP2,10090.0,Mus musculus (house mouse),TNFAIP2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4870,2013629,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7130,TNFAIP6,https://ctdbase.org/detail.go?type=gene&acc=7130,,,7130.0,TNFAIP6,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of TNFAIP6 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4871,2013630,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,3604,TNFRSF9,https://ctdbase.org/detail.go?type=gene&acc=3604,,,3604.0,TNFRSF9,10090.0,Mus musculus (house mouse),TNFRSF9 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4872,2013631,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,8742,TNFSF12,https://ctdbase.org/detail.go?type=gene&acc=8742,,,8742.0,TNFSF12,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of TNFSF12 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4873,2013632,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,64759,TNS3,https://ctdbase.org/detail.go?type=gene&acc=64759,,,64759.0,TNS3,10090.0,Mus musculus (house mouse),TNS3 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4874,2013642,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7177,TPSAB1,https://ctdbase.org/detail.go?type=gene&acc=7177,,,7177.0,TPSAB1,10090.0,Mus musculus (house mouse),TPSAB1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4875,2013643,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,64499,TPSB2,https://ctdbase.org/detail.go?type=gene&acc=64499,,,64499.0,TPSB2,10090.0,Mus musculus (house mouse),TPSB2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4876,2013644,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7188,TRAF5,https://ctdbase.org/detail.go?type=gene&acc=7188,,,7188.0,TRAF5,10090.0,Mus musculus (house mouse),TRAF5 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4877,2013645,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54209,TREM2,https://ctdbase.org/detail.go?type=gene&acc=54209,,,54209.0,TREM2,10090.0,Mus musculus (house mouse),TREM2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4878,2013646,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,9865,TRIL,https://ctdbase.org/detail.go?type=gene&acc=9865,,,9865.0,TRIL,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of TRIL mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4879,2013647,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10626,TRIM16,https://ctdbase.org/detail.go?type=gene&acc=10626,,,10626.0,TRIM16,10090.0,Mus musculus (house mouse),TRIM16 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4880,2013648,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,23321,TRIM2,https://ctdbase.org/detail.go?type=gene&acc=23321,,,23321.0,TRIM2,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of TRIM2 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4881,2013649,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,23321,TRIM2,https://ctdbase.org/detail.go?type=gene&acc=23321,,,23321.0,TRIM2,10090.0,Mus musculus (house mouse),TRIM2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4882,2013650,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7205,TRIP6,https://ctdbase.org/detail.go?type=gene&acc=7205,,,7205.0,TRIP6,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of TRIP6 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4883,2013659,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,60599,TRP53INP1,https://ctdbase.org/detail.go?type=gene&acc=60599,,,60599.0,Trp53inp1,10090.0,Mus musculus (house mouse),TRP53INP1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4884,2013660,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,76367,TRP53RKB,https://ctdbase.org/detail.go?type=gene&acc=76367,,,76367.0,Trp53rkb,10090.0,Mus musculus (house mouse),TRP53RKB results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4885,2013661,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,22074,TRY4,https://ctdbase.org/detail.go?type=gene&acc=22074,,,22074.0,Try4,10090.0,Mus musculus (house mouse),TRY4 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4886,2013662,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,57616,TSHZ3,https://ctdbase.org/detail.go?type=gene&acc=57616,,,57616.0,TSHZ3,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of TSHZ3 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4887,2013663,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,27075,TSPAN13,https://ctdbase.org/detail.go?type=gene&acc=27075,,,27075.0,TSPAN13,10090.0,Mus musculus (house mouse),TSPAN13 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4888,2013664,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,10867,TSPAN9,https://ctdbase.org/detail.go?type=gene&acc=10867,,,10867.0,TSPAN9,10090.0,Mus musculus (house mouse),TSPAN9 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4889,2013665,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7263,TST,https://ctdbase.org/detail.go?type=gene&acc=7263,,,7263.0,TST,10090.0,Mus musculus (house mouse),TST results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4890,2013666,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54970,TTC12,https://ctdbase.org/detail.go?type=gene&acc=54970,,,54970.0,TTC12,10090.0,Mus musculus (house mouse),TTC12 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4891,2013667,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,23508,TTC9,https://ctdbase.org/detail.go?type=gene&acc=23508,,,23508.0,TTC9,10090.0,Mus musculus (house mouse),TTC9 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4892,2013678,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84617,TUBB6,https://ctdbase.org/detail.go?type=gene&acc=84617,,,84617.0,TUBB6,10090.0,Mus musculus (house mouse),TUBB6 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4893,2013679,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7291,TWIST1,https://ctdbase.org/detail.go?type=gene&acc=7291,,,7291.0,TWIST1,10090.0,Mus musculus (house mouse),TWIST1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4894,2013680,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7294,TXK,https://ctdbase.org/detail.go?type=gene&acc=7294,,,7294.0,TXK,10090.0,Mus musculus (house mouse),TXK results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4895,2013681,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7305,TYROBP,https://ctdbase.org/detail.go?type=gene&acc=7305,,,7305.0,TYROBP,10090.0,Mus musculus (house mouse),TYROBP results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4896,2013682,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,84959,UBASH3B,https://ctdbase.org/detail.go?type=gene&acc=84959,,,84959.0,UBASH3B,10090.0,Mus musculus (house mouse),UBASH3B results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4897,2013683,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,80019,UBTD1,https://ctdbase.org/detail.go?type=gene&acc=80019,,,80019.0,UBTD1,10090.0,Mus musculus (house mouse),UBTD1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4898,2013684,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7345,UCHL1,https://ctdbase.org/detail.go?type=gene&acc=7345,,,7345.0,UCHL1,10090.0,Mus musculus (house mouse),UCHL1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4899,2013685,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,7371,UCK2,https://ctdbase.org/detail.go?type=gene&acc=7371,,,7371.0,UCK2,10090.0,Mus musculus (house mouse),UCK2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4900,2013686,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,55757,UGGT2,https://ctdbase.org/detail.go?type=gene&acc=55757,,,55757.0,UGGT2,10090.0,Mus musculus (house mouse),UGGT2 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4901,2013696,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,10090.0,Mus musculus (house mouse),UGT1A1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4902,2013707,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,574437,XLR3B,https://ctdbase.org/detail.go?type=gene&acc=574437,,,574437.0,Xlr3b,10090.0,Mus musculus (house mouse),XLR3B results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4903,2013708,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,326340,ZAR1,https://ctdbase.org/detail.go?type=gene&acc=326340,,,326340.0,ZAR1,10090.0,Mus musculus (house mouse),ZAR1 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4904,2013709,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,158866,ZDHHC15,https://ctdbase.org/detail.go?type=gene&acc=158866,,,158866.0,ZDHHC15,10090.0,Mus musculus (house mouse),ZDHHC15 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4905,2013710,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,233887,ZFP553,https://ctdbase.org/detail.go?type=gene&acc=233887,,,233887.0,Zfp553,10090.0,Mus musculus (house mouse),ZFP553 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4906,2013711,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,234725,ZFP612,https://ctdbase.org/detail.go?type=gene&acc=234725,,,234725.0,Zfp612,10090.0,Mus musculus (house mouse),ZFP612 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4907,2013712,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,72701,ZFP618,https://ctdbase.org/detail.go?type=gene&acc=72701,,,72701.0,Zfp618,10090.0,Mus musculus (house mouse),ZFP618 results in increased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4908,2013713,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,85416,ZIC5,https://ctdbase.org/detail.go?type=gene&acc=85416,,,85416.0,ZIC5,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of ZIC5 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4909,2013743,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,284307,ZIK1,https://ctdbase.org/detail.go?type=gene&acc=284307,,,284307.0,ZIK1,10090.0,Mus musculus (house mouse),ZIK1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4910,2013744,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,57178,ZMIZ1,https://ctdbase.org/detail.go?type=gene&acc=57178,,,57178.0,ZMIZ1,10090.0,Mus musculus (house mouse),ZMIZ1 results in decreased susceptibility to MRK 003,,,PMID:19903844,https://www.ncbi.nlm.nih.gov/pubmed/19903844,19903844,,
4911,2013745,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,79891,ZNF671,https://ctdbase.org/detail.go?type=gene&acc=79891,,,79891.0,ZNF671,9606.0,Homo sapiens (human),MRK 003 results in decreased expression of ZNF671 mRNA,,,PMID:21169257,https://www.ncbi.nlm.nih.gov/pubmed/21169257,21169257,,
4912,2013746,15953870,Chemical Probes Portal,KU-60019,KU-60019,KU-60019,https://www.chemicalprobes.org/ku-60019,,ATM,,Q13315,Serine-protein kinase ATM,472.0,ATM,9606.0,Homo sapiens (human),Inhibitor,,6.3 nM,PMID:19808981,https://www.ncbi.nlm.nih.gov/pubmed/19808981,19808981,,"www.doi.org/10.1158/1535-7163.MCT-09-0519, http://www.ncbi.nlm.nih.gov/pubmed/19808981"
4913,2014047,15959302,BindingDB,"ethyl (2E,4S)-5-phenyl-4-[(2S)-3-phenyl-2-[(2E)-3-(4-phenylphenyl)prop-2-enamido]propanamido]pent-2-enoate",11259,dipeptidomimetic unsaturated ester 18a,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11259,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,IC50 (nM),10000,PMID:26878082|DOI:10.1021/acs.jmedchem.5b01461,https://www.ncbi.nlm.nih.gov/pubmed/26878082|https://doi.org/10.1021/acs.jmedchem.5b01461,26878082,10.1021/acs.jmedchem.5b01461,
4914,2014048,15959302,BindingDB,"ethyl (2E,4S)-5-phenyl-4-[(2S)-3-phenyl-2-[(2E)-3-(4-phenylphenyl)prop-2-enamido]propanamido]pent-2-enoate",11259,dipeptidomimetic unsaturated ester 18a,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11259,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,Ki (nM),6440,PMID:26878082|DOI:10.1021/acs.jmedchem.5b01461,https://www.ncbi.nlm.nih.gov/pubmed/26878082|https://doi.org/10.1021/acs.jmedchem.5b01461,26878082,10.1021/acs.jmedchem.5b01461,
4915,2014049,15959302,BindingDB,"ethyl (2E,4S)-5-phenyl-4-[(2S)-3-phenyl-2-[(2E)-3-(4-phenylphenyl)prop-2-enamido]propanamido]pent-2-enoate",11259,dipeptidomimetic unsaturated ester 18a,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11259,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,,,PMID:26878082|DOI:10.1021/acs.jmedchem.5b01461,https://www.ncbi.nlm.nih.gov/pubmed/26878082|https://doi.org/10.1021/acs.jmedchem.5b01461,26878082,10.1021/acs.jmedchem.5b01461,
4916,2014050,15959303,BindingDB,"ethyl (2E,4S)-4-[(2S)-2-[(2E)-3-(4-nitrophenyl)prop-2-enamido]-3-phenylpropanamido]-5-phenylpent-2-enoate",428894,"jm5b01461, Compound 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=428894,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,IC50 (nM),5000,PMID:26878082|DOI:10.1021/acs.jmedchem.5b01461,https://www.ncbi.nlm.nih.gov/pubmed/26878082|https://doi.org/10.1021/acs.jmedchem.5b01461,26878082,10.1021/acs.jmedchem.5b01461,
4917,2014051,15959303,BindingDB,"ethyl (2E,4S)-4-[(2S)-2-[(2E)-3-(4-nitrophenyl)prop-2-enamido]-3-phenylpropanamido]-5-phenylpent-2-enoate",428894,"jm5b01461, Compound 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=428894,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,Ki (nM),2480,PMID:26878082|DOI:10.1021/acs.jmedchem.5b01461,https://www.ncbi.nlm.nih.gov/pubmed/26878082|https://doi.org/10.1021/acs.jmedchem.5b01461,26878082,10.1021/acs.jmedchem.5b01461,
4918,2014052,15959303,BindingDB,"ethyl (2E,4S)-4-[(2S)-2-[(2E)-3-(4-nitrophenyl)prop-2-enamido]-3-phenylpropanamido]-5-phenylpent-2-enoate",428894,"jm5b01461, Compound 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=428894,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,,,PMID:26878082|DOI:10.1021/acs.jmedchem.5b01461,https://www.ncbi.nlm.nih.gov/pubmed/26878082|https://doi.org/10.1021/acs.jmedchem.5b01461,26878082,10.1021/acs.jmedchem.5b01461,
4919,2014053,15959304,BindingDB,"ethyl (2E,4S)-4-[(2S)-2-[(2E)-3-(2,4-dimethoxyphenyl)prop-2-enamido]-3-phenylpropanamido]-5-phenylpent-2-enoate",11262,dipeptidomimetic unsaturated ester 18d,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11262,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,IC50 (nM),10000,PMID:26878082|DOI:10.1021/acs.jmedchem.5b01461,https://www.ncbi.nlm.nih.gov/pubmed/26878082|https://doi.org/10.1021/acs.jmedchem.5b01461,26878082,10.1021/acs.jmedchem.5b01461,
4920,2014054,15959304,BindingDB,"ethyl (2E,4S)-4-[(2S)-2-[(2E)-3-(2,4-dimethoxyphenyl)prop-2-enamido]-3-phenylpropanamido]-5-phenylpent-2-enoate",11262,dipeptidomimetic unsaturated ester 18d,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11262,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,Ki (nM),9040,PMID:26878082|DOI:10.1021/acs.jmedchem.5b01461,https://www.ncbi.nlm.nih.gov/pubmed/26878082|https://doi.org/10.1021/acs.jmedchem.5b01461,26878082,10.1021/acs.jmedchem.5b01461,
4921,2014055,15959304,BindingDB,"ethyl (2E,4S)-4-[(2S)-2-[(2E)-3-(2,4-dimethoxyphenyl)prop-2-enamido]-3-phenylpropanamido]-5-phenylpent-2-enoate",11262,dipeptidomimetic unsaturated ester 18d,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11262,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,,,PMID:26878082|DOI:10.1021/acs.jmedchem.5b01461,https://www.ncbi.nlm.nih.gov/pubmed/26878082|https://doi.org/10.1021/acs.jmedchem.5b01461,26878082,10.1021/acs.jmedchem.5b01461,
4922,2014056,15978579,Drug Gene Interaction database (DGIdb),Stanate,,STANNSOPORFIN,https://www.dgidb.org/drugs/ncit:C152424,,HMOX2,https://www.dgidb.org/genes/hgnc:5014,,,3163.0,HMOX2,9606.0,Homo sapiens (human),,,,,,,,
4923,2014057,15984937,IUPHAR/BPS Guide to PHARMACOLOGY,Camicinal,4035,camicinal,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4035,297,motilin receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=297,O43193,Motilin receptor,2862.0,MLNR,9606.0,Homo sapiens (human),Full agonist,pEC50,7.9,PMID:19374732|PMID:25341626,https://www.ncbi.nlm.nih.gov/pubmed/19374732|https://www.ncbi.nlm.nih.gov/pubmed/25341626,19374732|25341626,,
4924,2014058,15985251,IUPHAR/BPS Guide to PHARMACOLOGY,Dfmti,6335,MK-5435,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6335,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,Q13255,Metabotropic glutamate receptor 1,2911.0,GRM1,9606.0,Homo sapiens (human),Negative,pIC50,8.37,PMID:20524178,https://www.ncbi.nlm.nih.gov/pubmed/20524178,20524178,,
4925,2013767,16038368,BindingDB,trans-AUCB,25739,4-({4-[(adamantan-1-ylcarbamoyl)amino]cyclohexyl}oxy)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25739,2887,Epoxide hydrolase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2887,P95276,Epoxide hydrolase B,,,83331.0,Mycobacterium tuberculosis CDC1551,,IC50 (nM),3400,PMID:18585390|DOI:10.1016/j.jmb.2008.06.030,https://www.ncbi.nlm.nih.gov/pubmed/18585390|https://doi.org/10.1016/j.jmb.2008.06.030,18585390,10.1016/j.jmb.2008.06.030,
4926,2013788,16058629,BindingDB,(2-{[(4-Bromo-2-Fluorobenzyl)amino]carbonyl}-5-Chlorophenoxy)acetic Acid,16238,2-(2-{[(4-bromo-2-fluorophenyl)methyl]carbamoyl}-5-chlorophenoxy)acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16238,8452,"Aldo-keto reductase family 1 member B10 [K125R,V301L]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8452,O60218,Aldo-keto reductase family 1 member B10,57016.0,AKR1B10,9606.0,Homo sapiens (human),,IC50 (nM),4.4e+3,PMID:27359042|DOI:10.1021/acschembio.6b00382,https://www.ncbi.nlm.nih.gov/pubmed/27359042|https://doi.org/10.1021/acschembio.6b00382,27359042,10.1021/acschembio.6b00382,
4927,2013789,16058629,BindingDB,(2-{[(4-Bromo-2-Fluorobenzyl)amino]carbonyl}-5-Chlorophenoxy)acetic Acid,16238,2-(2-{[(4-bromo-2-fluorophenyl)methyl]carbamoyl}-5-chlorophenoxy)acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16238,8451,Aldo-keto reductase family 1 member B10,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8451,O60218,Aldo-keto reductase family 1 member B10,57016.0,AKR1B10,9606.0,Homo sapiens (human),,IC50 (nM),2.7e+3,PMID:27359042|DOI:10.1021/acschembio.6b00382,https://www.ncbi.nlm.nih.gov/pubmed/27359042|https://doi.org/10.1021/acschembio.6b00382,27359042,10.1021/acschembio.6b00382,
4928,2013790,16058629,BindingDB,(2-{[(4-Bromo-2-Fluorobenzyl)amino]carbonyl}-5-Chlorophenoxy)acetic Acid,16238,2-(2-{[(4-bromo-2-fluorophenyl)methyl]carbamoyl}-5-chlorophenoxy)acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16238,8450,Aldo-keto reductase family 1 member B1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8450,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),,IC50 (nM),4.0e+2,PMID:27359042|DOI:10.1021/acschembio.6b00382,https://www.ncbi.nlm.nih.gov/pubmed/27359042|https://doi.org/10.1021/acschembio.6b00382,27359042,10.1021/acschembio.6b00382,
4929,2013791,16058629,BindingDB,(2-{[(4-Bromo-2-Fluorobenzyl)amino]carbonyl}-5-Chlorophenoxy)acetic Acid,16238,2-(2-{[(4-bromo-2-fluorophenyl)methyl]carbamoyl}-5-chlorophenoxy)acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16238,8451,Aldo-keto reductase family 1 member B10,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8451,O60218,Aldo-keto reductase family 1 member B10,57016.0,AKR1B10,9606.0,Homo sapiens (human),,IC50 (nM),4.4e+3,PMID:27359042|DOI:10.1021/acschembio.6b00382,https://www.ncbi.nlm.nih.gov/pubmed/27359042|https://doi.org/10.1021/acschembio.6b00382,27359042,10.1021/acschembio.6b00382,
4930,2013864,16063568,ChEMBL,Elinzanetant,CHEMBL4802157,ELINZANETANT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4802157/,CHEMBL4429,Neurokinin 3 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL4429/,P29371,Neuromedin-K receptor,6870.0,TACR3,9606.0,Homo sapiens (human),Neurokinin 3 receptor antagonist,,,PMID:33624806,https://www.ncbi.nlm.nih.gov/pubmed/33624806,33624806,,
4931,2013865,16068431,BindingDB,"5-bromo-N-(4-methylphenyl)-1,3-thiazol-2-amine",25666,"5-bromo-N-(4-methylphenyl)-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25666,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),2840,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4932,2013866,16068432,BindingDB,"4-[(5-Bromo-1,3-thiazol-2-yl)amino]phenol",25669,"4-[(5-bromo-1,3-thiazol-2-yl)amino]phenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25669,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),510,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4933,2013867,16068522,BindingDB,"4-[(5-Bromo-1,3-thiazol-2-yl)amino]benzoic acid",25680,"4-[(5-bromo-1,3-thiazol-2-yl)amino]benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25680,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),79,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4934,2013868,16068522,BindingDB,"4-[(5-Bromo-1,3-thiazol-2-yl)amino]benzoic acid",25680,"4-[(5-bromo-1,3-thiazol-2-yl)amino]benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25680,1024,Aromatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1024,P11511,Aromatase,1588.0,CYP19A1,9606.0,Homo sapiens (human),,IC50 (nM),960,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4935,2013869,16068522,BindingDB,"4-[(5-Bromo-1,3-thiazol-2-yl)amino]benzoic acid",25680,"4-[(5-bromo-1,3-thiazol-2-yl)amino]benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25680,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4936,2013870,16068523,BindingDB,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-[2-(morpholin-4-yl)ethyl]benzamide",25688,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-[2-(morpholin-4-yl)ethyl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25688,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),2300,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4937,2013871,16068524,BindingDB,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-(2-methoxyethyl)benzamide",25683,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-(2-methoxyethyl)benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25683,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),97,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4938,2013904,16068631,BindingDB,"5-bromo-N-[4-(pyridin-4-yloxy)phenyl]-1,3-thiazol-2-amine",25673,"5-bromo-N-[4-(pyridin-4-yloxy)phenyl]-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25673,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),900,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4939,2013905,16068632,BindingDB,"5-bromo-N-(4-chlorophenyl)-1,3-thiazol-2-amine",25663,"5-bromo-N-(4-chlorophenyl)-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25663,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),3000,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4940,2013906,16068633,BindingDB,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-(2-hydroxyethyl)benzamide",25682,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-(2-hydroxyethyl)benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25682,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),1480,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4941,2014003,16068634,BindingDB,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-[2-(dimethylamino)ethyl]benzamide",25686,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-[2-(dimethylamino)ethyl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25686,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),5250,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4942,2014004,16068635,BindingDB,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-[2-(diethylamino)ethyl]benzamide",25687,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-[2-(diethylamino)ethyl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25687,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),4520,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4943,2014005,16068636,BindingDB,"N-(5-bromo-1,3-thiazol-2-yl)benzamide",25712,"N-(5-bromo-1,3-thiazol-2-yl)benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25712,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),5500,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4944,2014006,16068637,BindingDB,"5-bromo-N-(3-fluorophenyl)-1,3-thiazol-2-amine",25690,"5-bromo-N-(3-fluorophenyl)-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25690,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),9300,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4945,2014007,16068638,BindingDB,"5-bromo-N-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine",25692,"5-bromo-N-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25692,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),10000,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4946,2014008,16068639,BindingDB,"5-bromo-N-(3-methoxyphenyl)-1,3-thiazol-2-amine",25693,"5-bromo-N-(3-methoxyphenyl)-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25693,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),900,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4947,2014009,16068734,BindingDB,"5-bromo-N-(3-methylphenyl)-1,3-thiazol-2-amine",25691,"5-bromo-N-(3-methylphenyl)-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25691,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),1100,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4948,2014010,16068735,BindingDB,"1-N-(5-bromo-1,3-thiazol-2-yl)benzene-1,4-diamine",25676,"1-N-(5-bromo-1,3-thiazol-2-yl)benzene-1,4-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25676,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),600,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4949,2014314,16068852,BindingDB,"5-bromo-N-[3-(methylsulfanyl)phenyl]-1,3-thiazol-2-amine",25694,"5-bromo-N-[3-(methylsulfanyl)phenyl]-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25694,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),500,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4950,2014315,16068853,BindingDB,"5-bromo-N-(4-bromophenyl)-1,3-thiazol-2-amine",25664,"5-bromo-N-(4-bromophenyl)-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25664,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),2900,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4951,2014316,16068854,BindingDB,"5-bromo-N-(4-phenoxyphenyl)-1,3-thiazol-2-amine",25672,"5-bromo-N-(4-phenoxyphenyl)-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25672,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),1400,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4952,2014317,16068855,BindingDB,"5-bromo-N-(4-nitrophenyl)-1,3-thiazol-2-amine",25675,"5-bromo-N-(4-nitrophenyl)-1,3-thiazol-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25675,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),13000,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4953,2014318,16068956,BindingDB,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-[2-(pyrrolidin-1-yl)ethyl]benzamide",25689,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-[2-(pyrrolidin-1-yl)ethyl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25689,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),5320,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4954,2014319,16068957,BindingDB,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-(1-methoxypropan-2-yl)benzamide",25684,"4-[(5-bromo-1,3-thiazol-2-yl)amino]-N-(1-methoxypropan-2-yl)benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25684,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),330,PMID:18307303|DOI:10.1021/cb700200w,https://www.ncbi.nlm.nih.gov/pubmed/18307303|https://doi.org/10.1021/cb700200w,18307303,10.1021/cb700200w,
4955,2014356,16095400,Comparative Toxicogenomics Database (CTD),Fluxapyroxad,C000591719,fluxapyroxad,https://ctdbase.org/detail.go?type=chem&acc=C000591719,4760,NEUROD1,https://ctdbase.org/detail.go?type=gene&acc=4760,,,4760.0,NEUROD1,7955.0,Danio rerio (zebrafish),Fluxapyroxad results in decreased expression of NEUROD1 mRNA,,,PMID:32434089,https://www.ncbi.nlm.nih.gov/pubmed/32434089,32434089,,
4956,2014357,16095400,Comparative Toxicogenomics Database (CTD),Fluxapyroxad,C000591719,fluxapyroxad,https://ctdbase.org/detail.go?type=chem&acc=C000591719,58112,NKX2.4B,https://ctdbase.org/detail.go?type=gene&acc=58112,,,58112.0,nkx2.4b,7955.0,Danio rerio (zebrafish),Fluxapyroxad results in decreased expression of NKX2.4B mRNA,,,PMID:32434089,https://www.ncbi.nlm.nih.gov/pubmed/32434089,32434089,,
4957,2014358,16095400,Comparative Toxicogenomics Database (CTD),Fluxapyroxad,C000591719,fluxapyroxad,https://ctdbase.org/detail.go?type=chem&acc=C000591719,6286,S100P,https://ctdbase.org/detail.go?type=gene&acc=6286,,,6286.0,S100P,9606.0,Homo sapiens (human),Fluxapyroxad results in increased expression of S100P mrna|fluxapyroxad results in increased expression of S100P protein,,,PMID:32194361,https://www.ncbi.nlm.nih.gov/pubmed/32194361,32194361,,
4958,2014359,16109001,Chemical Probes Portal,"N-(2-((3-(dimethylamino)propyl)(methyl)amino)-5-(trifluoromethyl)phenyl)-2-fluoro-5-(3-(4-(methylamino)-1,3,5-triazin-2-yl)pyridin-2-yloxy)benzamide",2-MT 63,2-MT 63,https://www.chemicalprobes.org/2-mt-63,,TEK,,Q02763,Angiopoietin-1 receptor,7010.0,TEK,9606.0,Homo sapiens (human),Inhibitor,,30 nM,PMID:17253678,https://www.ncbi.nlm.nih.gov/pubmed/17253678,17253678,,"http://pubs.acs.org/doi/abs/10.1021/jm061107l, https://www.ncbi.nlm.nih.gov/pubmed/17253678"
4959,2014360,16110344,BindingDB,"6-methyl-5-[(3R)-3-(3,4,5-trimethoxyphenyl)but-1-ynyl]pyrimidine-2,4-diamine",18497,"6-methyl-5-[(3R)-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18497,1917,Bifunctional dihydrofolate reductase-thymidylate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1917,,,,,,,,IC50 (nM),38,PMID:18834108|DOI:10.1021/jm8009124,https://www.ncbi.nlm.nih.gov/pubmed/18834108|https://doi.org/10.1021/jm8009124,18834108,10.1021/jm8009124,
4960,2014361,16110344,BindingDB,"6-methyl-5-[(3R)-3-(3,4,5-trimethoxyphenyl)but-1-ynyl]pyrimidine-2,4-diamine",18497,"6-methyl-5-[(3R)-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18497,1875,Dihydrofolate reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1875,P00374,Dihydrofolate reductase,1719.0,DHFR,9606.0,Homo sapiens (human),,IC50 (nM),1380,PMID:18834108|DOI:10.1021/jm8009124,https://www.ncbi.nlm.nih.gov/pubmed/18834108|https://doi.org/10.1021/jm8009124,18834108,10.1021/jm8009124,
4961,2014362,16122583,BindingDB,"2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid",50212873,"((2'-(5-ETHYL-3,4-DIPHENYL-1H-PYRAZOL-1-YL)-3-BIPHENYLYL)OXY)ACETIC ACID",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50212873,8294,"Fatty acid-binding protein, liver",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8294,P12710,"Fatty acid-binding protein, liver",14080.0,Fabp1,10090.0,Mus musculus (house mouse),,Ki (nM),21,PMID:27552286|DOI:10.1021/acs.biochem.6b00446,https://www.ncbi.nlm.nih.gov/pubmed/27552286|https://doi.org/10.1021/acs.biochem.6b00446,27552286,10.1021/acs.biochem.6b00446,
4962,2014363,16122583,BindingDB,"2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid",50212873,"((2'-(5-ETHYL-3,4-DIPHENYL-1H-PYRAZOL-1-YL)-3-BIPHENYLYL)OXY)ACETIC ACID",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50212873,8294,"Fatty acid-binding protein, liver",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8294,P12710,"Fatty acid-binding protein, liver",14080.0,Fabp1,10090.0,Mus musculus (house mouse),,Ki (nM),52,PMID:27552286|DOI:10.1021/acs.biochem.6b00446,https://www.ncbi.nlm.nih.gov/pubmed/27552286|https://doi.org/10.1021/acs.biochem.6b00446,27552286,10.1021/acs.biochem.6b00446,
4963,2014364,16129706,ChEMBL,Somatostatin,CHEMBL1823872,SOMATOSTATIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1823872/,CHEMBL2111436,Somatostatin receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111436/,P30872,Somatostatin receptor type 1,6751.0,SSTR1,9606.0,Homo sapiens (human),Somatostatin receptor agonist,,,,,,,
4964,2014365,16129706,ChEMBL,Somatostatin,CHEMBL1823872,SOMATOSTATIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1823872/,CHEMBL2111436,Somatostatin receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111436/,P30874,Somatostatin receptor type 2,6752.0,SSTR2,9606.0,Homo sapiens (human),Somatostatin receptor agonist,,,,,,,
4965,2002150,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,7053,TGM3,https://ctdbase.org/detail.go?type=gene&acc=7053,,,7053.0,TGM3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TGM3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
4966,2002151,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,55145,THAP1,https://ctdbase.org/detail.go?type=gene&acc=55145,,,55145.0,THAP1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of THAP1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
4967,2002152,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,51078,THAP4,https://ctdbase.org/detail.go?type=gene&acc=51078,,,51078.0,THAP4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of THAP4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
4968,2014596,16215105,Comparative Toxicogenomics Database (CTD),"4-(6-Hydroxynaphthalen-2-yl)benzene-1,3-diol",C523393,"4-(6-hydroxy-2-naphthyl)-1,3-benzenediol",https://ctdbase.org/detail.go?type=chem&acc=C523393,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),"4-(6-hydroxy-2-naphthyl)-1,3-benzenediol results in decreased expression of CASP3 protein",,,PMID:20198347,https://www.ncbi.nlm.nih.gov/pubmed/20198347,20198347,,
4969,2014597,16215105,Comparative Toxicogenomics Database (CTD),"4-(6-Hydroxynaphthalen-2-yl)benzene-1,3-diol",C523393,"4-(6-hydroxy-2-naphthyl)-1,3-benzenediol",https://ctdbase.org/detail.go?type=chem&acc=C523393,7299,TYR,https://ctdbase.org/detail.go?type=gene&acc=7299,,,7299.0,TYR,10090.0,Mus musculus (house mouse),"4-(6-hydroxy-2-naphthyl)-1,3-benzenediol results in decreased activity of TYR protein",,,PMID:17827726,https://www.ncbi.nlm.nih.gov/pubmed/17827726,17827726,,
4970,2014598,16218906,Comparative Toxicogenomics Database (CTD),4-Aminobenzoyl-Gly-Pro-D-Leu-D-Ala hydroxamic acid,C095170,4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid,https://ctdbase.org/detail.go?type=chem&acc=C095170,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10090.0,Mus musculus (house mouse),4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [zinc results in increased expression of BDNF mrna]|4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [zinc results in increased expression of BDNF protein],,,PMID:21615740,https://www.ncbi.nlm.nih.gov/pubmed/21615740,21615740,,
4971,2014252,17757114,BindingDB,"triazolothiadiazine, 8A",30082,"triazolothiadiazine, 8A",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30082,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),>20000,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4972,2014253,17757115,BindingDB,"triazolothiadiazine, 9A",30093,"triazolothiadiazine, 9A",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30093,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),15000,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4973,2014254,17757116,BindingDB,"triazolothiadiazine, 11A",30115,"triazolothiadiazine, 11A",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30115,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),>20000,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4974,2014255,17757118,BindingDB,"triazolothiadiazine, 6B",30061,"triazolothiadiazine, 6B",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30061,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),13400,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4975,2014256,17757119,BindingDB,"triazolothiadiazine, 7B",30072,"triazolothiadiazine, 7B",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30072,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),12600,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4976,2014257,17757120,BindingDB,"triazolothiadiazine, 9B",30094,"triazolothiadiazine, 9B",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30094,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),14100,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4977,2014258,17757121,BindingDB,"triazolothiadiazine, 11B",30116,"triazolothiadiazine, 11B",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30116,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),>20000,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4978,2014259,17757123,BindingDB,"triazolothiadiazine, 6C",30062,"triazolothiadiazine, 6C",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30062,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),14100,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4979,2014260,17757124,BindingDB,"triazolothiadiazine, 9C",30095,"triazolothiadiazine, 9C",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30095,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),13400,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4980,2014261,17757125,BindingDB,"triazolothiadiazine, 11C",30117,"triazolothiadiazine, 11C",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30117,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),19700,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4981,2014281,17757145,BindingDB,"triazolothiadiazine, 11F",30120,"triazolothiadiazine, 11F",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30120,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),>20000,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4982,2014282,17757146,BindingDB,"3-(2,5-dimethoxyphenyl)-6-(3,4-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine",30019,BMCL181297 Compound 5F,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30019,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),10,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4983,2014283,17757146,BindingDB,"3-(2,5-dimethoxyphenyl)-6-(3,4-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine",30019,BMCL181297 Compound 5F,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30019,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),6.7,PMID:19464886|DOI:10.1016/j.bmcl.2009.01.057,https://www.ncbi.nlm.nih.gov/pubmed/19464886|https://doi.org/10.1016/j.bmcl.2009.01.057,19464886,10.1016/j.bmcl.2009.01.057,
4984,2014284,17757147,BindingDB,"triazolothiadiazine, 6G",30066,"triazolothiadiazine, 6G",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30066,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),8900,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4985,2014285,17757148,BindingDB,"triazolothiadiazine, 7G",30077,"triazolothiadiazine, 7G",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30077,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),9000,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4986,2014286,17757149,BindingDB,"triazolothiadiazine, 9G",30099,"triazolothiadiazine, 9G",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30099,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),6700,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4987,2014287,17757150,BindingDB,"triazolothiadiazine, 10G",30110,"triazolothiadiazine, 10G",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30110,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),6900,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4988,2014288,17757151,BindingDB,"triazolothiadiazine, 11G",30121,"triazolothiadiazine, 11G",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30121,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),14100,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4989,2014289,17757152,BindingDB,"triazolothiadiazine, 6H",30067,"triazolothiadiazine, 6H",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30067,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),13400,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4990,2014290,17757153,BindingDB,"triazolothiadiazine, 7H",30078,"triazolothiadiazine, 7H",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30078,1180,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1180,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),,IC50 (nM),13400,PMID:18243697|DOI:10.1016/j.bmcl.2008.01.028,https://www.ncbi.nlm.nih.gov/pubmed/18243697|https://doi.org/10.1016/j.bmcl.2008.01.028,18243697,10.1016/j.bmcl.2008.01.028,
4991,2030406,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2720,GLB1,https://ctdbase.org/detail.go?type=gene&acc=2720,,,2720.0,GLB1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GLB1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
4992,2030407,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2734,GLG1,https://ctdbase.org/detail.go?type=gene&acc=2734,,,2734.0,GLG1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GLG1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
4993,2030408,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2735,GLI1,https://ctdbase.org/detail.go?type=gene&acc=2735,,,2735.0,GLI1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GLI1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
4994,2030409,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2743,GLRB,https://ctdbase.org/detail.go?type=gene&acc=2743,,,2743.0,GLRB,9606.0,Homo sapiens (human),Tamoxifen affects the expression of GLRB mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
4995,2013651,21045424,BindingDB,5-Methyl diazepanone 13b,15541,"4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-5-methyl-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15541,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),1050,PMID:17291750|DOI:10.1016/j.bmcl.2007.01.039,https://www.ncbi.nlm.nih.gov/pubmed/17291750|https://doi.org/10.1016/j.bmcl.2007.01.039,17291750,10.1016/j.bmcl.2007.01.039,
4996,2013653,21045424,BindingDB,5-Methyl diazepanone 13b,15541,"4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-5-methyl-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15541,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17291750|DOI:10.1016/j.bmcl.2007.01.039,https://www.ncbi.nlm.nih.gov/pubmed/17291750|https://doi.org/10.1016/j.bmcl.2007.01.039,17291750,10.1016/j.bmcl.2007.01.039,
4997,2013654,21045424,BindingDB,5-Methyl diazepanone 13b,15541,"4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-5-methyl-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15541,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),44000,PMID:17291750|DOI:10.1016/j.bmcl.2007.01.039,https://www.ncbi.nlm.nih.gov/pubmed/17291750|https://doi.org/10.1016/j.bmcl.2007.01.039,17291750,10.1016/j.bmcl.2007.01.039,
4998,2013691,21045424,BindingDB,5-Methyl diazepanone 13b,15541,"4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-5-methyl-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15541,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17291750|DOI:10.1016/j.bmcl.2007.01.039,https://www.ncbi.nlm.nih.gov/pubmed/17291750|https://doi.org/10.1016/j.bmcl.2007.01.039,17291750,10.1016/j.bmcl.2007.01.039,
4999,2013652,21078080,Drug Gene Interaction database (DGIdb),"1H-Isoindol-1-one, 2-((1-(2-(4-fluorophenyl)-2-oxoethyl)-4-piperidinyl)methyl)-2,3-dihydro-, hydrochloride, hydrate (1:1:2)",,ROLUPERIDONE HYDROCHLORIDE,https://www.dgidb.org/drugs/chembl:CHEMBL4298043,,HTR2A,https://www.dgidb.org/genes/hgnc:5293,,,3356.0,HTR2A,9606.0,Homo sapiens (human),,,,,,,,
5000,2013692,21103107,BindingDB,"1-(1-{[4-(3-phenylquinolin-2-yl)phenyl]methyl}piperidin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one",15170,"1-(1-{[4-(3-phenylquinolin-2-yl)phenyl]methyl}piperidin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15170,1612,RAC-gamma serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1612,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606.0,Homo sapiens (human),,IC50 (nM),>50000,PMID:15686884|DOI:10.1016/j.bmcl.2004.12.062,https://www.ncbi.nlm.nih.gov/pubmed/15686884|https://doi.org/10.1016/j.bmcl.2004.12.062,15686884,10.1016/j.bmcl.2004.12.062,
5001,2013655,21155916,BindingDB,"L-Gamma-Glutamyl-S-(3-Methyl-1,4-Dioxo-1,4-Dihydronaphthalen-2-Yl)-L-Cysteinylglycine",24784,"(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)sulfanyl]ethyl]carbamoyl}butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24784,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),880,PMID:18318466|DOI:10.1021/jm7014155,https://www.ncbi.nlm.nih.gov/pubmed/18318466|https://doi.org/10.1021/jm7014155,18318466,10.1021/jm7014155,
5002,2013656,21158560,ChEMBL,Alcuronium,CHEMBL3305985,ALCURONIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3305985/,CHEMBL211,Muscarinic acetylcholine receptor M2,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL211/,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606.0,Homo sapiens (human),Muscarinic acetylcholine receptor M2 positive allosteric modulator,,,PMID:9720793|PMID:11961078|PMID:6601958|PMID:7931349|PMID:11562438,https://www.ncbi.nlm.nih.gov/pubmed/9720793|https://www.ncbi.nlm.nih.gov/pubmed/11961078|https://www.ncbi.nlm.nih.gov/pubmed/6601958|https://www.ncbi.nlm.nih.gov/pubmed/7931349|https://www.ncbi.nlm.nih.gov/pubmed/11562438,9720793|11961078|6601958|7931349|11562438,,
5003,2013657,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,10090.0,Mus musculus (house mouse),Thiocarbamates analog results in decreased activity of ALDH2 protein|1-benzylimidazole inhibits the reaction [NADP promotes the reaction [thiocarbamates analog results in decreased activity of ALDH2 protein]]|nadp promotes the reaction [thiocarbamates analog results in decreased activity of ALDH2 protein],,,PMID:9585485,https://www.ncbi.nlm.nih.gov/pubmed/9585485,9585485,,
5004,2013658,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Thiocarbamates analog inhibits the reaction [dimethylformamide results in increased expression of BAX protein],,,PMID:29984871,https://www.ncbi.nlm.nih.gov/pubmed/29984871,29984871,,
5005,2013668,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Thiocarbamates results in increased expression of BAX protein,,,PMID:20209498,https://www.ncbi.nlm.nih.gov/pubmed/20209498,20209498,,
5006,2013669,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Thiocarbamates results in decreased expression of BCL2 protein,,,PMID:20209498,https://www.ncbi.nlm.nih.gov/pubmed/20209498,20209498,,
5007,2013670,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),Thiocarbamates analog inhibits the reaction [dimethylformamide results in decreased expression of BCL2L1 protein],,,PMID:29984871,https://www.ncbi.nlm.nih.gov/pubmed/29984871,29984871,,
5008,2013671,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Thiocarbamates analog inhibits the reaction [dimethylformamide results in increased expression of CASP3 protein modified form],,,PMID:29984871,https://www.ncbi.nlm.nih.gov/pubmed/29984871,29984871,,
5009,2013672,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Thiocarbamates results in increased activity of CASP3 protein,,,PMID:20209498,https://www.ncbi.nlm.nih.gov/pubmed/20209498,20209498,,
5010,2013673,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Thiocarbamates analog inhibits the reaction [dimethylformamide results in increased expression of CASP9 protein modified form],,,PMID:29984871,https://www.ncbi.nlm.nih.gov/pubmed/29984871,29984871,,
5011,2013674,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Thiocarbamates results in increased activity of CASP9 protein,,,PMID:20209498,https://www.ncbi.nlm.nih.gov/pubmed/20209498,20209498,,
5012,2013675,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,10090.0,Mus musculus (house mouse),Thiocarbamates inhibits the reaction [reactive oxygen species results in increased expression of CSF2 protein],,,PMID:11752025,https://www.ncbi.nlm.nih.gov/pubmed/11752025,11752025,,
5013,2013676,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606.0,Homo sapiens (human),Thiocarbamates analog results in decreased activity of CYP2E1 protein,,,PMID:29984871,https://www.ncbi.nlm.nih.gov/pubmed/29984871,29984871,,
5014,2013677,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),NR1I2 protein promotes the reaction [thiocarbamates results in increased expression of CYP3A4 mrna]|thiocarbamates results in increased expression of CYP3A4 mRNA,,,PMID:17293382,https://www.ncbi.nlm.nih.gov/pubmed/17293382,17293382,,
5015,2013687,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),Thiocarbamates results in decreased expression of and results in decreased phosphorylation of EGFR protein,,,PMID:20209498,https://www.ncbi.nlm.nih.gov/pubmed/20209498,20209498,,
5016,2013688,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),NR1I2 protein promotes the reaction [thiocarbamates results in increased expression of CYP3A4 mrna],,,PMID:17293382,https://www.ncbi.nlm.nih.gov/pubmed/17293382,17293382,,
5017,2013689,21226412,Comparative Toxicogenomics Database (CTD),Thiocarbamate,D013859,Thiocarbamates,https://ctdbase.org/detail.go?type=chem&acc=D013859,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Thiocarbamates analog inhibits the reaction [dimethylformamide results in increased expression of TP53 protein],,,PMID:29984871,https://www.ncbi.nlm.nih.gov/pubmed/29984871,29984871,,
5018,2013690,21594000,Drug Gene Interaction database (DGIdb),Cimipronidine,,CIMIPRONIDINE,https://www.dgidb.org/drugs/chembl:CHEMBL485803,,HTR7,https://www.dgidb.org/genes/hgnc:5302,,,3363.0,HTR7,9606.0,Homo sapiens (human),,,,,,,,
5019,2013693,21881614,Comparative Toxicogenomics Database (CTD),alpha-Monobenzoyl glycerol,C003402,sapropterin,https://ctdbase.org/detail.go?type=chem&acc=C003402,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10116.0,Rattus norvegicus (Norway rat),Sapropterin inhibits the reaction [fructose results in decreased expression of ADIPOQ mrna]|sapropterin inhibits the reaction [fructose results in decreased expression of ADIPOQ protein],,,PMID:17098227,https://www.ncbi.nlm.nih.gov/pubmed/17098227,17098227,,
5020,2013694,21881614,Comparative Toxicogenomics Database (CTD),alpha-Monobenzoyl glycerol,C003402,sapropterin,https://ctdbase.org/detail.go?type=chem&acc=C003402,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606.0,Homo sapiens (human),APP gene mutant form results in increased oxidation of and results in decreased abundance of sapropterin|gw 501516 inhibits the reaction [APP gene mutant form results in increased oxidation of and results in decreased abundance of sapropterin],,,PMID:22886847,https://www.ncbi.nlm.nih.gov/pubmed/22886847,22886847,,
5021,2013695,21881614,Comparative Toxicogenomics Database (CTD),alpha-Monobenzoyl glycerol,C003402,sapropterin,https://ctdbase.org/detail.go?type=chem&acc=C003402,48805,CATSUP,https://ctdbase.org/detail.go?type=gene&acc=48805,,,48805.0,Catsup,7227.0,Drosophila melanogaster (fruit fly),CATSUP gene mutant form results in decreased abundance of sapropterin,,,PMID:17344383,https://www.ncbi.nlm.nih.gov/pubmed/17344383,17344383,,
5022,2013714,21881614,Comparative Toxicogenomics Database (CTD),alpha-Monobenzoyl glycerol,C003402,sapropterin,https://ctdbase.org/detail.go?type=chem&acc=C003402,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Sapropterin inhibits the reaction [methotrexate results in increased expression of CDKN1A protein],,,PMID:22183962,https://www.ncbi.nlm.nih.gov/pubmed/22183962,22183962,,
5023,2013715,21881614,Comparative Toxicogenomics Database (CTD),alpha-Monobenzoyl glycerol,C003402,sapropterin,https://ctdbase.org/detail.go?type=chem&acc=C003402,2056,EPO,https://ctdbase.org/detail.go?type=gene&acc=2056,,,2056.0,EPO,9606.0,Homo sapiens (human),EPO protein inhibits the reaction [GCH1 mutant form results in decreased abundance of sapropterin]|epo protein inhibits the reaction [HPH1 gene mutant form results in increased oxidation of sapropterin],,,PMID:25041251,https://www.ncbi.nlm.nih.gov/pubmed/25041251,25041251,,
5024,2013716,21881614,Comparative Toxicogenomics Database (CTD),alpha-Monobenzoyl glycerol,C003402,sapropterin,https://ctdbase.org/detail.go?type=chem&acc=C003402,2056,EPO,https://ctdbase.org/detail.go?type=gene&acc=2056,,,2056.0,EPO,10090.0,Mus musculus (house mouse),"EPO protein inhibits the reaction [[NOS3 protein co-treated with sapropterin deficiency] results in increased chemical synthesis of superoxides]|epo protein results in increased abundance of sapropterin|epo protein inhibits the reaction [[GCH1 gene mutant form results in increased oxidation of sapropterin] which results in increased chemical synthesis of 7,8-dihydrobiopterin]",,,PMID:25490417,https://www.ncbi.nlm.nih.gov/pubmed/25490417,25490417,,
5025,2013717,21881614,Comparative Toxicogenomics Database (CTD),alpha-Monobenzoyl glycerol,C003402,sapropterin,https://ctdbase.org/detail.go?type=chem&acc=C003402,2643,GCH1,https://ctdbase.org/detail.go?type=gene&acc=2643,,,2643.0,GCH1,9913.0,Bos taurus (cattle),[4-hydroxy-2-nonenal results in decreased activity of GCH1 protein] which results in decreased chemical synthesis of sapropterin|ascorbic acid inhibits the reaction [[4-hydroxy-2-nonenal results in decreased activity of GCH1 protein] which results in decreased chemical synthesis of sapropterin]|lactacystin inhibits the reaction [[4-hydroxy-2-nonenal results in decreased activity of GCH1 protein] which results in decreased chemical synthesis of sapropterin],,,PMID:17872449,https://www.ncbi.nlm.nih.gov/pubmed/17872449,17872449,,
5026,2013737,21881614,Comparative Toxicogenomics Database (CTD),alpha-Monobenzoyl glycerol,C003402,sapropterin,https://ctdbase.org/detail.go?type=chem&acc=C003402,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,9606.0,Homo sapiens (human),SNCA mutant form results in increased abundance of sapropterin,,,PMID:24148766,https://www.ncbi.nlm.nih.gov/pubmed/24148766,24148766,,
5027,2013738,21881614,Comparative Toxicogenomics Database (CTD),alpha-Monobenzoyl glycerol,C003402,sapropterin,https://ctdbase.org/detail.go?type=chem&acc=C003402,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Sapropterin inhibits the reaction [methotrexate results in increased expression of TP53 protein],,,PMID:22183962,https://www.ncbi.nlm.nih.gov/pubmed/22183962,22183962,,
5028,2013739,21924997,Drug Gene Interaction database (DGIdb),3-(2-Azidoethyl)thiophene,,CHEMBL:CHEMBL589270,https://www.dgidb.org/drugs/chembl:CHEMBL589270,,SIRT2,https://www.dgidb.org/genes/hgnc:10886,,,22933.0,SIRT2,9606.0,Homo sapiens (human),,,,,,,,
5029,2013740,22024915,Drug Gene Interaction database (DGIdb),Icotinib,,ICOTINIB,https://www.dgidb.org/drugs/ncit:C138996,,EGFR,https://www.dgidb.org/genes/hgnc:3236,,,1956.0,EGFR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5030,2013741,22063896,BindingDB,"1,3-dimethyl-5-[4-(3-methylphenyl)-2-(pyridin-3-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-1,3-benzodiazol-2-one",15437,"1,3-dimethyl-5-[4-(3-methylphenyl)-2-(pyridin-3-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-1,3-benzodiazol-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15437,3881,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3881,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,IC50 (nM),200,PMID:15012994|DOI:10.1016/j.bmcl.2003.12.023,https://www.ncbi.nlm.nih.gov/pubmed/15012994|https://doi.org/10.1016/j.bmcl.2003.12.023,15012994,10.1016/j.bmcl.2003.12.023,
5031,2013742,22063925,BindingDB,"1,3-Diethyl-5-(3-m-tolyl-1H-pyrazol-4-yl)-1,3-dihydro-benzoimidazol-2-one",15448,"1,3-diethyl-5-[3-(3-methylphenyl)-1H-pyrazol-4-yl]-2,3-dihydro-1H-1,3-benzodiazol-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15448,3881,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3881,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,IC50 (nM),9,PMID:15012994|DOI:10.1016/j.bmcl.2003.12.023,https://www.ncbi.nlm.nih.gov/pubmed/15012994|https://doi.org/10.1016/j.bmcl.2003.12.023,15012994,10.1016/j.bmcl.2003.12.023,
5032,2012996,22333242,BindingDB,Ethyl 1-methanesulfonyl-5-(N-methanesulfonylfuran-2-amido)-2-methyl-1H-indole-3-carboxylate,496265,CVD-0013091,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496265,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),282,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
5033,2012997,22431252,BindingDB,"5-methyl-N-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",28807,"5-methyl-N-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28807,1559,"Dihydroorotate dehydrogenase (quinone), mitochondrial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1559,Q08210,"Dihydroorotate dehydrogenase (quinone), mitochondrial",3885966.0,PF3D7_0603300,36329.0,Plasmodium falciparum 3D7,,IC50 (nM),>100000,PMID:19296651|DOI:10.1021/jm801343r,https://www.ncbi.nlm.nih.gov/pubmed/19296651|https://doi.org/10.1021/jm801343r,19296651,10.1021/jm801343r,
5034,2014310,22466004,BindingDB,"(2,4-Dihydroxyphenyl)(3-Hydroxyphenyl)methanone",225876,"Polyhydroxy benzophenone, 12",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=225876,9974,Polyphenol oxidase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9974,Q00024,Polyphenol oxidase 1,,,5341.0,Agaricus bisporus,,IC50 (nM),>2.00e+5,PMID:20939763|DOI:10.3109/14756366.2010.521745,https://www.ncbi.nlm.nih.gov/pubmed/20939763|https://doi.org/10.3109/14756366.2010.521745,20939763,10.3109/14756366.2010.521745,
5035,2012998,22496365,BindingDB,"Aminothiazole, 3",29106,"aminothiazole, 3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29106,242,Glucagon receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=242,P47871,Glucagon receptor,2642.0,GCGR,9606.0,Homo sapiens (human),,IC50 (nM),36,PMID:19385613|DOI:10.1021/jm8016249,https://www.ncbi.nlm.nih.gov/pubmed/19385613|https://doi.org/10.1021/jm8016249,19385613,10.1021/jm8016249,
5036,2012999,22496371,BindingDB,"Aminothiazole, 4",29107,"aminothiazole, 4",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29107,242,Glucagon receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=242,P47871,Glucagon receptor,2642.0,GCGR,9606.0,Homo sapiens (human),,IC50 (nM),48,PMID:19385613|DOI:10.1021/jm8016249,https://www.ncbi.nlm.nih.gov/pubmed/19385613|https://doi.org/10.1021/jm8016249,19385613,10.1021/jm8016249,
5037,2013000,22496412,BindingDB,"Aminothiazole, 2",29105,"aminothiazole, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29105,242,Glucagon receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=242,P47871,Glucagon receptor,2642.0,GCGR,9606.0,Homo sapiens (human),,IC50 (nM),118,PMID:19385613|DOI:10.1021/jm8016249,https://www.ncbi.nlm.nih.gov/pubmed/19385613|https://doi.org/10.1021/jm8016249,19385613,10.1021/jm8016249,
5038,2014134,22496431,BindingDB,"Aminothiazole, 5",29108,"aminothiazole, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29108,242,Glucagon receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=242,P47871,Glucagon receptor,2642.0,GCGR,9606.0,Homo sapiens (human),,IC50 (nM),86,PMID:19385613|DOI:10.1021/jm8016249,https://www.ncbi.nlm.nih.gov/pubmed/19385613|https://doi.org/10.1021/jm8016249,19385613,10.1021/jm8016249,
5039,2013002,22496445,BindingDB,"Aminothiazole, 8",29111,"aminothiazole, 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29111,242,Glucagon receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=242,P47871,Glucagon receptor,2642.0,GCGR,9606.0,Homo sapiens (human),,IC50 (nM),85,PMID:19385613|DOI:10.1021/jm8016249,https://www.ncbi.nlm.nih.gov/pubmed/19385613|https://doi.org/10.1021/jm8016249,19385613,10.1021/jm8016249,
5040,2013003,22496449,BindingDB,"Aminothiazole, 6",29109,"aminothiazole, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29109,242,Glucagon receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=242,P47871,Glucagon receptor,2642.0,GCGR,9606.0,Homo sapiens (human),,IC50 (nM),50,PMID:19385613|DOI:10.1021/jm8016249,https://www.ncbi.nlm.nih.gov/pubmed/19385613|https://doi.org/10.1021/jm8016249,19385613,10.1021/jm8016249,
5041,2013001,22496459,BindingDB,"Aminothiazole, 7",29110,"aminothiazole, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29110,242,Glucagon receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=242,P47871,Glucagon receptor,2642.0,GCGR,9606.0,Homo sapiens (human),,IC50 (nM),86,PMID:19385613|DOI:10.1021/jm8016249,https://www.ncbi.nlm.nih.gov/pubmed/19385613|https://doi.org/10.1021/jm8016249,19385613,10.1021/jm8016249,
5042,2014311,22691666,BindingDB,"(2S)-2-amino-2-phenyl-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one",12186,"(2S)-2-amino-2-phenyl-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12186,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:15664838|DOI:10.1016/j.bmcl.2004.11.023,https://www.ncbi.nlm.nih.gov/pubmed/15664838|https://doi.org/10.1016/j.bmcl.2004.11.023,15664838,10.1016/j.bmcl.2004.11.023,
5043,2014312,22691666,BindingDB,"(2S)-2-amino-2-phenyl-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one",12186,"(2S)-2-amino-2-phenyl-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12186,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:15664838|DOI:10.1016/j.bmcl.2004.11.023,https://www.ncbi.nlm.nih.gov/pubmed/15664838|https://doi.org/10.1016/j.bmcl.2004.11.023,15664838,10.1016/j.bmcl.2004.11.023,
5044,2014313,22691666,BindingDB,"(2S)-2-amino-2-phenyl-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one",12186,"(2S)-2-amino-2-phenyl-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12186,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:15664838|DOI:10.1016/j.bmcl.2004.11.023,https://www.ncbi.nlm.nih.gov/pubmed/15664838|https://doi.org/10.1016/j.bmcl.2004.11.023,15664838,10.1016/j.bmcl.2004.11.023,
5045,2014141,22731249,BindingDB,1-Dodecyl-3-(2-methylpropyl)urea,129249,"US8815951, 478",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=129249,6916,Juvenile hormone epoxide hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6916,Q25489,Juvenile hormone epoxide hydrolase,,,7130.0,Manduca sexta (tobacco hornworm),,IC50 (nM),2.3e+3,PMID:25711603|DOI:10.1002/cbic.201402650,https://www.ncbi.nlm.nih.gov/pubmed/25711603|https://doi.org/10.1002/cbic.201402650,25711603,10.1002/cbic.201402650,
5046,2014135,22731604,BindingDB,"2-Bromo-3,4-difluoroaniline",626204,EN300-717241,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626204,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),3000,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
5047,2013004,22737393,IUPHAR/BPS Guide to PHARMACOLOGY,"3-chloro-4-[(E)-2-(5,5-dimethyl-8-phenyl-6H-naphthalen-2-yl)ethenyl]benzoic acid",2651,BMS641,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2651,591,Retinoic acid receptor-,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=591,P10826,Retinoic acid receptor beta,5915.0,RARB,9606.0,Homo sapiens (human),Agonist,pIC50,8.6,PMID:15319780,https://www.ncbi.nlm.nih.gov/pubmed/15319780,15319780,,
5048,2014136,22748686,Toxin and Toxin Target Database (T3DB),Zinc beryllium silicate,T3D1376,Zinc beryllium silicate,http://www.t3db.ca/toxins/T3D1376,BE0005071,"HLA class II histocompatibility antigen, DP(W2) beta chain",http://www.t3db.ca/biodb/bio_entities/BE0005071,P13763,"RecName: Full=HLA class II histocompatibility antigen, DP(W2) beta chain; Short=SB-2-beta; Flags: Precursor",3115.0,HLA-DPB1,9606.0,Homo sapiens (human),"Once in the body, beryllium acts as a hapten and interacts with human leucocyte antigen (HLA) DP presenting cells in the lungs, becoming physically associated with a major histocompatability (MHC) class II molecule. this MHC class II-beryllium-peptide complex is recognized by the T lymphocyte receptor, triggering CD4+ T lymphocyte activation and proliferation. the resulting inflammatory response is a cell-mediated process orchestrated by cytokines and results in the formation of (usually pulmonary) granulomas. (L25, A37)",,,PMID:19191908,https://www.ncbi.nlm.nih.gov/pubmed/19191908,19191908,,
5049,2014137,22748686,Toxin and Toxin Target Database (T3DB),Zinc beryllium silicate,T3D1376,Zinc beryllium silicate,http://www.t3db.ca/toxins/T3D1376,BE0002390,Superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0002390,P00441,Superoxide dismutase [Cu-Zn],6647.0,SOD1,9606.0,Homo sapiens (human),"Unbalanced levels of copper and zinc binding to cu,zn-superoxide dismutase has been linked to amyotrophic lateral sclerosis (ALS). (A49)",,,PMID:19021549,https://www.ncbi.nlm.nih.gov/pubmed/19021549,19021549,,
5050,2014140,22748686,Toxin and Toxin Target Database (T3DB),Zinc beryllium silicate,T3D1376,Zinc beryllium silicate,http://www.t3db.ca/toxins/T3D1376,BE0005070,"HLA class II histocompatibility antigen, DP alpha 1 chain",http://www.t3db.ca/biodb/bio_entities/BE0005070,P20036,"HLA class II histocompatibility antigen, DP alpha 1 chain",3113.0,HLA-DPA1,9606.0,Homo sapiens (human),"Once in the body, beryllium acts as a hapten and interacts with human leucocyte antigen (HLA) DP presenting cells in the lungs, becoming physically associated with a major histocompatability (MHC) class II molecule. this MHC class II-beryllium-peptide complex is recognized by the T lymphocyte receptor, triggering CD4+ T lymphocyte activation and proliferation. the resulting inflammatory response is a cell-mediated process orchestrated by cytokines and results in the formation of (usually pulmonary) granulomas. (L25, A37)",,,PMID:19191908,https://www.ncbi.nlm.nih.gov/pubmed/19191908,19191908,,
5051,2014599,22748686,Toxin and Toxin Target Database (T3DB),Zinc beryllium silicate,T3D1376,Zinc beryllium silicate,http://www.t3db.ca/toxins/T3D1376,BE0005069,"HLA class II histocompatibility antigen, DP beta 1 chain",http://www.t3db.ca/biodb/bio_entities/BE0005069,P04440,"HLA class II histocompatibility antigen, DP beta 1 chain",3115.0,HLA-DPB1,9606.0,Homo sapiens (human),"Once in the body, beryllium acts as a hapten and interacts with human leucocyte antigen (HLA) DP presenting cells in the lungs, becoming physically associated with a major histocompatability (MHC) class II molecule. this MHC class II-beryllium-peptide complex is recognized by the T lymphocyte receptor, triggering CD4+ T lymphocyte activation and proliferation. the resulting inflammatory response is a cell-mediated process orchestrated by cytokines and results in the formation of (usually pulmonary) granulomas. (L25, A37)",,,PMID:19191908,https://www.ncbi.nlm.nih.gov/pubmed/19191908,19191908,,
5052,2014138,23001780,IUPHAR/BPS Guide to PHARMACOLOGY,"4-[(4-Bromo-3-hydroxy-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)carbamoyl]-2,6-difluorobenzoic acid",2649,AGN193836,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2649,590,Retinoic acid receptor-,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=590,P10276,Retinoic acid receptor alpha,5914.0,RARA,9606.0,Homo sapiens (human),Agonist,pKd,8.4,PMID:12372520,https://www.ncbi.nlm.nih.gov/pubmed/12372520,12372520,,
5053,2014139,23047684,BindingDB,MAT-POS-6da3605a-2,496387,CVD-0012807,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496387,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),65300,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
5054,2014600,23071856,Therapeutic Target Database (TTD),4-(2-ethylbutyl)-N-[3-(4-fluorophenoxy)phenyl]-4-hydroxypiperidine-1-carboxamide,D0T8FV,"US8975409, Comparative compound B",https://idrblab.net/ttd/data/drug/details/D0T8FV,T47888,Sphingosine-1-phosphate receptor 2 (S1PR2),https://idrblab.net/ttd/data/target/details/T47888,O95136,Sphingosine 1-phosphate receptor 2,9294.0,S1PR2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5055,2014603,23121947,Therapeutic Target Database (TTD),"3-oxo-1,1-di(phenyl)-N-(2-piperidin-1-ylethyl)-5,6,8,8a-tetrahydro-[1,3]oxazolo[4,3-c]pyrazine-7-carboxamide",D00JCQ,"Oxazolo[3,4-a]pyrazine derivative 4",https://idrblab.net/ttd/data/drug/details/D00JCQ,T20958,Neuropeptide S receptor (NPSR),https://idrblab.net/ttd/data/target/details/T20958,Q6W5P4,Neuropeptide S receptor,387129.0,NPSR1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
5056,2014604,23122056,Therapeutic Target Database (TTD),"Oxazolo[3,4-a]pyrazine derivative 5",D0QY3L,"Oxazolo[3,4-a]pyrazine derivative 5",https://idrblab.net/ttd/data/drug/details/D0QY3L,T20958,Neuropeptide S receptor (NPSR),https://idrblab.net/ttd/data/target/details/T20958,Q6W5P4,Neuropeptide S receptor,387129.0,NPSR1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
5057,2014685,23122113,Therapeutic Target Database (TTD),"N-[2-[4,7-dichloro-6-(3-chlorothiophen-2-yl)pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2,2,2-trifluoroacetamide",D0P8RK,PMID27828716-Compound-16,https://idrblab.net/ttd/data/drug/details/D0P8RK,T76910,Glycogen synthase kinase-3 alpha (GSK-3A),https://idrblab.net/ttd/data/target/details/T76910,P49840,Glycogen synthase kinase-3 alpha,2931.0,GSK3A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5058,2014601,23136170,BindingDB,Tridecylurea,150795,N-Tridecyl urea (10),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=150795,6916,Juvenile hormone epoxide hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6916,Q25489,Juvenile hormone epoxide hydrolase,,,7130.0,Manduca sexta (tobacco hornworm),,IC50 (nM),>1.00e+5,PMID:25711603|DOI:10.1002/cbic.201402650,https://www.ncbi.nlm.nih.gov/pubmed/25711603|https://doi.org/10.1002/cbic.201402650,25711603,10.1002/cbic.201402650,
5059,2014602,23457042,BindingDB,N-Dodecyl-N'-methylurea,150789,N-Methyl-N-dodecyl urea (4),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=150789,6916,Juvenile hormone epoxide hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6916,Q25489,Juvenile hormone epoxide hydrolase,,,7130.0,Manduca sexta (tobacco hornworm),,IC50 (nM),1.07e+4,PMID:25711603|DOI:10.1002/cbic.201402650,https://www.ncbi.nlm.nih.gov/pubmed/25711603|https://doi.org/10.1002/cbic.201402650,25711603,10.1002/cbic.201402650,
5060,2014686,23474896,BindingDB,"2-[(5Z)-5-{[5-(2,4-dichlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid",28854,"2-[(5Z)-5-{[5-(2,4-dichlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28854,50003485,Lethal factor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003485,P15917,Lethal factor,45025515.0,lef,1392.0,Bacillus anthracis,,IC50 (nM),1200,PMID:18221310|DOI:10.1111/j.1747-0285.2007.00617.x,https://www.ncbi.nlm.nih.gov/pubmed/18221310|https://doi.org/10.1111/j.1747-0285.2007.00617.x,18221310,10.1111/j.1747-0285.2007.00617.x,
5061,2014687,23474896,BindingDB,"2-[(5Z)-5-{[5-(2,4-dichlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid",28854,"2-[(5Z)-5-{[5-(2,4-dichlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28854,2349,Botulinum neurotoxin type A2 [1-425],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2349,Q45894,Botulinum neurotoxin type A2,,,536232.0,Clostridium botulinum A2 str. Kyoto,,IC50 (nM),>200000,PMID:18221310|DOI:10.1111/j.1747-0285.2007.00617.x,https://www.ncbi.nlm.nih.gov/pubmed/18221310|https://doi.org/10.1111/j.1747-0285.2007.00617.x,18221310,10.1111/j.1747-0285.2007.00617.x,
5062,2014605,23500906,BindingDB,2-Cyano-3-oxo-n-[4-(trifluoromethyl)phenyl]butanamide,14712,(2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14712,1559,"Dihydroorotate dehydrogenase (quinone), mitochondrial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1559,Q08210,"Dihydroorotate dehydrogenase (quinone), mitochondrial",3885966.0,PF3D7_0603300,36329.0,Plasmodium falciparum 3D7,,Ki (nM),22000,PMID:19351152|DOI:10.1021/jm800963t,https://www.ncbi.nlm.nih.gov/pubmed/19351152|https://doi.org/10.1021/jm800963t,19351152,10.1021/jm800963t,
5063,2014606,23500906,BindingDB,2-Cyano-3-oxo-n-[4-(trifluoromethyl)phenyl]butanamide,14712,(2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14712,5610,"Dihydroorotate dehydrogenase (quinone), mitochondrial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5610,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",1723.0,DHODH,9606.0,Homo sapiens (human),,Ki (nM),32,PMID:19351152|DOI:10.1021/jm800963t,https://www.ncbi.nlm.nih.gov/pubmed/19351152|https://doi.org/10.1021/jm800963t,19351152,10.1021/jm800963t,
5064,2014637,23582824,ChEMBL,"(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione",CHEMBL3544966,GSK-1059615,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3544966/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",5293.0,PIK3CD,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:19713247,https://www.ncbi.nlm.nih.gov/pubmed/19713247,19713247,,
5065,2014638,23582824,ChEMBL,"(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione",CHEMBL3544966,GSK-1059615,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3544966/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,O00459,Phosphatidylinositol 3-kinase regulatory subunit beta,5296.0,PIK3R2,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:19713247,https://www.ncbi.nlm.nih.gov/pubmed/19713247,19713247,,
5066,2014639,23582824,ChEMBL,"(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione",CHEMBL3544966,GSK-1059615,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3544966/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,5295.0,PIK3R1,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:19713247,https://www.ncbi.nlm.nih.gov/pubmed/19713247,19713247,,
5067,2014640,23582824,ChEMBL,"(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione",CHEMBL3544966,GSK-1059615,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3544966/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",5290.0,PIK3CA,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:19713247,https://www.ncbi.nlm.nih.gov/pubmed/19713247,19713247,,
5068,2014641,23582824,ChEMBL,"(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione",CHEMBL3544966,GSK-1059615,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3544966/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",5291.0,PIK3CB,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:19713247,https://www.ncbi.nlm.nih.gov/pubmed/19713247,19713247,,
5069,2014642,23582824,ChEMBL,"(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione",CHEMBL3544966,GSK-1059615,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3544966/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:19713247,https://www.ncbi.nlm.nih.gov/pubmed/19713247,19713247,,
5070,2014643,23582824,ChEMBL,"(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione",CHEMBL3544966,GSK-1059615,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3544966/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,Q8WYR1,Phosphoinositide 3-kinase regulatory subunit 5,23533.0,PIK3R5,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:19713247,https://www.ncbi.nlm.nih.gov/pubmed/19713247,19713247,,
5071,2014644,23582824,ChEMBL,"(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione",CHEMBL3544966,GSK-1059615,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3544966/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,Q92569,Phosphatidylinositol 3-kinase regulatory subunit gamma,8503.0,PIK3R3,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:19713247,https://www.ncbi.nlm.nih.gov/pubmed/19713247,19713247,,
5072,2014645,23585443,IUPHAR/BPS Guide to PHARMACOLOGY,"2,3-Dichloro-N-(5-fluoro-3-methoxy-pyrazin-2-yl)benzenesulfonamide",9679,AZD1678,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9679,61,CCR4,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=61,P51680,C-C chemokine receptor type 4,12773.0,Ccr4,10090.0,Mus musculus (house mouse),Antagonist,pIC50,9,PMID:28947948,https://www.ncbi.nlm.nih.gov/pubmed/28947948,28947948,,
5073,2014689,23605479,BindingDB,"5-[(2-Fluorobenzyl)sulfonyl]-2-(4-fluorophenyl)-4-(phenylsulfonyl)-1,3-oxazole",496260,CVD-0013086,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496260,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),397,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
5074,2014688,23615975,Drug Gene Interaction database (DGIdb),Zanosar,,STREPTOZOCIN,https://www.dgidb.org/drugs/rxcui:10114,,CSF2,https://www.dgidb.org/genes/hgnc:2434,,,1437.0,CSF2,9606.0,Homo sapiens (human),,,,,,,,
5075,2014690,23630026,ChEMBL,"3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-",CHEMBL1783256,AZD6280,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1783256/,CHEMBL4956,GABA receptor alpha-2 subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL4956/,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606.0,Homo sapiens (human),GABA receptor alpha-2 subunit positive allosteric modulator,,,PMID:25493397,https://www.ncbi.nlm.nih.gov/pubmed/25493397,25493397,,
5076,2014691,23630026,ChEMBL,"3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-",CHEMBL1783256,AZD6280,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1783256/,CHEMBL3026,GABA receptor alpha-3 subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3026/,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606.0,Homo sapiens (human),GABA receptor alpha-3 subunit positive allosteric modulator,,,PMID:25493397,https://www.ncbi.nlm.nih.gov/pubmed/25493397,25493397,,
5077,2014709,23642301,ChEMBL,Elacestrant,CHEMBL4297509,ELACESTRANT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297509/,CHEMBL206,Estrogen receptor alpha,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL206/,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Estrogen receptor alpha degrader,,,PMID:26164151,https://www.ncbi.nlm.nih.gov/pubmed/26164151,26164151,,
5078,2014710,23642339,IUPHAR/BPS Guide to PHARMACOLOGY,"[(3R)-3-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl] hydrogen sulfate",10198,INT-767,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10198,603,Farnesoid X receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=603,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606.0,Homo sapiens (human),Agonist,pEC50,7.52,PMID:20631053,https://www.ncbi.nlm.nih.gov/pubmed/20631053,20631053,,
5079,2014711,23643104,BindingDB,"(1R,5S,7R)-3-benzyl-2-oxo-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-carboxylic acid",29019,"(1R,5S,7R)-3-benzyl-2-oxo-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29019,6145,Macrophage metalloelastase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6145,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),,,,PMID:16899369|DOI:10.1016/j.bmc.2006.07.028,https://www.ncbi.nlm.nih.gov/pubmed/16899369|https://doi.org/10.1016/j.bmc.2006.07.028,16899369,10.1016/j.bmc.2006.07.028,
5080,2014712,23643664,IUPHAR/BPS Guide to PHARMACOLOGY,"6-(4-([1,1'-biphenyl]-2-yl)piperazin-1-yl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)hexanamide",8434,LP-12,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8434,6,5-HT2A receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=6,P28223,5-hydroxytryptamine receptor 2A,3356.0,HTR2A,9606.0,Homo sapiens (human),Agonist,pKi,5.83,PMID:17649988,https://www.ncbi.nlm.nih.gov/pubmed/17649988,17649988,,
5081,2014713,23643871,BindingDB,"Methanone, [5-(4-chlorophenyl)-2-(2,3-dimethoxyphenyl)-1,3,4-thiadiazol-3(2H)-yl](2,4,6-trifluorophenyl)-",20131,"5-(4-chlorophenyl)-2-(2,3-dimethoxyphenyl)-3-[(2,4,6-trifluorophenyl)carbonyl]-2,3-dihydro-1,3,4-thiadiazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20131,877,Oxysterols receptor LXR-alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=877,Q13133,Oxysterols receptor LXR-alpha,10062.0,NR1H3,9606.0,Homo sapiens (human),,,,PMID:17665897|DOI:10.1021/jm070453f,https://www.ncbi.nlm.nih.gov/pubmed/17665897|https://doi.org/10.1021/jm070453f,17665897,10.1021/jm070453f,
5082,2014714,23643871,BindingDB,"Methanone, [5-(4-chlorophenyl)-2-(2,3-dimethoxyphenyl)-1,3,4-thiadiazol-3(2H)-yl](2,4,6-trifluorophenyl)-",20131,"5-(4-chlorophenyl)-2-(2,3-dimethoxyphenyl)-3-[(2,4,6-trifluorophenyl)carbonyl]-2,3-dihydro-1,3,4-thiadiazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20131,878,Oxysterols receptor LXR-beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=878,P55055,Oxysterols receptor LXR-beta,7376.0,NR1H2,9606.0,Homo sapiens (human),,,,PMID:17665897|DOI:10.1021/jm070453f,https://www.ncbi.nlm.nih.gov/pubmed/17665897|https://doi.org/10.1021/jm070453f,17665897,10.1021/jm070453f,
5083,2014715,23643871,BindingDB,"Methanone, [5-(4-chlorophenyl)-2-(2,3-dimethoxyphenyl)-1,3,4-thiadiazol-3(2H)-yl](2,4,6-trifluorophenyl)-",20131,"5-(4-chlorophenyl)-2-(2,3-dimethoxyphenyl)-3-[(2,4,6-trifluorophenyl)carbonyl]-2,3-dihydro-1,3,4-thiadiazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20131,877,Oxysterols receptor LXR-alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=877,Q13133,Oxysterols receptor LXR-alpha,10062.0,NR1H3,9606.0,Homo sapiens (human),,IC50 (nM),9800,PMID:17665897|DOI:10.1021/jm070453f,https://www.ncbi.nlm.nih.gov/pubmed/17665897|https://doi.org/10.1021/jm070453f,17665897,10.1021/jm070453f,
5084,2014737,23645352,BindingDB,Geneserine N-oxide,10963,"(1R,3aS,8aS)-1-hydroxy-1,3a,8-trimethyl-5-[(methylcarbamoyl)oxy]-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-1-ium chloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10963,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),660,PMID:12166941|DOI:10.1021/jm010491d,https://www.ncbi.nlm.nih.gov/pubmed/12166941|https://doi.org/10.1021/jm010491d,12166941,10.1021/jm010491d,
5085,2013059,23657507,IUPHAR/BPS Guide to PHARMACOLOGY,3-[[4-(5-Hydroxy-2-methylanilino)pyrimidin-2-yl]amino]benzenesulfonamide,8146,compound 23 [PMID: 17600705],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8146,2230,spleen associated tyrosine kinase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2230,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),Inhibition,pIC50,8.4,PMID:17600705,https://www.ncbi.nlm.nih.gov/pubmed/17600705,17600705,,
5086,2013234,23658378,BindingDB,3-[(2S)-2-ethoxypropyl]-2-sulfanylidene-7H-purin-6-one,119874,"3&#8208;[(2S)&#8208;2&#8208;ethoxypropyl]&#8208;2&#8208;sulfanylidene&#8208;1,9&#8208; dihydropurin&#8208;6&#8208;one (D)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=119874,5152,Myeloperoxidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5152,P05164,Myeloperoxidase,4353.0,MPO,9606.0,Homo sapiens (human),,Ki (nM),429,PMID:24320749|DOI:10.1021/bi401354d,https://www.ncbi.nlm.nih.gov/pubmed/24320749|https://doi.org/10.1021/bi401354d,24320749,10.1021/bi401354d,
5087,2013235,23658379,BindingDB,"3-[(2r)-2-Ethoxypropyl]-2-Thioxo-1,2,3,9-Tetrahydro-6h-Purin-6-One",119873,"3&#8208;[(2R)&#8208;2&#8208;ethoxypropyl]&#8208;2&#8208;sulfanylidene&#8208;1,9&#8208; dihydropurin&#8208;6&#8208;one (C)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=119873,5152,Myeloperoxidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5152,P05164,Myeloperoxidase,4353.0,MPO,9606.0,Homo sapiens (human),,Ki (nM),546,PMID:24320749|DOI:10.1021/bi401354d,https://www.ncbi.nlm.nih.gov/pubmed/24320749|https://doi.org/10.1021/bi401354d,24320749,10.1021/bi401354d,
5088,2013236,23658607,Drug Gene Interaction database (DGIdb),Remimazolam Besylate,,REMIMAZOLAM BESYLATE,https://www.dgidb.org/drugs/rxcui:2383942,,GABRB2,https://www.dgidb.org/genes/hgnc:4082,,,2561.0,GABRB2,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
5089,2013237,23658607,Drug Gene Interaction database (DGIdb),Remimazolam Besylate,,REMIMAZOLAM BESYLATE,https://www.dgidb.org/drugs/rxcui:2383942,,GABRA4,https://www.dgidb.org/genes/hgnc:4078,,,2557.0,GABRA4,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
5090,2013238,23658607,Drug Gene Interaction database (DGIdb),Remimazolam Besylate,,REMIMAZOLAM BESYLATE,https://www.dgidb.org/drugs/rxcui:2383942,,GABRD,https://www.dgidb.org/genes/hgnc:4084,,,2563.0,GABRD,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
5091,2013239,23658607,Drug Gene Interaction database (DGIdb),Remimazolam Besylate,,REMIMAZOLAM BESYLATE,https://www.dgidb.org/drugs/rxcui:2383942,,GABRA5,https://www.dgidb.org/genes/hgnc:4079,,,2558.0,GABRA5,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
5092,2013240,23658607,Drug Gene Interaction database (DGIdb),Remimazolam Besylate,,REMIMAZOLAM BESYLATE,https://www.dgidb.org/drugs/rxcui:2383942,,GABRA1,https://www.dgidb.org/genes/hgnc:4075,,,2554.0,GABRA1,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
5093,2013241,23663870,DrugBank,Sodium Oxybate,DB09072,Sodium oxybate,https://www.drugbank.ca/drugs/DB09072,BE0010194,Gamma-aminobutyric acid type B receptor subunit 1,https://www.drugbank.ca/bio_entities/BE0010194,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,2550.0,GABBR1,9606.0,Homo sapiens (human),Agonist,,,PMID:15538955|PMID:18536781,https://www.ncbi.nlm.nih.gov/pubmed/15538955|https://www.ncbi.nlm.nih.gov/pubmed/18536781,15538955|18536781,,
5094,2013242,23663870,DrugBank,Sodium Oxybate,DB09072,Sodium oxybate,https://www.drugbank.ca/drugs/DB09072,BE0010194,Gamma-aminobutyric acid type B receptor subunit 2,https://www.drugbank.ca/bio_entities/BE0010194,O75899,Gamma-aminobutyric acid type B receptor subunit 2,9568.0,GABBR2,9606.0,Homo sapiens (human),Agonist,,,PMID:15538955|PMID:18536781,https://www.ncbi.nlm.nih.gov/pubmed/15538955|https://www.ncbi.nlm.nih.gov/pubmed/18536781,15538955|18536781,,
5095,2013243,23663870,DrugBank,Sodium Oxybate,DB09072,Sodium oxybate,https://www.drugbank.ca/drugs/DB09072,BE0004841,"Solute carrier family 52, riboflavin transporter, member 2",https://www.drugbank.ca/bio_entities/BE0004841,Q9HAB3,"Solute carrier family 52, riboflavin transporter, member 2",79581.0,SLC52A2,9606.0,Homo sapiens (human),Agonist,,,PMID:17381187,https://www.ncbi.nlm.nih.gov/pubmed/17381187,17381187,,
5096,2013244,23663870,DrugBank,Sodium Oxybate,DB09072,Sodium oxybate,https://www.drugbank.ca/drugs/DB09072,BE0000152,"Succinate-semialdehyde dehydrogenase, mitochondrial",https://www.drugbank.ca/bio_entities/BE0000152,P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",7915.0,ALDH5A1,9606.0,Homo sapiens (human),Substrate,,,PMID:19300440,https://www.ncbi.nlm.nih.gov/pubmed/19300440,19300440,,
5097,2013245,23663870,DrugBank,Sodium Oxybate,DB09072,Sodium oxybate,https://www.drugbank.ca/drugs/DB09072,BE0008675,"Hydroxyacid-oxoacid transhydrogenase, mitochondrial",https://www.drugbank.ca/bio_entities/BE0008675,Q8IWW8,"Hydroxyacid-oxoacid transhydrogenase, mitochondrial",137872.0,ADHFE1,9606.0,Homo sapiens (human),Substrate,,,PMID:16435184,https://www.ncbi.nlm.nih.gov/pubmed/16435184,16435184,,
5098,2013246,23663870,DrugBank,Sodium Oxybate,DB09072,Sodium oxybate,https://www.drugbank.ca/drugs/DB09072,BE0000008,"NAD(P) transhydrogenase, mitochondrial",https://www.drugbank.ca/bio_entities/BE0000008,Q13423,"NAD(P) transhydrogenase, mitochondrial",23530.0,NNT,9606.0,Homo sapiens (human),Substrate,,,,,,,
5099,2013247,23663956,Therapeutic Target Database (TTD),Divalproex Sodium,D03LGY,Divalproex sodium,https://idrblab.net/ttd/data/drug/details/D03LGY,T59045,GABA transaminase (ABAT),https://idrblab.net/ttd/data/target/details/T59045,P80404,"4-aminobutyrate aminotransferase, mitochondrial",18.0,ABAT,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5100,2013060,23663959,Drug Gene Interaction database (DGIdb),Meclofenamate Sodium,,MECLOFENAMATE SODIUM,https://www.dgidb.org/drugs/rxcui:6677,,CYP2C9,https://www.dgidb.org/genes/hgnc:2623,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),,,,,,,,
5101,2013061,23663959,Drug Gene Interaction database (DGIdb),Meclofenamate Sodium,,MECLOFENAMATE SODIUM,https://www.dgidb.org/drugs/rxcui:6677,,HIF1A,https://www.dgidb.org/genes/hgnc:4910,,,3091.0,HIF1A,9606.0,Homo sapiens (human),,,,,,,,
5102,2013248,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),ABCB1 protein affects the export of cerivastatin,,,PMID:15901800,https://www.ncbi.nlm.nih.gov/pubmed/15901800,15901800,,
5103,2013249,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Cerivastatin inhibits the reaction [ABCB11 protein affects the import of taurocholic acid],,,PMID:15901796,https://www.ncbi.nlm.nih.gov/pubmed/15901796,15901796,,
5104,2013250,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Cerivastatin results in decreased activity of ABCB11 protein|cerivastatin inhibits the reaction [ABCB11 protein results in increased transport of taurocholic acid],,,PMID:24014644,https://www.ncbi.nlm.nih.gov/pubmed/24014644,24014644,,
5105,2013251,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606.0,Homo sapiens (human),ABCC2 protein affects the export of cerivastatin,,,PMID:15901800,https://www.ncbi.nlm.nih.gov/pubmed/15901800,15901800,,
5106,2013252,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),ABCG2 protein affects the export of cerivastatin,,,PMID:15901800,https://www.ncbi.nlm.nih.gov/pubmed/15901800,15901800,,
5107,2013253,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,650,BMP2,https://ctdbase.org/detail.go?type=gene&acc=650,,,650.0,BMP2,9606.0,Homo sapiens (human),Cerivastatin results in increased secretion of BMP2 protein,,,PMID:16470222,https://www.ncbi.nlm.nih.gov/pubmed/16470222,16470222,,
5108,2013254,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Cerivastatin results in increased activity of CASP3 protein,,,PMID:15705602|PMID:16470222,https://www.ncbi.nlm.nih.gov/pubmed/15705602|https://www.ncbi.nlm.nih.gov/pubmed/16470222,15705602|16470222,,
5109,2013255,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Geranylgeranyl pyrophosphate inhibits the reaction [cerivastatin results in increased activity of CASP3 protein]|mevalonic acid inhibits the reaction [cerivastatin results in increased activity of CASP3 protein],,,PMID:16470222,https://www.ncbi.nlm.nih.gov/pubmed/16470222,16470222,,
5110,2013274,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),Cerivastatin results in increased activity of CASP8 protein,,,PMID:15705602,https://www.ncbi.nlm.nih.gov/pubmed/15705602,15705602,,
5111,2013275,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Cerivastatin results in increased activity of CASP9 protein,,,PMID:15705602|PMID:16470222,https://www.ncbi.nlm.nih.gov/pubmed/15705602|https://www.ncbi.nlm.nih.gov/pubmed/16470222,15705602|16470222,,
5112,2013276,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Cerivastatin inhibits the reaction [TNF results in increased expression of CCL2 mrna]|cerivastatin results in decreased expression of CCL2 mrna|cerivastatin results in decreased expression of and results in decreased secretion of CCL2 protein|mevalonic acid inhibits the reaction [cerivastatin inhibits the reaction [TNF results in increased expression of CCL2 mrna]],,,PMID:12117737,https://www.ncbi.nlm.nih.gov/pubmed/12117737,12117737,,
5113,2013277,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Geranylgeranyl pyrophosphate inhibits the reaction [cerivastatin results in increased expression of cdkn1a]|cerivastatin results in increased expression of CDKN1A,,,PMID:11950701,https://www.ncbi.nlm.nih.gov/pubmed/11950701,11950701,,
5114,2013278,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Cerivastatin results in decreased expression of CXCL8 mrna|cerivastatin results in decreased expression of and results in decreased secretion of CXCL8 protein|mevalonic acid inhibits the reaction [cerivastatin inhibits the reaction [TNF results in increased expression of CXCL8 mrna]]|cerivastatin inhibits the reaction [TNF results in increased expression of CXCL8 mrna],,,PMID:12117737,https://www.ncbi.nlm.nih.gov/pubmed/12117737,12117737,,
5115,2013279,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606.0,Homo sapiens (human),Cerivastatin results in increased expression of CYP2B6 mRNA,,,PMID:15802384,https://www.ncbi.nlm.nih.gov/pubmed/15802384,15802384,,
5116,2013280,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,1558,CYP2C8,https://ctdbase.org/detail.go?type=gene&acc=1558,,,1558.0,CYP2C8,9606.0,Homo sapiens (human),CYP2C8 gene mutant form affects the susceptibility to cerivastatin,,,PMID:15365880,https://www.ncbi.nlm.nih.gov/pubmed/15365880,15365880,,
5117,2013281,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,1558,CYP2C8,https://ctdbase.org/detail.go?type=gene&acc=1558,,,1558.0,CYP2C8,9606.0,Homo sapiens (human),CYP2C8 protein results in increased metabolism of cerivastatin,,,PMID:12464242|PMID:15365880|PMID:15716363,https://www.ncbi.nlm.nih.gov/pubmed/12464242|https://www.ncbi.nlm.nih.gov/pubmed/15365880|https://www.ncbi.nlm.nih.gov/pubmed/15716363,12464242|15365880|15716363,,
5118,2013282,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),CYP3A4 protein results in increased metabolism of cerivastatin,,,PMID:15365880,https://www.ncbi.nlm.nih.gov/pubmed/15365880,15365880,,
5119,2013303,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),CYP3A4 protein results in increased metabolism of cerivastatin,,,PMID:12243603,https://www.ncbi.nlm.nih.gov/pubmed/12243603,12243603,,
5120,2013304,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,56616,DIABLO,https://ctdbase.org/detail.go?type=gene&acc=56616,,,56616.0,DIABLO,9606.0,Homo sapiens (human),Cerivastatin results in increased localization of DIABLO protein,,,PMID:15705602,https://www.ncbi.nlm.nih.gov/pubmed/15705602,15705602,,
5121,2013305,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,953,ENTPD1,https://ctdbase.org/detail.go?type=gene&acc=953,,,953.0,ENTPD1,9606.0,Homo sapiens (human),Cerivastatin inhibits the reaction [F2 protein results in decreased expression of ENTPD1 protein],,,PMID:12067895,https://www.ncbi.nlm.nih.gov/pubmed/12067895,12067895,,
5122,2013306,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,2147,F2,https://ctdbase.org/detail.go?type=gene&acc=2147,,,2147.0,F2,9606.0,Homo sapiens (human),Cerivastatin inhibits the reaction [F2 protein results in decreased expression of ENTPD1 protein],,,PMID:12067895,https://www.ncbi.nlm.nih.gov/pubmed/12067895,12067895,,
5123,2013307,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247.0,FGF2,10116.0,Rattus norvegicus (Norway rat),Cerivastatin results in decreased expression of FGF2 mrna|cerivastatin results in decreased expression of FGF2 protein,,,PMID:11479256,https://www.ncbi.nlm.nih.gov/pubmed/11479256,11479256,,
5124,2013308,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),Cerivastatin results in decreased activity of HMGCR protein,,,PMID:11950701|PMID:15802384,https://www.ncbi.nlm.nih.gov/pubmed/11950701|https://www.ncbi.nlm.nih.gov/pubmed/15802384,11950701|15802384,,
5125,2013309,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Cerivastatin inhibits the reaction [TNF results in increased expression of ICAM1],,,PMID:12615677,https://www.ncbi.nlm.nih.gov/pubmed/12615677,12615677,,
5126,2013310,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Cerivastatin results in decreased expression of IL1B,,,PMID:12878482,https://www.ncbi.nlm.nih.gov/pubmed/12878482,12878482,,
5127,2013311,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Cerivastatin results in decreased expression of and results in decreased secretion of IL6 protein|mevalonic acid inhibits the reaction [cerivastatin inhibits the reaction [TNF results in increased expression of IL6 mrna]]|cerivastatin results in decreased expression of IL6 mrna|cerivastatin inhibits the reaction [TNF results in increased expression of IL6 mrna],,,PMID:12117737,https://www.ncbi.nlm.nih.gov/pubmed/12117737,12117737,,
5128,2013312,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Cerivastatin results in decreased expression of IL6,,,PMID:11479256,https://www.ncbi.nlm.nih.gov/pubmed/11479256,11479256,,
5129,2013343,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,3683,ITGAL,https://ctdbase.org/detail.go?type=gene&acc=3683,,,3683.0,ITGAL,9606.0,Homo sapiens (human),Cerivastatin inhibits the reaction [TNF results in increased expression of ITGAL],,,PMID:12615677,https://www.ncbi.nlm.nih.gov/pubmed/12615677,12615677,,
5130,2013344,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,3689,ITGB2,https://ctdbase.org/detail.go?type=gene&acc=3689,,,3689.0,ITGB2,9606.0,Homo sapiens (human),Cerivastatin inhibits the reaction [TNF results in increased expression of ITGB2],,,PMID:12615677,https://www.ncbi.nlm.nih.gov/pubmed/12615677,12615677,,
5131,2013345,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,4151,MB,https://ctdbase.org/detail.go?type=gene&acc=4151,,,4151.0,MB,10116.0,Rattus norvegicus (Norway rat),Cerivastatin results in increased secretion of MB protein,,,PMID:19628585,https://www.ncbi.nlm.nih.gov/pubmed/19628585,19628585,,
5132,2013346,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),Cerivastatin results in increased activity of NR1I2 protein,,,PMID:15802384,https://www.ncbi.nlm.nih.gov/pubmed/15802384,15802384,,
5133,2013347,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),Cerivastatin results in decreased activity of NR1I3 protein alternative form,,,PMID:21778469,https://www.ncbi.nlm.nih.gov/pubmed/21778469,21778469,,
5134,2013348,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),Cerivastatin results in increased activity of NR1I3 protein,,,PMID:15802384,https://www.ncbi.nlm.nih.gov/pubmed/15802384,15802384,,
5135,2013349,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),Geranylgeraniol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|mevalonic acid inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|farnesol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|srebf1 protein inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|cholesterol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
5136,2013350,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,36992,RAB4,https://ctdbase.org/detail.go?type=gene&acc=36992,,,36992.0,Rab4,10116.0,Rattus norvegicus (Norway rat),Cerivastatin results in decreased prenylation of RAB4 protein,,,PMID:16239165,https://www.ncbi.nlm.nih.gov/pubmed/16239165,16239165,,
5137,2013351,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,5867,RAB4A,https://ctdbase.org/detail.go?type=gene&acc=5867,,,5867.0,RAB4A,10116.0,Rattus norvegicus (Norway rat),Cerivastatin affects the expression of RAB4A protein,,,PMID:16239165,https://www.ncbi.nlm.nih.gov/pubmed/16239165,16239165,,
5138,2013395,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,5906,RAP1A,https://ctdbase.org/detail.go?type=gene&acc=5906,,,5906.0,RAP1A,9606.0,Homo sapiens (human),Cerivastatin results in decreased geranoylation of RAP1A protein|mevalonic acid inhibits the reaction [cerivastatin results in decreased geranoylation of RAP1A protein],,,PMID:25578243,https://www.ncbi.nlm.nih.gov/pubmed/25578243,25578243,,
5139,2013396,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,9606.0,Homo sapiens (human),Cerivastatin results in decreased localization of RHOA protein,,,PMID:15705602,https://www.ncbi.nlm.nih.gov/pubmed/15705602,15705602,,
5140,2013397,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,9606.0,Homo sapiens (human),Cerivastatin results in increased localization of and results in decreased prenylation of RHOA protein,,,PMID:16470222,https://www.ncbi.nlm.nih.gov/pubmed/16470222,16470222,,
5141,2013398,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,9606.0,Homo sapiens (human),Geranylgeranyl pyrophosphate inhibits the reaction [cerivastatin results in decreased localization of RHOA protein]|cerivastatin results in decreased localization of RHOA protein,,,PMID:11950701,https://www.ncbi.nlm.nih.gov/pubmed/11950701,11950701,,
5142,2013399,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Geranylgeraniol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|mevalonic acid inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|farnesol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|srebf1 protein inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|cholesterol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
5143,2013400,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,10599,SLCO1B1,https://ctdbase.org/detail.go?type=gene&acc=10599,,,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of and results in increased susceptibility to cerivastatin]|slco1b1 protein results in increased uptake of and results in increased susceptibility to cerivastatin,,,PMID:23564645,https://www.ncbi.nlm.nih.gov/pubmed/23564645,23564645,,
5144,2013401,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,10599,SLCO1B1,https://ctdbase.org/detail.go?type=gene&acc=10599,,,10599.0,SLCO1B1,9606.0,Homo sapiens (human),SLCO1B1 gene SNP results in decreased transport of cerivastatin,,,PMID:15970799,https://www.ncbi.nlm.nih.gov/pubmed/15970799,15970799,,
5145,2013402,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,9606.0,Homo sapiens (human),SREBF1 protein inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
5146,2013403,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Cerivastatin inhibits the reaction [TNF results in increased expression of CCL2 mrna]|cerivastatin inhibits the reaction [TNF results in increased expression of IL6 mrna]|mevalonic acid inhibits the reaction [cerivastatin inhibits the reaction [TNF results in increased expression of IL6 mrna]]|mevalonic acid inhibits the reaction [cerivastatin inhibits the reaction [TNF results in increased expression of CXCL8 mrna]]|mevalonic acid inhibits the reaction [cerivastatin inhibits the reaction [TNF results in increased expression of CCL2 mrna]]|cerivastatin inhibits the reaction [TNF results in increased expression of CXCL8 mrna],,,PMID:12117737,https://www.ncbi.nlm.nih.gov/pubmed/12117737,12117737,,
5147,2013412,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Cerivastatin inhibits the reaction [TNF results in increased expression of icam1]|cerivastatin inhibits the reaction [TNF results in increased expression of itgal]|cerivastatin inhibits the reaction [TNF results in increased expression of ITGB2],,,PMID:12615677,https://www.ncbi.nlm.nih.gov/pubmed/12615677,12615677,,
5148,2013413,23663992,Comparative Toxicogenomics Database (CTD),Cerivastatin Sodium,C086276,cerivastatin,https://ctdbase.org/detail.go?type=chem&acc=C086276,7136,TNNI2,https://ctdbase.org/detail.go?type=gene&acc=7136,,,7136.0,TNNI2,10116.0,Rattus norvegicus (Norway rat),Cerivastatin results in increased secretion of TNNI2 protein,,,PMID:19628585,https://www.ncbi.nlm.nih.gov/pubmed/19628585,19628585,,
5149,2013062,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,CYP2C19,https://www.dgidb.org/genes/hgnc:2621,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,,,,,
5150,2013063,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,,,,,
5151,2013064,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
5152,2013414,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,GALNT17,https://www.dgidb.org/genes/hgnc:16347,,,64409.0,GALNT17,9606.0,Homo sapiens (human),,,,,,,,
5153,2013415,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,MLLT3,https://www.dgidb.org/genes/hgnc:7136,,,4300.0,MLLT3,9606.0,Homo sapiens (human),,,,,,,,
5154,2013416,23664709,Drug Gene Interaction database (DGIdb),Penicillin G Potassium,,PENICILLIN G POTASSIUM,https://www.dgidb.org/drugs/rxcui:203133,,HLA-B,https://www.dgidb.org/genes/hgnc:4932,,,3106.0,HLA-B,9606.0,Homo sapiens (human),,,,,,,,
5155,2013417,23665770,Therapeutic Target Database (TTD),Sodium tetradecyl sulfate,D0Z5SM,Sodium Tetradecyl Sulfate,https://idrblab.net/ttd/data/drug/details/D0Z5SM,T24836,Vitamin K-dependent protein C (PROC),https://idrblab.net/ttd/data/target/details/T24836,P04070,Vitamin K-dependent protein C,5624.0,PROC,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5156,2013065,23666105,Drug Gene Interaction database (DGIdb),Monopril,,FOSINOPRIL SODIUM,https://www.dgidb.org/drugs/rxcui:227278,,ACE,https://www.dgidb.org/genes/hgnc:2707,,,1636.0,ACE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5157,2013066,23666110,Drug Gene Interaction database (DGIdb),Liothyronine Sodium,,LIOTHYRONINE SODIUM,https://www.dgidb.org/drugs/rxcui:142448,,THRB,https://www.dgidb.org/genes/hgnc:11799,,,7068.0,THRB,9606.0,Homo sapiens (human),Agonist,,,,,,,
5158,2013046,23666711,ChEMBL,Cefmetazole Sodium,CHEMBL1201118,CEFMETAZOLE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201118/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3898066,https://www.ncbi.nlm.nih.gov/pubmed/3898066,3898066,,
5159,2013047,23666711,ChEMBL,Cefmetazole Sodium,CHEMBL1201118,CEFMETAZOLE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201118/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3898066,https://www.ncbi.nlm.nih.gov/pubmed/3898066,3898066,,
5160,2013067,23667642,Drug Gene Interaction database (DGIdb),Diclofenac Potassium,,DICLOFENAC POTASSIUM,https://www.dgidb.org/drugs/rxcui:81997,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5161,2013418,23668193,DrugBank,Sodium Nitrite,DB09112,Nitrous acid,https://www.drugbank.ca/drugs/DB09112,BE0000130,Hemoglobin subunit alpha,https://www.drugbank.ca/bio_entities/BE0000130,P69905,Hemoglobin subunit alpha,3040.0,HBA2,9606.0,Homo sapiens (human),Oxidizer,,,PMID:1569239,https://www.ncbi.nlm.nih.gov/pubmed/1569239,1569239,,
5162,2013419,23668193,DrugBank,Sodium Nitrite,DB09112,Nitrous acid,https://www.drugbank.ca/drugs/DB09112,BE0000629,Hemoglobin subunit beta,https://www.drugbank.ca/bio_entities/BE0000629,P68871,Hemoglobin subunit beta,3043.0,HBB,9606.0,Homo sapiens (human),Oxidizer,,,PMID:1569239,https://www.ncbi.nlm.nih.gov/pubmed/1569239,1569239,,
5163,2013420,23668193,DrugBank,Sodium Nitrite,DB09112,Nitrous acid,https://www.drugbank.ca/drugs/DB09112,BE0004467,Myoglobin,https://www.drugbank.ca/bio_entities/BE0004467,P02144,Myoglobin,4151.0,MB,9606.0,Homo sapiens (human),Oxidizer,,,PMID:1569239,https://www.ncbi.nlm.nih.gov/pubmed/1569239,1569239,,
5164,2013048,23668479,Drug Gene Interaction database (DGIdb),Raltegravir Potassium,,RALTEGRAVIR POTASSIUM,https://www.dgidb.org/drugs/rxcui:1235585,,ERVW-4,https://www.dgidb.org/genes/hgnc:39043,,,100616496.0,ERVW-4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5165,2013068,23668479,Drug Gene Interaction database (DGIdb),Raltegravir Potassium,,RALTEGRAVIR POTASSIUM,https://www.dgidb.org/drugs/rxcui:1235585,,UGT1A1,https://www.dgidb.org/genes/hgnc:12530,,,54658.0,UGT1A1,9606.0,Homo sapiens (human),,,,,,,,
5166,2013421,23668825,Therapeutic Target Database (TTD),Ethacrynate Sodium,D0W5UV,Ethacrynate Sodium,https://idrblab.net/ttd/data/drug/details/D0W5UV,T93878,Solute carrier family 12 member 1 (SLC12A1),https://idrblab.net/ttd/data/target/details/T93878,Q13621,Solute carrier family 12 member 1,6557.0,SLC12A1,9606.0,Homo sapiens (human),Modulator,,,,,,,
5167,2013041,23668834,ChEMBL,Penicillin G Sodium,CHEMBL1126,PENICILLIN G SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1126/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
5168,2013042,23668834,ChEMBL,Penicillin G Sodium,CHEMBL1126,PENICILLIN G SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1126/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
5169,2013043,23668834,ChEMBL,Penicillin G Sodium,CHEMBL1126,PENICILLIN G SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1126/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
5170,2013044,23668834,ChEMBL,Penicillin G Sodium,CHEMBL1126,PENICILLIN G SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1126/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
5171,2013045,23668834,ChEMBL,Penicillin G Sodium,CHEMBL1126,PENICILLIN G SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1126/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
5172,2013422,23669322,Drug Gene Interaction database (DGIdb),"Sodium 1,6,6-trimethyl-10,11-dioxo-6,7,8,9,10,11-hexahydrophenanthro[1,2-b]furan-2-sulfonate",,TANSHINONE IIA SULFONATE,https://www.dgidb.org/drugs/chembl:CHEMBL1473252,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
5173,2013423,23669322,Drug Gene Interaction database (DGIdb),"Sodium 1,6,6-trimethyl-10,11-dioxo-6,7,8,9,10,11-hexahydrophenanthro[1,2-b]furan-2-sulfonate",,TANSHINONE IIA SULFONATE,https://www.dgidb.org/drugs/chembl:CHEMBL1473252,,BRCA1,https://www.dgidb.org/genes/hgnc:1100,,,672.0,BRCA1,9606.0,Homo sapiens (human),,,,,,,,
5174,2013424,23669322,Drug Gene Interaction database (DGIdb),"Sodium 1,6,6-trimethyl-10,11-dioxo-6,7,8,9,10,11-hexahydrophenanthro[1,2-b]furan-2-sulfonate",,TANSHINONE IIA SULFONATE,https://www.dgidb.org/drugs/chembl:CHEMBL1473252,,VDR,https://www.dgidb.org/genes/hgnc:12679,,,7421.0,VDR,9606.0,Homo sapiens (human),,,,,,,,
5175,2013049,23670318,ChEMBL,Cefuroxime Sodium,CHEMBL2146124,CEFUROXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2146124/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7968655,https://www.ncbi.nlm.nih.gov/pubmed/7968655,7968655,,
5176,2013069,23670318,Drug Gene Interaction database (DGIdb),Cefuroxime Sodium,,CEFUROXIME SODIUM,https://www.dgidb.org/drugs/rxcui:204144,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
5177,2013074,23670318,ChEMBL,Cefuroxime Sodium,CHEMBL2146124,CEFUROXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2146124/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7968655,https://www.ncbi.nlm.nih.gov/pubmed/7968655,7968655,,
5178,2013075,23670318,ChEMBL,Cefuroxime Sodium,CHEMBL2146124,CEFUROXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2146124/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7968655,https://www.ncbi.nlm.nih.gov/pubmed/7968655,7968655,,
5179,2013076,23670318,ChEMBL,Cefuroxime Sodium,CHEMBL2146124,CEFUROXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2146124/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7968655,https://www.ncbi.nlm.nih.gov/pubmed/7968655,7968655,,
5180,2013124,23670318,ChEMBL,Cefuroxime Sodium,CHEMBL2146124,CEFUROXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2146124/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7968655,https://www.ncbi.nlm.nih.gov/pubmed/7968655,7968655,,
5181,2013125,23670318,ChEMBL,Cefuroxime Sodium,CHEMBL2146124,CEFUROXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2146124/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7968655,https://www.ncbi.nlm.nih.gov/pubmed/7968655,7968655,,
5182,2013126,23670318,ChEMBL,Cefuroxime Sodium,CHEMBL2146124,CEFUROXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2146124/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7968655,https://www.ncbi.nlm.nih.gov/pubmed/7968655,7968655,,
5183,2013070,23670447,Drug Gene Interaction database (DGIdb),"sodium (Z)-2-(1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[(3,4,5-trimethoxyphenyl)methyl]but-2-enoate",,ANACARDIC ACID,https://www.dgidb.org/drugs/iuphar.ligand:6999,,KAT5,https://www.dgidb.org/genes/hgnc:5275,,,10524.0,KAT5,9606.0,Homo sapiens (human),,,,,,,,
5184,2013071,23670447,IUPHAR/BPS Guide to PHARMACOLOGY,"sodium (Z)-2-(1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[(3,4,5-trimethoxyphenyl)methyl]but-2-enoate",999,PD-156707,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=999,219,ETA receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=219,P25101,Endothelin-1 receptor,1909.0,EDNRA,9606.0,Homo sapiens (human),Antagonist,pA2,8.1 - 9.2,PMID:10066864|PMID:9023329,https://www.ncbi.nlm.nih.gov/pubmed/10066864|https://www.ncbi.nlm.nih.gov/pubmed/9023329,10066864|9023329,,
5185,2013072,23670447,IUPHAR/BPS Guide to PHARMACOLOGY,"sodium (Z)-2-(1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[(3,4,5-trimethoxyphenyl)methyl]but-2-enoate",999,PD-156707,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=999,219,ETA receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=219,P25101,Endothelin-1 receptor,1909.0,EDNRA,9606.0,Homo sapiens (human),Antagonist,pKd,9 - 9.8,PMID:9023329,https://www.ncbi.nlm.nih.gov/pubmed/9023329,9023329,,
5186,2014193,23672568,Drug Gene Interaction database (DGIdb),Cefamandole sodium,,CEFAMANDOLE SODIUM,https://www.dgidb.org/drugs/ncit:C47967,,POLK,https://www.dgidb.org/genes/hgnc:9183,,,51426.0,POLK,9606.0,Homo sapiens (human),,,,,,,,
5187,2014194,23672568,Drug Gene Interaction database (DGIdb),Cefamandole sodium,,CEFAMANDOLE SODIUM,https://www.dgidb.org/drugs/ncit:C47967,,POLH,https://www.dgidb.org/genes/hgnc:9181,,,5429.0,POLH,9606.0,Homo sapiens (human),,,,,,,,
5188,2013077,23673837,Drug Gene Interaction database (DGIdb),Docusate Sodium,,DOCUSATE SODIUM,https://www.dgidb.org/drugs/rxcui:71722,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
5189,2014195,23674746,Drug Gene Interaction database (DGIdb),Fandosentan potassium,,FANDOSENTAN POTASSIUM,https://www.dgidb.org/drugs/ncit:C72774,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606.0,Homo sapiens (human),,,,,,,,
5190,2013078,23675312,ChEMBL,Cephapirin Sodium,CHEMBL1201043,CEPHAPIRIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201043/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5191,2013079,23675312,ChEMBL,Cephapirin Sodium,CHEMBL1201043,CEPHAPIRIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201043/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5192,2013080,23675312,ChEMBL,Cephapirin Sodium,CHEMBL1201043,CEPHAPIRIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201043/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5193,2013081,23675312,ChEMBL,Cephapirin Sodium,CHEMBL1201043,CEPHAPIRIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201043/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5194,2013082,23675321,ChEMBL,Cephalothin Sodium,CHEMBL1632,CEPHALOTHIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1632/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7626623,https://www.ncbi.nlm.nih.gov/pubmed/7626623,7626623,,
5195,2013083,23675321,ChEMBL,Cephalothin Sodium,CHEMBL1632,CEPHALOTHIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1632/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7626623,https://www.ncbi.nlm.nih.gov/pubmed/7626623,7626623,,
5196,2013093,23675321,ChEMBL,Cephalothin Sodium,CHEMBL1632,CEPHALOTHIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1632/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7626623,https://www.ncbi.nlm.nih.gov/pubmed/7626623,7626623,,
5197,2013094,23675321,ChEMBL,Cephalothin Sodium,CHEMBL1632,CEPHALOTHIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1632/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7626623,https://www.ncbi.nlm.nih.gov/pubmed/7626623,7626623,,
5198,2013095,23675321,ChEMBL,Cephalothin Sodium,CHEMBL1632,CEPHALOTHIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1632/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7626623,https://www.ncbi.nlm.nih.gov/pubmed/7626623,7626623,,
5199,2013096,23675321,ChEMBL,Cephalothin Sodium,CHEMBL1632,CEPHALOTHIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1632/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7626623,https://www.ncbi.nlm.nih.gov/pubmed/7626623,7626623,,
5200,2013097,23675321,ChEMBL,Cephalothin Sodium,CHEMBL1632,CEPHALOTHIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1632/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7626623,https://www.ncbi.nlm.nih.gov/pubmed/7626623,7626623,,
5201,2013098,23675322,ChEMBL,Cefazolin Sodium,CHEMBL1200523,CEFAZOLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200523/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2722720|PMID:3266730,https://www.ncbi.nlm.nih.gov/pubmed/2722720|https://www.ncbi.nlm.nih.gov/pubmed/3266730,2722720|3266730,,
5202,2013099,23675322,ChEMBL,Cefazolin Sodium,CHEMBL1200523,CEFAZOLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200523/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2722720|PMID:3266730,https://www.ncbi.nlm.nih.gov/pubmed/2722720|https://www.ncbi.nlm.nih.gov/pubmed/3266730,2722720|3266730,,
5203,2013100,23675322,ChEMBL,Cefazolin Sodium,CHEMBL1200523,CEFAZOLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200523/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2722720|PMID:3266730,https://www.ncbi.nlm.nih.gov/pubmed/2722720|https://www.ncbi.nlm.nih.gov/pubmed/3266730,2722720|3266730,,
5204,2013101,23675322,ChEMBL,Cefazolin Sodium,CHEMBL1200523,CEFAZOLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200523/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2722720|PMID:3266730,https://www.ncbi.nlm.nih.gov/pubmed/2722720|https://www.ncbi.nlm.nih.gov/pubmed/3266730,2722720|3266730,,
5205,2013111,23675322,ChEMBL,Cefazolin Sodium,CHEMBL1200523,CEFAZOLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200523/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2722720|PMID:3266730,https://www.ncbi.nlm.nih.gov/pubmed/2722720|https://www.ncbi.nlm.nih.gov/pubmed/3266730,2722720|3266730,,
5206,2013112,23675322,ChEMBL,Cefazolin Sodium,CHEMBL1200523,CEFAZOLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200523/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2722720|PMID:3266730,https://www.ncbi.nlm.nih.gov/pubmed/2722720|https://www.ncbi.nlm.nih.gov/pubmed/3266730,2722720|3266730,,
5207,2013113,23675322,ChEMBL,Cefazolin Sodium,CHEMBL1200523,CEFAZOLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200523/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2722720|PMID:3266730,https://www.ncbi.nlm.nih.gov/pubmed/2722720|https://www.ncbi.nlm.nih.gov/pubmed/3266730,2722720|3266730,,
5208,2013145,23675322,Comparative Toxicogenomics Database (CTD),Cefazolin Sodium,D002437,Cefazolin,https://ctdbase.org/detail.go?type=chem&acc=D002437,788,SLC25A20,https://ctdbase.org/detail.go?type=gene&acc=788,,,788.0,SLC25A20,10116.0,Rattus norvegicus (Norway rat),Cefazolin inhibits the reaction [SLC25A20 protein results in increased transport of carnitine]|cefazolin binds to and results in decreased activity of SLC25A20 protein,,,PMID:18452908,https://www.ncbi.nlm.nih.gov/pubmed/18452908,18452908,,
5209,2012921,23675456,Therapeutic Target Database (TTD),3-(6-(((3-Aminophenyl)sulfinyl)methyl)-3-((8-(4-methoxyphenyl)octyl)oxy)pyridin-2-yl)acrylic acid lithium salt,D04AWZ,SB-201146,https://idrblab.net/ttd/data/drug/details/D04AWZ,T59626,Leukotriene B4 receptor 1 (LTB4R),https://idrblab.net/ttd/data/target/details/T59626,Q15722,Leukotriene B4 receptor 1,1241.0,LTB4R,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5210,2014196,23675739,Drug Gene Interaction database (DGIdb),Acid Blue 129,,ACID BLUE 129,https://www.dgidb.org/drugs/chembl:CHEMBL133576,,ALDH1A1,https://www.dgidb.org/genes/hgnc:402,,,216.0,ALDH1A1,9606.0,Homo sapiens (human),,,,,,,,
5211,2014197,23675739,Drug Gene Interaction database (DGIdb),Acid Blue 129,,ACID BLUE 129,https://www.dgidb.org/drugs/chembl:CHEMBL133576,,RECQL,https://www.dgidb.org/genes/hgnc:9948,,,5965.0,RECQL,9606.0,Homo sapiens (human),,,,,,,,
5212,2013114,23675947,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-((7-chloro-2-quinoxalinyl)oxy)phenoxy)propionate,C118180,XK 469,https://ctdbase.org/detail.go?type=chem&acc=C118180,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,9606.0,Homo sapiens (human),AOX1 protein affects the metabolism of XK 469,,,PMID:20444863,https://www.ncbi.nlm.nih.gov/pubmed/20444863,20444863,,
5213,2013115,23675947,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-((7-chloro-2-quinoxalinyl)oxy)phenoxy)propionate,C118180,XK 469,https://ctdbase.org/detail.go?type=chem&acc=C118180,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,9606.0,Homo sapiens (human),XK 469 results in increased expression of CCNA2 protein,,,PMID:11774253,https://www.ncbi.nlm.nih.gov/pubmed/11774253,11774253,,
5214,2013116,23675947,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-((7-chloro-2-quinoxalinyl)oxy)phenoxy)propionate,C118180,XK 469,https://ctdbase.org/detail.go?type=chem&acc=C118180,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606.0,Homo sapiens (human),XK 469 results in decreased ubiquitination of and results in increased expression of CCNB1 protein,,,PMID:11774253,https://www.ncbi.nlm.nih.gov/pubmed/11774253,11774253,,
5215,2013117,23675947,Comparative Toxicogenomics Database (CTD),Sodium 2-(4-((7-chloro-2-quinoxalinyl)oxy)phenoxy)propionate,C118180,XK 469,https://ctdbase.org/detail.go?type=chem&acc=C118180,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),XK 469 results in increased expression of TP53 protein,,,PMID:11774253,https://www.ncbi.nlm.nih.gov/pubmed/11774253,11774253,,
5216,2013118,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,O00591,Gamma-aminobutyric acid receptor subunit pi,2568.0,GABRP,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5217,2013119,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,O14764,Gamma-aminobutyric acid receptor subunit delta,2563.0,GABRD,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5218,2013120,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5219,2013121,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P18505,Gamma-aminobutyric acid receptor subunit beta-1,2560.0,GABRB1,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5220,2013122,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5221,2013123,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P28472,Gamma-aminobutyric acid receptor subunit beta-3,2562.0,GABRB3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5222,2013127,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,2558.0,GABRA5,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5223,2013137,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5224,2013138,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5225,2013139,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P47870,Gamma-aminobutyric acid receptor subunit beta-2,2561.0,GABRB2,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5226,2013140,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,2557.0,GABRA4,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5227,2013141,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P78334,Gamma-aminobutyric acid receptor subunit epsilon,2564.0,GABRE,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5228,2013142,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,2559.0,GABRA6,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5229,2013143,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,2565.0,GABRG1,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5230,2013144,23676152,ChEMBL,Pentobarbital Sodium,CHEMBL971,PENTOBARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL971/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,2567.0,GABRG3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:8961191|PMID:11264449|PMID:23205959,https://www.ncbi.nlm.nih.gov/pubmed/8961191|https://www.ncbi.nlm.nih.gov/pubmed/11264449|https://www.ncbi.nlm.nih.gov/pubmed/23205959,8961191|11264449|23205959,,
5231,2013462,23676225,Therapeutic Target Database (TTD),Cenestin,D0N6YV,Cenestin,https://idrblab.net/ttd/data/drug/details/D0N6YV,T89534,Estrogen receptor (ESR),https://idrblab.net/ttd/data/target/details/T89534,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Agonist,,,,,,,
5232,2013825,23676503,ChEMBL,Carbenicillin Indanyl Sodium,CHEMBL1200991,CARBENICILLIN INDANYL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200991/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2112536|PMID:6821456|PMID:20974151,https://www.ncbi.nlm.nih.gov/pubmed/2112536|https://www.ncbi.nlm.nih.gov/pubmed/6821456|https://www.ncbi.nlm.nih.gov/pubmed/20974151,2112536|6821456|20974151,,
5233,2013463,23676736,Toxin and Toxin Target Database (T3DB),Trifloxysulfuron-sodium,T3D3940,Trifloxysulfuron-sodium,http://www.t3db.ca/toxins/T3D3940,BE0002433,Cytochrome P450 1A2,http://www.t3db.ca/biodb/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5234,2013464,23676736,Toxin and Toxin Target Database (T3DB),Trifloxysulfuron-sodium,T3D3940,Trifloxysulfuron-sodium,http://www.t3db.ca/toxins/T3D3940,BE0002638,Cytochrome P450 3A4,http://www.t3db.ca/biodb/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5235,2013465,23676736,Toxin and Toxin Target Database (T3DB),Trifloxysulfuron-sodium,T3D3940,Trifloxysulfuron-sodium,http://www.t3db.ca/toxins/T3D3940,BE0003549,Cytochrome P450 2B6,http://www.t3db.ca/biodb/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5236,2013886,23676736,Toxin and Toxin Target Database (T3DB),Trifloxysulfuron-sodium,T3D3940,Trifloxysulfuron-sodium,http://www.t3db.ca/toxins/T3D3940,BE0005460,Early activation antigen CD69,http://www.t3db.ca/biodb/bio_entities/BE0005460,Q07108,Early activation antigen CD69,969.0,CD69,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5237,2013890,23676736,Toxin and Toxin Target Database (T3DB),Trifloxysulfuron-sodium,T3D3940,Trifloxysulfuron-sodium,http://www.t3db.ca/toxins/T3D3940,BE0005459,ADP-ribosyl cyclase 1,http://www.t3db.ca/biodb/bio_entities/BE0005459,P28907,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,952.0,CD38,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5238,2013826,23676814,ChEMBL,Penicillin V Potassium,CHEMBL1200852,PENICILLIN V POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200852/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5239,2013827,23676814,ChEMBL,Penicillin V Potassium,CHEMBL1200852,PENICILLIN V POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200852/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5240,2013828,23676814,ChEMBL,Penicillin V Potassium,CHEMBL1200852,PENICILLIN V POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200852/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5241,2013829,23676814,ChEMBL,Penicillin V Potassium,CHEMBL1200852,PENICILLIN V POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200852/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5242,2013830,23676814,ChEMBL,Penicillin V Potassium,CHEMBL1200852,PENICILLIN V POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200852/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5243,2013831,23676814,ChEMBL,Penicillin V Potassium,CHEMBL1200852,PENICILLIN V POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200852/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5244,2013832,23676814,ChEMBL,Penicillin V Potassium,CHEMBL1200852,PENICILLIN V POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200852/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5245,2013146,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0001408,Tubulin beta-4A chain,http://www.t3db.ca/biodb/bio_entities/BE0001408,P04350,Tubulin beta-4A chain,10382.0,TUBB4A,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5246,2013147,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0001367,Tubulin beta-4B chain,http://www.t3db.ca/biodb/bio_entities/BE0001367,P68371,Tubulin beta-4B chain,10383.0,TUBB4B,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5247,2013148,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0003402,Tubulin beta-6 chain,http://www.t3db.ca/biodb/bio_entities/BE0003402,Q9BUF5,Tubulin beta-6 chain,84617.0,TUBB6,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5248,2013149,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0005038,Tubulin beta-8 chain,http://www.t3db.ca/biodb/bio_entities/BE0005038,Q3ZCM7,Tubulin beta-8 chain,347688.0,TUBB8,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5249,2013150,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0005087,Tubulin beta-8 chain-like protein LOC260334,http://www.t3db.ca/biodb/bio_entities/BE0005087,A6NNZ2,Tubulin beta 8B,,,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5250,2013151,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0005078,"Actin, gamma-enteric smooth muscle",http://www.t3db.ca/biodb/bio_entities/BE0005078,P63267,"Actin, gamma-enteric smooth muscle",72.0,ACTG2,9606.0,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
5251,2013152,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0005077,"Actin, alpha cardiac muscle 1",http://www.t3db.ca/biodb/bio_entities/BE0005077,P68032,"Actin, alpha cardiac muscle 1",70.0,ACTC1,9606.0,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
5252,2013153,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0002101,"Actin, alpha skeletal muscle",http://www.t3db.ca/biodb/bio_entities/BE0002101,P68133,"Actin, alpha skeletal muscle",58.0,ACTA1,9606.0,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
5253,2013163,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0005076,"Actin, aortic smooth muscle",http://www.t3db.ca/biodb/bio_entities/BE0005076,P62736,"Actin, aortic smooth muscle",59.0,ACTA2,9606.0,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
5254,2013164,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0004966,"Actin, cytoplasmic 1",http://www.t3db.ca/biodb/bio_entities/BE0004966,P60709,"Actin, cytoplasmic 1",60.0,ACTB,9606.0,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
5255,2013165,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0005013,"Actin, cytoplasmic 2",http://www.t3db.ca/biodb/bio_entities/BE0005013,P63261,"Actin, cytoplasmic 2",71.0,ACTG1,9606.0,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
5256,2013166,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0005051,DNA repair protein complementing XP-A cells,http://www.t3db.ca/biodb/bio_entities/BE0005051,P23025,DNA repair protein complementing XP-A cells,7507.0,XPA,9606.0,Homo sapiens (human),Arsenic binding of XPA is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5257,2013167,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0000065,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000065,P10515,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",1737.0,DLAT,9606.0,Homo sapiens (human),"Arsenic disrupts ATP production through several mechanisms. at the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1)",,,,,,,
5258,2013168,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Arsenic binds to the estrogen receptor. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5259,2013169,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0000794,Glucocorticoid receptor,http://www.t3db.ca/biodb/bio_entities/BE0000794,P04150,Glucocorticoid receptor,2908.0,NR3C1,9606.0,Homo sapiens (human),Arsenic binds to the glucocorticoid receptor. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5260,2013170,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0000648,"Glutathione reductase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000648,P00390,"Glutathione reductase, mitochondrial",2936.0,GSR,9606.0,Homo sapiens (human),"Arsenic binds glutathione reductase, which results in the inhibition of essential biochemical reactions, alteration of cellular redox status, and eventual cytotoxicity. (L2)",,,,,,,
5261,2013171,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0005035,Haptoglobin,http://www.t3db.ca/biodb/bio_entities/BE0005035,P00738,Haptoglobin,3240.0,HP,9606.0,Homo sapiens (human),Arsenic binds to haptoglobin. (A15),,,PMID:18247522,https://www.ncbi.nlm.nih.gov/pubmed/18247522,18247522,,
5262,2013181,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0000130,Hemoglobin subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0000130,P69905,Hemoglobin subunit alpha,3040.0,HBA2,9606.0,Homo sapiens (human),Arsenic binds to hemoglobin. (A15),,,PMID:18247522,https://www.ncbi.nlm.nih.gov/pubmed/18247522,18247522,,
5263,2013182,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0000629,Hemoglobin subunit beta,http://www.t3db.ca/biodb/bio_entities/BE0000629,P68871,Hemoglobin subunit beta,3043.0,HBB,9606.0,Homo sapiens (human),Arsenic binds to hemoglobin. (A15),,,PMID:18247522,https://www.ncbi.nlm.nih.gov/pubmed/18247522,18247522,,
5264,2013183,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0004756,Kelch-like ECH-associated protein 1,http://www.t3db.ca/biodb/bio_entities/BE0004756,Q14145,Kelch-like ECH-associated protein 1,9817.0,KEAP1,9606.0,Homo sapiens (human),Arsenic binds to kelch-like ECH-associated protein 1. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5265,2013184,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142.0,PARP1,9606.0,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5266,2013185,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0003398,Putative tubulin-like protein alpha-4B,http://www.t3db.ca/biodb/bio_entities/BE0003398,Q9H853,Putative tubulin-like protein alpha-4B,,,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5267,2013186,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0000571,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000571,P08559,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",5160.0,PDHA1,9606.0,Homo sapiens (human),"Arsenic disrupts ATP production through several mechanisms. at the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1)",,,,,,,
5268,2013187,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0000609,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000609,P29803,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial",5161.0,PDHA2,9606.0,Homo sapiens (human),"Arsenic disrupts ATP production through several mechanisms. at the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1)",,,,,,,
5269,2013188,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0000098,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000098,P11177,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",5162.0,PDHB,9606.0,Homo sapiens (human),"Arsenic disrupts ATP production through several mechanisms. at the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1)",,,,,,,
5270,2013198,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0005052,"Pyruvate dehydrogenase protein X component, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005052,O00330,"Pyruvate dehydrogenase protein X component, mitochondrial",8050.0,PDHX,9606.0,Homo sapiens (human),"Arsenic disrupts ATP production through several mechanisms. at the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1)",,,,,,,
5271,2013199,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0001979,"Thioredoxin reductase 1, cytoplasmic",http://www.t3db.ca/biodb/bio_entities/BE0001979,Q16881,"Thioredoxin reductase 1, cytoplasmic",7296.0,TXNRD1,9606.0,Homo sapiens (human),"Arsenic binds thioredoxin reductase, which results in the inhibition of essential biochemical reactions, alteration of cellular redox status, and eventual cytotoxicity. (L2)",,,,,,,
5272,2013200,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0003388,"Thioredoxin reductase 2, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003388,Q9NNW7,"Thioredoxin reductase 2, mitochondrial",10587.0,TXNRD2,9606.0,Homo sapiens (human),"Arsenic binds thioredoxin reductase, which results in the inhibition of essential biochemical reactions, alteration of cellular redox status, and eventual cytotoxicity. (L2)",,,,,,,
5273,2013201,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0004992,Thioredoxin reductase 3,http://www.t3db.ca/biodb/bio_entities/BE0004992,Q86VQ6,Thioredoxin reductase 3,114112.0,TXNRD3,9606.0,Homo sapiens (human),"Arsenic binds thioredoxin reductase, which results in the inhibition of essential biochemical reactions, alteration of cellular redox status, and eventual cytotoxicity. (L2)",,,,,,,
5274,2013202,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0005086,Tubulin alpha chain-like 3,http://www.t3db.ca/biodb/bio_entities/BE0005086,A6NHL2,Tubulin alpha chain-like 3,79861.0,TUBAL3,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5275,2013203,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0001340,Tubulin alpha-1A chain,http://www.t3db.ca/biodb/bio_entities/BE0001340,Q71U36,Tubulin alpha-1A chain,7846.0,TUBA1A,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5276,2013204,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0001275,Tubulin alpha-1B chain,http://www.t3db.ca/biodb/bio_entities/BE0001275,P68363,Tubulin alpha-1B chain,10376.0,TUBA1B,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5277,2013205,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0001388,Tubulin alpha-1C chain,http://www.t3db.ca/biodb/bio_entities/BE0001388,Q9BQE3,Tubulin alpha-1C chain,84790.0,TUBA1C,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5278,2013206,23677060,Toxin and Toxin Target Database (T3DB),Sodium dihydrogen arsenate,T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0001425,Tubulin alpha-3C/D chain,http://www.t3db.ca/biodb/bio_entities/BE0001425,Q13748,RecName: Full=Tubulin alpha-3C/D chain; AltName: Full=Alpha-tubulin 2; AltName: Full=Alpha-tubulin 3C/D; AltName: Full=Tubulin alpha-2 chain; Contains: RecName: Full=Detyrosinated tubulin alpha-3C/D chain,113457.0,TUBA3D,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
5279,2013833,23677832,ChEMBL,Triclofos Sodium,CHEMBL1200789,TRICLOFOS SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200789/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,O00591,Gamma-aminobutyric acid receptor subunit pi,2568.0,GABRP,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive modulator,,,PMID:14302355,https://www.ncbi.nlm.nih.gov/pubmed/14302355,14302355,,
5280,2013834,23677832,ChEMBL,Triclofos Sodium,CHEMBL1200789,TRICLOFOS SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200789/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,O14764,Gamma-aminobutyric acid receptor subunit delta,2563.0,GABRD,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive modulator,,,PMID:14302355,https://www.ncbi.nlm.nih.gov/pubmed/14302355,14302355,,
5281,2013835,23677832,ChEMBL,Triclofos Sodium,CHEMBL1200789,TRICLOFOS SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200789/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive modulator,,,PMID:14302355,https://www.ncbi.nlm.nih.gov/pubmed/14302355,14302355,,
5282,2013844,23677832,ChEMBL,Triclofos Sodium,CHEMBL1200789,TRICLOFOS SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200789/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P78334,Gamma-aminobutyric acid receptor subunit epsilon,2564.0,GABRE,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive modulator,,,PMID:14302355,https://www.ncbi.nlm.nih.gov/pubmed/14302355,14302355,,
5283,2013872,23677961,ChEMBL,Dextrothyroxine Sodium,CHEMBL3545058,DEXTROTHYROXINE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545058/,CHEMBL2111462,Thyroid hormone receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111462/,P10828,Thyroid hormone receptor beta,7068.0,THRB,9606.0,Homo sapiens (human),Thyroid hormone receptor agonist,,,PMID:9440092|PMID:20935564,https://www.ncbi.nlm.nih.gov/pubmed/9440092|https://www.ncbi.nlm.nih.gov/pubmed/20935564,9440092|20935564,,
5284,2013873,23680530,Comparative Toxicogenomics Database (CTD),Methylprednisolone Sodium Succinate,D008776,Methylprednisolone Hemisuccinate,https://ctdbase.org/detail.go?type=chem&acc=D008776,8824,CES2,https://ctdbase.org/detail.go?type=gene&acc=8824,,,8824.0,CES2,10116.0,Rattus norvegicus (Norway rat),Dexamethasone promotes the reaction [CES2 protein results in increased hydrolysis of methylprednisolone hemisuccinate]|ces2 protein results in increased hydrolysis of methylprednisolone hemisuccinate,,,PMID:15794950,https://www.ncbi.nlm.nih.gov/pubmed/15794950,15794950,,
5285,2013874,23681059,ChEMBL,Naproxen Sodium,CHEMBL1200806,NAPROXEN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200806/,CHEMBL2094253,Cyclooxygenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094253/,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606.0,Homo sapiens (human),Cyclooxygenase inhibitor,,,PMID:17521299|PMID:17604186|PMID:17607546|PMID:17612049,https://www.ncbi.nlm.nih.gov/pubmed/17521299|https://www.ncbi.nlm.nih.gov/pubmed/17604186|https://www.ncbi.nlm.nih.gov/pubmed/17607546|https://www.ncbi.nlm.nih.gov/pubmed/17612049,17521299|17604186|17607546|17612049,,
5286,2013466,23681107,Drug Gene Interaction database (DGIdb),Alendronate Sodium,,ALENDRONATE SODIUM,https://www.dgidb.org/drugs/rxcui:203152,,VDR,https://www.dgidb.org/genes/hgnc:12679,,,7421.0,VDR,9606.0,Homo sapiens (human),,,,,,,,
5287,2013467,23682187,Toxin and Toxin Target Database (T3DB),Pyrithiobac-sodium,T3D3917,Pyrithiobac-sodium,http://www.t3db.ca/toxins/T3D3917,BE0000956,Nuclear receptor subfamily 1 group I member 2,http://www.t3db.ca/biodb/bio_entities/BE0000956,O75469,Nuclear receptor subfamily 1 group I member 2,8856.0,NR1I2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5288,2013468,23682187,Toxin and Toxin Target Database (T3DB),Pyrithiobac-sodium,T3D3917,Pyrithiobac-sodium,http://www.t3db.ca/toxins/T3D3917,BE0001004,Solute carrier organic anion transporter family member 1B1,http://www.t3db.ca/biodb/bio_entities/BE0001004,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5289,2013469,23682187,Toxin and Toxin Target Database (T3DB),Pyrithiobac-sodium,T3D3917,Pyrithiobac-sodium,http://www.t3db.ca/toxins/T3D3917,BE0005481,"Hydroxymethylglutaryl-CoA synthase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005481,P54868,"Hydroxymethylglutaryl-CoA synthase, mitochondrial",3158.0,HMGCS2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5290,2013470,23682187,Toxin and Toxin Target Database (T3DB),Pyrithiobac-sodium,T3D3917,Pyrithiobac-sodium,http://www.t3db.ca/toxins/T3D3917,BE0003549,Cytochrome P450 2B6,http://www.t3db.ca/biodb/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5291,2013471,23682187,Toxin and Toxin Target Database (T3DB),Pyrithiobac-sodium,T3D3917,Pyrithiobac-sodium,http://www.t3db.ca/toxins/T3D3917,BE0005459,ADP-ribosyl cyclase 1,http://www.t3db.ca/biodb/bio_entities/BE0005459,P28907,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,952.0,CD38,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5292,2013472,23682187,Toxin and Toxin Target Database (T3DB),Pyrithiobac-sodium,T3D3917,Pyrithiobac-sodium,http://www.t3db.ca/toxins/T3D3917,BE0001114,Vascular cell adhesion protein 1,http://www.t3db.ca/biodb/bio_entities/BE0001114,P19320,Vascular cell adhesion protein 1,7412.0,VCAM1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5293,2013885,23682187,Toxin and Toxin Target Database (T3DB),Pyrithiobac-sodium,T3D3917,Pyrithiobac-sodium,http://www.t3db.ca/toxins/T3D3917,BE0000886,Bile salt sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000886,Q06520,Sulfotransferase 2A1,6822.0,SULT2A1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5294,2014160,23685177,ChEMBL,Mezlocillin sodium,CHEMBL1697708,MEZLOCILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697708/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2683579|PMID:6220263,https://www.ncbi.nlm.nih.gov/pubmed/2683579|https://www.ncbi.nlm.nih.gov/pubmed/6220263,2683579|6220263,,
5295,2014161,23685177,ChEMBL,Mezlocillin sodium,CHEMBL1697708,MEZLOCILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697708/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2683579|PMID:6220263,https://www.ncbi.nlm.nih.gov/pubmed/2683579|https://www.ncbi.nlm.nih.gov/pubmed/6220263,2683579|6220263,,
5296,2014162,23685177,ChEMBL,Mezlocillin sodium,CHEMBL1697708,MEZLOCILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697708/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2683579|PMID:6220263,https://www.ncbi.nlm.nih.gov/pubmed/2683579|https://www.ncbi.nlm.nih.gov/pubmed/6220263,2683579|6220263,,
5297,2014163,23685177,ChEMBL,Mezlocillin sodium,CHEMBL1697708,MEZLOCILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697708/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2683579|PMID:6220263,https://www.ncbi.nlm.nih.gov/pubmed/2683579|https://www.ncbi.nlm.nih.gov/pubmed/6220263,2683579|6220263,,
5298,2014164,23685177,ChEMBL,Mezlocillin sodium,CHEMBL1697708,MEZLOCILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697708/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2683579|PMID:6220263,https://www.ncbi.nlm.nih.gov/pubmed/2683579|https://www.ncbi.nlm.nih.gov/pubmed/6220263,2683579|6220263,,
5299,2014165,23685177,ChEMBL,Mezlocillin sodium,CHEMBL1697708,MEZLOCILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697708/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2683579|PMID:6220263,https://www.ncbi.nlm.nih.gov/pubmed/2683579|https://www.ncbi.nlm.nih.gov/pubmed/6220263,2683579|6220263,,
5300,2014166,23685177,ChEMBL,Mezlocillin sodium,CHEMBL1697708,MEZLOCILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1697708/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2683579|PMID:6220263,https://www.ncbi.nlm.nih.gov/pubmed/2683579|https://www.ncbi.nlm.nih.gov/pubmed/6220263,2683579|6220263,,
5301,2013891,23690206,Comparative Toxicogenomics Database (CTD),Sodium scymnol sulfate,C059448,scymnol sulfate ester,https://ctdbase.org/detail.go?type=chem&acc=C059448,381463,NR1H5,https://ctdbase.org/detail.go?type=gene&acc=381463,,,381463.0,Nr1h5,7782.0,Leucoraja erinacea (little skate),Scymnol sulfate ester results in increased activity of NR1H5 protein,,,PMID:17567710,https://www.ncbi.nlm.nih.gov/pubmed/17567710,17567710,,
5302,2013073,23690315,Drug Gene Interaction database (DGIdb),Ibuprofen sodium dihydrate,,"IBUPROFEN, SODIUM SALT",https://www.dgidb.org/drugs/rxcui:1429044,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5303,2013883,23690315,Drug Gene Interaction database (DGIdb),Ibuprofen sodium dihydrate,,"IBUPROFEN, SODIUM SALT",https://www.dgidb.org/drugs/rxcui:1429044,,HPGD,https://www.dgidb.org/genes/hgnc:5154,,,3248.0,HPGD,9606.0,Homo sapiens (human),,,,,,,,
5304,2013884,23690315,ChEMBL,Ibuprofen sodium dihydrate,CHEMBL3989408,IBUPROFEN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989408/,CHEMBL2094253,Cyclooxygenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094253/,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606.0,Homo sapiens (human),Cyclooxygenase inhibitor,,,,,,,
5305,2013887,23690315,Drug Gene Interaction database (DGIdb),Ibuprofen sodium dihydrate,,"IBUPROFEN, SODIUM SALT",https://www.dgidb.org/drugs/rxcui:1429044,,APC,https://www.dgidb.org/genes/hgnc:583,,,324.0,APC,9606.0,Homo sapiens (human),,,,,,,,
5306,2014167,23690315,Drug Gene Interaction database (DGIdb),Ibuprofen sodium dihydrate,,"IBUPROFEN, SODIUM SALT",https://www.dgidb.org/drugs/rxcui:1429044,,CXCR2,https://www.dgidb.org/genes/hgnc:6027,,,3579.0,CXCR2,9606.0,Homo sapiens (human),,,,,,,,
5307,2014168,23690315,Drug Gene Interaction database (DGIdb),Ibuprofen sodium dihydrate,,"IBUPROFEN, SODIUM SALT",https://www.dgidb.org/drugs/rxcui:1429044,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606.0,Homo sapiens (human),,,,,,,,
5308,2013888,23690433,Therapeutic Target Database (TTD),Thyroid,D03TPR,Dextrothyroxine Sodium,https://idrblab.net/ttd/data/drug/details/D03TPR,T79591,Thyroid hormone receptor alpha (THRA),https://idrblab.net/ttd/data/target/details/T79591,P10827,Thyroid hormone receptor alpha,7067.0,THRA,9606.0,Homo sapiens (human),Modulator,,,,,,,
5309,2013889,23690433,Therapeutic Target Database (TTD),Thyroid,D03TPR,Dextrothyroxine Sodium,https://idrblab.net/ttd/data/drug/details/D03TPR,T98933,Thyroid hormone receptor beta (THRB),https://idrblab.net/ttd/data/target/details/T98933,P10828,Thyroid hormone receptor beta,7068.0,THRB,9606.0,Homo sapiens (human),Modulator,,,,,,,
5310,2014169,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,O00591,Gamma-aminobutyric acid receptor subunit pi,2568.0,GABRP,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5311,2014170,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,O14764,Gamma-aminobutyric acid receptor subunit delta,2563.0,GABRD,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5312,2014171,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5313,2014172,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P18505,Gamma-aminobutyric acid receptor subunit beta-1,2560.0,GABRB1,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5314,2014173,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5315,2014174,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P28472,Gamma-aminobutyric acid receptor subunit beta-3,2562.0,GABRB3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5316,2014175,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,2558.0,GABRA5,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5317,2014176,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5318,2014177,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5319,2014178,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P47870,Gamma-aminobutyric acid receptor subunit beta-2,2561.0,GABRB2,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5320,2014179,23690443,ChEMBL,Methohexital Sodium,CHEMBL30219,METHOHEXITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL30219/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,2557.0,GABRA4,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/11264449,11264449,,
5321,2014427,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,O14764,Gamma-aminobutyric acid receptor subunit delta,2563.0,GABRD,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5322,2014428,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5323,2014429,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P18505,Gamma-aminobutyric acid receptor subunit beta-1,2560.0,GABRB1,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5324,2014430,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5325,2014431,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P28472,Gamma-aminobutyric acid receptor subunit beta-3,2562.0,GABRB3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5326,2014432,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,2558.0,GABRA5,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5327,2014433,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5328,2014434,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5329,2014435,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P47870,Gamma-aminobutyric acid receptor subunit beta-2,2561.0,GABRB2,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5330,2014436,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,2557.0,GABRA4,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5331,2014437,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,P78334,Gamma-aminobutyric acid receptor subunit epsilon,2564.0,GABRE,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5332,2014506,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,2567.0,GABRG3,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5333,2014507,23695352,ChEMBL,"Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt",CHEMBL1200982,BUTABARBITAL SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200982/,CHEMBL2093872,GABA-A receptor; anion channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093872/,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,55879.0,GABRQ,9606.0,Homo sapiens (human),GABA-A receptor; anion channel positive allosteric modulator,,,PMID:10209232|PMID:11264449,https://www.ncbi.nlm.nih.gov/pubmed/10209232|https://www.ncbi.nlm.nih.gov/pubmed/11264449,10209232|11264449,,
5334,2014546,23695542,Comparative Toxicogenomics Database (CTD),Sodium hexadecyl sulfate,C002211,cetyl sulfate,https://ctdbase.org/detail.go?type=chem&acc=C002211,389434,IYD,https://ctdbase.org/detail.go?type=gene&acc=389434,,,389434.0,IYD,9606.0,Homo sapiens (human),Cetyl sulfate inhibits the reaction [IYD protein results in increased metabolism of monoiodotyrosine],,,PMID:33352258,https://www.ncbi.nlm.nih.gov/pubmed/33352258,33352258,,
5335,2014508,23702958,Drug Gene Interaction database (DGIdb),8-Bromo-cAMP sodium salt,,CHEMBL:CHEMBL1256796,https://www.dgidb.org/drugs/chembl:CHEMBL1256796,,RAPGEF3,https://www.dgidb.org/genes/hgnc:16629,,,10411.0,RAPGEF3,9606.0,Homo sapiens (human),,,,,,,,
5336,2014509,23702958,Drug Gene Interaction database (DGIdb),8-Bromo-cAMP sodium salt,,CHEMBL:CHEMBL1256796,https://www.dgidb.org/drugs/chembl:CHEMBL1256796,,RAPGEF4,https://www.dgidb.org/genes/hgnc:16626,,,11069.0,RAPGEF4,9606.0,Homo sapiens (human),,,,,,,,
5337,2013892,23709079,Therapeutic Target Database (TTD),Trexima,D07NJI,Treximet,https://idrblab.net/ttd/data/drug/details/D07NJI,T78709,5-HT 1A receptor (HTR1A),https://idrblab.net/ttd/data/target/details/T78709,P08908,5-hydroxytryptamine receptor 1A,3350.0,HTR1A,9606.0,Homo sapiens (human),Antagonist,,,,,,,
5338,2014510,23721821,ChEMBL,Invanz,CHEMBL1232,ERTAPENEM SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1232/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5339,2014511,23721821,ChEMBL,Invanz,CHEMBL1232,ERTAPENEM SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1232/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5340,2014512,23721821,ChEMBL,Invanz,CHEMBL1232,ERTAPENEM SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1232/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5341,2014513,23721821,ChEMBL,Invanz,CHEMBL1232,ERTAPENEM SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1232/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5342,2014514,23721821,ChEMBL,Invanz,CHEMBL1232,ERTAPENEM SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1232/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
5343,2014460,23724263,Drug Gene Interaction database (DGIdb),2-[(4-Benzhydrylpiperazin-1-yl)methyl]-6-methoxyphenol;oxalic acid,,CHEMBL:CHEMBL587092,https://www.dgidb.org/drugs/chembl:CHEMBL587092,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
5344,2014461,23724914,Drug Gene Interaction database (DGIdb),Ganirelix Acetate,,GANIRELIX ACETATE,https://www.dgidb.org/drugs/rxcui:259264,,GNRHR,https://www.dgidb.org/genes/hgnc:4421,,,2798.0,GNRHR,9606.0,Homo sapiens (human),,,,,,,,
5345,2014462,23724940,DrugBank,Liothyronine I-131,DB12425,Liothyronine I-131,https://www.drugbank.ca/drugs/DB12425,BE0000537,Thyroxine-binding globulin,https://www.drugbank.ca/bio_entities/BE0000537,P05543,Thyroxine-binding globulin,6906.0,SERPINA7,9606.0,Homo sapiens (human),Substrate,,,,,,,
5346,2014569,23725028,Therapeutic Target Database (TTD),Stannsoporfin,D02JAY,Stannsoporfin,https://idrblab.net/ttd/data/drug/details/D02JAY,T25703,Heme oxygenase 1 (HMOX1),https://idrblab.net/ttd/data/target/details/T25703,P09601,Heme oxygenase 1,3162.0,HMOX1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5347,2013893,23725095,Drug Gene Interaction database (DGIdb),"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",,TEZAMPANEL,https://www.dgidb.org/drugs/ncit:C77316,,GRIA1,https://www.dgidb.org/genes/hgnc:4571,,,2890.0,GRIA1,9606.0,Homo sapiens (human),,,,,,,,
5348,2014463,23725095,Drug Gene Interaction database (DGIdb),"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",,TEZAMPANEL,https://www.dgidb.org/drugs/ncit:C77316,,GRIA3,https://www.dgidb.org/genes/hgnc:4573,,,2892.0,GRIA3,9606.0,Homo sapiens (human),,,,,,,,
5349,2013907,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,ATM,https://www.dgidb.org/genes/hgnc:795,,,472.0,ATM,9606.0,Homo sapiens (human),,,,,,,,
5350,2013908,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,RAD54L,https://www.dgidb.org/genes/hgnc:9826,,,8438.0,RAD54L,9606.0,Homo sapiens (human),,,,,,,,
5351,2013909,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PIK3CA,https://www.dgidb.org/genes/hgnc:8975,,,5290.0,PIK3CA,9606.0,Homo sapiens (human),,,,,,,,
5352,2013910,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,RAD51B,https://www.dgidb.org/genes/hgnc:9822,,,5890.0,RAD51B,9606.0,Homo sapiens (human),,,,,,,,
5353,2013911,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142.0,PARP1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5354,2013912,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PARP2,https://www.dgidb.org/genes/hgnc:272,,,10038.0,PARP2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5355,2014464,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,FANCL,https://www.dgidb.org/genes/hgnc:20748,,,55120.0,FANCL,9606.0,Homo sapiens (human),,,,,,,,
5356,2014570,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,BRCA1,https://www.dgidb.org/genes/hgnc:1100,,,672.0,BRCA1,9606.0,Homo sapiens (human),,,,,,,,
5357,2014571,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,CHEK2,https://www.dgidb.org/genes/hgnc:16627,,,11200.0,CHEK2,9606.0,Homo sapiens (human),,,,,,,,
5358,2014465,23725699,Therapeutic Target Database (TTD),(5-Chloro-6-((6-methylpyridin-3-yl)amino)pyridin-3-yl)-((2R)-2-ethylpiperidin-1-yl)methanone,D0DX6U,PMID19931453C16m,https://idrblab.net/ttd/data/drug/details/D0DX6U,T99347,Metabotropic glutamate receptor 5 (mGluR5),https://idrblab.net/ttd/data/target/details/T99347,P41594,Metabotropic glutamate receptor 5,2915.0,GRM5,9606.0,Homo sapiens (human),Modulator (allosteric modulator),,,,,,,
5359,2014539,23728722,Chemical Probes Portal,"5-[(6r)-5-Ethanoyl-4-Methyl-2-Oxidanylidene-3-[3-(Trifluoromethyl)phenyl]-1,6-Dihydropyrimidin-6-Yl]pyridine-2-Carbonitrile",BAY-678,BAY-678,https://www.chemicalprobes.org/bay-678,,ELANE,,P08246,Neutrophil elastase,1991.0,ELANE,9606.0,Homo sapiens (human),Inhibitor,,"20 nM, 15 nM",,,,,
5360,2012915,23729157,Drug Gene Interaction database (DGIdb),Tirasemtiv,,TIRASEMTIV,https://www.dgidb.org/drugs/ncit:C152657,,TNNT3,https://www.dgidb.org/genes/hgnc:11950,,,7140.0,TNNT3,9606.0,Homo sapiens (human),Activator,,,,,,,
5361,2014572,23729157,Therapeutic Target Database (TTD),Tirasemtiv,D07EBF,CK-2017357,https://idrblab.net/ttd/data/drug/details/D07EBF,T00419,Fast skeletal muscle troponin complex (TNNC2),https://idrblab.net/ttd/data/target/details/T00419,P02585,"Troponin C, skeletal muscle",7125.0,TNNC2,9606.0,Homo sapiens (human),Modulator,,,,,,,
5362,2014466,23729580,BindingDB,cyclo[Arg-Hcy(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly],21750,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31S,34S,40S,43S,49S)-25-(4-aminobutyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.5.0^{7,11}.0^{13,17}.0^{43,47}]hexapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21750,2203,Suppressor of tumorigenicity 14 protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2203,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,6768.0,ST14,9606.0,Homo sapiens (human),,Ki (nM),380,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
5363,2014662,23730136,Therapeutic Target Database (TTD),Hydrogen {2-[decyl(methyl)sulfaniumyl]-1-phosphonoethyl}phosphonate,D0R0UV,PMID17963374C31,https://idrblab.net/ttd/data/drug/details/D0R0UV,T86528,Geranyltranstransferase (FDPS),https://idrblab.net/ttd/data/target/details/T86528,P14324,Farnesyl pyrophosphate synthase,2224.0,FDPS,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5364,2014677,23730341,BindingDB,"2-{5-[(1S)-1-(2-amino-2-methylpropanamido)-2-(benzyloxy)ethyl]-1H-1,2,3,4-tetrazol-1-yl}ethyl (3R)-3-acetamidopyrrolidine-1-carboxylate",21949,"2-{5-[(1S)-1-(2-amino-2-methylpropanamido)-2-(benzyloxy)ethyl]-1H-1,2,3,4-tetrazol-1-yl}ethyl (3R)-3-acetamidopyrrolidine-1-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21949,1991,Growth hormone secretagogue receptor type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1991,Q92847,Growth hormone secretagogue receptor type 1,2693.0,GHSR,9606.0,Homo sapiens (human),,,,PMID:17973363|DOI:10.1021/jm7010595,https://www.ncbi.nlm.nih.gov/pubmed/17973363|https://doi.org/10.1021/jm7010595,17973363,10.1021/jm7010595,
5365,2014678,23730342,BindingDB,"2-{5-[(1S)-1-(2-amino-2-methylpropanamido)-2-(benzyloxy)ethyl]-1H-1,2,3,4-tetrazol-1-yl}ethyl N-[2-(3-hydroxyphenyl)ethyl]carbamate",21950,"2-{5-[(1S)-1-(2-amino-2-methylpropanamido)-2-(benzyloxy)ethyl]-1H-1,2,3,4-tetrazol-1-yl}ethyl N-[2-(3-hydroxyphenyl)ethyl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21950,1991,Growth hormone secretagogue receptor type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1991,Q92847,Growth hormone secretagogue receptor type 1,2693.0,GHSR,9606.0,Homo sapiens (human),,,,PMID:17973363|DOI:10.1021/jm7010595,https://www.ncbi.nlm.nih.gov/pubmed/17973363|https://doi.org/10.1021/jm7010595,17973363,10.1021/jm7010595,
5366,2014692,23730589,BindingDB,cyclo[Asp-Gly-Cit-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro],21742,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(4-aminobutyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-[3-(carbamoylamino)propyl]-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21742,8073,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8073,P00735,Prothrombin ,280685.0,F2,9913.0,Bos taurus (cattle),,Ki (nM),826800,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
5367,2014693,23730589,BindingDB,cyclo[Asp-Gly-Cit-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro],21742,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(4-aminobutyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-[3-(carbamoylamino)propyl]-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21742,2203,Suppressor of tumorigenicity 14 protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2203,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,6768.0,ST14,9606.0,Homo sapiens (human),,Ki (nM),22500,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
5368,2014694,23730696,BindingDB,cyclo[Arg-Cys(1)-Thr-hLys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly],21743,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(5-aminopentyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21743,2203,Suppressor of tumorigenicity 14 protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2203,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,6768.0,ST14,9606.0,Homo sapiens (human),,Ki (nM),28000,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
5369,2014695,23730696,BindingDB,cyclo[Arg-Cys(1)-Thr-hLys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly],21743,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(5-aminopentyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21743,8073,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8073,P00735,Prothrombin ,280685.0,F2,9913.0,Bos taurus (cattle),,Ki (nM),45600,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
5370,2014127,24103431,BindingDB,"CB2 Inhibitor, 5",93029,"CB2 Inhibitor, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=93029,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),2364,PMID:23217060|DOI:10.1111/cbdd.12095,https://www.ncbi.nlm.nih.gov/pubmed/23217060|https://doi.org/10.1111/cbdd.12095,23217060,10.1111/cbdd.12095,
5371,2014573,24180124,Drug Gene Interaction database (DGIdb),"3,4,5-trimethoxy-N-(2-(3-(piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)benzamide",,CHEMBL:CHEMBL254156,https://www.dgidb.org/drugs/chembl:CHEMBL254156,,SIRT1,https://www.dgidb.org/genes/hgnc:14929,,,23411.0,SIRT1,9606.0,Homo sapiens (human),,,,,,,,
5372,2013924,24180709,Toxin and Toxin Target Database (T3DB),Metam-sodium hydrate,T3D3877,Metam-sodium hydrate,http://www.t3db.ca/toxins/T3D3877,BE0000704,Tumor necrosis factor,http://www.t3db.ca/biodb/bio_entities/BE0000704,P01375,Tumor necrosis factor,7124.0,TNF,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5373,2013925,24180709,Toxin and Toxin Target Database (T3DB),Metam-sodium hydrate,T3D3877,Metam-sodium hydrate,http://www.t3db.ca/toxins/T3D3877,BE0001114,Vascular cell adhesion protein 1,http://www.t3db.ca/biodb/bio_entities/BE0001114,P19320,Vascular cell adhesion protein 1,7412.0,VCAM1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5374,2013926,24180709,Toxin and Toxin Target Database (T3DB),Metam-sodium hydrate,T3D3877,Metam-sodium hydrate,http://www.t3db.ca/toxins/T3D3877,BE0000886,Bile salt sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000886,Q06520,Sulfotransferase 2A1,6822.0,SULT2A1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5375,2013927,24180709,Toxin and Toxin Target Database (T3DB),Metam-sodium hydrate,T3D3877,Metam-sodium hydrate,http://www.t3db.ca/toxins/T3D3877,BE0003536,Cytochrome P450 2C19,http://www.t3db.ca/biodb/bio_entities/BE0003536,P33261,Cytochrome P450 2C19,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5376,2013928,24180709,Toxin and Toxin Target Database (T3DB),Metam-sodium hydrate,T3D3877,Metam-sodium hydrate,http://www.t3db.ca/toxins/T3D3877,BE0005497,P2Y purinoceptor 1,http://www.t3db.ca/biodb/bio_entities/BE0005497,P47900,P2Y purinoceptor 1,5028.0,P2RY1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5377,2014534,24180719,DrugBank,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide",DB06999,PLX-4720,https://www.drugbank.ca/drugs/DB06999,BE0000634,Serine/threonine-protein kinase B-raf,https://www.drugbank.ca/bio_entities/BE0000634,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5378,2014535,24180719,Drug Gene Interaction database (DGIdb),"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide",,PLX-4720,https://www.dgidb.org/drugs/drugbank:DB06999,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673.0,BRAF,9606.0,Homo sapiens (human),,,,,,,,
5379,2014536,24180719,Therapeutic Target Database (TTD),"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide",D0F5JZ,PLX-4720,https://idrblab.net/ttd/data/drug/details/D0F5JZ,T90648,B-Raf messenger RNA (BRAF mRNA),https://idrblab.net/ttd/data/target/details/T90648,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5380,2014537,24180719,Therapeutic Target Database (TTD),"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide",D0F5JZ,PLX-4720,https://idrblab.net/ttd/data/drug/details/D0F5JZ,T80975,Vascular endothelial growth factor receptor 2 (KDR),https://idrblab.net/ttd/data/target/details/T80975,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5381,2014574,24180719,Drug Gene Interaction database (DGIdb),"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide",,PLX-4720,https://www.dgidb.org/drugs/drugbank:DB06999,,PTEN,https://www.dgidb.org/genes/hgnc:9588,,,5728.0,PTEN,9606.0,Homo sapiens (human),,,,,,,,
5382,2014575,24180719,IUPHAR/BPS Guide to PHARMACOLOGY,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide",5703,PLX-4720,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5703,1943,"B-Raf proto-oncogene, serine/threonine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1943,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),Inhibition,pIC50,6.8,PMID:18287029,https://www.ncbi.nlm.nih.gov/pubmed/18287029,18287029,,
5383,2014576,24180719,IUPHAR/BPS Guide to PHARMACOLOGY,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide",5703,PLX-4720,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5703,1943,"B-Raf proto-oncogene, serine/threonine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1943,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),Inhibition,pKd,6.48,PMID:22037378,https://www.ncbi.nlm.nih.gov/pubmed/22037378,22037378,,
5384,2014538,24180720,DrugBank,"N-{2,4-Difluoro-3-[(5-Pyridin-3-Yl-1h-Pyrrolo[2,3-B]pyridin-3-Yl)carbonyl]phenyl}ethanesulfonamide",DB07000,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",https://www.drugbank.ca/drugs/DB07000,BE0000634,Serine/threonine-protein kinase B-raf,https://www.drugbank.ca/bio_entities/BE0000634,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5385,2012914,24180722,DrugBank,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",DB07525,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",https://www.drugbank.ca/drugs/DB07525,BE0002131,Fibroblast growth factor receptor 1,https://www.drugbank.ca/bio_entities/BE0002131,P11362,Fibroblast growth factor receptor 1,2260.0,FGFR1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5386,2012916,24193367,Toxin and Toxin Target Database (T3DB),,T3D1572,Allylpalladium chloride dimer,http://www.t3db.ca/toxins/T3D1572,BE0000714,Creatine kinase M-type,http://www.t3db.ca/biodb/bio_entities/BE0000714,P06732,Creatine kinase M-type,1158.0,CKM,9606.0,Homo sapiens (human),Palladium inhibits creatine kinase by forming a complex with its essential SH groups. (A241),,,PMID:422942,https://www.ncbi.nlm.nih.gov/pubmed/422942,422942,,
5387,2012917,24193367,Toxin and Toxin Target Database (T3DB),,T3D1572,Allylpalladium chloride dimer,http://www.t3db.ca/toxins/T3D1572,BE0002253,Prolyl 4-hydroxylase subunit alpha-2,http://www.t3db.ca/biodb/bio_entities/BE0002253,O15460,Prolyl 4-hydroxylase subunit alpha-2,8974.0,P4HA2,9606.0,Homo sapiens (human),"Palladium irreversibly inhibits prolyl hydroxylase by replacing fe2+ in the active site, forming a strong complex with the enzyme. (A242)",,,PMID:177068,https://www.ncbi.nlm.nih.gov/pubmed/177068,177068,,
5388,2012918,24193367,Toxin and Toxin Target Database (T3DB),,T3D1572,Allylpalladium chloride dimer,http://www.t3db.ca/toxins/T3D1572,BE0005224,Prolyl 4-hydroxylase subunit alpha-3,http://www.t3db.ca/biodb/bio_entities/BE0005224,Q7Z4N8,Prolyl 4-hydroxylase subunit alpha-3,283208.0,P4HA3,9606.0,Homo sapiens (human),"Palladium irreversibly inhibits prolyl hydroxylase by replacing fe2+ in the active site, forming a strong complex with the enzyme. (A242)",,,PMID:177068,https://www.ncbi.nlm.nih.gov/pubmed/177068,177068,,
5389,2012919,24193367,Toxin and Toxin Target Database (T3DB),,T3D1572,Allylpalladium chloride dimer,http://www.t3db.ca/toxins/T3D1572,BE0002223,Transmembrane prolyl 4-hydroxylase,http://www.t3db.ca/biodb/bio_entities/BE0002223,Q9NXG6,Transmembrane prolyl 4-hydroxylase,54681.0,P4HTM,9606.0,Homo sapiens (human),"Palladium irreversibly inhibits prolyl hydroxylase by replacing fe2+ in the active site, forming a strong complex with the enzyme. (A242)",,,PMID:177068,https://www.ncbi.nlm.nih.gov/pubmed/177068,177068,,
5390,2012920,24193367,Toxin and Toxin Target Database (T3DB),,T3D1572,Allylpalladium chloride dimer,http://www.t3db.ca/toxins/T3D1572,BE0000060,Prolyl 4-hydroxylase subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000060,P13674,Prolyl 4-hydroxylase subunit alpha-1,5033.0,P4HA1,9606.0,Homo sapiens (human),"Palladium irreversibly inhibits prolyl hydroxylase by replacing fe2+ in the active site, forming a strong complex with the enzyme. (A242)",,,PMID:177068,https://www.ncbi.nlm.nih.gov/pubmed/177068,177068,,
5391,2012922,24194596,Toxin and Toxin Target Database (T3DB),,T3D1589,"Dichloro(1,5-cyclooctadiene) palladium(II)",http://www.t3db.ca/toxins/T3D1589,BE0000714,Creatine kinase M-type,http://www.t3db.ca/biodb/bio_entities/BE0000714,P06732,Creatine kinase M-type,1158.0,CKM,9606.0,Homo sapiens (human),Palladium inhibits creatine kinase by forming a complex with its essential SH groups. (A241),,,PMID:422942,https://www.ncbi.nlm.nih.gov/pubmed/422942,422942,,
5392,2012923,24194596,Toxin and Toxin Target Database (T3DB),,T3D1589,"Dichloro(1,5-cyclooctadiene) palladium(II)",http://www.t3db.ca/toxins/T3D1589,BE0005224,Prolyl 4-hydroxylase subunit alpha-3,http://www.t3db.ca/biodb/bio_entities/BE0005224,Q7Z4N8,Prolyl 4-hydroxylase subunit alpha-3,283208.0,P4HA3,9606.0,Homo sapiens (human),"Palladium irreversibly inhibits prolyl hydroxylase by replacing fe2+ in the active site, forming a strong complex with the enzyme. (A242)",,,PMID:177068,https://www.ncbi.nlm.nih.gov/pubmed/177068,177068,,
5393,2013845,24194596,Toxin and Toxin Target Database (T3DB),,T3D1589,"Dichloro(1,5-cyclooctadiene) palladium(II)",http://www.t3db.ca/toxins/T3D1589,BE0002223,Transmembrane prolyl 4-hydroxylase,http://www.t3db.ca/biodb/bio_entities/BE0002223,Q9NXG6,Transmembrane prolyl 4-hydroxylase,54681.0,P4HTM,9606.0,Homo sapiens (human),"Palladium irreversibly inhibits prolyl hydroxylase by replacing fe2+ in the active site, forming a strong complex with the enzyme. (A242)",,,PMID:177068,https://www.ncbi.nlm.nih.gov/pubmed/177068,177068,,
5394,2013847,24194596,Toxin and Toxin Target Database (T3DB),,T3D1589,"Dichloro(1,5-cyclooctadiene) palladium(II)",http://www.t3db.ca/toxins/T3D1589,BE0000060,Prolyl 4-hydroxylase subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000060,P13674,Prolyl 4-hydroxylase subunit alpha-1,5033.0,P4HA1,9606.0,Homo sapiens (human),"Palladium irreversibly inhibits prolyl hydroxylase by replacing fe2+ in the active site, forming a strong complex with the enzyme. (A242)",,,PMID:177068,https://www.ncbi.nlm.nih.gov/pubmed/177068,177068,,
5395,2013848,24194596,Toxin and Toxin Target Database (T3DB),,T3D1589,"Dichloro(1,5-cyclooctadiene) palladium(II)",http://www.t3db.ca/toxins/T3D1589,BE0002253,Prolyl 4-hydroxylase subunit alpha-2,http://www.t3db.ca/biodb/bio_entities/BE0002253,O15460,Prolyl 4-hydroxylase subunit alpha-2,8974.0,P4HA2,9606.0,Homo sapiens (human),"Palladium irreversibly inhibits prolyl hydroxylase by replacing fe2+ in the active site, forming a strong complex with the enzyme. (A242)",,,PMID:177068,https://www.ncbi.nlm.nih.gov/pubmed/177068,177068,,
5396,2013929,24199313,Therapeutic Target Database (TTD),CID 24199313,D0L2UN,Auranofin,https://idrblab.net/ttd/data/drug/details/D0L2UN,T68066,Steroid hormone receptor ERR (ESRR),https://idrblab.net/ttd/data/target/details/T68066,P11474,Steroid hormone receptor ERR1,2101.0,ESRRA,9606.0,Homo sapiens (human),Modulator,,,,,,,
5397,2013930,24199313,Therapeutic Target Database (TTD),CID 24199313,D0L2UN,Auranofin,https://idrblab.net/ttd/data/drug/details/D0L2UN,T68066,Steroid hormone receptor ERR (ESRR),https://idrblab.net/ttd/data/target/details/T68066,O95718,Steroid hormone receptor ERR2,2103.0,ESRRB,9606.0,Homo sapiens (human),Modulator,,,,,,,
5398,2013931,24199313,Therapeutic Target Database (TTD),CID 24199313,D0L2UN,Auranofin,https://idrblab.net/ttd/data/drug/details/D0L2UN,T68066,Steroid hormone receptor ERR (ESRR),https://idrblab.net/ttd/data/target/details/T68066,P62508,Estrogen-related receptor gamma,2104.0,ESRRG,9606.0,Homo sapiens (human),Modulator,,,,,,,
5399,2014542,24344410,Drug Gene Interaction database (DGIdb),1-(4-Morpholinophenylamino)-1-oxopropan-2-yl 1-hydroxy-2-naphthoate,,CHEMBL:CHEMBL554475,https://www.dgidb.org/drugs/chembl:CHEMBL554475,,RAC1,https://www.dgidb.org/genes/hgnc:9801,,,5879.0,RAC1,9606.0,Homo sapiens (human),,,,,,,,
5400,2014577,24604289,BindingDB,MAT-POS-e10a589d-4,496367,MAT-POS-e10a589d-4,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496367,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),2870,,,,,
5401,2014540,24701909,BindingDB,"N,3-dihydroxybenzamide",26110,"N,3-dihydroxybenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26110,2963,Lysine-specific demethylase 4E,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2963,B2RXH2,Lysine-specific demethylase 4E,390245.0,KDM4E,9606.0,Homo sapiens (human),,IC50 (nM),28000,PMID:18942826|DOI:10.1021/jm800936s,https://www.ncbi.nlm.nih.gov/pubmed/18942826|https://doi.org/10.1021/jm800936s,18942826,10.1021/jm800936s,
5402,2014541,24737629,Drug Gene Interaction database (DGIdb),"[1,1'-Biphenyl]-4-methanamine, N-(2,3-dihydro-1H-inden-2-yl)-3,5-difluoro-3'-(1H-1,2,4-triazol-5-yl)-",,GSK-1521498,https://www.dgidb.org/drugs/drugbank:DB12886,,OPRM1,https://www.dgidb.org/genes/hgnc:8156,,,4988.0,OPRM1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5403,2013846,24741806,DrugBank,,DB07452,"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",https://www.drugbank.ca/drugs/DB07452,BE0001405,Queuine tRNA-ribosyltransferase,https://www.drugbank.ca/bio_entities/BE0001405,P28720,Queuine tRNA-ribosyltransferase,79904432.0,,264203.0,Zymomonas mobilis subsp. mobilis ZM4 = ATCC 31821,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5404,2013849,24747025,Drug Gene Interaction database (DGIdb),2-[3-(2-Hydroxy-ethyl)-3H-benzothiazol-2-ylidenemethyl]-1-methyl-pyridinium,,CHEMBL:CHEMBL589711,https://www.dgidb.org/drugs/chembl:CHEMBL589711,,APOBEC3A,https://www.dgidb.org/genes/hgnc:17343,,,200315.0,APOBEC3A,9606.0,Homo sapiens (human),,,,,,,,
5405,2014129,24748047,DrugBank,(1r)-4-(3-Phenoxyphenyl)-1-Phosphonobutane-1-Sulfonic Acid,DB07420,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,https://www.drugbank.ca/drugs/DB07420,BE0003866,Dehydrosqualene synthase,https://www.drugbank.ca/bio_entities/BE0003866,A9JQL9,"4,4'-diapophytoene synthase",,,1280.0,Staphylococcus aureus,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5406,2013853,24748050,DrugBank,4-(2-Aminoethyl)-2-ethylphenol,DB07346,4-(2-aminoethyl)-2-ethylphenol,https://www.drugbank.ca/drugs/DB07346,BE0000988,Beta-secretase 1,https://www.drugbank.ca/bio_entities/BE0000988,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5407,2013850,24748051,DrugBank,4-(2-Aminoethyl)-2-cyclohexylphenol,DB07345,4-(2-aminoethyl)-2-cyclohexylphenol,https://www.drugbank.ca/drugs/DB07345,BE0000988,Beta-secretase 1,https://www.drugbank.ca/bio_entities/BE0000988,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5408,2013851,24748204,Drug Gene Interaction database (DGIdb),MK-5108,,AURORA A KINASE INHIBITOR MK5108,https://www.dgidb.org/drugs/ncit:C90585,,AURKA,https://www.dgidb.org/genes/hgnc:11393,,,6790.0,AURKA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5409,2013852,24748204,Drug Gene Interaction database (DGIdb),MK-5108,,MK-5108,https://www.dgidb.org/drugs/drugbank:DB12556,,AURKA,https://www.dgidb.org/genes/hgnc:11393,,,6790.0,AURKA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5410,2014543,24748573,Drug Gene Interaction database (DGIdb),Silmitasertib,,SILMITASERTIB,https://www.dgidb.org/drugs/ncit:C98054,,CSNK2A1,https://www.dgidb.org/genes/hgnc:2457,,,1457.0,CSNK2A1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5411,2014544,24748573,Chemical Probes Portal,Silmitasertib,CX-4945,CX-4945,https://www.chemicalprobes.org/cx-4945,,CSNK2A1,,P68400,Casein kinase II subunit alpha,1457.0,CSNK2A1,9606.0,Homo sapiens (human),ATP-competitive inhbitor,,"0.38 nM, 1 nM",PMID:21159648,https://www.ncbi.nlm.nih.gov/pubmed/21159648,21159648,,"http://cancerres.aacrjournals.org/content/70/24/10288.long, http://www.nature.com/leu/journal/v28/n1/full/leu2013232a.html, http://cancerres.aacrjournals.org/content/70/24/10288.long, http://www.ncbi.nlm.nih.gov/pubmed/21159648, https://www.ncbi.nlm.nih.gov/pubmed/?term=21755459"
5412,2014545,24750278,BindingDB,"8-((S)-3-amino-piperidin-1-yl)-3-methyl-7-(3-methyl-but-2-enyl)-1-(2-oxo-2-phenyl-ethyl)-3,7-dihydro-purine-2,6-dione",50228397,"8-((S)-3-amino-piperidin-1-yl)-3-methyl-7-(3-methyl-but-2-enyl)-1-(2-oxo-2-phenyl-ethyl)-3,7-dihydro-purine-2,6-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50228397,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),3,PMID:24674599|DOI:10.1111/cbdd.12327,https://www.ncbi.nlm.nih.gov/pubmed/24674599|https://doi.org/10.1111/cbdd.12327,24674599,10.1111/cbdd.12327,
5413,2014128,24752296,IUPHAR/BPS Guide to PHARMACOLOGY,"5'-Chloro-7'-methyl-1'-[[3-(trifluoromethyl)phenyl]methyl]spiro[imidazolidine-5,3'-indole]-2,2',4-trione",7820,AZD1386,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7820,507,TRPV1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=507,Q8NER1,Transient receptor potential cation channel subfamily V member 1,7442.0,TRPV1,9606.0,Homo sapiens (human),Inhibition,pIC50,7.6,,,,,
5414,2013854,24752832,DrugBank,"N-((1R,2S)-2-(5-chloro-1H-indole-2-carboxamido)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide",DB07629,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",https://www.drugbank.ca/drugs/DB07629,BE0000216,Coagulation factor X,https://www.drugbank.ca/bio_entities/BE0000216,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5415,2014122,24752833,DrugBank,"N-((1R,2R)-2-(5-Chloro-1H-indole-2-carboxamido)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-C]pyridine-2-carboxamide",DB07630,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",https://www.drugbank.ca/drugs/DB07630,BE0000216,Coagulation factor X,https://www.drugbank.ca/bio_entities/BE0000216,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5416,2014123,24752838,DrugBank,"(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-YL 1H-pyrrolo[2,3-B]pyridine-3-carboxylate",DB07243,"(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE",https://www.drugbank.ca/drugs/DB07243,BE0003382,Serine/threonine-protein kinase Chk1,https://www.drugbank.ca/bio_entities/BE0003382,O14757,Serine/threonine-protein kinase Chk1,1111.0,CHEK1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5417,2014124,24752875,Therapeutic Target Database (TTD),Pyrimidinone derivative 4,D09VDQ,Pyrimidinone derivative 4,https://idrblab.net/ttd/data/drug/details/D09VDQ,T40332,Neutrophil elastase (NE),https://idrblab.net/ttd/data/target/details/T40332,P08246,Neutrophil elastase,1991.0,ELANE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5418,2014142,24755478,Comparative Toxicogenomics Database (CTD),(2s)-2-[[(2s)-2-Acetamido-5-[[n-(Methylcarbamoyl)carbamimidoyl]amino]pentanoyl]-Methyl-Amino]-3-Phenyl-Propanoic Acid,D004151,Dipeptides,https://ctdbase.org/detail.go?type=chem&acc=D004151,6565,SLC15A2,https://ctdbase.org/detail.go?type=gene&acc=6565,,,6565.0,SLC15A2,10141.0,Cavia porcellus (domestic guinea pig),SLC15A2 protein results in increased transport of dipeptides,,,PMID:16041713,https://www.ncbi.nlm.nih.gov/pubmed/16041713,16041713,,
5419,2014547,24756034,Drug Gene Interaction database (DGIdb),"1-Naphthalenecarboxamide, 6-((6-(hydroxymethyl)-4-pyrimidinyl)oxy)-N-(3-(trifluoromethyl)phenyl)-",,BFH-772,https://www.dgidb.org/drugs/chembl:CHEMBL4080062,,KDR,https://www.dgidb.org/genes/hgnc:6307,,,3791.0,KDR,9606.0,Homo sapiens (human),,,,,,,,
5420,2014125,24756910,Drug Gene Interaction database (DGIdb),Cudc-101,,CUDC-101,https://www.dgidb.org/drugs/drugbank:DB12174,,HDAC11,https://www.dgidb.org/genes/hgnc:19086,,,79885.0,HDAC11,9606.0,Homo sapiens (human),,,,,,,,
5421,2014126,24756910,Drug Gene Interaction database (DGIdb),Cudc-101,,CUDC-101,https://www.dgidb.org/drugs/drugbank:DB12174,,ERBB2,https://www.dgidb.org/genes/hgnc:3430,,,2064.0,ERBB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5422,2014143,24756910,BindingDB,Cudc-101,50307768,7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50307768,7795,"Ferrochelatase, mitochondrial [R115L]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7795,P22830,"Ferrochelatase, mitochondrial",2235.0,FECH,9606.0,Homo sapiens (human),,,,PMID:26863403|DOI:10.1021/acschembio.5b01063,https://www.ncbi.nlm.nih.gov/pubmed/26863403|https://doi.org/10.1021/acschembio.5b01063,26863403,10.1021/acschembio.5b01063,
5423,2014548,24756910,Drug Gene Interaction database (DGIdb),Cudc-101,,CUDC-101,https://www.dgidb.org/drugs/drugbank:DB12174,,HDAC3,https://www.dgidb.org/genes/hgnc:4854,,,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,,,,,
5424,2014549,24756910,Drug Gene Interaction database (DGIdb),Cudc-101,,CUDC-101,https://www.dgidb.org/drugs/drugbank:DB12174,,HDAC4,https://www.dgidb.org/genes/hgnc:14063,,,9759.0,HDAC4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5425,2014550,24756910,Drug Gene Interaction database (DGIdb),Cudc-101,,CUDC-101,https://www.dgidb.org/drugs/drugbank:DB12174,,HDAC2,https://www.dgidb.org/genes/hgnc:4853,,,3066.0,HDAC2,9606.0,Homo sapiens (human),,,,,,,,
5426,2014551,24756910,Drug Gene Interaction database (DGIdb),Cudc-101,,CUDC-101,https://www.dgidb.org/drugs/drugbank:DB12174,,HDAC9,https://www.dgidb.org/genes/hgnc:14065,,,9734.0,HDAC9,9606.0,Homo sapiens (human),,,,,,,,
5427,2014552,24756910,Drug Gene Interaction database (DGIdb),Cudc-101,,CUDC-101,https://www.dgidb.org/drugs/drugbank:DB12174,,EGFR,https://www.dgidb.org/genes/hgnc:3236,,,1956.0,EGFR,9606.0,Homo sapiens (human),,,,,,,,
5428,2014553,24756910,Drug Gene Interaction database (DGIdb),Cudc-101,,CUDC-101,https://www.dgidb.org/drugs/drugbank:DB12174,,HDAC8,https://www.dgidb.org/genes/hgnc:13315,,,55869.0,HDAC8,9606.0,Homo sapiens (human),,,,,,,,
5429,2014554,24756910,Drug Gene Interaction database (DGIdb),Cudc-101,,CUDC-101,https://www.dgidb.org/drugs/drugbank:DB12174,,HDAC6,https://www.dgidb.org/genes/hgnc:14064,,,10013.0,HDAC6,9606.0,Homo sapiens (human),,,,,,,,
5430,2014744,24760659,Therapeutic Target Database (TTD),4-{4-[6-Methyl-4-(4-trifluoromethyl-phenyl)-pyridin-2-yl]-pyrimidin-2-yl}-pyridin-2-ylamine,D06NZY,PMID25435285-Compound-44,https://idrblab.net/ttd/data/drug/details/D06NZY,T62820,Metabotropic glutamate receptor 2 (mGluR2),https://idrblab.net/ttd/data/target/details/T62820,Q14416,Metabotropic glutamate receptor 2,2912.0,GRM2,9606.0,Homo sapiens (human),Antagonist,,,,,,,
5431,2014130,24761402,Drug Gene Interaction database (DGIdb),1-(4-Methoxyphenoxy)-3-[4-(4-methoxyphenyl)piperazin-1-yl]propan-2-ol,,CHEMBL:CHEMBL591864,https://www.dgidb.org/drugs/chembl:CHEMBL591864,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
5432,2014131,24761402,Drug Gene Interaction database (DGIdb),1-(4-Methoxyphenoxy)-3-[4-(4-methoxyphenyl)piperazin-1-yl]propan-2-ol,,CHEMBL:CHEMBL591864,https://www.dgidb.org/drugs/chembl:CHEMBL591864,,KMT2A,https://www.dgidb.org/genes/hgnc:7132,,,4297.0,KMT2A,9606.0,Homo sapiens (human),,,,,,,,
5433,2014132,24761402,Drug Gene Interaction database (DGIdb),1-(4-Methoxyphenoxy)-3-[4-(4-methoxyphenyl)piperazin-1-yl]propan-2-ol,,CHEMBL:CHEMBL591864,https://www.dgidb.org/drugs/chembl:CHEMBL591864,,MEN1,https://www.dgidb.org/genes/hgnc:7010,,,4221.0,MEN1,9606.0,Homo sapiens (human),,,,,,,,
5434,2014555,24761406,Drug Gene Interaction database (DGIdb),"2-[(Z)-(5-methoxy-3-methyl-1,3-benzothiazol-2(3H)-ylidene)methyl]-1-methylpyridinium",,CHEMBL:CHEMBL585240,https://www.dgidb.org/drugs/chembl:CHEMBL585240,,FEN1,https://www.dgidb.org/genes/hgnc:3650,,,2237.0,FEN1,9606.0,Homo sapiens (human),,,,,,,,
5435,2014133,24761551,Drug Gene Interaction database (DGIdb),2-{(E)-2-[4-(diethylamino)phenyl]vinyl}-1-ethyl-7-methoxyquinolinium,,CHEMBL:CHEMBL585502,https://www.dgidb.org/drugs/chembl:CHEMBL585502,,FEN1,https://www.dgidb.org/genes/hgnc:3650,,,2237.0,FEN1,9606.0,Homo sapiens (human),,,,,,,,
5436,2014745,24768190,Therapeutic Target Database (TTD),4-((4-(Hexylcarbamoyl)-2-(naphthalen-1-yl)oxazol-5-yl)methyl)phenyl dihydrogen phosphate,D0EZ6V,Oxazole derivative 1,https://idrblab.net/ttd/data/drug/details/D0EZ6V,T29130,Signal transducer and activator of transcription 3 (STAT3),https://idrblab.net/ttd/data/target/details/T29130,P40763,Signal transducer and activator of transcription 3,6774.0,STAT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5437,2014746,24768190,Therapeutic Target Database (TTD),4-((4-(Hexylcarbamoyl)-2-(naphthalen-1-yl)oxazol-5-yl)methyl)phenyl dihydrogen phosphate,D0EZ6V,Oxazole derivative 1,https://idrblab.net/ttd/data/drug/details/D0EZ6V,T64205,Signal transducer and activator of transcription 1 (STAT1),https://idrblab.net/ttd/data/target/details/T64205,P42224,Signal transducer and activator of transcription 1-alpha/beta,6772.0,STAT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5438,2014635,24768435,BindingDB,N-[6-methoxy-2-(methylsulfanyl)pyrimidin-4-yl]acetamide,21222,"2-mercaptopyrimidine analogue, 5a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21222,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5439,2014636,24768435,BindingDB,N-[6-methoxy-2-(methylsulfanyl)pyrimidin-4-yl]acetamide,21222,"2-mercaptopyrimidine analogue, 5a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21222,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5440,2014652,24768439,BindingDB,N-[6-methoxy-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21226,"2-mercaptopyrimidine analogue, 5e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21226,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),166,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5441,2014653,24768439,BindingDB,N-[6-methoxy-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21226,"2-mercaptopyrimidine analogue, 5e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21226,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5442,2014654,24768440,BindingDB,N-[6-methoxy-2-(propylsulfanyl)pyrimidin-4-yl]propanamide,21227,"2-mercaptopyrimidine analogue, 5f",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21227,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5443,2014655,24768440,BindingDB,N-[6-methoxy-2-(propylsulfanyl)pyrimidin-4-yl]propanamide,21227,"2-mercaptopyrimidine analogue, 5f",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21227,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),276,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5444,2014656,24768441,BindingDB,N-[6-propoxy-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21228,"2-mercaptopyrimidine analogue, 5g",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21228,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),26,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5445,2014657,24768441,BindingDB,N-[6-propoxy-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21228,"2-mercaptopyrimidine analogue, 5g",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21228,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5446,2014658,24768442,BindingDB,N-[6-propoxy-2-(propylsulfanyl)pyrimidin-4-yl]propanamide,21229,"2-mercaptopyrimidine analogue, 5h",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21229,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,Ki (nM),71,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5447,2014659,24768442,BindingDB,N-[6-propoxy-2-(propylsulfanyl)pyrimidin-4-yl]propanamide,21229,"2-mercaptopyrimidine analogue, 5h",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21229,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),38,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5448,2014660,24768443,BindingDB,N-[2-(benzylsulfanyl)-6-propoxypyrimidin-4-yl]acetamide,21230,"2-mercaptopyrimidine analogue, 5i",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21230,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),525,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5449,2014661,24768443,BindingDB,N-[2-(benzylsulfanyl)-6-propoxypyrimidin-4-yl]acetamide,21230,"2-mercaptopyrimidine analogue, 5i",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21230,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5450,2014669,24768444,BindingDB,N-[6-(benzyloxy)-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21231,"2-mercaptopyrimidine analogue, 5j",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21231,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5451,2014670,24768444,BindingDB,N-[6-(benzyloxy)-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21231,"2-mercaptopyrimidine analogue, 5j",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21231,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),7.5,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5452,2014671,24768445,BindingDB,N-{6-[(2-chlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21232,"2-mercaptopyrimidine analogue, 5k",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21232,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),6.3,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5453,2014672,24768445,BindingDB,N-{6-[(2-chlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21232,"2-mercaptopyrimidine analogue, 5k",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21232,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,Ki (nM),4149,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5454,2014673,24768446,BindingDB,N-{6-[(3-chlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21233,"2-mercaptopyrimidine analogue, 5l",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21233,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5455,2014674,24768446,BindingDB,N-{6-[(3-chlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21233,"2-mercaptopyrimidine analogue, 5l",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21233,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),582,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5456,2014675,24768446,BindingDB,N-{6-[(3-chlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21233,"2-mercaptopyrimidine analogue, 5l",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21233,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),7.1,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5457,2014676,24768447,BindingDB,N-{6-[(4-chlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21234,"2-mercaptopyrimidine analogue, 5m",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21234,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),3.5,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5458,2014738,24768447,BindingDB,N-{6-[(4-chlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21234,"2-mercaptopyrimidine analogue, 5m",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21234,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5459,2014739,24768447,BindingDB,N-{6-[(4-chlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21234,"2-mercaptopyrimidine analogue, 5m",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21234,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5460,2014740,24768448,BindingDB,"N-{6-[(2,4-dichlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide",21235,"2-mercaptopyrimidine analogue, 5n",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21235,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5461,2014741,24768448,BindingDB,"N-{6-[(2,4-dichlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide",21235,"2-mercaptopyrimidine analogue, 5n",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21235,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5462,2014742,24768448,BindingDB,"N-{6-[(2,4-dichlorophenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide",21235,"2-mercaptopyrimidine analogue, 5n",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21235,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),30,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5463,2014743,24768449,BindingDB,N-{6-[(4-methoxyphenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21236,"2-mercaptopyrimidine analogue, 5o",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21236,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),1.8,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5464,2014747,24768449,BindingDB,N-{6-[(4-methoxyphenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21236,"2-mercaptopyrimidine analogue, 5o",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21236,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),2443,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5465,2014748,24768449,BindingDB,N-{6-[(4-methoxyphenyl)methoxy]-2-(propylsulfanyl)pyrimidin-4-yl}acetamide,21236,"2-mercaptopyrimidine analogue, 5o",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21236,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5466,2014749,24768450,BindingDB,N-[6-(2-phenylethoxy)-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21237,"2-mercaptopyrimidine analogue, 5p",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21237,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5467,2014750,24768450,BindingDB,N-[6-(2-phenylethoxy)-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21237,"2-mercaptopyrimidine analogue, 5p",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21237,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),2080,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5468,2014751,24768450,BindingDB,N-[6-(2-phenylethoxy)-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21237,"2-mercaptopyrimidine analogue, 5p",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21237,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),1.4,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5469,2014752,24768451,BindingDB,N-[6-(cyclohexylmethoxy)-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21238,"2-mercaptopyrimidine analogue, 5q",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21238,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),22,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5470,2014753,24768451,BindingDB,N-[6-(cyclohexylmethoxy)-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21238,"2-mercaptopyrimidine analogue, 5q",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21238,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5471,2014754,24768451,BindingDB,N-[6-(cyclohexylmethoxy)-2-(propylsulfanyl)pyrimidin-4-yl]acetamide,21238,"2-mercaptopyrimidine analogue, 5q",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21238,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5472,2014755,24768452,BindingDB,N-{6-[(4-chlorophenyl)methoxy]-2-(ethylsulfanyl)pyrimidin-4-yl}acetamide,21239,"2-mercaptopyrimidine analogue, 5r",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21239,2130,Adenosine receptor A2a,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2130,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),,,,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5473,2014756,24768452,BindingDB,N-{6-[(4-chlorophenyl)methoxy]-2-(ethylsulfanyl)pyrimidin-4-yl}acetamide,21239,"2-mercaptopyrimidine analogue, 5r",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21239,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),4480,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5474,2014757,24768452,BindingDB,N-{6-[(4-chlorophenyl)methoxy]-2-(ethylsulfanyl)pyrimidin-4-yl}acetamide,21239,"2-mercaptopyrimidine analogue, 5r",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21239,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),2.0,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5475,2014758,24768453,BindingDB,N-[2-(tert-butylsulfanyl)-6-[(4-chlorophenyl)methoxy]pyrimidin-4-yl]acetamide,21240,"2-mercaptopyrimidine analogue, 5s",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21240,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),8.6,PMID:18269230|DOI:10.1021/jm701159t,https://www.ncbi.nlm.nih.gov/pubmed/18269230|https://doi.org/10.1021/jm701159t,18269230,10.1021/jm701159t,
5476,2014771,24768459,BindingDB,1-(4-chlorophenyl)-N-cyclohexyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,21249,1-(4-chlorophenyl)-N-cyclohexyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21249,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),1750,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5477,2014772,24768459,BindingDB,1-(4-chlorophenyl)-N-cyclohexyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,21249,1-(4-chlorophenyl)-N-cyclohexyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21249,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),280,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5478,2014773,24768460,BindingDB,1-(4-chlorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,21250,1-(4-chlorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21250,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),110,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5479,2014774,24768460,BindingDB,1-(4-chlorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,21250,1-(4-chlorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21250,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),2180,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5480,2014775,24768461,BindingDB,1-(4-chlorophenyl)-N-(cyclohexylmethyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,21251,1-(4-chlorophenyl)-N-(cyclohexylmethyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21251,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),390,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5481,2014776,24768461,BindingDB,1-(4-chlorophenyl)-N-(cyclohexylmethyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,21251,1-(4-chlorophenyl)-N-(cyclohexylmethyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21251,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),110,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5482,2014777,24768462,BindingDB,1-(4-chlorophenyl)-4-cyano-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,21252,1-(4-chlorophenyl)-4-cyano-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21252,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),2820,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5483,2014778,24768462,BindingDB,1-(4-chlorophenyl)-4-cyano-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,21252,1-(4-chlorophenyl)-4-cyano-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21252,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),>3940,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5484,2014779,24768463,BindingDB,1-(4-chlorophenyl)-3-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide,21253,1-(4-chlorophenyl)-3-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21253,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),>3940,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5485,2014780,24768463,BindingDB,1-(4-chlorophenyl)-3-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide,21253,1-(4-chlorophenyl)-3-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21253,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),>2820,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5486,2014781,24768464,BindingDB,"1-(4-chlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-3-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide",21254,"1-(4-chlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-3-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21254,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),2820,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5487,2014782,24768464,BindingDB,"1-(4-chlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-3-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide",21254,"1-(4-chlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-3-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21254,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),>3940,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5488,2014783,24768465,BindingDB,"1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21255,"1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21255,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),1730,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5489,2014784,24768465,BindingDB,"1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21255,"1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21255,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),1850,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5490,2014785,24768466,BindingDB,"1-(2,4-dichlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21256,"1-(2,4-dichlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21256,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),37,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5491,2014786,24768466,BindingDB,"1-(2,4-dichlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21256,"1-(2,4-dichlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21256,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),510,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5492,2014787,24768467,BindingDB,"N-cyclohexyl-1-(2,4-dichlorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21257,"N-cyclohexyl-1-(2,4-dichlorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21257,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),64,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5493,2014788,24768467,BindingDB,"N-cyclohexyl-1-(2,4-dichlorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21257,"N-cyclohexyl-1-(2,4-dichlorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21257,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),56,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5494,2014789,24768468,BindingDB,"1-(2,4-dichlorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",21258,"1-(2,4-dichlorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21258,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),38,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5495,2014790,24768468,BindingDB,"1-(2,4-dichlorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",21258,"1-(2,4-dichlorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21258,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),980,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5496,2014791,24768469,BindingDB,"1-(2,4-dichlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",21259,"1-(2,4-dichlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21259,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),3940,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5497,2014792,24768469,BindingDB,"1-(2,4-dichlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",21259,"1-(2,4-dichlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21259,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),28,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5498,2014805,24768476,BindingDB,"N-cyclohexyl-1-(3,4-dichlorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",21266,"N-cyclohexyl-1-(3,4-dichlorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21266,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),14,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5499,2014806,24768476,BindingDB,"N-cyclohexyl-1-(3,4-dichlorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",21266,"N-cyclohexyl-1-(3,4-dichlorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21266,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),1.3,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5500,2014807,24768477,BindingDB,"1-(2,4-difluorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21267,"1-(2,4-difluorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21267,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),2400,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5501,2014808,24768477,BindingDB,"1-(2,4-difluorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21267,"1-(2,4-difluorophenyl)-4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21267,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),2800,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5502,2014809,24768478,BindingDB,"1-(2,4-difluorophenyl)-4-methyl-N-(morpholin-4-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21268,"1-(2,4-difluorophenyl)-4-methyl-N-(morpholin-4-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21268,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),>2820,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5503,2014810,24768478,BindingDB,"1-(2,4-difluorophenyl)-4-methyl-N-(morpholin-4-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21268,"1-(2,4-difluorophenyl)-4-methyl-N-(morpholin-4-yl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21268,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),>3940,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5504,2014811,24768479,BindingDB,"N-[(3,4-dichlorophenyl)methyl]-1-(2,4-difluorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21269,"N-[(3,4-dichlorophenyl)methyl]-1-(2,4-difluorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21269,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),390,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5505,2014812,24768479,BindingDB,"N-[(3,4-dichlorophenyl)methyl]-1-(2,4-difluorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21269,"N-[(3,4-dichlorophenyl)methyl]-1-(2,4-difluorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21269,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),2800,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5506,2014813,24768480,BindingDB,"N-cyclohexyl-1-(2,4-difluorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21270,"N-cyclohexyl-1-(2,4-difluorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21270,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),1600,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5507,2014814,24768480,BindingDB,"N-cyclohexyl-1-(2,4-difluorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",21270,"N-cyclohexyl-1-(2,4-difluorophenyl)-4-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21270,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),65,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5508,2014815,24768481,BindingDB,"1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",21271,"1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21271,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),3940,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5509,2014816,24768481,BindingDB,"1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",21271,"1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21271,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),1600,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5510,2014817,24768482,BindingDB,"N-[(3,4-dichlorophenyl)methyl]-1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",21272,"N-[(3,4-dichlorophenyl)methyl]-1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21272,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),35,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5511,2014818,24768482,BindingDB,"N-[(3,4-dichlorophenyl)methyl]-1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",21272,"N-[(3,4-dichlorophenyl)methyl]-1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21272,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),3940,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5512,2014819,24768483,BindingDB,"N-cyclohexyl-1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",21273,"N-cyclohexyl-1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21273,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),570,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5513,2014820,24768483,BindingDB,"N-cyclohexyl-1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",21273,"N-cyclohexyl-1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21273,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),35,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5514,2014821,24768484,BindingDB,"4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",21274,"4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21274,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),1800,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5515,2014822,24768484,BindingDB,"4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",21274,"4-methyl-N-(piperidin-1-yl)-5-(1H-pyrrol-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21274,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),>3940,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5516,2014823,24768485,BindingDB,"N-[(3,4-dichlorophenyl)methyl]-4-methyl-5-(1H-pyrrol-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",21275,"N-[(3,4-dichlorophenyl)methyl]-4-methyl-5-(1H-pyrrol-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21275,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),>3940,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5517,2014824,24768485,BindingDB,"N-[(3,4-dichlorophenyl)methyl]-4-methyl-5-(1H-pyrrol-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",21275,"N-[(3,4-dichlorophenyl)methyl]-4-methyl-5-(1H-pyrrol-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21275,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),280,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5518,2014825,24768486,BindingDB,"5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",21276,"5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21276,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),110,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5519,2014826,24768486,BindingDB,"5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",21276,"5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-N-(piperidin-1-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21276,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),3940,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5520,2014827,24768487,BindingDB,"N-cyclohexyl-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",21277,"N-cyclohexyl-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21277,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),390,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5521,2014828,24768487,BindingDB,"N-cyclohexyl-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",21277,"N-cyclohexyl-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1-(2,4,6-trichlorophenyl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21277,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),28,PMID:18293908|DOI:10.1021/jm070566z,https://www.ncbi.nlm.nih.gov/pubmed/18293908|https://doi.org/10.1021/jm070566z,18293908,10.1021/jm070566z,
5522,2014829,24768488,BindingDB,"4,5,6,7-tetrafluoro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21285,"4,5,6,7-tetrafluoro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21285,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),66,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5523,2014830,24768488,BindingDB,"4,5,6,7-tetrafluoro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21285,"4,5,6,7-tetrafluoro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21285,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),5,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5524,2014831,24768489,BindingDB,"5-fluoro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21286,"5-fluoro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21286,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),1.6,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5525,2014832,24768489,BindingDB,"5-fluoro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21286,"5-fluoro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21286,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),1210,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5526,2014833,24768490,BindingDB,"5-chloro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21287,"5-chloro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21287,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),512,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5527,2014834,24768490,BindingDB,"5-chloro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21287,"5-chloro-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21287,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),3.0,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5528,2014835,24768491,BindingDB,"5-bromo-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21288,"5-bromo-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21288,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),6.6,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5529,2014836,24768491,BindingDB,"5-bromo-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21288,"5-bromo-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21288,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),1930,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5530,2014837,24768492,BindingDB,"6-bromo-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21290,"6-bromo-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21290,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),13,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5531,2014838,24768492,BindingDB,"6-bromo-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21290,"6-bromo-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21290,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),0.65,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5532,2014839,24768493,BindingDB,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-6-(trifluoromethyl)-1H-indole",21292,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-6-(trifluoromethyl)-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21292,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),3.5,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5533,2014840,24768493,BindingDB,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-6-(trifluoromethyl)-1H-indole",21292,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-6-(trifluoromethyl)-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21292,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),70,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5534,2014841,24768494,BindingDB,"6-methanesulfonyl-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21293,"6-methanesulfonyl-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21293,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),1270,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5535,2014842,24768494,BindingDB,"6-methanesulfonyl-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21293,"6-methanesulfonyl-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21293,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),3.0,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5536,2014843,24768495,BindingDB,"5-(benzyloxy)-6-methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21306,"5-(benzyloxy)-6-methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21306,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),1.8,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5537,2014844,24768495,BindingDB,"5-(benzyloxy)-6-methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21306,"5-(benzyloxy)-6-methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21306,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),2804,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5538,2014845,24768496,BindingDB,"6-methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-ol",21307,"6-methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21307,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),783,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5539,2014846,24768496,BindingDB,"6-methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-ol",21307,"6-methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21307,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),0.7,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5540,2014847,24768497,BindingDB,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-5,6-diol",21308,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-5,6-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21308,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),21,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5541,2014848,24768497,BindingDB,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-5,6-diol",21308,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-5,6-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21308,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),395,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5542,2014849,24768498,BindingDB,"5-(oxan-4-ylmethyl)-7-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-2H,5H-[1,3]dioxolo[4,5-f]indole",21309,"5-(oxan-4-ylmethyl)-7-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-2H,5H-[1,3]dioxolo[4,5-f]indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21309,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),28,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5543,2014850,24768498,BindingDB,"5-(oxan-4-ylmethyl)-7-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-2H,5H-[1,3]dioxolo[4,5-f]indole",21309,"5-(oxan-4-ylmethyl)-7-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-2H,5H-[1,3]dioxolo[4,5-f]indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21309,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),1.0,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5544,2014851,24768499,BindingDB,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-amine",21310,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21310,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),9.3,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5545,2014852,24768499,BindingDB,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-amine",21310,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21310,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),>1000,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5546,2014853,24768500,BindingDB,"1-[2-(morpholin-4-yl)ethyl]-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-ol",21312,"1-[2-(morpholin-4-yl)ethyl]-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21312,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),>10000,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5547,2014854,24768500,BindingDB,"1-[2-(morpholin-4-yl)ethyl]-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-ol",21312,"1-[2-(morpholin-4-yl)ethyl]-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21312,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),92,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5548,2014855,24768501,BindingDB,"4-(2-{5-methoxy-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-1-yl}ethyl)morpholine",21314,"4-(2-{5-methoxy-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-1-yl}ethyl)morpholine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21314,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),237,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5549,2014856,24768501,BindingDB,"4-(2-{5-methoxy-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-1-yl}ethyl)morpholine",21314,"4-(2-{5-methoxy-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-1-yl}ethyl)morpholine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21314,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),>3500,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5550,2014857,24768502,BindingDB,"4-{2-[5-(benzyloxy)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-1-yl]ethyl}morpholine",21316,"4-{2-[5-(benzyloxy)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-1-yl]ethyl}morpholine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21316,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),>10000,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5551,2014858,24768502,BindingDB,"4-{2-[5-(benzyloxy)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-1-yl]ethyl}morpholine",21316,"4-{2-[5-(benzyloxy)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-1-yl]ethyl}morpholine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21316,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),>1000,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5552,2014859,24768503,BindingDB,"N-{1-[2-(morpholin-4-yl)ethyl]-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-4-yl}acetamide",21321,"Morpholino-ethyl analogue, 42",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21321,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),>1000,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5553,2014860,24768503,BindingDB,"N-{1-[2-(morpholin-4-yl)ethyl]-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-4-yl}acetamide",21321,"Morpholino-ethyl analogue, 42",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21321,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),>2200,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5554,2014861,24768504,BindingDB,"N-{1-[2-(morpholin-4-yl)ethyl]-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-4-yl}methanesulfonamide",21322,"Morpholino-ethyl analogue, 43",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21322,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),4077,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5555,2014862,24768504,BindingDB,"N-{1-[2-(morpholin-4-yl)ethyl]-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-4-yl}methanesulfonamide",21322,"Morpholino-ethyl analogue, 43",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21322,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),>1000,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5556,2014863,24768505,BindingDB,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-5-carbonitrile",21325,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-5-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21325,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),30,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5557,2014864,24768505,BindingDB,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-5-carbonitrile",21325,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-5-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21325,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),3326,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5558,2014865,24768506,BindingDB,"[1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-yl]methanamine",21326,"Tetrahydropyranyl-methyl analogue, 47",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21326,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),>10000,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5559,2014866,24768506,BindingDB,"[1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-yl]methanamine",21326,"Tetrahydropyranyl-methyl analogue, 47",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21326,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),>1000,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5560,2014867,24768507,BindingDB,"[1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-yl]methanol",21327,"Tetrahydropyranyl-methyl analogue, 48",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21327,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),113,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5561,2014868,24768507,BindingDB,"[1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-yl]methanol",21327,"Tetrahydropyranyl-methyl analogue, 48",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21327,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),>10000,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5562,2014869,24768508,BindingDB,"5-(methoxymethyl)-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21328,"5-(methoxymethyl)-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21328,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),1702,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5563,2014870,24768508,BindingDB,"5-(methoxymethyl)-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21328,"5-(methoxymethyl)-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21328,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),26,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5564,2014871,24768509,BindingDB,"1-(oxan-4-ylmethyl)-5-phenyl-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21330,"1-(oxan-4-ylmethyl)-5-phenyl-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21330,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),58,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5565,2014872,24768509,BindingDB,"1-(oxan-4-ylmethyl)-5-phenyl-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",21330,"1-(oxan-4-ylmethyl)-5-phenyl-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21330,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),1875,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5566,2014873,24768510,BindingDB,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-6-carbonitrile",21331,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-6-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21331,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),31,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5567,2014874,24768510,BindingDB,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-6-carbonitrile",21331,"1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-6-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21331,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),5.0,PMID:18311894|DOI:10.1021/jm7011613,https://www.ncbi.nlm.nih.gov/pubmed/18311894|https://doi.org/10.1021/jm7011613,18311894,10.1021/jm7011613,
5568,2014567,24770445,Drug Gene Interaction database (DGIdb),"Alanine, N,N'-((5-(2-amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl)-2-furanyl)phosphinylidene)bis(2-methyl-, diethyl ester",,MB-07803,https://www.dgidb.org/drugs/chembl:CHEMBL4297400,,FBP2,https://www.dgidb.org/genes/hgnc:3607,,,8789.0,FBP2,9606.0,Homo sapiens (human),,,,,,,,
5569,2014568,24770445,Drug Gene Interaction database (DGIdb),"Alanine, N,N'-((5-(2-amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl)-2-furanyl)phosphinylidene)bis(2-methyl-, diethyl ester",,MB-07803,https://www.dgidb.org/drugs/chembl:CHEMBL4297400,,FBP1,https://www.dgidb.org/genes/hgnc:3606,,,2203.0,FBP1,9606.0,Homo sapiens (human),,,,,,,,
5570,2014188,24785956,Drug Gene Interaction database (DGIdb),Elagolix Sodium,,ELAGOLIX SODIUM,https://www.dgidb.org/drugs/rxcui:2049847,,GNRHR,https://www.dgidb.org/genes/hgnc:4421,,,2798.0,GNRHR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5571,2014189,24788740,ChEMBL,Ipatasertib,CHEMBL2177390,IPATASERTIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2177390/,CHEMBL2111353,Serine/threonine-protein kinase AKT,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111353/,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),Serine/threonine-protein kinase AKT inhibitor,,,PMID:23287563|PMID:22934575,https://www.ncbi.nlm.nih.gov/pubmed/23287563|https://www.ncbi.nlm.nih.gov/pubmed/22934575,23287563|22934575,,
5572,2014190,24788740,ChEMBL,Ipatasertib,CHEMBL2177390,IPATASERTIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2177390/,CHEMBL2111353,Serine/threonine-protein kinase AKT,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111353/,P31751,RAC-beta serine/threonine-protein kinase,208.0,AKT2,9606.0,Homo sapiens (human),Serine/threonine-protein kinase AKT inhibitor,,,PMID:23287563|PMID:22934575,https://www.ncbi.nlm.nih.gov/pubmed/23287563|https://www.ncbi.nlm.nih.gov/pubmed/22934575,23287563|22934575,,
5573,2014191,24788740,ChEMBL,Ipatasertib,CHEMBL2177390,IPATASERTIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2177390/,CHEMBL2111353,Serine/threonine-protein kinase AKT,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111353/,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606.0,Homo sapiens (human),Serine/threonine-protein kinase AKT inhibitor,,,PMID:23287563|PMID:22934575,https://www.ncbi.nlm.nih.gov/pubmed/23287563|https://www.ncbi.nlm.nih.gov/pubmed/22934575,23287563|22934575,,
5574,2014192,24794392,Therapeutic Target Database (TTD),"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",D0K4ZP,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",https://idrblab.net/ttd/data/drug/details/D0K4ZP,T03500,Matrix metalloproteinase-12 (MMP-12),https://idrblab.net/ttd/data/target/details/T03500,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5575,2013451,24812758,IUPHAR/BPS Guide to PHARMACOLOGY,Canagliflozin,4582,canagliflozin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4582,915,Sodium/glucose cotransporter 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=915,P13866,Sodium/glucose cotransporter 1,6523.0,SLC5A1,9606.0,Homo sapiens (human),Inhibition,pIC50,6.2,PMID:22355316,https://www.ncbi.nlm.nih.gov/pubmed/22355316,22355316,,
5576,2013452,24812758,IUPHAR/BPS Guide to PHARMACOLOGY,Canagliflozin,4582,canagliflozin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4582,916,Sodium/glucose cotransporter 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=916,P31639,Sodium/glucose cotransporter 2,6524.0,SLC5A2,9606.0,Homo sapiens (human),Inhibition,pIC50,8.4,PMID:22355316,https://www.ncbi.nlm.nih.gov/pubmed/22355316,22355316,,
5577,2013445,24819222,Drug Gene Interaction database (DGIdb),N-[3-(1H-indol-2-yl)phenyl]-1-[(1-isopropylpyrazol-4-yl)methyl]nipecotamide,,CHEMBL:CHEMBL536008,https://www.dgidb.org/drugs/chembl:CHEMBL536008,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606.0,Homo sapiens (human),,,,,,,,
5578,2013443,24821094,Drug Gene Interaction database (DGIdb),Ibrutinib,,IBRUTINIB,https://www.dgidb.org/drugs/rxcui:1442981,,MYD88,https://www.dgidb.org/genes/hgnc:7562,,,4615.0,MYD88,9606.0,Homo sapiens (human),,,,,,,,
5579,2013444,24823649,Drug Gene Interaction database (DGIdb),GS-9256,,GS-9256,https://www.dgidb.org/drugs/drugbank:DB12876,,ABCB11,https://www.dgidb.org/genes/hgnc:42,,,8647.0,ABCB11,9606.0,Homo sapiens (human),,,,,,,,
5580,2013446,24831714,IUPHAR/BPS Guide to PHARMACOLOGY,Sotagliflozin,8312,sotagliflozin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8312,916,Sodium/glucose cotransporter 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=916,P31639,Sodium/glucose cotransporter 2,6524.0,SLC5A2,9606.0,Homo sapiens (human),Inhibition,pIC50,8.74,PMID:22739142,https://www.ncbi.nlm.nih.gov/pubmed/22739142,22739142,,
5581,2013447,24831714,IUPHAR/BPS Guide to PHARMACOLOGY,Sotagliflozin,8312,sotagliflozin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8312,915,Sodium/glucose cotransporter 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=915,P13866,Sodium/glucose cotransporter 1,6523.0,SLC5A1,9606.0,Homo sapiens (human),Inhibition,pIC50,7.44,PMID:22739142,https://www.ncbi.nlm.nih.gov/pubmed/22739142,22739142,,
5582,2013448,24832019,DrugBank,"2-[4-(Dimethylamino)phenyl]-6-Hydroxy-3-Methyl-1,3-Benzothiazol-3-Ium",DB08615,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",https://www.drugbank.ca/drugs/DB08615,BE0000426,Acetylcholinesterase,https://www.drugbank.ca/bio_entities/BE0000426,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5583,2013449,24832027,DrugBank,"Octane-1,3,5,7-Tetracarboxylic Acid",DB08368,"OCTANE-1,3,5,7-TETRACARBOXYLIC ACID",https://www.drugbank.ca/drugs/DB08368,BE0003753,Carboxypeptidase A1,https://www.drugbank.ca/bio_entities/BE0003753,P15085,Carboxypeptidase A1,1357.0,CPA1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5584,2013450,24836810,DrugBank,"2,2,2-Trifluoro-1-{5-[(3-Phenyl-5,6-Dihydroimidazo[1,2-A]pyrazin-7(8h)-Yl)carbonyl]thiophen-2-Yl}ethane-1,1-Diol",DB08613,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",https://www.drugbank.ca/drugs/DB08613,BE0003523,Histone deacetylase 4,https://www.drugbank.ca/bio_entities/BE0003523,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5585,2013453,24856357,DrugBank,4-Amino-N-[(2-Sulfanylethyl)carbamoyl]benzenesulfonamide,DB08484,4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE,https://www.drugbank.ca/drugs/DB08484,BE0002431,"Fructose-1,6-bisphosphatase 1",https://www.drugbank.ca/bio_entities/BE0002431,P09467,"Fructose-1,6-bisphosphatase 1",2203.0,FBP1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5586,2013932,24856436,Drug Gene Interaction database (DGIdb),Adavosertib,,ADAVOSERTIB,https://www.dgidb.org/drugs/ncit:C91725,,TBK1,https://www.dgidb.org/genes/hgnc:11584,,,29110.0,TBK1,9606.0,Homo sapiens (human),,,,,,,,
5587,2013933,24856436,Drug Gene Interaction database (DGIdb),Adavosertib,,ADAVOSERTIB,https://www.dgidb.org/drugs/ncit:C91725,,CLK4,https://www.dgidb.org/genes/hgnc:13659,,,57396.0,CLK4,9606.0,Homo sapiens (human),,,,,,,,
5588,2013944,24864553,ChEMBL,"Methyl 4-((3-(6,7-dimethoxy-2-(methylamino)quinazolin-4-yl)phenyl)carbamoyl)benzoate",CHEMBL3989967,LOTAMILAST,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989967/,CHEMBL2093863,Phosphodiesterase 4,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093863/,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),Phosphodiesterase 4 inhibitor,,,PMID:29068253,https://www.ncbi.nlm.nih.gov/pubmed/29068253,29068253,,
5589,2013945,24864553,ChEMBL,"Methyl 4-((3-(6,7-dimethoxy-2-(methylamino)quinazolin-4-yl)phenyl)carbamoyl)benzoate",CHEMBL3989967,LOTAMILAST,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989967/,CHEMBL2093863,Phosphodiesterase 4,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093863/,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",5144.0,PDE4D,9606.0,Homo sapiens (human),Phosphodiesterase 4 inhibitor,,,PMID:29068253,https://www.ncbi.nlm.nih.gov/pubmed/29068253,29068253,,
5590,2013946,24864553,ChEMBL,"Methyl 4-((3-(6,7-dimethoxy-2-(methylamino)quinazolin-4-yl)phenyl)carbamoyl)benzoate",CHEMBL3989967,LOTAMILAST,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989967/,CHEMBL2093863,Phosphodiesterase 4,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093863/,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",5142.0,PDE4B,9606.0,Homo sapiens (human),Phosphodiesterase 4 inhibitor,,,PMID:29068253,https://www.ncbi.nlm.nih.gov/pubmed/29068253,29068253,,
5591,2013947,24865390,DrugBank,"1-Tert-Butyl-3-(3-Methylbenzyl)-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine",DB08699,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",https://www.drugbank.ca/drugs/DB08699,BE0004384,Calcium/calmodulin-dependent protein kinase type II subunit gamma,https://www.drugbank.ca/bio_entities/BE0004384,Q13555,Calcium/calmodulin-dependent protein kinase type II subunit gamma,818.0,CAMK2G,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
5592,2013948,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10090.0,Mus musculus (house mouse),SCH772984 inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein],,,PMID:31706003,https://www.ncbi.nlm.nih.gov/pubmed/31706003,31706003,,
5593,2013949,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,133,ADM,https://ctdbase.org/detail.go?type=gene&acc=133,,,133.0,ADM,10116.0,Rattus norvegicus (Norway rat),SCH772984 inhibits the reaction [diphenylarsinic acid results in increased secretion of ADM protein]|sch772984 results in decreased secretion of ADM protein,,,PMID:28087833,https://www.ncbi.nlm.nih.gov/pubmed/28087833,28087833,,
5594,2013950,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116.0,Rattus norvegicus (Norway rat),SCH772984 inhibits the reaction [APP protein modified form results in increased expression of GRK2 protein],,,PMID:30399361,https://www.ncbi.nlm.nih.gov/pubmed/30399361,30399361,,
5595,2013951,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),SCH772984 inhibits the reaction [pachastrissamine analog inhibits the reaction [BCL2 protein binds to BECN1 protein]],,,PMID:35123989,https://www.ncbi.nlm.nih.gov/pubmed/35123989,35123989,,
5596,2013952,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),SCH772984 inhibits the reaction [pachastrissamine analog inhibits the reaction [BCL2L1 protein binds to BECN1 protein]],,,PMID:35123989,https://www.ncbi.nlm.nih.gov/pubmed/35123989,35123989,,
5597,2013953,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,9606.0,Homo sapiens (human),SCH772984 inhibits the reaction [pachastrissamine analog inhibits the reaction [BCL2L1 protein binds to BECN1 protein]]|sch772984 inhibits the reaction [pachastrissamine analog inhibits the reaction [BCL2 protein binds to BECN1 protein]],,,PMID:35123989,https://www.ncbi.nlm.nih.gov/pubmed/35123989,35123989,,
5598,2013954,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),SCH772984 inhibits the reaction [diphenylarsinic acid results in increased secretion of CCL2 protein],,,PMID:28087833,https://www.ncbi.nlm.nih.gov/pubmed/28087833,28087833,,
5599,2013974,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),SCH772984 inhibits the reaction [pachastrissamine analog results in increased phosphorylation of MAPK1 protein],,,PMID:35123989,https://www.ncbi.nlm.nih.gov/pubmed/35123989,35123989,,
5600,2013975,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),SCH772984 inhibits the reaction [saikosaponin D results in increased phosphorylation of and results in increased activity of MAPK1 protein],,,PMID:32822868,https://www.ncbi.nlm.nih.gov/pubmed/32822868,32822868,,
5601,2013976,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),SCH772984 results in increased phosphorylation of MAPK1 protein|sch772984 results in decreased expression of MAPK1 protein|sch772984 results in decreased activity of MAPK1 protein|sch772984 inhibits the reaction [diphenylarsinic acid results in increased phosphorylation of MAPK1 protein],,,PMID:28087833,https://www.ncbi.nlm.nih.gov/pubmed/28087833,28087833,,
5602,2013977,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),"SCH772984 results in decreased phosphorylation of MAPK3 protein|sch772984 inhibits the reaction [3,4,5-tri-O-(E)-caffeoylquinic acid analog results in increased phosphorylation of MAPK3 protein]",,,PMID:32156566,https://www.ncbi.nlm.nih.gov/pubmed/32156566,32156566,,
5603,2013978,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),SCH772984 inhibits the reaction [GPR4 protein affects the phosphorylation of MAPK3 protein],,,PMID:33161135,https://www.ncbi.nlm.nih.gov/pubmed/33161135,33161135,,
5604,2014504,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10116.0,Rattus norvegicus (Norway rat),SCH772984 inhibits the reaction [diphenylarsinic acid results in increased phosphorylation of MAPK8 protein]|sch772984 results in decreased expression of MAPK8 protein,,,PMID:28087833,https://www.ncbi.nlm.nih.gov/pubmed/28087833,28087833,,
5605,2014505,24866313,Comparative Toxicogenomics Database (CTD),(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide,C587178,SCH772984,https://ctdbase.org/detail.go?type=chem&acc=C587178,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),SCH772984 inhibits the reaction [diphenylarsinic acid results in increased expression of NFE2L2 protein],,,PMID:28087833,https://www.ncbi.nlm.nih.gov/pubmed/28087833,28087833,,
5606,2056940,24901523,BindingDB,"2-(7,8-Dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-amine",24110,"2-(7,8-dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24110,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,IC50 (nM),2270,PMID:16458511|DOI:10.1016/j.bmcl.2006.01.056,https://www.ncbi.nlm.nih.gov/pubmed/16458511|https://doi.org/10.1016/j.bmcl.2006.01.056,16458511,10.1016/j.bmcl.2006.01.056,
5607,2056941,24901524,BindingDB,"3-(7,8-Dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-2-yl)propan-1-amine",24111,"3-(7,8-dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-2-yl)propan-1-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24111,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,IC50 (nM),3060,PMID:16458511|DOI:10.1016/j.bmcl.2006.01.056,https://www.ncbi.nlm.nih.gov/pubmed/16458511|https://doi.org/10.1016/j.bmcl.2006.01.056,16458511,10.1016/j.bmcl.2006.01.056,
5608,2056942,24901525,BindingDB,"4-(7,8-Dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-2-yl)butan-1-amine",24112,"4-(7,8-dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-2-yl)butan-1-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24112,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,IC50 (nM),4650,PMID:16458511|DOI:10.1016/j.bmcl.2006.01.056,https://www.ncbi.nlm.nih.gov/pubmed/16458511|https://doi.org/10.1016/j.bmcl.2006.01.056,16458511,10.1016/j.bmcl.2006.01.056,
5609,2056943,24901526,BindingDB,"7,8-dimethyl-4-phenyl-2-[2-(1H-pyrrol-1-yl)ethyl]-1,2,3,4-tetrahydroisoquinoline",24113,"7,8-dimethyl-4-phenyl-2-[2-(1H-pyrrol-1-yl)ethyl]-1,2,3,4-tetrahydroisoquinoline",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24113,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,IC50 (nM),>25000,PMID:16458511|DOI:10.1016/j.bmcl.2006.01.056,https://www.ncbi.nlm.nih.gov/pubmed/16458511|https://doi.org/10.1016/j.bmcl.2006.01.056,16458511,10.1016/j.bmcl.2006.01.056,
5610,2056944,24901527,BindingDB,"[3-(7,8-Dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]dimethylamine",24114,"[3-(7,8-dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]dimethylamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24114,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,IC50 (nM),8880,PMID:16458511|DOI:10.1016/j.bmcl.2006.01.056,https://www.ncbi.nlm.nih.gov/pubmed/16458511|https://doi.org/10.1016/j.bmcl.2006.01.056,16458511,10.1016/j.bmcl.2006.01.056,
5611,2030410,24971396,BindingDB,"3-{[1-(4-Chlorophenyl)ethyl]sulfanyl}-5-[(methylcarbamoyl)amino]-1,2-thiazole-4-carboxamide",24899,"3-{[1-(4-chlorophenyl)ethyl]sulfanyl}-5-[(methylcarbamoyl)amino]-1,2-thiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24899,3688,High affinity nerve growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3688,P04629,High affinity nerve growth factor receptor,4914.0,NTRK1,9606.0,Homo sapiens (human),,IC50 (nM),3,PMID:16632359|DOI:10.1016/j.bmcl.2006.04.003,https://www.ncbi.nlm.nih.gov/pubmed/16632359|https://doi.org/10.1016/j.bmcl.2006.04.003,16632359,10.1016/j.bmcl.2006.04.003,
5612,2030411,24971397,BindingDB,"3-{[1-(4-Chlorophenyl)propyl]sulfanyl}-5-[(methylcarbamoyl)amino]-1,2-thiazole-4-carboxamide",24900,"3-{[1-(4-chlorophenyl)propyl]sulfanyl}-5-[(methylcarbamoyl)amino]-1,2-thiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24900,3688,High affinity nerve growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3688,P04629,High affinity nerve growth factor receptor,4914.0,NTRK1,9606.0,Homo sapiens (human),,IC50 (nM),9,PMID:16632359|DOI:10.1016/j.bmcl.2006.04.003,https://www.ncbi.nlm.nih.gov/pubmed/16632359|https://doi.org/10.1016/j.bmcl.2006.04.003,16632359,10.1016/j.bmcl.2006.04.003,
5613,2030412,24971398,BindingDB,"3-{[(1R)-1-(4-chlorophenyl)propyl]sulfanyl}-5-[(methylcarbamoyl)amino]-1,2-thiazole-4-carboxamide",24901,"3-{[(1R)-1-(4-chlorophenyl)propyl]sulfanyl}-5-[(methylcarbamoyl)amino]-1,2-thiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24901,3688,High affinity nerve growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3688,P04629,High affinity nerve growth factor receptor,4914.0,NTRK1,9606.0,Homo sapiens (human),,IC50 (nM),4,PMID:16632359|DOI:10.1016/j.bmcl.2006.04.003,https://www.ncbi.nlm.nih.gov/pubmed/16632359|https://doi.org/10.1016/j.bmcl.2006.04.003,16632359,10.1016/j.bmcl.2006.04.003,
5614,2013771,25020250,IUPHAR/BPS Guide to PHARMACOLOGY,"N-cyclohexyl-4-(1-(piperazin-1-yl)-2,6-naphthyridin-3-yl)pyridin-2-amine",9681,compound 13c [PMID: 20684591],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9681,1489,protein kinase D1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1489,Q15139,Serine/threonine-protein kinase D1,5587.0,PRKD1,9606.0,Homo sapiens (human),Inhibition,pIC50,9.22,PMID:20684591,https://www.ncbi.nlm.nih.gov/pubmed/20684591,20684591,,
5615,2013331,25025654,Therapeutic Target Database (TTD),2-[4-[2-[5-(cyclopentylmethyl)-1H-imidazol-2-yl]ethyl]phenyl]benzoic acid,D0A0DS,[3H]bag-2,https://idrblab.net/ttd/data/drug/details/D0A0DS,T68887,Bombesin receptor (BS),https://idrblab.net/ttd/data/target/details/T68887,P30550,Gastrin-releasing peptide receptor,2925.0,GRPR,9606.0,Homo sapiens (human),Agonist,,,,,,,
5616,2013332,25052630,ChEMBL,Zamicastat,CHEMBL4594440,ZAMICASTAT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594440/,CHEMBL3102,Dopamine beta-hydroxylase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3102/,P09172,Dopamine beta-hydroxylase,1621.0,DBH,9606.0,Homo sapiens (human),Dopamine beta-hydroxylase inhibitor,,,PMID:32259069,https://www.ncbi.nlm.nih.gov/pubmed/32259069,32259069,,
5617,2013335,25053598,IUPHAR/BPS Guide to PHARMACOLOGY,RasGRP activator 1,10066,RasGRP activator 1,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10066,1482,protein kinase C alpha,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1482,P17252,Protein kinase C alpha type,5578.0,PRKCA,9606.0,Homo sapiens (human),Binding,pKi,7.79,PMID:24794745,https://www.ncbi.nlm.nih.gov/pubmed/24794745,24794745,,
5618,2013336,25053598,IUPHAR/BPS Guide to PHARMACOLOGY,RasGRP activator 1,10066,RasGRP activator 1,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10066,1486,protein kinase C epsilon,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1486,Q02156,Protein kinase C epsilon type,5581.0,PRKCE,9606.0,Homo sapiens (human),Binding,pKi,7.68,PMID:24794745,https://www.ncbi.nlm.nih.gov/pubmed/24794745,24794745,,
5619,2013333,25058138,BindingDB,"3-[2-Bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",27618,"3-(2-bromo-4-{1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl}phenoxy)-5-methylbenzonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27618,276,"Gag-Pol polyprotein [588-1027,K691N,Y769C]/[588-1147,K691N,Y769C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=276,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,,,PMID:19007201|DOI:10.1021/jm800527x,https://www.ncbi.nlm.nih.gov/pubmed/19007201|https://doi.org/10.1021/jm800527x,19007201,10.1021/jm800527x,
5620,2013334,25058138,BindingDB,"3-[2-Bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",27618,"3-(2-bromo-4-{1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl}phenoxy)-5-methylbenzonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27618,266,Gag-Pol polyprotein [588-1027],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=266,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,,,PMID:19007201|DOI:10.1021/jm800527x,https://www.ncbi.nlm.nih.gov/pubmed/19007201|https://doi.org/10.1021/jm800527x,19007201,10.1021/jm800527x,
5621,2013772,25060878,IUPHAR/BPS Guide to PHARMACOLOGY,"N-cyclopropyl-3-fluoro-4-methyl-5-[3-(1-methylcyclopropyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]benzamide",8125,compound 12 [PMID: 22521646],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8125,1499,mitogen-activated protein kinase 14,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1499,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),Inhibition,pIC50,9.19,PMID:22521646,https://www.ncbi.nlm.nih.gov/pubmed/22521646,22521646,,
5622,2013773,25060878,Therapeutic Target Database (TTD),"N-cyclopropyl-3-fluoro-4-methyl-5-[3-(1-methylcyclopropyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]benzamide",D09OKU,PMID22521646C12,https://idrblab.net/ttd/data/drug/details/D09OKU,T65864,Stress-activated protein kinase 2a (p38 alpha),https://idrblab.net/ttd/data/target/details/T65864,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5623,2013337,25063260,Drug Gene Interaction database (DGIdb),Ezatiostat hydrochloride,,EZATIOSTAT HYDROCHLORIDE,https://www.dgidb.org/drugs/ncit:C61326,,GSTP1,https://www.dgidb.org/genes/hgnc:4638,,,2950.0,GSTP1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5624,2013338,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMD3,https://www.dgidb.org/genes/hgnc:9560,,,5709.0,PSMD3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5625,2013339,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMD7,https://www.dgidb.org/genes/hgnc:9565,,,5713.0,PSMD7,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5626,2013340,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMD12,https://www.dgidb.org/genes/hgnc:9557,,,5718.0,PSMD12,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5627,2013341,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMD8,https://www.dgidb.org/genes/hgnc:9566,,,5714.0,PSMD8,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5628,2013342,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMA7,https://www.dgidb.org/genes/hgnc:9536,,,5688.0,PSMA7,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5629,2013362,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMA5,https://www.dgidb.org/genes/hgnc:9534,,,5686.0,PSMA5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5630,2013363,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMC2,https://www.dgidb.org/genes/hgnc:9548,,,5701.0,PSMC2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5631,2013364,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMB2,https://www.dgidb.org/genes/hgnc:9539,,,5690.0,PSMB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5632,2013365,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMA4,https://www.dgidb.org/genes/hgnc:9533,,,5685.0,PSMA4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5633,2013366,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMD13,https://www.dgidb.org/genes/hgnc:9558,,,5719.0,PSMD13,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5634,2013367,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMA2,https://www.dgidb.org/genes/hgnc:9531,,,5683.0,PSMA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5635,2013368,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMD2,https://www.dgidb.org/genes/hgnc:9559,,,5708.0,PSMD2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5636,2013369,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMB1,https://www.dgidb.org/genes/hgnc:9537,,,5689.0,PSMB1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5637,2013370,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMA1,https://www.dgidb.org/genes/hgnc:9530,,,5682.0,PSMA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5638,2013371,25074887,Drug Gene Interaction database (DGIdb),Cetrorelix,,CETRORELIX,https://www.dgidb.org/drugs/rxcui:68147,,GNRHR,https://www.dgidb.org/genes/hgnc:4421,,,2798.0,GNRHR,9606.0,Homo sapiens (human),,,,,,,,
5639,2013372,25075991,Therapeutic Target Database (TTD),Dynorphin B,D0H0OO,dynorphin B,https://idrblab.net/ttd/data/drug/details/D0H0OO,T60693,Opioid receptor kappa (OPRK1),https://idrblab.net/ttd/data/target/details/T60693,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),Agonist,,,,,,,
5640,2013373,25075991,Therapeutic Target Database (TTD),Dynorphin B,D0H0OO,dynorphin B,https://idrblab.net/ttd/data/drug/details/D0H0OO,T58992,Opioid receptor delta (OPRD1),https://idrblab.net/ttd/data/target/details/T58992,P41143,Delta-type opioid receptor,4985.0,OPRD1,9606.0,Homo sapiens (human),Agonist,,,,,,,
5641,2013374,25075991,Therapeutic Target Database (TTD),Dynorphin B,D0H0OO,dynorphin B,https://idrblab.net/ttd/data/drug/details/D0H0OO,T47768,Opioid receptor mu (MOP),https://idrblab.net/ttd/data/target/details/T47768,P35372,Mu-type opioid receptor,4988.0,OPRM1,9606.0,Homo sapiens (human),Agonist,,,,,,,
5642,2013375,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,2212,Kappa-type opioid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2212,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5643,2013376,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,2212,Kappa-type opioid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2212,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),8,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5644,2013404,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9072,Kappa-type opioid receptor [Y66A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9072,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),78,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5645,2013405,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9073,Kappa-type opioid receptor [Q115A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9073,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),1.2e+2,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5646,2013406,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9074,Kappa-type opioid receptor [Y119A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9074,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),2.0e+2,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5647,2013407,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9075,Kappa-type opioid receptor [Y119F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9075,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),2e+1,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5648,2013408,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9076,Kappa-type opioid receptor [I135A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9076,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),6.2,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5649,2013409,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9077,Kappa-type opioid receptor [D138A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9077,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),5.2e+3,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5650,2013410,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9078,Kappa-type opioid receptor [D138N],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9078,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),1.6e+3,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5651,2013411,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9079,Kappa-type opioid receptor [Y139A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9079,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),35,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5652,2013768,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9080,Kappa-type opioid receptor [Y139F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9080,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),29,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5653,2013769,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9081,Kappa-type opioid receptor [M142A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9081,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),16,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5654,2013770,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9082,Kappa-type opioid receptor [K200A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9082,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),4.8,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5655,2013774,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9083,Kappa-type opioid receptor [K212A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9083,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),5.4,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5656,2013775,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9084,Kappa-type opioid receptor [M226A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9084,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),7.1,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5657,2013776,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9085,Kappa-type opioid receptor [K227A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9085,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),2.2,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5658,2013777,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9086,Kappa-type opioid receptor [H291A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9086,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),91,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5659,2013792,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9094,Kappa-type opioid receptor [I316A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9094,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),2e+2,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5660,2013793,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9095,Kappa-type opioid receptor [Y320A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9095,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),6.6,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5661,2013794,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9096,Kappa-type opioid receptor [Y320F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9096,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,Ki (nM),18,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5662,2013795,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9072,Kappa-type opioid receptor [Y66A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9072,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5663,2013796,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9073,Kappa-type opioid receptor [Q115A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9073,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5664,2013807,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9085,Kappa-type opioid receptor [K227A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9085,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5665,2013808,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9086,Kappa-type opioid receptor [H291A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9086,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5666,2013809,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9087,Kappa-type opioid receptor [H291F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9087,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5667,2013810,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9088,Kappa-type opioid receptor [I294A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9088,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5668,2013811,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9089,Kappa-type opioid receptor [E297A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9089,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5669,2013812,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9090,Kappa-type opioid receptor [Y312A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9090,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5670,2013813,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9091,Kappa-type opioid receptor [Y312F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9091,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5671,2013814,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9092,Kappa-type opioid receptor [Y313A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9092,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5672,2013815,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9093,Kappa-type opioid receptor [Y313F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9093,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5673,2013816,25075996,BindingDB,Dynorphin A (1-13),214798,Dynorphin A (1-17),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=214798,9094,Kappa-type opioid receptor [I316A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9094,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
5674,2014705,25102761,Drug Gene Interaction database (DGIdb),"5'-Guanidinonaltrindole di(trifluoroacetate) salt hydrate, hydrochloride",,CHEMBL:CHEMBL1255944,https://www.dgidb.org/drugs/chembl:CHEMBL1255944,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
5675,2014706,25102846,Drug Gene Interaction database (DGIdb),Cabozantinib s-malate,,CABOZANTINIB S-MALATE,https://www.dgidb.org/drugs/rxcui:1363267,,ROS1,https://www.dgidb.org/genes/hgnc:10261,,,6098.0,ROS1,9606.0,Homo sapiens (human),,,,,,,,
5676,2014707,25105689,Drug Gene Interaction database (DGIdb),Evenamide,,EVENAMIDE,https://www.dgidb.org/drugs/ncit:C174804,,SCN10A,https://www.dgidb.org/genes/hgnc:10582,,,6336.0,SCN10A,9606.0,Homo sapiens (human),Blocker,,,,,,,
5677,2014708,25105689,Drug Gene Interaction database (DGIdb),Evenamide,,EVENAMIDE,https://www.dgidb.org/drugs/ncit:C174804,,SCN1A,https://www.dgidb.org/genes/hgnc:10585,,,6323.0,SCN1A,9606.0,Homo sapiens (human),Blocker,,,,,,,
5678,2013979,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673.0,BRAF,9606.0,Homo sapiens (human),,,,,,,,
5679,2013592,25178128,Therapeutic Target Database (TTD),"N-(1H-indazol-5-yl)icosa-5,8,11,14-tetraenamide",D0PE8U,"N-(1H-indazol-5-yl)icosa-5,8,11,14-tetraenamide",https://idrblab.net/ttd/data/drug/details/D0PE8U,T76685,Cannabinoid receptor 1 (CB1),https://idrblab.net/ttd/data/target/details/T76685,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5680,2013589,25180300,Therapeutic Target Database (TTD),"6-Pyridin-3-yl-3,4-dihydroquinoline-2(1H)-thione",D0E8DX,"6-Pyridin-3-yl-3,4-dihydroquinoline-2(1H)-thione",https://idrblab.net/ttd/data/drug/details/D0E8DX,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5681,2013590,25180303,Therapeutic Target Database (TTD),"3-(5,6,7,8-Tetrahydronaphthalen-2-yl)pyridine",D0VL3R,"3-(5,6,7,8-Tetrahydronaphthalen-2-yl)pyridine",https://idrblab.net/ttd/data/drug/details/D0VL3R,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5682,2013591,25180306,Therapeutic Target Database (TTD),"3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)pyridine",D0I9PA,"3-(2,3-Dihydro-1,4-benzodioxin-6-yl)pyridine",https://idrblab.net/ttd/data/drug/details/D0I9PA,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5683,2013980,25180489,Therapeutic Target Database (TTD),[Sar1Gly]GAL-B2,D01LMH,[Sar1Gly]GAL-B2,https://idrblab.net/ttd/data/drug/details/D01LMH,T13453,Galanin receptor type 2 (GAL2-R),https://idrblab.net/ttd/data/target/details/T13453,O43603,Galanin receptor type 2,8811.0,GALR2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5684,2013981,25182860,Drug Gene Interaction database (DGIdb),"Urea, N-[6-[[6-(4-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]thio]-2-benzothiazolyl]-N'-[2-(4-morpholinyl)ethyl]-",,-SAR125844.00,https://www.dgidb.org/drugs/drugbank:DB15382,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5685,2013982,25183872,Drug Gene Interaction database (DGIdb),Ixazomib,,IXAZOMIB,https://www.dgidb.org/drugs/rxcui:1723735,,PSMB5,https://www.dgidb.org/genes/hgnc:9542,,,5693.0,PSMB5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5686,2013983,25183872,Drug Gene Interaction database (DGIdb),Ixazomib,,IXAZOMIB,https://www.dgidb.org/drugs/rxcui:1723735,,PSMA6,https://www.dgidb.org/genes/hgnc:9535,,,5687.0,PSMA6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5687,2013984,25183872,Drug Gene Interaction database (DGIdb),Ixazomib,,IXAZOMIB,https://www.dgidb.org/drugs/rxcui:1723735,,PSMD4,https://www.dgidb.org/genes/hgnc:9561,,,5710.0,PSMD4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5688,2014234,25192184,Therapeutic Target Database (TTD),"3-[4-(4-Hydroxyphenyl)-1,3-oxazol-2-yl]phenol",D0IZ4Z,"3-[4-(4-Hydroxyphenyl)-1,3-oxazol-2-yl]phenol",https://idrblab.net/ttd/data/drug/details/D0IZ4Z,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5689,2014228,25195495,IUPHAR/BPS Guide to PHARMACOLOGY,(S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide,4461,SB-649868,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4461,322,OX2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=322,P58308,Orexin receptor type 2,387285.0,Hcrtr2,10090.0,Mus musculus (house mouse),Antagonist,pKB,8.8,PMID:24376396,https://www.ncbi.nlm.nih.gov/pubmed/24376396,24376396,,
5690,2014229,25195624,ChEMBL,Bexagliflozin,CHEMBL1808388,BEXAGLIFLOZIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1808388/,CHEMBL3884,Sodium/glucose cotransporter 2,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3884/,P31639,Sodium/glucose cotransporter 2,6524.0,SLC5A2,9606.0,Homo sapiens (human),Sodium/glucose cotransporter 2 inhibitor,,,,,,,
5691,2014230,25243905,IUPHAR/BPS Guide to PHARMACOLOGY,"P1,P4-Bis(5'-adenosyl) tetraphosphate",1732,Ap4A,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1732,328,P2Y12 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=328,Q9H244,P2Y purinoceptor 12,64805.0,P2RY12,9606.0,Homo sapiens (human),Antagonist,pIC50,6,PMID:12815166,https://www.ncbi.nlm.nih.gov/pubmed/12815166,12815166,,
5692,2014231,25243905,IUPHAR/BPS Guide to PHARMACOLOGY,"P1,P4-Bis(5'-adenosyl) tetraphosphate",1732,Ap4A,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1732,324,P2Y2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=324,P41231,P2Y purinoceptor 2,5029.0,P2RY2,9606.0,Homo sapiens (human),Full agonist,pEC50,6.1,PMID:11711032|PMID:1393282,https://www.ncbi.nlm.nih.gov/pubmed/11711032|https://www.ncbi.nlm.nih.gov/pubmed/1393282,11711032|1393282,,
5693,2014232,25243905,IUPHAR/BPS Guide to PHARMACOLOGY,"P1,P4-Bis(5'-adenosyl) tetraphosphate",1732,Ap4A,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1732,325,P2Y4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=325,O35811,P2Y purinoceptor 4,63843.0,P2ry4,10116.0,Rattus norvegicus (Norway rat),Partial agonist,pEC50,5.9,PMID:10779375,https://www.ncbi.nlm.nih.gov/pubmed/10779375,10779375,,
5694,2014233,25243905,IUPHAR/BPS Guide to PHARMACOLOGY,"P1,P4-Bis(5'-adenosyl) tetraphosphate",1732,Ap4A,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1732,329,P2Y13 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=329,Q9BPV8,P2Y purinoceptor 13,53829.0,P2RY13,9606.0,Homo sapiens (human),Antagonist,pIC50,6.7,PMID:12815166,https://www.ncbi.nlm.nih.gov/pubmed/12815166,12815166,,
5695,2014456,25886893,IUPHAR/BPS Guide to PHARMACOLOGY,Butaprost (free acid form),1892,butaprost (free acid form),https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1892,342,EP3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=342,P34980,Prostaglandin E2 receptor EP3 subtype,24929.0,Ptger3,10116.0,Rattus norvegicus (Norway rat),Full agonist,pKi,4.93,PMID:9537820,https://www.ncbi.nlm.nih.gov/pubmed/9537820,9537820,,
5696,2014457,25886893,IUPHAR/BPS Guide to PHARMACOLOGY,Butaprost (free acid form),1892,butaprost (free acid form),https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1892,342,EP3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=342,P43115,Prostaglandin E2 receptor EP3 subtype,5733.0,PTGER3,9606.0,Homo sapiens (human),Full agonist,pKi,5.78,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
5697,2014458,25886893,IUPHAR/BPS Guide to PHARMACOLOGY,Butaprost (free acid form),1892,butaprost (free acid form),https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1892,346,TP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=346,P21731,Thromboxane A2 receptor ,6915.0,TBXA2R,9606.0,Homo sapiens (human),Full agonist,pKi,4.7,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
5698,2014459,25886893,IUPHAR/BPS Guide to PHARMACOLOGY,Butaprost (free acid form),1892,butaprost (free acid form),https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1892,345,IP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=345,P43119,Prostacyclin receptor,5739.0,PTGIR,9606.0,Homo sapiens (human),Full agonist,pKi,4.3,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
